<SEC-DOCUMENT>0000885725-21-000036.txt : 20210806
<SEC-HEADER>0000885725-21-000036.hdr.sgml : 20210806
<ACCEPTANCE-DATETIME>20210806163602
ACCESSION NUMBER:		0000885725-21-000036
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		67
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210806
DATE AS OF CHANGE:		20210806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		211153419

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bsx-20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:70f263dc-70b5-4726-816e-8c716916294a,g:26cfe26e-80ae-4508-82da-1214ca3ae539,d:82746c1ad92049b181a877873a6cc318--><html xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:bsx="http://www.bostonscientific.com/20210630" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bsx-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80L2ZyYWc6YWQwYTE0YTAyNDFjNDJiYmFhYjFiNGM3YjUxYzJlZjgvdGFibGU6NjE0MWM5NjkyZTRjNDBhN2EwNGJhNWY1ZDBjNjA0MDIvdGFibGVyYW5nZTo2MTQxYzk2OTJlNGM0MGE3YTA0YmE1ZjVkMGM2MDQwMl8zLTEtMS0xLTA_44227cb7-21c4-4d08-a493-65dc1801faf5">0000885725</ix:nonNumeric><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80L2ZyYWc6YWQwYTE0YTAyNDFjNDJiYmFhYjFiNGM3YjUxYzJlZjgvdGFibGU6NjE0MWM5NjkyZTRjNDBhN2EwNGJhNWY1ZDBjNjA0MDIvdGFibGVyYW5nZTo2MTQxYzk2OTJlNGM0MGE3YTA0YmE1ZjVkMGM2MDQwMl80LTEtMS0xLTA_4983dd78-baf9-47ce-9b55-17b4bd7aabe8">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80L2ZyYWc6YWQwYTE0YTAyNDFjNDJiYmFhYjFiNGM3YjUxYzJlZjgvdGFibGU6NjE0MWM5NjkyZTRjNDBhN2EwNGJhNWY1ZDBjNjA0MDIvdGFibGVyYW5nZTo2MTQxYzk2OTJlNGM0MGE3YTA0YmE1ZjVkMGM2MDQwMl81LTEtMS0xLTA_499007ca-ea46-4f0e-873f-f5a1941610f3">2021</ix:nonNumeric><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80L2ZyYWc6YWQwYTE0YTAyNDFjNDJiYmFhYjFiNGM3YjUxYzJlZjgvdGFibGU6NjE0MWM5NjkyZTRjNDBhN2EwNGJhNWY1ZDBjNjA0MDIvdGFibGVyYW5nZTo2MTQxYzk2OTJlNGM0MGE3YTA0YmE1ZjVkMGM2MDQwMl82LTEtMS0xLTA_b763a9e9-ee00-4b73-8bbf-c289bac549d9">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80L2ZyYWc6YWQwYTE0YTAyNDFjNDJiYmFhYjFiNGM3YjUxYzJlZjgvdGFibGU6NjE0MWM5NjkyZTRjNDBhN2EwNGJhNWY1ZDBjNjA0MDIvdGFibGVyYW5nZTo2MTQxYzk2OTJlNGM0MGE3YTA0YmE1ZjVkMGM2MDQwMl83LTEtMS0xLTA_929b2abc-f3de-4017-8523-55ee26bf9c97">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bsx-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f7b6d3b742a4d51865ca65aad09fe72_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64954d944d4b4bccab9f6197e481ec8b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i8d5d572ce7ed4e2b92e847dfb3345843_I20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i1270609d6b744578a62058c51995ce33_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40d4bbc844644023a5878306b022201d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79e7f5e22b45494cb5031e20d21c5988_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ab5a160fd2842d19f763f45b6d09e89_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e6d8515e25d47aba9ea9c0df13760db_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff4ae26c4d5d46608d3add43ad05bbb7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacf6fa5b9d2e4cb38a2b47625e11f694_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407e005872e847169249dc236fd723a1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibee203a2a57249aaa21381f631fdf46e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0da7317746ad4fd683a1ce1bc96f8f22_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07039c3201414d96884a16b718546a13_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17c0a7e09ea4403ba4b016e00d085205_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15d4e3340e604a44a2fcefd0f1a628cd_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f075e6862bc484dabc2a2c6cd1d7c37_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic68c9bd1b9604c838f68baa4497ef3dc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i323d08dbbf434656aa0a30682aefdeab_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb1e17562676450a8f71a4ef6a375849_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fdde603126345a9a39d5b631edb96c2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dc6cd3645f6405b90a96753c13a9cb0_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbfc05f74eb341e78530b80a19abf65b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d53662410834885b7dbdc824ed4b103_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibca19cebdd0949a1b26b48f24eb12161_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i054fa70f408e4539865aee238d844341_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if51fbced07284741ad5b6ad72598bac1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75faaf5aef3241e1bbf28cbd0d043d16_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28e7fd546b52414bb22a99df2fb6e6d1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ba117f5e9a14bee84ef83a283e82114_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81e27f9feb6741bfbc6aa8b9c2b21974_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8023920188754b2a995080b31ccd868e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03dcdfcf4e244a95a8ab8e736a188d92_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8652d5fb943a4587a8793dc14afb84c3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia213a6ff66974627946e8fd3a7382872_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64d424319a394d27ad50e628661c82fd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaf7b07ebc9642edb11f1367901401c2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b6c5fe863db4dacb550eba84fd8836e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i850cc4a1d1c24cad88a0c8605cc8c364_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64fe29b381c14063af8331516c517635_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b3a8264bc9d4884896faec1361a29f2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27c4310b23f24941bfe4832943becdd5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3e5d0796dba4b21a297db8829d0bba0_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5adcdaba03f8425280b41743c1b6a4a8_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic49b06d7552349519467e47ae89ecc2e_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30e29fec4ee74bcfb877317c0b851a69_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40dc3c728f4f4406ad21325f8c547a8f_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15add9d704da4ad1a802469251779a75_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aa153463d4e4b10bdd112f21b499711_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib439965aa50741ed94d896621a53d24f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7422e8c7c9ac4cbfaffd4115d01b32f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b8093806ec94f8a82c561e795c452a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic09defab5a6b4fcea525bbc5a70b2eff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb59d96b0c5240b880d48b08300df3ba_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i568faa2df0b7487aac4477602e023e13_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4fb7a73d720449eb35e51e5c42bde88_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifffbb07e504b44f39e055b5bbe1c5ea4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5712d73ab4594b168ee2ebdc3c0b169d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0db57ccee8d4694893d34eeb2fdfe2b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide71e62aef2140e081c5bf792558264a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2716ea4458a542bc9c88d29a297073ed_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if96fc34936b14bdba670cff9c58d6e24_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90fb13e8b59f4a29a69d162134fcbb7a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc8a50967227451ab60dd06313b66069_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5ff7d6319ec43c7a77cc183eb669155_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic42f5761199a4db4bfe046448896c355_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23f5234796e94be18871e317e297f8f1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i103db90a98ed4fadae2e32d5e1d5d63d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ee81bbde07a44368fcb9d1addd7d122_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia18bf18de3e5421ba842d5317c3f8f9f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8bb9328c6444517b9390466b44fc5a6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8bbd48792b2442d936ce7b773a35f08_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib432c787f0c944d2a88f98e14ab15f00_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5e655ae113847fcb0d0f49867baed93_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dd21833f22a4ead8d64d3beea08b065_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="business"><xbrli:measure>bsx:business</xbrli:measure></xbrli:unit><xbrli:context id="i7035bd8158c64efc87cb5197cb0b1c08_D20210303-20210303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-03</xbrli:startDate><xbrli:endDate>2021-03-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3b8aa9405924b21b11a85634596952f_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9c9a81fddbb4fad955c9b1435142cec_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i57c0758a66684a7982d502068215aa6f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6898b58f4aec40418ecc3bd0375059cf_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:FarapulseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fdccd8db4934e95b5b9d89057e641dd_D20210806-20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:FarapulseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-06</xbrli:startDate><xbrli:endDate>2021-08-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a862692f9994fb897884cba9e5d394c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42615c1dcc2b43d5bfd401f89db86ee2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2761998d541845db93a74305c87ca265_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91ca5ff3927c42fd8cec3812dac442ed_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id114a2fef9024cbca1a1f0663c76241c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib89073632b554a279ba4e8ab72aee35b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb276f2411404adb93fe59870c17c192_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="units"><xbrli:measure>bsx:units</xbrli:measure></xbrli:unit><xbrli:context id="i8074394ed0a841f6b6a00976ce6a3b7c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1a8632c557548d6a28c88cdfcd4c788_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e3062416e504886865dc878139930d2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a1667398e9d4227ad18866f00a781a1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ea9ee04f244471cb85a3fafa0014325_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i4b1f6c1a9c3545cb8c54c62563bbe3af_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f69f4096f2641279151434275d31698_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafec8073344141919bf348e3f6128888_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i599a67975f864f07aebaf0697665cb54_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b78aeabdedf468b9432e0fbf7b1d35e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b873251f0164fcc87a5f68eb8697f6b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia31b341f23ca42dd99d1f28259ed9778_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i106a39a0f8a64d958a6b4fc9ab669182_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b198018bdf848d58391e917618a9a73_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4614798867554623b71db7e485b17073_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66b850e1cf4c483cb4f780f209eb416e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie78944db109b43dab16a18b210d06a11_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f4dc84c7b7d4d6784d95efacd9d16b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6c58776dd93450391e647ab995a55fa_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96e317c9a09f414dac29a749f0646452_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f13c163b758433eb6e1965892fb50b6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic290401c00e44941bbe65f481b18918a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7879670f05dc464cace4562bebcef4af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1cd550c4b9f4493a5098816e165a726_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if893495841d548ada62dd960d69a89bc_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0f4ff16aef048c5951b2ef3630ab4fe_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i508addd37e5f4f7ab05debf8ce4a40c5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9276b8fd7c5e459cb81f0d109ea9c590_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i7c9a9df7371e47288ad47514abc3d299_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id15fe40bbc1a49598899e77eca657086_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="derivative_instrument"><xbrli:measure>bsx:derivative_instrument</xbrli:measure></xbrli:unit><xbrli:context id="i337a6f01680a4261a534fe13d39a19aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0484760d76d648ef90f70bb1389a147f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3139c7b655da4d49a12993d29146beea_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia68688cce8064b70bcca08cd6512a4ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ffac8f2ce0d4293b26df78d0ad2d8e0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i424e4f7e39a9410981b8ba416ccac4c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadf7143e00714f7a9f615443b868ca37_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61f98deb368144a69329cdfbbd8f2cc3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3020f06cb394eccb08b9f3827b65587_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27bdbdb9fd8a47e9b5c80577d41a1ec4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifff3446af476436f83c776f6272d3517_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f69fa3f42484de3a5cd8686c169cf5e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dc0aeafc5504f8491f1d7e2d12710bc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2952dc166454f9fb8cff9b5579e82ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if744488d910741f99e4dde8ee82cf4fa_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife61a35414c94d28863d163cb3379eee_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0446aef545942b8b12a84b25e182179_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba71732844214aa3859047cf4cd1b074_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic356266b05f74a6b9f1191f2b815f11b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05caf238eba7451e935612a5c094056c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95c41329358c426dbfde24ddb1b29c13_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i001157b3c6c14f6ab4a49a1468cbba56_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0d946dede0f4f31a139ab6bc367b6a4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idff7731f281941c9b10a57598c4f3fa3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88819d9575244b1f9ae25324bd55ef4f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26eb37997b434810bb1db3a61e1958c8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95b1b2df03b543738424133c5483532f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i413490b8a5b549428c780264cd0fca96_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7898c0ae54f649e3b3bd7531b4e96637_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e501501753d4bc3893312052f231981_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc334024d192429bb461fc883b913f95_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i210e93bd44c944e39350884a3a028415_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b553319bf064b3fa60f0b256efd9a1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a91e7a45fbc446c8783c08420680904_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e8b4d9c146e4af78c9649552b795b81_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb50746f189146428dc3a086275c1f6e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21748e73c93f404ebf1695c897f921fc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcd5967abae8433c8e776f2d4c8e34f5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i946142230e0d45968c7d35a681ee1ca7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d5a78c050d24c3998ce9d7394914716_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8b3a25a0021455c82d237efda98677a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28be2cc81b8646da8951fe8f886431ae_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd3a971d105c47e3b030d7146612746b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1d17d52c56344148e6f68416205f316_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18328309825f40b887eb0ef197588dd3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f8a220efc374460aac18c0864628e67_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1696ff74ab3647bb87732da6158a3427_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff031e690ad46fcb10f2ceedfa9fcf9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40d5ba9cb66f46eba6179aa8dc2f4775_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b99fcb316c84c26af31432735c4acc8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebc173f0990b4117b9314d607dba9671_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if33791e7ffab49859998b3df9fa1bafb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied2279ddd55248389453413b491c815f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e77807bef8c44ccb81fbc0e7ba9b799_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20ed1fc05de34698bdf7cd17009bebce_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i600d7a0e156944d8a7e0b2f8e0296f7b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21198075aed84d47b40aa66db088ddc3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EurodenominatedoutstandingdebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i103abe8f6cc04293824af37a171f38cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EurodenominatedoutstandingdebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i967915e4b5a34078a3ed31f7f97e8af1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9b8b74de08d42a5b1c298735f31c874_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia41c2dcb7c86466189b28d6c0003d505_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadb3d909cec9465983bd9071804b27c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id982ae5b53e04126a7116a0047e53636_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i113b5c1b952f4594980deebf9d2fb6a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifab91815c6bd40d0a0b1e317ea65c8da_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38a47cf5a6694115904cfd355585ca6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d2f3b419c994bdc94530fd56efedbc8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i561c09a8d18c4e8bb44fee39130ac6ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46ac7a01ed6b40a8b651ab864a06c209_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0ae2e6d62514176973bc35a7110c630_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id72fc66e7aab4c62aaf40ffff524b1e0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia351226c94354547b45c1fab925a288e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ca05e25f325480fa19833b9a5aa88d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62a197ee399d4df089f8b6bc2882477f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91e07d9a4bf44725bb8890bf0ddccb0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bbf7a2beb3741228b363f15a8f99e4d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic01cfb8ffa714da4ac584f4ba607a604_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2273a18a922d4ba9bb8f7b6d48223471_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide4c06b245c8483d952138db789ef503_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1023571c063440c1b72bde0cc574f3fc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6c5049e8c5a466cacfec15d36c0b17c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic047224d612c40f3b5da3c6df601c6b4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba59ff767fc24dffbfa0f7a3f3061b30_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5320ad72c40043dbadbade7185c3451d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90a40bf358b54433a3a649f92522cdd3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i809eea6504914ca685965d4b388d35d1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b03ff8312654acdabd6f4b180d73c5f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia44ed01226c64b529960a7be9715fdb1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if06d4aa1475745f9bd667036ca6a77e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0771aaf382b64bbbb9ca530005018dcb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibce283f07399443fbbfa2409543233c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie78d090db6af43d5964a7c874aa66780_I20210510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5bb1bffb92d48848c682a120ac50575_D20210510-20210510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-10</xbrli:startDate><xbrli:endDate>2021-05-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e96838cdc7b44c4a1afe15baaa3ef77_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a4283b5db0d475db38e71d73bfd1d3c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26601067bda84bc3b9685478594ecd99_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:CurrentRequirementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e0d083bcc1b4a04b64d12c8d91b4941_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20c8d3b79ea24e50b1f3b5cff5b34259_I20210510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfJune302021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2386476e4d86430cb1177af6ed201651_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfSeptember302021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73dd07304f00449f9f1e3862f53fd60c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8cfbd87e22b48faaa5fcd00545825a2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0047d354b82246a986ea67a506f95e0f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia027378c26254f43aa24b3d62083d405_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSixthQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic85f1b8888bb425194c965e58e0b2e74_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec922493e5094a03bf6f1519d2177851_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11e8d32cc0a047e98a98d79bfa03d913_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b8038e17bb14aca9760b9b13c4a71eb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id36ab86f2da34a9c8eac8655594d345f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24cd97ee251b48559141f4a71903a86f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ac4d1c50e424a77a8190f95382d7215_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaaff822293a4cdd9e2c363357a949b3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e14eaa94afa46c089e40f5f8fc742f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib85a49f2cb27434db4be4cdcf2cd10c4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e0c97078b824377aae934b984b2c65a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a197d277f374157b6cbffd8871e4fff_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dcfc90377704002bd6e0af127de50c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i436cfe41ac964ae79776eea028f62811_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e99e4069c604693bacde07aad3c5702_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claims"><xbrli:measure>bsx:claims</xbrli:measure></xbrli:unit><xbrli:context id="iba90cf22a3284fb59a07eb50be79d5fe_I20210720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77c92e5241fe49138fd00651d03d0ec6_I20210720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0ad409ecce44b268852058674771336_I20210720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bsx:AssignedtoonejudgeinMAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i026d0c112cb44011bed4a40ce907adcb_D20171110-20171110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-10</xbrli:startDate><xbrli:endDate>2017-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6bc3d74e781494aa5f8d841b5dd5783_I20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib072725f878d490891c935180e76efae_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f1c2b882edd4e289dc69107378a5023_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dbfe80c9a6c4f1fbd50cde474b1f462_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6a63df2abd449589aa54a60a6aa45cb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>bsx:day</xbrli:measure></xbrli:unit><xbrli:context id="ibe8974f83a41404480fe53c20b651092_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c82a8e57953431395abd5f8de82b993_D20210723-20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-23</xbrli:startDate><xbrli:endDate>2021-07-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i931d3fba103a41da93709c2ad126cda8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80131178752d4d72933977f1f39077b2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i872461569f5c44cc9806dce827685f3e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dd96420c83b4f6fbd2317a8063fe8e8_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94ceea52a45242bbb3456459eec3203a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8b39a268f3f4c688dd37a207b541d3c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if28997b0cb7f412abd0e94a0120251a4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia22d58f6c86d470aa34c0f3cdd713039_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bcab03a819b4e56b7ba98f0bd557f87_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dd5712978054816851d620283d3a5a1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b8776f4806d49a896745a9a4bb90b81_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a123b6a6d02472f84544e157b785b07_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8ac7dde02784ed2a3c939e70748808d_I20201214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="reportablesegments"><xbrli:measure>bsx:reportablesegments</xbrli:measure></xbrli:unit><xbrli:context id="icf3d85296ff14a7fa38a4e77b4c22259_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee7ac48795d7495bb324539450207488_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc87b0e1aea540f5afcf25232dd8e768_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fa95cedc94d43a78ad39a377b3b4597_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87a9703d05a846d58b5180826ffe5050_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ddaea5b070844abb018d02ea99642ce_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a812afca36c4308ad9bff7ee2032b3b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10ee3e6c967c46a4b31eb6264056e524_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9920b68656de40d1b14321411d7fbf04_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08c5d30357d9461faac846d9a7f6f58c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3f1a45e38524eada4c409914683546a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbfbdc30d0ab449094a90e70fd595751_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id96d30c4d41a4cdb9fe2a6c8498a6753_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia69c68d3663c4d20b8e7aa1db007db37_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i917d4854b7a7437bbd99ae988171a69e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6987d6c22f4b44dc92c281c44ea04ff4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i875553a9513a45a38f8a905416d7829c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e3373e787f64b69879354c4d90cb4d6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a73a4533f85472db78cd678e9428f83_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2329374481a64746916e19c25b31e4a9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icea85ab448ac4f31a40e693d00c9232f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9425d933351842c69c2377a549b55d63_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdbc19706ca841dab5c448ba34ebf25f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0af53d7a56246a6a7195bfe2f410ab8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06f6ceb4a20040a5a4fb3825accef1ad_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2ec85ae1ab744838e2f0043d7c74fc7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d7c3b80fe00450391af229f01a0d200_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30338b7d70584d428b0e030a91c0bd1f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf9a180b4192402eb3bf5e60522bf759_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic949cdc25a0746a4a459b8a0d6db3a07_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16978436b3dc4702931fc4b84f04a48e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aaf1372dd9946df9396ccc9020383a6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i169d8e210b0c42a7bef3c40e6e0a6e32_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i061cd56ba7464abca39e645d60f76a24_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaedeb686cee4d8d9dab6a94ba25b3ca_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcba7c4ff23d4a36bf3a797d17d3fc25_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia88afd4ada2e4380867080d946a426ab_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96cfef3ea9ca4aa19b2bbb07b400eb80_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42ab9e136af1432d93223a27751196da_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22601e81ae894a8ead01e52c7c6c27d8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29a590a1212940f2a9899f47bc99255f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd29119a8cc84be69467437c76bb82de_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7af6058e474a47f6be0373df26d2c88b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5638e698e73f4b489f93a04619cb4765_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82c8d382689b4777829b44c174c65fbc_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1373eb6d094a4864854a6d14ee507632_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22d89029dd434509a14af75abe8b39bb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i625505b6d3a940a5bcb761bf0b3959f7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19fc598ea5cf4543b98c31b363392b72_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8adde05e0aa442a2b88ca23ff4e546f2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ff91ebf23ae4decb4c9ef0283823434_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99e80edb795146f8b45480c4add3365e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f4c3566c44c4157a5e11d70f391081a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bce46e49184470a8222ed14bd378c26_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f47e99793034137b15f7fa228eb0b29_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38a51bdaccc2484c9e70993e21677ca3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aa30fb1b39f4d348ef1434541427e01_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a72d4a50a4d4e74b93be9e82777898f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eab68a05c01485c92e57bee7e7e0f01_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c54e4912e96435091d529ae0ed78f07_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibea06e5f733245528b5328dc3e82297f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5706fb2a0a0e47db92eafa5aede01ccf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e88da73b0484cceb9e60fbd4e7e2fab_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad77ae9479ab455da7367cecb7c17bc5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08630dd608644cc08764c701dd22f7aa_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic338ea419c3440558697b27cc49de9db_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i690ac34917b44b20906e730e3dcdc4af_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief8a91fe2ca84ac0b18ff0e6844a0287_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5201686b80024557a80a7f33db43a5c8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0e96b146aad466ea7d9f8d5dcca942d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18a4ce2ee9e8410fa314a7f39ae7cb6d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba26343c342547479828a2dd2e8d7bd9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i947c377abd4c4941b4a244d5948eebd2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de128567b724b5984a99d95eef02d4d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f2f3e5b12e432ea299981ae16b6fe8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idef0574f3eef4b9e8e842b614403cda3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7ef4aa393984e2ebb13ebe33340a910_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i372f4fcd9ee74bd6a7b738ffb8609de3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcf9760e631443339b33601a02bd59ce_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d063662de5e4b32ab5ce0c83ed22b8e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bc4e56a2f2c49849c55cba2ac3445ae_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7801f5155a6141c18f17232cef1a5392_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec63b166a7d5454683d6ec2e2bab3b66_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i546ecb80f9f54844bc0e3f3b677fee89_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97435401a6bf486aa47a9cc538781a9d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d83d8f92f6647f0a79e0353d43220d2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b1d77aa85474402b82a7b22a91d3791_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82c87e029c8940349ae408f228d3b510_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cdb3e06e9a64a59b0a05eddb13cb154_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60e576728e7343f7821a9f0a44eb3d8a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e6dacb4e8874b21b6822d368a2a953f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e85a2c232e64290b8ebd6a6cd0bbdc4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i953e0fe9f9b847f49ab077fb9c939709_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ec33aa8ba414dcd8d8eddba16bf0dfb_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55ddef33ab0e4fa78d3e05af2245debc_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i705075d05b1c4df98d3f2b6311ee1876_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0149779720b14a1e9890c2e5463703cd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48d5ab1bada04b428d1dc449d38e68aa_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i056eb40cf563486c946aa704d28fa8ab_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a0d737980c64923b5659d62f3434702_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i999387ed85af40aa960e8fb85fe24e8f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37862215da8c46a5911d56efc33e6a34_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d8a9a823a7e497a910c47ea98654d1a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9a20d757b68446898d764ace8105642_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib01f3231917a42399388b8430f7dd5c4_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia92d1f0a20454a3b9bce021d757a34e6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89f659ee14624fde88e16586c89ce9d8_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if71b684d3c024d3886c8ef1e65dfa46d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0734e4182c448e3a1999d0400528fb7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1a9f292c5b94a01b78a4918d33aa51f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fe7c0ba7c514a5aa6e493bab9893659_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ef0989ede014a41b44c8c421e9c80b6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a99ca748d5e4edfa719dfdea5bd3311_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2ba737e9d8f461ba5881d87b666c936_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf3328c2059f45a99c8ed36d5544d2c2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27a241c1c7e14b908561f55b9bea06af_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d4a66cacd3c409a8583c1f4d7c949a0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f81f839a1994584aee39783ecacbdcd_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70b422de2e4e4b18a8970d5b6f6d4282_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10cd8488ed6a4a9f9cfca5758ddc5d1f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a954338141045799352d36c639ad37e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cff98864b9e45f2a169a4724b33ce66_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i009fdb9395ce49bdb5ee3d78d5dd59b5_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f221a488db642a294dc6d9112291dc5_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa71dec95dc94eeca8f7131ee2264446_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80dc82869bb14419b4927d17ccb893c3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic86c037a105047ff8e30c52d263c8b1c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73e4ecee96fe4a029361a7becb75ea87_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if876951023d64e46a24c7d835b5faa3b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00e3dbb86db0418ca06c3632c8c1b5e7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i122407c5128c49f5a374ce6bf633b754_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77bb9297fb7c44c6b02abde208157004_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8456f3d09026487583de79d141ac5a57_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88135e1e5b9e48138fa29ce5f22d50a0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7322afa2bcb4680be71b6adae30c6a0_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i719d3d1d3dfc4900a97050942bbe31de_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eb35a14aae34796be04212920a94266_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37162a776ece4d0bb843164a63a34546_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8d04eeeafb94eb9bd136daeb8176cbf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied8010a52167452ea357069eec7e9c7e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb29b1f5e9c04d7f8e4e8c597595337c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84fc90d4c0574d2180bf795e9ea8019a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f7d90c59416456b8c31e32e8d530bcf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3cc9570466e432bb34716e1723c76ed_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d1a58b8b2a64926afbacb03ceb0e46f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d618ba150584c2d8089fc515133c197_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6590a83019bd4768911ab6e74a8ead5f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6016cb0bcb5645e79fb9453c064d1070_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5393f9f0da0e48d99af036f07bc71c8f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae7822dc00ec44efa94a5d7b8f0d51df_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8952d06cea3f4179a4e5e6ed3a7d7641_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i877c5d6831884713ad635096adea9fff_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icba8e95f00734703a480e7de812a5575_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic27d3ee5d397485ba3bd063f9697f20b_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i82746c1ad92049b181a877873a6cc318_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDA3_89ced2d6-b953-44cb-943e-d89da0aa4e59">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6NTY4YmEwNWI5MmI3NGU3YTkyMDZjMDQxZTE1ZTkwNDAvdGFibGVyYW5nZTo1NjhiYTA1YjkyYjc0ZTdhOTIwNmMwNDFlMTVlOTA0MF8wLTAtMS0xLTA_6a14c2aa-f270-49ed-8cc4-d1826407a9e4">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:1pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18xMjA_e3970d93-9ba8-49ef-8e60-a56d4bb5b85d">June&#160;30, 2021</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6MjgxMzNiZjU2ZjI2NDVjOGEzNDE1Y2ZjZjgzMWQ0OTcvdGFibGVyYW5nZToyODEzM2JmNTZmMjY0NWM4YTM0MTVjZmNmODMxZDQ5N18wLTAtMS0xLTA_9a2d4662-6bd3-4cdb-95a5-8cc5bb053146">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No.&#160;<ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDEz_fb8f49b8-248a-4c4a-97eb-7bd0bf716104">1-11083</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDE0_e134a143-be46-46eb-8a5e-06abe24be860">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZmRhZGFjY2Y1YTExNDYzZGJiZDIxYzRjOGJhNDJlOTcvdGFibGVyYW5nZTpmZGFkYWNjZjVhMTE0NjNkYmJkMjFjNGM4YmE0MmU5N18wLTAtMS0xLTA_770e2ea4-1cc7-4d59-90ba-d724b533f15f">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZmRhZGFjY2Y1YTExNDYzZGJiZDIxYzRjOGJhNDJlOTcvdGFibGVyYW5nZTpmZGFkYWNjZjVhMTE0NjNkYmJkMjFjNGM4YmE0MmU5N18wLTItMS0xLTA_cd426034-45e3-4e00-910c-905a6c41a1b6">04-2695240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDE1_c147608a-14f6-4953-b08d-5ff10d61f4da">300 Boston Scientific Way</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDA4_ce3f88f8-de16-4585-a444-b9464523aff2">Marlborough</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDA5_526d0100-8d55-4fa3-83be-846c62eed6e9">Massachusetts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDA0_4dd03ecc-c5ba-4de6-b234-79e8a8a3a89a">01752-1234</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Address of Principal Executive Offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  (Zip Code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDE2_b17a0f51-bf31-4ac6-a761-795323b91860">508</ix:nonNumeric> <ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDEw_f4caf2bd-bf56-412f-a76c-0fd6590aabc4">683-4000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.187%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f7b6d3b742a4d51865ca65aad09fe72_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8xLTAtMS0xLTA_713a19f3-6ddb-4cf7-87d7-aaedddc8ee0a">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f7b6d3b742a4d51865ca65aad09fe72_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8xLTItMS0xLTA_39f4a23a-f3b9-416d-b112-17368809b49f">BSX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f7b6d3b742a4d51865ca65aad09fe72_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8xLTQtMS0xLTA_33a97913-7796-4092-8939-56da472d7939">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64954d944d4b4bccab9f6197e481ec8b_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8yLTAtMS0xLTA_39d997a1-cbdb-4287-b073-73b478ddf121">0.625% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64954d944d4b4bccab9f6197e481ec8b_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8yLTItMS0xLTA_8b9dabcf-23ea-405c-a0ad-ae7642e7d2bc">BSX27</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64954d944d4b4bccab9f6197e481ec8b_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8yLTQtMS0xLTA_b562538a-f6f2-4904-a6e4-254ac78a8125">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8zLTAtMS0xLTA_47f681cf-38de-457f-90f4-c919e5d741b2">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8zLTItMS0xLTA_b8d23436-da07-43c0-830b-2d1b28e17668">BSX PR A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8zLTQtMS0xLTA_0ec560a1-6efe-4c0e-b66f-1a107d2bca6e">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDEx_9b717c05-7f2d-426b-956c-dd8d554a9b51">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDEy_587c40f6-c03d-4b9b-b0c7-e529147fa7a2">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6NTBiNzZmOTMyOWU5NDQyZjkwNzYzMDA5MDYyOGEwOWYvdGFibGVyYW5nZTo1MGI3NmY5MzI5ZTk0NDJmOTA3NjMwMDkwNjI4YTA5Zl8wLTAtMS0xLTA_a468ecd6-bd7d-410e-ad70-c2bd9e630a37">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6NTBiNzZmOTMyOWU5NDQyZjkwNzYzMDA5MDYyOGEwOWYvdGFibGVyYW5nZTo1MGI3NmY5MzI5ZTk0NDJmOTA3NjMwMDkwNjI4YTA5Zl8xLTMtMS0xLTA_d18ecdf7-9bc5-466f-971d-e7ba18fc0fe0">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6NTBiNzZmOTMyOWU5NDQyZjkwNzYzMDA5MDYyOGEwOWYvdGFibGVyYW5nZTo1MGI3NmY5MzI5ZTk0NDJmOTA3NjMwMDkwNjI4YTA5Zl8yLTMtMS0xLTA_f6f3b5a4-13f0-4d16-9c4a-49b7b4f68fb4">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDA1_d77257f3-75cd-4846-b4e2-ef1fdf576fe4">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares outstanding of Common Stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="2" name="dei:EntityListingParValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18xOTY1_f9c9a8b8-f3fd-49ff-86e0-fd29399ce6d3">0.01</ix:nonFraction> par value per share, as of July&#160;30, 2021 was <ix:nonFraction unitRef="shares" contextRef="i8d5d572ce7ed4e2b92e847dfb3345843_I20210730" decimals="0" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDAy_d38e1986-8b55-409f-9af8-c71a4e0acf38">1,423,852,648</ix:nonFraction>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_13">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_16">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_16">Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_19">Consolidated Statements of Operations (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_22">Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_22">4</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_25">Consolidated Balance Sheets (Unaudited as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_25">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_25">, 2021)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_25">5</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_28">Consolidated Statements of Stockholders' Equity (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_31">Consolidated Statements of Cash Flows (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_31">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_34">Notes to the Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_34">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_127">ITEM 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_127">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_127">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_154">ITEM 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_154">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_154">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_157">ITEM 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_157">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_157">60</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_160">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_160">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_160">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_163">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_163">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_163">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_166">ITEM 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_166">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_166">61</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_172">ITEM 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_172">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_172">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_175">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_175">62</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_16"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMy0xLTEtMS0w_d4545ee3-a7a2-451f-a301-7ba4d51fb29c">3,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMy0zLTEtMS0w_ea672747-e4df-4ce4-ac9a-de5a079a3bdf">2,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMy01LTEtMS0w_e80f095a-4b58-4a90-8274-c353d1dac7f4">5,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMy03LTEtMS0w_9c9478f6-f536-40ef-b747-4c43ec9347e2">4,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNC0xLTEtMS0w_388bb8ee-e08b-45cd-8617-f2079c14f9ba">945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNC0zLTEtMS0w_394d5849-4dac-4380-b011-435a28bc4cca">791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNC01LTEtMS0w_630cb986-8bfd-4dfc-8328-039d266dac6e">1,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNC03LTEtMS0w_00f9dce4-f336-4feb-8948-d9153ebad8f9">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNS0xLTEtMS0w_7484bb8c-d8fc-489c-b6bb-0ecf2bc88973">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNS0zLTEtMS0w_84e64956-6624-4c33-a709-e936b34610a4">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNS01LTEtMS0w_f97cf4f4-e636-454d-a8a2-439cf97d75d6">3,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNS03LTEtMS0w_44cb627a-cd68-4018-a486-75bd729d6202">2,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOC0xLTEtMS0w_a001ed56-cf83-495a-803f-bf0a797f3316">1,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOC0zLTEtMS0w_f607d9f5-edc4-4d38-a172-062ee6a07ec8">798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOC01LTEtMS0w_e9f48709-e6d0-41c3-ad74-cd6b8070ef6f">2,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOC03LTEtMS0w_44a66519-6358-4444-811d-114f18a94d70">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOS0xLTEtMS0w_bd9b2bbf-6da7-42a4-ba86-da51d2f48e56">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOS0zLTEtMS0w_9b4f7aff-ad65-48a4-8984-b5ad8e5c32d8">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOS01LTEtMS0w_a1f9299c-081b-44a4-b042-3a948a88b105">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOS03LTEtMS0w_eb3dc689-8f5d-492c-999b-0fe2869a772f">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTAtMS0xLTEtMA_16fc22b5-1a16-4000-b62f-a936a338a252">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTAtMy0xLTEtMA_cdead5ed-f4de-4341-98a7-65e8c1db01e7">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTAtNS0xLTEtMA_bb997f24-c124-405c-9287-7a41ab83241a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTAtNy0xLTEtMA_f9c8bb87-176c-44a1-b5d6-c5787ba73b7f">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTEtMS0xLTEtMA_7e58988d-0d79-4379-94d9-419c19b48afa">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTEtMy0xLTEtMA_39d12b1c-42b8-478c-b2be-49382f7458d0">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTEtNS0xLTEtMA_7fef2140-f447-486e-af93-c784d53c4e1f">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTEtNy0xLTEtMA_8bd25344-1e38-4994-a121-c819714acca8">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTMtMS0xLTEtMA_eee19bb6-ab38-43b0-90e0-3f3ca0f8e9ec">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTMtMy0xLTEtMA_8f87e357-772d-4d2a-99ba-fb07867fa167">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTMtNS0xLTEtMA_8fa4f25d-c82c-411c-b1b4-4f2d25e2f5ca">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTMtNy0xLTEtMA_041de048-3fd2-401b-89f7-5a7f7091e1e3">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTQtMS0xLTEtMA_ca484066-31e4-48a6-b647-eaa9610b1ac9">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTQtMy0xLTEtMA_ad7f5282-dd5f-4ba0-bad6-aed3203b7f2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTQtNS0xLTEtMA_f75a4fb6-c3da-44f6-9bc2-7b8880d37178">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTQtNy0xLTEtMA_8e5e395a-0a13-4ada-a014-0300d44037af">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTUtMS0xLTEtMA_500e7a43-d771-47ff-81c5-8b6840a93ff3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTUtMy0xLTEtMA_8339a0ce-9ff8-42b0-9cc9-331ceba2bc49">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTUtNS0xLTEtMA_f9c3f3f7-b3a3-45fa-b74a-209a6f63db33">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTUtNy0xLTEtMA_55af64b4-338f-404e-9b15-bbb1163ad48e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTYtMS0xLTEtMA_33ff8825-b310-4684-9509-902db3460373">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTYtMy0xLTEtMA_1a9564d9-c1eb-4e6d-a621-565c42da63d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTYtNS0xLTEtMA_4a213716-384d-4a6d-a198-bb04b3708cf1">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTYtNy0xLTEtMA_234334fb-8e67-40b4-b6e1-7312bbf24b3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTctMS0xLTEtMA_d5c150ea-5f86-4ca8-aed5-b8e2c3292ee1">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTctMy0xLTEtMA_3afb5ed9-6ff5-4f87-a76e-fb216e113d49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTctNS0xLTEtMTk2MA_339c65d7-e2d6-4554-b80a-cfd7f559ef5f">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTctNy0xLTEtMTk2NQ_5d44ba97-de10-4b2a-bdd2-81d7c37197c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTgtMS0xLTEtMA_b2e94949-ba04-4986-beb2-9443db293d34">1,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTgtMy0xLTEtMA_7853cd6a-9e79-4703-8448-bdd0f0f50f01">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTgtNS0xLTEtMA_8f89e667-2841-4ff5-b825-b5c526281f7b">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTgtNy0xLTEtMA_5ea2e7ae-8fc7-4376-ab1e-e4156bdace85">2,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTktMS0xLTEtMA_5dc62f09-9fdb-465f-ae20-943c1e4dd053">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTktMy0xLTEtMA_1dd71e87-6580-4d92-87aa-b90dcefbcf53">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTktNS0xLTEtMA_21018b20-c707-4303-abd3-60969d195416">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTktNy0xLTEtMA_108c0ca2-4179-438a-920a-dfe6c075afdc">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjItMS0xLTEtMA_8be447ec-390e-49e5-b928-e51d0d6afc27">86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjItMy0xLTEtMA_3c3b52a4-8b1b-482f-b607-6237d614be50">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjItNS0xLTEtMA_ac3793a8-9d24-4108-87b7-cc5065c18b06">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjItNy0xLTEtMA_8ae08704-0dbb-4e69-b28b-34467bbbc25a">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjMtMS0xLTEtMA_939dfa79-3901-4e02-b9e2-d48b64e3f8e5">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjMtMy0xLTEtMA_13165bc7-27b8-405c-b400-ccc85c6f8f90">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjMtNS0xLTEtMA_48e84303-2b2e-4003-80ad-42ecc7b22319">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjMtNy0xLTEtMA_f6efdd10-3385-4e94-8b4b-7ccc87b83aaa">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss)&#160;before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjQtMS0xLTEtMA_53a092d6-edad-40ff-8b6c-879dd674861c">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjQtMy0xLTEtMA_d3203251-11be-4d90-8c48-71e1cb380a2a">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjQtNS0xLTEtMA_3a062616-ec04-41c3-946a-89cb52dd3bf7">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjQtNy0xLTEtMA_a4b2da91-c54b-4422-9b5a-ede7911a5270">159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjUtMS0xLTEtMA_22602ada-91be-4e20-8a6a-51450829a176">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjUtMy0xLTEtMA_2b66b067-428f-42e0-8ccd-6c5e1a0ae9f3">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjUtNS0xLTEtMA_f4550b1b-385d-4686-9705-575c68deb84e">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjUtNy0xLTEtMA_4d02d6f3-10e7-4450-94a0-14d321f2fabd">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjYtMS0xLTEtMA_e207738f-9d46-427a-bc4e-087f5a985587">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjYtMy0xLTEtMA_dfcbf6cc-3621-4d5b-8d5f-a1dcadc53fd0">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjYtNS0xLTEtMA_40791fd7-1529-4ddb-962d-19e9ec228ed5">527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjYtNy0xLTEtMA_d5bf38ee-5096-4e2e-8ed5-ca964bcc430d">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjctMS0xLTEtMA_0b62154b-e1b9-4208-82eb-db7ccf1f78f4">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjctMy0xLTEtMA_61986470-f8fc-4ed7-b0ff-bbd8b02040f1">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjctNS0xLTEtMA_3eaa83a5-c56b-4ee6-ae2e-f965913c7cce">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjctNy0xLTEtMA_5ca417ca-dac8-4354-96bb-7909d477d7eb">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjgtMS0xLTEtMA_5b6fc423-3c25-4520-88b9-d0ef94d3fb30">172</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjgtMy0xLTEtMA_a0c426b5-6072-4943-8e53-d08b9dff21b0">153</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjgtNS0xLTEtMA_67f87e06-249e-455e-b12a-55df94f00a59">500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjgtNy0xLTEtMA_4959ced4-07d4-454d-ad8a-2941c6b16a3e">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)&#160;per common share &#8212; basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzAtMS0xLTEtMA_53396166-cd64-409c-9001-c1596e749ed4">0.12</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzAtMy0xLTEtMA_833702b7-3c04-49a0-b3cb-875406633ce4">0.11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzAtNS0xLTEtMA_265ccb45-540d-420f-b2e9-25b36640d216">0.35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzAtNy0xLTEtMA_988c45c1-866c-40a9-9c22-9b22e4932fe4">0.10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)&#160;per common share &#8212; assuming dilution</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzEtMS0xLTEtMA_454f8996-bc20-4822-b3c2-932f23ec4386">0.12</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzEtMy0xLTEtMA_2637cbee-9e98-4153-8b83-01ce233bfffc">0.11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzEtNS0xLTEtMA_b154a4a6-5fa5-4395-9f13-c8f401bf6062">0.35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzEtNy0xLTEtMA_588607b9-49be-4b7b-9bf7-65d95ffc3fe8">0.10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Weighted-average shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzQtMS0xLTEtMA_2320625a-ceee-40b8-b7f1-639550ffdf18">1,421.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzQtMy0xLTEtMA_0f4945ee-2336-4526-9c33-d0f547de6bf1">1,410.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzQtNS0xLTEtMA_ad6c607c-fc1d-414e-a6aa-77c62744a8ac">1,420.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzQtNy0xLTEtMA_a8a01bc3-23a7-4970-a416-f6ed1f21f3b0">1,404.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assuming dilution</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzUtMS0xLTEtMA_0bef0c6d-f98e-425d-91ab-7524842a6715">1,432.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzUtMy0xLTEtMA_9575ce05-413c-4aa6-adc6-a30ed1c7dee7">1,410.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzUtNS0xLTEtMA_49cc078d-dc5a-4e85-a4a9-a645b02bd5e0">1,431.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzUtNy0xLTEtMA_cfc93df8-2f07-4778-baae-819c9ef6eaf9">1,404.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfMi0xLTEtMS0w_e207738f-9d46-427a-bc4e-087f5a985587">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfMi0zLTEtMS0w_dfcbf6cc-3621-4d5b-8d5f-a1dcadc53fd0">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfMi01LTEtMS0w_40791fd7-1529-4ddb-962d-19e9ec228ed5">527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfMi03LTEtMS0w_d5bf38ee-5096-4e2e-8ed5-ca964bcc430d">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNC0xLTEtMS0w_90ecdca3-8ff0-4b10-8640-69b187ec11d5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNC0zLTEtMS0w_df937b36-a9b6-4dc3-9c37-f9fd6762eba7">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNC01LTEtMS0w_9a9db524-7a4a-41b6-be3b-4f09b6516a0c">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNC03LTEtMS0w_5c59a486-1607-4944-b9c0-194a15003679">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNS0xLTEtMS0w_0c2b8e2b-d0a0-4e92-b042-71a4f326b2d6">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNS0zLTEtMS0w_2385ae75-c7eb-406e-adf3-6964dce36956">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNS01LTEtMS0w_1766d2b4-3a5a-4462-9fef-1947ffe5a1bc">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNS03LTEtMS0w_85e40179-717e-44d1-96d1-6e267b22b2ed">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in defined benefit pensions and other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNy0xLTEtMS0w_cbaf9083-f7a7-40d3-9c28-e5198063a824">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNy0zLTEtMS0w_0778db11-d2bd-4282-9ad9-48bdddfb26e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNy01LTEtMS0w_b94e4afb-ebb1-4e73-a2d2-22e4f9e3c984">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNy03LTEtMS0w_2d8120f0-2f0b-4d00-9438-30e66c2eccf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOC0xLTEtMS0w_19666b0c-5678-4acc-a6d6-913acbc2d327">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOC0zLTEtMS0w_a1b029c0-140e-40ab-8262-653a5fed7acd">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOC01LTEtMS0w_d468ef56-89dc-4ec3-b3f9-4df6a40a5578">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOC03LTEtMS0w_f6a961c0-9f78-46de-93b7-765bceb60815">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOS0xLTEtMS0w_cb94463f-ad18-41d2-8f29-f522c561d678">170</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOS0zLTEtMS0w_3ad00d43-f3b9-4278-9857-de79b74953ee">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOS01LTEtMS0w_4e846a87-a56c-477b-823e-b7946572f2e8">558</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOS03LTEtMS0w_4f2db1a8-164b-4e9e-b69f-cf98dbc7523f">276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share and per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNS0xLTEtMS0w_261bbf57-4cf1-4240-8ae8-13c123625cb6">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNS0zLTEtMS0w_023e0fb9-637c-43bb-bf60-3273bf73014a">1,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNi0xLTEtMS0w_24b3b3fc-9c0b-4416-93bc-e5bb7b3eb6f9">1,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNi0zLTEtMS0w_a6ed1055-71d9-49c2-be9a-e9d7ab110d7b">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNy0xLTEtMS0w_b0ddb6d5-4401-4669-93cb-ff42ebeb9efb">1,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNy0zLTEtMS0w_c83c7adf-1475-4dcf-9edb-51a2c7072ae9">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfOC0xLTEtMS0w_65d136db-6caa-435a-b150-e150b6422d50">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfOC0zLTEtMS0w_223e4bbf-6cba-43d6-9236-bf31312449ad">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfOS0xLTEtMS0w_5542959c-5e1a-40c2-89e7-969aab9d9a0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfOS0zLTEtMS0w_7f2ea96e-4918-4220-be7f-bd01a3546201">1,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTAtMS0xLTEtMA_7fc16b79-6213-4b27-a294-b10bd89299d8">777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTAtMy0xLTEtMA_a0fa1cc8-3a69-40c6-9c5e-67588247e0d8">751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTEtMS0xLTEtMA_3ae336db-943d-45b5-a4e6-15ed13a8054a">6,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTEtMy0xLTEtMA_05dc11f6-ee64-4e1b-a692-77aa157a1105">6,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTItMS0xLTEtMA_7fca81e1-a627-4c11-b075-f90d2c530cda">2,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTItMy0xLTEtMA_d156e724-b7b9-41ca-a4a1-5bfbdebf5f91">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTMtMS0xLTEtMA_43b70f5c-15e3-44ce-88e6-2a758531c7b1">10,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTMtMy0xLTEtMA_2c0bf3a3-ac1f-44eb-9a87-14a1f795c704">9,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTQtMS0xLTEtMA_deedb56b-b3c8-4a78-9f39-d44d17917e45">5,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTQtMy0xLTEtMA_91c02709-6159-42a4-b2f0-cab5c3a0492c">5,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTUtMS0xLTEtMA_47934a8e-7576-4c7f-9bdd-2b440af0fe2c">4,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTUtMy0xLTEtMA_8edcbaab-9e86-44ad-b738-1586912746de">4,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTYtMS0xLTEtMA_2cda3337-efda-4fc0-9bdf-de5e49b22bd4">1,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTYtMy0xLTEtMA_1587f87f-86e4-4b07-aac2-f4f1081ae541">1,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTctMS0xLTEtMA_597d2ff9-9cd0-4ba5-a17b-5f66ae2ab482">31,168</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTctMy0xLTEtMA_c86a6009-b425-48f7-8c02-3ce262c7cb4e">30,777</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjEtMS0xLTEtMA_6c4dfbca-ba43-4a5d-a8f6-692b68b38daf">262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjEtMy0xLTEtMA_9ed2ccf0-b2e8-4c24-b6e0-19341f8a33d6">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjItMS0xLTEtMA_e0749006-4b92-41f0-9207-da9e35ea42f7">689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjItMy0xLTEtMA_83993019-c376-447f-92a0-d3032ceee169">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjMtMS0xLTEtMA_c0068945-5a05-4e0d-936f-c9531f0227b6">2,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjMtMy0xLTEtMA_7b08c458-015f-4521-9588-77aa6122790b">2,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjQtMS0xLTEtMA_3314ff25-c336-4472-bb15-567724de5d8e">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjQtMy0xLTEtMA_6d1468e0-1a13-4270-b67f-b4642645af8f">958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjUtMS0xLTEtMA_e7729bcb-f005-402d-863b-a64cffca7a97">4,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjUtMy0xLTEtMA_e0f0cf14-9046-452c-9595-27671fb201d0">3,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjYtMS0xLTEtMA_9f630e87-48ef-4576-86d2-dc80c0f783a5">8,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjYtMy0xLTEtMA_47f06938-1163-4987-9fb8-66c424dcaad3">9,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjctMS0xLTEtMA_0ea38e4d-d09a-4ca9-9aa3-8aad079f2c85">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjctMy0xLTEtMA_e622af29-c1d9-4855-8645-76950afff139">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjgtMS0xLTEtMA_e7a8a2d1-1409-4d37-b805-a600b0944b37">2,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjgtMy0xLTEtMA_08e27f17-94f8-446c-babe-065624d7d2c9">2,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzAtMS0xLTEtMA_ee8b8915-0477-4b9f-a96a-753ce42798fa"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzAtMy0xLTEtMA_301200b2-3f0b-4679-93fe-64c6d690227b"></ix:nonFraction></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzIx_638c9e21-f9f2-4ca5-a4da-8008610b9bea"><ix:nonFraction unitRef="usdPerShare" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzIx_e6411676-0d5b-4fde-958d-c2b196e67567">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzQ3_86321d61-8218-49fc-bacc-ab08546f2391"><ix:nonFraction unitRef="shares" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzQ3_f851dc18-a4ec-47dc-8cc2-e448b8c67707">50,000,000</ix:nonFraction></ix:nonFraction> shares - issued <ix:nonFraction unitRef="shares" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzY2_073c99aa-93f8-4ebe-b981-014969309452"><ix:nonFraction unitRef="shares" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzY2_453169d3-7d53-4c99-90eb-2be7e1f590a6">10,062,500</ix:nonFraction></ix:nonFraction> shares as of June 30, 2021 and December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMS0xLTEtMA_380cf9d6-87a5-49c9-9c33-48ac34e5e9ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMy0xLTEtMA_7c204165-360a-43a0-8c7b-0afdf6e025fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzE4_12c06763-db96-42dc-9a4a-aecb74fb81e3"><ix:nonFraction unitRef="usdPerShare" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzE4_80616609-2877-4aba-8de4-a30291a0440a">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzQ0_3a8aa065-1beb-4490-adac-beb56e96b6a7"><ix:nonFraction unitRef="shares" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzQ0_f5c31350-af91-4d65-a040-08de3e656fc7">2,000,000,000</ix:nonFraction></ix:nonFraction> shares - issued <ix:nonFraction unitRef="shares" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzYz_e134bdbe-efd1-43fd-8856-4aea69dd9fa8">1,685,006,608</ix:nonFraction> shares as of June 30, 2021 and <ix:nonFraction unitRef="shares" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzk4_b9dab216-9f58-43aa-96c8-2f1bad1ac424">1,679,911,918</ix:nonFraction> shares as of December 31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMS0xLTEtMA_56e768bf-aafe-4817-afbe-ea69be4ddb4f">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMy0xLTEtMA_3e0c78f6-a8f9-4531-a372-bbee373e3baa">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost - <ix:nonFraction unitRef="shares" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjg3YjQ1MjU0Zjc5MTQzNDk5YTM4NDVlZWMxYWI5MDVjXzMw_4505e2d9-07fa-427a-872d-b35483d0dd52"><ix:nonFraction unitRef="shares" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjg3YjQ1MjU0Zjc5MTQzNDk5YTM4NDVlZWMxYWI5MDVjXzMw_fd4e366f-7b1e-4d71-87f5-a244bb428aa4">263,289,848</ix:nonFraction></ix:nonFraction> shares as of June 30, 2021 and December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzUtMS0xLTEtMA_82b46ad0-6a78-4cf0-8290-831dfa4bcb9b">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzUtMy0xLTEtMA_35f4f6a9-94ab-46e8-b89d-b907d02568ff">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzYtMS0xLTEtMA_c2c9bc3a-2be2-45d4-8350-29bfbe84e853">19,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzYtMy0xLTEtMA_03524d78-c2db-4491-bdb1-13bedd310819">19,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzctMS0xLTEtMA_3ada8418-05d6-4be2-b7b3-0af6bb939253">1,878</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzctMy0xLTEtMA_b27fdb05-faf2-465e-b27c-7c83b2685951">2,378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzgtMS0xLTEtMA_dff9b5fb-c2a5-425c-9dcd-064c7a0afbc5">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzgtMy0xLTEtMA_be6b8fed-c3ef-4986-b6ad-5f5702adc2f6">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzktMS0xLTEtMA_6bb30b3c-aefa-4a42-a145-12e625987f97">15,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzktMy0xLTEtMA_c42d0775-12a9-4d2d-963b-7e6def1ec6bc">15,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNDAtMS0xLTEtMA_92feb875-9c68-405e-be36-06ad55d72983">31,168</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNDAtMy0xLTEtMA_d6a195bf-35d0-4716-9d1c-2f7742e59360">30,777</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.630%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss), Net of Tax</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares Issued</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares Issued</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79e7f5e22b45494cb5031e20d21c5988_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtMS0xLTEtMA_899a5209-2bea-4eeb-8b12-e084d06f469f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79e7f5e22b45494cb5031e20d21c5988_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtMy0xLTEtMA_ce37dfe9-e7b7-4f6c-88be-0d6b7c514623">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ab5a160fd2842d19f763f45b6d09e89_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtNS0xLTEtMA_0b4c5041-9f3d-4a22-9388-1a9b6c1ebd46">1,642,488,911</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ab5a160fd2842d19f763f45b6d09e89_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtNy0xLTEtMA_3d623e06-0574-491d-b1b4-bbf2207ec041">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e6d8515e25d47aba9ea9c0df13760db_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtOS0xLTEtMA_b5c02d8b-0d47-442b-a661-d9e4a86cf784">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff4ae26c4d5d46608d3add43ad05bbb7_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtMTEtMS0xLTA_33605216-34e9-4480-8239-595d19f73c20">17,561</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacf6fa5b9d2e4cb38a2b47625e11f694_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtMTMtMS0xLTA_8ff80fbe-37e1-4ddf-a723-57f6192cce60">2,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i407e005872e847169249dc236fd723a1_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtMTUtMS0xLTA_5ed0b45e-368a-439e-aabb-5efb5aff9563">270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee203a2a57249aaa21381f631fdf46e_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzctMTMtMS0xLTA_163f2c08-ec38-434f-b638-d25ce4d2d720">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibee203a2a57249aaa21381f631fdf46e_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzgtMTMtMS0xLTA_718492d0-f09f-4387-bb64-5bec0d286f05">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0da7317746ad4fd683a1ce1bc96f8f22_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzktMTUtMS0xLTA_3de45282-458f-4d08-9877-f33892443c30">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07039c3201414d96884a16b718546a13_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDAtNS0xLTEtMA_dde4529b-a53e-4890-8201-79a7a5084fea">4,388,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17c0a7e09ea4403ba4b016e00d085205_D20200101-20200331" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDAtMTEtMS0xLTA_41470aeb-f377-413f-9343-4cd42fc8974a">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15d4e3340e604a44a2fcefd0f1a628cd_I20200331" decimals="0" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtMS0xLTEtMA_1ab7aab3-22cc-4ab7-8a5e-51dbdffe49ae">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15d4e3340e604a44a2fcefd0f1a628cd_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtMy0xLTEtMA_dcb53882-bc05-4e80-8a64-32c389e57250">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f075e6862bc484dabc2a2c6cd1d7c37_I20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtNS0xLTEtMA_781bb128-881d-4283-a42d-4ba01862729d">1,646,877,242</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f075e6862bc484dabc2a2c6cd1d7c37_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtNy0xLTEtMA_525b4a75-5c9d-4906-8b27-bd8025449fbd">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic68c9bd1b9604c838f68baa4497ef3dc_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtOS0xLTEtMA_15e533fb-7d29-4009-8758-41e55b68dbf8">1,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i323d08dbbf434656aa0a30682aefdeab_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtMTEtMS0xLTA_d3ed3d61-9322-4d00-be51-473b247416f6">17,589</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb1e17562676450a8f71a4ef6a375849_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtMTMtMS0xLTA_d78a8fd3-b5e0-4de2-9282-a965b4cdada0">2,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdde603126345a9a39d5b631edb96c2_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtMTUtMS0xLTA_a02ed34b-8a74-458a-be11-86c89e2b2c3f">168</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1dc6cd3645f6405b90a96753c13a9cb0_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDItMTMtMS0xLTA_a742211e-94e4-427b-926c-dbd0daf8bc80">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbfc05f74eb341e78530b80a19abf65b_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDMtMTUtMS0xLTA_e8d78ba0-681a-4a49-8fd8-7a0e5ae8cbc4">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d53662410834885b7dbdc824ed4b103_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDQtMS0xLTEtMA_6236f011-ce6c-4af8-a2a9-137948432b01">10,062,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d53662410834885b7dbdc824ed4b103_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDQtMy0xLTEtMA_a7d732b3-a880-42b0-b40c-b018d0b8f382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibca19cebdd0949a1b26b48f24eb12161_D20200401-20200630" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDQtMTEtMS0xLTA_a49eb18c-71e4-466b-8285-0bdc4f5f36de">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i054fa70f408e4539865aee238d844341_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDUtNS0xLTEtMA_d120e811-1931-4b1e-82cd-958f16632013">29,382,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054fa70f408e4539865aee238d844341_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDUtNy0xLTEtMA_3416b281-eced-490d-9d13-c619f31707ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibca19cebdd0949a1b26b48f24eb12161_D20200401-20200630" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDUtMTEtMS0xLTA_dd08a5f2-caf8-4bf6-a6df-03a12db79abf">975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1dc6cd3645f6405b90a96753c13a9cb0_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDYtMTMtMS0xLTA_de49d7b8-d6b5-4eea-a5cd-e6e1aaa1c208">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i054fa70f408e4539865aee238d844341_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDctNS0xLTEtMA_8c3b78c7-3f82-4b7a-ad33-506a65ed9b9d">493,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibca19cebdd0949a1b26b48f24eb12161_D20200401-20200630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDctMTEtMS0xLTA_31c781f3-996e-4874-97c8-7a3bf156c15f">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if51fbced07284741ad5b6ad72598bac1_I20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtMS0xLTEtMA_32150295-f995-49aa-99bb-3692a4a677a4">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if51fbced07284741ad5b6ad72598bac1_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtMy0xLTEtMA_7f85f45e-e6b2-4994-b834-abe34a85cf5d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75faaf5aef3241e1bbf28cbd0d043d16_I20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtNS0xLTEtMA_affae8b9-8752-4d32-b10d-6bfc9c438aa5">1,676,753,566</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75faaf5aef3241e1bbf28cbd0d043d16_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtNy0xLTEtMA_89228f96-e6ce-41d9-9e26-bad7ce699654">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28e7fd546b52414bb22a99df2fb6e6d1_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtOS0xLTEtMA_5d1de9c3-cbe4-4f5a-94f6-700c2f2cfe6a">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ba117f5e9a14bee84ef83a283e82114_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtMTEtMS0xLTA_d0ad8dcd-d991-4495-b5cf-de37f06720ac">19,590</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81e27f9feb6741bfbc6aa8b9c2b21974_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtMTMtMS0xLTA_6a0be187-e23d-4e96-87c1-bc24cb63e353">2,405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8023920188754b2a995080b31ccd868e_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtMTUtMS0xLTA_9912b5f5-38b6-4be3-a91b-4b7d945bdf30">131</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03dcdfcf4e244a95a8ab8e736a188d92_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDktMTMtMS0xLTA_897e53f5-f726-49c1-9593-61e49f62cd25">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8652d5fb943a4587a8793dc14afb84c3_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTAtMTUtMS0xLTA_1eec3698-cb48-4248-a220-44335e99ffbf">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03dcdfcf4e244a95a8ab8e736a188d92_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTEtMTMtMS0xLTA_0d64cbe3-eb02-4b43-9a4f-fa1f7930777c">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia213a6ff66974627946e8fd3a7382872_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTItNS0xLTEtMA_71a05827-17a8-4363-b6d8-b5e333e5e36e">2,674,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64d424319a394d27ad50e628661c82fd_D20200701-20200930" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTItMTEtMS0xLTA_4d482594-7ae6-473c-92bf-aea63e127762">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaf7b07ebc9642edb11f1367901401c2_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtMS0xLTEtMA_5cb9454b-7414-482e-9a4d-9db687e47734">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaf7b07ebc9642edb11f1367901401c2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtMy0xLTEtMA_1dd43ddd-efc4-4005-8b0f-b7aba20f47b1">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b6c5fe863db4dacb550eba84fd8836e_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtNS0xLTEtMA_45fb72cf-4294-4fbd-b029-1bdb0e8fe150">1,679,428,209</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b6c5fe863db4dacb550eba84fd8836e_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtNy0xLTEtMA_a8b61108-ca0f-47db-abd0-833b2926d863">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i850cc4a1d1c24cad88a0c8605cc8c364_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtOS0xLTEtMA_38dca218-65c3-4f96-b3ca-fdc87e28ebf2">1,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64fe29b381c14063af8331516c517635_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtMTEtMS0xLTA_589a003d-7ee2-453f-9e70-ae7639fb53d9">19,687</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b3a8264bc9d4884896faec1361a29f2_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtMTMtMS0xLTA_2cfc0f01-80ea-4be7-969d-68b75a46ddc5">2,574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c4310b23f24941bfe4832943becdd5_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtMTUtMS0xLTA_5312d00b-2dc1-4efb-bca2-552d97d4c6c8">151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e5d0796dba4b21a297db8829d0bba0_D20201001-20201231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTQtMTMtMS0xLTA_97e8df83-91ac-4af8-8c7d-23062edc9417">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5adcdaba03f8425280b41743c1b6a4a8_D20201001-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTUtMTUtMS0xLTA_100998bb-a119-450d-988a-a1ce759e809f">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3e5d0796dba4b21a297db8829d0bba0_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTYtMTMtMS0xLTA_7b836c2b-b8a9-4c7e-a3e8-da1fc859921d">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic49b06d7552349519467e47ae89ecc2e_D20201001-20201231" decimals="-6" sign="-" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTctOS0xLTEtMA_ff61d9e4-4d50-4f80-903f-3e213c84fdd9">535</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i30e29fec4ee74bcfb877317c0b851a69_D20201001-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTgtNS0xLTEtMA_939c17af-f301-4d1d-b5c2-6100ea588124">483,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40dc3c728f4f4406ad21325f8c547a8f_D20201001-20201231" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTgtMTEtMS0xLTA_e0bc8ba3-b869-4639-87f9-d1c9804953f5">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15add9d704da4ad1a802469251779a75_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktMS0xLTEtMA_7a8438de-8d7f-4d0f-81b8-7556744ff7df">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15add9d704da4ad1a802469251779a75_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktMy0xLTEtMA_99657c2f-007a-4eb7-8924-150af02fd58c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8aa153463d4e4b10bdd112f21b499711_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktNS0xLTEtMA_38e3b56c-8a72-43de-9e06-f99c3a033921">1,679,911,918</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa153463d4e4b10bdd112f21b499711_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktNy0xLTEtMA_01fc3423-d929-4781-987c-3d36b4d669a0">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib439965aa50741ed94d896621a53d24f_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktOS0xLTEtMA_16ea6642-d0e0-47aa-878f-f87c8f97130e">2,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7422e8c7c9ac4cbfaffd4115d01b32f4_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktMTEtMS0xLTA_f8e6410d-307e-42bf-8cdc-418ca0571578">19,732</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b8093806ec94f8a82c561e795c452a6_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktMTMtMS0xLTA_73377add-955e-4d2b-8d2f-55d4ea5228bf">2,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic09defab5a6b4fcea525bbc5a70b2eff_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktMTUtMS0xLTA_6c7cb85a-bce8-47e1-9b43-78710b32ef42">207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb59d96b0c5240b880d48b08300df3ba_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjAtMTMtMS0xLTA_19f0adec-fbc6-49bb-aaa0-224b20b1e6f6">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i568faa2df0b7487aac4477602e023e13_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjEtMTUtMS0xLTA_d07bab5b-20ba-4b44-b6ed-b830b58aaa57">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb59d96b0c5240b880d48b08300df3ba_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjItMTMtMS0xLTA_18f6902b-3062-41e7-9149-d07517190f83">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4fb7a73d720449eb35e51e5c42bde88_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjMtNS0xLTEtMA_634e54c4-5bf2-4326-93a6-ff9cd5b16a9d">3,949,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifffbb07e504b44f39e055b5bbe1c5ea4_D20210101-20210331" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjMtMTEtMS0xLTA_ad773637-913a-40fa-9177-f0e5a4c480ca">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5712d73ab4594b168ee2ebdc3c0b169d_I20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtMS0xLTEtMA_bbf669b5-3728-4af0-8392-3864aa514afc">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5712d73ab4594b168ee2ebdc3c0b169d_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtMy0xLTEtMA_252d6258-3b3b-46ca-ac6e-26ea543a9799">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0db57ccee8d4694893d34eeb2fdfe2b_I20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtNS0xLTEtMA_46fc6605-848d-4e11-b8da-12f0d5d91bde">1,683,861,226</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0db57ccee8d4694893d34eeb2fdfe2b_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtNy0xLTEtMA_0d47ddd2-150b-4618-9413-fed9aa86fb27">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide71e62aef2140e081c5bf792558264a_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtOS0xLTEtMA_8bae3fcc-b1ea-48f3-842c-0b3833e2c7c5">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2716ea4458a542bc9c88d29a297073ed_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtMTEtMS0xLTA_537fb14a-b4e3-4cb0-b1b7-8c67204f2608">19,750</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96fc34936b14bdba670cff9c58d6e24_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtMTMtMS0xLTA_54d41308-c92a-403e-98d1-350e9de4b92c">2,050</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90fb13e8b59f4a29a69d162134fcbb7a_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtMTUtMS0xLTA_d56df7e1-b63e-43db-94cd-1551c7599ac9">254</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc8a50967227451ab60dd06313b66069_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjUtMTMtMS0xLTE0ODU_24c342bf-4225-4a16-a0ab-86bed5b8596f">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5ff7d6319ec43c7a77cc183eb669155_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjYtMTUtMS0xLTE0OTU_37109f87-21eb-4b1c-8a96-5da2f5422026">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc8a50967227451ab60dd06313b66069_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjctMTMtMS0xLTE0OTA_b5967895-45de-463f-82d7-49df41153e26">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic42f5761199a4db4bfe046448896c355_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjgtNS0xLTEtMTQ3Ng_986b026a-7ab0-43c1-a0cb-2bf44864b5fd">1,145,382</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23f5234796e94be18871e317e297f8f1_D20210401-20210630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjgtMTEtMS0xLTE0ODA_d90414ad-cd01-48d0-960b-ca65c2bdc8a8">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i103db90a98ed4fadae2e32d5e1d5d63d_I20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktMS0xLTEtNDM_4af4242c-fb2d-4f30-b666-c6adccf4f1d4">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103db90a98ed4fadae2e32d5e1d5d63d_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktMy0xLTEtNTE_2ff35398-73a6-4654-8394-ffbfcfb0c9b1">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ee81bbde07a44368fcb9d1addd7d122_I20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktNS0xLTEtNTU_4b903d24-b44e-426e-99b7-709deaf9bae3">1,685,006,608</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee81bbde07a44368fcb9d1addd7d122_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktNy0xLTEtNjE_4687bd53-1bb4-4cad-adf7-32bb4a2302f8">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia18bf18de3e5421ba842d5317c3f8f9f_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktOS0xLTEtNzA_e72d85ca-aa16-46e6-8bab-6ae3290969cf">2,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8bb9328c6444517b9390466b44fc5a6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktMTEtMS0xLTc0_134f94d8-7850-4e85-bfa5-1fc2ecee1b16">19,817</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8bbd48792b2442d936ce7b773a35f08_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktMTMtMS0xLTg2_f6a697dc-6ab5-42c5-866d-6fb167d31cf0">1,878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib432c787f0c944d2a88f98e14ab15f00_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktMTUtMS0xLTkw_a6d7c66b-93b9-42b2-a1ab-d770cada44ad">237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMi0xLTEtMS0w_4dfd7f6f-87a7-4c74-b29e-03d856a58f2a">527</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMi0zLTEtMS0w_c6b531a4-09ef-414c-8131-7d1661c3eedd">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on disposal of businesses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNC0xLTEtMS0w_e47c00a4-f95b-4d00-b1b6-425f793622d5">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNC0zLTEtMS0w_78d3b88c-90ef-4e19-a56d-b5be01e59834">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNS0xLTEtMS0w_a146df38-c11c-473a-b501-1158252ddde2">531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNS0zLTEtMS0w_2b4f6a94-8816-4145-a432-64567567265f">552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred and prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNi0xLTEtMS0w_edaf1eb6-dc72-45d3-b81e-b36f995ecd72">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNi0zLTEtMS0w_9b995892-0fa8-4ad9-8455-62536c08c327">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNy0xLTEtMS0w_cd0dea13-2144-4e5a-995e-ea4251f13465">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNy0zLTEtMS0w_91075e81-7eec-48a9-a7a5-8d9259ac0025">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfOC0xLTEtMS0w_52106e57-cafe-4558-bd6f-1a99b2816ef4">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfOC0zLTEtMS0w_b3862fd7-a54e-4f4e-86e4-9808d9df2f19">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss (gain) on investments and notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfOS0xLTEtMS0w_d8b26daf-9293-42ad-b7b5-ee8808be93d6">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfOS0zLTEtMS0w_20c273ce-642b-4c77-bf4a-492caadb11d3">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTAtMS0xLTEtMA_2cd55d29-6582-4202-bb33-1f4c2b3a0e0c">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTAtMy0xLTEtMA_fdf295e2-b7bd-40fe-8879-610bebda80b5">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory step-up amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="bsx:InventoryStepUpAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTEtMS0xLTEtMA_66676466-ba50-4a1f-8b19-fbc3f14aeabf">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="bsx:InventoryStepUpAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTEtMy0xLTEtMA_c36dfb83-db11-41a3-9f5e-56cc11276917">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign exchange (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTItMS0xLTEtMA_8667c007-afcb-4473-97a9-9e031adff8f8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTItMy0xLTEtMA_9f5db0df-c539-489a-a7b7-74fd9750f275">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTMtMS0xLTEtMA_163f9900-2bb8-4011-9285-cd9430284303">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="bsx:OtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTMtMy0xLTEtMA_778ac084-907d-4d70-90da-d9683f14e307">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Increase (decrease) in operating assets and liabilities, excluding purchase accounting:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTUtMS0xLTEtMA_74c024dd-72bc-48c4-b8ed-00a53d534119">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTUtMy0xLTEtMA_857b52c2-dc8d-4abb-b5cd-ec361461ebee">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTYtMS0xLTEtMA_54bbe2e4-8e6f-4a32-8040-61c8b141d1d5">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTYtMy0xLTEtMA_92f1a83c-6254-4d8e-8652-3042b4b135f7">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTctMS0xLTEtMA_12f520a2-2823-4428-ac77-ddd29eec34a9">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTctMy0xLTEtMA_8ed841ca-3050-46b2-bc02-3501f6f05b8d">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTgtMS0xLTEtMA_6c7f2617-d449-43bc-816e-4f8819b23655">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTgtMy0xLTEtMA_ec534472-a2bb-4a80-b05e-ba9ffe7d8221">531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTktMS0xLTEtMA_25fa9317-ec50-4c04-99e4-15738e4f8412">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTktMy0xLTEtMA_88fd2481-3897-432c-9df1-ca3c0dae0744">181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjAtMS0xLTEtMA_9656a0ad-4719-4c27-a412-fe9ea6faa679">927</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjAtMy0xLTEtMA_03e2a3b1-680a-4404-9d72-2572c780cb18">192</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjMtMS0xLTEtMA_c7a2cdfe-7b92-496a-8138-74dba7a307f4">181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjMtMy0xLTEtMA_e4648d6d-41b5-418f-aa11-c32a437f961a">168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjQtMS0xLTEtMA_d74fe039-db26-4751-afe0-e0f79d1c73a5">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjQtMy0xLTEtMA_1b6d668d-7be4-4467-a984-34365a9335c4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for acquisitions of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjUtMS0xLTEtMA_a9b4d677-813c-4190-a56b-dac5d15e9629">706</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjUtMy0xLTEtMA_d831f379-821e-4bcc-967a-f8a7fffe6f05">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjYtMS0xLTEtMA_fc59eeb5-4682-45d8-99d1-6dc5a28e071a">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjYtMy0xLTEtMA_b2a14a8a-ce9a-4a5c-a07b-fb39758b8d88">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for investments and acquisitions of certain technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjctMS0xLTEtMA_12a6e247-157b-49c2-a5d9-22906ee5d564">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjctMy0xLTEtMA_b80515bd-6d00-418e-8783-fca3124a7108">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjgtMS0xLTEtMA_84ab85ac-d3ae-4492-8efc-c7273dcc631d">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjgtMy0xLTEtMA_615b4705-af02-403a-8677-fa122bbc6a1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from disposal of businesses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjktMS0xLTEtMA_97ce59b7-fc43-4901-80c9-d1d81e167ae9">801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjktMy0xLTEtMA_a8725fa2-8391-4912-8e8e-4c8c70893145">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from settlements of hedge contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzAtMS0xLTEtMA_2c2d9d86-9c45-4eec-ae3b-f314c8389396">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzAtMy0xLTEtMA_d78ca090-5367-417c-a56b-d9909b6c4c61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzEtMS0xLTEtMA_2443b2b4-9b11-4d4e-9c9b-ccb58379d10b">71</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzEtMy0xLTEtMA_8e4287bb-2bf5-4690-a585-7aa42c3658c2">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of contingent consideration previously established in purchase accounting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzQtMS0xLTEtMA_9cf37e5c-e37e-4a20-9139-b9a403c20664">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzQtMy0xLTEtMA_fc0cac01-2fa1-434c-b2e3-9ed16d4986e5">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzUtMS0xLTEtMA_114fe186-8ce5-4691-be06-aa754fb24a7e">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="bsx:PaymentsForRoyaltyRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzUtMy0xLTEtMA_5fb345e3-867d-41ed-8d96-89a0e02892b1">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzYtMS0xLTEtMA_b655ae31-db58-4634-99c3-c9b6d2d93cc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzYtMy0xLTEtMA_56bfda7a-272f-43ca-97b0-c127c4ae67fe">2,700</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings, net of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzctMS0xLTEtMA_e7f1fc71-3e92-4f71-b0ae-794a8f1ef5b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzctMy0xLTEtMA_7cf9c471-ce00-45cb-9db7-a01fa35e8b0e">2,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzgtMS0xLTEtMA_8d1c3cfe-455b-4bea-a5ca-2f561a6c8463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzgtMy0xLTEtMA_b271e88f-4d86-4f3a-b1fb-eaa0f54838f9">714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on borrowings from credit facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzktMS0xLTEtMA_459c04eb-f3ca-4f61-a1d2-a3307d6bf8c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzktMy0xLTEtMA_44ab61c7-70d1-4e3a-8451-47ddacd3d053">1,919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from borrowings on credit facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDAtMS0xLTEtMA_d7fddaa1-57f5-420c-a3ea-e0440cbacfee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDAtMy0xLTEtMA_76696b18-361e-4e89-939e-fe6b73c5687b">1,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on long-term borrowings and debt extinguishment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDEtMS0xLTEtMA_44e9c226-6878-431d-b96d-c0a2082d46ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDEtMy0xLTEtMA_bab69f41-f67b-44f9-90fe-a026788ac4ff">1,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from long-term borrowings, net of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDItMS0xLTEtMA_5e4a4d46-0c05-461b-8a6f-5de35c562ab0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDItMy0xLTEtMA_bd63fee0-6c48-4e08-8fda-2c1c04d42f81">1,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends paid on preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDMtMS0xLTEtMA_c767cd0f-0993-421e-9084-bee8f1e21e07">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDMtMy0xLTEtMA_2c2ffc50-faee-4a53-a8fd-948c91c2b52f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from issuance of preferred stock in connection with public offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDQtMS0xLTEtMA_be2cfab0-3dcf-4736-b943-45e377d26cb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDQtMy0xLTEtMA_917c35ba-ced1-4a26-b824-9309b70a8b93">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock in connection with public offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDUtMS0xLTEtMA_2ed11375-02d4-4eeb-9cb1-ac947a7d13c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDUtMy0xLTEtMA_80062daf-36cb-4a40-9770-ace7b51017e7">975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash used to net share settle employee equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDYtMS0xLTEtMA_771b1378-4ff7-4dc7-a7c6-6f06b6b11fd0">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDYtMy0xLTEtMA_052d9e8b-7849-47e2-9bb5-b67ad2426410">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDctMS0xLTEtMA_ddedafa1-55e6-4662-81b6-3ab3a304523e">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDctMy0xLTEtMA_13031040-0bfc-44c6-bee1-c6c5d17c248f">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDgtMS0xLTEtMA_74736466-741c-442d-bf5c-20336c7d406d">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDgtMy0xLTEtMA_f7e24f6a-edc0-42ad-985a-d68c32a8aa47">1,361</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of foreign exchange rates on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTAtMS0xLTEtMA_7b30eb18-ba6d-499c-86d0-f6774619470c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTAtMy0xLTEtMA_47f18c2d-8929-4539-ab5b-8287aa378377">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTItMS0xLTEtMA_dd9813fd-f70d-456f-bb21-5fe93bb325a3">903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTItMy0xLTEtMA_9d4c8130-d05d-4345-a45c-4873934e72c7">1,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTMtMS0xLTEtMA_a21e6116-25e6-4e3a-b234-bedc273e0f17">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTMtMy0xLTEtMA_455a07d6-db6c-46fa-a2d0-0468dc4154ee">607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTQtMS0xLTEtMA_2d487bfe-845e-4567-8d36-70009b60b71b">2,898</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTQtMy0xLTEtMA_4dc023ae-04d3-4976-8835-07da498d32e7">2,016</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(SUPPLEMENTAL INFORMATION)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Supplemental Information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfMy0xLTEtMS0w_83146702-fa29-4613-b1e3-a153226b51af">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfMy0zLTEtMS0w_587ccbbe-36f3-4716-b9de-3738aba92096">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of contingent consideration recorded in purchase accounting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfNC0xLTEtMS0w_872856bd-61ff-4a9c-97fa-18cd324c8310">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfNC0zLTEtMS0w_3ebe597f-6f22-4253-99d3-d1b350d159cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" sign="-" name="bsx:Noncashimpactoftransferredroyaltyrights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfNS0xLTEtMS0w_22dfb21d-8d10-42d5-b435-9e1ac086cb1c">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" sign="-" name="bsx:Noncashimpactoftransferredroyaltyrights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfNS0zLTEtMS0w_44888a40-dae9-4501-967c-ade3faf38ec5">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Reconciliation to amounts in the unaudited consolidated balance sheets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfMi0xLTEtMS0w_261bbf57-4cf1-4240-8ae8-13c123625cb6">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfMi0zLTEtMS0w_f30817e4-3bd6-4b00-9c13-e8fecef6b4ce">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfMy0xLTEtMS0w_e9e062f2-7869-49d6-babb-ae044850838d">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfMy0zLTEtMS0w_7e150ba4-0092-4701-95f8-ea8bb141ef49">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfNC0xLTEtMS0w_b0940d04-41f0-4676-8840-5c16b06e69f4">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfNC0zLTEtMS0w_a7f21e03-d45f-4611-855d-11ba204eb7a5">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfNS0xLTEtMS0w_0c9546b0-a895-4ec9-a1aa-72274d9d712e"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfNS0xLTEtMS0w_ff55b2b2-4d6b-43de-8dc3-d9593d899508">2,898</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfNS0zLTEtMS0w_d678ee41-a082-4efd-a0ca-36f79d26cbf8">2,016</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the unaudited consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_37"></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zNy9mcmFnOjhmMTM4ODc1MTdmOTRhYjJiZTgyZDNkZGNhZWFkM2NhL3RleHRyZWdpb246OGYxMzg4NzUxN2Y5NGFiMmJlODJkM2RkY2FlYWQzY2FfMTgxMw_994169ab-bcc8-4277-9bf0-e08d340defcc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; BASIS OF PRESENTATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X, and they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three and six months ended June&#160;30, 2021 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2021. Accordingly, our unaudited consolidated financial statements and footnotes thereto should be read in conjunction with our audited consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zNy9mcmFnOjhmMTM4ODc1MTdmOTRhYjJiZTgyZDNkZGNhZWFkM2NhL3RleHRyZWdpb246OGYxMzg4NzUxN2Y5NGFiMmJlODJkM2RkY2FlYWQzY2FfMTgxNw_489ba846-2423-47cb-a882-9f326d83c4b6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments, Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_43"></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzYwOQ_dbdbb207-173d-4e72-98e7-964ab27cf3df" continuedAt="i5fb729cebf72492ba0ba7b3263986535" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accompanying unaudited consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We completed <ix:nonFraction unitRef="business" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTc1OTIxODYwNjU0NDg_2164a1f7-3e1e-4f96-991b-5c6eb8d78a9d">one</ix:nonFraction> acquisition and <ix:nonFraction unitRef="business" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="0" format="ixt-sec:numwordsen" name="bsx:NumberOfBusinessesDivested" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTc1OTIxODYwNjU0NTY_a769f012-a2ec-4572-91f8-1cfa97ac2206">one</ix:nonFraction> divestiture in the first six months of 2021 and did <ix:nonFraction unitRef="business" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTc1OTIxODYwNjU0NjQ_b069aa0b-39c2-456d-8bd0-05e3ce6e07a2"><ix:nonFraction unitRef="business" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="0" format="ixt-sec:numwordsen" name="bsx:NumberOfBusinessesDivested" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTc1OTIxODYwNjU0NjQ_cf540816-d26d-4dd5-b189-6a5739ab38a7">no</ix:nonFraction></ix:nonFraction>t complete any significant acquisitions or divestitures during the first six months of 2020. We have not presented supplemental pro forma financial information for completed acquisitions or divestitures given their results are not material to our accompanying unaudited consolidated financial statements. Further, transaction costs were immaterial to our accompanying unaudited consolidated financial statements and were expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2021, we announced our entry into a definitive agreement to acquire the global surgical business of Lumenis LTD. (Lumenis), a privately-held company that develops and commercializes energy-based medical solutions, for an upfront cash payment of approximately $<ix:nonFraction unitRef="usd" contextRef="i7035bd8158c64efc87cb5197cb0b1c08_D20210303-20210303" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfODYy_6fdacd36-8655-4044-bfd6-3bdc8d15f340">1.070</ix:nonFraction> billion subject to closing adjustments. The global surgical business of Lumenis includes innovative laser systems, fibers, and accessories used for urology and otolaryngology procedures. The acquisition is expected to close during the second half of 2021, subject to customary closing conditions. Following the closing of the acquisition, we plan to integrate the Lumenis business into our Urology and Pelvic Health division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the acquisition of Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. The transaction consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="id3b8aa9405924b21b11a85634596952f_D20210301-20210301" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTY1Mg_f170df61-270d-4c69-87d4-57f7a5e71aae">925</ix:nonFraction> million and up to an additional $<ix:nonFraction unitRef="usd" contextRef="ib9c9a81fddbb4fad955c9b1435142cec_I20210301" decimals="-6" format="ixt:numdotdecimal" name="bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTY3OQ_6add0f0a-bf7d-4056-83f4-dcf4ef6cdc48">300</ix:nonFraction> million in a potential commercial milestone payment. We have been an investor in Preventice since 2015 and held an equity stake of approximately <ix:nonFraction unitRef="number" contextRef="ib9c9a81fddbb4fad955c9b1435142cec_I20210301" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTgxOQ_a0b6004d-394d-4f9a-b084-7b3b126ef397">22</ix:nonFraction> percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests, which resulted in a $<ix:nonFraction unitRef="usd" contextRef="i57c0758a66684a7982d502068215aa6f_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjAzNw_804997eb-66f7-4b56-a944-9ca76a1f3dc9">195</ix:nonFraction> million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the first quarter of 2021. The transaction price for the remaining stake consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="id3b8aa9405924b21b11a85634596952f_D20210301-20210301" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjE3NA_42fb5861-ec2b-4b51-b62f-8639458f9fd2">706</ix:nonFraction> million, net of cash acquired, and up to approximately $<ix:nonFraction unitRef="usd" contextRef="ib9c9a81fddbb4fad955c9b1435142cec_I20210301" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjIyNA_11577549-a222-41de-8ee7-685a8639fc58">230</ix:nonFraction> million in an additional future revenue-based payment. The Preventice business is being managed by our Cardiac Rhythm Management division. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="i5fb729cebf72492ba0ba7b3263986535" continuedAt="ibc79912900f44a55bc5e188de5244d71"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, we completed our acquisition of the remaining shares of Farapulse, Inc. (Farapulse), a privately-held company that has developed a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias in which we previously held an equity stake of approximately <ix:nonFraction unitRef="number" contextRef="i6898b58f4aec40418ecc3bd0375059cf_I20210806" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4OTk2OQ_1f98d82f-592d-4513-83ad-cb477ff4fda8">27</ix:nonFraction> percent. The transaction price consists of $<ix:nonFraction unitRef="usd" contextRef="i6fdccd8db4934e95b5b9d89057e641dd_D20210806-20210806" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4OTk0OA_27e0ac37-7e29-4d3f-a6b4-febee73699bb">450</ix:nonFraction> million upfront, or approximately $<ix:nonFraction unitRef="usd" contextRef="i6fdccd8db4934e95b5b9d89057e641dd_D20210806-20210806" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4OTk2NQ_f7d0316c-524c-4d87-9e6d-52567856b59a">295</ix:nonFraction> million after adjustments for our prior equity stake, debt and other closing adjustments; up to $<ix:nonFraction unitRef="usd" contextRef="i6898b58f4aec40418ecc3bd0375059cf_I20210806" decimals="-6" format="ixt:numdotdecimal" name="bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4OTk5OQ_dbe589c1-ca93-4d02-8a56-0a27c2888499">125</ix:nonFraction> million upon achievement of certain clinical and regulatory milestones, or $<ix:nonFraction unitRef="usd" contextRef="i6898b58f4aec40418ecc3bd0375059cf_I20210806" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA5MDAzMQ_21432617-0a55-40cc-9d74-05390de4783f">92</ix:nonFraction> million for the portion not previously owned; and additional revenue-based payments over the next <ix:nonNumeric contextRef="i6fdccd8db4934e95b5b9d89057e641dd_D20210806-20210806" format="ixt-sec:durwordsen" name="bsx:BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTc1OTIxODYwNjU0NzQ_62867048-330a-4236-90c4-a4bca623d40d">three years</ix:nonNumeric>. The valuation studies necessary to determine the fair value of the various purchase price components are currently in process.  Once completed, we will remeasure the fair value of our previously held equity interest and recognize a gain of at least $<ix:nonFraction unitRef="usd" contextRef="i6fdccd8db4934e95b5b9d89057e641dd_D20210806-20210806" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA5MDAxNg_2d4cb9f1-2147-4407-b8a0-dbda754ff1df">150</ix:nonFraction> million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the third quarter of 2021.  The Farapulse business will be integrated into our Electrophysiology division.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price for acquisitions completed during the first six months of 2021 was comprised of the amounts presented below, which represent the preliminary determination of the fair value of identifiable assets acquired and liabilities assumed. The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><ix:nonNumeric contextRef="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzYxMw_70bd2c2f-d59f-492c-aa39-a15999a61c76" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjhiNDNjYWVmMmFhMjQ2YmRiNGJkNjExMDY4MWQ3NzFiL3RhYmxlcmFuZ2U6OGI0M2NhZWYyYWEyNDZiZGI0YmQ2MTEwNjgxZDc3MWJfMS0xLTEtMS0w_9a99ae60-7b89-430a-94fa-9cc4225e477d">706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjhiNDNjYWVmMmFhMjQ2YmRiNGJkNjExMDY4MWQ3NzFiL3RhYmxlcmFuZ2U6OGI0M2NhZWYyYWEyNDZiZGI0YmQ2MTEwNjgxZDc3MWJfMi0xLTEtMS0w_5fe4b179-c9bf-44ca-9a49-87ddb855280b">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjhiNDNjYWVmMmFhMjQ2YmRiNGJkNjExMDY4MWQ3NzFiL3RhYmxlcmFuZ2U6OGI0M2NhZWYyYWEyNDZiZGI0YmQ2MTEwNjgxZDc3MWJfMy0xLTEtMS0w_e1144d62-6bb6-4517-9144-4aacde3cd40e">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjhiNDNjYWVmMmFhMjQ2YmRiNGJkNjExMDY4MWQ3NzFiL3RhYmxlcmFuZ2U6OGI0M2NhZWYyYWEyNDZiZGI0YmQ2MTEwNjgxZDc3MWJfNC0xLTEtMS0w_b54ab460-436b-474f-a85d-dfd777a8dbc6">1,197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price allocation for acquisitions completed during the first six months of 2021 was comprised of the following components:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzYzNQ_ac52f389-480c-4da6-9fbd-b3bcbbf8bb87" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjNhNzVjY2IzYWI4YjQxOTNhMmQ0OTdmNjhhMDFiMTBiL3RhYmxlcmFuZ2U6M2E3NWNjYjNhYjhiNDE5M2EyZDQ5N2Y2OGEwMWIxMGJfMS0xLTEtMS0w_382c83b5-1c64-4624-9231-ec353f2bedb1">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjNhNzVjY2IzYWI4YjQxOTNhMmQ0OTdmNjhhMDFiMTBiL3RhYmxlcmFuZ2U6M2E3NWNjYjNhYjhiNDE5M2EyZDQ5N2Y2OGEwMWIxMGJfMi0xLTEtMS0w_90bb3bd3-4256-4590-ad6b-41e218c565eb">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjNhNzVjY2IzYWI4YjQxOTNhMmQ0OTdmNjhhMDFiMTBiL3RhYmxlcmFuZ2U6M2E3NWNjYjNhYjhiNDE5M2EyZDQ5N2Y2OGEwMWIxMGJfNC0xLTEtMS0w_f5767ba4-f104-4a40-9f54-fed157934be8">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjNhNzVjY2IzYWI4YjQxOTNhMmQ0OTdmNjhhMDFiMTBiL3RhYmxlcmFuZ2U6M2E3NWNjYjNhYjhiNDE5M2EyZDQ5N2Y2OGEwMWIxMGJfNi0xLTEtMS0w_97cb0c54-ee11-460e-a7d7-90ca716400d8">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjNhNzVjY2IzYWI4YjQxOTNhMmQ0OTdmNjhhMDFiMTBiL3RhYmxlcmFuZ2U6M2E3NWNjYjNhYjhiNDE5M2EyZDQ5N2Y2OGEwMWIxMGJfOC0xLTEtMS0w_8423429e-0977-48e5-9c97-02c4ce37aff8">1,197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the preliminary purchase price for acquisitions completed during the first six months of 2021 to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzY4MQ_fe04bb2d-498b-4644-9b27-6d995eda6c6a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a862692f9994fb897884cba9e5d394c_I20210630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfMi0xLTEtMS0w_448ecc9a-d08e-4ba0-9bd4-28bd6bcd2eef">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i42615c1dcc2b43d5bfd401f89db86ee2_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfMi0zLTEtMS0w_5ce94c09-f578-4ed1-bd43-e53070178b41">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2761998d541845db93a74305c87ca265_I20210630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfMi03LTEtMS0w_c8bfdd40-2fa9-443e-8337-5b2ea3df66dc">10</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ca5ff3927c42fd8cec3812dac442ed_I20210630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfNC0xLTEtMS0w_13fc0c82-c2fe-4b30-8d72-d3a47454b53f">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id114a2fef9024cbca1a1f0663c76241c_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfNC0zLTEtMS0w_8b0f366d-2c3f-4d99-b7b7-a6364b8085be">8</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib89073632b554a279ba4e8ab72aee35b_I20210630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfNC03LTEtMS0w_1e6575b5-4535-4364-a67d-352d0ae02cde">10</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfNy0xLTEtMS0w_f739c57f-9d1b-45dd-884c-1604fca0dd0f">237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies and is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="ibb276f2411404adb93fe59870c17c192_I20210301" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMzg3Mg_fff00f1e-7470-4ccb-aa87-c68ce58b2312">800</ix:nonFraction> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="ibc79912900f44a55bc5e188de5244d71" continuedAt="i4fa007d7a0754a0a860732035301a186"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million, subject to certain adjustments including cash on hand at the closing of the transaction. The agreement included the transfer of <ix:nonFraction unitRef="units" contextRef="ibb276f2411404adb93fe59870c17c192_I20210301" decimals="0" format="ixt-sec:numwordsen" name="bsx:DivestitureAgreementTransferOfFacilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNDAwNA_8047693e-134d-4bd8-8f14-2877e52b3bdf">five</ix:nonFraction> facilities and approximately <ix:nonFraction unitRef="units" contextRef="ibb276f2411404adb93fe59870c17c192_I20210301" decimals="0" name="bsx:DivestitureAgreementTransferOfGlobalEmployees" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNDAzNg_0f84b5c8-c0ee-4101-8fd1-e8ee0813d96a">280</ix:nonFraction> employees globally. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classified the assets and liabilities of the Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet as of December 31, 2020 at their respective carrying values, which approximated fair value, less costs to sell. Assets within the disposal group are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our consolidated balance sheet as of December 31, 2020. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information. In the second quarter and first six months of 2021, we recognized a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain on disposal of business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the transaction of $<ix:nonFraction unitRef="usd" contextRef="i8074394ed0a841f6b6a00976ce6a3b7c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4MDQwNw_b1a97289-982f-4048-b37d-1b6c3eead28f">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic1a8632c557548d6a28c88cdfcd4c788_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4MjI3Ng_6f986a36-70fe-4671-9a48-9216ee49eca8">9</ix:nonFraction> million respectively, within our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzYyNw_e0de5576-a08d-412c-8659-ca4808819c55" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability during the first six months of 2021 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjUzNWU0ZWE4ODY0ZjQ1ZmE4MGUzZmJjNTJlMmUzZjg2L3RhYmxlcmFuZ2U6NTM1ZTRlYTg4NjRmNDVmYTgwZTNmYmM1MmUyZTNmODZfMS0xLTEtMS0w_ad17c138-e3b5-491b-91a6-d78f3078f2bf">196</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded related to current year acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjUzNWU0ZWE4ODY0ZjQ1ZmE4MGUzZmJjNTJlMmUzZjg2L3RhYmxlcmFuZ2U6NTM1ZTRlYTg4NjRmNDVmYTgwZTNmYmM1MmUyZTNmODZfMi0xLTEtMS0w_cabacdde-4f9d-45ab-89b9-b5ae9eb18ed0">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjUzNWU0ZWE4ODY0ZjQ1ZmE4MGUzZmJjNTJlMmUzZjg2L3RhYmxlcmFuZ2U6NTM1ZTRlYTg4NjRmNDVmYTgwZTNmYmM1MmUyZTNmODZfNC0xLTEtMS0w_58edc17f-46c4-434c-95df-b9922e85355a">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="bsx:PaymentOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjUzNWU0ZWE4ODY0ZjQ1ZmE4MGUzZmJjNTJlMmUzZjg2L3RhYmxlcmFuZ2U6NTM1ZTRlYTg4NjRmNDVmYTgwZTNmYmM1MmUyZTNmODZfNS0xLTEtMS0w_29c9a7f5-c961-4ca8-b4b7-3837a35cb36f">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjUzNWU0ZWE4ODY0ZjQ1ZmE4MGUzZmJjNTJlMmUzZjg2L3RhYmxlcmFuZ2U6NTM1ZTRlYTg4NjRmNDVmYTgwZTNmYmM1MmUyZTNmODZfNi0xLTEtMS0w_b24a1cb5-0253-41c1-b5fa-bebce8047a09">312</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our completed acquisitions was $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNTA4Nw_313868a4-bb5d-42fb-bd1a-4c14578edd41">751</ix:nonFraction> million, which includes amounts related to our recent acquisition of Preventice. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information. In the second quarter of 2021 we recorded a contingent consideration net benefit of $<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4MjQ5MA_ca484066-31e4-48a6-b647-eaa9610b1ac9">85</ix:nonFraction> million.  The benefit related to certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzYzMg_9379e8f3-15bf-43e8-ab24-ce941a90bc96" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i2e3062416e504886865dc878139930d2_I20210630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfMS0xLTEtMS0w_0da63de6-dad1-4e17-a62e-44de8abd78bc">22</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e3062416e504886865dc878139930d2_I20210630" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfMS00LTEtMS0w_617e762b-5d26-4f77-8670-4a3dccf79bf1">2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a1667398e9d4227ad18866f00a781a1_I20210630" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfMS03LTEtMS0w_f7942656-f829-4bd9-9876-3ab7cb8ebdf7">2</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e3062416e504886865dc878139930d2_I20210630" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfMi00LTEtMS0w_b1e0c55c-97e3-4d06-85c2-23d3607a9752">20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a1667398e9d4227ad18866f00a781a1_I20210630" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfMi03LTEtMS0w_f7d5bdf1-b53f-4bbc-944e-3ad2d2ed2c28">20</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4ea9ee04f244471cb85a3fafa0014325_I20210630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNC0xLTEtMS0w_46b2171a-c9a3-4073-a999-bfdd5c742962">290</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="i4b1f6c1a9c3545cb8c54c62563bbe3af_I20210630" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNC00LTEtMS0w_b4d4e4dc-64b8-46ed-957e-455d93648b85">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f69f4096f2641279151434275d31698_I20210630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNC02LTEtMS0w_0ed4b3e8-5639-4a53-91d7-8fdc92307f80">14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="iafec8073344141919bf348e3f6128888_I20210630" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNC03LTEtMS0w_dc81d9fe-91b0-4848-8126-e18c58bf43ab">6</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4b1f6c1a9c3545cb8c54c62563bbe3af_I20210630" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNS00LTEtMS0w_314c744f-6c00-4a8c-84ae-b1e5c431e75d">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f69f4096f2641279151434275d31698_I20210630" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNS02LTEtMS0w_76e3044e-9dbc-4f05-8291-e2811744e488">100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iafec8073344141919bf348e3f6128888_I20210630" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNS03LTEtMS0w_d3467207-6d7b-4138-88f5-a9d4882ddaf4">100</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to research and development (R&amp;D), commercialization-based and revenue-based milestones are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of June&#160;30, 2021. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="i4fa007d7a0754a0a860732035301a186" continuedAt="ia257809995ee4d59a101cd3846923cb1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzY1MQ_02132d4b-c525-40da-a82b-60cfb9e343a2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:40.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.787%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfMi0xLTEtMS0w_735ec0ec-5a23-4001-b65d-4307d059cba0">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfMi0zLTEtMS0w_51eb1188-eb39-446f-9d5f-25d340495736">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfMy0xLTEtMS0w_6b9d182d-0087-4237-9da0-38c8000dc995">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfMy0zLTEtMS0w_0899e22a-5750-4e33-ad03-660a28675fc5">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNC0xLTEtMS0w_efa36aa2-9f8f-412d-9aa2-3cdebeda4766">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNC0zLTEtMS0w_d9e5955c-230b-4bf6-8d82-40389e074926">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNS0xLTEtMS0w_bae4d7a6-91cc-4798-9e27-2a3fdb24536c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNS0zLTEtMS0w_f6c02e93-5e1d-4482-a192-d3ecd098df83">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNi0xLTEtMS0w_6069fbcd-a01a-4566-b9c1-31a84224b89d">616</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNi0zLTEtMS0w_49f96ebd-27e1-4e27-bdad-a06aba75bb9a">918</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ia257809995ee4d59a101cd3846923cb1" continuedAt="i6915db533a324fa29162d69c44e73593"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter and first six months of 2021, we recorded losses of $<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTA5OTUxMTYzNTU5Nw_9788e169-1aae-4212-9af9-b4ccb75e2e04">8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNjk5Mg_7b2977d7-b8c4-407d-8847-4f3f36478346">154</ix:nonFraction> million, respectively, on our investment in Pulmonx Corporation presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6915db533a324fa29162d69c44e73593"> associated with the partial disposition of our ownership and remeasurement of our remaining investment to fair value based on observable market prices. On March 1, 2021, we completed our acquisition of Preventice, in which we previously held an equity interest of approximately <ix:nonFraction unitRef="number" contextRef="ib9c9a81fddbb4fad955c9b1435142cec_I20210301" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA5MDg4NA_a0b6004d-394d-4f9a-b084-7b3b126ef397">22</ix:nonFraction> percent. In addition, on August 6, 2021, we completed the acquisition of the remaining shares of Farapulse, in which we previously held an equity stake of approximately <ix:nonFraction unitRef="number" contextRef="i6898b58f4aec40418ecc3bd0375059cf_I20210806" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA5MDA2OA_1f98d82f-592d-4513-83ad-cb477ff4fda8">27</ix:nonFraction> percent.  As of June&#160;30, 2021, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzQ2OA_59e905e0-a4de-4b07-876f-86d891461f46">314</ix:nonFraction> million, which represents amortizable intangible assets, in-process research and development (IPR&amp;D), goodwill and deferred tax liabilities.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_49"></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfNDcwMg_f09d0fa6-01d5-4692-a47b-c635963d2015" continuedAt="ifb72411f1a4445dbacb3ed2631699591" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfNDY5Ng_1d37f1a4-1a03-45fb-8e54-f1c59f4169af" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill are as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:40.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i599a67975f864f07aebaf0697665cb54_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMi0xLTEtMS0w_89ea4822-ec33-47bd-9889-4a5c7e166078">11,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i599a67975f864f07aebaf0697665cb54_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMi0zLTEtMS0w_e9e5a98d-7c25-42f3-b75c-77b447a0a08e">6,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b78aeabdedf468b9432e0fbf7b1d35e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMi01LTEtMS0w_3cc68668-d9d9-4931-a268-3836cc55c21b">11,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b78aeabdedf468b9432e0fbf7b1d35e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMi03LTEtMS0w_c7e720fb-05be-4764-b4c8-4389229a434f">6,179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b873251f0164fcc87a5f68eb8697f6b_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMy0xLTEtMS0w_65dd1ed3-fa40-4929-b158-1c61298c5980">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b873251f0164fcc87a5f68eb8697f6b_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMy0zLTEtMS0w_a6df428c-7761-46b9-8fae-7a0539fdec97">397</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31b341f23ca42dd99d1f28259ed9778_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMy01LTEtMS0w_f84d9794-d955-40bd-9a54-7ef7c07fb938">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia31b341f23ca42dd99d1f28259ed9778_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMy03LTEtMS0w_74596438-d2cc-447b-9e8e-f8f7c912659e">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i106a39a0f8a64d958a6b4fc9ab669182_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNC0xLTEtMS0w_b22410dd-8933-4bc1-8d9f-7f1ed8f9acd3">1,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i106a39a0f8a64d958a6b4fc9ab669182_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNC0zLTEtMS0w_5b815e30-9603-48f6-bb08-d8450994f87e">1,278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b198018bdf848d58391e917618a9a73_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNC01LTEtMS0w_ea117e63-9483-4249-975b-9e16e395b022">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b198018bdf848d58391e917618a9a73_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNC03LTEtMS0w_b63b7a34-13e7-4244-8f86-4d06b00ac856">1,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNS0xLTEtMS0w_857c8535-ee8f-4de9-a5ec-f3ee77d0a8a6">13,607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNS0zLTEtMS0w_fd956a88-2c40-42d2-a647-de25425afffd">8,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNS01LTEtMS0w_67c8db57-fa5f-4cf9-b527-c261517083da">13,345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNS03LTEtMS0w_40e97ee9-15d9-416f-af77-8b25bff13a2d">7,806</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4614798867554623b71db7e485b17073_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNy0xLTEtMS0w_c4606122-1e86-4433-ba1b-638b8a2a44b0">20,774</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4614798867554623b71db7e485b17073_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNy0zLTEtMS0w_0697b056-c05c-4307-83b6-3cb448ef3efb">9,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66b850e1cf4c483cb4f780f209eb416e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNy01LTEtMS0w_f3940379-59da-4653-ac6d-abb4cbe7cb9d">19,924</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66b850e1cf4c483cb4f780f209eb416e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNy03LTEtMS0w_ea3f56af-85c6-4cc5-9b7a-e47df7934c52">9,973</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78944db109b43dab16a18b210d06a11_I20210630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfOS0xLTEtMS0w_99b2c116-f2ee-4910-8154-5f1e44c45fc5">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f4dc84c7b7d4d6784d95efacd9d16b7_I20201231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfOS01LTEtMS0w_30ec309d-18c3-4d84-ab15-bab6a1e54521">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6c58776dd93450391e647ab995a55fa_I20210630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMTAtMS0xLTEtMA_0a4442fa-952d-42ee-9699-678be9000ad7">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96e317c9a09f414dac29a749f0646452_I20201231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMTAtNS0xLTEtMA_8d9e244b-deb9-4ee8-bb72-d6582f71967b">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMTEtMS0xLTEtMA_8eafba4f-a94b-44b2-82eb-1d612569274c">330</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMTEtNS0xLTEtMA_6e2f1a1e-e781-4081-97ef-bdf153e63dcf">377</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In the fourth quarter of 2020, we recorded goodwill impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i4f13c163b758433eb6e1965892fb50b6_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfMjk5_10d353ea-6b41-48d1-aeb5-c1ab0856e005">73</ix:nonFraction>&#160;million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i4f13c163b758433eb6e1965892fb50b6_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfNTcx_10d353ea-6b41-48d1-aeb5-c1ab0856e005">73</ix:nonFraction>&#160;million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of June 30, 2021.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in our balance of goodwill and intangible assets is primarily related to our acquisition of Preventice in the first quarter of 2021.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ifb72411f1a4445dbacb3ed2631699591"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives. Our IPR&amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfNDcyNA_aef2bd2a-9684-4c72-9567-92bee912338d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic290401c00e44941bbe65f481b18918a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfMS0xLTEtMS0w_2e5818d7-a9a7-4414-a2a0-d05cb7314ad6">2,059</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7879670f05dc464cace4562bebcef4af_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfMS0zLTEtMS0w_c47d95e7-420a-493d-93dd-3fd98498d3e2">2,194</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1cd550c4b9f4493a5098816e165a726_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfMS01LTEtMS0w_f0f1bcba-585c-4139-9143-f8b5b80f1f7f">5,697</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfMS05LTEtMS0w_7a286fb4-1204-4d88-b06d-ca45259656c3">9,951</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and other changes in carrying amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if893495841d548ada62dd960d69a89bc_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNC0xLTEtMS0w_904f4c46-f93e-4150-94ca-c1de48b34592">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNC0zLTEtMS0w_6f529d8d-c6e9-4071-8d85-15669bf85329">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNC01LTEtMS0w_491825ec-ffd5-41f5-9e1a-18eb0baf07f6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNC05LTEtMS0w_c0db8b7f-59e6-4017-8546-06da7e17f1b3">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if893495841d548ada62dd960d69a89bc_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNS0xLTEtMS0w_5a27b57c-fe04-4c36-b951-9a595134179e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNS0zLTEtMS0w_3c88cf2d-94f0-488c-9100-ccced185f434">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNS01LTEtMS0w_d4bc4dc8-883e-45e8-952d-31320db9ce43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNS05LTEtMS0w_9480512c-e954-4178-ac42-1d42092d8c1c">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f4ff16aef048c5951b2ef3630ab4fe_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNy0xLTEtMS0w_6893a2f9-0114-4457-9778-02023dfe5a39">2,057</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i508addd37e5f4f7ab05debf8ce4a40c5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNy0zLTEtMS0w_7df9bbc3-280e-4d0a-a3b8-3c5c31e72d01">3,120</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9276b8fd7c5e459cb81f0d109ea9c590_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNy01LTEtMS0w_860ffb48-755b-4e48-bcf8-857a7d983681">5,698</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNy05LTEtMS0w_48bbdf81-1ac2-4eac-be11-0cb21145466e">10,874</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the divestiture on March 1, 2021, we presented the Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Asset Impairments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not record any goodwill impairment charges in the second quarter or first six months of 2021 or 2020. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of&#160;2021, we performed our annual goodwill impairment test for all of our reporting units using the quantitative approach described in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Othe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r (FASB ASC Topic 350). We identified the following reporting units in our 2021 annual goodwill impairment test: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health and Neuromodulation. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350.  We determined that the fair value of each reporting unit exceeded its carrying value and concluded that goodwill was not impaired or at risk of impairment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of  $<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfMTA5OTUxMTYzNDg5NA_1ace8909-c829-4f93-99a0-117b3edb4d6d">45</ix:nonFraction> million in the second quarter and first six months of 2021, $<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfMTA5OTUxMTYzNDkyNQ_fe06dc6f-0ef7-404e-b2fa-403c645d50ca">34</ix:nonFraction> million in the second quarter of 2020 and $<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfMTA5OTUxMTYzNDk3OQ_786486f6-c449-4e17-8283-ce29a1b9d993">233</ix:nonFraction> million in the first six months of 2020. We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life.  We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets.  In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist.  During the second quarter of 2021, we determined it was more likely than not that one of our indefinite-lived intangible assets was impaired based on our qualitative assessment of impairment indicators.  We tested the intangible asset for recoverability and recorded an impairment charge associated with incremental time and cost to complete the associated in-process research and development (IPR&amp;D) project.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment charges recorded in the first six months of 2020 were primarily associated with amortizable technology-related intangible assets that were initially established following our acquisition of nVision. These charges were recorded as a result of management&#8217;s decision to change commercial launch plans or discontinue certain R&amp;D programs based on cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTg0MDY_bccbd6ef-8437-4937-908f-0cc2750ab74f" continuedAt="i4cfee5a1efa7470dbcb9f11d88d9f7d8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. <ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzNzM_46970bd1-b9de-4c98-a32e-81693dca667c" continuedAt="i326c9f44f58b461591cf2ab6f79b9a0f" escape="true">Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i326c9f44f58b461591cf2ab6f79b9a0f">We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities, forecasted intercompany and third-party transactions, and net investments in certain subsidiaries. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in Euro, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax (OCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax (AOCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. For these derivative instruments, we elected to use the spot method to assess hedge effectiveness. We also elected to exclude the spot-forward difference, referred to as the excluded component, from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. As such, we defer recognition of foreign currency gains and losses within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and we reclassify amortization of the excluded component from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of June&#160;30, 2021 and December&#160;31, 2020, we designated as a net investment hedge a portion of our &#8364;<ix:nonFraction unitRef="eur" contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfNDY0OA_067e34e9-4261-4113-bfe8-f6a209bb059a">900</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfNDY4NA_97e4c152-9d82-4793-adc7-408e7d9a664a">0.625</ix:nonFraction>% senior notes issued in November 2019 and due in 2027. For these nonderivative instruments, we defer recognition of the foreign currency remeasurement gains </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="i4cfee5a1efa7470dbcb9f11d88d9f7d8" continuedAt="i86b5ba785ed543c3bcee509620aebaa7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and losses within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We reclassify these gains and losses to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than <ix:nonNumeric contextRef="id15fe40bbc1a49598899e77eca657086_D20210101-20210630" format="ixt-sec:durwordsen" name="us-gaap:DerivativeTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM2ODQ_c79c229a-f1f4-4f0a-91f4-e9f0ecc9ba7f">one year</ix:nonNumeric>, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="derivative_instrument" contextRef="i337a6f01680a4261a534fe13d39a19aa_I20201231" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfInterestRateDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MjQ_2654df20-1eff-4cc3-b5fd-e99cb98ec4b4"><ix:nonFraction unitRef="derivative_instrument" contextRef="i0484760d76d648ef90f70bb1389a147f_I20210630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfInterestRateDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MjQ_d8308761-8392-4462-a818-163976a17769">no</ix:nonFraction></ix:nonFraction> interest rate derivative instruments designated as cash flow hedges outstanding as of June&#160;30, 2021 and December&#160;31, 2020. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was a $<ix:nonFraction unitRef="usd" contextRef="i3139c7b655da4d49a12993d29146beea_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfNzM3Ng_9fa589e0-89c6-4b18-a2b0-ac569961657b">27</ix:nonFraction> million loss as of June&#160;30, 2021</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and a $<ix:nonFraction unitRef="usd" contextRef="ia68688cce8064b70bcca08cd6512a4ea_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfNzM5OQ_7ba43100-5ffc-4e40-a3d2-f2e96e443fc7">29</ix:nonFraction> million loss as of December&#160;31, 2020. We recognized immaterial gains and losses in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of our terminated cash flow hedges in the current and prior periods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="derivative_instrument" contextRef="i6ffac8f2ce0d4293b26df78d0ad2d8e0_I20210630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfInterestRateDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MTY_245a0d8b-d4df-4841-9bbf-f3cfa024c6ce"><ix:nonFraction unitRef="derivative_instrument" contextRef="i424e4f7e39a9410981b8ba416ccac4c3_I20201231" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfInterestRateDerivativesHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MTY_fc41e181-ab35-4dab-a5af-8d3eecff7a1c">no</ix:nonFraction></ix:nonFraction> interest rate derivative instruments designated as fair value hedges outstanding as of June&#160;30, 2021 and December&#160;31, 2020. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated balance sheets into earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which generally offset. The balance of the deferred gains on our terminated fair value hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was immaterial as of June&#160;30, 2021 and December&#160;31, 2020. We recognized immaterial gains in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of the terminated fair value hedges in the current and prior periods.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i86b5ba785ed543c3bcee509620aebaa7" continuedAt="i3edcd7a0e578496a8a97e31c54fbe852"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTg0MTQ_2b49b85d-7b6d-4361-81a1-dd09554cbc6c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.430%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf7143e00714f7a9f615443b868ca37_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfMi00LTEtMS0w_8d433ff6-6825-485e-9d42-bcf89bae55d2">4,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f98deb368144a69329cdfbbd8f2cc3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfMi02LTEtMS0w_b10c262b-7934-4319-8192-719f6089c2ba">4,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3020f06cb394eccb08b9f3827b65587_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfMy00LTEtMS0w_409c4c5a-2fac-4e89-8626-c4cc85e04abf">493</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27bdbdb9fd8a47e9b5c80577d41a1ec4_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfMy02LTEtMS0w_7600e480-06ed-420a-8f2a-f3cb9584dc88">1,004</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff3446af476436f83c776f6272d3517_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNC00LTEtMS0w_d7627040-d42c-49fb-b504-2f03c64a5731">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f69fa3f42484de3a5cd8686c169cf5e_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNC02LTEtMS0w_155a65ea-d458-4a13-b337-c209cc7511a0">868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc0aeafc5504f8491f1d7e2d12710bc_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNS00LTEtMS0w_57a50ece-51dd-4519-8efa-af9803d3e360">5,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2952dc166454f9fb8cff9b5579e82ac_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNS02LTEtMS0w_132f48d4-fa90-486b-934b-9f00eebcf447">4,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNy00LTEtMS0w_71509962-b824-41a2-98ee-51a4e45422c6">11,340</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNy02LTEtMS0w_10a53779-1216-4f0c-a32d-3ae0b7c56852">11,349</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;<ix:nonFraction unitRef="eur" contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfODgwNw_067e34e9-4261-4113-bfe8-f6a209bb059a">900</ix:nonFraction> million debt principal designated as a net investment hedge.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of June&#160;30, 2021 is within <ix:nonFraction unitRef="units" contextRef="if744488d910741f99e4dde8ee82cf4fa_I20210630" decimals="INF" name="bsx:ForwardCurrencyContractsTimetoMaturity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfODkxNA_1205fb5e-57ec-44f0-9717-31ec789e13ae">60</ix:nonFraction>&#160;months for all forward currency contracts designated as cash flow hedges and generally less than <ix:nonNumeric contextRef="id15fe40bbc1a49598899e77eca657086_D20210101-20210630" format="ixt-sec:durwordsen" name="us-gaap:DerivativeRemainingMaturity1" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MDE_f2d38532-4b4c-4407-b00e-eeb402081001">one year</ix:nonNumeric> for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next year. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="i3edcd7a0e578496a8a97e31c54fbe852" continuedAt="ica60a438bc474a75b2af3a274d1482c8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note M &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our accompanying unaudited consolidated statements of comprehensive income (loss).</span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzNjc_88444bea-8eb4-4fe3-b529-f80f2dc71316" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS0xLTEtMS0w_991eb754-054d-4c3f-b3b3-b241bbf91839">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS0yLTEtMS0w_3bfa2ead-3ae5-4dce-aba0-e2a5b2c944f6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS0zLTEtMS0w_bfccbaba-cac2-4066-99b5-7712c7e11780">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS02LTEtMS0w_1ea0b65f-3c8d-4020-b8b6-9f20ed1f6b4b">945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS04LTEtMS0w_95d2cfe6-316f-40c3-af6d-09161342dade">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS05LTEtMS0w_adee0f43-81b3-425d-8ec7-ffb61304fc70">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS0xMC0xLTEtMA_42a40994-41ee-4ee0-ba05-343f9f69fe54">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi0xLTEtMS0w_252782e9-0ec7-4e3d-8cf6-4e45490a458c">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi0yLTEtMS0w_ac22e943-2ec8-4860-9e00-eb576c3bab29">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi0zLTEtMS0w_1061ab01-6da0-48f5-8027-102188a8a00b">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi02LTEtMS0w_e04a22a4-52f7-418f-b9f9-936e1ec40a47">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi04LTEtMS0w_6bf34dd8-5294-479f-b0bb-57eb26199d52">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi05LTEtMS0w_16c441ff-b16f-47f3-b216-5e279fd7a919">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi0xMC0xLTEtMA_2bf097ba-8f2d-44b9-9a38-674679d8d381">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC0xLTEtMS0w_6e9beff1-0dbf-4f0c-bd26-fa244b27fa7b">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC0yLTEtMS0w_a8637ee3-4b33-4e54-9308-9ab75e7acd28">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC0zLTEtMS0w_dcebc427-c8dd-4fd3-90a8-c4ccab8d63eb">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC02LTEtMS0w_4eca890b-1c3c-43b3-a379-54db5a8de2a3">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC04LTEtMS0w_cdc0b017-afcb-4f99-beb8-cf509a23e2e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC05LTEtMS0w_5bff0805-d718-44bf-bcc4-1ade3eb31fe5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC0xMC0xLTEtMA_56b8a2eb-55e3-49ec-927a-ef00ce3d96c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtMS0xLTEtMA_e0264a3b-6d0e-43e3-b672-bb2830aa047c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtMi0xLTEtMA_a77bd999-1b1a-41fc-8bde-48f759e599c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtMy0xLTEtMA_f44d56dd-8969-4d92-a1c4-58357c4da15a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtNi0xLTEtMA_e04a22a4-52f7-418f-b9f9-936e1ec40a47">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtOC0xLTEtMA_acb1f94b-f990-4e2e-ae6a-bab3d07786d9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtOS0xLTEtMA_019ac6a9-3958-412d-a94a-50331248d3f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtMTAtMS0xLTA_89a8f566-19cd-4101-b746-940781d92a0b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtMS0xLTEtMA_6d0ed58d-0301-442e-b80e-26a6ca4f488f">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtMi0xLTEtMA_940464ec-999f-4f8a-82d0-cdd023ce4b4c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtMy0xLTEtMA_dd508aef-bd76-4aa9-bd55-7f528efa43de">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtNi0xLTEtMA_e13c179b-840b-4ff9-9fdd-c77218c21875">791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtOC0xLTEtMA_dbcb4b09-ea09-4bff-b5bf-f45e392a5771">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtOS0xLTEtMA_10822c3d-9aac-4a95-85d5-ba7d6cfc2c49">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtMTAtMS0xLTA_82aea098-54f5-44e8-baea-3a262935f54b">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtMS0xLTEtMA_c7215688-cd22-4162-8a8f-c2c649adb335">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtMi0xLTEtMA_9cb31f61-ce30-4f82-b453-091dcb9f8c94">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtMy0xLTEtMA_e17caf78-a40e-4620-9701-466ec8561f5b">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtNi0xLTEtMA_a03cfe2a-7064-4a60-bcc1-68b6368d68e3">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtOC0xLTEtMA_b348ae12-773a-4273-87d2-eae7bfec9530">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtOS0xLTEtMA_2c11c7df-ff76-4207-8a97-8d315766a5f8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtMTAtMS0xLTA_efa8cc1e-bacc-4355-bc86-c8b88f28f166">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtMS0xLTEtMA_a984509e-16c4-4367-bc7f-e5381466c3e7">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtMi0xLTEtMA_f13dd8e8-749c-4ea6-8da0-c2240db60863">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtMy0xLTEtMA_6029087d-2f57-45c0-9411-a802ba52e524">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtNi0xLTEtMA_9703e017-162c-4b79-9f7a-64e11e3cc06c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtOC0xLTEtMA_2f905414-cf2d-4c8c-8588-b5968af01bdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtOS0xLTEtMA_7840ae80-ccd3-4f5b-a290-af264bc34bdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtMTAtMS0xLTA_d6f28370-7c7e-43a4-b3cb-39f18b0d5304">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtMS0xLTEtMA_0e1f4574-8c30-4654-a307-3abce24ee875">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtMi0xLTEtMA_187eefc5-4c33-449c-a318-d2d41575ec64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtMy0xLTEtMA_acdf74b9-a372-4c92-a3ec-0a0c80aafdad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtNi0xLTEtMA_a03cfe2a-7064-4a60-bcc1-68b6368d68e3">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtOC0xLTEtMA_a73d3a3e-fd12-4204-8002-1847a35aa49f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtOS0xLTEtMA_923ea147-fb88-4117-a9da-96b4c9b313e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtMTAtMS0xLTA_83ec2ced-2244-414e-bfa3-a29ce75ada89">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtMS0xLTEtMA_2e6e524c-d5de-4f27-b953-2f2e501cf0fa">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtMi0xLTEtMA_9c07a64f-9ae1-4557-bb97-1e7025e624eb">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtMy0xLTEtMA_1b64f36f-ef0d-4f27-986b-adffc2cc103f">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtNi0xLTEtMA_cb45645d-2fe4-4394-9b09-5e92140c07d1">1,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtOC0xLTEtMA_51706250-b5a0-43d1-9919-c53bd003d4ff">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtOS0xLTEtMA_18a4b8e6-73c8-4296-8e04-d28092ed4580">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtMTAtMS0xLTA_8eac0ce8-c368-4c94-afa7-c73a6bb67b78">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItMS0xLTEtMA_67be6ed1-4e98-4282-8bec-220ad73f6230">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItMi0xLTEtMA_b23590a2-3b9d-49a4-85e0-6eebd947b2cb">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItMy0xLTEtMA_818f2b40-f24e-4ea8-9e74-4415cd27625a">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItNi0xLTEtMA_66aae967-2831-4749-bd0c-387703f44ac8">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItOC0xLTEtMA_d5ad9aef-f4a1-4eef-9522-796480f59d6e">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItOS0xLTEtMA_dc6f51f4-4eb0-4985-9677-a01c0236d54f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItMTAtMS0xLTA_4f55966f-9270-464a-964a-3371933dd92c">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtMS0xLTEtMA_febdf0bc-82a2-4334-8466-17c1658db4aa">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtMi0xLTEtMA_e807478c-4c93-4e4e-bf45-08557e892822">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtMy0xLTEtMA_bdc0274d-d739-477b-b141-7db2f51592c2">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtNi0xLTEtMA_a1943abd-edb9-4d5c-8bbe-434b0779a4ef">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtOC0xLTEtMA_22c300fe-595b-4458-bc1c-d52f279db06d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtOS0xLTEtMA_5eec4e18-2e89-4f02-964d-428b91cbfe78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtMTAtMS0xLTA_c9ca9b22-d728-4bdb-914e-b667d439c0d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtMS0xLTEtMA_994d720a-a4bc-4920-bfb0-cfec124e4c15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtMi0xLTEtMA_32f22dff-ee37-4f03-b27b-b8b67e5d9364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtMy0xLTEtMA_81274602-2f9b-4a33-a9ea-fe6fc493ba3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtNi0xLTEtMA_66aae967-2831-4749-bd0c-387703f44ac8">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtOC0xLTEtMA_a4584259-56d3-411c-9f27-043d8464f146">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtOS0xLTEtMA_2098315f-549e-4a8c-94c3-9b4cc1ec84a8">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtMTAtMS0xLTA_6652bb89-5f1c-4565-abac-375c5ae80ef3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktMS0xLTEtMA_9eaa7fd8-d653-4231-be26-3359f1e66572">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktMi0xLTEtMA_1b1489b5-2f5d-4a79-b369-8d7c582279d9">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktMy0xLTEtMA_f50906d5-da8a-4683-873b-3b338a9f4f59">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktNi0xLTEtMA_8c560163-dc37-4d04-9037-52a200d3f7ff">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktOC0xLTEtMA_9664e9a3-ca17-44a6-88db-41f385e4a76f">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktOS0xLTEtMA_a5f1cc5b-6363-4027-af53-98a86c38f44a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktMTAtMS0xLTA_427b1aa5-c568-41cf-826f-c4c3b907774d">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtMS0xLTEtMA_14967330-9251-451b-b0ca-66b309905255">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtMi0xLTEtMA_7b32db53-702d-4d8f-8f47-255e6e4766bb">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtMy0xLTEtMA_c997a784-7b9d-4eeb-9d8d-9d51c5288caf">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtNi0xLTEtMA_c81a8fbd-8f2c-46fa-ab79-e6bac39ed182">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtOC0xLTEtMA_09c4fed4-b000-42b3-9a4f-65cdfaa06e9d">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtOS0xLTEtMA_871e01a2-ba2f-4d48-96cc-c0231ce306f1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtMTAtMS0xLTA_a2d6ee0a-04e5-4dc6-bdbe-79abe0e8288a">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMS0xLTEtNTg5_230badf6-95cf-47cb-9bd9-df0befc63d15">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMi0xLTEtNTg5_c3c03e9b-2237-4bcf-a184-60bb358b4440">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMy0xLTEtNTg5_5325378b-1f97-4960-8798-273f150bf8ac">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItNi0xLTEtNjAz_a9cc47fb-e532-4a5d-9c9a-8d4a6e7003d7">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItOC0xLTEtNTk2_8ec74b2c-df9f-4144-9030-9cf1cb6fa46d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItOS0xLTEtNTk2_3d721657-1b44-459d-9bb6-947a4d57350c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMTAtMS0xLTU5Ng_823c9f53-c3ca-47a7-8c1b-a89fc527bd03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMS0xLTEtMA_bf74968f-930e-4224-b741-b3be7ceac950">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMi0xLTEtMA_919b29f8-15bb-441d-8656-7160025eadbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMy0xLTEtMA_20fe9f3b-fc78-4fbf-bae5-3b4e2dc83885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItNi0xLTEtMA_c81a8fbd-8f2c-46fa-ab79-e6bac39ed182">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItOC0xLTEtMA_8c0fdc44-4a8b-4797-b123-d0b876daaafa">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItOS0xLTEtMA_7f8be863-70d2-40b3-9004-8fbee3a0ad2f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMTAtMS0xLTA_cffea55a-4add-4a5a-a171-7749d613963a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. <ix:nonFraction unitRef="usd" contextRef="if0446aef545942b8b12a84b25e182179_D20200101-20200630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MzI_5f1a7ad7-0f72-406a-bdd5-9beb8ee0880e"><ix:nonFraction unitRef="usd" contextRef="iba71732844214aa3859047cf4cd1b074_D20200401-20200630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MzI_67d09de3-0f27-4504-b6d6-80f6ab87b1f9"><ix:nonFraction unitRef="usd" contextRef="ic356266b05f74a6b9f1191f2b815f11b_D20210401-20210630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MzI_f8a1fcca-0769-4728-892d-160bd16ba8de"><ix:nonFraction unitRef="usd" contextRef="i05caf238eba7451e935612a5c094056c_D20210101-20210630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MzI_fdc18186-e36d-459e-869a-8b01baa84757">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ica60a438bc474a75b2af3a274d1482c8" continuedAt="ic14b29d64fca450ea0a5732d55bf63b1"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzODM_f40a95cf-9ad8-4cf0-b15e-875a9d69db83" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:28.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.663%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c41329358c426dbfde24ddb1b29c13_I20210630" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjZmYWUyZWRlNjhmYTRmNzE4MTZhN2RiYTdhMTM0M2IwL3RhYmxlcmFuZ2U6NmZhZTJlZGU2OGZhNGY3MTgxNmE3ZGJhN2ExMzQzYjBfMS02LTEtMS0w_8a33686e-ef7e-4daa-866e-5b8a386fcebd">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i001157b3c6c14f6ab4a49a1468cbba56_I20210630" decimals="-6" name="bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjZmYWUyZWRlNjhmYTRmNzE4MTZhN2RiYTdhMTM0M2IwL3RhYmxlcmFuZ2U6NmZhZTJlZGU2OGZhNGY3MTgxNmE3ZGJhN2ExMzQzYjBfMi02LTEtMS0w_996cdfea-54ba-488e-9c28-f092d15a7639">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0d946dede0f4f31a139ab6bc367b6a4_I20210630" decimals="-6" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjZmYWUyZWRlNjhmYTRmNzE4MTZhN2RiYTdhMTM0M2IwL3RhYmxlcmFuZ2U6NmZhZTJlZGU2OGZhNGY3MTgxNmE3ZGJhN2ExMzQzYjBfMy02LTEtMS0w_98e7352d-d038-4852-907d-39da2b6174e8">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzNjE_ae074bb5-8233-45b8-a704-49412c1e5be0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idff7731f281941c9b10a57598c4f3fa3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMi00LTEtMS0w_7ed426d9-b49f-4088-9bf0-70b45dde74d9">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88819d9575244b1f9ae25324bd55ef4f_D20200401-20200630" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMi02LTEtMS0w_345430d9-7ec6-4410-95af-c0d08e297c89">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26eb37997b434810bb1db3a61e1958c8_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMi04LTEtMS0w_b1f28df4-a4d3-4479-9fa2-482d4d859c1a">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95b1b2df03b543738424133c5483532f_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMi0xMC0xLTEtMA_aa578989-95d3-4175-b4cb-8375121f7313">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idff7731f281941c9b10a57598c4f3fa3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMy00LTEtMS0w_4f2e1edd-3c75-440d-a104-7922deb68fa5">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88819d9575244b1f9ae25324bd55ef4f_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMy02LTEtMS0w_247b4705-3609-4009-abf8-89fca62a0367">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26eb37997b434810bb1db3a61e1958c8_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMy04LTEtMS0w_4eb7080e-40b8-4923-a12e-41e1112fbbad">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95b1b2df03b543738424133c5483532f_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMy0xMC0xLTEtMA_44da5ebc-26bf-4bb2-8e11-03abafa54a9c">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idff7731f281941c9b10a57598c4f3fa3_D20210401-20210630" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfNC00LTEtMS0w_aef9db64-64bd-4fe4-9f39-db041b87ea18">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88819d9575244b1f9ae25324bd55ef4f_D20200401-20200630" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfNC02LTEtMS0w_76c10f90-2c4b-4a44-abb2-5fc7c2474d3c">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26eb37997b434810bb1db3a61e1958c8_D20210101-20210630" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfNC04LTEtMS0w_b0d38794-97f3-4ec6-8d76-a91ff5532d28">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95b1b2df03b543738424133c5483532f_D20200101-20200630" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfNC0xMC0xLTEtMA_ddd5b089-49cc-44da-9eef-dca6ff8c833f">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzOTc_df1d1ed0-6169-45fd-be60-88c08fa063ae" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="ic14b29d64fca450ea0a5732d55bf63b1" continuedAt="i340f5c48fcea4455b6e1a03113a4366f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. <ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzOTQ_98aabb27-d837-4627-959e-259c1bf40629" continuedAt="ibadd034b9453452197ced37666862a5e" escape="true">The following are the balances of our derivative and nonderivative assets and liabilities:</ix:nonNumeric></span></div><ix:continuation id="ibadd034b9453452197ced37666862a5e"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.911%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i413490b8a5b549428c780264cd0fca96_I20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNC00LTEtMS0w_745f93f1-d9ae-4f47-9f9d-cc9e4bd9bac5">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7898c0ae54f649e3b3bd7531b4e96637_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNC02LTEtMS0w_ef4394d3-2c65-4dcb-be73-0011042c7c48">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e501501753d4bc3893312052f231981_I20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNS00LTEtMS0w_1eca8546-364f-4f06-95ee-85e2a5cd9d39">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc334024d192429bb461fc883b913f95_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNS02LTEtMS0w_1f057bd5-774a-449d-a334-064f2650f099">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i210e93bd44c944e39350884a3a028415_I20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNi00LTEtMS0w_0bb42a90-1f85-453b-baf4-b5ebbbcb8e69">284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b553319bf064b3fa60f0b256efd9a1e_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNi02LTEtMS0w_581552ac-1f3d-468c-ad03-be4e55a3e742">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a91e7a45fbc446c8783c08420680904_I20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfOC00LTEtMS0w_bab33cc7-8a03-4af7-b63a-166f03ba9335">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e8b4d9c146e4af78c9649552b795b81_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfOC02LTEtMS0w_12e08e0e-c8b6-4065-9712-3b40ed27f6d5">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTAtNC0xLTEtMA_a6423abe-b483-46e2-b8d1-f5e5e02f200c">322</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTAtNi0xLTEtMA_6e54a1af-ca9a-4c40-bc1d-11f5d05adfe1">242</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb50746f189146428dc3a086275c1f6e_I20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTQtNC0xLTEtMA_c742ff15-ee63-46a9-90f5-b83fc9c0ade9">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21748e73c93f404ebf1695c897f921fc_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTQtNi0xLTEtMA_13be6d9e-1e96-4373-9239-1c1dade2d294">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcd5967abae8433c8e776f2d4c8e34f5_I20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTUtNC0xLTEtMA_2c8524f0-80c9-4025-81cc-276904c23a72">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946142230e0d45968c7d35a681ee1ca7_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTUtNi0xLTEtMA_b820a557-76d2-4c8b-8e2f-92aefe7e0806">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d5a78c050d24c3998ce9d7394914716_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTYtNC0xLTEtMA_d7b97673-c4da-478a-a72b-7e53d620bfd4">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b3a25a0021455c82d237efda98677a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTYtNi0xLTEtMA_0f253fc8-13c2-414d-a44e-6bb911f29721">1,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i210e93bd44c944e39350884a3a028415_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTgtNC0xLTEtMA_7e29eef0-9514-418e-a9f4-5da6c9c4b945">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b553319bf064b3fa60f0b256efd9a1e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTgtNi0xLTEtMA_ec8c4602-ad5e-4626-94ac-0ae337e705d8">1,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28be2cc81b8646da8951fe8f886431ae_I20210630" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMjAtNC0xLTEtMA_6b1fbc1d-68a2-4a46-8d3c-91b9602fffa2">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd3a971d105c47e3b030d7146612746b_I20201231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMjAtNi0xLTEtMA_4d604062-0167-41fb-8916-0214e4a7c625">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMjEtNC0xLTEtMA_69ad0ee1-ed5f-40fe-ba1f-270da93d52a0">1,163</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMjEtNi0xLTEtMA_489214a8-5f8a-450e-899e-de629d9b73b7">1,262</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;<ix:nonFraction unitRef="eur" contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTI0ODY_067e34e9-4261-4113-bfe8-f6a209bb059a">900</ix:nonFraction> million debt principal designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="i340f5c48fcea4455b6e1a03113a4366f" continuedAt="ia98084bc83e74f5885f7c9c972d00b86"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzOTU_8bf78683-799c-4060-b752-a939b9617435" continuedAt="i04be5a10948e40f2909b21136faea578" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.039%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC0xLTEtMS0w_fc486bba-21d3-4409-b127-f1aba5563e3f">2,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d17d52c56344148e6f68416205f316_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC0zLTEtMS0w_a30088b4-ee29-486f-bfed-021b038e2a04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18328309825f40b887eb0ef197588dd3_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC01LTEtMS0w_89f3108a-1ee8-493e-8e10-954eb0ee4bb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8a220efc374460aac18c0864628e67_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC03LTEtMS0w_c69927e2-322b-4dfa-9cb3-f6e0d557a9a5">2,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC05LTEtMS0w_644c5b1e-7588-4943-9017-955d6780abd6">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC0xMS0xLTEtMA_0c1b45d4-4f9d-42bd-b111-7106f03e8404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC0xMy0xLTEtMA_84e19eb7-021e-494e-ba7d-d1a5a8aad9e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC0xNS0xLTEtMA_8048db0c-ba6b-4972-8fb2-2ad029b55851">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS0xLTEtMS0w_95f9d179-bcbb-43e6-a191-698555bec51f">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d17d52c56344148e6f68416205f316_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS0zLTEtMS0w_d1ea4731-e42e-41ab-9f74-292d4d9d13f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18328309825f40b887eb0ef197588dd3_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS01LTEtMS0w_8b6d8614-74e9-4a83-baa4-4607fe8ea18e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8a220efc374460aac18c0864628e67_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS03LTEtMS0w_04bfc84e-bcd5-49ff-a57b-eae5203efd15">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS05LTEtMS0w_c50769e4-54d8-416f-b0c5-33fc8530ae5f">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS0xMS0xLTEtMA_6befafe0-a61c-45f4-b987-452a89fd151f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS0xMy0xLTEtMA_9978b4c4-fd7c-4369-b09d-a35ca16b11d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS0xNS0xLTEtMA_95bb586c-021e-484c-8087-55845e30239a">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi0xLTEtMS0w_414b4c11-0549-4a75-b1a3-ed366647252e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d17d52c56344148e6f68416205f316_I20210630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi0zLTEtMS0w_5bad3be6-58ea-4260-9183-c0a348b4d1ee">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18328309825f40b887eb0ef197588dd3_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi01LTEtMS0w_5d480719-dd59-4e08-96dc-a6cbdd2f375f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8a220efc374460aac18c0864628e67_I20210630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi03LTEtMS0w_317c912e-09ce-4fe0-84cf-f771deae7e52">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi05LTEtMS0w_52aa409b-c04e-4bf4-9cca-3757e4132802">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi0xMS0xLTEtMA_cb6d15b4-08d8-455d-acbc-1c783b07e31a">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi0xMy0xLTEtMA_3c17218a-45df-4ead-add4-78628188589b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi0xNS0xLTEtMA_ee071d6a-d22a-4c42-b6dd-d69b686ecf50">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy0xLTEtMS0w_e1da296e-6919-4795-9623-d6d69b4c0673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d17d52c56344148e6f68416205f316_I20210630" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy0zLTEtMS0w_420add8a-a14b-41d6-8536-1d01d5b96db7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18328309825f40b887eb0ef197588dd3_I20210630" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy01LTEtMS0w_5f4ab9ac-ad8b-4bfc-8064-6ec6255543a5">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8a220efc374460aac18c0864628e67_I20210630" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy03LTEtMS0w_284d743f-a984-41de-bfbb-ad32ea5b92f0">311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy05LTEtMS0w_856054a3-3d60-4cb3-93ad-4e95746390f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy0xMS0xLTEtMA_687062f3-f8e4-4060-919e-ac9337f08a0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy0xMy0xLTEtMA_2fceb99c-a58b-4744-bc3f-37b6bc53bc49">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy0xNS0xLTEtMA_531da08d-c71b-46b7-8783-54cb37e230bd">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC0xLTEtMS0w_904e10b5-5595-48f5-bde5-2e753c3217f8">2,556</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d17d52c56344148e6f68416205f316_I20210630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC0zLTEtMS0w_cd893a99-41aa-4650-84fa-8101841e4665">322</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18328309825f40b887eb0ef197588dd3_I20210630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC01LTEtMS0w_30d5d746-0cc8-4fde-a32e-f12961c45e0a">311</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8a220efc374460aac18c0864628e67_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC03LTEtMS0w_bbba3b97-f732-4a45-aca2-60b233cc87be">3,189</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC05LTEtMS0w_a2254a9e-f564-4209-a2da-5f9861f88808">1,998</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC0xMS0xLTEtMA_625fe5fb-d8e6-45b8-8f14-299bed75d0da">242</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC0xMy0xLTEtMA_cd00a508-f338-4a16-854c-ad28a98f51f7">365</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC0xNS0xLTEtMA_d1eabee5-b13d-4bcd-8956-3682fa23e896">2,605</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtMS0xLTEtMA_853a2051-c5eb-4291-9e0e-85e3fb77bb39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d17d52c56344148e6f68416205f316_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtMy0xLTEtMA_58734b57-07b6-47de-920b-3c28da4b482d">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18328309825f40b887eb0ef197588dd3_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtNS0xLTEtMA_31ac34ce-2792-42a3-9ab2-76ba2cb480b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8a220efc374460aac18c0864628e67_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtNy0xLTEtMA_7b280743-469c-4853-a96f-113b54edd81a">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtOS0xLTEtMA_81c3339f-0e7c-4e13-9f91-c2017e76b58d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtMTEtMS0xLTA_e0af9e0f-67f9-4a25-ba5d-7e7baba57597">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtMTMtMS0xLTA_415b9a09-cf8e-4528-970c-171dc7aae1bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtMTUtMS0xLTA_83c9228a-8d1b-4da8-98db-d49a8f0848be">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtMS0xLTEtMA_5c4db3b9-b285-4129-a729-fa7565cc3304">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d17d52c56344148e6f68416205f316_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtMy0xLTEtMA_932c8da9-7987-41ab-9a08-7fe7b61386e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18328309825f40b887eb0ef197588dd3_I20210630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtNS0xLTEtMA_5b16dd2f-4da7-4a85-a812-31902ece6175">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8a220efc374460aac18c0864628e67_I20210630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtNy0xLTEtMA_c0d9150b-5921-490f-af01-d999ccac4ef6">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtOS0xLTEtMA_148f7a7f-94eb-44e0-b330-aae36cddf5bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtMTEtMS0xLTA_c7656389-b712-4729-be4c-610c53b53e3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtMTMtMS0xLTA_b0a15904-1097-46c8-aff7-d6b539e74122">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtMTUtMS0xLTA_05a138d6-6a78-404d-8190-09f105000aab">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItMS0xLTEtMA_d920cf25-3dcb-477f-9ba7-d461603cdda3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d17d52c56344148e6f68416205f316_I20210630" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItMy0xLTEtMA_71e00b47-a0cf-45f2-ab5a-434c03a03e1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18328309825f40b887eb0ef197588dd3_I20210630" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItNS0xLTEtMA_8bd55583-7823-4589-82f8-1b17992091f1">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8a220efc374460aac18c0864628e67_I20210630" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItNy0xLTEtMA_27dfe8b0-b6e6-4e21-a1b6-03d1f42eb51d">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItOS0xLTEtMA_e2fe8f6a-6277-473d-b18f-529cc15cc45f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItMTEtMS0xLTA_d59d57f1-3220-4878-88e0-cf3be323fde8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItMTMtMS0xLTA_e42584b8-d5af-4a4b-88aa-6d41f9ba2095">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItMTUtMS0xLTA_c55108ba-1820-472a-aa2f-159d16ad0628">407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtMS0xLTEtMA_8b6e5a67-b483-49fa-8277-94a8eabc7f28">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d17d52c56344148e6f68416205f316_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtMy0xLTEtMA_55160e3a-9bb8-46b0-9ed8-0a1e39d902ca">1,163</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18328309825f40b887eb0ef197588dd3_I20210630" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtNS0xLTEtMA_d1179ce2-15d0-441f-b4be-5063494b95d1">662</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f8a220efc374460aac18c0864628e67_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtNy0xLTEtMA_b422fee9-fe1d-4c2e-9926-84b049f8538c">1,825</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtOS0xLTEtMA_6e7a56df-e98c-4c70-9ba7-b86cf6b00de2">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtMTEtMS0xLTA_6be413ff-e211-4e37-bbae-857aea2500c9">1,262</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtMTMtMS0xLTA_d4be7b76-1b57-4a9a-a3d3-1de0eff3f46c">603</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtMTUtMS0xLTA_23eee5f0-d86f-4b7a-ba3f-7e4953536ba1">1,865</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $<ix:nonFraction unitRef="usd" contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTQxODg_fc486bba-21d3-4409-b127-f1aba5563e3f">2.379</ix:nonFraction> billion invested in money market funds and time deposits as of June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTQyNTM_644c5b1e-7588-4943-9017-955d6780abd6">1.584</ix:nonFraction> billion as of December&#160;31, 2020, we held $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTQyNzQ_90932876-3414-4301-b527-e8b746b77660">296</ix:nonFraction> million in interest-bearing and non-interest-bearing bank accounts as of June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTQzNDk_ddeddbbb-ea20-4ebc-b061-5dc2b74e2da9">150</ix:nonFraction> million as of December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#8482; Drug. We recognized a financial asset and associated liability for our licensing arrangements at fair value in our accompanying unaudited consolidated balance sheets using the fair value option in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own the contractual right to receive <ix:nonFraction unitRef="number" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="2" format="ixt:numdotdecimal" name="bsx:LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMjc0ODc3OTA4OTExMw_c56e2464-3117-4266-9988-3840af10aba5">50</ix:nonFraction> percent of the future royalty payments from the licensee and remit such payments to the inventors associated with the intellectual property. Royalty payments we receive reduce the fair value of the financial asset and are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and payments we remit to inventors reduce the fair value of the financial liability and are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our unaudited consolidated statements of cash flows. We sold our right to receive and retain the other <ix:nonFraction unitRef="number" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="2" format="ixt:numdotdecimal" name="bsx:LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMjc0ODc3OTA4OTUzMg_cb3f785d-d5fa-4c01-80f8-f89cc5c7c776">50</ix:nonFraction> percent of the future royalty payments in 2019 for an upfront cash payment, which we accounted for as a secured borrowing in accordance with FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Although we sold these rights, we continue to recognize at fair value the future royalty payments as a financial asset and associated liability. Royalty payments associated with the rights we sold no longer impact our cash flows, and we present this activity as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-cash impact of transferred royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the supplemental information to our unaudited consolidated statements of cash flows. We reduce the fair value of the financial asset and associated liability when such non-cash activity occurs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recorded the fair value of the financial asset and associated liability using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of June&#160;30, 2021.  However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains and losses from the licensing arrangement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i04be5a10948e40f2909b21136faea578" continuedAt="i81165599410c4378bab9cb79eb2639cb">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2021 include the following significant unobservable inputs:</ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="ia98084bc83e74f5885f7c9c972d00b86"><ix:continuation id="i81165599410c4378bab9cb79eb2639cb"><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (1)</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iaff031e690ad46fcb10f2ceedfa9fcf9_I20210630" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfMS0xLTEtMS0w_1f53eaf0-0f52-44d5-a703-c9733b8c1696">311</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40d5ba9cb66f46eba6179aa8dc2f4775_I20210630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfMS00LTEtMS0w_8a4e95c5-4dc0-4c6c-95ff-c397054c2402">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1b99fcb316c84c26af31432735c4acc8_I20210630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfMS03LTEtMS0w_0ffeda7a-1040-406e-aa8c-9255999ea70f">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iaff031e690ad46fcb10f2ceedfa9fcf9_I20210630" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfNC0xLTEtMS0w_05f42270-5f28-4050-996b-25f5f6e37a3f">350</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebc173f0990b4117b9314d607dba9671_I20210630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfNC00LTEtMS0w_2ca6d882-efd9-42cd-9d8a-6503c5ee198c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if33791e7ffab49859998b3df9fa1bafb_I20210630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfNC02LTEtMS0w_1200c783-1020-482b-ab5f-a63879fdf2b0">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied2279ddd55248389453413b491c815f_I20210630" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfNC03LTEtMS0w_be2b0112-abe9-430f-89b7-e9bb606ac02e">13</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmNjYjExNzcxM2Q3NTRhMzBiNDlkMzE0OTI4ZTVlNzMwL3RhYmxlcmFuZ2U6Y2NiMTE3NzEzZDc1NGEzMGI0OWQzMTQ5MjhlNWU3MzBfMS0xLTEtMS0w_5bfb400d-4009-4e62-a076-041956881eda">365</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e77807bef8c44ccb81fbc0e7ba9b799_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmNjYjExNzcxM2Q3NTRhMzBiNDlkMzE0OTI4ZTVlNzMwL3RhYmxlcmFuZ2U6Y2NiMTE3NzEzZDc1NGEzMGI0OWQzMTQ5MjhlNWU3MzBfMy0xLTEtMS0w_75d23b36-a83b-4bea-8517-c8044cccc140">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40d5ba9cb66f46eba6179aa8dc2f4775_I20210630" decimals="-6" sign="-" name="bsx:Noncashimpactoftransferredroyaltyrights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmNjYjExNzcxM2Q3NTRhMzBiNDlkMzE0OTI4ZTVlNzMwL3RhYmxlcmFuZ2U6Y2NiMTE3NzEzZDc1NGEzMGI0OWQzMTQ5MjhlNWU3MzBfNS0xLTEtMS0w_5f1b5fa2-9c7e-44ef-a7e3-3557ba5afd88">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e77807bef8c44ccb81fbc0e7ba9b799_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmNjYjExNzcxM2Q3NTRhMzBiNDlkMzE0OTI4ZTVlNzMwL3RhYmxlcmFuZ2U6Y2NiMTE3NzEzZDc1NGEzMGI0OWQzMTQ5MjhlNWU3MzBfNi0xLTEtMS0w_adc5ddda-558b-4c21-9061-74474386734c">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18328309825f40b887eb0ef197588dd3_I20210630" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmNjYjExNzcxM2Q3NTRhMzBiNDlkMzE0OTI4ZTVlNzMwL3RhYmxlcmFuZ2U6Y2NiMTE3NzEzZDc1NGEzMGI0OWQzMTQ5MjhlNWU3MzBfNy0xLTEtMS0w_79056c2e-3ce0-477a-98b6-54871ebe6508">311</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjdhZTYwNmI0Y2VlNTQwNDZhYzM3ZjBkYmFhYjBiZmI5L3RhYmxlcmFuZ2U6N2FlNjA2YjRjZWU1NDA0NmFjMzdmMGRiYWFiMGJmYjlfMS0xLTEtMS0w_f1f3d48d-3c2d-4643-8666-20990c89a79f">407</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20ed1fc05de34698bdf7cd17009bebce_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsForRoyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjdhZTYwNmI0Y2VlNTQwNDZhYzM3ZjBkYmFhYjBiZmI5L3RhYmxlcmFuZ2U6N2FlNjA2YjRjZWU1NDA0NmFjMzdmMGRiYWFiMGJmYjlfMy0xLTEtMS0w_84a14513-5441-41fc-9d44-6fceba6a758a">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i600d7a0e156944d8a7e0b2f8e0296f7b_I20210630" decimals="-6" sign="-" name="bsx:Noncashimpactoftransferredroyaltyrights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjdhZTYwNmI0Y2VlNTQwNDZhYzM3ZjBkYmFhYjBiZmI5L3RhYmxlcmFuZ2U6N2FlNjA2YjRjZWU1NDA0NmFjMzdmMGRiYWFiMGJmYjlfNi0xLTEtMS0w_9c2b1522-5bf1-4006-8867-6b0e53c862a4">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20ed1fc05de34698bdf7cd17009bebce_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjdhZTYwNmI0Y2VlNTQwNDZhYzM3ZjBkYmFhYjBiZmI5L3RhYmxlcmFuZ2U6N2FlNjA2YjRjZWU1NDA0NmFjMzdmMGRiYWFiMGJmYjlfNy0xLTEtMS0w_30f6238e-66fc-4c28-bdf4-299c46ce2b15">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18328309825f40b887eb0ef197588dd3_I20210630" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjdhZTYwNmI0Y2VlNTQwNDZhYzM3ZjBkYmFhYjBiZmI5L3RhYmxlcmFuZ2U6N2FlNjA2YjRjZWU1NDA0NmFjMzdmMGRiYWFiMGJmYjlfOC0xLTEtMS0w_8c29d907-3f77-488a-a75e-5f4e92263c3b">350</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc5Mjg_aba47dae-e318-4fa0-a4fa-3104cda8490f">10.431</ix:nonFraction> billion as of June&#160;30, 2021, including $<ix:nonFraction unitRef="usd" contextRef="i21198075aed84d47b40aa66db088ddc3_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc5NTE_8fbe7b46-c5ee-4fd8-87c6-831324212419">1.085</ix:nonFraction> billion relating to our euro-denominated December 2027 Notes, and $<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc5OTU_0e183312-5c81-4f6e-be9c-f72c206e2d6a">10.774</ix:nonFraction> billion as of December&#160;31, 2020, including $<ix:nonFraction unitRef="usd" contextRef="i103abe8f6cc04293824af37a171f38cb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgwMTg_91ea671b-6e9a-4d42-83df-afbafe4e522f">1.118</ix:nonFraction> billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMzI5ODUzNDg5NzAxMw_c4cca33c-9d27-4b6e-bdc4-70ccc9f1f3f5" continuedAt="ie20050b6edd34dcbbeac6d0a94a2c418" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE E &#8211; CONTRACTUAL OBLIGATIONS AND COMMITMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings and Credit Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total debt outstanding of $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNzk_623a70cd-aa78-441d-b1fd-065b064ec636">9.109</ix:nonFraction> billion as of June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfOTU_7f12e15a-d3a8-4804-91aa-8241d8cbbbee">9.143</ix:nonFraction> billion as of December&#160;31, 2020, with current maturities of $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTM1_ac277396-494f-4899-92d6-fc524ac830ce">262</ix:nonFraction> million as of June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTUx_f38e27a3-00d2-4298-aae8-13a49fbe111a">13</ix:nonFraction> million as of December&#160;31, 2020. The debt maturity schedule for our long-term debt obligations is presented below: </span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNjAxNA_9a0d0171-766d-40c9-8df3-30876ed1a70e" escape="true"><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:29.398%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.847%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, <br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967915e4b5a34078a3ed31f7f97e8af1_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMi02LTEtMS0w_73ce400f-4102-4aab-ba84-b9d7eae35b92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b8b74de08d42a5b1c298735f31c874_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMi04LTEtMS0w_0e10eb86-ddec-4de0-b3d9-62468b4a62e2">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i967915e4b5a34078a3ed31f7f97e8af1_I20210630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMi0xMC0xLTEtMA_c15ce4ce-2c44-4b24-ae97-07afb9737c0d">3.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia41c2dcb7c86466189b28d6c0003d505_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMy02LTEtMS0w_1ed1bf8a-5ca3-444f-9a45-6741232ce7ea">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadb3d909cec9465983bd9071804b27c8_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMy04LTEtMS0w_abef792f-fd98-4490-be5f-77446f09c0ab">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia41c2dcb7c86466189b28d6c0003d505_I20210630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMy0xMC0xLTEtMA_08d2c108-3571-4f60-81df-fcd4f048ffe8">4.125</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id982ae5b53e04126a7116a0047e53636_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNC02LTEtMS0w_fdd941bb-4175-47e0-b2e2-719e0fcd7ab6">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i113b5c1b952f4594980deebf9d2fb6a3_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNC04LTEtMS0w_2e32a79b-4923-495a-9835-ab683f0c2a44">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id982ae5b53e04126a7116a0047e53636_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNC0xMC0xLTEtMA_32113cd5-96a5-476d-b90c-c5a3906f7645">3.450</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab91815c6bd40d0a0b1e317ea65c8da_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNS02LTEtMS0w_87c63e8a-9b75-44dd-a550-b1029058a289">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a47cf5a6694115904cfd355585ca6a_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNS04LTEtMS0w_75e472d2-bb9f-48a5-a800-357c2fdf045b">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifab91815c6bd40d0a0b1e317ea65c8da_I20210630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNS0xMC0xLTEtMA_a26f4e2d-bb73-4770-9eb1-29e242f04e26">3.850</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d2f3b419c994bdc94530fd56efedbc8_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNi02LTEtMS0w_b1d36ed3-bfc7-4cff-8992-d44147b52289">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561c09a8d18c4e8bb44fee39130ac6ab_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNi04LTEtMS0w_0a5d527c-b467-4e39-b314-f07749f0b7bd">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9d2f3b419c994bdc94530fd56efedbc8_I20210630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNi0xMC0xLTEtMA_4ef807ab-1682-4be4-9131-6200c0eeea6e">1.900</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ac7a01ed6b40a8b651ab864a06c209_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNy02LTEtMS0w_1f791372-8195-47fc-aefc-e9d0a96432aa">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ae2e6d62514176973bc35a7110c630_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNy04LTEtMS0w_62e282f4-c863-4373-b094-23d01daec4c7">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i46ac7a01ed6b40a8b651ab864a06c209_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNy0xMC0xLTEtMA_b8c73163-e981-405e-860a-bb1acb6447aa">3.750</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOC02LTEtMS0w_8a541254-ca4d-46de-8b49-59f022007abc">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id72fc66e7aab4c62aaf40ffff524b1e0_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOC04LTEtMS0w_9bfda7d6-a993-4978-b2b5-6e24fa17e6ab">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOC0xMC0xLTEtMA_64dd6e6e-cf0d-4c8e-a40d-5cf045200ac5">0.625</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia351226c94354547b45c1fab925a288e_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOS02LTEtMS0w_50598f99-ffce-47f9-a6cc-77e64ad59c27">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ca05e25f325480fa19833b9a5aa88d6_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOS04LTEtMS0w_1192aeea-9bd3-4fcb-bbe4-51c4adf9da31">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia351226c94354547b45c1fab925a288e_I20210630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOS0xMC0xLTEtMA_75dcb723-e76f-4a65-b596-0f2a496f2b62">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a197ee399d4df089f8b6bc2882477f_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTAtNi0xLTEtMA_29870ec5-9728-4ca4-94e8-0a9d6960c516">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e07d9a4bf44725bb8890bf0ddccb0c_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTAtOC0xLTEtMA_a226da5e-d5c3-497f-9a48-7fa41262bfb4">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62a197ee399d4df089f8b6bc2882477f_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTAtMTAtMS0xLTA_be18d88a-058b-45b3-a7cf-455b450b01a0">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbf7a2beb3741228b363f15a8f99e4d_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTEtNi0xLTEtMA_4a272fb0-d185-432c-b55b-5646ef3d9bbc">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic01cfb8ffa714da4ac584f4ba607a604_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTEtOC0xLTEtMA_fb4acda2-1a71-4f14-b7df-2f642a5ace35">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bbf7a2beb3741228b363f15a8f99e4d_I20210630" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTEtMTAtMS0xLTA_fbf72558-363d-4365-b6a2-85f2491161ca">2.650</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2273a18a922d4ba9bb8f7b6d48223471_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTItNi0xLTEtMA_3c7666b1-cd6d-4f6a-978b-3c36e5a1244f">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide4c06b245c8483d952138db789ef503_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTItOC0xLTEtMA_10c87010-1087-4a6e-893f-cde7b6d44823">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2273a18a922d4ba9bb8f7b6d48223471_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTItMTAtMS0xLTA_a8dda4fd-d424-46c7-b78c-3e0a11442fad">7.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1023571c063440c1b72bde0cc574f3fc_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTMtNi0xLTEtMA_f5acd0bb-ef91-4368-813c-7b61b03cddb8">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6c5049e8c5a466cacfec15d36c0b17c_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTMtOC0xLTEtMA_548a715a-23f8-4b3a-be4f-3ee46f7352c4">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1023571c063440c1b72bde0cc574f3fc_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTMtMTAtMS0xLTA_ad7bce35-274e-42ae-b4cd-40151b8f062a">4.550</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic047224d612c40f3b5da3c6df601c6b4_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTQtNi0xLTEtMA_48563624-7949-49bb-a42a-e7cae9cd3026">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba59ff767fc24dffbfa0f7a3f3061b30_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTQtOC0xLTEtMA_a246d7cc-2fd4-424b-8405-f247e6ebf6ab">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic047224d612c40f3b5da3c6df601c6b4_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTQtMTAtMS0xLTA_ef47d023-d4a0-4cb2-b733-24bfc2957229">7.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5320ad72c40043dbadbade7185c3451d_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTUtNi0xLTEtMA_2a1816a5-d430-4eb0-bb53-9c7a083eaba6">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90a40bf358b54433a3a649f92522cdd3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTUtOC0xLTEtMA_4b190b9b-b712-4de3-8f6a-0a3d79d9db43">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5320ad72c40043dbadbade7185c3451d_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTUtMTAtMS0xLTA_706cd27d-d6a7-402c-b123-3c8ab527ce54">4.700</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Deferred Financing Costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i809eea6504914ca685965d4b388d35d1_I20210630" decimals="-6" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTYtNi0xLTEtMA_53237542-a018-4843-8958-f4f9ca472105">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b03ff8312654acdabd6f4b180d73c5f_I20201231" decimals="-6" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTYtOC0xLTEtMA_09f32223-5815-41e2-a61d-0d4bb027cdbb">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia44ed01226c64b529960a7be9715fdb1_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTctNi0xLTEtMA_dc64b091-0af5-41f3-9a6a-97f7c1d462b5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06d4aa1475745f9bd667036ca6a77e6_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTctOC0xLTEtMA_5d5b8abf-1cf3-47cf-b66c-283ce84c00ff">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0771aaf382b64bbbb9ca530005018dcb_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTgtNi0xLTEtMA_301992e6-f482-48df-a2e0-3fa18d706ef9">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce283f07399443fbbfa2409543233c0_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTgtOC0xLTEtMA_e577715b-2dcd-4b0b-b3f1-aa303680cb19">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTktNi0xLTEtMA_b3922d38-f031-4966-9a8d-523f10fca5b2">8,847</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTktOC0xLTEtMA_dfb4dbf9-0697-4856-a05a-5bcb3627c034">9,130</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)   As of June 30, 2021 the outstanding balance is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Current Debt Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our unaudited consolidated balance sheet.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2021 we entered into a new $<ix:nonFraction unitRef="usd" contextRef="ie78d090db6af43d5964a7c874aa66780_I20210510" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTA5OTUxMTYzNTc4Mg_dff319ca-7b63-481f-9eda-a35abeb5679b">2.750</ix:nonFraction> billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with <ix:nonNumeric contextRef="ie5bb1bffb92d48848c682a120ac50575_D20210510-20210510" format="ixt-sec:durwordsen" name="bsx:DebtInstrumentExtensionOptionTerm" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTc1OTIxODYwNTUzMjU_501408fa-a52f-4e83-8498-e2d5a94c15cb">one-year</ix:nonNumeric> extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were <ix:nonFraction unitRef="usd" contextRef="i9e96838cdc7b44c4a1afe15baaa3ef77_I20210630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTc1OTIxODYwNTUzMjg_0e1ab228-19cf-4be6-9639-0e5b4113b1cf"><ix:nonFraction unitRef="usd" contextRef="i3a4283b5db0d475db38e71d73bfd1d3c_I20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTc1OTIxODYwNTUzMjg_af5a3d9a-d141-4655-b478-15d80c8c11dd">no</ix:nonFraction></ix:nonFraction> amounts outstanding under the 2021 Revolving Credit Facility as of June&#160;30, 2021 or under the 2018 Revolving Credit Facility as of December&#160;31, 2020.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="ie20050b6edd34dcbbeac6d0a94a2c418" continuedAt="i634e13a243ea495da039d9750075874b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through June&#160;30, 2021, we were in compliance with the financial covenant required by the credit facilities described above: </span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNTk5Mw_7122d4ee-da12-4b63-a68c-cf18085a85bd" escape="true"><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:32.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26601067bda84bc3b9685478594ecd99_I20210630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjdlMjhiMTE4NTM3ODRkNjBhMmVmYTI3YzBhOWU2ZTIwL3RhYmxlcmFuZ2U6N2UyOGIxMTg1Mzc4NGQ2MGEyZWZhMjdjMGE5ZTZlMjBfMi0yLTEtMS0w_d94985b8-6d04-407b-ae6d-c9f1025aac1d">4.25</ix:nonFraction> times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d083bcc1b4a04b64d12c8d91b4941_I20210630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjdlMjhiMTE4NTM3ODRkNjBhMmVmYTI3YzBhOWU2ZTIwL3RhYmxlcmFuZ2U6N2UyOGIxMTg1Mzc4NGQ2MGEyZWZhMjdjMGE5ZTZlMjBfMi00LTEtMS0w_d502904f-7432-4a28-88c5-1a22fc9a0087">3.06</ix:nonFraction> times</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 2021 Revolving Credit Facility includes the following financial covenant requirement for all of our credit arrangements (i)  maintain the maximum permitted leverage ratio of <ix:nonFraction unitRef="number" contextRef="i20c8d3b79ea24e50b1f3b5cff5b34259_I20210510" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjE0MA_a04c3004-3586-46a5-b8da-88190c6e3838">4.25</ix:nonFraction> times for the second quarter of 2021, with a step-down for each succeeding fiscal quarter end, beginning with the third quarter of 2021, to <ix:nonFraction unitRef="number" contextRef="i2386476e4d86430cb1177af6ed201651_I20210630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTA5OTUxMTYzNjE2OA_abe53960-a40b-4c4f-8f18-bf1d327731d9">4.00</ix:nonFraction> times and <ix:nonFraction unitRef="number" contextRef="i73dd07304f00449f9f1e3862f53fd60c_I20210630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTA5OTUxMTYzNjI3OA_973836ca-7307-452f-ade9-ae866ef3a5c2">3.75</ix:nonFraction> times for the fourth quarter of 2021 and through the remaining term of the 2021 Revolving Credit Facility. The agreement provides for higher leverage ratios for the period following a qualified acquisition, at our election, for which consideration exceeds $<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="bsx:QualifiedAcquisitionConsideration" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA3ODg2MQ_ef4d1e14-64eb-466d-8326-7a11b7f44cfb">1.000</ix:nonFraction> billion.  In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted leverage ratio is <ix:nonFraction unitRef="number" contextRef="ic8cfbd87e22b48faaa5fcd00545825a2_I20210630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA4Mjk5MA_f9e5b3ac-a630-452d-899d-fcc08b7742fe">4.75</ix:nonFraction> times.  It steps down for the fifth, sixth and seventh succeeding quarters to <ix:nonFraction unitRef="number" contextRef="i0047d354b82246a986ea67a506f95e0f_I20210630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA4MzAwMw_607c0273-c8b7-4b6f-bc7e-c8f40975b67c">4.50</ix:nonFraction> times, <ix:nonFraction unitRef="number" contextRef="ia027378c26254f43aa24b3d62083d405_I20210630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA4MzAxNg_6d99a4c0-9b0e-4772-a001-03c7c5aadb44">4.25</ix:nonFraction> times  and <ix:nonFraction unitRef="number" contextRef="ic85f1b8888bb425194c965e58e0b2e74_I20210630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA4MzAzMA_6048f3a9-29e4-4eba-9064-eebaa0055f5c">4.00</ix:nonFraction> times, respectively.  Thereafter, a maximum leverage ratio of <ix:nonFraction unitRef="number" contextRef="iec922493e5094a03bf6f1519d2177851_I20210630" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA4MzA0Mw_c6185041-3e51-4398-b412-1aea821d165d">3.75</ix:nonFraction> times is required through the remaining term of the 2021 Revolving Credit Facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreements, through maturity, of any non-cash charges and up to  $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bsx:ExclusionFromEbitdaForRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjU3NA_d52a53aa-1ace-4f20-abcd-ac5e9078db55">500</ix:nonFraction> million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of June&#160;30, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjcwOA_e35997a8-2757-4c8c-b779-cb121ee96363">467</ix:nonFraction> million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed  $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bsx:LitigationAndDebtExclusionFromEbitda" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMzA0MA_aa17080c-5dc8-4cac-8627-f72a70776e8e">1.455</ix:nonFraction> billion in the aggregate. As of June&#160;30, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMzA3OA_5df0186b-71af-4b32-ae63-0b9f08e86781">1.303</ix:nonFraction> billion of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this covenant could require us to seek to further renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our commercial paper program is backed by the 2021 Revolving Credit Facility, as discussed above, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. We did not have any commercial paper outstanding as of June&#160;30, 2021 or December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $<ix:nonFraction unitRef="usd" contextRef="i809eea6504914ca685965d4b388d35d1_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNDI2OA_036ef291-0434-4676-aa23-851d6883ed35">9.168</ix:nonFraction> billion as of June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i8b03ff8312654acdabd6f4b180d73c5f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNDI4NA_e324c8e6-403e-4b74-aec6-9fa783611383">9.205</ix:nonFraction> billion as of December&#160;31, 2020. Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="i634e13a243ea495da039d9750075874b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts de-recognized for accounts and notes receivable, which are excluded from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying unaudited consolidated balance sheets, are aggregated by contract denominated currency below (in millions):</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNTk5NA_48d0d7c3-a1d5-4d3f-8b47-83548a61acc8" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.912%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11e8d32cc0a047e98a98d79bfa03d913_I20210630" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMi0xLTEtMS0w_ffc8dfca-5f01-4c90-9410-3ea77f8e4d92">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b8038e17bb14aca9760b9b13c4a71eb_D20210101-20210630" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMi0zLTEtMS0w_d5904be1-65a4-44a3-8f66-92b6d0f101bb">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id36ab86f2da34a9c8eac8655594d345f_I20201231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMi01LTEtMS0w_062832be-1c86-438f-b80b-b1cd52ae50c5">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24cd97ee251b48559141f4a71903a86f_D20200101-20201231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMi03LTEtMS0w_760f2410-8928-4fd2-82ee-28059a10ca57">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ac4d1c50e424a77a8190f95382d7215_I20210630" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMy0xLTEtMS0w_d0263136-9c73-45cb-bac0-c971ddc61698">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icaaff822293a4cdd9e2c363357a949b3_D20210101-20210630" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMy0zLTEtMS0w_ac729c9a-1fce-4aa9-be10-17ffd82b1d9e">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e14eaa94afa46c089e40f5f8fc742f6_I20201231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMy01LTEtMS0w_f81ca6d2-8799-45e1-8895-02ebad7d9627">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib85a49f2cb27434db4be4cdcf2cd10c4_D20200101-20201231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMy03LTEtMS0w_c38894e8-8128-4081-88c1-8144a5c5097b">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e0c97078b824377aae934b984b2c65a_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfNC0xLTEtMS0w_0e155cc4-c10c-45d1-93d3-db9cc7f3fe41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9a197d277f374157b6cbffd8871e4fff_D20210101-20210630" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfNC0zLTEtMS0w_6e0a4ed0-4179-46f8-ad91-96e208d37c4d">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dcfc90377704002bd6e0af127de50c6_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfNC01LTEtMS0w_fd1ade6d-365e-4d6a-af93-ce8df30f205f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i436cfe41ac964ae79776eea028f62811_D20200101-20201231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfNC03LTEtMS0w_cf5c6658-dc11-4776-a636-fdecbcb2c0b1">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNTM5Mg_10f189af-d722-4188-acee-e2e14ce4a320">135</ix:nonFraction> million as of June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNTQwOA_36b4ac0c-9459-4a37-aaff-9db902b81981">124</ix:nonFraction> million as of December&#160;31, 2020, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of June&#160;30, 2021 and December&#160;31, 2020, none of the beneficiaries had drawn upon the letters of credit or guarantees, and accordingly, we have not recognized a related liability for our outstanding letters of credit in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2021 and December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_73"></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU5OA_54334634-e513-4f63-989d-10352e5a8747" continuedAt="i97df6e577bfb4544bd7163ccd552faaf" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in our accompanying unaudited consolidated balance sheets are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU0Ng_380bb1bd-600b-4131-9b65-b124d14e6342" continuedAt="i3673def91c034a7ea8ac8e6c7770eaef" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfMi0xLTEtMS0w_8aca5a30-3378-4208-a805-23eb3e29fb14">1,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfMi0zLTEtMS0w_95c0897d-6d2a-4d6f-817d-78a6a3f9e546">1,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfMy0xLTEtMS0w_3eecdb20-d355-4932-b83f-e25cdd37e38e">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfMy0zLTEtMS0w_1675d202-b50d-48c4-87bf-1d981b5c5c3d">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfNC0xLTEtMS0w_6e5052f4-7efc-48d0-8557-5ca3a4f72815">1,675</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfNC0zLTEtMS0w_2c59fee8-3e83-4fae-a0b5-7baaef23281a">1,531</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><ix:continuation id="i3673def91c034a7ea8ac8e6c7770eaef"><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfMi0xLTEtMS0w_c875b042-4f49-45f5-a76e-b78cb5d7758c">101</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e99e4069c604693bacde07aad3c5702_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfMi0zLTEtMS0w_c6ca7fab-3ad8-498b-ab45-ea25064e96f5">87</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfMi01LTEtMS0w_2bb9e8e1-e499-4395-9ae4-4efabfd0fea0">105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfMi03LTEtMS0w_4f8b396f-7f2f-4aa7-875d-103f368d11cd">74</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfMy03LTEtMS0w_f11503cc-edad-4322-800a-6a07a639ad4d">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNC0xLTEtMS0w_3bd617e2-85fc-4378-a887-02e327e95f21">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNC0zLTEtMS0w_18d92f5f-7ee8-49a4-8f75-24cb4a94c325">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNC01LTEtMS0w_f26fa44d-abfa-455e-bb9c-d73b09f55f30">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNC03LTEtMS0w_77225e6b-267e-4411-a83c-7b0fb6e9d426">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNS0xLTEtMS0w_c8b671e5-f6b7-4fa5-a098-9c5b86b0b4c8">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNS0zLTEtMS0w_5484a138-23e5-4776-be06-4c81c6ffbadf">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNS01LTEtMS0w_3b0f7ab9-caab-4201-8bc3-d655143b8f1d">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNS03LTEtMS0w_2f70f6fb-2da5-4d19-8c8d-7c45deca86f7">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNi0xLTEtMS0w_55e34d8a-ef47-462f-ba12-c4a42902310d">107</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNi0zLTEtMS0w_b1d9759b-50b6-4d45-867b-a3966aae87f2">94</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNi01LTEtMS0w_33799c91-2dc0-4905-83f4-5e1b6bc5efcc">107</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNi03LTEtMS0w_33e86180-9a71-4eb7-a214-0f9559697272">94</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Effective January 1, 2020, we adopted FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note R &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information.</span></div></ix:continuation></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="i97df6e577bfb4544bd7163ccd552faaf" continuedAt="i73f6cdf8118549b5a29c42049159c3d6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 326, we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, we have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers and office-based laboratories. Many of these customers are smaller than those we have historically done business with and may have limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions based on collection trends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU4MQ_5978aaa1-2ea9-490b-b22c-663c14059feb" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfMi0xLTEtMS0w_d061694d-0659-4802-bc64-427a027086e5">933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfMi0zLTEtMS0w_e0c3b0ba-03f8-423c-a849-be2ed3068204">893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfMy0xLTEtMS0w_1f26f61b-832b-459d-b58c-758d7e9adbbd">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfMy0zLTEtMS0w_1a625b9f-eb74-49f1-ba9e-5512ca282899">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfNC0xLTEtMS0w_91b9ff26-d52c-410f-a5d0-85aa88307125">376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfNC0zLTEtMS0w_85125834-f5b5-42c7-af2f-bae2c2bbf7ca">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfNS0xLTEtMS0w_4b58df28-cf5e-4a22-b97e-9e857cae83f0">1,430</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfNS0zLTEtMS0w_681d7913-6f69-461f-8771-efa6fe09edac">1,351</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span></div><div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU2Nw_ab72a698-74ad-4865-9bed-64e63500fad9" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfMi0xLTEtMS0w_cdd8ebf7-1c0e-49d4-a5a5-95e06a3c9fff">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfMi0zLTEtMS0w_21573428-da84-486f-bf1b-9b5ed74a7a12">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfMy0xLTEtMS0w_13821ace-3bb3-47c0-b9e4-9d901c7c7fb9">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfMy0zLTEtMS0w_3858b735-f14d-450b-8cd3-51c5ea316153">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="bsx:Licensingarrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNC0xLTEtMS0w_4cfb2602-6b08-4fc0-8261-ce99581593e9">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="bsx:Licensingarrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNC0zLTEtMS0w_18afc017-60f2-4358-ab6a-e9da4beea16e">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNS0xLTEtMS0w_5da43297-0724-4539-953e-c4eb82a78fbb">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNS0zLTEtMS0w_cd00612f-2ffe-42a9-a36c-c50e79e0e8dd">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNi0xLTEtMS0w_d8a740c2-ee47-447e-ac9d-a14266d8313f">777</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNi0zLTEtMS0w_0478fe33-b3d3-4cc3-9c8b-239371ac4c5e">751</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU3OA_d654a392-9fe5-4d80-9b99-31c13ce40985" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfMi0xLTEtMS0w_b52f6b3b-27cd-44ba-b6ad-d51a18b85d7d">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfMi0zLTEtMS0w_f37f1057-d915-49ea-a82a-e1418b319a03">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfMy0xLTEtMS0w_2efbb467-9d02-487c-8bda-0ce55b84db2b">1,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfMy0zLTEtMS0w_a9cbe0c1-c243-43ab-af7d-e4da6092a83a">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bsx:EquipmentFurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNC0xLTEtMS0w_ff7e8226-12dc-4ab8-be75-b645c840f6c8">3,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bsx:EquipmentFurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNC0zLTEtMS0w_3ea75f29-8c52-4d27-9f73-ac76122698d1">3,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNS0xLTEtMS0w_7ac7f6f4-8569-4f84-87c7-6c61147f381b">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNS0zLTEtMS0w_8d21650d-9dbb-482b-a4b1-8813e4536046">446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNi0xLTEtMS0w_c5993314-cf5d-4bfd-9e99-657cc628aeb1">5,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNi0zLTEtMS0w_eefff5ef-fa1b-4cf3-9569-e7e657c0705f">5,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNy0xLTEtMS0w_1c208d01-5535-4a97-b83b-9d9b6ddcfaee">3,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNy0zLTEtMS0w_8ff80da3-cfcf-4879-a10b-2889b4b9f6e0">3,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfOC0xLTEtMS0w_8cb15c7f-43dc-4c0c-bda9-ae777b4f30e7">2,082</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfOC0zLTEtMS0w_ac854f6e-5f3f-4dc9-a0b9-f77a1090b440">2,084</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjM1Ng_88632efc-e399-48b6-8440-4d92c934f801">83</ix:nonFraction> million&#160;for the second quarter of 2021, $<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjM4OA_ce3336ed-8d83-4b0e-9c45-0f62b4832953">78</ix:nonFraction> million for the second quarter of 2020, $<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMTA5OTUxMTYzMDQxNA_a3dd630d-8f42-464f-99e5-d38f5ad6376d">166</ix:nonFraction> million for the first six months of 2021 and $<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMTA5OTUxMTYzMDQzOA_d224b474-5561-4ae5-ab2d-413e0bd709de">154</ix:nonFraction> million for the first six months of 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="i73f6cdf8118549b5a29c42049159c3d6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU4NA_96bd607b-16b2-4ee5-813b-76b161aee2ce" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfMi0xLTEtMS0w_77e84c83-fe10-4923-8727-46434fc1003e">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfMi0zLTEtMS0w_062e1349-1b88-4b20-8552-029acd4b83ce">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfMy0xLTEtMS0w_330835df-86fa-47b8-b5d5-160b11baacb1">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfMy0zLTEtMS0w_7bffe4ed-89de-46d3-bbfb-4b80eb6b8f68">458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNC0xLTEtMS0w_dbef00fd-61af-47b4-8ef4-ad0f51f6e9c4">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNC0zLTEtMS0w_2cb76fe0-f55d-474e-9a74-eb8af506beb9">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNS0xLTEtMS0w_920391a3-5899-4dd4-a882-635ea038633a">616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNS0zLTEtMS0w_da747f78-5f94-420d-ac07-4b1086125d38">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNi0xLTEtMS0w_949b0e2e-44e5-4088-be73-ef0f6e29ef4a">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNi0zLTEtMS0w_089a538a-a485-40d8-acd5-f6a084c67eaf">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="bsx:OtherOtherLongtermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNy0xLTEtMS0w_96635c3f-8432-4783-881c-ef59617ae248">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="bsx:OtherOtherLongtermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNy0zLTEtMS0w_7e1784ac-504f-4644-8e20-bc2c8d293db5">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfOC0xLTEtMS0w_cab297bf-3b40-4b58-b389-b23bdf82da94">1,629</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfOC0zLTEtMS0w_35bd63dd-d982-4df4-8029-15cd8b2a37dc">1,921</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjUzMw_00196f3b-b41a-4d88-b315-c202688c2e96" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfMi0xLTEtMS0w_6aa7d901-230c-40ea-9992-c5e628ad2bed">417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfMi0zLTEtMS0w_424fff99-1a80-4012-aaf5-3b4261264110">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfMy0xLTEtMS0w_aedd16d3-784f-45b2-8d3b-3bce10f8e23a">801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfMy0zLTEtMS0w_773bf2ae-6c8f-4dd4-aeae-4e46238ec09d">681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNC0xLTEtMS0w_40183612-55e8-4ed3-a1eb-c131971d02ec">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNC0zLTEtMS0w_8c08419b-0d88-4c1a-bde3-e9b0b0635e78">331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNS0xLTEtMS0w_56015557-ed51-42c4-952d-5b433f34c232">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNS0zLTEtMS0w_0fcc0637-99ac-4bda-ac3d-a5473f5ea661">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNi0xLTEtMS0w_5049b120-ec63-4b1e-a6fe-63bd53acab83">612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNi0zLTEtMS0w_44c62be2-e6f5-4686-ba6c-2472b9cae3fd">656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNy0xLTEtMS0w_97bf8b19-8413-49af-afc3-c824f0e1dd60">2,442</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNy0zLTEtMS0w_8a5e38ec-0c9f-4e10-b7cf-0d764991ca33">2,197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjUzNA_8992c95d-7e97-434e-8e1d-9d2e93533d79" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfMi0xLTEtMS0w_59d436f1-fa25-4c0f-9af5-3bad983b2f5a">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfMi0zLTEtMS0w_0232c834-09f3-4525-899c-ea034806e49f">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfMy0xLTEtMS0w_87ed8bea-7aa8-4332-a808-14b2156661a1">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfMy0zLTEtMS0w_56ca17df-1666-40b3-8958-34e5bfe308de">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNC0xLTEtMS0w_89e82e4f-72e7-454c-937a-74a537db7fe2">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNC0zLTEtMS0w_c4ee441f-0cb5-4e0d-b4dd-bf66f3890653">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNS0xLTEtMS0w_130ae793-b9a3-4fd3-b677-0fcf44fa8bea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNS0zLTEtMS0w_31ff75de-e75a-44f3-9cd6-bc6159274707">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNi0xLTEtMS0w_e7c11fa5-46eb-47a7-b8ec-d1882f91aa10">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNi0zLTEtMS0w_01cbe10a-336a-468e-b9c2-5b074db04b3f">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNy0xLTEtMS0w_e7935ea9-4e0e-4bae-823f-c84ceb2f74ea">680</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNy0zLTEtMS0w_cbc2109f-84c9-4bb5-a083-7d304972c189">958</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span></div><div style="margin-bottom:1pt;margin-top:9pt"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU1MQ_8872571c-fbd2-4535-a292-324bf6db0027" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfMi0xLTEtMS0w_32d4f1be-7a96-4784-a22f-46f9b7788188">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfMi0zLTEtMS0w_da6c05e8-8537-4cb6-b33d-682e9a55115f">547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfMy0xLTEtMS0w_0f107903-6dba-48b9-a04e-0ccb4cc33fc5">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfMy0zLTEtMS0w_9c39ff1b-bf8a-4bff-99c3-0af5c8bb5d5c">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNC0xLTEtMS0w_de3ed60a-92b9-47e4-8c31-507ea8450fc8">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNC0zLTEtMS0w_10b2f57c-ebd3-4e19-beb9-6e565e41567d">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNS0xLTEtMS0w_8f612a2a-bfea-40a0-95a7-40e102ffccdb">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNS0zLTEtMS0w_ab1f6589-21c0-4e3f-a519-3f69bc5c4cde">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNi0xLTEtMS0w_874969ae-1802-41e3-8df9-ec77afc26541">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNi0zLTEtMS0w_391b0c9c-7d8a-4568-8ba0-d12d16558110">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNy0xLTEtMS0w_fbc607fc-20fb-4fc2-8074-afaa04b48f55">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNy0zLTEtMS0w_fa7a9369-4204-472b-b2c1-5f01b581a56c">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfOC0xLTEtMS0w_ca604f38-7c92-46f3-9177-372e9f480099">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfOC0zLTEtMS0w_f6f15047-1333-4717-9c64-edf440907517">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfOS0xLTEtMS0w_c3dd474c-0fb8-4c9c-bb84-396789c93165">2,190</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfOS0zLTEtMS0w_73271f44-e9f0-4a8b-ba05-97153251586e">2,309</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfMjE4NQ_1421934a-14e4-43b4-be3e-aed145fa6c95" continuedAt="i61cc73db498b4f59a3164349ce4efdf8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfMjE4Ng_5068bdaa-6af2-4205-9923-cdae3e1cd479" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RhYmxlOmJjYTkwOTcyMjcxOTRjY2RiNDljYjAwMTMxMWM2MjgxL3RhYmxlcmFuZ2U6YmNhOTA5NzIyNzE5NGNjZGI0OWNiMDAxMzExYzYyODFfMi0xLTEtMS0w_2729658f-4e93-4dbe-8239-be6c81ba8d0f">24.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RhYmxlOmJjYTkwOTcyMjcxOTRjY2RiNDljYjAwMTMxMWM2MjgxL3RhYmxlcmFuZ2U6YmNhOTA5NzIyNzE5NGNjZGI0OWNiMDAxMzExYzYyODFfMi0zLTEtMS0w_e0155aba-a3ef-47b1-b155-3b2bf2c1bd88">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RhYmxlOmJjYTkwOTcyMjcxOTRjY2RiNDljYjAwMTMxMWM2MjgxL3RhYmxlcmFuZ2U6YmNhOTA5NzIyNzE5NGNjZGI0OWNiMDAxMzExYzYyODFfMi01LTEtMS0w_121a799d-7e73-4db7-8efa-14244f28a266">11.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RhYmxlOmJjYTkwOTcyMjcxOTRjY2RiNDljYjAwMTMxMWM2MjgxL3RhYmxlcmFuZ2U6YmNhOTA5NzIyNzE5NGNjZGI0OWNiMDAxMzExYzYyODFfMi03LTEtMS0w_3c3ae7e7-3f84-4d04-89f8-d8a404952162">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in our reported tax rates for the second quarter and first six months of 2021, as compared to the same periods in 2020, relates primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These receipts and charges include acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credit), litigation charges, investment portfolio net losses (gains), as well as certain discrete tax items primarily related to changes in foreign tax rates, and changes in tax laws adopted in the second quarter of 2021, as well as the impacts of the Coronavirus Aid, Relief and Economic Security (CARES) Act in the second quarter of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfNjk5_40b74ab4-6099-4426-a2af-272ee0256a6c">280</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfNzUz_f41a3cd4-3054-4797-bccf-134fe4aee5b9">195</ix:nonFraction> million, if recognized, would affect our effective tax rate. As of December&#160;31, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfODI2_c5e21387-f9b7-41fc-aa54-246e60887848">261</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfODgw_badd64fb-19ab-4df9-b44c-60356dd4991d">183</ix:nonFraction> million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to positions on new entities we acquired through recent acquisitions and restructuring activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12 months, we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfMTMyMg_53d325c1-3610-4822-b4e3-5e5c24299b59">24</ix:nonFraction> million.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i61cc73db498b4f59a3164349ce4efdf8">Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act, enacted on March 27, 2020, provided an estimated $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-11" format="ixt:numdotdecimal" name="bsx:TheCARESAct" scale="12" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfMTU1NQ_25cf4c0d-0bc3-4999-8c0e-3387a90fd92b">2.2</ix:nonFraction> trillion in COVID-19 pandemic-related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes incurred in 2020. This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments and is expected to be paid in full by the end of 2022 as permitted by the legislation.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_88"></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTc1Nzg_a1677eb2-8477-45f8-b0f5-8ed1f7c69328" continuedAt="i43583e8814dc468b9b011671cdced528" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">NOTE H &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="i43583e8814dc468b9b011671cdced528" continuedAt="i944ca663667e4488bac5f90c95ca88f3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:LegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTc1NzQ_1d1a99da-d6f1-4866-accd-36d4207e57b9" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accrual for legal matters that are probable and estimable was $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMzkxNA_168888b2-a944-49a4-86df-8db558157a68">617</ix:nonFraction> million as of June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMzkzMA_1df77cd6-b14c-419b-b5df-dbf74448a8dd">569</ix:nonFraction> million as of December&#160;31, 2020 and includes certain estimated costs of settlement, damages and defense. The increase in our legal accrual was mainly due to product liability cases or claims related to transvaginal surgical mesh products. A portion of our legal accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfNDM3NQ_e9e062f2-7869-49d6-babb-ae044850838d">167</ix:nonFraction> million as of June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfNDM5MQ_4f6ac7cc-754d-4ca4-89be-e2df5a420351">208</ix:nonFraction> million as of December&#160;31, 2020. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Supplemental Balance Sheet Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfNDQ5Mg_33ff8825-b310-4684-9509-902db3460373">298</ix:nonFraction> million during the second quarter of 2021 and $<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTA5OTUxMTY0NTM5OQ_4a213716-384d-4a6d-a198-bb04b3708cf1">302</ix:nonFraction> million during the first six months of 2021, related primarily to transvaginal surgical mesh products.  We did not record any litigation-related net charges during the first six months of 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying unaudited consolidated statements of operations. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, &#8220;Cook&#8221;) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#8217;s Instinct&#8482; Endoscopic Hemoclip. The case was transferred to the District Court for the Southern District of Indiana. Cook filed seven Inter Partes Review (&#8220;IPR&#8221;) requests with the U.S. Patent and Trademark Office (USPTO) against the four asserted patents. All IPRs have concluded and Cook and the Company both appealed the Patent Office&#8217;s IPR decisions to the Federal Circuit Court of Appeals. On April 30, 2020, the U.S. Court of Appeals ruled that claims from two of the Company's patents remain valid, remanding two of the patents for further review by the USPTO&#8217;s Patent Trial and Appeal Board. In November 2020, the Patent Office issued remand rulings invalidating several additional claims. The district court stayed the case pending the appeals court decision on the IPRs, which is now complete. The case is proceeding before the United States District Court for the Southern District of Indiana, with the Company asserting three patents against Cook. Trial is anticipated in October 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2021, Nevro Corp. (&#8220;Nevro&#8221;) filed a complaint against the Company in the United States District Court for the District of Delaware (21-cv-258). The complaint alleges infringement of five Nevro patents by certain of the Company&#8217;s spinal cord stimulation systems.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="i944ca663667e4488bac5f90c95ca88f3" continuedAt="ia5406c1803d5471db28c3be7b6025a79"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 20, 2021, approximately <ix:nonFraction unitRef="claims" contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfNzYxNQ_aa37ccd8-7dc9-463b-bb58-0dac0ff3d3b8">54,500</ix:nonFraction> product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. As of July 20, 2021, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately <ix:nonFraction unitRef="claims" contextRef="i77c92e5241fe49138fd00651d03d0ec6_I20210720" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfNzk5Mg_66fa81d1-bb7d-4f72-b5de-65afc4a9f3af">52,500</ix:nonFraction> cases and claims, adjusted to reflect the Company&#8217;s analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately <ix:nonFraction unitRef="claims" contextRef="i77c92e5241fe49138fd00651d03d0ec6_I20210720" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfODM2MA_66fa81d1-bb7d-4f72-b5de-65afc4a9f3af">52,500</ix:nonFraction> cases and claims, approximately <ix:nonFraction unitRef="claims" contextRef="i77c92e5241fe49138fd00651d03d0ec6_I20210720" decimals="0" format="ixt:numdotdecimal" name="bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfODM5NQ_da8e9d7e-edfe-48bf-a3a3-7647458b94f9">49,000</ix:nonFraction> have met the conditions of the settlement and are final. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. The pending cases are in various federal and state courts in the U.S. Generally, the plaintiffs allege personal injury associated with use of our transvaginal surgical mesh products. The plaintiffs assert design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. Over <ix:nonFraction unitRef="claims" contextRef="ib0ad409ecce44b268852058674771336_I20210720" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfODk2OA_5df21256-4168-42b2-b310-94ba4b66b1bd">3,100</ix:nonFraction> of the cases were specially assigned to one judge in state court in Massachusetts. On February 7, 2012, the Judicial Panel on Multi-District Litigation (MDL) established MDL-2326 in the U.S. District Court for the Southern District of West Virginia and transferred the federal court transvaginal surgical mesh cases to MDL-2326 for coordinated pretrial proceedings. The Court issued an Order closing the MDL on February 11, 2021, as all cases that had been pending were dismissed or remanded to courts of primary jurisdiction. Outside the United States, there are fewer than <ix:nonFraction unitRef="claims" contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720" decimals="0" name="bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfOTU0Ng_0ab19013-db23-4baa-9078-b305839ca63d">75</ix:nonFraction> claims in the United Kingdom and Ireland. In the first quarter of 2021, <ix:nonFraction unitRef="claims" contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720" decimals="0" format="ixt-sec:numwordsen" name="bsx:CertifiedClassActionsInAustraliaMesh" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfOTYwOQ_3c078e93-e525-43bc-8551-3cf4467f7604">two</ix:nonFraction> class actions were filed against the Company in Australia.  In the second quarter of 2021, one of these class actions was permanently stayed, while the other is proceeding.  At this time, the Company is aware of fewer than <ix:nonFraction unitRef="usd" contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720" decimals="0" name="bsx:ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfOTY5OA_392ad6c7-9891-405c-9771-1e74cc63bbd3">125</ix:nonFraction> claims in Australia. There are also fewer than <ix:nonFraction unitRef="claims" contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720" decimals="0" name="bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfOTczNQ_22aed736-5457-4682-916e-3039306f4edf">10</ix:nonFraction> cases in Canada, inclusive of <ix:nonFraction unitRef="claims" contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720" decimals="0" format="ixt-sec:numwordsen" name="bsx:CertifiedclassactionsinCanadaMesh" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfOTc2OA_a10a9486-43a7-4209-854c-5ac2d26b4381">one</ix:nonFraction> certified class action, which has settled and received Court approval. On April 16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#8217;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. In April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records. The Company has notified our insurer and retained counsel to respond to the demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. In the second quarter of 2021, we increased the accrual associated with this matter by $<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMjc0ODc3OTA5ODE0Nw_33ff8825-b310-4684-9509-902db3460373">298</ix:nonFraction> million to account for increased, post-COVID-19 settlement and litigation activity related to the remaining cases and claims the Company faces, our revision of the per-case settlement amount for these cases based on recent settlement and litigation activity, and changes to our expectations regarding the rate of incoming cases and claims.  We continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest the cases and claims asserted against us that do not settle and expect that more cases will go to trial through 2023.  The final resolution of the cases and claims is uncertain and could have a further material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently named as a defendant in <ix:nonFraction unitRef="claims" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="0" name="bsx:ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTE3ODA_e42547a8-eb21-4a1b-a487-ab29153e00d4">147</ix:nonFraction> filed product liability cases involving our Greenfield Vena Cava Filter, which we discontinued marketing and active selling in the fourth quarter of 2018, alleging various injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional <ix:nonFraction unitRef="claims" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="0" name="bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTIyMDU_3be7905b-b624-4977-a383-b474d8ed1fb7"><ix:nonFraction unitRef="claims" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="0" name="bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTc1OTA_f1a11c6a-93b2-4168-bc67-43ca5f720ea2">521</ix:nonFraction></ix:nonFraction> claims, none of which have been filed.  As of June 24, 2021, we have entered into master settlement agreements in principle or are in the final stages of entering with certain plaintiffs&#8217; counsel to resolve approximately 200 cases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Investigations and Qui Tam Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2014, we were served with a subpoena from the U.S. Department of Health and Human Services, Office of the Inspector General. The subpoena seeks information relating to the launch of the Cognis&#8482; CRT-D and Teligen&#8482; ICD line of devices in 2008, the performance of those devices from 2007 to 2009 and the operation of our Physician Guided Learning Program. We are cooperating with this request. On May 6, 2016, a qui tam lawsuit in this matter was unsealed in the United States District Court for the District of Minnesota. At the same time, we learned that the U.S. federal government and the State of California had earlier declined to intervene in that lawsuit on April 15, 2016. The complaint was served on us on July 21, 2016. On October 7, 2016, the plaintiff/relator served an amended complaint that dropped the allegations relating to our Physician Guided Learning Program. We filed a motion to dismiss the amended complaint on December 7, 2016 and the court </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="ia5406c1803d5471db28c3be7b6025a79" continuedAt="iff2831f94a57454999ca56a904ac9a2d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">heard our motion to dismiss on April 5, 2017. On August 29, 2017, the Court granted the motion to dismiss, without prejudice and on September 19, 2017, the relator filed a Second Amended Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We filed a motion to dismiss the Second Amended Complaint on October 10, 2017 and the Court denied that motion on December 13, 2017. On July 31, 2018, the relator filed a motion seeking leave to file a Third Amended Complaint. The Court denied the motion on October 30, 2018.  In February 2021, we filed a motion for summary judgment, which the relator opposed, and on April 29, 2021, the Court held a hearing on that motion.  The motion remains pending.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Proceedings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 4, 2020 Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against the Company, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#8482; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all other similarly situated, filed a second, materially similar class action complaint against the Company, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. Subsequently, on March 30, 2021, the Court consolidated the two actions, and appointed Mariano Errichiello as the lead plaintiff. Under the terms of the Court-approved Scheduling Order, Counsel for Mr. Errichiello was required to file an Amended Complaint on or before June 4, 2021, which it did, and, in response the Company brought a Motion to Dismiss the Amended Complaint by July 19, 2021.  On December 15, 2020, the Securities and Exchange Commission&#8217;s Boston Regional Office (Boston SEC) notified the Company that it was conducting an investigation related to the Company&#8217;s decision to retire the LOTUS System, and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company is cooperating fully with the investigation. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#8217;s Board of Directors conduct an investigation into actions by the Company&#8217;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System. The Trust subsequently agreed to stay its demand, pending the outcome of any dispositive motion against the Amended Complaint in the class action complaint described above.  The Company received letters on behalf of the Union Excavators Local 731 Pension Fund and Diane Nachbaur, two stockholders of the Company, on July 26, 2021 and July 29, 2021, respectively, each demanding access to certain books and records of the Company, pursuant to 8 Delaware Section 220, regarding the business, operations, effectiveness and commercial viability of the LOTUS system, and related items.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matters Concluded Since December 31, 2020</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2015, a judge for the Court of Modena (Italy) ordered a trial for the Company and three of its employees, as well as numerous other defendants charged in criminal proceedings. The charges arose from allegations that the defendants made improper donations to certain healthcare providers and other employees of the Hospital of Modena in order to induce them to conduct unauthorized clinical trials, as well as related government fraud in relation to the financing of such clinical trials. A trial began on February 24, 2016. On November 10, 2017, the Court issued a ruling that convicted one Company employee but acquitted two others and levied a fine of &#8364;<ix:nonFraction unitRef="eur" contextRef="i026d0c112cb44011bed4a40ce907adcb_D20171110-20171110" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTY1MTA_228d8b3c-5cc1-4d4a-a84c-ab3e39b55edd">245</ix:nonFraction> thousand against us and imposed joint and several civil damages of &#8364;<ix:nonFraction unitRef="eur" contextRef="i026d0c112cb44011bed4a40ce907adcb_D20171110-20171110" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesPaidValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTY1NzE_136051a9-1553-4418-928f-7b9c0790449e">620</ix:nonFraction> thousand on all defendants. We continue to deny these allegations, and timely appealed the decision on May 10, 2018. On November 9, 2020, the Court of Appeal in Bologna reversed the judgements against the Company and its employee and acquitted them of all charges. This judgment of acquittal became final as to the Company and its employee on April 15, 2021 when the prosecution chose not to appeal.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general regarding our transvaginal surgical mesh products and related alleged violations of states&#8217; consumer protection statutes. On December 12, 2019, the Mississippi Attorney General filed suit against us in a Mississippi state court alleging violations of the Mississippi Consumer Protection Act. In the fourth quarter of 2020 and the first quarter of 2021, we reached settlements with <ix:nonFraction unitRef="units" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="0" name="bsx:StateAGSettlementsMeshRelatedNumberOfStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTc0NTg_f7932904-3c6b-4271-97ec-056ed0c30e1c">48</ix:nonFraction> states, including Mississippi, and the District of Columbia. These settlements were finalized in March of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iff2831f94a57454999ca56a904ac9a2d">May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders. On April 8, 2021, the parties settled the dispute, and, on April 12, 2021, the parties filed stipulations with the court to dismiss the remaining legal proceedings. The settlement did not result in any material benefit or liability to the Company.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_94"></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNDAxMw_97bd69a4-7490-4948-8c92-9958600edca1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; STOCKHOLDERS' EQUITY</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue <ix:nonFraction unitRef="shares" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNTI_e0653631-14ef-4b41-b8f6-db57551e236e">50</ix:nonFraction> million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of <ix:nonFraction unitRef="shares" contextRef="ia6bc3d74e781494aa5f8d841b5dd5783_I20200527" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNDY4_73d500ce-c820-44a9-8d98-c7041d68952f">10,062,500</ix:nonFraction> shares of <ix:nonFraction unitRef="number" contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNDgx_e2d4405a-4e62-43c4-915c-84b3afba62a2">5.50</ix:nonFraction>% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="ia6bc3d74e781494aa5f8d841b5dd5783_I20200527" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNTky_3ccbbf44-18c5-401e-9380-0bb5a30d215e">100</ix:nonFraction> per share. The net proceeds from the MCPS offering were approximately $<ix:nonFraction unitRef="usd" contextRef="ib072725f878d490891c935180e76efae_D20200527-20200527" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNjYz_af4e6eb9-3371-4f93-a25e-148ddcee0c6e">975</ix:nonFraction>&#160;million after deducting underwriting discounts and commissions and offering expenses. As of June&#160;30, 2021, our MCPS had an aggregate liquidation preference of $<ix:nonFraction unitRef="usd" contextRef="i7f1c2b882edd4e289dc69107378a5023_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfODA0_9585caa6-47d3-4deb-bc71-e4ecff15dfc0">1.006</ix:nonFraction>&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of <ix:nonFraction unitRef="number" contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMTAyNw_e2d4405a-4e62-43c4-915c-84b3afba62a2">5.50</ix:nonFraction>% of the liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="i7f1c2b882edd4e289dc69107378a5023_I20210630" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMTA2Mw_b5f29578-aaab-4263-ad2b-a961074863bb">100</ix:nonFraction> per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="i7f1c2b882edd4e289dc69107378a5023_I20210630" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMjE2NQ_b5f29578-aaab-4263-ad2b-a961074863bb">100</ix:nonFraction> per share plus accumulated and unpaid dividends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between <ix:nonFraction unitRef="number" contextRef="i7dbfe80c9a6c4f1fbd50cde474b1f462_D20210101-20210630" decimals="4" name="bsx:ConvertiblePreferredStockSharesIssuedForEachConvertedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMjM4MA_3de64436-66f0-4ace-a977-16dac665d597">2.3834</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="ic6a63df2abd449589aa54a60a6aa45cb_D20210101-20210630" decimals="4" name="bsx:ConvertiblePreferredStockSharesIssuedForEachConvertedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMjM4Nw_1e9a2d8d-3d34-4b26-9529-30599ad495ec">2.9197</ix:nonFraction> shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the <ix:nonFraction unitRef="day" contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630" decimals="0" name="bsx:ConvertiblePreferredStockThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMTc1OTIxODYwNDg1NzQ_87669335-f7ff-4f47-a2a8-22319c2944ed">20</ix:nonFraction> consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the second quarter of 2021, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared and we paid a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="ibe8974f83a41404480fe53c20b651092_D20210401-20210630" decimals="4" name="us-gaap:PreferredStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMzMyNg_b3175982-2bd1-4e8d-b6f6-ff532f8f4ead">1.375</ix:nonFraction> per MCPS share to holders of our MCPS as of May 15, 2021, representing a dividend period from March through May 2021. On July 23, 2021, the Committee declared a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1c82a8e57953431395abd5f8de82b993_D20210723-20210723" decimals="4" name="us-gaap:PreferredStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMzUyNA_665cb2d9-574a-4ed8-a300-1a1da5a2e30a">1.375</ix:nonFraction> per MCPS share to holders of our MCPS as of August 15, 2021, representing a dividend period from June through August 2021. We have presented cumulative, unpaid dividends within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within our unaudited consolidated balance sheet as of June&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for information on the pertinent rights and privileges of our outstanding common stock.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzIwNjA_be8e3f8b-98d2-4282-9a1d-6b01351b6439" continuedAt="i04c0cc8f437047dabad0ce05517d0fc7" escape="true"><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzIwNTU_01add682-8aa6-4bb9-bb11-3d4439561d50" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzItMS0xLTEtMA_2320625a-ceee-40b8-b7f1-639550ffdf18">1,421.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzItMy0xLTEtMA_0f4945ee-2336-4526-9c33-d0f547de6bf1">1,410.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzItNS0xLTEtMA_ad6c607c-fc1d-414e-a6aa-77c62744a8ac">1,420.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzItNy0xLTEtMA_a8a01bc3-23a7-4970-a416-f6ed1f21f3b0">1,404.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzMtMS0xLTEtMA_ea87f80d-3dd0-43d5-9ec1-364ec64ea919">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzMtMy0xLTEtMA_2078f186-cd0e-4dbf-b62f-4674dc31ff2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzMtNS0xLTEtMA_2ce95a15-656a-44c2-9354-a2b90581628b">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzMtNy0xLTEtMA_cd9de47c-ce3a-42aa-8ada-d4442c3656cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzQtMS0xLTEtMA_0bef0c6d-f98e-425d-91ab-7524842a6715">1,432.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzQtMy0xLTEtMA_9575ce05-413c-4aa6-adc6-a30ed1c7dee7">1,410.9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzQtNS0xLTEtMA_49cc078d-dc5a-4e85-a4a9-a645b02bd5e0">1,431.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzQtNy0xLTEtMA_cfc93df8-2f07-4778-baae-819c9ef6eaf9">1,404.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzIwNTg_234ba696-3b2b-4b27-9dc4-0b73824ede7f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been anti-dilutive:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i931d3fba103a41da93709c2ad126cda8_D20210401-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzItMS0xLTEtMA_62c645f1-5749-48a2-89de-8e9505f05db9">0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80131178752d4d72933977f1f39077b2_D20200401-20200630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzItMy0xLTEtMA_6254409a-0cce-4816-a5b7-1df1f1e04e4a">13</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i872461569f5c44cc9806dce827685f3e_D20210101-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzItNS0xLTEtMA_f7fd0526-fbfd-4823-b4a3-57d4c1511595">0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4dd96420c83b4f6fbd2317a8063fe8e8_D20200101-20200630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzItNy0xLTEtMA_7cce6ce6-36b7-4f87-9e99-8c5826b7e611">14</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94ceea52a45242bbb3456459eec3203a_D20210401-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzMtMS0xLTEtMA_60193747-9a71-456d-9426-26b3efe07ba2">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8b39a268f3f4c688dd37a207b541d3c_D20200401-20200630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzMtMy0xLTEtMA_8ca46bff-1575-4126-a88c-6a5db15e5ab7">6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if28997b0cb7f412abd0e94a0120251a4_D20210101-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzMtNS0xLTEtMA_06b645c7-ff9c-4a8d-821a-4814fb68cb6c">6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia22d58f6c86d470aa34c0f3cdd713039_D20200101-20200630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzMtNy0xLTEtMA_c5f9f9af-0b14-4791-8e80-a27941d8e612">6</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bcab03a819b4e56b7ba98f0bd557f87_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzQtMS0xLTEtMA_c6bd7625-00a2-4ee8-bc29-62f055fb9952">24</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5dd5712978054816851d620283d3a5a1_D20200401-20200630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzQtMy0xLTEtMA_c19632ae-e912-4f01-ade4-983f89d37ab9">9</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b8776f4806d49a896745a9a4bb90b81_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzQtNS0xLTEtMA_40a94842-aab6-467a-92ae-379364c7f26a">24</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a123b6a6d02472f84544e157b785b07_D20200101-20200630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzQtNy0xLTEtMA_85bf603e-2d01-4d70-9e2e-17d2e2aced75">5</ix:nonFraction></span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in the second quarter and first six months of 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> position in those periods.&#160;&#160;&#160;&#160;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the second quarter and first six months of 2021, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, as presented in our accompanying unaudited consolidated statements of operations, for purposes of calculating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i04c0cc8f437047dabad0ce05517d0fc7">We issued approximately <ix:nonFraction unitRef="shares" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzE1MDU_4bdd1ca0-7982-44a1-8e05-3ac71c40bfa5">one</ix:nonFraction> million shares of our common stock in the second quarter of 2021 and 2020, and <ix:nonFraction unitRef="shares" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzEwOTk1MTE2MzAwNTU_75a0b948-57aa-42c1-884b-29308f8a96a8">five</ix:nonFraction> million shares in the first six months of 2021 and 2020, following the exercise of stock options, vesting of deferred stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first six months of 2021 or 2020. On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="ia8ac7dde02784ed2a3c939e70748808d_I20201214" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzEwOTk1MTE2MzAzMzU_4644f733-1099-49d3-a568-6d60775a41a6">1.000</ix:nonFraction> billion of our common stock. As of June&#160;30, 2021, we had the full amount remaining available under the authorization.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90ZXh0cmVnaW9uOjFkN2M4MGE4ZWYwNTQ4MGE5ZGJiN2E1ODFkODgwY2E2XzE2NDY_920b822a-e600-4992-bd5f-8c1fd2a67ee8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our <ix:nonFraction unitRef="business" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="0" format="ixt-sec:numwordsen" name="bsx:NumberOfBusinesses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90ZXh0cmVnaW9uOjFkN2M4MGE4ZWYwNTQ4MGE5ZGJiN2E1ODFkODgwY2E2XzE3NTkyMTg2MDQ2MDgy_449df45b-6b4c-445b-8f2b-69ad02433282">seven</ix:nonFraction> core businesses are organized into <ix:nonFraction unitRef="reportablesegments" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90ZXh0cmVnaW9uOjFkN2M4MGE4ZWYwNTQ4MGE5ZGJiN2E1ODFkODgwY2E2XzU1_d244b7c0-85f5-489f-8d5b-47cd81457a8a">three</ix:nonFraction> reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. Operating income of reportable segments as a percentage of net sales of reportable segments is defined as operating income of reportable segments divided by net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits); and certain litigation-related net charges (credits) and European Union (EU) Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in our accompanying unaudited consolidated statements of operations and are included in the reconciliation below.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90ZXh0cmVnaW9uOjFkN2M4MGE4ZWYwNTQ4MGE5ZGJiN2E1ODFkODgwY2E2XzE2NDU_61cf1a87-26b9-4d4d-843d-2502c10308b7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages): </span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3d85296ff14a7fa38a4e77b4c22259_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzItMS0xLTEtMA_0d52c459-6a5b-448d-809f-6b0c7093544c">948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee7ac48795d7495bb324539450207488_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzItMy0xLTEtMA_aebde2a5-83b8-4ec0-bc41-e18ab0716e6a">576</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if893495841d548ada62dd960d69a89bc_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzItNS0xLTEtMA_55761d5c-1a82-4a5c-94f9-8aeebc27d34d">1,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc87b0e1aea540f5afcf25232dd8e768_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzItNy0xLTEtMA_cc2cd4ab-a6f3-48ae-a6aa-8b2456a78abb">1,350</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa95cedc94d43a78ad39a377b3b4597_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzMtMS0xLTEtMA_49e9a8df-d0b5-43be-83fd-f21745641ac9">866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87a9703d05a846d58b5180826ffe5050_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzMtMy0xLTEtMA_4395f499-9509-4f28-85b3-90ec67eb05bc">525</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzMtNS0xLTEtMA_20f7b7ae-3ec0-478c-bb08-a4df6bdfb9d7">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ddaea5b070844abb018d02ea99642ce_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzMtNy0xLTEtMA_90e03b19-e90b-4e2b-96fe-72c3378307a8">1,228</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a812afca36c4308ad9bff7ee2032b3b_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzQtMS0xLTEtMA_37e20ebf-5dce-4e97-8207-7ba788608e8a">1,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10ee3e6c967c46a4b31eb6264056e524_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzQtMy0xLTEtMA_9c49758e-5bf3-4268-aae3-08e125582436">834</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzQtNS0xLTEtMA_a0c65c3c-f474-48ed-be59-1a15f96fb80e">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9920b68656de40d1b14321411d7fbf04_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzQtNy0xLTEtMA_4eaab294-4eef-4f1c-9eb8-22de76f4be48">1,860</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08c5d30357d9461faac846d9a7f6f58c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzUtMS0xLTEtMA_1db9666f-57d7-4f34-abbd-d25a5aee345d">3,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f1a45e38524eada4c409914683546a_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzUtMy0xLTEtMA_e3392733-d5c6-4394-8fd0-c175d6fa0300">1,935</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbfbdc30d0ab449094a90e70fd595751_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzUtNS0xLTEtMA_109a5089-c3ee-4349-8531-bc13a0f93664">5,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id96d30c4d41a4cdb9fe2a6c8498a6753_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzUtNy0xLTEtMA_111f702c-2a06-4d4f-a76d-577ef48611a4">4,437</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69c68d3663c4d20b8e7aa1db007db37_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzYtMS0xLTEtMA_a53bae81-7e6b-4e32-bdd7-7e7d64028268">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i917d4854b7a7437bbd99ae988171a69e_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzYtMy0xLTEtMA_a02775d1-9058-4d73-b02d-42ba4ef962bd">68</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6987d6c22f4b44dc92c281c44ea04ff4_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzYtNS0xLTEtMA_ce7c31db-6a6a-431c-96a8-c2fa1851c34d">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875553a9513a45a38f8a905416d7829c_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzYtNy0xLTEtMA_6d16b149-c26b-44e6-b247-87e4e1f33110">109</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzctMS0xLTEtMA_fb8a89f2-739c-44be-8a28-4df266742888">3,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzctMy0xLTEtMA_23b44335-629c-4398-acf0-48eec0ee9bd9">2,003</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzctNS0xLTEtMA_197404df-1def-4780-bc31-d994c996cb5d">5,829</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzctNy0xLTEtMA_86130f99-db38-4f28-9c66-8bcae76c45b5">4,546</ix:nonFraction></span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3d85296ff14a7fa38a4e77b4c22259_D20210401-20210630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzExLTEtMS0xLTA_a3cc1305-db0d-45d3-8c79-1106c2b28d00">363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee7ac48795d7495bb324539450207488_D20200401-20200630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzExLTMtMS0xLTA_179f162b-f48b-48f3-8b57-f37a8f387bce">173</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if893495841d548ada62dd960d69a89bc_D20210101-20210630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzExLTUtMS0xLTA_54c5c41b-c757-43fc-a83d-3232c2bf50e4">695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc87b0e1aea540f5afcf25232dd8e768_D20200101-20200630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzExLTctMS0xLTA_50e5ce41-ea92-4c96-8d4c-b3d7dba96c66">432</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa95cedc94d43a78ad39a377b3b4597_D20210401-20210630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEyLTEtMS0xLTA_a54422a5-fdb7-4623-9901-adf58755c664">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87a9703d05a846d58b5180826ffe5050_D20200401-20200630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEyLTMtMS0xLTA_eb158363-3e84-45ea-b133-04082a12c87f">32</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEyLTUtMS0xLTA_2d97c369-7607-406e-8bef-01fc1970992f">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ddaea5b070844abb018d02ea99642ce_D20200101-20200630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEyLTctMS0xLTA_b7df0e26-2068-4406-9a20-aaea1d50a1cc">131</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a812afca36c4308ad9bff7ee2032b3b_D20210401-20210630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEzLTEtMS0xLTA_e8e01c4d-5c0e-4868-9ee7-fd0a6c6a4cb5">418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10ee3e6c967c46a4b31eb6264056e524_D20200401-20200630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEzLTMtMS0xLTA_4e66a785-731a-46e8-9104-fc89818b579f">186</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEzLTUtMS0xLTA_1f869c39-5d5c-4ca6-8acc-82ce87986a76">756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9920b68656de40d1b14321411d7fbf04_D20200101-20200630" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEzLTctMS0xLTA_c05d0bde-d0d2-407e-97c4-186eb0dede4b">385</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3373e787f64b69879354c4d90cb4d6_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE0LTEtMS0xLTA_a0c92ed5-e207-43d7-b79d-c91e4e3354f5">949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a73a4533f85472db78cd678e9428f83_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE0LTMtMS0xLTA_a997164b-4fa3-4a8e-87e8-4ae55ed8fd9d">391</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2329374481a64746916e19c25b31e4a9_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE0LTUtMS0xLTA_3e80cdad-44fa-49a7-95d0-f6ea42f76a39">1,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea85ab448ac4f31a40e693d00c9232f_D20200101-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE0LTctMS0xLTA_dc0cc128-0c49-427c-b44c-2c524d71715a">947</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9425d933351842c69c2377a549b55d63_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE1LTEtMS0xLTA_dbb05998-b2ad-4403-9321-0247119d40c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdbc19706ca841dab5c448ba34ebf25f_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE1LTMtMS0xLTA_48c25aad-6510-427b-b8ff-b24390c57177">49</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0af53d7a56246a6a7195bfe2f410ab8_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE1LTUtMS0xLTA_5f000346-ae42-498d-8ca8-fef2fba191b4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f6ceb4a20040a5a4fb3825accef1ad_D20200101-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE1LTctMS0xLTA_8a7d8a1f-b9bf-4e63-a245-6890d1a21b7d">75</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2ec85ae1ab744838e2f0043d7c74fc7_D20210401-20210630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE3LTEtMS0xLTA_83ddb412-a788-4cb1-85b5-db43701b5814">176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d7c3b80fe00450391af229f01a0d200_D20200401-20200630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE3LTMtMS0xLTA_c0a63c0a-f868-41c2-9800-a344a6eb9870">189</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30338b7d70584d428b0e030a91c0bd1f_D20210101-20210630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE3LTUtMS0xLTA_1fce3d07-0162-4797-afbc-f94d14bafd08">329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf9a180b4192402eb3bf5e60522bf759_D20200101-20200630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE3LTctMS0xLTA_bfc316cc-139b-486a-bf77-c0c34ac3a1e3">222</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits) and EU MDR implementation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic949cdc25a0746a4a459b8a0d6db3a07_D20210401-20210630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE4LTEtMS0xLTA_127379e8-2a47-40e4-a826-a463d5789691">331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16978436b3dc4702931fc4b84f04a48e_D20200401-20200630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE4LTMtMS0xLTA_bc232bc4-ea19-4466-9b84-29da22436c7e">125</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2aaf1372dd9946df9396ccc9020383a6_D20210101-20210630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE4LTUtMS0xLTA_3f47aecc-559c-4f29-aea1-e096bce6f117">445</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i169d8e210b0c42a7bef3c40e6e0a6e32_D20200101-20200630" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE4LTctMS0xLTA_3e60d0e9-74b5-4ac7-b215-9f68020278f1">327</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE5LTEtMS0xLTA_1825d519-467d-40f5-871e-b49f116f9523">180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE5LTMtMS0xLTA_8f751189-7cb8-463e-b57e-f776551f1a2e">197</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE5LTUtMS0xLTA_9f1b6a7d-9308-4ef5-abb4-c0c3fc256375">365</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE5LTctMS0xLTA_9ed0bd93-970d-4f7b-ad21-6124b2962e01">398</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIwLTEtMS0xLTA_a6f50650-2913-4036-9d81-cab4fc89dd57">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIwLTMtMS0xLTA_04c5f2b8-e689-442e-a67b-189f8d664494">71</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIwLTUtMS0xLTA_3afe4885-5a8c-4d5f-a457-43f4c3924785">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIwLTctMS0xLTA_66c760d8-219a-4511-9926-8f0bd09e2c09">75</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIxLTEtMS0xLTA_ff750897-71cb-4756-9ba9-3d5216648c7b">113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIxLTMtMS0xLTA_a912dca5-1061-42b8-97b8-54e51820a766">110</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIxLTUtMS0xLTA_802711e0-9474-474e-9fa2-e884d17ca087">157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIxLTctMS0xLTA_32210ee8-a989-4aab-9b29-bb0cbaf4d81e">234</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIyLTEtMS0xLTA_bb63c78d-e326-4aea-bb86-56e3c2aa2fd6">149</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIyLTMtMS0xLTA_c3b03dfd-9061-42d5-975f-4a129e6679b9">181</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIyLTUtMS0xLTA_b6e3a4f0-fc7f-4215-8c87-6b2cc248422d">474</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIyLTctMS0xLTA_47657c5d-a913-4d34-9f5f-5b1241545b82">159</ix:nonFraction>)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1) On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income margin of reportable segments</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icf3d85296ff14a7fa38a4e77b4c22259_D20210401-20210630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI3LTEtMS0xLTA_17e9f9c0-9209-4fb2-a0fb-2a5b78e4de82">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee7ac48795d7495bb324539450207488_D20200401-20200630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI3LTMtMS0xLTA_b848d24a-1d4b-40df-8136-302a6592868e">30.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if893495841d548ada62dd960d69a89bc_D20210101-20210630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI3LTUtMS0xLTA_7890be3d-d895-43ee-ad13-6a75183d41e1">38.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc87b0e1aea540f5afcf25232dd8e768_D20200101-20200630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI3LTctMS0xLTA_1861681d-f7a8-499f-9080-e89499430266">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1fa95cedc94d43a78ad39a377b3b4597_D20210401-20210630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI4LTEtMS0xLTA_8daebcd9-6903-44ff-96f3-cd5cb49afac4">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87a9703d05a846d58b5180826ffe5050_D20200401-20200630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI4LTMtMS0xLTA_cacddc58-dfaa-4d7a-965b-693390172d60">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI4LTUtMS0xLTA_c909aa52-33de-4f39-8ba2-2b9a9ab912d2">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0ddaea5b070844abb018d02ea99642ce_D20200101-20200630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI4LTctMS0xLTA_3f168e29-9d13-479c-ba86-e5afa8768ae5">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a812afca36c4308ad9bff7ee2032b3b_D20210401-20210630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI5LTEtMS0xLTA_05b4c9d4-3f0d-4456-9551-79b736341b3c">33.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i10ee3e6c967c46a4b31eb6264056e524_D20200401-20200630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI5LTMtMS0xLTA_bb8b7c90-4bd8-454f-994e-6246e813f9b0">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI5LTUtMS0xLTA_6e017aed-f8f3-4c9c-9170-a85f4286400f">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9920b68656de40d1b14321411d7fbf04_D20200101-20200630" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI5LTctMS0xLTA_18644a88-d1c2-4c8d-8f8a-493eec47f3a2">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzM5NTk_e4d46601-d32c-4f05-a22b-68fd5effaa21" continuedAt="i1a3912cc4c704b01b45f0abc0cf33b50" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; REVENUE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our accompanying unaudited consolidated statements of operations. <ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzM5NjM_490075e2-580b-4a27-bfa9-1f4661e0877f" continuedAt="i478d1b36379a4ea4bf33582824ca4dc0" escape="true">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):</ix:nonNumeric></span></div><ix:continuation id="i478d1b36379a4ea4bf33582824ca4dc0" continuedAt="i3c62f0b008144174990932157df2342f"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i061cd56ba7464abca39e645d60f76a24_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtMS0xLTEtMA_8a247c45-7a64-4760-b182-59872f723ae8">316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaedeb686cee4d8d9dab6a94ba25b3ca_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtMy0xLTEtMA_d5ebcd17-6507-4a00-81c1-b8659137df02">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcba7c4ff23d4a36bf3a797d17d3fc25_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtNS0xLTEtMA_10efeae1-4efc-428e-9827-c1c43da862ef">551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88afd4ada2e4380867080d946a426ab_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtNy0xLTEtMA_3f255c33-8a10-4af9-959f-a9722310744a">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96cfef3ea9ca4aa19b2bbb07b400eb80_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtOS0xLTEtMA_8321d8f0-652e-469c-a840-a392912911ad">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42ab9e136af1432d93223a27751196da_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtMTEtMS0xLTA_06df3a28-3312-4c13-9043-13fbc6f56b19">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22601e81ae894a8ead01e52c7c6c27d8_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtMS0xLTEtMA_1a9a39ef-7e1c-4852-92a6-526c8af943b1">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a590a1212940f2a9899f47bc99255f_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtMy0xLTEtMA_684abaee-925f-48b7-acf9-0c13216e0a52">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd29119a8cc84be69467437c76bb82de_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtNS0xLTEtMA_78b0a89b-b99b-4109-989d-ebb2c825916d">397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af6058e474a47f6be0373df26d2c88b_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtNy0xLTEtMA_13c03df7-2dab-4860-8a4f-d555d6446f5b">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5638e698e73f4b489f93a04619cb4765_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtOS0xLTEtMA_420c12d2-4783-4f36-acc6-6d9e8780fc03">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82c8d382689b4777829b44c174c65fbc_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtMTEtMS0xLTA_db09defa-627c-4fd4-9271-e2ab74be387b">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1373eb6d094a4864854a6d14ee507632_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtMS0xLTEtMA_e53e5cfb-088f-42c8-b874-f3351aae622a">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d89029dd434509a14af75abe8b39bb_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtMy0xLTEtMA_95ced925-1eb6-4c06-824d-a1e00f3bed48">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625505b6d3a940a5bcb761bf0b3959f7_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtNS0xLTEtMA_ef9c331d-20b4-494d-90f4-d868014a6e79">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19fc598ea5cf4543b98c31b363392b72_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtNy0xLTEtMA_d34672c8-b2c9-42f0-b1aa-182aa24d66ac">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8adde05e0aa442a2b88ca23ff4e546f2_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtOS0xLTEtMA_bf05ce31-543a-49a6-999c-370b88c8e55b">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ff91ebf23ae4decb4c9ef0283823434_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtMTEtMS0xLTA_2f093cd2-9793-41c6-8f66-649aba4c2d0c">351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99e80edb795146f8b45480c4add3365e_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtMS0xLTEtMA_c10aaf39-5a6b-48c6-945f-85432ec9c5d9">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4c3566c44c4157a5e11d70f391081a_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtMy0xLTEtMA_7a12ed22-2c8e-4511-977b-11aa372b7ae7">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bce46e49184470a8222ed14bd378c26_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtNS0xLTEtMA_0a409529-c20f-4447-9fb0-57fd886cb654">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f47e99793034137b15f7fa228eb0b29_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtNy0xLTEtMA_31b02c02-cddc-45b9-9031-be9b01aa9774">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a51bdaccc2484c9e70993e21677ca3_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtOS0xLTEtMA_905a5f79-de15-44fd-ad7a-b5ff1b5e98e4">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aa30fb1b39f4d348ef1434541427e01_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtMTEtMS0xLTA_e820ceeb-aefd-46a6-af44-defeacb3c301">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a72d4a50a4d4e74b93be9e82777898f_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctMS0xLTEtMA_ebc4c3d7-55d6-4d2e-842b-a6e515d7bd04">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eab68a05c01485c92e57bee7e7e0f01_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctMy0xLTEtMA_f05adbfd-78e9-46c4-8a80-f0f192c187e2">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c54e4912e96435091d529ae0ed78f07_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctNS0xLTEtMA_b4646c03-da75-4f0b-8726-6c152913d605">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea06e5f733245528b5328dc3e82297f_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctNy0xLTEtMA_924ce05c-6215-4c01-a525-dd258b33d827">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5706fb2a0a0e47db92eafa5aede01ccf_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctOS0xLTEtMA_5db90d8f-4a09-4f52-a7e4-56a75c19e945">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e88da73b0484cceb9e60fbd4e7e2fab_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctMTEtMS0xLTA_1ce36a51-9497-4c3f-9922-6996f75305e0">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad77ae9479ab455da7367cecb7c17bc5_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtMS0xLTEtMA_ee6b5ca4-e1db-4768-b98e-52411c5e634c">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08630dd608644cc08764c701dd22f7aa_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtMy0xLTEtMA_72db1ab8-03aa-49f5-b491-061940a9b713">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic338ea419c3440558697b27cc49de9db_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtNS0xLTEtMA_014e2177-af64-45c6-924c-380d41fe90ba">790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i690ac34917b44b20906e730e3dcdc4af_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtNy0xLTEtMA_69cb83b4-9548-48cd-8ea4-4297df45d226">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8a91fe2ca84ac0b18ff0e6844a0287_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtOS0xLTEtMA_d81a1859-add5-4922-8499-c6a0197f9d7c">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5201686b80024557a80a7f33db43a5c8_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtMTEtMS0xLTA_2d1930ba-89d5-47b6-b09d-646a9bfb8307">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0e96b146aad466ea7d9f8d5dcca942d_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktMS0xLTEtMA_167ccf01-3df0-4396-acd3-90e4fec0348c">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18a4ce2ee9e8410fa314a7f39ae7cb6d_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktMy0xLTEtMA_1ec255d9-93dc-4609-bdcc-b0d1f9a97bda">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba26343c342547479828a2dd2e8d7bd9_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktNS0xLTEtMA_7d70c7ed-cbc5-4104-9db5-5c0747ab705a">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i947c377abd4c4941b4a244d5948eebd2_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktNy0xLTEtMA_b1c5db5f-dac1-4b05-9ecc-562fd3a6f7fe">189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de128567b724b5984a99d95eef02d4d_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktOS0xLTEtMA_0d99ed4b-c170-4589-ac42-901d8597fe1a">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f2f3e5b12e432ea299981ae16b6fe8_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktMTEtMS0xLTA_2f79912d-02c2-4236-8316-a2bf1d8bb560">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idef0574f3eef4b9e8e842b614403cda3_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTEtMS0xLTA_812df141-df6d-4bda-a288-484d6a1d0a60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ef4aa393984e2ebb13ebe33340a910_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTMtMS0xLTA_1bf3088b-b1eb-4f65-a417-87168b291c99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69c68d3663c4d20b8e7aa1db007db37_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTUtMS0xLTA_940e496e-0fb0-4815-ac5a-b6f2df7cc267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i372f4fcd9ee74bd6a7b738ffb8609de3_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTctMS0xLTA_1f03340f-bd8e-4c5f-ac2f-e4de2c570a6d">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf9760e631443339b33601a02bd59ce_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTktMS0xLTA_e8743a52-c49f-4c3b-9be9-f6e51e2939c3">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i917d4854b7a7437bbd99ae988171a69e_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTExLTEtMS0w_d3e38333-9068-48e4-85d9-4cc977f41e39">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d063662de5e4b32ab5ce0c83ed22b8e_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTEtMS0xLTA_b5bae5af-01df-4872-a119-e3aa20156574">1,800</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc4e56a2f2c49849c55cba2ac3445ae_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTMtMS0xLTA_b951897e-a468-4e99-b65f-881437678a81">1,277</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTUtMS0xLTA_fb8a89f2-739c-44be-8a28-4df266742888">3,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7801f5155a6141c18f17232cef1a5392_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTctMS0xLTA_39089f89-008b-4416-80e4-2b0f0c7369ea">1,118</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec63b166a7d5454683d6ec2e2bab3b66_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTktMS0xLTA_2062bce2-d424-4a41-ad59-4538e98f1b82">885</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTExLTEtMS0w_23b44335-629c-4398-acf0-48eec0ee9bd9">2,003</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i546ecb80f9f54844bc0e3f3b677fee89_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtMS0xLTEtMjIz_3a40a2cc-edfc-45f1-b801-8f6f582e5c39">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97435401a6bf486aa47a9cc538781a9d_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtMy0xLTEtMjIz_95617f20-1896-49a9-ac85-7ed8ac27db2c">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d83d8f92f6647f0a79e0353d43220d2_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtNS0xLTEtMjIz_e19bc07c-66f5-402e-931f-1d85afca8d08">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b1d77aa85474402b82a7b22a91d3791_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtNy0xLTEtMjIz_684e43bb-305f-4754-99b3-60ceb8c5265f">445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82c87e029c8940349ae408f228d3b510_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtOS0xLTEtMjIz_b9b87a30-da8d-41a8-9af3-f8d9fa773495">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cdb3e06e9a64a59b0a05eddb13cb154_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtMTEtMS0xLTIyMw_dcf9d25e-9335-466a-bfec-51f16494b638">790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e576728e7343f7821a9f0a44eb3d8a_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtMS0xLTEtMjIz_1f87f016-99e3-4abe-9bc3-7b4a6fc60a19">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6dacb4e8874b21b6822d368a2a953f_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtMy0xLTEtMjIz_e2553051-6683-46a9-9a0e-1e116efa345b">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e85a2c232e64290b8ebd6a6cd0bbdc4_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtNS0xLTEtMjIz_447046e8-b730-44be-8170-a945f6d2c926">758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i953e0fe9f9b847f49ab077fb9c939709_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtNy0xLTEtMjIz_eb72f87c-6cf5-4026-9e1a-305c1bc5a52f">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ec33aa8ba414dcd8d8eddba16bf0dfb_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtOS0xLTEtMjIz_73d11911-b815-41ed-96ac-a9038ac50efd">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55ddef33ab0e4fa78d3e05af2245debc_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtMTEtMS0xLTIyMw_66c6a71d-379e-4fe1-ac86-c6068c4b68d9">560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i705075d05b1c4df98d3f2b6311ee1876_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtMS0xLTEtMjIz_4014ed9b-0c5c-4aa4-be6e-7bba41657c75">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0149779720b14a1e9890c2e5463703cd_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtMy0xLTEtMjIz_4651f9e7-191a-482e-bc53-a1f85ea55933">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d5ab1bada04b428d1dc449d38e68aa_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtNS0xLTEtMjIz_508ddaa6-e11e-47b3-8f15-9898f000475d">993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056eb40cf563486c946aa704d28fa8ab_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtNy0xLTEtMjIz_a5f2d4d2-a11d-4d22-8985-13ec89be8a7c">463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a0d737980c64923b5659d62f3434702_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtOS0xLTEtMjIz_ed92845e-fae8-4be0-9704-852695c1b933">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999387ed85af40aa960e8fb85fe24e8f_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtMTEtMS0xLTIyMw_397c6854-620f-46c7-9896-ec81d08d856c">788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37862215da8c46a5911d56efc33e6a34_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtMS0xLTEtMjIz_9f3f7379-152e-4772-9a4a-d709cf1a3064">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8a9a823a7e497a910c47ea98654d1a_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtMy0xLTEtMjIz_1582c2d8-0094-4f21-a130-5dcd21c64f49">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a20d757b68446898d764ace8105642_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtNS0xLTEtMjIz_64697759-3a97-4dc4-a3b4-38e1b907d02d">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib01f3231917a42399388b8430f7dd5c4_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtNy0xLTEtMjIz_97fc0936-f4ce-4efe-9b44-f7f785d3d117">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia92d1f0a20454a3b9bce021d757a34e6_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtOS0xLTEtMjIz_0c6fdf65-96f6-4a1a-8afe-7fe727e0883b">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89f659ee14624fde88e16586c89ce9d8_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtMTEtMS0xLTIyMw_0f12c6d2-8182-420d-b796-d01bf961b91f">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if71b684d3c024d3886c8ef1e65dfa46d_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctMS0xLTEtMjIz_08259949-d619-48af-a3da-2337d4504f67">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0734e4182c448e3a1999d0400528fb7_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctMy0xLTEtMjIz_5af0a7de-7913-4dbb-8dc7-3622cbad72c0">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1a9f292c5b94a01b78a4918d33aa51f_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctNS0xLTEtMjIz_39e03c9a-919a-4248-a84f-695bc22ef556">444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe7c0ba7c514a5aa6e493bab9893659_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctNy0xLTEtMjIz_d78a1f43-a58e-41b5-9590-cd58365cd501">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ef0989ede014a41b44c8c421e9c80b6_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctOS0xLTEtMjIz_11796524-6752-4009-8802-d0706eb76d3b">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a99ca748d5e4edfa719dfdea5bd3311_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctMTEtMS0xLTIyMw_fc7a7385-0742-4846-93ef-13fad4ab8bf0">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ba737e9d8f461ba5881d87b666c936_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtMS0xLTEtMjIz_b062d81c-0f3a-4b02-857d-2e08ac1000d8">741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf3328c2059f45a99c8ed36d5544d2c2_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtMy0xLTEtMjIz_f76c8c55-c0ea-4c93-8e3f-d90860bd190a">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a241c1c7e14b908561f55b9bea06af_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtNS0xLTEtMjIz_8508f65e-af55-42ae-8f09-108f848a9525">1,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d4a66cacd3c409a8583c1f4d7c949a0_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtNy0xLTEtMjIz_c983f86a-fce1-44ce-9bf0-09db609739b1">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f81f839a1994584aee39783ecacbdcd_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtOS0xLTEtMjIz_c32d128c-385e-49e4-8670-cc5eb0859c1d">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70b422de2e4e4b18a8970d5b6f6d4282_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtMTEtMS0xLTIyMw_78b01121-646c-4a96-9344-cb3b52e060a9">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10cd8488ed6a4a9f9cfca5758ddc5d1f_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktMS0xLTEtMjIz_a124abd4-395e-4ed0-8597-e332fb731939">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a954338141045799352d36c639ad37e_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktMy0xLTEtMjIz_4d4ed06d-baa4-4e5d-b341-5e071d859f49">407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cff98864b9e45f2a169a4724b33ce66_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktNS0xLTEtMjIz_0aceef74-abe5-46b3-973d-b155e15bdadf">906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009fdb9395ce49bdb5ee3d78d5dd59b5_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktNy0xLTEtMjIz_cf0953d0-5c8a-41c3-99b1-c6806428f177">413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f221a488db642a294dc6d9112291dc5_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktOS0xLTEtMjIz_52b834f7-7a62-4ec3-adfd-56b96cef849d">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa71dec95dc94eeca8f7131ee2264446_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktMTEtMS0xLTIyMw_1c3109b6-6d4e-4653-90be-1570a2a99d8f">732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80dc82869bb14419b4927d17ccb893c3_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTEtMS0xLTIyMw_95b44638-cf54-49d2-b1eb-18fb0b291780">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic86c037a105047ff8e30c52d263c8b1c_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTMtMS0xLTIyMw_67a1213f-8c24-4ea6-914b-00d3191d3858">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6987d6c22f4b44dc92c281c44ea04ff4_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTUtMS0xLTIyMw_ce7c31db-6a6a-431c-96a8-c2fa1851c34d">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e4ecee96fe4a029361a7becb75ea87_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTctMS0xLTIyMw_72da4e61-7a47-46ce-a951-ba2b4a21790f">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if876951023d64e46a24c7d835b5faa3b_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTktMS0xLTIyMw_b6800e82-db3f-476a-bba2-8b2952daed45">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875553a9513a45a38f8a905416d7829c_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTExLTEtMS0yMjM_1900799a-9ee5-4142-99c2-750c66b8f3ed">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00e3dbb86db0418ca06c3632c8c1b5e7_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTEtMS0xLTIyMw_15b96da5-5878-4e9d-8b81-c30794c5d990">3,386</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i122407c5128c49f5a374ce6bf633b754_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTMtMS0xLTIyMw_808ee0f8-0c79-4fc5-8326-57d4a9696c89">2,443</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTUtMS0xLTIyMw_197404df-1def-4780-bc31-d994c996cb5d">5,829</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77bb9297fb7c44c6b02abde208157004_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTctMS0xLTIyMw_a0e117e9-8080-4bd9-99e1-814a0faa3d87">2,607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8456f3d09026487583de79d141ac5a57_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTktMS0xLTIyMw_3118d34a-c402-42e6-88c4-aea1c5559dd1">1,939</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTExLTEtMS0yMjM_86130f99-db38-4f28-9c66-8bcae76c45b5">4,546</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88135e1e5b9e48138fa29ce5f22d50a0_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzItMS0xLTEtMA_30eff467-a515-4e18-8077-0904068271e2">1,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7322afa2bcb4680be71b6adae30c6a0_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzItMy0xLTEtMA_ac34a59b-efc2-416b-8830-e55332c53fa7">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i719d3d1d3dfc4900a97050942bbe31de_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzItNS0xLTEtMA_eb40e0aa-f017-49fa-9a38-2fb6672718cc">3,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb35a14aae34796be04212920a94266_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzItNy0xLTEtMA_f2076442-3740-44ef-9e41-058f1f033a3f">2,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37162a776ece4d0bb843164a63a34546_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzMtMS0xLTEtMA_9950c112-ceec-4eb8-b5b7-3670ff7ade9a">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8d04eeeafb94eb9bd136daeb8176cbf_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzMtMy0xLTEtMA_1010a2d8-6347-45da-80cc-0405abab1269">416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8010a52167452ea357069eec7e9c7e_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzMtNS0xLTEtMA_2944cf63-0675-415a-8b13-512d6cec2441">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb29b1f5e9c04d7f8e4e8c597595337c_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzMtNy0xLTEtMA_34d5aaaf-2c05-483c-a68b-6d424082e880">968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84fc90d4c0574d2180bf795e9ea8019a_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzQtMS0xLTEtMA_94c0a04a-40de-4b50-94ff-50bb89677866">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f7d90c59416456b8c31e32e8d530bcf_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzQtMy0xLTEtMA_1332a4b9-c6d1-44b6-a0e2-431c348eaca3">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3cc9570466e432bb34716e1723c76ed_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzQtNS0xLTEtMA_83ba9333-7cd1-4395-b89c-d2cd799c0340">994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d1a58b8b2a64926afbacb03ceb0e46f_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzQtNy0xLTEtMA_6c165d71-5b3d-4d64-9ce9-4d63c41a5174">819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d618ba150584c2d8089fc515133c197_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzUtMS0xLTEtMA_4c786cb9-e09b-48eb-a247-7f41ee5d1f29">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6590a83019bd4768911ab6e74a8ead5f_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzUtMy0xLTEtMA_903efe49-795f-4061-a593-7ef7c6c21423">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6016cb0bcb5645e79fb9453c064d1070_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzUtNS0xLTEtMA_7fbf2c76-72a7-4d94-ac8e-7dcef2ca6727">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5393f9f0da0e48d99af036f07bc71c8f_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzUtNy0xLTEtMA_2c7dac59-764f-41a5-ae68-17502daa9d3a">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08c5d30357d9461faac846d9a7f6f58c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzYtMS0xLTEtMA_67b2acd3-345a-4b20-b6ac-a1a4992538e1">3,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f1a45e38524eada4c409914683546a_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzYtMy0xLTEtMA_8d207d38-f06d-47d6-a6bf-fd16961161a1">1,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbfbdc30d0ab449094a90e70fd595751_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzYtNS0xLTEtMA_e008ef75-1e39-4037-9c7c-18b927de8615">5,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id96d30c4d41a4cdb9fe2a6c8498a6753_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzYtNy0xLTEtMA_315faf52-b358-4a41-8791-d2ce06da37d7">4,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idef0574f3eef4b9e8e842b614403cda3_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzctMS0xLTEtMA_812df141-df6d-4bda-a288-484d6a1d0a60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i372f4fcd9ee74bd6a7b738ffb8609de3_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzctMy0xLTEtMA_1f03340f-bd8e-4c5f-ac2f-e4de2c570a6d">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80dc82869bb14419b4927d17ccb893c3_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzctNS0xLTEtMA_95b44638-cf54-49d2-b1eb-18fb0b291780">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e4ecee96fe4a029361a7becb75ea87_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzctNy0xLTEtMA_72da4e61-7a47-46ce-a951-ba2b4a21790f">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7ef4aa393984e2ebb13ebe33340a910_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzgtMS0xLTEtMA_1bf3088b-b1eb-4f65-a417-87168b291c99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcf9760e631443339b33601a02bd59ce_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzgtMy0xLTEtMA_e8743a52-c49f-4c3b-9be9-f6e51e2939c3">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic86c037a105047ff8e30c52d263c8b1c_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzgtNS0xLTEtMA_67a1213f-8c24-4ea6-914b-00d3191d3858">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if876951023d64e46a24c7d835b5faa3b_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzgtNy0xLTEtMA_b6800e82-db3f-476a-bba2-8b2952daed45">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69c68d3663c4d20b8e7aa1db007db37_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzktMS0xLTEtMA_940e496e-0fb0-4815-ac5a-b6f2df7cc267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i917d4854b7a7437bbd99ae988171a69e_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzktMy0xLTEtMA_d3e38333-9068-48e4-85d9-4cc977f41e39">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6987d6c22f4b44dc92c281c44ea04ff4_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzktNS0xLTEtMA_a6e5eb85-dede-4912-b6fe-a201c78e32a0">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875553a9513a45a38f8a905416d7829c_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzktNy0xLTEtMA_1900799a-9ee5-4142-99c2-750c66b8f3ed">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEwLTEtMS0xLTA_fb8a89f2-739c-44be-8a28-4df266742888">3,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEwLTMtMS0xLTA_b1ad0a0b-c1db-4e25-af90-37012e9e36b0">2,003</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEwLTUtMS0xLTA_d16f65f3-4f43-4442-ba2a-8d783b119fb3">5,829</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEwLTctMS0xLTA_3bd09140-8a11-40e6-bf97-d0fef2e8f85e"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEwLTctMS0xLTA_772bf79b-02f6-47d5-8efe-7732b7411f1a">4,546</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae7822dc00ec44efa94a5d7b8f0d51df_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEyLTEtMS0xLTA_ad63d0c7-a77b-4200-947d-e13ea31d7d22">359</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8952d06cea3f4179a4e5e6ed3a7d7641_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEyLTMtMS0xLTA_87b90c3f-367c-47f0-9ae7-30b8291e3f67">268</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877c5d6831884713ad635096adea9fff_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEyLTUtMS0xLTA_07632403-c45b-44da-bb4a-02a770469efe">676</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icba8e95f00734703a480e7de812a5575_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEyLTctMS0xLTA_f009a9c4-4dc6-4143-b15b-ac5b8ae43e60">542</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="i1a3912cc4c704b01b45f0abc0cf33b50"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i3c62f0b008144174990932157df2342f">(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the <ix:nonFraction unitRef="units" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="0" name="bsx:EmergingMarketstotalnumberofcountries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzU1Mg_668d7529-3267-48b2-b205-d97d5ca0e936">20</ix:nonFraction> countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation which had an immaterial impact on previously reported Emerging Markets net sales.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated balance sheets. Our deferred revenue balance was $<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzEzOTM_01b4aa61-629f-430e-bf61-6871253793e3">424</ix:nonFraction> million as of June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzE0MDk_18bf8814-d230-4e53-a9bd-23a9e64d3a98">395</ix:nonFraction> million as of December&#160;31, 2020. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System within our Cardiac Rhythm Management (CRM) business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzE5Nzg_e3d4b1c4-12e7-453d-8b50-0d02c4ef9803">38</ix:nonFraction> million in the second quarter and $<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzEwOTk1MTE2MzE4MDQ_7591dc7d-5f0f-4539-8d1e-fceb81e43c6e">74</ix:nonFraction> million in the first six months of 2021 that was included in the above contract liability balance as of December&#160;31, 2020. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.</span></div></ix:continuation><div><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_115"></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90ZXh0cmVnaW9uOmRmMzc1ODMwMjUwYjQwOGY4NTY4NTUxNDRmMmRhMTA5XzkxNQ_1e49b1db-6d3b-4874-b52e-baf31447f857" continuedAt="ide10cb2ea6eb45de84f5c61995ddf293" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90ZXh0cmVnaW9uOmRmMzc1ODMwMjUwYjQwOGY4NTY4NTUxNDRmMmRhMTA5XzkwOQ_973c0f0d-3f84-40be-b8aa-63d4f2c5a1fc" continuedAt="i2931924405c74b998e449d2661538aa6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzEtMS0xLTEtMA_c19018ca-4521-483b-be98-e80e8c6f1697">134</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzEtMy0xLTEtMA_661b6f93-7bde-4173-958f-448e84f15e86">165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzEtNy0xLTEtMA_e19f6dcc-b395-4d61-a1e7-2470f9560e07">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzEtOS0xLTEtMA_a62a129d-e5b7-414a-856b-5c5065b419a6">254</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzItMS0xLTEtMA_1d718e29-1cd0-4ce6-8de2-bcf9d109572e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzItMy0xLTEtMA_6eff805e-dbc5-4104-849f-ca254ab2c9fe">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzItNy0xLTEtMA_73a82307-72ca-4426-b423-94b628012a25">0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzItOS0xLTEtMA_6d9528f7-e4fc-47c1-9a66-3876bc0a1d8c">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzMtMS0xLTEtMA_8508f02f-b7ef-492b-b91d-7842a2dfa010">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzMtMy0xLTEtMA_5a00c920-a70b-46e3-bd45-970118b6e27c">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzMtNy0xLTEtMA_e247cb48-dcc7-4039-bc4f-c88bb2497c61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzMtOS0xLTEtMA_3f05757b-5606-4b0a-b207-ad6a0890363a">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzQtMS0xLTEtMA_02be1fcf-85a5-4266-b9c0-446859a1be27">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzQtMy0xLTEtMA_2376e930-9439-4114-bc7b-058648395099">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzQtNy0xLTEtMA_c9947aa9-6792-46c1-9a8e-b4c77c9dfa3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzQtOS0xLTEtMA_adfa1b5b-2184-433c-ae56-c7b4ad35f391">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzUtMS0xLTEtMA_6c74384e-cc5c-43e4-8665-c3a4e8c8008d">136</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzUtMy0xLTEtMA_ca5c847b-a490-4b3d-b957-6730f505072e">146</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzUtNy0xLTEtMA_0da173dc-6c58-47e8-b3b3-c1db1304a9a8">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzUtOS0xLTEtMA_372487a9-991c-42cb-8cf2-d115f4942bf8">237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:continuation id="ide10cb2ea6eb45de84f5c61995ddf293" continuedAt="i011a54beaad443e2a5206d67d345e1ac"><ix:continuation id="i2931924405c74b998e449d2661538aa6"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e99e4069c604693bacde07aad3c5702_I20200331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzEtMS0xLTEtMA_528b3eb1-ec45-406d-8fd0-e5a55cd3500d">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e99e4069c604693bacde07aad3c5702_I20200331" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzEtMy0xLTEtMA_609fc39c-d292-420f-b638-6a3b1206a65d">248</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e99e4069c604693bacde07aad3c5702_I20200331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzEtNy0xLTEtMA_65873ce0-8e4d-441f-9c5f-e82fa45acf0a">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e99e4069c604693bacde07aad3c5702_I20200331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzEtOS0xLTEtMA_57bf5c3a-b90b-42fd-8fa1-39954f8ec47f">168</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzItMS0xLTEtMA_4d4bdeb1-ebd8-4b5b-9a4f-8a00746d6cdb">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzItMy0xLTEtMA_d87a6f85-dfda-4ca1-8169-35169a71dd5b">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzItNy0xLTEtMA_a8efebac-6ab7-43a3-a9ea-dea8ff5096cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzItOS0xLTEtMA_cc87967e-a6ca-40c3-b4a5-75b5d7b2a920">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzMtMS0xLTEtMA_2f4ef7a3-f8e8-466e-8919-0cf14ff12b7e">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzMtMy0xLTEtMA_2f898758-afc0-4138-a128-7f87d00be1f7">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzMtNy0xLTEtMA_2108fa29-b6b7-4fb9-a47e-6459c08eef3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzMtOS0xLTEtMA_0f77f68d-ef37-4c24-9e67-e7417cb0662f">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzQtMS0xLTEtMA_bc892e39-000e-4b07-8644-ba4918b76c8a">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzQtMy0xLTEtMA_689e6b91-ded2-41f2-896d-34c48e6ba0c2">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzQtNy0xLTEtMA_de270eb4-21aa-45c5-9135-dcbbe0c84e34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzQtOS0xLTEtMA_ead6e3df-ca5a-4179-87a0-86a280581b58">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzUtMS0xLTEtMA_b80ef3a9-6e20-417d-aa6d-f9cb8ca673a7">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzUtMy0xLTEtMA_51526e21-0f83-4adf-ab77-fe89a8b7cb76">222</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzUtNy0xLTEtMA_70f14582-057c-4887-99a9-d16d6478b807">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzUtOS0xLTEtMA_03a55be6-4fa4-498a-b79f-0c8297287558">131</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzEtMS0xLTEtMjA0_1cd4b085-6f7c-4db9-a485-f4134ff47883">218</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzEtMy0xLTEtMjA0_d3bf31fb-a6ea-4da0-bc52-f0f22a72d32e">36</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzEtNy0xLTEtMjA0_b468e42e-f771-48c9-b0f8-a4dd27313a2a">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d4bbc844644023a5878306b022201d_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzEtOS0xLTEtMjA0_c7b7d9db-2a3f-4a98-93ec-5ba61822018b">207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzItMS0xLTEtMjA0_9ca23491-673c-4237-9832-730706028ae9">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzItMy0xLTEtMjA0_e76bbf0c-04ac-42c8-8ba7-d59549bed3af">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzItNy0xLTEtMjA0_3d87c1bb-7565-4abb-882b-d99d0d7ae4b1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzItOS0xLTEtMjA0_b4360556-0503-4b9f-beb6-d3f8d9e40322">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzMtMS0xLTEtMjA0_6e7e9c08-9a8c-427b-93af-0b1e6f313185">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzMtMy0xLTEtMjA0_8a2e1cc4-d6ff-4ce5-812c-abd50a38a009">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzMtNy0xLTEtMjA0_834c3241-3b04-4edf-92c3-a710f8990ae6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzMtOS0xLTEtMjA0_bfbc6f10-f21a-46f6-a984-db66019440ca">144</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzQtMS0xLTEtMjA0_1ae5a677-2110-4a0f-9200-6811a05e40fd">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzQtMy0xLTEtMjA0_69e34c95-dda2-44c9-b9a9-5f1ed629ef5f">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzQtNy0xLTEtMjA0_e21d03bf-aafb-4af7-af72-248d15841614">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzQtOS0xLTEtMjA0_63d9cffa-870a-47f7-b824-78934f8d3aef">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzUtMS0xLTEtMjA0_05c1e823-7b14-4a40-9b46-0f4ac9b06e10">136</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzUtMy0xLTEtMjA0_cd61dcce-146f-4306-b464-f0918df149ca">146</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzUtNy0xLTEtMjA0_8e5090de-8b6c-4ede-8985-45a260d168f8">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzUtOS0xLTEtMjA0_15b5316a-e7de-414f-bf5b-c8a27b7ad25d">237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In connection with the completion of the divestiture of the Specialty Pharmaceuticals business in the first quarter of 2021, we released $<ix:nonFraction unitRef="usd" contextRef="ic27d3ee5d397485ba3bd063f9697f20b_D20210301-20210301" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90ZXh0cmVnaW9uOmRmMzc1ODMwMjUwYjQwOGY4NTY4NTUxNDRmMmRhMTA5XzI3NDg3NzkwNzA1MzI_ed5f3e7c-b3cb-4ea2-ab55-501b9f593c38">127</ix:nonFraction> million of cumulative translation adjustments associated with the disposed business from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzEtMS0xLTEtMjA0_d8341936-c4f6-4ac7-a707-36ac81b278c3">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzEtMy0xLTEtMjA0_59223cb5-54b1-4b97-98eb-be295cd37722">173</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzEtNy0xLTEtMjA0_029bd92a-ac7c-48af-80bd-05f22a2525eb">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzEtOS0xLTEtMjA0_10526d0a-5fc2-49b5-b931-c19a46ec5452">270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzItMS0xLTEtMjA0_d9fdaa44-c772-411d-ab7e-01fc3ae03f76">178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzItMy0xLTEtMjA0_23ac03ff-3b71-4006-a9a7-a7fa71ce675c">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzItNy0xLTEtMjA0_733fc135-1bcb-40de-9260-bb787a2e54ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzItOS0xLTEtMjA0_5406c275-d416-4a21-8433-fc0c147ffda2">92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzMtMS0xLTEtMjA0_f6110195-8edc-4072-b9b0-84412714beff">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzMtMy0xLTEtMjA0_437924ef-1ac6-406d-a888-b8eb05299c19">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzMtNy0xLTEtMjA0_93abedac-5d87-48f2-8734-71c8fbe584f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzMtOS0xLTEtMjA0_bc973988-344b-4fb1-890b-f3b53f81d67c">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzQtMS0xLTEtMjA0_4b315bde-8fea-4bab-9f5f-194ad8bc3a09">187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzQtMy0xLTEtMjA0_92b30116-0646-40e6-a0bd-c89d2b0b9635">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzQtNy0xLTEtMjA0_49d0eb8a-f1e8-4503-af5b-01a173425233">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzQtOS0xLTEtMjA0_1005a2ce-6948-4719-a9e4-962815235a48">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzUtMS0xLTEtMjA0_c94b2505-5878-4511-ae18-ed6fed7c31f8">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzUtMy0xLTEtMjA0_c57557c1-8e88-4491-b336-aae5e4edc204">222</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzUtNy0xLTEtMjA0_3c1337a2-18f0-4781-8652-d7b69dd24a18">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzUtOS0xLTEtMjA0_dfb005c4-2dd6-4ce6-b46f-a624daff4176">131</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i011a54beaad443e2a5206d67d345e1ac" continuedAt="i98386200335f46fe922470c854066fb2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i98386200335f46fe922470c854066fb2"> were reduced by immaterial income tax impacts in the second quarter and first six months of 2021 and 2020.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="bsx:NewAccountingPronouncementsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMjEvZnJhZzo1ZDE5OTIyYWM5NTE0NjEzODM2MmEyN2QxMWZiZGIzYS90ZXh0cmVnaW9uOjVkMTk5MjJhYzk1MTQ2MTM4MzYyYTI3ZDExZmJkYjNhXzI3NDg3NzkwNzM1MDI_afead29d-0336-4d26-a11e-7e8b0f0cb0b4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our accompanying unaudited consolidated financial statements. During the first quarter of 2021, we implemented the following standards, which did not have a material impact on our financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMjEvZnJhZzo1ZDE5OTIyYWM5NTE0NjEzODM2MmEyN2QxMWZiZGIzYS90ZXh0cmVnaW9uOjVkMTk5MjJhYzk1MTQ2MTM4MzYyYTI3ZDExZmJkYjNhXzI1MTQ_1f95e837-8c6e-4cc8-8abd-a16c3bdf04ee" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-10</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMjEvZnJhZzo1ZDE5OTIyYWM5NTE0NjEzODM2MmEyN2QxMWZiZGIzYS90ZXh0cmVnaW9uOjVkMTk5MjJhYzk1MTQ2MTM4MzYyYTI3ZDExZmJkYjNhXzI1Mjc_cec684a5-c0ff-41ed-ac1c-1f2eaf3863af" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="bsx:ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMjEvZnJhZzo1ZDE5OTIyYWM5NTE0NjEzODM2MmEyN2QxMWZiZGIzYS90ZXh0cmVnaW9uOjVkMTk5MjJhYzk1MTQ2MTM4MzYyYTI3ZDExZmJkYjNhXzI1MTU_69345bca-cb20-46b6-ba93-85a2f59f3480" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2019-12 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630" name="bsx:ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMjEvZnJhZzo1ZDE5OTIyYWM5NTE0NjEzODM2MmEyN2QxMWZiZGIzYS90ZXh0cmVnaW9uOjVkMTk5MjJhYzk1MTQ2MTM4MzYyYTI3ZDExZmJkYjNhXzI3NDg3NzkwNzM1MDE_2b29784a-448a-4376-972f-60a9f5fff2e9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-05</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Lessors&#8212;Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases.  Such classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We have the option to apply the amendments retrospectively to leases that commenced or were modified on or after the adoption of FASB ASC Topic 842, or prospectively.  We are currently in the process of determining the effect that the adoption will have on our financial position and results of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our accompanying unaudited consolidated financial statements.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="padding-left:49.5pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.36pt">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Introduction</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world. As a medical technology leader for more than 40 years, we have advanced the practice of less-invasive medicine by helping physicians and other medical professionals diagnose and treat a wide range of diseases and medical conditions and improve patients&#8217; quality of life by providing alternatives to surgery and other medical procedures that are typically traumatic to the body. Our net sales have increased substantially since our formation, fueled in part by strategic acquisitions designed to improve our ability to take advantage of growth opportunities in the medical device industry and to build diversified portfolios within our core businesses. We advance science for life by providing a broad range of high performance solutions to address unmet patient needs and reduce the cost of healthcare.  When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the novel strain of coronavirus (SARS-Cov-2), and its disease commonly known as COVID-19 (COVID-19), was reported in China and has since widely impacted the global public health and economic environment. In March 2020, the World Health Organization (WHO) declared COVID-19, including all additional variations and strains thereof, a global pandemic (COVID-19 pandemic). While the majority of procedures using our products are deferrable, most of the conditions that we treat are generally fairly acute and cannot be deferred for extended periods. As the pandemic spread worldwide and with COVID-19 cases confirmed in all major geographies, many elective and semi-emergent procedures were postponed, enabling hospital staff to focus critical resources on caring for COVID-19 patients. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing COVID-19 pandemic and accompanying restrictions negatively impacted our net sales and our results of operations beginning in March 2020. We experienced sequential improvement in our global sales trends beginning in the third quarter of 2020 which continued through the second quarter of 2021, as procedure volumes resumed and referral rates improved. During the second quarter of 2021, the resumption of elective procedures strengthened in the U.S. and improved in many parts of the globe as COVID-19 vaccines were increasingly made available.  However, COVID-19 cases continue to rise in many locations around the world where vaccination rates remain low and new, more contagious variant strains of COVID-19 have emerged, resulting in continued restrictions.  In particular, certain countries within our Asia Pacific region, including India and Japan, as well as Latin America have been significantly impacted.  These restrictions continued to negatively impact our net sales in the first six months of 2021.  The timing and success of efforts to distribute and administer COVID-19 vaccines to these locations and to broad portions of the worldwide population, enabling widespread immunity to COVID-19, will continue to have an impact on the duration and extent of the pandemic and its effect on demand for our products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences continue to be uncertain, the pandemic&#8217;s impact on our operations and financial performance, as well as its impact on our ability to execute our business strategies and initiatives successfully, remains uncertain and difficult to predict. Procedural delays from the further resurgence of COVID-19 infections and the emergence of new, more contagious variant strains of COVID-19 may negatively impact demand for our products, net sales, gross profit margin and operating expenses as a percentage of net sales in 2021.  In addition, conditions created by the COVID-19 pandemic, the economic recovery that has followed in many areas and other macroeconomic factors have led to a challenging labor market in which we compete, which may affect our ability to retain and attract new talent and put inflationary pressure on certain operational costs due to wage increases and supply constraints.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to focus our efforts on the health and safety of patients, healthcare providers and employees, while executing our mission of transforming lives through innovative medical solutions to improve the health of patients around the world. Since the onset of the COVID-19 pandemic, our global crisis management team has focused on protecting our employees and customers, optimizing our operations and securing our supply chain. We have successfully implemented business continuity plans including establishing a medical advisory group for employees, leveraging work from home infrastructure to facilitate social distancing and accelerating capabilities to provide remote physician support. While we expect the COVID-19 pandemic will continue to negatively impact our 2021 performance to an extent,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we continue to believe our long-term fundamentals remain strong and we will manage through these challenges with strategic focus and the winning spirit of our global team. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Sustainability</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sustainable economic, environmental and social practices underpin all aspects of our global business. Our approach is aligned with the United Nations Sustainable Development Goals and our material topics and practices are informed by a broad range of internal and external stakeholders &#8211; locally, nationally and globally. Our employees around the world work with suppliers and other organizations that share our commitment to these practices that help address issues related to health inequity, economic disparity, climate change and environmental protection. These efforts are supported by our cross-functional Corporate Social Responsibility Council, our Environmental Health and Safety teams and policies, our Global Council for Inclusion, as well as local, regional and national employee and community programs. Key examples of our programs include setting measurable, transparent diversity, equity and inclusion (DE&amp;I) goals. Our &#8220;3UP by 2023&#8221; initiative furthers our focus on increasing the representation of women and multicultural talent at the supervisor and manager level by three percentage points or more by December 31, 2022. Our DE&amp;I progress has been recognized in 2021 when we were ranked in the Top 10 America's Best Employers for Diversity by Forbes, named on the JUST Capital Top 100 list of Companies Supporting Healthy Families and Communities and recognized as a "Best Place to Work for Disability Inclusion", achieving top marks on Disability:IN&#8217;s 2021 Disability Equality Index (DEI).  We are also proactively addressing ways to minimize energy consumption, carbon emissions, waste management and water use. We are focused on a &#8220;C3&#8221; strategy: Cutting energy use, Converting to renewable energy sources and Compensating with carbon offset projects where needed. We are on track with our commitment to carbon neutrality in our manufacturing and key distribution sites by 2030, and expect to source or generate 100 percent of electricity from renewable sources by 2024, and have already achieved our interim goal of 50 percent.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Summary </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended June 30, 2021 </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales for the second quarter of 2021 were $3.077 billion, as compared to $2.003 billion for the second quarter of 2020. This increase of $1.074 billion, or 53.6 percent, included operational net sales growth of 49.6 percent and the positive impact of 400 basis points from foreign currency fluctuations, and includes net sales from Preventice Solutions, Inc. (Preventice) following the completion of the acquisition on March 1, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The increase in our net sales was significantly driven by the recovery of elective and semi-emergent procedure volumes compared to the prior year when the COVID-19 pandemic had peak impact on our net sales.  Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our net sales by global business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income available to common stockholders for the second quarter of 2021 was $172 million, or $0.12 per diluted share. Our reported results for the second quarter of 2021 included certain charges and/or credits totaling $405 million (after-tax), or $0.28 per diluted share. Excluding these items, adjusted net income available to common stockholders for the second quarter of 2021 was $577 million, or $0.40 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1, 2 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net loss available to common stockholders for the second quarter of 2020 was $153 million, or $(0.11) per diluted share. Our reported results for the second quarter of 2020 included certain charges and/or credits totaling $273 million (after-tax), or $0.19 per diluted share. Excluding these items, adjusted net income available to common stockholders for the second quarter of 2020 was $120 million, or $0.08 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operational net sales growth rates, which exclude the impact of foreign currency fluctuations, and other adjusted measures, which exclude certain items required by generally accepted accounting principles in the United States (U.S. GAAP) are not prepared in accordance with U.S. GAAP and should not be considered in isolation from, or as a replacement for, the most directly comparable GAAP measure. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for a discussion of management&#8217;s use of these non-GAAP financial measures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In May 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) at a price to the public and liquidation preference of $100 per share. Refer to the reconciliations below for the impact of the MCPS cumulative preferred stock dividends on our calculations of earnings per share (EPS).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of these reconciling items:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.743%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss) available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">172</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net income (loss) available to common stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">577</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(3) For the second quarter of 2021, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> and Adjusted net income were reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">, as presented in our unaudited consolidated statements of operations, for purposes of calculating GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(147)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss) available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(153)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net income (loss) available to common stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(4) For the second quarter of 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> and Adjusted net loss were reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">, as presented in our unaudited consolidated statements of operations, for purposes of calculating EPS. We have assumed dilution of 12.6 million common stock equivalents related to employee stock options for all or a portion of the non-GAAP adjustments, which were anti-dilutive for GAAP purposes due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> position.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Six Months Ended June 30, 2021 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales for the first six months of 2021 were $5.829 billion, as compared to $4.546 billion for the first six months of 2020. This increase of $1.283 billion, or 28.2 percent, included operational net sales growth of 25.0 percent and the positive impact of 320 basis points from foreign currency fluctuations, and includes net sales from Preventice following the completion of the acquisition on March 1, 2021.  The increase in our net sales was significantly driven by the recovery of elective and semi-emergent procedure volumes compared to the prior year when the COVID-19 pandemic had peak impact on our net sales.   Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our net sales by global business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income available to common stockholders for the first six months of 2021 was $500 million, or $0.35 per diluted share. Our reported results for the first six months of 2021 included certain charges and/or credits totaling $602 million (after-tax), or $0.42 per diluted share. Excluding these items, adjusted net income available to common stockholders for the first six months of 2021 was $1.102 billion, or $0.77 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net loss available to common stockholders for the first six months of 2020 was $142 million, or $(0.10) per diluted share. Our reported results for the first six months of 2020 included certain charges and/or credits totaling $653 million (after-tax), or $0.46 per diluted share. Excluding these items, adjusted net income available to common stockholders for the first six months of 2020 was $511&#160;million, or $0.36 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of these reconciling items:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">527</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss) available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition/divestitures-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment portfolio net losses (gains)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net income (loss) available to common stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.77</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(5) For the first six months of 2021, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> and Adjusted net income were reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">, as presented in our unaudited consolidated statements of operations, for purposes of calculating GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(137)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss) available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(142)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union (EU) Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net income (loss) available to common stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">511</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(6) For the first six months of 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> and Adjusted net income were reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">, as presented in our unaudited consolidated statements of operations, for purposes of calculating EPS. We have assumed dilution of 14.4 million common stock equivalents related to employee stock options for all or a portion of the non-GAAP adjustments, which were anti-dilutive for GAAP purposes due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> position.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities was $927&#160;million for the first six months of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of June 30, 2021, we had total debt outstanding of $9.109 billion net of unamortized debt issuance discounts and deferred financing costs, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $2.675 billion and working capital of $2.685 billion. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly Results and Business Overview </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following section describes our net sales and results of operations by reportable segment and business unit. For additional information on our businesses and product offerings, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item&#160;1. Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">948</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">576</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64.6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.5%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">866</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">525</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">834</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51.4%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(100.0)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53.6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.813%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,808</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,350</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33.9%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,617</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,228</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.7%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,392</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,860</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28.6%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,816</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,437</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.1%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">109</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(87.8)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28.2%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7) On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales include Specialty Pharmaceuticals up to the date of the closing of the transaction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MedSurg </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Endoscopy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with innovative, less-invasive technologies. Our net sales of Endoscopy products were $551 million for the second quarter of 2021 and $1.050 billion for the first six months of 2021, and represented 18 percent of our consolidated net sales in both the second quarter and first six months of 2021. Our Endoscopy net sales increased $203 million, or 58.5 percent, in the second quarter of 2021 and increased $260 million, or 33.0 percent, in the first six months of 2021, compared to the prior year periods. In the second quarter of 2021, this increase included operational net sales growth of 54.1 percent and a positive impact of 440 basis points from foreign currency fluctuations, compared to the prior year period. In the first six months of 2021, this increase included operational net sales growth of 29.4 percent and a positive impact of 360 basis points from foreign currency fluctuations, compared to the prior year period. This growth was primarily driven by our biliary, single-use imaging, hemostasis and infection prevention franchises due to the recovery of elective and semi-emergent procedure volumes compared to the prior year when the COVID-19 pandemic had peak impact on our net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Urology and Pelvic Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Urology and Pelvic Health business develops and manufactures devices to treat various urological and pelvic conditions for both male and female anatomies. Our net sales of Urology and Pelvic Health products were $397 million for the second quarter of 2021 and $758 million for the first six months of 2021, representing 13 percent of our consolidated net sales in both the second quarter and first six months of 2021.  Our Urology and Pelvic Health net sales increased $169 million, or 73.9 percent, in the second quarter of 2021 and increased $197 million, or 35.2 percent, in the first six months of 2021, compared to the prior year periods. In the second quarter of 2021, this increase included operational net sales growth of 70.4 percent and a positive impact of 350 basis points from foreign currency fluctuations, compared to the prior year period.  Operational net sales growth included organic sales growth of 70.8 percent and the unfavorable impact of 40 basis points from the divestiture of the Intrauterine Health business in the second quarter of 2020.  In the first six months of 2021, this increase included operational net sales growth of 32.7 percent and a positive impact of 250 basis points from foreign currency fluctuations, compared to the prior year period.  Operational net sales growth included organic net sales growth of 34.3 percent and the negative impact of 160 basis points from the divestiture of the Intrauterine Health business in the second quarter of 2020.  Organic growth was driven by our stone management, prosthetic urology and prostate health franchises in addition to the recovery of elective and semi-emergent procedure volumes compared to the prior year when the COVID-19 pandemic had peak impact on our net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rhythm and Neuro </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cardiac Rhythm Management </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Cardiac Rhythm Management (CRM) business develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. Our net sales of CRM products were $524 million for the second quarter of 2021 and $993 million for the first six months of 2021, representing 17 percent of our consolidated net sales in both the second quarter and first six months of 2021.  Our CRM net sales increased $173 million, or 49.2 percent, in the second quarter of 2021 and increased $205 million, or 26.0 percent, in the first six months of 2021, compared to the prior year periods. In the second quarter of 2021, this increase included operational net sales growth of 44.9 percent and a positive impact of 430 basis points from foreign currency fluctuations, compared to the prior year period. Operational net sales growth included organic sales growth of 31.2 percent and the favorable impact of 1380 basis points from the acquisition of Preventice in the first quarter of 2021, adding to our CRM business a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry.  In the first six months of 2021, this increase included operational net sales growth of 22.5 percent and a positive impact of 350 basis points from foreign currency fluctuations, compared to the prior year period.  Operational net sales growth included organic net sales growth of 14.2 percent and the positive impact of 830 basis points from the Preventice acquisition. Organic net sales growth was attributable to our defibrillator and pacemaker franchises, due to the recovery of semi-emergent and emergent procedure volumes compared to the prior year when the COVID-19 pandemic had peak impact on our net sales, as well as our cardiac diagnostics franchise, led by our LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Electrophysiology </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Electrophysiology business develops and manufactures less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart. Our net sales of Electrophysiology products were $95 million for the second </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">quarter of 2021 and $179 million for the first six months of 2021, representing three percent of our consolidated net sales in both the second quarter and first six months of 2021. Our Electrophysiology net sales increased $44 million, or 85.8 percent, in the second quarter of 2021 and increased $53 million, or 42.0 percent, in the first six months of 2021, compared to the prior year periods. In the second quarter of 2021, this increase included operational net sales growth of 78.7 percent and a positive impact of 710 basis points from foreign currency fluctuations, compared to the prior year period.  In the first six months of 2021, this increase included operational net sales growth of 36.7 percent and a positive impact of 530 basis points from foreign currency fluctuations, compared to the prior year period. This growth was driven by the recovery of elective procedure volumes compared to the prior year when the COVID-19 pandemic had peak impact on our net sales and the success of our ongoing POLARx&#8482; Cryoablation System and Stablepoint Force-Sensing catheter international launches. On August 6, 2021, we completed our acquisition of the remaining shares of Farapulse, Inc., a privately-held company that develops and commercializes a pulsed field ablation system, a non-thermal ablation treatment of atrial fibrillation and the only company with  a commercially approved pulsed field ablation product in Europe, which will complement our existing electrophysiology portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neuromodulation </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Our net sales of Neuromodulation products were $247 million for the second quarter of 2021 and $444 million for the first six months of 2021, representing eight percent of our consolidated net sales in both the second quarter and first six months of 2021.  Our Neuromodulation net sales increased $124 million, or 101.5 percent, in the second quarter of 2021 and increased $131 million, or 41.8 percent, in the first six months of 2021, compared to the prior year periods. In the second quarter of 2021, this increase included operational net sales growth of 98.0 percent and a positive impact of 360 basis points from foreign currency fluctuations, compared to the prior year period. In the first six months of 2021, this increase included operational net sales growth of 39.3 percent and a positive impact of 250 basis points from foreign currency fluctuations, compared to the prior year period. This growth was primarily driven by our spinal cord stimulation (SCS) systems, led by our next generation WaveWriter Alpha&#8482; SCS System and deep brain stimulation (DBS) systems, including our Vercise Genus&#8482; DBS System, due to the recovery of elective procedure volumes compared to the prior year when the COVID-19 pandemic had peak impact on our net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cardiovascular </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional Cardiology </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Interventional Cardiology business develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions. Our net sales of Interventional Cardiology products were $790 million or 26 percent of our consolidated net sales for the second quarter of 2021 and $1.486 billion or 25 percent of our consolidated net sales for the first six months of 2021.  Our Interventional Cardiology net sales increased $296 million, or 59.8 percent, in the second quarter of 2021 and increased $358 million, or 31.7 percent, in the first six months of 2021, compared to the prior year periods. In the second quarter of 2021, this increase included operational net sales growth of 55.2 percent and a positive impact of 460 basis points from foreign currency fluctuations, compared to the prior year period. In the first six months of 2021, this increase included operational net sales growth of 28.2 percent and a positive impact of 350 basis points from foreign currency fluctuations, compared to the prior year period. This growth was driven by our WATCHMAN&#8482; FLX Left Atrial Appendage Closure Device, our percutaneous coronary intervention guidance (PCIG) franchise and our drug-eluting stent (DES) systems due to the recovery of procedure volumes compared to the prior year when the COVID-19 pandemic had peak impact on our net sales. These increases were partially offset by the discontinuation of our LOTUS Edge&#8482; Aortic Valve System in the fourth quarter of 2020, general price declines associated with our DES systems and the unfavorable impact of China tender pricing on both DES systems and balloon catheter net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Peripheral Interventions </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Peripheral Interventions business develops and manufactures products to diagnose and treat peripheral arterial and venous diseases, as well as products to diagnose, treat and ease various forms of cancer. Our net sales of Peripheral Interventions products were $473 million or 15 percent of our consolidated net sales for the second quarter of 2021 and $906 million or 16 percent of our consolidated net sales for the first six months of 2021. Our Peripheral Interventions net sales increased $133 million, or 39.1 percent, in the second quarter of 2021 and increased $174 million, or 23.7 percent, in the first six months of 2021, compared to the prior year periods. In the second quarter of 2021, this increase included operational net sales growth of 35.6 percent and a positive impact of 350 basis points from foreign currency fluctuations, compared to the prior year period. In the first six months of 2021, this increase included operational net sales growth of 20.6 percent and a positive impact of 310 basis points from foreign currency fluctuations, compared to the prior year period. This growth was primarily driven by the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interventional Oncology franchise, including our TheraSphere&#8482; Y-90 Radioactive Glass Microspheres, which received U.S. Food and Drug Administration (FDA) approval in the first quarter of 2021 after 20 years as a humanitarian device exemption (HDE).  In addition, growth was driven by our drug-eluting portfolio, including the Eluvia&#8482; Drug-Eluting Stent and Ranger&#8482; Drug-Coated Balloon due to the recovery of procedure volumes compared to the prior year when the COVID-19 pandemic had peak impact on our net sales and continued worldwide commercial execution and adoption in recently approved countries.  In the first quarter of 2021, we received approval from Japan&#8217;s Ministry of Health, Labor and Welfare (MHLW) for our Ranger Drug-Coated Balloon and initiated a full launch.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Pharmaceuticals </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business for a purchase price of approximately $800 million. Our consolidated net sales include Specialty Pharmaceuticals up to the date of the closing of the transaction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategic imperative to drive global expansion, we are seeking to grow net sales and market share by expanding our global presence, including in Emerging Markets. We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation which had an immaterial impact on previously reported Emerging Markets net sales. Our Emerging Markets net sales represented 12 percent of our consolidated net sales in both the second quarter and first six months of 2021, 13 percent in the second quarter of 2020, and 12 percent in the first six months of 2020. In the second quarter of 2021, our Emerging Markets net sales grew 33.8 percent on a reported basis, which included operational net sales growth of 25.8 percent and a positive impact of 800 basis points from foreign currency fluctuations, compared to the prior year period. In the first six months of 2021, our Emerging Markets net sales grew 24.8 percent on a reported basis, which included operational net sales growth of 19.5 percent and a positive impact of 530 basis points from foreign currency fluctuations, compared to the prior year period. The growth in the second quarter and first six months of 2021 compared to the prior year periods was driven primarily by our net sales in China, which have largely recovered from the impact of the COVID-19 pandemic on procedural volumes.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_136"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $2.132 billion for the second quarter of 2021, $1.212 billion for the second quarter of 2020, $3.990 billion for the first six months of 2021 and $2.950 billion for the first six months of 2020. As a percentage of net sales, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased to 69.3 percent in the second quarter of 2021, as compared to 60.5 percent in the second quarter of 2020 and 68.4 percent in the first six months of 2021, as compared to 64.9 percent in the first six months of 2020. The following is a reconciliation of our gross profit margin and a description of the drivers of the changes from period to period:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage of Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin - period ended June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60.5%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64.9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abnormal production variances</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales pricing, volume and mix</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of foreign currency fluctuations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, including other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin - period ended June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.4%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The primary factors contributing to the increase in our gross profit margin in the second quarter and first six months of 2021, as compared to the same periods in 2020, were higher sales volumes and favorable product mix associated with the resumption of procedures using higher-margin products, as well as the impact in the prior year of abnormal production variances attributable to manufacturing plant shut-downs driven by the COVID-19 pandemic in the prior year.  These improvements were partially offset by price declines related primarily to sales of our coronary drug-eluting stent systems and foreign currency fluctuations.  In addition, inflation has put pressure on our gross profit margin, particularly with increases in costs of certain raw materials, direct labor and freight.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain of our operating expenses:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.489%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative (SG&amp;A) expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development (R&amp;D) expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $322 million, or 40 percent, as compared to the second quarter of 2020 and were 350 basis points lower as a percentage of net sales. In the first six months of 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $363 million, or 20 percent, as compared to the first six months of 2020 and were 240 basis points lower as a percentage of net sales. The increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the second quarter and first six months of 2021, as compared to the same period in the prior year, was primarily due to higher selling costs driven by higher global net sales and the targeted lifting of spending controls implemented in the first half of 2020 in response to the escalating COVID-19 pandemic.  In addition, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the first half of 2021 were further impacted by higher restructuring-related spend.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain committed to advancing medical technologies and investing in meaningful R&amp;D projects across our businesses. In the second quarter of 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $57 million, or 23 percent, as compared to the second quarter of 2020 and were 240 basis points lower as a percentage of net sales. In the first six months of 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $32 million, or 6 percent, as compared to the first six months of 2020, and were 200 basis points lower as a percentage of net sales. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased in the second quarter and the first six months of 2021, as compared to the same period in the prior year, as a result of investments across our businesses in order to maintain a pipeline of new products that we believe will contribute to profitable sales growth. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased $4 million, or 48 percent as compared to the second quarter of 2020 and remained flat as a percentage of net sales. In the first six months of 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $4 million, or 21 percent, as compared to the first six months of 2020, and remained flat as a percentage of net sales, primarily due to global net sales growth in the second quarter and first six months of 2021 as compared to the second quarter and first six months of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain of our other operating expenses, which are excluded by management for purposes of evaluating operating performance, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a further description of certain operating expenses:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $17 million, or 9 percent, as compared to second quarter of 2020.  In the first six months of 2021, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $33 million, or 8 percent, as compared to first six months of 2020.  The decrease in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the second quarter of 2021, as compared to the same period in the prior year, was driven by a decrease in the balance of amortizable intangible assets due to the divestiture of the Specialty Pharmaceuticals business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Asset Impairment Charges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $45 million in the second quarter of 2021, $34 million in the second quarter of 2020, $45 million in the first six months of 2021 and $233 million in the first six months of 2020.  The impairment charges recorded in the second quarter and first six months of 2021 were primarily attributable to incremental time and cost to complete an acquired in-process research and development (IPR&amp;D) project.  The impairment charges recorded in the first six months of 2020 were primarily associated with amortizable technology-related intangible assets that were initially established following our acquisition of nVision Medical Corporation (nVision). These charges were recorded as a result of management&#8217;s decision to change commercial launch plans or discontinue certain R&amp;D programs based on cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Item&#160;7 of our most recent Annual Report on Form 10-K for additional details and a discussion of key assumptions used in our goodwill and intangible asset impairment testing and future events that could have a negative impact on the recoverability of our goodwill and intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Net Expense (Benefit)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To recognize changes in the fair value of our contingent consideration liability, we recorded net benefits of $85 million and  $91 million in the second quarter and first six months of 2021, respectively, a net expense of  less than one million in the second quarter of 2020 and a net benefit of $108 million in the first six months of  2020.   The net benefits recorded in the first six months of 2021 and 2020 related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or, in the case of nVision, for milestones that would not be achieved due to management's discontinuation of the R&amp;D program. In addition, we made payments of $14 million associated with prior acquisitions during the first six months of 2021, following the achievement of a revenue-based milestone. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for additional details related to our contingent consideration arrangements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges (Credits)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, our Board of Directors approved, and we committed to, a new global restructuring program (the 2019 Restructuring Plan). The 2019 Restructuring Plan, for which our Board of Directors approved an extension and expansion in February 2021, is expected to result in total pre-tax charges of approximately $375 million to $475 million and approximately $340 million to $440 million of these charges are expected to result in cash outlays. We expect the majority of activity associated with our 2019 Restructuring Plan, including the extension, to be substantially complete by the end of 2022. A substantial portion of the savings are being reinvested in strategic growth initiatives. Pursuant to this program, restructuring charges were $3 million in the second quarter of 2021 and 2020, $6 million in the first six months of 2021 and $13 million in the first six months of 2020.  Restructuring-related charges were $35 million in the second quarter of 2021, $20 million in the second quarter of 2020, $64 million in the first six months of 2021 and $40 million in the first six months of 2020 and were recorded primarily in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on November 17, 2020, we announced a global, voluntary recall of all unused inventory of our LOTUS Edge&#8482; Aortic Valve System, and our decision to retire the entire LOTUS&#8482; Valve platform. We recorded immaterial restructuring and restructuring-related charges associated with the product discontinuation in the second quarter of 2021 and recorded $2 million of restructuring charges and $16 million of restructuring-related charges associated with the product discontinuation in the first six months of 2021.  The product discontinuation resulted in total pre-tax restructuring and restructuring-related net charges of approximately $80 million.  We substantially completed the restructuring activities in the first quarter of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Restructuring-related Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $298 million during the second quarter of 2021 and $302 million during the first six months of 2021, related primarily to transvaginal surgical mesh products.  We increased the accrual associated with this matter to account for increased, post-COVID-19 settlement and litigation activity related to the remaining cases and claims the Company faces, our revision of the per-case settlement amount for these cases based on recent settlement and litigation activity and changes to our expectations regarding the rate of incoming cases and claims.  We did not record any litigation-related net charges during the first six months of 2020.  We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation, and therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with the financial covenant required by our credit arrangements. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for discussion of our material legal proceedings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and average borrowing rate:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.343%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average borrowing rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our average borrowing rate remained relatively flat in the second quarter and first six months of 2021, as compared to the same periods in the prior year. During the first six months of 2020, we began to take proactive steps to manage the potential impact of the COVID-19 pandemic on our short-term liquidity and refinanced existing term loans and outstanding commercial paper with proceeds from new term loans and our 2018 Revolving Credit Facility.  We refinanced this short-term, variable-rate debt in May 2020 with our issuances of $500 million 1.900% senior notes due June 2025 and $1.200 billion 2.650% senior notes due June 2030. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for information regarding our debt obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other, net </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the components of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.907%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.907%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign currency gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains (losses) on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the acquisition of Preventice in the first quarter of 2021, we remeasured the fair value of our previously-held equity interest, which resulted in a $195 million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the first six months of 2021. In the second quarter and first six months of 2021, we recorded losses of $8 million and $154 million, respectively, on our investment in Pulmonx Corporation presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> associated with the partial disposition of our ownership and remeasurement of our remaining investment to fair value based on observable market prices. The Preventice gain is included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Acquisition/</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">divestiture-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and the Pulmonx loss is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Investment portfolio net losses (gains) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">presented in the reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for the reconciliation and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for a discussion of management's use of non-GAAP financial measures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, we completed our acquisition of the remaining shares of Farapulse.  The transaction price consists of $450 million upfront, or approximately $295 million after adjustments for our prior equity stake, debt and other closing adjustments; up to $125 million upon achievement of certain clinical and regulatory milestones, or $92 million for the portion not previously owned; and additional revenue-based payments over the next three years. The valuation studies necessary to determine the fair value of the various purchase price components are currently in process.  Once completed, we will remeasure the fair value of our previously held equity interest and recognize a gain of at least $150 million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the accompanying unaudited consolidated statements of operations during the third quarter of 2021.  The gain will be included within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition/divestiture related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> presented in the reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management.</span></div><div id="i82746c1ad92049b181a877873a6cc318_142"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Rates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in our reported tax rates for the second quarter and first six months of 2021, as compared to the same periods in 2020, relates primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These receipts and charges include acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credit), litigation charges, investment portfolio net losses (gains), as well as certain discrete tax items primarily related to changes in foreign tax rates, and changes in tax laws adopted in the second quarter of 2021, as well as the impacts of the Coronavirus Aid, Relief and Economic Security (CARES) Act in the second quarter of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act, enacted on March 27, 2020, provided an estimated $2.2 trillion in COVID-19 pandemic-related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes incurred in 2020. This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments and is expected to be paid in full by the end of 2022 as permitted by the legislation. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_145"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial results are affected by the selection and application of accounting policies and methods. In the first six months of 2021, there were no changes to the application of critical accounting policies previously disclosed in our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_148"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty of the impact of the COVID-19 pandemic on our business, we took proactive steps in 2020 to reduce costs and ensure we are in a strong position to support customers and patients as healthcare systems recover and elective and semi-emergent procedures resume. These actions included taking steps to manage outstanding borrowings and increase available liquidity, and preemptively amending our financial covenant requirement for our outstanding credit arrangements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current business plan, we believe our existing balance of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, future cash generated from operations, access to capital markets and existing credit facilities will be sufficient to fund our operations, invest in our infrastructure, pay our legal-related liabilities, pay taxes due and service and repay our existing debt for at least the next 12 months. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for additional details on our future payment obligations and commitments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, we had $2.675 billion of unrestricted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on hand, comprised of $2.379 billion invested in money market funds and time deposits and $296 million in interest bearing and non-interest-bearing bank accounts. We invest excess cash on hand in short-term financial instruments that earn at market interest rates while mitigating principal risk through instrument and counterparty diversification, as well as what we believe to be prudent instrument selection. We limit our direct exposure to securities in any one industry or issuer. As of&#160;June&#160;30, 2021, we had no commercial paper debt outstanding, resulting in an additional $2.750 billion of available liquidity.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional details related to our debt obligations, including our financial covenant requirement, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides a summary and description of our net cash inflows (outflows):</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of 2021, cash provided by operating activities increased $735 million as compared to the first six months of 2020, primarily due to comparatively higher net sales and operating income compared to the same period in the prior year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of 2021, cash provided by investing activities included proceeds of $801 million from the divestiture of the Specialty Pharmaceuticals business and $122 million from the sale of investments partially offset by a net cash payment of $706 million for the acquisition of Preventice. For more information, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q. In addition, we made purchases of property, plant and equipment of $181 million in the first six months of 2021 and $168 million in the first six months of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of 2021, cash used for financing activities primarily included cash payments associated with the settlement of employee equity awards and payments for royalty rights associated with the Zytiga&#8482; Drug.  On May 10, 2021 we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with one-year extension options, subject to certain conditions. We have not made any borrowings against the 2021 Revolving Credit Facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first six months of 2020, we took proactive steps to manage the potential impact of the emerging COVID-19 pandemic on our short-term liquidity and refinanced our existing term loans and outstanding commercial paper with proceeds from new term loans, borrowings against our 2018 Revolving Credit Facility, a senior notes offering and public equity offerings of preferred and common stock.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information regarding financing activities for the year ended December 31, 2020, including the full repayment of amounts borrowed against our credit facility and partial repayment of amounts borrowed under term loans in the first six months of 2020.  </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Covenant</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through June&#160;30, 2021, we were in compliance with the financial covenant required by the credit facilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Revolving Credit Facility includes the following financial covenant requirement for all of our credit arrangements (i)  maintain the maximum permitted leverage ratio of 4.25 times for the second quarter of 2021, with a step-down for each succeeding fiscal quarter end, beginning with the third quarter of 2021, to 4.00 times and 3.75 times for the fourth quarter of 2021 and through the remaining term of the 2021 Revolving Credit Facility. The agreement provides for higher leverage ratios for the period following a qualified acquisition, at our election, for which consideration exceeds $1.000 billion.  In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted leverage ratio is 4.75 times.  It steps down for the fifth, sixth and seventh succeeding quarters to 4.50 times, 4.25 times and 4.00 times, respectively.  Thereafter, a maximum leverage ratio of 3.75 is required through the remaining term of the 2021 Revolving Credit Facility.  We believe that we have the ability to comply with the financial covenant for the next 12 months.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreements, through maturity, of any non-cash charges and up to  $500 million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of June&#160;30, 2021, we had $467 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed  $1.455 billion in the aggregate. As of June&#160;30, 2021, we had $1.303 billion of the litigation exclusion remaining.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our acquisitions involve the payment of contingent consideration. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for further details regarding the estimated potential amount of future contingent consideration we could be required to pay associated with our acquisitions. There have been no other material changes to our contractual obligations and commitments as reported in our most recent Annual Report filed on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. On May 27, 2020, we also completed an offering of 29,382,500 shares of common stock at a public offering price of $34.25 per share. The net proceeds from the common stock offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received $38 million in the first six months of 2021 and $48 million in the first six months of 2020 in proceeds from stock issuances related to our stock option and employee stock purchase plans. Proceeds from the exercise of employee stock options and employee stock purchases vary from period to period based upon, among other factors, fluctuations in the trading price of our common stock and in the exercise and stock purchase patterns of our employees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares of our common stock in the first six months of 2021 or 2020. On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock. As of June&#160;30, 2021, we had the full amount remaining available under the authorization. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our material legal proceedings see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note K &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding new accounting pronouncements implemented since December&#160;31, 2020 is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and information regarding new accounting pronouncements to be implemented is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note N &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item 1 of this Quarterly Report on Form 10-Q.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cybersecurity</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established controls and procedures to escalate enterprise level issues, including cybersecurity matters, to the appropriate management levels within our organization and our Board of Directors, or members or committees thereof, as appropriate. Under our framework, cybersecurity issues are analyzed by subject matter experts and a crisis committee for potential financial, operational, and reputational risks, based on, among other factors, the nature of the matter and breadth of impact. Matters determined to present potential material impacts to the Company&#8217;s financial results, operations, and/or reputation are immediately reported by management to the Board of Directors, or individual members or committees thereof, as appropriate, in accordance with our escalation framework. In addition, we have established procedures to ensure that management responsible for overseeing the effectiveness of disclosure controls is informed in a timely manner of known cybersecurity risks and incidents that may materially impact our operations and that timely public disclosure is made as appropriate.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Trading Policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our directors and executive officers are subject to our Stock Trading Policy, which is designed to facilitate compliance with insider trading laws and governs transactions in our common stock and related derivative securities. Our policy designates certain regular periods, dictated by release of financial results, in which trading is restricted for individuals in information-sensitive positions, including directors and executive officers. In addition, additional periods of trading restriction may be imposed as determined by the President, General Counsel, or Chief Financial Officer in light of material pending developments. Further, during permitted windows, individuals in information-sensitive positions are required to seek pre-clearance for trades from the General Counsel, who assesses whether there are any important pending developments, including cybersecurity matters, which need to be made public before the individual may participate in the market.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Periodically, certain of our executive officers adopt written stock trading plans in accordance with Rule 10b5-1 under the Exchange Act and our own Stock Trading Policy. A Rule 10b5-1 Trading Plan is a written document that pre-establishes the amount, prices and dates (or formulas for determining the amounts, prices and dates) of future purchases or sales of our stock, including shares issued upon exercise of stock options or vesting of deferred stock units. These plans are entered into at a time when the person is not in possession of material non-public information about the Company. We disclose details regarding individual Rule 10b5-1 Trading Plans on the Investor Relations section of our website.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share (EPS) that exclude certain amounts; operational net sales, which exclude the impact of foreign currency fluctuations; and organic net sales, which exclude the impact of foreign currency fluctuations as well as the impact of certain acquisitions and divestitures with less than a full period of comparable net sales. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To calculate adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share we exclude certain charges (credits) from GAAP net income (loss) and GAAP net income (loss) available to common stockholders. Amounts are presented after-tax using our effective tax rate, unless the amount is a significant unusual or infrequently occurring item in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) section 740-270-30, "General Methodology and Use of Estimated Annual Effective Tax Rate." Please refer to Part II, Item 7. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report filed on Form 10-K filed with the Securities and Exchange Commission (SEC) for an explanation of each of these adjustments and the reasons for excluding each item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The GAAP financial measures most directly comparable to adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share are GAAP net income (loss), GAAP net income (loss) available to common stockholders and GAAP net income (loss) per common share - assuming dilution, respectively. </span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To calculate operational net sales growth rates, which exclude the impact of foreign currency fluctuations, we convert actual net sales from local currency to U.S. dollars using constant foreign currency exchange rates in the current and prior periods. To calculate organic net sales growth rates, we also remove the impact of acquisitions and divestitures with less than a full period of comparable net sales. The GAAP financial measure most directly comparable to operational net sales and organic net sales is net sales on a GAAP basis.</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of each of these non-GAAP financial measures to the corresponding GAAP financial measure are included in the relevant sections of this Quarterly Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses these supplemental non-GAAP financial measures to evaluate performance period over period, to analyze the underlying trends in our business, to assess our performance relative to our competitors and to establish operational goals and forecasts that are used in allocating resources. In addition, management uses these non-GAAP financial measures to further its understanding of the performance of our operating segments. The adjustments excluded from our non-GAAP financial measures are consistent with those excluded from our operating segments&#8217; measures of net sales and profit or loss. These adjustments are excluded from the segment measures reported to our chief operating decision maker that are used to make operating decisions and assess performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that presenting adjusted net income (loss), adjusted net income (loss) available to common stockholders, adjusted net income (loss) per share, operational net sales and organic net sales growth rates, in addition to the corresponding GAAP financial measures, provides investors greater transparency to the information used by management for its operational decision-making and allows investors to see our results &#8220;through the eyes&#8221; of management. We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Safe Harbor for Forward-Looking Statements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements that we may make from time to time, including statements contained in this Quarterly Report on Form 10-Q and information incorporated by reference herein, constitute &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;believe,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;aim&#8221; and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements in this Quarterly Report on Form 10-Q are based on certain risks and uncertainties, including the risk factors described in Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report on Form 10-K and the specific risk factors discussed herein and in connection with forward-looking statements throughout this Quarterly Report on Form 10-Q, which could cause actual results to vary materially from the expectations and projections expressed or implied by our forward-looking statements. These risks and uncertainties, in some cases, have affected and in the future could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this Quarterly Report.&#160;As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. Risks and uncertainties that may cause such differences include, among other things: the impact of the ongoing COVID-19 pandemic on our operations and financial results, future U.S. and global economic, political, competitive, reimbursement and regulatory conditions, new product introductions and the market acceptance of those products, markets for our products, expected pricing environment, expected procedural volumes, the closing and integration of acquisitions, clinical trial results, demographic trends, intellectual property rights, litigation, financial market conditions, the execution and effect of our restructuring program, the execution and effect of our business strategy, including our cost-savings and growth initiatives and future business decisions made by us and our competitors. New risks and uncertainties may arise from time to time and are difficult to predict, including those that have emerged or have increased in significance or likelihood as a result of the COVID-19 pandemic.&#160;All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report on Form 10-K filed with the SEC, which we may update in Part II, Item 1A.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in subsequent Quarterly Reports on Form 10-Q that we will file hereafter, and Part II, Item 1A.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in this Quarterly Report on Form 10-Q.&#160;We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.&#160;This cautionary statement is applicable to all forward-looking statements contained in this Quarterly Report.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some of the important risk factors that could cause our actual results to differ materially from our expectations in any forward-looking statements. For further discussion of these and other risk factors, see Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report on Form 10-K and Part II, Item 1A.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in this Quarterly Report on Form 10-Q. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Businesses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic on the worldwide economy and financial markets, and developments related to the disease, including the time it will take for vaccines to be broadly produced, distributed and administered worldwide, and the effectiveness of such vaccines in slowing or stopping the spread of COVID-19 and variants thereof and mitigating the economic effects of the pandemic,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic upon the scheduling of elective and semi-emergent procedures,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic on our global manufacturing and distribution system, including the quality of our products, availability and cost of raw materials and direct labor,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Our ability to recover from the impact of the COVID-19 pandemic on our business and increase net sales, expand the markets in which we participate, capture market share and adapt to market volatility,</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of natural disasters, climate change, additional future public health crises and other catastrophic events on our ability to manufacture, distribute and sell our products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competitive offerings and related declines in average selling prices for our products,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ongoing impact on our business of physician alignment to hospitals, governmental investigations and audits of hospitals and other market and economic conditions on the overall number of procedures performed,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The performance of, and physician and patient confidence in, our products and technologies or those of our competitors,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact and outcome of ongoing and future clinical trials and market studies undertaken by us, our competitors or other third parties or perceived product performance of our or our competitors' products,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Variations in clinical results, reliability or product performance of our and our competitors' products, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to acquire or develop, launch and supply new or next-generation products and technologies worldwide and in line with our commercialization strategies in a timely and successful manner and with respect to our recent acquisitions,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of consolidation and competition in the markets in which we do business or plan to do business,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruption in the manufacture or supply of certain components, materials or products, or the failure to secure in a timely manner alternative manufacturing or additional or replacement components, materials or products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:14.5pt">Our ability to achieve our projected level or mix of product sales, as some of our products are more profitable than others,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to attract and retain key personnel, including those associated with recent acquisitions, and maintain our robust corporate culture, especially in light of the remote working conditions imposed by the COVID-19 pandemic, and execute plans to return employees to offices in jurisdictions where safe and feasible,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The inability of certain of our employees to return to work full time following reduced work schedules associated with the COVID-19 pandemic, or our inability to recruit personnel into direct labor roles for the duration of the pandemic,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of enhanced requirements to obtain regulatory approval in the U.S. and around the world, including EU MDR and the associated timing and cost of product approval, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased pressure on the availability and rate of third-party reimbursement for our products and procedures in the U.S. and around the world, including with respect to the timing and costs of creating and expanding markets for new products and technologies, </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The issuance of new or revised accounting standards by the Financial Accounting Standards Board or the Securities and Exchange Commission, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of potential goodwill and intangible asset impairment charges on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Compliance, Litigation and Data Protection</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of healthcare policy changes and legislative or regulatory efforts in the U.S., the EU and around the world to modify product approval or reimbursement processes, including a trend toward demonstrating clinical outcomes, comparative effectiveness and cost efficiency, as well as the impact of other healthcare reform legislation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with our regulatory compliance and quality systems and activities in the U.S., the EU and around the world, including meeting regulatory standards applicable to manufacturing and quality processes,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of legal, regulatory or market responses to global climate change,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to minimize or avoid future field actions or FDA warning letters relating to our products and processes and the ongoing inherent risk of potential physician advisories related to our or our competitors' products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased scrutiny of and heightened global regulatory enforcement facing the medical device industry arising from political and regulatory changes, economic pressures or otherwise, including under U.S. Anti-Kickback Statute, U.S. False Claims Act and similar laws in other jurisdictions, U.S. Foreign Corrupt Practices Act (FCPA) and similar laws in other jurisdictions, and U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Costs and risks associated with current and future asserted litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of our litigation and risk management practices, including self-insurance and compliance activities on our loss contingencies, legal provision and cash flows,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of, diversion of management attention as a result of, and costs to cooperate with, litigate and/or resolve governmental investigations and our class action, product liability, contract and other legal proceedings,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of failure to protect our intellectual property rights and the outcome of patent litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to operate properly our information systems that support our business operations and protect our data integrity and products from a cyber-attack or other breach that has a material adverse effect on our business, reputation or results of operations, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact to internal control over financial reporting relating to potential restrictions to access to consigned inventory at customer locations for our inventory count procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Innovation and Certain Growth Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing, size and nature of our strategic growth initiatives and market opportunities, including with respect to our internal research and development platforms and externally available research and development platforms and technologies and the ultimate cost and success of those initiatives and opportunities,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to complete planned clinical trials successfully, obtain regulatory approvals and launch new and next generation products in a timely manner consistent with cost estimates, including the successful completion of projects from in-process research and development,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to identify and prioritize our internal research and development project portfolio and our external investment portfolio on profitable net sales growth opportunities as well as to maintain the estimated timing and costs of such projects and expected revenue levels for the resulting products and technologies,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to develop, manufacture and market new products and technologies successfully and in a timely manner and the ability of our competitors and other third parties to develop products or technologies that render our products or technologies noncompetitive or obsolete, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute appropriate decisions to discontinue, write-down or reduce the funding of any of our research and development projects, including projects from in-process research and development from our acquisitions, in our growth adjacencies or otherwise,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on acquisitions, alliances or investments to introduce new products or technologies and to enter new or adjacent growth markets and our ability to fund them or to fund contingent payments with respect to those acquisitions, alliances and investments, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential failure to successfully integrate and realize the expected benefits, including cost synergies, from the strategic acquisitions, alliances and investments we have consummated or may consummate in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Markets</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependency on international net sales to achieve growth, including in emerging markets,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing and collectability of customer payments, as well as our ability to continue factoring customer receivables where we have factoring arrangements, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact on pricing due to national tenders,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geopolitical and economic conditions, including civil unrest, terrorist activity, governmental changes, restrictions on the ability to transfer capital across borders, tariffs and other protectionist measures,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:14.5pt">The impact of the United Kingdom&#8217;s departure from the European Union,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Protection of our intellectual property, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with established and developing U.S. and foreign legal and regulatory requirements, including FCPA, EU MDR and similar laws in other jurisdictions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes in reimbursement practices and policies,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of significant developments or uncertainties stemming from changes in the U.S. administration following the 2020 presidential and congressional elections, including changes in U.S. trade policies, tariffs and the reaction of other countries thereto, particularly China,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to maintain or expand our worldwide market positions in the various markets in which we compete or seek to compete, including through investments in product diversification and emerging markets such as Brazil, Russia, India and China,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute and realize anticipated benefits from our investments in emerging markets, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential effect of foreign currency fluctuations and interest rate fluctuations on our net sales, expenses and resulting margins.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to generate sufficient cash flow to fund operations, capital expenditures, global expansion initiatives, any litigation settlements and judgments, share repurchases and strategic investments and acquisitions as well as maintaining our investment grade ratings and managing our debt levels and financial covenant compliance, particularly in light of the COVID-19 pandemic and lower demand for our products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to access the public and private capital markets when desired and to issue debt or equity securities on terms reasonably acceptable to us,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The unfavorable resolution of open tax matters, exposure to additional tax liabilities and the impact of changes in U.S. and international tax laws,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The unfavorable resolution of open litigation matters, exposure to additional loss contingencies and legal provisions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of examinations and assessments by domestic and international taxing authorities on our tax provision, financial condition or results of operations,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of counterparty default on our derivative financial instruments, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to collect outstanding and future receivables and/or sell receivables under our factoring programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost Reduction and Optimization Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with changes made or expected to be made to our organizational and operational structure, pursuant to our restructuring plans as well as any further restructuring or optimization plans we may undertake in the future and our ability to recognize benefits and cost reductions from such programs and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Business disruption and employee distraction as we execute our global compliance program, restructuring and optimization plans and divestitures of assets or businesses and implement our other strategic and cost reduction initiatives.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:35.36pt">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture and sell medical devices globally and our earnings and cash flows are exposed to market risk from changes in currency exchange rates and interest rates. We address these risks through a risk management program that includes the use of derivative financial instruments. We operate the program pursuant to documented corporate risk management policies. We do not enter derivative transactions for speculative purposes. Gains and losses on derivative financial instruments substantially offset losses and gains on underlying hedged exposures. Furthermore, we manage our exposure to counterparty risk on derivative instruments by entering into contracts with a diversified group of major financial institutions and by actively monitoring outstanding positions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our currency risk consists primarily of foreign currency denominated firm commitments, forecasted foreign currency denominated intercompany and third-party transactions and net investments in certain subsidiaries. We use both nonderivative (primarily European manufacturing operations) and derivative instruments to manage our earnings and cash flow exposure to changes in currency exchange rates. We had currency derivative instruments outstanding in the contract amount of $10.343 billion as of June&#160;30, 2021 and $10.481 billion as of December&#160;31, 2020. A ten percent appreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would increase the derivative instruments&#8217; fair value by $380 million as of June&#160;30, 2021 as compared to $333 million as of December&#160;31, 2020. A ten percent depreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would decrease the derivative instruments&#8217; fair value by $465 million as of June&#160;30, 2021 as compared to $407 million as of December&#160;31, 2020. Any increase or decrease in the fair value of our currency exchange rate sensitive derivative instruments would be substantially offset by a corresponding decrease or increase in the fair value of the hedged underlying asset, liability or forecasted transaction, resulting in minimal impacts on our unaudited consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We have historically used interest rate derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. We had no interest rate derivative instruments outstanding as of June&#160;30, 2021 and December&#160;31, 2020. As of June&#160;30, 2021, $9.168 billion in aggregate principal amount of our outstanding debt obligations were at fixed interest rates, representing approximately 100 percent of our total debt, on an amortized cost basis. As of June&#160;30, 2021, our outstanding debt obligations at fixed interest rates were comprised of senior notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for further information regarding our derivative financial instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:35.36pt">CONTROLS AND PROCEDURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer (CEO) and our Chief Financial Officer (CFO), evaluated the effectiveness of our disclosure controls and procedures as of June&#160;30, 2021 pursuant to Rule&#160;13a-15(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Disclosure controls and procedures are designed to ensure that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such material information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on their evaluation, our CEO and CFO concluded that, as of June&#160;30, 2021, our disclosure controls and procedures were effective.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were no changes in our internal control over financial reporting in the second quarter of 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Further, while many of our employees continued to work remotely to adhere to COVID-19 social distancing requirements, this did not affect our ability to maintain financial reporting systems, internal controls over financial reporting or disclosure controls and procedures. Prior to the COVID-19 pandemic, we were leveraging electronic tools to facilitate our global close process and to connect our physically dispersed team of finance professionals in offices around the world. While the quarterly close cycle was performed remotely, fundamentally, the work performed, and the processes and controls executed did not change.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_163"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note G &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_166"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to other information contained elsewhere in this report, you should carefully consider the factors discussed in Part&#160;I, Item&#160;1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report filed on Form 10-K, which could materially affect our business, financial condition or future results.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i82746c1ad92049b181a877873a6cc318_172"></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (* documents filed or furnished with this report,) </span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000885725/000110465921065917/tm2116033d1_ex10-1.htm">Credit Agreement, dated as of May 10, 2021, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent (incorporated herein by reference to Exhibit 10.1, Current Report on Form 8-K dated May 13, 2021, File No. 1-11083)</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-ceo302q22021.htm">Certification of the Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-cfo302q22021.htm">Certification of the Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-ceo906q22021.htm">Certification of the Chief Executive Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-cfo906q22021.htm">Certification of the Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 73pt;text-align:left;text-indent:-72pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i82746c1ad92049b181a877873a6cc318_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i82746c1ad92049b181a877873a6cc318_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on August&#160;6, 2021.  </span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BOSTON SCIENTIFIC CORPORATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and<br/>Chief Financial Officer&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311-ceo302q22021.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i785928d74b2e46b9ad48eca0637da279_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael F. Mahoney, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 6, 2021</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312-cfo302q22021.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib069f5c536d44cdf9e580d75ebf5f7ae_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel J. Brennan, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.542%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 6, 2021</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321-ceo906q22021.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib9dc5d1cd81c459382dba04fbd09b087_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ended June&#160;30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification shall not be deemed &#34;filed&#34; for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934 regardless of any general incorporation language in such filing.</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 6, 2021</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322-cfo906q22021.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i11dab9d5d5ac48b7b69a624384363eaa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ended June&#160;30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification shall not be deemed &#34;filed&#34; for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934 regardless of any general incorporation language in such filing.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:4.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 6, 2021</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>bsx-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:70f263dc-70b5-4726-816e-8c716916294a,g:26cfe26e-80ae-4508-82da-1214ca3ae539-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bsx="http://www.bostonscientific.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bostonscientific.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverDocument" roleURI="http://www.bostonscientific.com/role/CoverDocument">
        <link:definition>0001001 - Document - Cover Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited">
        <link:definition>1001002 - Statement - Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1002003 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited">
        <link:definition>1003004 - Statement - Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1004005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited">
        <link:definition>1005006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1006007 - Statement - Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsSupplementalDisclosure" roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure">
        <link:definition>1007008 - Statement - Consolidated Statements of Cash Flows (Supplemental Disclosure)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.bostonscientific.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationBasisofPresentationPolicies" roleURI="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandStrategicInvestments" roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments">
        <link:definition>2103102 - Disclosure - Acquisitions and Strategic Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandStrategicInvestmentsTables" roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables">
        <link:definition>2304301 - Disclosure - Acquisitions and Strategic Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDetails" roleURI="http://www.bostonscientific.com/role/AcquisitionsDetails">
        <link:definition>2405401 - Disclosure - Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationDetails" roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails">
        <link:definition>2406402 - Disclosure - Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StrategicInvestmentsDetails" roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails">
        <link:definition>2407403 - Disclosure - Strategic Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>2108103 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillTables" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables">
        <link:definition>2309302 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsDetails" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails">
        <link:definition>2410404 - Disclosure - Goodwill and Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurements" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements">
        <link:definition>2111104 - Disclosure - Hedging Activities and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies">
        <link:definition>2212202 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurementsTables" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables">
        <link:definition>2313303 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurementsDetails" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails">
        <link:definition>2414405 - Disclosure - Hedging Activities and Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitments" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments">
        <link:definition>2115105 - Disclosure - Contractual Obligations and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsTables" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables">
        <link:definition>2316304 - Disclosure - Contractual Obligations and Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsDetails" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails">
        <link:definition>2417406 - Disclosure - Contractual Obligations and Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformation" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation">
        <link:definition>2118106 - Disclosure - Supplemental Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationTables" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables">
        <link:definition>2319305 - Disclosure - Supplemental Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationDetails" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails">
        <link:definition>2420407 - Disclosure - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.bostonscientific.com/role/IncomeTaxes">
        <link:definition>2121107 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables">
        <link:definition>2322306 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetails">
        <link:definition>2423408 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies">
        <link:definition>2124108 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesCommitmentsandContingenciesPolicies" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies">
        <link:definition>2225203 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2426409 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.bostonscientific.com/role/StockholdersEquity">
        <link:definition>2127109 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails">
        <link:definition>2428410 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstanding" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding">
        <link:definition>2129110 - Disclosure - Weighted Average Shares Outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingTables" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables">
        <link:definition>2330307 - Disclosure - Weighted Average Shares Outstanding (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingDetails" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails">
        <link:definition>2431411 - Disclosure - Weighted Average Shares Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.bostonscientific.com/role/SegmentReporting">
        <link:definition>2132111 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.bostonscientific.com/role/SegmentReportingTables">
        <link:definition>2333308 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails">
        <link:definition>2434412 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.bostonscientific.com/role/Revenue">
        <link:definition>2135112 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.bostonscientific.com/role/RevenueTables">
        <link:definition>2336309 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://www.bostonscientific.com/role/RevenueDetails">
        <link:definition>2437413 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncome" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome">
        <link:definition>2138113 - Disclosure - Changes in Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies">
        <link:definition>2239204 - Disclosure - Changes in Other Comprehensive Income Changes in Other Comprehensive Income (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeTables" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables">
        <link:definition>2340310 - Disclosure - Changes in Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeDetails" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails">
        <link:definition>2441414 - Disclosure - Changes in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements">
        <link:definition>2142114 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsPolicies" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies">
        <link:definition>2243205 - Disclosure - New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" abstract="false" name="ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_GlobalInterventionalCardiologyIcReportingUnitMember" abstract="true" name="GlobalInterventionalCardiologyIcReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SeniorNotedue2027Member" abstract="true" name="SeniorNotedue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_InventoryStepUpAmortization" abstract="false" name="InventoryStepUpAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_LumenisLTDMember" abstract="true" name="LumenisLTDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_March2024NotesMember" abstract="true" name="March2024NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" abstract="false" name="DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_January2040NotesMember" abstract="true" name="January2040NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_PreventiceMember" abstract="true" name="PreventiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" abstract="false" name="TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_DivestitureAgreementTransferOfFacilities" abstract="false" name="DivestitureAgreementTransferOfFacilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" abstract="true" name="RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" abstract="false" name="ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_ActualCovenantMember" abstract="true" name="ActualCovenantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EmergingMarketsMember" abstract="true" name="EmergingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_NumberOfBusinesses" abstract="false" name="NumberOfBusinesses" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_OperatingIncomeUnallocatedToSegment" abstract="false" name="OperatingIncomeUnallocatedToSegment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RDRegulatoryandCommercializationbasedMilestoneMember" abstract="true" name="RDRegulatoryandCommercializationbasedMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RequirementAsOfSeptember302021Member" abstract="true" name="RequirementAsOfSeptember302021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" abstract="false" name="ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_ForeigncurrencydenominatedindebtMember" abstract="true" name="ForeigncurrencydenominatedindebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SpecialtyPharmaceuticalsMember" abstract="true" name="SpecialtyPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_BSXReportableSegmentsMember" abstract="true" name="BSXReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_AccruedRebatesCurrent" abstract="false" name="AccruedRebatesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" abstract="false" name="SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_PaymentsForRoyaltyRights" abstract="false" name="PaymentsForRoyaltyRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationLineItems" abstract="true" name="ScheduleofIncomeTaxRateReconciliationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_ContingentConsiderationLiabilityProbabilityOfPayment" abstract="false" name="ContingentConsiderationLiabilityProbabilityOfPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_March2049NotesMember" abstract="true" name="March2049NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CertifiedclassactionsinCanadaMesh" abstract="false" name="CertifiedclassactionsinCanadaMesh" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" abstract="false" name="ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_Noncashimpactoftransferredroyaltyrights" abstract="false" name="Noncashimpactoftransferredroyaltyrights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_GlobalEndoscopyEndoReportingUnitMember" abstract="true" name="GlobalEndoscopyEndoReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_StatementDomain" abstract="true" name="StatementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare" abstract="false" name="ConvertiblePreferredStockSharesIssuedForEachConvertedShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bsx_Licensingarrangementsasset" abstract="false" name="Licensingarrangementsasset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CertifiedClassActionsInAustraliaMesh" abstract="false" name="CertifiedClassActionsInAustraliaMesh" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments" abstract="false" name="LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_The2018FacilityDomain" abstract="true" name="The2018FacilityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EuroDenominatedFactoringArrangementsMember" abstract="true" name="EuroDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_March2028NotesMember" abstract="true" name="March2028NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ScheduleofIntangibleAssetsandGoodwillTable" abstract="true" name="ScheduleofIntangibleAssetsandGoodwillTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_AssignedtoonejudgeinMAMember" abstract="true" name="AssignedtoonejudgeinMAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OtherCurrentAssetsAbstract" abstract="true" name="OtherCurrentAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_OtherOtherLongtermAssets" abstract="false" name="OtherOtherLongtermAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_GlobalNeuromodulationNmReportingUnitMember" abstract="true" name="GlobalNeuromodulationNmReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CorporateExpensesincludinghedgingactivitiesMember" abstract="true" name="CorporateExpensesincludinghedgingactivitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ExclusionFromEbitdaForRestructuringCharges" abstract="false" name="ExclusionFromEbitdaForRestructuringCharges" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" abstract="true" name="RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_GlobalElectrophysiologyEpReportingUnitMember" abstract="true" name="GlobalElectrophysiologyEpReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Paymenttonetsharesettleemployeeequityawards" abstract="false" name="Paymenttonetsharesettleemployeeequityawards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_StatementAxis" abstract="true" name="StatementAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_OperatingIncomeAllocatedToReportableSegments" abstract="false" name="OperatingIncomeAllocatedToReportableSegments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_GlobalUrologyandPelvicHealthReportingUnitMember" abstract="true" name="GlobalUrologyandPelvicHealthReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CardiovascularMember" abstract="true" name="CardiovascularMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod" abstract="false" name="BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_MaximumLeverageRatio" abstract="false" name="MaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" abstract="false" name="ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_LitigationAndDebtExclusionFromEbitda" abstract="false" name="LitigationAndDebtExclusionFromEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_A550MCPSSeriesAMember" abstract="true" name="A550MCPSSeriesAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_PaymentOfContingentConsideration" abstract="false" name="PaymentOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_LicensingarrangementliabilitiesMember" abstract="true" name="LicensingarrangementliabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationAbstract" abstract="true" name="SupplementalBalanceSheetInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RequirementAsOfJune302021Member" abstract="true" name="RequirementAsOfJune302021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ConvertiblePreferredStockThresholdTradingDays" abstract="false" name="ConvertiblePreferredStockThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_TotalAllocatedToReportableSegmentsMember" abstract="true" name="TotalAllocatedToReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_YenDenominatedFactoringArrangementsMember" abstract="true" name="YenDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_NumberOfBusinessesDivested" abstract="false" name="NumberOfBusinessesDivested" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_CovenantAxis" abstract="true" name="CovenantAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_June2025NotesMember" abstract="true" name="June2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EmergingMarketstotalnumberofcountries" abstract="false" name="EmergingMarketstotalnumberofcountries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" abstract="false" name="DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_SegmentOperatingIncomeasaPercentageofNetSales" abstract="false" name="SegmentOperatingIncomeasaPercentageofNetSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_November2035NotesMember" abstract="true" name="November2035NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_QualifiedAcquisitionConsideration" abstract="false" name="QualifiedAcquisitionConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_IntangibleAssetsDomain" abstract="true" name="IntangibleAssetsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_TheCARESAct" abstract="false" name="TheCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_June2030NotesMember" abstract="true" name="June2030NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EurodenominatedoutstandingdebtMember" abstract="true" name="EurodenominatedoutstandingdebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_MedsurgMember" abstract="true" name="MedsurgMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" abstract="false" name="ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_Licensingarrangements" abstract="false" name="Licensingarrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" abstract="false" name="CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_DiscountRateFairValueInput" abstract="false" name="DiscountRateFairValueInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_May2022NotesMember" abstract="true" name="May2022NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod" abstract="false" name="DebtInstrumentHigherLeverageRatiosQualificationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_RenminbiDenominatedFactoringArrangementsMember" abstract="true" name="RenminbiDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CovenantDomain" abstract="true" name="CovenantDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_DivestitureAgreementTransferOfGlobalEmployees" abstract="false" name="DivestitureAgreementTransferOfGlobalEmployees" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_StateAGSettlementsMeshRelatedNumberOfStates" abstract="false" name="StateAGSettlementsMeshRelatedNumberOfStates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_GlobalPeripheralInterventionsPiReportingUnitMember" abstract="true" name="GlobalPeripheralInterventionsPiReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_LatinAmericaandCanadaMember" abstract="true" name="LatinAmericaandCanadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_GlobalCrmReportingUnitMember" abstract="true" name="GlobalCrmReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" abstract="false" name="Productliabilitycasesorclaimsrelatedtomeshproduct" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_DebtInstrumentExtensionOptionTerm" abstract="false" name="DebtInstrumentExtensionOptionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" abstract="true" name="CondensedConsolidatedBalanceSheetParentheticalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_EquipmentFurnitureAndFixturesGross" abstract="false" name="EquipmentFurnitureAndFixturesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ForwardCurrencyContractsTimetoMaturity" abstract="false" name="ForwardCurrencyContractsTimetoMaturity" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_SpecialChargesMember" abstract="true" name="SpecialChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" abstract="false" name="ProductliabilitycasesorclaimsrelatedtomeshproductCanada" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_Netcurrencyexchangegainloss" abstract="false" name="Netcurrencyexchangegainloss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" abstract="false" name="ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_RhythmandNeuroMember" abstract="true" name="RhythmandNeuroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationTable" abstract="true" name="ScheduleofIncomeTaxRateReconciliationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" abstract="true" name="CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_EntityAbstract" abstract="true" name="EntityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationTextualsAbstract" abstract="true" name="SupplementalBalanceSheetInformationTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold" abstract="false" name="LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementthirdquarterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_December2027NotesMember" abstract="true" name="December2027NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_IntangibleAssetsandGoodwillLineItems" abstract="true" name="IntangibleAssetsandGoodwillLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_LicensingarrangementassetsMember" abstract="true" name="LicensingarrangementassetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" abstract="true" name="CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_October2023NotesMember" abstract="true" name="October2023NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_March2029NotesMember" abstract="true" name="March2029NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesPreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_IntangibleAssetsAxis" abstract="true" name="IntangibleAssetsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_OtherNet" abstract="false" name="OtherNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" abstract="true" name="RequirementSixthQuarterFollowingQualifiedAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_NewAccountingPronouncementsPolicyTextBlock" abstract="false" name="NewAccountingPronouncementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_RevenueBasedPaymentsMember" abstract="true" name="RevenueBasedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_March2026NotesMember" abstract="true" name="March2026NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" abstract="false" name="ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_FarapulseMember" abstract="true" name="FarapulseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock" abstract="false" name="ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_March2039NotesMember" abstract="true" name="March2039NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RevolvingCreditFacility2021Member" abstract="true" name="RevolvingCreditFacility2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CurrentRequirementMember" abstract="true" name="CurrentRequirementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_May2025NotesMember" abstract="true" name="May2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Licensingarrangementsliability" abstract="false" name="Licensingarrangementsliability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementfifthquarterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>bsx-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:70f263dc-70b5-4726-816e-8c716916294a,g:26cfe26e-80ae-4508-82da-1214ca3ae539-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ca7045e7-0b1e-4430-a059-983f5cb9929c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0c41fd26-b4c3-4996-87db-5773d408b51c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ca7045e7-0b1e-4430-a059-983f5cb9929c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0c41fd26-b4c3-4996-87db-5773d408b51c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b2cbe4e8-2dd1-4ca3-acff-100b5ab15f64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ca7045e7-0b1e-4430-a059-983f5cb9929c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b2cbe4e8-2dd1-4ca3-acff-100b5ab15f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ca576cce-3dbe-4c18-91a4-c53b555b2b7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5e142a95-9f4f-4fbd-aa60-8f96f3efaf3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ca576cce-3dbe-4c18-91a4-c53b555b2b7f" xlink:to="loc_us-gaap_GrossProfit_5e142a95-9f4f-4fbd-aa60-8f96f3efaf3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f1ee122b-d312-4740-acd6-82bfdc1b0c25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ca576cce-3dbe-4c18-91a4-c53b555b2b7f" xlink:to="loc_us-gaap_OperatingExpenses_f1ee122b-d312-4740-acd6-82bfdc1b0c25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2f0b44e4-d753-4c45-97cb-e7d47eccb1c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4a905d73-24ba-4212-ac8c-4c57754fd819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_2f0b44e4-d753-4c45-97cb-e7d47eccb1c6" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4a905d73-24ba-4212-ac8c-4c57754fd819" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cce86d98-9cd8-426f-b905-8b472c93f9c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_2f0b44e4-d753-4c45-97cb-e7d47eccb1c6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cce86d98-9cd8-426f-b905-8b472c93f9c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c7d87855-b043-4623-90df-8bc17534ad49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_38251a85-40d9-4f6e-9eaf-a58b210214f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c7d87855-b043-4623-90df-8bc17534ad49" xlink:to="loc_us-gaap_DividendsPreferredStockStock_38251a85-40d9-4f6e-9eaf-a58b210214f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d6695ffa-9be1-482d-af9b-fda346821272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c7d87855-b043-4623-90df-8bc17534ad49" xlink:to="loc_us-gaap_ProfitLoss_d6695ffa-9be1-482d-af9b-fda346821272" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f6d267d2-5105-4f72-b5ff-c7c720370ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_01a9a8a8-d105-4b36-8d00-c5a92084d07e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f6d267d2-5105-4f72-b5ff-c7c720370ef2" xlink:to="loc_us-gaap_RoyaltyExpense_01a9a8a8-d105-4b36-8d00-c5a92084d07e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_4bdb3d2d-dcca-4a44-a98c-aedea7175261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f6d267d2-5105-4f72-b5ff-c7c720370ef2" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_4bdb3d2d-dcca-4a44-a98c-aedea7175261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_92c92150-2bb6-4fd6-96b3-6a1b7dc43a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f6d267d2-5105-4f72-b5ff-c7c720370ef2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_92c92150-2bb6-4fd6-96b3-6a1b7dc43a9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_6cdf36f9-a9c9-4014-8810-7721f99f734b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f6d267d2-5105-4f72-b5ff-c7c720370ef2" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_6cdf36f9-a9c9-4014-8810-7721f99f734b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5312388f-f1f9-44e2-8427-bbeeaea22d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f6d267d2-5105-4f72-b5ff-c7c720370ef2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5312388f-f1f9-44e2-8427-bbeeaea22d90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_3f27bc47-5ffc-455d-a491-45437939343c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f6d267d2-5105-4f72-b5ff-c7c720370ef2" xlink:to="loc_us-gaap_LitigationSettlementExpense_3f27bc47-5ffc-455d-a491-45437939343c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_67afb791-c57d-4050-a9da-c4e3c03237db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f6d267d2-5105-4f72-b5ff-c7c720370ef2" xlink:to="loc_us-gaap_RestructuringCharges_67afb791-c57d-4050-a9da-c4e3c03237db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_f9d53bf1-fcbc-449c-b785-4af9630f4919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f6d267d2-5105-4f72-b5ff-c7c720370ef2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_f9d53bf1-fcbc-449c-b785-4af9630f4919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_016e75e3-eb0a-44e8-870e-41af9ff0efbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f6d267d2-5105-4f72-b5ff-c7c720370ef2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_016e75e3-eb0a-44e8-870e-41af9ff0efbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f24f03bc-7222-4ef0-b304-44685cc168ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_21d46140-97ab-4243-af4a-e497759a256b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f24f03bc-7222-4ef0-b304-44685cc168ad" xlink:to="loc_us-gaap_OperatingIncomeLoss_21d46140-97ab-4243-af4a-e497759a256b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a9c39c07-d639-44a4-81e6-94c25c4e2949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f24f03bc-7222-4ef0-b304-44685cc168ad" xlink:to="loc_us-gaap_InterestExpense_a9c39c07-d639-44a4-81e6-94c25c4e2949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a9834ff8-0a90-4e46-9b98-b4ce1ae8aa2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f24f03bc-7222-4ef0-b304-44685cc168ad" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a9834ff8-0a90-4e46-9b98-b4ce1ae8aa2b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1c674b10-9e45-47cf-a65d-efb4b3c49a61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7a822592-8870-4fab-b996-5beb801d3b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1c674b10-9e45-47cf-a65d-efb4b3c49a61" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7a822592-8870-4fab-b996-5beb801d3b47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5345fa58-63b3-4bec-b4a0-0576005f8d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1c674b10-9e45-47cf-a65d-efb4b3c49a61" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5345fa58-63b3-4bec-b4a0-0576005f8d2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d5db634b-5041-4b35-a1bc-1916a9f0a1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1c674b10-9e45-47cf-a65d-efb4b3c49a61" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d5db634b-5041-4b35-a1bc-1916a9f0a1b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d8772568-4f3f-45bc-99fb-3c57f0d2e742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3168b59b-df8a-4be6-ad4c-64bc4157cea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d8772568-4f3f-45bc-99fb-3c57f0d2e742" xlink:to="loc_us-gaap_ProfitLoss_3168b59b-df8a-4be6-ad4c-64bc4157cea3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5a23ad5a-93cc-4a74-b63f-20ed182cefd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d8772568-4f3f-45bc-99fb-3c57f0d2e742" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5a23ad5a-93cc-4a74-b63f-20ed182cefd9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f9d556e6-a465-4032-9354-59a31bf01a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_de2e0add-bb11-44d9-ad5b-d40c73149585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9d556e6-a465-4032-9354-59a31bf01a51" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_de2e0add-bb11-44d9-ad5b-d40c73149585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b361ddea-ec52-44b9-ace9-3c06b1af932c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9d556e6-a465-4032-9354-59a31bf01a51" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b361ddea-ec52-44b9-ace9-3c06b1af932c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_b841fb4e-c374-4dbe-a237-bcae2d044fad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9d556e6-a465-4032-9354-59a31bf01a51" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_b841fb4e-c374-4dbe-a237-bcae2d044fad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_9c3315fa-caf5-4ddf-8651-df7c5288d198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9d556e6-a465-4032-9354-59a31bf01a51" xlink:to="loc_us-gaap_PrepaidTaxes_9c3315fa-caf5-4ddf-8651-df7c5288d198" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0c00d4f4-8705-46c9-97b7-43909d4b5431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9d556e6-a465-4032-9354-59a31bf01a51" xlink:to="loc_us-gaap_InventoryNet_0c00d4f4-8705-46c9-97b7-43909d4b5431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9f8f0a7f-1e32-4274-9a6a-6faf95855bbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9d556e6-a465-4032-9354-59a31bf01a51" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9f8f0a7f-1e32-4274-9a6a-6faf95855bbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a4a89f94-23a0-4a84-aab3-bdaf31661b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a0a349fc-9bae-4ebf-a02b-4117b6c82d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4a89f94-23a0-4a84-aab3-bdaf31661b4a" xlink:to="loc_us-gaap_AssetsCurrent_a0a349fc-9bae-4ebf-a02b-4117b6c82d90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ae5f1fc8-7eca-4461-82d2-c6af04227e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4a89f94-23a0-4a84-aab3-bdaf31661b4a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ae5f1fc8-7eca-4461-82d2-c6af04227e28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ffe20b2f-166f-49d9-a43a-cd4959194076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4a89f94-23a0-4a84-aab3-bdaf31661b4a" xlink:to="loc_us-gaap_Goodwill_ffe20b2f-166f-49d9-a43a-cd4959194076" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ac4372e4-3257-4b1b-ad70-1ef2670b28db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4a89f94-23a0-4a84-aab3-bdaf31661b4a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ac4372e4-3257-4b1b-ad70-1ef2670b28db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_2e2d7cbc-7303-455d-9fae-c0f09d714ec5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4a89f94-23a0-4a84-aab3-bdaf31661b4a" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_2e2d7cbc-7303-455d-9fae-c0f09d714ec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_39cc2175-1216-43af-a61c-8542554e337d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4a89f94-23a0-4a84-aab3-bdaf31661b4a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_39cc2175-1216-43af-a61c-8542554e337d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d847614-b9dc-4b98-a3a9-0b0462f8fe6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ae267fec-bde6-4eef-8dcd-b94a78a33cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d847614-b9dc-4b98-a3a9-0b0462f8fe6a" xlink:to="loc_us-gaap_PreferredStockValue_ae267fec-bde6-4eef-8dcd-b94a78a33cf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3b5e2a4f-58eb-4d3d-a1e9-d15252e3d750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d847614-b9dc-4b98-a3a9-0b0462f8fe6a" xlink:to="loc_us-gaap_CommonStockValue_3b5e2a4f-58eb-4d3d-a1e9-d15252e3d750" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_a018d515-c306-4a8c-a4fa-ab8a3336afec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d847614-b9dc-4b98-a3a9-0b0462f8fe6a" xlink:to="loc_us-gaap_TreasuryStockValue_a018d515-c306-4a8c-a4fa-ab8a3336afec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e90c4d39-8389-4faa-b980-ca42bfbe2528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d847614-b9dc-4b98-a3a9-0b0462f8fe6a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e90c4d39-8389-4faa-b980-ca42bfbe2528" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ea5bf19a-9245-44fc-8327-28509bed0af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d847614-b9dc-4b98-a3a9-0b0462f8fe6a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ea5bf19a-9245-44fc-8327-28509bed0af8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_10b88e38-4766-4032-a286-fff82b82a07d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d847614-b9dc-4b98-a3a9-0b0462f8fe6a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_10b88e38-4766-4032-a286-fff82b82a07d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9e980f6-1bfb-4c98-9b85-c6163a24ba3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_38d55729-407d-43d7-a878-3935843d1cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9e980f6-1bfb-4c98-9b85-c6163a24ba3d" xlink:to="loc_us-gaap_LiabilitiesCurrent_38d55729-407d-43d7-a878-3935843d1cb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5fbc714e-9d61-418e-b877-d3af8177af0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9e980f6-1bfb-4c98-9b85-c6163a24ba3d" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5fbc714e-9d61-418e-b877-d3af8177af0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_1131b906-d976-438a-8392-6b0abe6f5003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9e980f6-1bfb-4c98-9b85-c6163a24ba3d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_1131b906-d976-438a-8392-6b0abe6f5003" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1b322e6d-176b-4f04-87a3-a96eae1e9f38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9e980f6-1bfb-4c98-9b85-c6163a24ba3d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1b322e6d-176b-4f04-87a3-a96eae1e9f38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f4835194-9c22-4860-a152-f24a41368ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9e980f6-1bfb-4c98-9b85-c6163a24ba3d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f4835194-9c22-4860-a152-f24a41368ca4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e64bc3d7-3ceb-4b76-bf40-5da05464942a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9e980f6-1bfb-4c98-9b85-c6163a24ba3d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e64bc3d7-3ceb-4b76-bf40-5da05464942a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8ce83eb4-76e8-4bbf-8f9e-cae13b076836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_637f6ffe-a835-4bfb-875c-e0469a166792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8ce83eb4-76e8-4bbf-8f9e-cae13b076836" xlink:to="loc_us-gaap_DebtCurrent_637f6ffe-a835-4bfb-875c-e0469a166792" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_efd32074-899d-47cd-bdc6-232f788da80f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8ce83eb4-76e8-4bbf-8f9e-cae13b076836" xlink:to="loc_us-gaap_AccountsPayableCurrent_efd32074-899d-47cd-bdc6-232f788da80f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_bb6e7521-4eae-4242-abf3-56f004f71a92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8ce83eb4-76e8-4bbf-8f9e-cae13b076836" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_bb6e7521-4eae-4242-abf3-56f004f71a92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_8537ca45-5b41-462e-b04e-b289b3ca8be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_8ce83eb4-76e8-4bbf-8f9e-cae13b076836" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_8537ca45-5b41-462e-b04e-b289b3ca8be1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2a6d786e-2663-4a98-8dfe-8261bed2b73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e9c204a1-9124-41d2-b062-59a15b3c137a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2a6d786e-2663-4a98-8dfe-8261bed2b73d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e9c204a1-9124-41d2-b062-59a15b3c137a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_911cc365-91c9-465b-b6ad-9b5da11ed1b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2a6d786e-2663-4a98-8dfe-8261bed2b73d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_911cc365-91c9-465b-b6ad-9b5da11ed1b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_76c998af-cfda-48b7-87cb-f1fc24b88a28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2a6d786e-2663-4a98-8dfe-8261bed2b73d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_76c998af-cfda-48b7-87cb-f1fc24b88a28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1ac84f86-7d31-44ab-99eb-e0cab5b3e17c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2a6d786e-2663-4a98-8dfe-8261bed2b73d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1ac84f86-7d31-44ab-99eb-e0cab5b3e17c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_63891194-10bb-4b18-a697-2b26b12c489d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_ProfitLoss_63891194-10bb-4b18-a697-2b26b12c489d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_03046434-7dd4-499a-a3e8-3cdb74a1d190" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_03046434-7dd4-499a-a3e8-3cdb74a1d190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d7ab8e1f-9025-4e30-a60e-b98719faa624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d7ab8e1f-9025-4e30-a60e-b98719faa624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_1a8fab19-8688-4635-ae02-008f168b05d1" xlink:href="bsx-20210630.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_1a8fab19-8688-4635-ae02-008f168b05d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9553e2fd-b4e1-4051-83c3-b5c75a275d18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_ShareBasedCompensation_9553e2fd-b4e1-4051-83c3-b5c75a275d18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_fce5a5a8-521b-4394-b0c2-00508197043c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_fce5a5a8-521b-4394-b0c2-00508197043c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_117eeee3-f34c-478a-9985-975a8d67c040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_GainLossOnInvestments_117eeee3-f34c-478a-9985-975a8d67c040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3a68e26d-f256-4ff7-9e45-fa93b9175c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3a68e26d-f256-4ff7-9e45-fa93b9175c06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_4db02c62-c694-4454-b192-8a541ce529e3" xlink:href="bsx-20210630.xsd#bsx_InventoryStepUpAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_bsx_InventoryStepUpAmortization_4db02c62-c694-4454-b192-8a541ce529e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss_157043ae-e9c8-424a-a178-70fb31e43e9f" xlink:href="bsx-20210630.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_bsx_Netcurrencyexchangegainloss_157043ae-e9c8-424a-a178-70fb31e43e9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_28ef0501-d18a-46bf-ac99-d7fe22ce0b99" xlink:href="bsx-20210630.xsd#bsx_OtherNet"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_bsx_OtherNet_28ef0501-d18a-46bf-ac99-d7fe22ce0b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d2d266a5-d036-4d1c-85a5-8278fc315745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d2d266a5-d036-4d1c-85a5-8278fc315745" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1647a5b3-d996-4919-ac92-a4476e3528d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1647a5b3-d996-4919-ac92-a4476e3528d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d9e90836-6ba0-4156-a26a-bb15fcbc77c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d9e90836-6ba0-4156-a26a-bb15fcbc77c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_fd2b9749-f801-4f7f-9e1b-8ebc8ce4be7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_fd2b9749-f801-4f7f-9e1b-8ebc8ce4be7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_15d1d9a0-fa63-4888-b1b3-24f412fa45ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_781a7c08-2cb2-4845-ae15-d66acd7443bc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_15d1d9a0-fa63-4888-b1b3-24f412fa45ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b62e44b3-8429-456c-b230-a6697e86a5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b62e44b3-8429-456c-b230-a6697e86a5ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_84e18b88-a06e-4a3e-ac57-3fe9954b42d1" xlink:href="bsx-20210630.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_bsx_PaymentsForRoyaltyRights_84e18b88-a06e-4a3e-ac57-3fe9954b42d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_e878af1d-adad-42aa-8d7d-ae5273572864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_e878af1d-adad-42aa-8d7d-ae5273572864" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_cd232d9a-4e9d-4676-8f3d-a2dfeeffae59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_cd232d9a-4e9d-4676-8f3d-a2dfeeffae59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_dc5c69a3-527c-457e-a1f2-26598a2f1f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_dc5c69a3-527c-457e-a1f2-26598a2f1f97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_cd2b98a4-fcb7-4011-b265-09f56fd84f08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_cd2b98a4-fcb7-4011-b265-09f56fd84f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_d8f11a88-619a-4477-98cb-c556b703639f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_d8f11a88-619a-4477-98cb-c556b703639f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_8d9efba4-3a23-4d16-bec2-f7a674493baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_8d9efba4-3a23-4d16-bec2-f7a674493baa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_721c7a3c-a58c-47c7-b06e-a23a345a2ea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_721c7a3c-a58c-47c7-b06e-a23a345a2ea1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_efda3b43-f2f5-4f94-bf74-f6e65ca85d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_PaymentsOfDividends_efda3b43-f2f5-4f94-bf74-f6e65ca85d85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_e90bdea4-d6e7-421b-a803-b2db2c4fc9b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_e90bdea4-d6e7-421b-a803-b2db2c4fc9b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f2222d99-006c-4749-ad65-6c4b90358c98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f2222d99-006c-4749-ad65-6c4b90358c98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_725f57b4-ce1a-4e33-ab63-963adf036c85" xlink:href="bsx-20210630.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_725f57b4-ce1a-4e33-ab63-963adf036c85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_db13a389-f6b7-48c4-8a52-52e8c9a92b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fd0288f-58e8-41d0-8a65-66b8127cade1" xlink:to="loc_us-gaap_ProceedsFromStockPlans_db13a389-f6b7-48c4-8a52-52e8c9a92b2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6921f68-20b7-4f51-8a33-13de8a2ad889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_1e1ebb5d-b11e-4971-ad42-607d5bb364de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6921f68-20b7-4f51-8a33-13de8a2ad889" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_1e1ebb5d-b11e-4971-ad42-607d5bb364de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_7d2c36a4-83b2-410c-a4af-a0d32121a413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6921f68-20b7-4f51-8a33-13de8a2ad889" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_7d2c36a4-83b2-410c-a4af-a0d32121a413" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4831a73a-d65d-4d79-a929-710faab30e31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6921f68-20b7-4f51-8a33-13de8a2ad889" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_4831a73a-d65d-4d79-a929-710faab30e31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a2e20dca-5ac9-4284-b29b-369f2f780108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6921f68-20b7-4f51-8a33-13de8a2ad889" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a2e20dca-5ac9-4284-b29b-369f2f780108" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_96316756-7cb0-4cd0-bf14-9659a22c7f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6921f68-20b7-4f51-8a33-13de8a2ad889" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_96316756-7cb0-4cd0-bf14-9659a22c7f01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_e17925c0-b385-4220-b20c-78fe7561f21a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6921f68-20b7-4f51-8a33-13de8a2ad889" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_e17925c0-b385-4220-b20c-78fe7561f21a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6be73267-2e27-4f30-8f3c-fc777da72f08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6921f68-20b7-4f51-8a33-13de8a2ad889" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6be73267-2e27-4f30-8f3c-fc777da72f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_b7b54c7e-7e67-4ebd-bf31-3684c99f758e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d6921f68-20b7-4f51-8a33-13de8a2ad889" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_b7b54c7e-7e67-4ebd-bf31-3684c99f758e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a6489c90-c43b-4a55-8122-911d6c0610b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_0afa942e-f728-4a4a-ae4a-04b1ccb6d50c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_a6489c90-c43b-4a55-8122-911d6c0610b2" xlink:to="loc_us-gaap_TaxesPayableCurrent_0afa942e-f728-4a4a-ae4a-04b1ccb6d50c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_c412fdf7-3fad-4f06-ac96-38ab50ea147d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_a6489c90-c43b-4a55-8122-911d6c0610b2" xlink:to="loc_us-gaap_DeferredRevenueCurrent_c412fdf7-3fad-4f06-ac96-38ab50ea147d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_98962e32-3ca2-41de-b416-c8422a9398e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_a6489c90-c43b-4a55-8122-911d6c0610b2" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_98962e32-3ca2-41de-b416-c8422a9398e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_35dbc441-9b7e-44f3-a2a9-22289d6833a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_a6489c90-c43b-4a55-8122-911d6c0610b2" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_35dbc441-9b7e-44f3-a2a9-22289d6833a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_4027d5ad-b07c-4ae3-915b-90be36e7c6c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_a6489c90-c43b-4a55-8122-911d6c0610b2" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_4027d5ad-b07c-4ae3-915b-90be36e7c6c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cb4301d5-8d85-4403-b138-fd21b8fc6cc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_08775f44-451a-433f-bbc9-60969020214b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_cb4301d5-8d85-4403-b138-fd21b8fc6cc7" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_08775f44-451a-433f-bbc9-60969020214b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4e3a3643-2408-4dd4-962b-4928b3bed268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_cb4301d5-8d85-4403-b138-fd21b8fc6cc7" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4e3a3643-2408-4dd4-962b-4928b3bed268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2133a6d8-0cc8-4288-a67d-f67671a18e71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_cb4301d5-8d85-4403-b138-fd21b8fc6cc7" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2133a6d8-0cc8-4288-a67d-f67671a18e71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fd3d1330-d5c6-4ddb-a605-f02d669cb7a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_85104d2b-9f29-460f-83bc-1bd706b7696d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_fd3d1330-d5c6-4ddb-a605-f02d669cb7a4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_85104d2b-9f29-460f-83bc-1bd706b7696d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6ff88d8c-4e34-443d-8eed-72c852b301bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_fd3d1330-d5c6-4ddb-a605-f02d669cb7a4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6ff88d8c-4e34-443d-8eed-72c852b301bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_9ff55b7f-c960-4271-a868-7f49024a5a27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_994e44c3-976e-4eb3-80c5-a27b35085856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_9ff55b7f-c960-4271-a868-7f49024a5a27" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_994e44c3-976e-4eb3-80c5-a27b35085856" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ee042f62-c9c3-4511-b20e-fd21ca340936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_9ff55b7f-c960-4271-a868-7f49024a5a27" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ee042f62-c9c3-4511-b20e-fd21ca340936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_52c287f7-0c3e-462d-86f9-c92f9e876497" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_a5e9dd0d-ca1a-44ea-a91a-5da433601324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_52c287f7-0c3e-462d-86f9-c92f9e876497" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_a5e9dd0d-ca1a-44ea-a91a-5da433601324" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_978633c2-e5e0-4ce0-982f-c45c41d779e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_52c287f7-0c3e-462d-86f9-c92f9e876497" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_978633c2-e5e0-4ce0-982f-c45c41d779e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_5ae492a2-1f0a-44e4-84cd-37ed0e1338f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_52c287f7-0c3e-462d-86f9-c92f9e876497" xlink:to="loc_us-gaap_DerivativeAssets_5ae492a2-1f0a-44e4-84cd-37ed0e1338f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_fb2951b0-4a78-4b66-ba5c-ecbcc7987048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_52c287f7-0c3e-462d-86f9-c92f9e876497" xlink:to="loc_us-gaap_Investments_fb2951b0-4a78-4b66-ba5c-ecbcc7987048" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_8731bc48-6145-49b7-9aaf-0eb8028e404d" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangementsasset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_52c287f7-0c3e-462d-86f9-c92f9e876497" xlink:to="loc_bsx_Licensingarrangementsasset_8731bc48-6145-49b7-9aaf-0eb8028e404d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets_4b182efa-4bf6-4192-8d83-bbe75eab14f3" xlink:href="bsx-20210630.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_52c287f7-0c3e-462d-86f9-c92f9e876497" xlink:to="loc_bsx_OtherOtherLongtermAssets_4b182efa-4bf6-4192-8d83-bbe75eab14f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_53828c1b-ce52-4e2b-a745-f0f9f2856cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_b2f543d0-f3b4-4b30-92ab-66b216f575a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_53828c1b-ce52-4e2b-a745-f0f9f2856cff" xlink:to="loc_us-gaap_LitigationReserveCurrent_b2f543d0-f3b4-4b30-92ab-66b216f575a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_23d04ca5-445e-4592-8b1e-ebd7cf27211d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_53828c1b-ce52-4e2b-a745-f0f9f2856cff" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_23d04ca5-445e-4592-8b1e-ebd7cf27211d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_9e0c8da5-48e8-46ff-98f3-c5010d0650c9" xlink:href="bsx-20210630.xsd#bsx_AccruedRebatesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_53828c1b-ce52-4e2b-a745-f0f9f2856cff" xlink:to="loc_bsx_AccruedRebatesCurrent_9e0c8da5-48e8-46ff-98f3-c5010d0650c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7e874f20-ffc5-4cb8-a9ed-5c49652a2183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_53828c1b-ce52-4e2b-a745-f0f9f2856cff" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7e874f20-ffc5-4cb8-a9ed-5c49652a2183" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ea7c0db1-90ae-48b2-9051-1e0305b37eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_53828c1b-ce52-4e2b-a745-f0f9f2856cff" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ea7c0db1-90ae-48b2-9051-1e0305b37eca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8ee43af5-420d-4909-8f7c-dadc2cafe059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_209103f5-4063-480c-b815-b65fbabd9a82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_8ee43af5-420d-4909-8f7c-dadc2cafe059" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_209103f5-4063-480c-b815-b65fbabd9a82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_2127d618-ae70-4b88-b2d3-dd98535a5160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_8ee43af5-420d-4909-8f7c-dadc2cafe059" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_2127d618-ae70-4b88-b2d3-dd98535a5160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_255c5c14-db8b-4c5f-86f6-e1dadedd0137" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_8ee43af5-420d-4909-8f7c-dadc2cafe059" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_255c5c14-db8b-4c5f-86f6-e1dadedd0137" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_162938e3-f194-4f0e-932d-e63d6db189d5" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangementsliability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_8ee43af5-420d-4909-8f7c-dadc2cafe059" xlink:to="loc_bsx_Licensingarrangementsliability_162938e3-f194-4f0e-932d-e63d6db189d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7ff7d329-6931-443f-84ce-361ccc7d16a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_8ee43af5-420d-4909-8f7c-dadc2cafe059" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7ff7d329-6931-443f-84ce-361ccc7d16a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_9d208ae8-09e8-4656-9fa4-7f8fdbfe8dd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_8ee43af5-420d-4909-8f7c-dadc2cafe059" xlink:to="loc_us-gaap_DeferredRevenue_9d208ae8-09e8-4656-9fa4-7f8fdbfe8dd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_e56215bf-fbe4-4a75-b785-b6a58723a13f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_8ee43af5-420d-4909-8f7c-dadc2cafe059" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_e56215bf-fbe4-4a75-b785-b6a58723a13f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_9a74cbcb-a6b0-48b8-967e-e73e7caf88c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_3e6af39a-e3b2-4ee7-8318-4a2a09598da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_9a74cbcb-a6b0-48b8-967e-e73e7caf88c1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_3e6af39a-e3b2-4ee7-8318-4a2a09598da3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_530cfa0e-997f-4c35-b6f1-325dbe8c7841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_9a74cbcb-a6b0-48b8-967e-e73e7caf88c1" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_530cfa0e-997f-4c35-b6f1-325dbe8c7841" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements_4dba2c5a-ffba-4b21-a828-1f955801c79c" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_9a74cbcb-a6b0-48b8-967e-e73e7caf88c1" xlink:to="loc_bsx_Licensingarrangements_4dba2c5a-ffba-4b21-a828-1f955801c79c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_fba502cb-7ff2-4929-ae14-f4b009e29b8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_9a74cbcb-a6b0-48b8-967e-e73e7caf88c1" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_fba502cb-7ff2-4929-ae14-f4b009e29b8d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ce0f7657-106d-498d-ab71-e0fdc48c0d23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b0c0328c-ff23-454c-a069-90506c5a74a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ce0f7657-106d-498d-ab71-e0fdc48c0d23" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b0c0328c-ff23-454c-a069-90506c5a74a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_691b0d37-b7d6-4202-aaa4-d0d3b787a148" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ce0f7657-106d-498d-ab71-e0fdc48c0d23" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_691b0d37-b7d6-4202-aaa4-d0d3b787a148" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#SegmentReportingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d5a9e9c-ddc8-4c59-a201-077b3114f419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4b57af19-8247-4a8f-b2a5-6f9290d5f437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d5a9e9c-ddc8-4c59-a201-077b3114f419" xlink:to="loc_us-gaap_OperatingIncomeLoss_4b57af19-8247-4a8f-b2a5-6f9290d5f437" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_165e11cd-30fd-43da-8b66-2a0b2f748537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d5a9e9c-ddc8-4c59-a201-077b3114f419" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_165e11cd-30fd-43da-8b66-2a0b2f748537" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8d0c7372-f8cf-453f-bcad-c507190f504e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_09fc7974-d2e6-4e4b-9aa8-7caaff6542c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8d0c7372-f8cf-453f-bcad-c507190f504e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_09fc7974-d2e6-4e4b-9aa8-7caaff6542c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c1598d97-2cc6-4fad-b09a-fe72b31484c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8d0c7372-f8cf-453f-bcad-c507190f504e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c1598d97-2cc6-4fad-b09a-fe72b31484c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4b3f70ec-68dc-428b-9ce7-e750144fe59b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_235cbdea-35ff-47a9-8fe4-4ba6e2ac52c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4b3f70ec-68dc-428b-9ce7-e750144fe59b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_235cbdea-35ff-47a9-8fe4-4ba6e2ac52c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_90603570-5b4a-4fa5-b8b4-88b9fe4470a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4b3f70ec-68dc-428b-9ce7-e750144fe59b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_90603570-5b4a-4fa5-b8b4-88b9fe4470a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_072e8403-9803-452e-9b10-f9fe4dabe0e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_8eec0d36-5ffb-4cc2-8107-b7bb35c30c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_072e8403-9803-452e-9b10-f9fe4dabe0e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_8eec0d36-5ffb-4cc2-8107-b7bb35c30c66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_6f89687c-086f-4209-931c-76ec394c657f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_072e8403-9803-452e-9b10-f9fe4dabe0e2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_6f89687c-086f-4209-931c-76ec394c657f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f34b6f61-77b8-4b8e-ac2c-1b6373200984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_0f1e6875-e690-4285-99d2-9f819b8abcba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f34b6f61-77b8-4b8e-ac2c-1b6373200984" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_0f1e6875-e690-4285-99d2-9f819b8abcba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6cf4b5db-5b02-4f32-bf9a-ba5ebbd99e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f34b6f61-77b8-4b8e-ac2c-1b6373200984" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6cf4b5db-5b02-4f32-bf9a-ba5ebbd99e3f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>bsx-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:70f263dc-70b5-4726-816e-8c716916294a,g:26cfe26e-80ae-4508-82da-1214ca3ae539-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20210630.xsd#CoverDocument"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended" id="i81e245c027d04cea863a125a9056be72_CoverDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_25bd0660-2e15-47c4-9d6d-efd6eb0de7a0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentType_25bd0660-2e15-47c4-9d6d-efd6eb0de7a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_e3a52393-08ca-48ba-86b4-f1214dde44bf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentQuarterlyReport_e3a52393-08ca-48ba-86b4-f1214dde44bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_64c7bbad-62a6-47b0-95e9-ee7fc77c1c70" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentPeriodEndDate_64c7bbad-62a6-47b0-95e9-ee7fc77c1c70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_50b431f4-fcf6-4c86-94b0-717608782ca5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentTransitionReport_50b431f4-fcf6-4c86-94b0-717608782ca5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bc6bde34-e728-4ae1-9e54-01d01766efd8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityFileNumber_bc6bde34-e728-4ae1-9e54-01d01766efd8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_332b48e5-b245-482a-a2b0-0b3454ef84bc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityRegistrantName_332b48e5-b245-482a-a2b0-0b3454ef84bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0b0ad7de-2128-4c2e-b728-60c0c3c999c1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0b0ad7de-2128-4c2e-b728-60c0c3c999c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bc645709-9254-4a47-b72f-de91d64aed33" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityTaxIdentificationNumber_bc645709-9254-4a47-b72f-de91d64aed33" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e6ed2624-de6a-435b-81bc-33ae0acabb21" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityAddressAddressLine1_e6ed2624-de6a-435b-81bc-33ae0acabb21" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1b463da3-71e6-42b6-9c2e-cd24b8b5aebb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityAddressCityOrTown_1b463da3-71e6-42b6-9c2e-cd24b8b5aebb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_081b6e10-a7bc-4f0d-8eb5-7d6649eae1f0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityAddressStateOrProvince_081b6e10-a7bc-4f0d-8eb5-7d6649eae1f0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1a387a69-a6f4-4092-9d64-08f8d25fcfb9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityAddressPostalZipCode_1a387a69-a6f4-4092-9d64-08f8d25fcfb9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ea790e05-e689-45c7-8c5e-e47e3fa98ee1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_CityAreaCode_ea790e05-e689-45c7-8c5e-e47e3fa98ee1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2407ae2e-511d-4bd6-bbe3-b4b357642c33" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_LocalPhoneNumber_2407ae2e-511d-4bd6-bbe3-b4b357642c33" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_847e5c30-9912-4dab-a594-630368065ca8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_Security12bTitle_847e5c30-9912-4dab-a594-630368065ca8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c82ecda3-0158-41f0-8a7a-36dc000b6873" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_TradingSymbol_c82ecda3-0158-41f0-8a7a-36dc000b6873" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_23501528-e977-4092-bfb3-4d57a15a9dbf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_SecurityExchangeName_23501528-e977-4092-bfb3-4d57a15a9dbf" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c091c8f0-67e9-4613-ad4c-61fa67a93793" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityCurrentReportingStatus_c091c8f0-67e9-4613-ad4c-61fa67a93793" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e37ba5a3-94c3-4e6a-a953-30df18b8acf0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityInteractiveDataCurrent_e37ba5a3-94c3-4e6a-a953-30df18b8acf0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_69d866cc-5aed-40fe-a3d5-492c212a3bae" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityFilerCategory_69d866cc-5aed-40fe-a3d5-492c212a3bae" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9472a7b1-50e1-4358-ab63-1a7bcfee913e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntitySmallBusiness_9472a7b1-50e1-4358-ab63-1a7bcfee913e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_876defa6-3275-40d2-bc23-f49f9ac19d78" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityEmergingGrowthCompany_876defa6-3275-40d2-bc23-f49f9ac19d78" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_94f12349-8449-423a-aed3-09e9021e8d54" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityShellCompany_94f12349-8449-423a-aed3-09e9021e8d54" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_4f66c4b9-6e6c-4038-9301-b98b84c391a5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityListingParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityListingParValuePerShare_4f66c4b9-6e6c-4038-9301-b98b84c391a5" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0642186e-bff0-47cd-85af-cf19efad129f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0642186e-bff0-47cd-85af-cf19efad129f" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a53def80-b0e7-4fde-97bd-4a49f8d2b5b4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityCentralIndexKey_a53def80-b0e7-4fde-97bd-4a49f8d2b5b4" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_35c8f882-187c-468f-8b36-26c2de716ca4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_CurrentFiscalYearEndDate_35c8f882-187c-468f-8b36-26c2de716ca4" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_78ab265f-7fac-41d7-a7dc-db2d5e65e277" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentFiscalYearFocus_78ab265f-7fac-41d7-a7dc-db2d5e65e277" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9ea1f064-e004-4576-96a5-1222ed564029" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9ea1f064-e004-4576-96a5-1222ed564029" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_49dbe590-a275-490f-a130-c8af6574ccc8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_AmendmentFlag_49dbe590-a275-490f-a130-c8af6574ccc8" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_785655bc-9aca-40b0-abfe-0fc6893198f7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntitiesTable_785655bc-9aca-40b0-abfe-0fc6893198f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_37a12f8e-4101-4ab9-adc0-c5e146c73267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_785655bc-9aca-40b0-abfe-0fc6893198f7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_37a12f8e-4101-4ab9-adc0-c5e146c73267" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_37a12f8e-4101-4ab9-adc0-c5e146c73267_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37a12f8e-4101-4ab9-adc0-c5e146c73267" xlink:to="loc_us-gaap_ClassOfStockDomain_37a12f8e-4101-4ab9-adc0-c5e146c73267_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3747b1c4-c50c-432c-8e49-41371f1f89ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37a12f8e-4101-4ab9-adc0-c5e146c73267" xlink:to="loc_us-gaap_ClassOfStockDomain_3747b1c4-c50c-432c-8e49-41371f1f89ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ad8083fa-cc20-4662-a59d-ee29754d19ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3747b1c4-c50c-432c-8e49-41371f1f89ee" xlink:to="loc_us-gaap_CommonStockMember_ad8083fa-cc20-4662-a59d-ee29754d19ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_424ebbed-07f3-463a-a3a0-f3e454c5eaa6" xlink:href="bsx-20210630.xsd#bsx_SeniorNotedue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3747b1c4-c50c-432c-8e49-41371f1f89ee" xlink:to="loc_bsx_SeniorNotedue2027Member_424ebbed-07f3-463a-a3a0-f3e454c5eaa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_ec561b09-281b-41bd-8fd4-6eff1b7cbecd" xlink:href="bsx-20210630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3747b1c4-c50c-432c-8e49-41371f1f89ee" xlink:to="loc_bsx_A550MCPSSeriesAMember_ec561b09-281b-41bd-8fd4-6eff1b7cbecd" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="i9821990294f14644b87e176062218ea4_ConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2c1f276-22c8-4a10-9823-8945cd2766ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2c1f276-22c8-4a10-9823-8945cd2766ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_33db0f73-bb5e-48e6-89b1-2e1ac5ad0a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_33db0f73-bb5e-48e6-89b1-2e1ac5ad0a59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_562c7a67-4595-4f47-991d-3ad06261ac76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_GrossProfit_562c7a67-4595-4f47-991d-3ad06261ac76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1d584be4-62a8-4e76-902e-f885944695e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1d584be4-62a8-4e76-902e-f885944695e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9161e725-6007-4834-8e61-e682bfa027ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9161e725-6007-4834-8e61-e682bfa027ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_84786360-b602-499b-bb22-4ffa020add82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_RoyaltyExpense_84786360-b602-499b-bb22-4ffa020add82" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_20c5e6d4-96e0-4e8b-aeb7-4035fcb9572e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_20c5e6d4-96e0-4e8b-aeb7-4035fcb9572e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_78dd906a-18db-4eb2-82cf-0ccc0951f657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_78dd906a-18db-4eb2-82cf-0ccc0951f657" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5caa7941-c0bf-4499-a076-aab3676b7c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5caa7941-c0bf-4499-a076-aab3676b7c57" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a34bd3cc-254f-48e1-86ec-4d08e133fab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_RestructuringCharges_a34bd3cc-254f-48e1-86ec-4d08e133fab9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_8eae0fc4-644c-49bb-b0c1-19e043a8fc11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_LitigationSettlementExpense_8eae0fc4-644c-49bb-b0c1-19e043a8fc11" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_6a12a7f9-0326-4e26-96fb-1180e9ecd2ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_6a12a7f9-0326-4e26-96fb-1180e9ecd2ea" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d87d0c34-4ebc-46a2-b31e-6a61feb12fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_OperatingExpenses_d87d0c34-4ebc-46a2-b31e-6a61feb12fe5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0464223d-66e1-4b42-8b6d-3eb6c9d3a193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_OperatingIncomeLoss_0464223d-66e1-4b42-8b6d-3eb6c9d3a193" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_d9d33e08-7425-45d5-89ce-6caa99dda915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_d9d33e08-7425-45d5-89ce-6caa99dda915" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_abc14f40-11f2-44be-9d3d-e9b15117d0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_d9d33e08-7425-45d5-89ce-6caa99dda915" xlink:to="loc_us-gaap_InterestExpense_abc14f40-11f2-44be-9d3d-e9b15117d0d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_70fdb61c-1d8f-4ff6-ac15-c1fcd434db14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_d9d33e08-7425-45d5-89ce-6caa99dda915" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_70fdb61c-1d8f-4ff6-ac15-c1fcd434db14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd155eba-af30-4176-82eb-0ea184692a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd155eba-af30-4176-82eb-0ea184692a8e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5c6f85b1-4138-4a55-883f-7ca59c814e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5c6f85b1-4138-4a55-883f-7ca59c814e2f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bc8f6299-3314-409e-90bd-a03ff3eff62f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_ProfitLoss_bc8f6299-3314-409e-90bd-a03ff3eff62f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_bd1d79ce-aa4e-4354-818c-d34ff9a192f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_DividendsPreferredStockStock_bd1d79ce-aa4e-4354-818c-d34ff9a192f4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f8893cc7-122b-4744-873f-ff04837b2b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f8893cc7-122b-4744-873f-ff04837b2b53" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_19d22865-4a2b-4da2-898f-81236f2fce5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_EarningsPerShareBasic_19d22865-4a2b-4da2-898f-81236f2fce5d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d8c6ef58-0312-4a7d-b3f2-ae9c0a9f8c3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d8c6ef58-0312-4a7d-b3f2-ae9c0a9f8c3b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e1e3d556-ef3f-420f-b5d6-c802181cf7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e1e3d556-ef3f-420f-b5d6-c802181cf7f6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8d2851c9-5192-4e78-b369-2e00db37f791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e1e3d556-ef3f-420f-b5d6-c802181cf7f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8d2851c9-5192-4e78-b369-2e00db37f791" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8bf665b2-9947-4124-8d42-46792e42cfdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e1e3d556-ef3f-420f-b5d6-c802181cf7f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8bf665b2-9947-4124-8d42-46792e42cfdd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a1acf401-efab-4c93-a6ee-673c44dc514b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_StatementTable_a1acf401-efab-4c93-a6ee-673c44dc514b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_649a6675-c5ed-40a4-a915-4c04e7effcb7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a1acf401-efab-4c93-a6ee-673c44dc514b" xlink:to="loc_srt_StatementScenarioAxis_649a6675-c5ed-40a4-a915-4c04e7effcb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_649a6675-c5ed-40a4-a915-4c04e7effcb7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_649a6675-c5ed-40a4-a915-4c04e7effcb7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_649a6675-c5ed-40a4-a915-4c04e7effcb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0519c622-0b6b-49a3-aa40-13c8d234d3b9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_649a6675-c5ed-40a4-a915-4c04e7effcb7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0519c622-0b6b-49a3-aa40-13c8d234d3b9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="i9e518fb5ae9246f48e9157f576ab5689_ConsolidatedStatementsofComprehensiveIncomeLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f9e964e3-5d9e-4234-8bf8-5ada8b6c2127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8ea6062e-bbfa-45d4-a872-d33fd45a45af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9e964e3-5d9e-4234-8bf8-5ada8b6c2127" xlink:to="loc_us-gaap_ProfitLoss_8ea6062e-bbfa-45d4-a872-d33fd45a45af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9e964e3-5d9e-4234-8bf8-5ada8b6c2127" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_77bdea1d-2a10-44ea-9a14-2b73e9b6946b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_77bdea1d-2a10-44ea-9a14-2b73e9b6946b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_080c6389-c793-455a-a63a-b8988a8078e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_080c6389-c793-455a-a63a-b8988a8078e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7d655020-43bc-417a-a1bf-46d523417348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7d655020-43bc-417a-a1bf-46d523417348" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85ffb71b-b8fd-42a7-97e1-fdca79a49322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85ffb71b-b8fd-42a7-97e1-fdca79a49322" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c864da17-b5f4-42d4-a18a-bbbab5d2c4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f9e964e3-5d9e-4234-8bf8-5ada8b6c2127" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c864da17-b5f4-42d4-a18a-bbbab5d2c4ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_73b96129-43e0-4384-a1be-c6002dcf1b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f9e964e3-5d9e-4234-8bf8-5ada8b6c2127" xlink:to="loc_us-gaap_StatementTable_73b96129-43e0-4384-a1be-c6002dcf1b5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_cefce4e8-8b6f-45d6-8f95-0386f3496faa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_73b96129-43e0-4384-a1be-c6002dcf1b5f" xlink:to="loc_srt_StatementScenarioAxis_cefce4e8-8b6f-45d6-8f95-0386f3496faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cefce4e8-8b6f-45d6-8f95-0386f3496faa_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_cefce4e8-8b6f-45d6-8f95-0386f3496faa" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cefce4e8-8b6f-45d6-8f95-0386f3496faa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cd1300c9-a08e-474b-ae64-de7c23fefd2d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_cefce4e8-8b6f-45d6-8f95-0386f3496faa" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cd1300c9-a08e-474b-ae64-de7c23fefd2d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended" id="i11f78f5a404048689ccd9513352b2785_ConsolidatedBalanceSheetsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5a0275fd-46f0-4d49-ac2c-6ffa2da6d493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5a0275fd-46f0-4d49-ac2c-6ffa2da6d493" xlink:to="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8fbb3337-3e41-47a5-a063-3337edc2b81c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8fbb3337-3e41-47a5-a063-3337edc2b81c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_ea5a672e-4692-4d7d-bdce-82aa405556a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_ea5a672e-4692-4d7d-bdce-82aa405556a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f81abf76-d651-4827-bed8-e0cbfd29a366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_InventoryNet_f81abf76-d651-4827-bed8-e0cbfd29a366" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_2c139d75-487b-4d3e-ab32-1d49c9ecce4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_PrepaidTaxes_2c139d75-487b-4d3e-ab32-1d49c9ecce4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_9a4ae8a5-7a46-4825-a315-a81d9fc61b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_9a4ae8a5-7a46-4825-a315-a81d9fc61b37" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2daa3e58-85d9-42a9-a037-3dc6382a1bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2daa3e58-85d9-42a9-a037-3dc6382a1bdb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8274456e-4071-4e99-bcf9-ec8858e97b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_AssetsCurrent_8274456e-4071-4e99-bcf9-ec8858e97b03" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2dc83c4e-dcdf-40a1-b329-cc3f07259539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2dc83c4e-dcdf-40a1-b329-cc3f07259539" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_67a7cf74-d6e8-453f-bfd8-d8f48a4e23cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_Goodwill_67a7cf74-d6e8-453f-bfd8-d8f48a4e23cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9077c19d-d6f1-4eb3-9d98-b22b4838b8ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9077c19d-d6f1-4eb3-9d98-b22b4838b8ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_94966f0d-28d3-4d31-a828-ca8d15f93414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_94966f0d-28d3-4d31-a828-ca8d15f93414" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0bc37cb0-5c34-4f78-8623-aeeb26e919a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0bc37cb0-5c34-4f78-8623-aeeb26e919a3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9e205e50-a03b-4dbf-85cb-3995f1a35fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_Assets_9e205e50-a03b-4dbf-85cb-3995f1a35fd6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5a0275fd-46f0-4d49-ac2c-6ffa2da6d493" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_12f6029f-0894-4486-ac78-79c2c0113f30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:to="loc_us-gaap_DebtCurrent_12f6029f-0894-4486-ac78-79c2c0113f30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6d76f315-8ba4-4166-8016-2aadf70967c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:to="loc_us-gaap_AccountsPayableCurrent_6d76f315-8ba4-4166-8016-2aadf70967c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9fd8297c-b328-4123-8a66-d5e403d43ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9fd8297c-b328-4123-8a66-d5e403d43ca0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_926dfbb6-ab82-43e5-8e6b-a04483ed8ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_926dfbb6-ab82-43e5-8e6b-a04483ed8ae8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_911895fe-a15d-4e0a-b419-cfea1db6673a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:to="loc_us-gaap_LiabilitiesCurrent_911895fe-a15d-4e0a-b419-cfea1db6673a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_69800e57-496b-4ca2-a300-874ccdbdaa85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_69800e57-496b-4ca2-a300-874ccdbdaa85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7bf8dad0-85d4-4f76-871f-5dd1b7fc525f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7bf8dad0-85d4-4f76-871f-5dd1b7fc525f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_18959151-cf56-4902-bcfa-156a81697d0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_18959151-cf56-4902-bcfa-156a81697d0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b672eb1d-c3ca-43d8-904b-a8d5f40d4f69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b672eb1d-c3ca-43d8-904b-a8d5f40d4f69" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_79d17137-1dcb-4b69-8c82-136647c9eae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_PreferredStockValue_79d17137-1dcb-4b69-8c82-136647c9eae7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c1c24027-84bc-4739-8cdc-db995e6725ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_CommonStockValue_c1c24027-84bc-4739-8cdc-db995e6725ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_feeb32aa-3a4d-4c5f-92ed-35bdd10a4bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_TreasuryStockValue_feeb32aa-3a4d-4c5f-92ed-35bdd10a4bf5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b6de785e-b34d-4204-9fc0-8bbbe23af00f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b6de785e-b34d-4204-9fc0-8bbbe23af00f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_43b29e5d-4c2d-4aba-86a2-1f7828297194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_43b29e5d-4c2d-4aba-86a2-1f7828297194" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_30acfb55-ab5f-4275-98ec-862eb18060c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_30acfb55-ab5f-4275-98ec-862eb18060c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8e8759d6-5d84-4484-9e4e-a4729e1f7f00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8e8759d6-5d84-4484-9e4e-a4729e1f7f00" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0e3751a2-d85d-4bf4-9c82-400fff58bbcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0e3751a2-d85d-4bf4-9c82-400fff58bbcf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_240fb277-27f7-45d2-93ff-b426310ecdbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5a0275fd-46f0-4d49-ac2c-6ffa2da6d493" xlink:to="loc_us-gaap_StatementTable_240fb277-27f7-45d2-93ff-b426310ecdbc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_9396d0e8-a81c-4c66-8af8-dbd83953323b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_240fb277-27f7-45d2-93ff-b426310ecdbc" xlink:to="loc_srt_StatementScenarioAxis_9396d0e8-a81c-4c66-8af8-dbd83953323b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9396d0e8-a81c-4c66-8af8-dbd83953323b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_9396d0e8-a81c-4c66-8af8-dbd83953323b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9396d0e8-a81c-4c66-8af8-dbd83953323b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a7e9ed8f-06b3-4806-830d-4140b4017cd2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_9396d0e8-a81c-4c66-8af8-dbd83953323b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a7e9ed8f-06b3-4806-830d-4140b4017cd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e20fd705-3d4c-4b5b-9d9c-690930d510b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_240fb277-27f7-45d2-93ff-b426310ecdbc" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e20fd705-3d4c-4b5b-9d9c-690930d510b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e20fd705-3d4c-4b5b-9d9c-690930d510b9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e20fd705-3d4c-4b5b-9d9c-690930d510b9" xlink:to="loc_us-gaap_ClassOfStockDomain_e20fd705-3d4c-4b5b-9d9c-690930d510b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_99ea53cf-b1cb-4b24-b27b-17799c1fef11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e20fd705-3d4c-4b5b-9d9c-690930d510b9" xlink:to="loc_us-gaap_ClassOfStockDomain_99ea53cf-b1cb-4b24-b27b-17799c1fef11" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended" id="i1a01fc7001644f7b9b86e9983c44eac9_ConsolidatedStatementsofStockholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4a60b0d3-9d0d-4ca7-801e-464419b7812e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4a60b0d3-9d0d-4ca7-801e-464419b7812e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_856ada8f-5eb5-445c-85f3-5c880d8587e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_856ada8f-5eb5-445c-85f3-5c880d8587e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_2649aea2-ad24-4ae6-b22e-7dc358ad107e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_SharesIssued_2649aea2-ad24-4ae6-b22e-7dc358ad107e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fed3c58e-027b-4723-a887-e099e2c58086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_ProfitLoss_fed3c58e-027b-4723-a887-e099e2c58086" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_a66ff427-a2cd-4927-8131-559cef6a7d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_a66ff427-a2cd-4927-8131-559cef6a7d2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_903579fa-882d-4872-b0cd-49e17f543015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_903579fa-882d-4872-b0cd-49e17f543015" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_39d4b3f0-2e5e-4693-8316-15ff9f0c54e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_39d4b3f0-2e5e-4693-8316-15ff9f0c54e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_8d7a0181-d0a3-4c15-b118-152d33c041a1" xlink:href="bsx-20210630.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_8d7a0181-d0a3-4c15-b118-152d33c041a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_006d9a2e-bc7f-4e0b-af56-8f5105d4dbb5" xlink:href="bsx-20210630.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_006d9a2e-bc7f-4e0b-af56-8f5105d4dbb5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_74fef628-c087-4676-be28-144242a1ddb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_74fef628-c087-4676-be28-144242a1ddb8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_466575f5-8fde-4ad2-a0ca-643362513731" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_DividendsPreferredStockCash_466575f5-8fde-4ad2-a0ca-643362513731" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4e2be493-ad18-4e3b-8ac8-215c64745ca3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4e2be493-ad18-4e3b-8ac8-215c64745ca3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_59522a16-1827-4d82-a66a-2591577ffcc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_59522a16-1827-4d82-a66a-2591577ffcc1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_3bd91771-723b-4484-83b3-e4e56312242a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_3bd91771-723b-4484-83b3-e4e56312242a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d31708d2-587d-46d5-be2f-4bf338de5b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_d8f9f283-1c6d-4b37-9fbe-471709b31b70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_622a1c64-335e-4d8d-a0bd-61af9715f1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4a60b0d3-9d0d-4ca7-801e-464419b7812e" xlink:to="loc_us-gaap_StatementTable_622a1c64-335e-4d8d-a0bd-61af9715f1c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c558d5f3-6869-4776-9cef-ac1cf241bd4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_622a1c64-335e-4d8d-a0bd-61af9715f1c5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c558d5f3-6869-4776-9cef-ac1cf241bd4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c558d5f3-6869-4776-9cef-ac1cf241bd4c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c558d5f3-6869-4776-9cef-ac1cf241bd4c" xlink:to="loc_us-gaap_EquityComponentDomain_c558d5f3-6869-4776-9cef-ac1cf241bd4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c558d5f3-6869-4776-9cef-ac1cf241bd4c" xlink:to="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_bfb565b3-ffcd-4026-b2f7-61177ee58d49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_PreferredStockMember_bfb565b3-ffcd-4026-b2f7-61177ee58d49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a5a31f68-5b65-4a91-b24b-2f47138d20f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_CommonStockMember_a5a31f68-5b65-4a91-b24b-2f47138d20f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_73212383-a574-42c7-be2f-03b290f03878" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_TreasuryStockMember_73212383-a574-42c7-be2f-03b290f03878" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4ac08fd1-382d-47dc-8913-2515a6496dd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4ac08fd1-382d-47dc-8913-2515a6496dd2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eaf30cdf-97f9-4bdf-8f44-733ef5125a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_RetainedEarningsMember_eaf30cdf-97f9-4bdf-8f44-733ef5125a46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e67d39d3-b7e7-46be-b28e-a4a0767099a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e67d39d3-b7e7-46be-b28e-a4a0767099a2" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended" id="i749310108a78434abe91ffbd70cbf27d_ConsolidatedStatementsofCashFlowsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4fe19bfc-56cd-45fd-8cc5-cda6e773b742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_ProfitLoss_4fe19bfc-56cd-45fd-8cc5-cda6e773b742" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_88620a70-546f-4f28-95ea-92d5c8e06283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_88620a70-546f-4f28-95ea-92d5c8e06283" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e037a28c-44ff-4435-9d7b-38576fc5ee56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e037a28c-44ff-4435-9d7b-38576fc5ee56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_7fc00401-474e-46e9-936e-463881b9dca5" xlink:href="bsx-20210630.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_7fc00401-474e-46e9-936e-463881b9dca5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9e36b39a-27a1-4e58-b173-9d6e347a1eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_ShareBasedCompensation_9e36b39a-27a1-4e58-b173-9d6e347a1eb0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f05d7460-fe3b-46aa-b059-b42b2a94ba7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f05d7460-fe3b-46aa-b059-b42b2a94ba7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_d5b3df9f-9018-4c09-9509-f6641bf5845f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_GainLossOnInvestments_d5b3df9f-9018-4c09-9509-f6641bf5845f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1d9c0aa3-f1e4-426a-8c8b-34104061d451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1d9c0aa3-f1e4-426a-8c8b-34104061d451" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_c28c8ce2-8c69-4485-b20a-0d9ae8b46106" xlink:href="bsx-20210630.xsd#bsx_InventoryStepUpAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_bsx_InventoryStepUpAmortization_c28c8ce2-8c69-4485-b20a-0d9ae8b46106" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss_5a7a96f7-d0e6-4e1f-b927-111d30a8c06e" xlink:href="bsx-20210630.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_bsx_Netcurrencyexchangegainloss_5a7a96f7-d0e6-4e1f-b927-111d30a8c06e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_08c2f27a-d154-4032-abb3-a4132182a791" xlink:href="bsx-20210630.xsd#bsx_OtherNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_bsx_OtherNet_08c2f27a-d154-4032-abb3-a4132182a791" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9548732b-1d1d-43c8-912a-663409a5d054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9548732b-1d1d-43c8-912a-663409a5d054" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b448f99e-c116-4e08-bdd8-ac2f32f0a587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b448f99e-c116-4e08-bdd8-ac2f32f0a587" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_efa42f98-6dd2-4d3f-b044-cdf7ff0decb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_efa42f98-6dd2-4d3f-b044-cdf7ff0decb9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2d5cec5a-a53b-400a-b355-7d2704d2fc67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2d5cec5a-a53b-400a-b355-7d2704d2fc67" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6078469c-bce5-49ff-b1e9-3305079a9558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6078469c-bce5-49ff-b1e9-3305079a9558" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_11a948db-248d-47c1-ad47-3679cb1877aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_11a948db-248d-47c1-ad47-3679cb1877aa" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_50ab97aa-28f5-47f3-8987-1ab43cfa346e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_50ab97aa-28f5-47f3-8987-1ab43cfa346e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ec643c34-8c60-4942-b2a2-6799a5f12c30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ec643c34-8c60-4942-b2a2-6799a5f12c30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_15700f27-0227-40b6-8ced-a5cadd25767e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_15700f27-0227-40b6-8ced-a5cadd25767e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_efb45fd0-bd16-419f-b4f9-89bcb68e09da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_efb45fd0-bd16-419f-b4f9-89bcb68e09da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_6078d558-a480-444c-a90c-15ea744b5c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_6078d558-a480-444c-a90c-15ea744b5c20" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_fb05ffc9-eefe-40bb-90bd-dd5f95d6b24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_fb05ffc9-eefe-40bb-90bd-dd5f95d6b24c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_08a0f226-df6f-4c6c-881a-7697e9647129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_08a0f226-df6f-4c6c-881a-7697e9647129" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_627f85e0-79c9-4dc7-8cd7-3e1b2c007399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_627f85e0-79c9-4dc7-8cd7-3e1b2c007399" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e2fc9bc4-826d-4630-99df-625a31ab74dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e2fc9bc4-826d-4630-99df-625a31ab74dc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d3997cec-8165-441a-82a4-68b2154f733b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d3997cec-8165-441a-82a4-68b2154f733b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_1c453a59-9d33-4aff-95ca-a6b4828fc8ae" xlink:href="bsx-20210630.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_bsx_PaymentsForRoyaltyRights_1c453a59-9d33-4aff-95ca-a6b4828fc8ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_ee93ebf9-f31e-4886-9569-ae362088fba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_ee93ebf9-f31e-4886-9569-ae362088fba6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_9450b099-0490-48ad-8df5-bc2b13fcebd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_9450b099-0490-48ad-8df5-bc2b13fcebd0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_02f86f95-08f9-4e37-948a-b1aebf790f72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_02f86f95-08f9-4e37-948a-b1aebf790f72" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_0f6aa1e8-8279-4dad-be58-c6527b8734db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_0f6aa1e8-8279-4dad-be58-c6527b8734db" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1b553430-2daa-4601-b05b-06e62b060902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1b553430-2daa-4601-b05b-06e62b060902" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_7fd47f5e-6470-4fa9-926d-4984062b4a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_7fd47f5e-6470-4fa9-926d-4984062b4a9e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_83de1827-a887-42df-9740-6a50328daa9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_83de1827-a887-42df-9740-6a50328daa9d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_89a5327a-01d5-408b-a431-cfb23f3ec1ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_PaymentsOfDividends_89a5327a-01d5-408b-a431-cfb23f3ec1ae" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_cad0c3cc-ea55-4217-af1c-db0b1c6de46b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_cad0c3cc-ea55-4217-af1c-db0b1c6de46b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6383da9d-7607-4ca1-95de-97085ad578c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6383da9d-7607-4ca1-95de-97085ad578c8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_2781508f-baa6-44e8-95e0-7ad0a099fa4a" xlink:href="bsx-20210630.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_2781508f-baa6-44e8-95e0-7ad0a099fa4a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_55ace21f-2115-4107-be4a-342f1fff206f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromStockPlans_55ace21f-2115-4107-be4a-342f1fff206f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3a119e5d-7373-4fd1-b81e-2988d46a0e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3a119e5d-7373-4fd1-b81e-2988d46a0e28" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3c0ab44b-0bf3-4e86-94f6-bd256b0f3203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3c0ab44b-0bf3-4e86-94f6-bd256b0f3203" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1efe0698-009e-4e20-8332-dbe89d2d098b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1efe0698-009e-4e20-8332-dbe89d2d098b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c948821f-bb84-4a8d-8306-c7f385b7e742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c948821f-bb84-4a8d-8306-c7f385b7e742" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c7c9e18-4f06-423a-86f9-3813268f82c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_28ac6007-3ee4-4d0b-b9d7-6f22720a5f76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_28ac6007-3ee4-4d0b-b9d7-6f22720a5f76" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f0e91ce8-490e-44bf-8b26-8fd40e863784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_3d39445b-603b-4957-a0d0-c4035342ebc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_28ac6007-3ee4-4d0b-b9d7-6f22720a5f76" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_3d39445b-603b-4957-a0d0-c4035342ebc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_a61653a8-b30f-4505-8be8-a14857e5252e" xlink:href="bsx-20210630.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_28ac6007-3ee4-4d0b-b9d7-6f22720a5f76" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_a61653a8-b30f-4505-8be8-a14857e5252e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b5fcf3f4-3e0a-48ca-a850-b7e51386fb0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_StatementTable_b5fcf3f4-3e0a-48ca-a850-b7e51386fb0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e996f87e-b255-4c5a-b466-f9c0051bcc04" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b5fcf3f4-3e0a-48ca-a850-b7e51386fb0a" xlink:to="loc_srt_StatementScenarioAxis_e996f87e-b255-4c5a-b466-f9c0051bcc04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e996f87e-b255-4c5a-b466-f9c0051bcc04_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_e996f87e-b255-4c5a-b466-f9c0051bcc04" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e996f87e-b255-4c5a-b466-f9c0051bcc04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8aed1acf-f405-4675-8354-26707613bf00" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_e996f87e-b255-4c5a-b466-f9c0051bcc04" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8aed1acf-f405-4675-8354-26707613bf00" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofCashFlowsSupplementalDisclosure"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="extended" id="i070b3bbf212342b9b2bbb27bb1ebb8bf_ConsolidatedStatementsofCashFlowsSupplementalDisclosure">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_480149f9-6474-4235-89b8-664c229ff704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_480149f9-6474-4235-89b8-664c229ff704" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_44482f33-6715-41a7-b743-50359ae32c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_44482f33-6715-41a7-b743-50359ae32c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_f6975f91-77fd-4ff7-bba0-844f7ae2944f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_f6975f91-77fd-4ff7-bba0-844f7ae2944f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f7ce42ef-ad98-41ed-b0b3-8db5a62f814e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f7ce42ef-ad98-41ed-b0b3-8db5a62f814e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5d0c14be-8264-46cf-b41d-fb549be165d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:to="loc_us-gaap_StatementTable_5d0c14be-8264-46cf-b41d-fb549be165d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_aa9e2ee6-5874-4c0e-9f45-58e7efdbefdb" xlink:href="bsx-20210630.xsd#bsx_StatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5d0c14be-8264-46cf-b41d-fb549be165d7" xlink:to="loc_bsx_StatementAxis_aa9e2ee6-5874-4c0e-9f45-58e7efdbefdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_aa9e2ee6-5874-4c0e-9f45-58e7efdbefdb_default" xlink:href="bsx-20210630.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_StatementAxis_aa9e2ee6-5874-4c0e-9f45-58e7efdbefdb" xlink:to="loc_bsx_StatementDomain_aa9e2ee6-5874-4c0e-9f45-58e7efdbefdb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_dbcfbfe6-ad08-451e-ba2b-0adefab03b87" xlink:href="bsx-20210630.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_StatementAxis_aa9e2ee6-5874-4c0e-9f45-58e7efdbefdb" xlink:to="loc_bsx_StatementDomain_dbcfbfe6-ad08-451e-ba2b-0adefab03b87" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#AcquisitionsandStrategicInvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="extended" id="i905313ae060b4866b4b41c69bb8d8b1e_AcquisitionsandStrategicInvestmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_3a6e247f-8b30-47d6-94a6-1b9e9ec7c641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_3a6e247f-8b30-47d6-94a6-1b9e9ec7c641" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_566f8c73-9bc4-48e5-adaa-f1593e89ba87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_566f8c73-9bc4-48e5-adaa-f1593e89ba87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_a12cc49a-eef5-40c9-a223-baf79240d5fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_a12cc49a-eef5-40c9-a223-baf79240d5fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ee6e7341-8648-47ea-bc50-6df98c20d4fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ee6e7341-8648-47ea-bc50-6df98c20d4fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_0b5b1a1e-460c-4b27-8175-9b073a9743b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_0b5b1a1e-460c-4b27-8175-9b073a9743b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_767b7469-e8b4-4d4b-a419-eacf04b015d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_767b7469-e8b4-4d4b-a419-eacf04b015d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_401a82bd-229a-41ca-b2a6-4e5aeb9fdcf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_401a82bd-229a-41ca-b2a6-4e5aeb9fdcf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_401a82bd-229a-41ca-b2a6-4e5aeb9fdcf3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_401a82bd-229a-41ca-b2a6-4e5aeb9fdcf3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_401a82bd-229a-41ca-b2a6-4e5aeb9fdcf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad4219ad-76be-41c3-8753-4a6ce10a31d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_401a82bd-229a-41ca-b2a6-4e5aeb9fdcf3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad4219ad-76be-41c3-8753-4a6ce10a31d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisLTDMember_0e117ed1-3d18-46cb-929d-817f924e8580" xlink:href="bsx-20210630.xsd#bsx_LumenisLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad4219ad-76be-41c3-8753-4a6ce10a31d6" xlink:to="loc_bsx_LumenisLTDMember_0e117ed1-3d18-46cb-929d-817f924e8580" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceMember_14066c0f-de65-4050-bb8d-a22c07ade14b" xlink:href="bsx-20210630.xsd#bsx_PreventiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad4219ad-76be-41c3-8753-4a6ce10a31d6" xlink:to="loc_bsx_PreventiceMember_14066c0f-de65-4050-bb8d-a22c07ade14b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7cdc2734-536d-4df3-8e9a-9b43c9a0240b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7cdc2734-536d-4df3-8e9a-9b43c9a0240b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7cdc2734-536d-4df3-8e9a-9b43c9a0240b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7cdc2734-536d-4df3-8e9a-9b43c9a0240b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7cdc2734-536d-4df3-8e9a-9b43c9a0240b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_633d7521-d485-40ca-8ba1-e0dada935273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7cdc2734-536d-4df3-8e9a-9b43c9a0240b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_633d7521-d485-40ca-8ba1-e0dada935273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_67e55e77-118e-4317-aad4-ee4f62f37a49" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:to="loc_srt_OwnershipAxis_67e55e77-118e-4317-aad4-ee4f62f37a49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_67e55e77-118e-4317-aad4-ee4f62f37a49_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_67e55e77-118e-4317-aad4-ee4f62f37a49" xlink:to="loc_srt_OwnershipDomain_67e55e77-118e-4317-aad4-ee4f62f37a49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5809d990-baff-4e15-b3bd-9491c3b22e66" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_67e55e77-118e-4317-aad4-ee4f62f37a49" xlink:to="loc_srt_OwnershipDomain_5809d990-baff-4e15-b3bd-9491c3b22e66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a85b37d0-7147-46c8-a62f-f967c5a4f1f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a85b37d0-7147-46c8-a62f-f967c5a4f1f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a85b37d0-7147-46c8-a62f-f967c5a4f1f5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a85b37d0-7147-46c8-a62f-f967c5a4f1f5" xlink:to="loc_us-gaap_ClassOfStockDomain_a85b37d0-7147-46c8-a62f-f967c5a4f1f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c8383dd0-d5a4-47c5-828b-8f91096ef22d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a85b37d0-7147-46c8-a62f-f967c5a4f1f5" xlink:to="loc_us-gaap_ClassOfStockDomain_c8383dd0-d5a4-47c5-828b-8f91096ef22d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#AcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsDetails" xlink:type="extended" id="i6a10165fab3b44fca8061443335c7f8c_AcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_34b10b23-b39a-46f7-9c3c-30c77a686da7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_34b10b23-b39a-46f7-9c3c-30c77a686da7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinessesDivested_069efbae-e49b-428d-972b-e407a9b49cc3" xlink:href="bsx-20210630.xsd#bsx_NumberOfBusinessesDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_NumberOfBusinessesDivested_069efbae-e49b-428d-972b-e407a9b49cc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_288ef209-1efa-49c8-9f33-ede015ba4c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_288ef209-1efa-49c8-9f33-ede015ba4c85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_b1f6cab7-83b4-4469-8843-661aaa4eb216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_b1f6cab7-83b4-4469-8843-661aaa4eb216" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_19eccc62-89b5-4a94-a053-cd3b1d842794" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_19eccc62-89b5-4a94-a053-cd3b1d842794" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_98f2b457-58aa-47d4-9a7b-9e6938e2a6aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_98f2b457-58aa-47d4-9a7b-9e6938e2a6aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_44305485-14e5-4fc2-b57a-388e107a5caf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_44305485-14e5-4fc2-b57a-388e107a5caf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8453b449-9832-476e-a872-c3b20c15fe9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8453b449-9832-476e-a872-c3b20c15fe9d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b2215a8c-c21b-41b2-afe3-7a5c7c8ece19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b2215a8c-c21b-41b2-afe3-7a5c7c8ece19" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod_c52d4894-0d84-4c02-aab7-431e85c78f6f" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod_c52d4894-0d84-4c02-aab7-431e85c78f6f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6c74ab86-876a-4765-b463-a2a81e821816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6c74ab86-876a-4765-b463-a2a81e821816" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_26002a53-f7f2-43a0-87b5-2c6258c7a3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_26002a53-f7f2-43a0-87b5-2c6258c7a3a9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_aa684994-0d80-4978-af6c-a8a78aecd0de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_aa684994-0d80-4978-af6c-a8a78aecd0de" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7e8fe70a-e377-4a9e-851a-487c87f79fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_Goodwill_7e8fe70a-e377-4a9e-851a-487c87f79fe5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_761b8796-39ff-42a3-9e4a-903e9df4f91a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_761b8796-39ff-42a3-9e4a-903e9df4f91a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b7d4434b-79b1-4fa8-9a2b-3b77d90c9cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b7d4434b-79b1-4fa8-9a2b-3b77d90c9cd0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5d5af037-b682-4e29-9788-8326684185de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5d5af037-b682-4e29-9788-8326684185de" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_33574e5a-c1dd-4297-b392-d522ae04eba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_33574e5a-c1dd-4297-b392-d522ae04eba1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ba4f0db1-8f99-4ac2-abaa-8f12dbab2e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ba4f0db1-8f99-4ac2-abaa-8f12dbab2e4b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_9f280472-e546-410a-8f36-0b01e02ac2cf" xlink:href="bsx-20210630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_DiscountRateFairValueInput_9f280472-e546-410a-8f36-0b01e02ac2cf" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d9461d6e-d3bc-4ce3-9f5e-f3c097e38aac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d9461d6e-d3bc-4ce3-9f5e-f3c097e38aac" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfFacilities_d98a0359-2b99-4cd8-a1a8-8d80386fc8e5" xlink:href="bsx-20210630.xsd#bsx_DivestitureAgreementTransferOfFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_DivestitureAgreementTransferOfFacilities_d98a0359-2b99-4cd8-a1a8-8d80386fc8e5" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_9ff45d5b-888a-4154-b5d0-aaa25e7947d2" xlink:href="bsx-20210630.xsd#bsx_DivestitureAgreementTransferOfGlobalEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_9ff45d5b-888a-4154-b5d0-aaa25e7947d2" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f1cfce16-56af-481e-9ad0-ac1bccb49188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f1cfce16-56af-481e-9ad0-ac1bccb49188" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b4c9646a-be49-4351-84b3-167f74a256e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b4c9646a-be49-4351-84b3-167f74a256e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4c9646a-be49-4351-84b3-167f74a256e3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b4c9646a-be49-4351-84b3-167f74a256e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4c9646a-be49-4351-84b3-167f74a256e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b6a9f44-858e-48de-bfa0-467cc4025143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b4c9646a-be49-4351-84b3-167f74a256e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b6a9f44-858e-48de-bfa0-467cc4025143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisLTDMember_85f70ae8-6950-40aa-a538-544e15284cb6" xlink:href="bsx-20210630.xsd#bsx_LumenisLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b6a9f44-858e-48de-bfa0-467cc4025143" xlink:to="loc_bsx_LumenisLTDMember_85f70ae8-6950-40aa-a538-544e15284cb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceMember_7665e3c4-1ca7-4977-b7f9-70fd0b44c9bb" xlink:href="bsx-20210630.xsd#bsx_PreventiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b6a9f44-858e-48de-bfa0-467cc4025143" xlink:to="loc_bsx_PreventiceMember_7665e3c4-1ca7-4977-b7f9-70fd0b44c9bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FarapulseMember_7368f867-017b-4820-bd1a-bafa0f6c2921" xlink:href="bsx-20210630.xsd#bsx_FarapulseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b6a9f44-858e-48de-bfa0-467cc4025143" xlink:to="loc_bsx_FarapulseMember_7368f867-017b-4820-bd1a-bafa0f6c2921" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ce249548-40cf-499f-bbcd-dbb1f839f92b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_srt_RangeAxis_ce249548-40cf-499f-bbcd-dbb1f839f92b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ce249548-40cf-499f-bbcd-dbb1f839f92b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ce249548-40cf-499f-bbcd-dbb1f839f92b" xlink:to="loc_srt_RangeMember_ce249548-40cf-499f-bbcd-dbb1f839f92b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e15bb5f6-a24f-4afe-a974-aeb1288a1410" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ce249548-40cf-499f-bbcd-dbb1f839f92b" xlink:to="loc_srt_RangeMember_e15bb5f6-a24f-4afe-a974-aeb1288a1410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ac498b57-77b1-49f2-906d-b9d41dcccb7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e15bb5f6-a24f-4afe-a974-aeb1288a1410" xlink:to="loc_srt_MinimumMember_ac498b57-77b1-49f2-906d-b9d41dcccb7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a9172019-ca62-4e13-8613-d38ffc25a44c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e15bb5f6-a24f-4afe-a974-aeb1288a1410" xlink:to="loc_srt_MaximumMember_a9172019-ca62-4e13-8613-d38ffc25a44c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_2a2fba01-3cbf-433e-b08c-4025bc4d5a6c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e15bb5f6-a24f-4afe-a974-aeb1288a1410" xlink:to="loc_srt_WeightedAverageMember_2a2fba01-3cbf-433e-b08c-4025bc4d5a6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c2c900e-bab5-4c9f-a065-29c6412897fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c2c900e-bab5-4c9f-a065-29c6412897fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c2c900e-bab5-4c9f-a065-29c6412897fb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c2c900e-bab5-4c9f-a065-29c6412897fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c2c900e-bab5-4c9f-a065-29c6412897fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c88c6155-f686-4b9d-a388-b93b15baf7a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c2c900e-bab5-4c9f-a065-29c6412897fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c88c6155-f686-4b9d-a388-b93b15baf7a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c1c89a73-7491-4b83-9392-070004e4e1eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c88c6155-f686-4b9d-a388-b93b15baf7a5" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c1c89a73-7491-4b83-9392-070004e4e1eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_849a913a-2161-4129-9d57-0555f16b85ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c88c6155-f686-4b9d-a388-b93b15baf7a5" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_849a913a-2161-4129-9d57-0555f16b85ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f842ab53-9bf6-4999-ab27-cb795d9e2a15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f842ab53-9bf6-4999-ab27-cb795d9e2a15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f842ab53-9bf6-4999-ab27-cb795d9e2a15_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f842ab53-9bf6-4999-ab27-cb795d9e2a15" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f842ab53-9bf6-4999-ab27-cb795d9e2a15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cc236c30-6863-424a-8ef8-64bb7dadb860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f842ab53-9bf6-4999-ab27-cb795d9e2a15" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cc236c30-6863-424a-8ef8-64bb7dadb860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_2708d4cf-a1f4-40aa-8f09-43a0d178c3ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cc236c30-6863-424a-8ef8-64bb7dadb860" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_2708d4cf-a1f4-40aa-8f09-43a0d178c3ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_a730f91f-bda0-4267-9644-f5a672a70d80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cc236c30-6863-424a-8ef8-64bb7dadb860" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_a730f91f-bda0-4267-9644-f5a672a70d80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4b47e20b-8800-4ca0-b4a5-dfb959dd2a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4b47e20b-8800-4ca0-b4a5-dfb959dd2a6f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4b47e20b-8800-4ca0-b4a5-dfb959dd2a6f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4b47e20b-8800-4ca0-b4a5-dfb959dd2a6f" xlink:to="loc_us-gaap_SegmentDomain_4b47e20b-8800-4ca0-b4a5-dfb959dd2a6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd1a9b4c-303b-4423-b7a3-d3e80038a329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4b47e20b-8800-4ca0-b4a5-dfb959dd2a6f" xlink:to="loc_us-gaap_SegmentDomain_cd1a9b4c-303b-4423-b7a3-d3e80038a329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d9268bdc-b1f0-48fb-b97e-b8507d73371f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d9268bdc-b1f0-48fb-b97e-b8507d73371f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d9268bdc-b1f0-48fb-b97e-b8507d73371f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d9268bdc-b1f0-48fb-b97e-b8507d73371f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d9268bdc-b1f0-48fb-b97e-b8507d73371f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_15e28607-a6c8-47b2-a25a-13841cc04193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d9268bdc-b1f0-48fb-b97e-b8507d73371f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_15e28607-a6c8-47b2-a25a-13841cc04193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_28a89f2b-1c16-41a1-bee9-ab124d76adaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_15e28607-a6c8-47b2-a25a-13841cc04193" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_28a89f2b-1c16-41a1-bee9-ab124d76adaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a9f6197b-1eac-4ac1-aa32-214bc859fe25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a9f6197b-1eac-4ac1-aa32-214bc859fe25" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a9f6197b-1eac-4ac1-aa32-214bc859fe25_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a9f6197b-1eac-4ac1-aa32-214bc859fe25" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a9f6197b-1eac-4ac1-aa32-214bc859fe25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a3899f10-a393-4079-8d5f-25cd4a581f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a9f6197b-1eac-4ac1-aa32-214bc859fe25" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a3899f10-a393-4079-8d5f-25cd4a581f54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_a01629d4-d007-4ef8-bac1-74edfd3151c8" xlink:href="bsx-20210630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a3899f10-a393-4079-8d5f-25cd4a581f54" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_a01629d4-d007-4ef8-bac1-74edfd3151c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_758e18c3-3931-440d-8ce5-b4f3e9ed0a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_758e18c3-3931-440d-8ce5-b4f3e9ed0a9f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_758e18c3-3931-440d-8ce5-b4f3e9ed0a9f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_758e18c3-3931-440d-8ce5-b4f3e9ed0a9f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_758e18c3-3931-440d-8ce5-b4f3e9ed0a9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f47385c8-b038-4d20-ba0c-57824c0d0505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_758e18c3-3931-440d-8ce5-b4f3e9ed0a9f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f47385c8-b038-4d20-ba0c-57824c0d0505" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8c9a8803-de28-4d31-8830-1ad861837102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f47385c8-b038-4d20-ba0c-57824c0d0505" xlink:to="loc_us-gaap_SubsequentEventMember_8c9a8803-de28-4d31-8830-1ad861837102" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#ContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended" id="if2256fffbfe74485987270b986ef5371_ContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_a4b839b4-64b4-446d-8f34-8eee06404424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_a4b839b4-64b4-446d-8f34-8eee06404424" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b5f1ce51-5202-4aad-b7d2-537d5b2bb4d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b5f1ce51-5202-4aad-b7d2-537d5b2bb4d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_da4da3b0-534c-46f1-904d-9ac6ec719f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_da4da3b0-534c-46f1-904d-9ac6ec719f86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a00dfa8f-ec1c-42fb-8de7-b1d01571c3f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a00dfa8f-ec1c-42fb-8de7-b1d01571c3f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_16e204f4-0511-4e3e-ba9e-93d564243132" xlink:href="bsx-20210630.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:to="loc_bsx_PaymentOfContingentConsideration_16e204f4-0511-4e3e-ba9e-93d564243132" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_63a10c9c-c11e-4dc1-b69f-8431eb914d35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_89c55818-adaf-4738-8911-f930eba35713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_a4b839b4-64b4-446d-8f34-8eee06404424" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_89c55818-adaf-4738-8911-f930eba35713" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2d413cb3-8386-4e07-b847-fa18c2080f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_89c55818-adaf-4738-8911-f930eba35713" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2d413cb3-8386-4e07-b847-fa18c2080f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8612e309-6cd4-4909-846c-b1f59e3cd8b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_89c55818-adaf-4738-8911-f930eba35713" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8612e309-6cd4-4909-846c-b1f59e3cd8b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8a52fe92-2564-405b-9d98-a2c886487ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_553d6b51-9d30-4303-9417-be6a2977815e" xlink:href="bsx-20210630.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8612e309-6cd4-4909-846c-b1f59e3cd8b4" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_553d6b51-9d30-4303-9417-be6a2977815e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_62ba9fae-6bf2-418c-a42b-a65b3486b316" xlink:href="bsx-20210630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8612e309-6cd4-4909-846c-b1f59e3cd8b4" xlink:to="loc_bsx_DiscountRateFairValueInput_62ba9fae-6bf2-418c-a42b-a65b3486b316" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_1b42e63d-feb5-4381-8a4a-8480aa7d2c95" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_a4b839b4-64b4-446d-8f34-8eee06404424" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_1b42e63d-feb5-4381-8a4a-8480aa7d2c95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_a4b839b4-64b4-446d-8f34-8eee06404424" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5f054db6-a33c-417f-9d1b-4f406869702e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:to="loc_srt_RangeAxis_5f054db6-a33c-417f-9d1b-4f406869702e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5f054db6-a33c-417f-9d1b-4f406869702e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5f054db6-a33c-417f-9d1b-4f406869702e" xlink:to="loc_srt_RangeMember_5f054db6-a33c-417f-9d1b-4f406869702e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_da129bc8-d563-476b-acb8-bcfccb427099" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5f054db6-a33c-417f-9d1b-4f406869702e" xlink:to="loc_srt_RangeMember_da129bc8-d563-476b-acb8-bcfccb427099" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fd5a8b36-536d-48fe-8b7e-c8e20c22d7ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_da129bc8-d563-476b-acb8-bcfccb427099" xlink:to="loc_srt_MinimumMember_fd5a8b36-536d-48fe-8b7e-c8e20c22d7ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_db022b9d-59a7-4d07-a658-f6b468ec4ad0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_da129bc8-d563-476b-acb8-bcfccb427099" xlink:to="loc_srt_MaximumMember_db022b9d-59a7-4d07-a658-f6b468ec4ad0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_83e9ec43-d54b-404c-895a-0e65f696ab80" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_da129bc8-d563-476b-acb8-bcfccb427099" xlink:to="loc_srt_WeightedAverageMember_83e9ec43-d54b-404c-895a-0e65f696ab80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_d84ffa09-8da1-4b36-a74e-4a6da16a5de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:to="loc_us-gaap_ValuationTechniqueAxis_d84ffa09-8da1-4b36-a74e-4a6da16a5de1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_d84ffa09-8da1-4b36-a74e-4a6da16a5de1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_d84ffa09-8da1-4b36-a74e-4a6da16a5de1" xlink:to="loc_us-gaap_ValuationTechniqueDomain_d84ffa09-8da1-4b36-a74e-4a6da16a5de1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_8db5859e-0d2e-48d3-bb6c-cc184fd0b609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_d84ffa09-8da1-4b36-a74e-4a6da16a5de1" xlink:to="loc_us-gaap_ValuationTechniqueDomain_8db5859e-0d2e-48d3-bb6c-cc184fd0b609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_6e1d4262-3ffb-4b83-af0c-44b26715d363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_8db5859e-0d2e-48d3-bb6c-cc184fd0b609" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_6e1d4262-3ffb-4b83-af0c-44b26715d363" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7262efe7-1b6f-44ec-955a-75491714d5e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7262efe7-1b6f-44ec-955a-75491714d5e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7262efe7-1b6f-44ec-955a-75491714d5e9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7262efe7-1b6f-44ec-955a-75491714d5e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7262efe7-1b6f-44ec-955a-75491714d5e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dcb27828-0f99-44c2-85c2-4c483fe0ae52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7262efe7-1b6f-44ec-955a-75491714d5e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dcb27828-0f99-44c2-85c2-4c483fe0ae52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_7376c259-83dc-44e6-b4a1-367f7bd60583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_7376c259-83dc-44e6-b4a1-367f7bd60583" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_7376c259-83dc-44e6-b4a1-367f7bd60583_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_7376c259-83dc-44e6-b4a1-367f7bd60583" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_7376c259-83dc-44e6-b4a1-367f7bd60583_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_73688df4-60af-473b-b159-db00cd08adea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_7376c259-83dc-44e6-b4a1-367f7bd60583" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_73688df4-60af-473b-b159-db00cd08adea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_4be57a82-8cc1-4e05-935c-ebac78b45a8a" xlink:href="bsx-20210630.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_73688df4-60af-473b-b159-db00cd08adea" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_4be57a82-8cc1-4e05-935c-ebac78b45a8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_74101217-75ab-43c4-85d1-8eb69807063c" xlink:href="bsx-20210630.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_73688df4-60af-473b-b159-db00cd08adea" xlink:to="loc_bsx_RevenueBasedPaymentsMember_74101217-75ab-43c4-85d1-8eb69807063c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2d7547aa-dbe2-44f2-8ad7-d3b8b1a94f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2d7547aa-dbe2-44f2-8ad7-d3b8b1a94f6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2d7547aa-dbe2-44f2-8ad7-d3b8b1a94f6b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2d7547aa-dbe2-44f2-8ad7-d3b8b1a94f6b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2d7547aa-dbe2-44f2-8ad7-d3b8b1a94f6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5203e242-d2a0-4e0b-8fd4-f49a1fdc70f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2d7547aa-dbe2-44f2-8ad7-d3b8b1a94f6b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5203e242-d2a0-4e0b-8fd4-f49a1fdc70f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c559ba12-7998-4b4a-9a6d-10db98c5ded7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5203e242-d2a0-4e0b-8fd4-f49a1fdc70f6" xlink:to="loc_us-gaap_SubsequentEventMember_c559ba12-7998-4b4a-9a6d-10db98c5ded7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#StrategicInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended" id="i2cd462b673a2438ba1c05e7bcd6dca7e_StrategicInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ea270b80-5eee-4c43-a9b7-7424ab30c197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_EquityMethodInvestments_ea270b80-5eee-4c43-a9b7-7424ab30c197" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d2d7db2a-d5ff-47e3-9d5b-fc315b767d7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d2d7db2a-d5ff-47e3-9d5b-fc315b767d7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_822e4679-c0a4-46ce-8599-654efbeec790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_822e4679-c0a4-46ce-8599-654efbeec790" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f4ea3ce6-d890-474e-9705-4a43291adc6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f4ea3ce6-d890-474e-9705-4a43291adc6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e8add88d-7f20-4ecc-b5c9-b84c273e025c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_Investments_e8add88d-7f20-4ecc-b5c9-b84c273e025c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_48b697ba-c19d-45c5-93c0-01141c0f03cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_48b697ba-c19d-45c5-93c0-01141c0f03cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_070f7c2a-f5dd-47ee-be67-d9748926f205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_070f7c2a-f5dd-47ee-be67-d9748926f205" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_2dd2dc70-6b24-4172-9a18-746a148680b1" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_2dd2dc70-6b24-4172-9a18-746a148680b1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_5fd72769-3803-4c55-880c-1b1e4e9a9ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_5fd72769-3803-4c55-880c-1b1e4e9a9ab9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6bd444b4-df87-4312-bc51-3ae6e0b167c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_5fd72769-3803-4c55-880c-1b1e4e9a9ab9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6bd444b4-df87-4312-bc51-3ae6e0b167c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6bd444b4-df87-4312-bc51-3ae6e0b167c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6bd444b4-df87-4312-bc51-3ae6e0b167c8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6bd444b4-df87-4312-bc51-3ae6e0b167c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f3f1e542-0ebd-43c1-9b29-0b571b8ca681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6bd444b4-df87-4312-bc51-3ae6e0b167c8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f3f1e542-0ebd-43c1-9b29-0b571b8ca681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_adbb3206-28cd-49a1-a898-0bd9d1f86f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f3f1e542-0ebd-43c1-9b29-0b571b8ca681" xlink:to="loc_us-gaap_SubsequentEventMember_adbb3206-28cd-49a1-a898-0bd9d1f86f21" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended" id="ie24dcdabf4d54698a1fd35fabb1ddbe8_GoodwillandOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:href="bsx-20210630.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_affe6ffe-3d09-4c71-a06d-ab69d5c7edd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_affe6ffe-3d09-4c71-a06d-ab69d5c7edd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6528d3b7-5ed1-46a0-b343-c09012c68a91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6528d3b7-5ed1-46a0-b343-c09012c68a91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_6dcbdfff-9e5a-49c0-81b1-785fac23554b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_GoodwillGross_6dcbdfff-9e5a-49c0-81b1-785fac23554b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4d883961-83aa-47c7-b2f3-7602247bf01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4d883961-83aa-47c7-b2f3-7602247bf01c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ceee2282-474a-4404-ba1c-1bdaf87da25e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ceee2282-474a-4404-ba1c-1bdaf87da25e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_26db6142-2d18-447b-b472-237db501333b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_26db6142-2d18-447b-b472-237db501333b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_003cf006-7871-4409-873f-9f4b8c884f82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_GoodwillRollForward_003cf006-7871-4409-873f-9f4b8c884f82" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5cf31998-6ce5-47de-821a-006dfcea39e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_003cf006-7871-4409-873f-9f4b8c884f82" xlink:to="loc_us-gaap_Goodwill_5cf31998-6ce5-47de-821a-006dfcea39e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_883806ee-0a43-40ce-8404-f6a55608c385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_003cf006-7871-4409-873f-9f4b8c884f82" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_883806ee-0a43-40ce-8404-f6a55608c385" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_dc862eef-f593-43b5-8161-c5c8d3e643ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_003cf006-7871-4409-873f-9f4b8c884f82" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_dc862eef-f593-43b5-8161-c5c8d3e643ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fd1c0c1e-c234-4371-9f12-7e6b9761377f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_36bbc481-c135-4c2d-9763-31dba40353a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_36bbc481-c135-4c2d-9763-31dba40353a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6123228f-0eb0-4926-bfe1-cf8c34f5727c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6123228f-0eb0-4926-bfe1-cf8c34f5727c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_5ea8b560-9321-4957-9c13-db8100f4f92d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_5ea8b560-9321-4957-9c13-db8100f4f92d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_dd7be080-1f49-446a-9875-0443ccc525bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_dd7be080-1f49-446a-9875-0443ccc525bd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_830b5bfc-d685-4812-807b-ab25798ed135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_830b5bfc-d685-4812-807b-ab25798ed135" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_a0bf41c0-4d5b-4b8e-b153-0d0a80cc32d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_a0bf41c0-4d5b-4b8e-b153-0d0a80cc32d1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_fcddbac3-1c4a-4fdd-9d14-911b578a8559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_fcddbac3-1c4a-4fdd-9d14-911b578a8559" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ffc427a1-7f28-47c8-9f93-6323fc7e1b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ffc427a1-7f28-47c8-9f93-6323fc7e1b24" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_284dedeb-acf9-440e-a98f-b10f32d014fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_284dedeb-acf9-440e-a98f-b10f32d014fb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_f9299f2a-ee17-496a-9137-fbe990b5afd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_f9299f2a-ee17-496a-9137-fbe990b5afd4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b505d966-fc35-4078-be0d-5d20e6745b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b505d966-fc35-4078-be0d-5d20e6745b37" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_65b71c80-8e2d-4f40-889c-223d9ddbca81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_InterestExpense_65b71c80-8e2d-4f40-889c-223d9ddbca81" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_e76dc656-f84d-4235-b4ae-7dad83443f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_e76dc656-f84d-4235-b4ae-7dad83443f9c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_d8ce1bfa-8950-4709-8f6d-8428148999c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_d8ce1bfa-8950-4709-8f6d-8428148999c4" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_f611a144-e32d-4527-bf3c-ddac49e43da7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_f611a144-e32d-4527-bf3c-ddac49e43da7" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_b05915b6-ba63-4f70-b415-53a56b3b1243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_b05915b6-ba63-4f70-b415-53a56b3b1243" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_f490a800-9593-43e5-b192-260d4846ffbc" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_f490a800-9593-43e5-b192-260d4846ffbc" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:href="bsx-20210630.xsd#bsx_ScheduleofIntangibleAssetsandGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsAxis_038d3b76-003c-493c-b0ca-9aa66f022b47" xlink:href="bsx-20210630.xsd#bsx_IntangibleAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_bsx_IntangibleAssetsAxis_038d3b76-003c-493c-b0ca-9aa66f022b47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsDomain_038d3b76-003c-493c-b0ca-9aa66f022b47_default" xlink:href="bsx-20210630.xsd#bsx_IntangibleAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_IntangibleAssetsAxis_038d3b76-003c-493c-b0ca-9aa66f022b47" xlink:to="loc_bsx_IntangibleAssetsDomain_038d3b76-003c-493c-b0ca-9aa66f022b47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsDomain_6eef8f69-467b-43ae-97fa-04e94548ffdb" xlink:href="bsx-20210630.xsd#bsx_IntangibleAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_IntangibleAssetsAxis_038d3b76-003c-493c-b0ca-9aa66f022b47" xlink:to="loc_bsx_IntangibleAssetsDomain_6eef8f69-467b-43ae-97fa-04e94548ffdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_edf50cc8-b341-46d6-9b20-39eda7e826e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_edf50cc8-b341-46d6-9b20-39eda7e826e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_edf50cc8-b341-46d6-9b20-39eda7e826e4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_edf50cc8-b341-46d6-9b20-39eda7e826e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_edf50cc8-b341-46d6-9b20-39eda7e826e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b622dedc-f156-4201-839d-ff8f89a22239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_edf50cc8-b341-46d6-9b20-39eda7e826e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b622dedc-f156-4201-839d-ff8f89a22239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4ba9abdf-4b0b-43a1-b9bd-5cd6b3c0b161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b622dedc-f156-4201-839d-ff8f89a22239" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4ba9abdf-4b0b-43a1-b9bd-5cd6b3c0b161" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_ea34f598-35e1-4249-b434-ed95d56413c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b622dedc-f156-4201-839d-ff8f89a22239" xlink:to="loc_us-gaap_PatentsMember_ea34f598-35e1-4249-b434-ed95d56413c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_04f5704e-0739-45b0-80b0-44347e5a7bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b622dedc-f156-4201-839d-ff8f89a22239" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_04f5704e-0739-45b0-80b0-44347e5a7bdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c10bd1a5-f189-4aec-9cb7-f03ffd40eaeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c10bd1a5-f189-4aec-9cb7-f03ffd40eaeb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c10bd1a5-f189-4aec-9cb7-f03ffd40eaeb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c10bd1a5-f189-4aec-9cb7-f03ffd40eaeb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c10bd1a5-f189-4aec-9cb7-f03ffd40eaeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_51df81cc-44da-4f9f-9115-12e97fccbe28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c10bd1a5-f189-4aec-9cb7-f03ffd40eaeb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_51df81cc-44da-4f9f-9115-12e97fccbe28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_851a4beb-e8c6-4a5e-96a9-8c12625abeff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_51df81cc-44da-4f9f-9115-12e97fccbe28" xlink:to="loc_us-gaap_GoodwillMember_851a4beb-e8c6-4a5e-96a9-8c12625abeff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1ab43daf-30a1-47e0-b4d7-e01598bd58e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_51df81cc-44da-4f9f-9115-12e97fccbe28" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1ab43daf-30a1-47e0-b4d7-e01598bd58e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_54774074-5def-41f5-962a-e786c8529930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_51df81cc-44da-4f9f-9115-12e97fccbe28" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_54774074-5def-41f5-962a-e786c8529930" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4a58640e-d3e0-46dc-89ad-9d5ac98ec683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4a58640e-d3e0-46dc-89ad-9d5ac98ec683" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4a58640e-d3e0-46dc-89ad-9d5ac98ec683_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a58640e-d3e0-46dc-89ad-9d5ac98ec683" xlink:to="loc_us-gaap_SegmentDomain_4a58640e-d3e0-46dc-89ad-9d5ac98ec683_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a58640e-d3e0-46dc-89ad-9d5ac98ec683" xlink:to="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_4df8c5a2-6a32-4799-ac19-c94aa1344fc7" xlink:href="bsx-20210630.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:to="loc_bsx_MedsurgMember_4df8c5a2-6a32-4799-ac19-c94aa1344fc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_6d22d7c8-bbb3-45b2-8e3c-62c766f124a8" xlink:href="bsx-20210630.xsd#bsx_RhythmandNeuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:to="loc_bsx_RhythmandNeuroMember_6d22d7c8-bbb3-45b2-8e3c-62c766f124a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_b22ebc5f-99e9-4020-9736-66acd32a8c2b" xlink:href="bsx-20210630.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:to="loc_bsx_CardiovascularMember_b22ebc5f-99e9-4020-9736-66acd32a8c2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_d78f29db-3a93-4232-9bf8-e2983f9209a0" xlink:href="bsx-20210630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_d78f29db-3a93-4232-9bf8-e2983f9209a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0e731150-df2d-49bc-9ea5-3b55580f2a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0e731150-df2d-49bc-9ea5-3b55580f2a35" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0e731150-df2d-49bc-9ea5-3b55580f2a35_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0e731150-df2d-49bc-9ea5-3b55580f2a35" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0e731150-df2d-49bc-9ea5-3b55580f2a35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6ce3fb6d-4845-449f-a6c5-7ed63599853b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0e731150-df2d-49bc-9ea5-3b55580f2a35" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6ce3fb6d-4845-449f-a6c5-7ed63599853b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ce24272d-d1cd-4f6f-857c-e8702b7d0d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6ce3fb6d-4845-449f-a6c5-7ed63599853b" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ce24272d-d1cd-4f6f-857c-e8702b7d0d9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember_22ed7451-776e-4d1f-8d95-85a232eda423" xlink:href="bsx-20210630.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6ce3fb6d-4845-449f-a6c5-7ed63599853b" xlink:to="loc_bsx_ForeigncurrencydenominatedindebtMember_22ed7451-776e-4d1f-8d95-85a232eda423" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_8cc2bdb9-ca4d-43b2-8560-c20260e64cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6ce3fb6d-4845-449f-a6c5-7ed63599853b" xlink:to="loc_us-gaap_InterestRateContractMember_8cc2bdb9-ca4d-43b2-8560-c20260e64cc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_83180526-0dea-4b22-973a-4d9825d0ab7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_83180526-0dea-4b22-973a-4d9825d0ab7b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_83180526-0dea-4b22-973a-4d9825d0ab7b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_83180526-0dea-4b22-973a-4d9825d0ab7b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_83180526-0dea-4b22-973a-4d9825d0ab7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0866a0fb-516a-4f13-907f-7ec681985e86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_83180526-0dea-4b22-973a-4d9825d0ab7b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0866a0fb-516a-4f13-907f-7ec681985e86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1ef774e1-4860-4961-8f5d-34803284c648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0866a0fb-516a-4f13-907f-7ec681985e86" xlink:to="loc_us-gaap_CashFlowHedgingMember_1ef774e1-4860-4961-8f5d-34803284c648" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5443b67c-665c-4c64-999c-a4c8d3849e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0866a0fb-516a-4f13-907f-7ec681985e86" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5443b67c-665c-4c64-999c-a4c8d3849e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7b0404c8-f19a-421e-bfd3-2773025d850f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_HedgingDesignationAxis_7b0404c8-f19a-421e-bfd3-2773025d850f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7b0404c8-f19a-421e-bfd3-2773025d850f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7b0404c8-f19a-421e-bfd3-2773025d850f" xlink:to="loc_us-gaap_HedgingDesignationDomain_7b0404c8-f19a-421e-bfd3-2773025d850f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_94659ce3-7fc4-4bfa-8c67-d35b5232f683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7b0404c8-f19a-421e-bfd3-2773025d850f" xlink:to="loc_us-gaap_HedgingDesignationDomain_94659ce3-7fc4-4bfa-8c67-d35b5232f683" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0217a070-abed-4592-b810-c6f4d55287e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_94659ce3-7fc4-4bfa-8c67-d35b5232f683" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0217a070-abed-4592-b810-c6f4d55287e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c33cabdd-872d-472d-8195-c1c6bca57683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c33cabdd-872d-472d-8195-c1c6bca57683" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c33cabdd-872d-472d-8195-c1c6bca57683_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c33cabdd-872d-472d-8195-c1c6bca57683" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c33cabdd-872d-472d-8195-c1c6bca57683_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_781571c1-a5ab-404c-86c8-d2f1bd192f1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c33cabdd-872d-472d-8195-c1c6bca57683" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_781571c1-a5ab-404c-86c8-d2f1bd192f1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_15160d0b-2b7f-4a61-9a2f-6cdb6f7deb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_781571c1-a5ab-404c-86c8-d2f1bd192f1f" xlink:to="loc_us-gaap_CostOfSalesMember_15160d0b-2b7f-4a61-9a2f-6cdb6f7deb38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d596ca38-3374-448c-bc5e-9dced0c23910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_781571c1-a5ab-404c-86c8-d2f1bd192f1f" xlink:to="loc_us-gaap_InterestExpenseMember_d596ca38-3374-448c-bc5e-9dced0c23910" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended" id="i29f125a8215143abbb2a9887d8d82f5a_HedgingActivitiesandFairValueMeasurementsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_bc384333-e96b-42c1-aa25-04b7c923b558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_bc384333-e96b-42c1-aa25-04b7c923b558" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_daee26f3-b946-4296-9911-158138fe1f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_daee26f3-b946-4296-9911-158138fe1f05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_4c4ddb6e-e3d2-4f21-8f39-333398838d96" xlink:href="bsx-20210630.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_4c4ddb6e-e3d2-4f21-8f39-333398838d96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_6979e601-b561-400e-9fb0-ad02192b2df6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_6979e601-b561-400e-9fb0-ad02192b2df6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5bb57f7e-7a9f-452a-b4fe-f920415e9227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5bb57f7e-7a9f-452a-b4fe-f920415e9227" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_a9b0226a-0ca9-4de3-98de-9091d37db114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:to="loc_us-gaap_DerivativeTable_a9b0226a-0ca9-4de3-98de-9091d37db114" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9d386aac-03cf-4ed3-ad9f-a1e9805c52ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a9b0226a-0ca9-4de3-98de-9091d37db114" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9d386aac-03cf-4ed3-ad9f-a1e9805c52ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9d386aac-03cf-4ed3-ad9f-a1e9805c52ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9d386aac-03cf-4ed3-ad9f-a1e9805c52ac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9d386aac-03cf-4ed3-ad9f-a1e9805c52ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_acefa609-083f-4579-a998-a7853265b177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9d386aac-03cf-4ed3-ad9f-a1e9805c52ac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_acefa609-083f-4579-a998-a7853265b177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c13ce9f8-63dd-4f89-99ec-c296f112ce60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_48a8273c-3b00-447e-b2b3-c570c0c94e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c13ce9f8-63dd-4f89-99ec-c296f112ce60" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_48a8273c-3b00-447e-b2b3-c570c0c94e33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84049df6-8697-4154-90eb-cbe03930fb58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c13ce9f8-63dd-4f89-99ec-c296f112ce60" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84049df6-8697-4154-90eb-cbe03930fb58" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_759b9923-6732-40e5-afb1-51ffbaf2cfa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84049df6-8697-4154-90eb-cbe03930fb58" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_759b9923-6732-40e5-afb1-51ffbaf2cfa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_759b9923-6732-40e5-afb1-51ffbaf2cfa3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_759b9923-6732-40e5-afb1-51ffbaf2cfa3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_759b9923-6732-40e5-afb1-51ffbaf2cfa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d836aa90-9b8b-4870-9f38-1d9477213cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_759b9923-6732-40e5-afb1-51ffbaf2cfa3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d836aa90-9b8b-4870-9f38-1d9477213cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83b77747-ffba-4a5e-b4a6-611a773daa05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84049df6-8697-4154-90eb-cbe03930fb58" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83b77747-ffba-4a5e-b4a6-611a773daa05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_83b77747-ffba-4a5e-b4a6-611a773daa05_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83b77747-ffba-4a5e-b4a6-611a773daa05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_83b77747-ffba-4a5e-b4a6-611a773daa05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a1413602-ae41-4def-bf3f-4fe73e770814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83b77747-ffba-4a5e-b4a6-611a773daa05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a1413602-ae41-4def-bf3f-4fe73e770814" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#HedgingActivitiesandFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="extended" id="i233de507c38045b5991054f36fd6ca60_HedgingActivitiesandFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_fab56ab4-f655-4665-97a8-842617d32c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_LongTermDebt_fab56ab4-f655-4665-97a8-842617d32c62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a97c4693-b8e6-43f8-aabe-6d6b6ff3637b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a97c4693-b8e6-43f8-aabe-6d6b6ff3637b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_2f4d6736-2a27-46ae-b865-966c7e9a519c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeTermOfContract_2f4d6736-2a27-46ae-b865-966c7e9a519c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_5fe6ff24-9a3b-4c8d-9d42-c8ad973ad39a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_5fe6ff24-9a3b-4c8d-9d42-c8ad973ad39a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_04fd6995-faaa-4c4f-bb86-701660c20c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_04fd6995-faaa-4c4f-bb86-701660c20c5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f174831d-96b8-4135-8a59-b773eec247d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f174831d-96b8-4135-8a59-b773eec247d6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_0fd621c9-2e0c-4fda-a84b-f04ce3d493d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_0fd621c9-2e0c-4fda-a84b-f04ce3d493d7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_e41ef2fb-23fc-470e-a23c-2c2dddc26db4" xlink:href="bsx-20210630.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_e41ef2fb-23fc-470e-a23c-2c2dddc26db4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1_214e418c-8f17-406d-ba91-8732299ef5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeRemainingMaturity1_214e418c-8f17-406d-ba91-8732299ef5ee" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_76482740-d7b1-4b05-ad2d-334dfc6a71ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_76482740-d7b1-4b05-ad2d-334dfc6a71ed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_fd822de4-f7a6-4ff3-b5a3-c51f613f20fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_fd822de4-f7a6-4ff3-b5a3-c51f613f20fa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_768fa5ed-dbf6-4034-b70a-4edc4b26a7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_768fa5ed-dbf6-4034-b70a-4edc4b26a7b5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_fda3b9fe-3364-4f63-bf43-3e77e4d4df00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_fda3b9fe-3364-4f63-bf43-3e77e4d4df00" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_429a8106-0109-4c5a-af66-103d27f7fbb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_429a8106-0109-4c5a-af66-103d27f7fbb4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_c03a555b-7066-499c-9756-6bc8b5a3f9c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_c03a555b-7066-499c-9756-6bc8b5a3f9c9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_14119d43-b848-4bc0-a5bc-ebc8ca2c8181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_14119d43-b848-4bc0-a5bc-ebc8ca2c8181" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_6d836b39-2ef1-47a3-a5f9-786dad43e3a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_6d836b39-2ef1-47a3-a5f9-786dad43e3a1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_8a1c2559-62c6-487f-a0ff-0c948ad02775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_8a1c2559-62c6-487f-a0ff-0c948ad02775" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_80ffd9c9-d104-4e79-acc8-2d8f05d5f637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_80ffd9c9-d104-4e79-acc8-2d8f05d5f637" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e318a0d9-b8a8-4bff-b6d6-bdb4ca0d7ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_InterestExpense_e318a0d9-b8a8-4bff-b6d6-bdb4ca0d7ef2" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_90c7845e-376c-4476-91b4-36cc8e182175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_90c7845e-376c-4476-91b4-36cc8e182175" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_ac07012b-2253-47e3-bef3-cb732a97ea3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_ac07012b-2253-47e3-bef3-cb732a97ea3b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_98b5309b-ccad-4ecc-a233-41dff56083cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_98b5309b-ccad-4ecc-a233-41dff56083cf" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_8436e7c0-db0a-4388-8be8-e99fd567c25c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_8436e7c0-db0a-4388-8be8-e99fd567c25c" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_4ed3caec-c763-4da2-8241-26992e44af5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_4ed3caec-c763-4da2-8241-26992e44af5c" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_c43101b4-05d4-4440-810e-bca615ec0de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_c43101b4-05d4-4440-810e-bca615ec0de1" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_790aff87-c545-4151-96fc-4f12a9f01287" xlink:href="bsx-20210630.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_790aff87-c545-4151-96fc-4f12a9f01287" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_6bf8cb2d-305d-46bb-aa5f-be608143da59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_6bf8cb2d-305d-46bb-aa5f-be608143da59" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0232af80-2fa5-43d8-9b38-af8444fc7665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0232af80-2fa5-43d8-9b38-af8444fc7665" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss_7d8c27af-8df9-415f-807f-8d40b9259662" xlink:href="bsx-20210630.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_bsx_Netcurrencyexchangegainloss_7d8c27af-8df9-415f-807f-8d40b9259662" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_81f92a56-8749-48dd-9c5c-ab3128e29c28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_81f92a56-8749-48dd-9c5c-ab3128e29c28" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_8416c521-5e07-4543-93cf-b4e153c42bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_8416c521-5e07-4543-93cf-b4e153c42bc1" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_970a76ce-0b77-4b4d-8076-d8c380032ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_970a76ce-0b77-4b4d-8076-d8c380032ac6" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_0635dba1-1cd7-4d18-9f8e-6ad678c9160c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_0635dba1-1cd7-4d18-9f8e-6ad678c9160c" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_ef84cd29-e1f9-4c7f-baa7-397f325199fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_ef84cd29-e1f9-4c7f-baa7-397f325199fa" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0f9643b3-705e-4fe7-b762-e5db6ca1690c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0f9643b3-705e-4fe7-b762-e5db6ca1690c" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c357ad3c-975e-4ce8-b7fc-f7c236f085d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c357ad3c-975e-4ce8-b7fc-f7c236f085d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c357ad3c-975e-4ce8-b7fc-f7c236f085d7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c357ad3c-975e-4ce8-b7fc-f7c236f085d7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c357ad3c-975e-4ce8-b7fc-f7c236f085d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_da2395c5-6818-4127-b1b2-b30e1bc3ed45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c357ad3c-975e-4ce8-b7fc-f7c236f085d7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_da2395c5-6818-4127-b1b2-b30e1bc3ed45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_82aabe2d-8846-46c4-b0c6-315e41fa7b52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_da2395c5-6818-4127-b1b2-b30e1bc3ed45" xlink:to="loc_us-gaap_CashFlowHedgingMember_82aabe2d-8846-46c4-b0c6-315e41fa7b52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c36fdac2-60c1-4999-b355-3238102b4263" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_da2395c5-6818-4127-b1b2-b30e1bc3ed45" xlink:to="loc_us-gaap_FairValueHedgingMember_c36fdac2-60c1-4999-b355-3238102b4263" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_55f44d1d-d1b3-4a58-89f6-d220af1f2ea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_da2395c5-6818-4127-b1b2-b30e1bc3ed45" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_55f44d1d-d1b3-4a58-89f6-d220af1f2ea1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_64d3792a-cbaf-4d1f-ac0a-a6551e28678e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_HedgingDesignationAxis_64d3792a-cbaf-4d1f-ac0a-a6551e28678e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_64d3792a-cbaf-4d1f-ac0a-a6551e28678e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_64d3792a-cbaf-4d1f-ac0a-a6551e28678e" xlink:to="loc_us-gaap_HedgingDesignationDomain_64d3792a-cbaf-4d1f-ac0a-a6551e28678e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_be4f2c15-39d4-415d-b07d-e43e0cabbe04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_64d3792a-cbaf-4d1f-ac0a-a6551e28678e" xlink:to="loc_us-gaap_HedgingDesignationDomain_be4f2c15-39d4-415d-b07d-e43e0cabbe04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_54dfc049-cd08-4dcb-ad52-1ec0da737366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_be4f2c15-39d4-415d-b07d-e43e0cabbe04" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_54dfc049-cd08-4dcb-ad52-1ec0da737366" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d2eaa939-4049-48df-b1fd-fd6f6d8dc046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_be4f2c15-39d4-415d-b07d-e43e0cabbe04" xlink:to="loc_us-gaap_NondesignatedMember_d2eaa939-4049-48df-b1fd-fd6f6d8dc046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ed1ac7d8-2234-4b03-852f-50704264c2bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ed1ac7d8-2234-4b03-852f-50704264c2bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ed1ac7d8-2234-4b03-852f-50704264c2bd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ed1ac7d8-2234-4b03-852f-50704264c2bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ed1ac7d8-2234-4b03-852f-50704264c2bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ed1ac7d8-2234-4b03-852f-50704264c2bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_970f9abf-a6db-4b49-9635-8e214df8deb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_970f9abf-a6db-4b49-9635-8e214df8deb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_14a444cf-c25b-43f9-83b0-1d16076c8ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:to="loc_us-gaap_ForeignExchangeContractMember_14a444cf-c25b-43f9-83b0-1d16076c8ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember_d94d8455-b9c6-4dd8-99f7-dca970ab9ea3" xlink:href="bsx-20210630.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:to="loc_bsx_ForeigncurrencydenominatedindebtMember_d94d8455-b9c6-4dd8-99f7-dca970ab9ea3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_5d2c602a-1ed6-4ba1-833e-d9d724cb9ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:to="loc_us-gaap_InterestRateContractMember_5d2c602a-1ed6-4ba1-833e-d9d724cb9ba9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_00338f02-84fe-403b-b980-56672404adca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_00338f02-84fe-403b-b980-56672404adca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_47a936a7-af95-4f5a-94c3-b6f5875b7bcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_47a936a7-af95-4f5a-94c3-b6f5875b7bcb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_47a936a7-af95-4f5a-94c3-b6f5875b7bcb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_47a936a7-af95-4f5a-94c3-b6f5875b7bcb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_47a936a7-af95-4f5a-94c3-b6f5875b7bcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_47a936a7-af95-4f5a-94c3-b6f5875b7bcb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a72f1c58-e861-48f0-8db0-af9acb816b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a72f1c58-e861-48f0-8db0-af9acb816b0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_44e3a441-ac10-40c0-a961-01b9be0b61ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_44e3a441-ac10-40c0-a961-01b9be0b61ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_fe384665-8378-4d62-93e9-137a1674b4b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_fe384665-8378-4d62-93e9-137a1674b4b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7fb8ea92-2b5c-4b50-af41-dc04cd7a6161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7fb8ea92-2b5c-4b50-af41-dc04cd7a6161" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2c346a12-3671-4f21-bb10-22db36af8e27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2c346a12-3671-4f21-bb10-22db36af8e27" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2c346a12-3671-4f21-bb10-22db36af8e27_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2c346a12-3671-4f21-bb10-22db36af8e27" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2c346a12-3671-4f21-bb10-22db36af8e27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b3e68967-5c18-45ef-9328-ee38f0d78247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2c346a12-3671-4f21-bb10-22db36af8e27" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b3e68967-5c18-45ef-9328-ee38f0d78247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_ec3f99ad-38dc-4958-a0ec-7bb4939e1bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b3e68967-5c18-45ef-9328-ee38f0d78247" xlink:to="loc_us-gaap_CostOfSalesMember_ec3f99ad-38dc-4958-a0ec-7bb4939e1bb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_fc37e227-253d-484f-932c-fe9e42ee1ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b3e68967-5c18-45ef-9328-ee38f0d78247" xlink:to="loc_us-gaap_InterestExpenseMember_fc37e227-253d-484f-932c-fe9e42ee1ba8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_032a9190-b0f0-4b5e-80ba-97b4637772db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b3e68967-5c18-45ef-9328-ee38f0d78247" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_032a9190-b0f0-4b5e-80ba-97b4637772db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cc9d5498-ce4d-4a5c-8072-8be8b594a861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cc9d5498-ce4d-4a5c-8072-8be8b594a861" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cc9d5498-ce4d-4a5c-8072-8be8b594a861_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cc9d5498-ce4d-4a5c-8072-8be8b594a861" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cc9d5498-ce4d-4a5c-8072-8be8b594a861_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_19a7a697-84e8-4b5a-aa68-5ee78cd35cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cc9d5498-ce4d-4a5c-8072-8be8b594a861" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_19a7a697-84e8-4b5a-aa68-5ee78cd35cc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_2b363741-f9d4-4f43-ae2e-84da7cca6f0a" xlink:href="bsx-20210630.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_19a7a697-84e8-4b5a-aa68-5ee78cd35cc5" xlink:to="loc_bsx_December2027NotesMember_2b363741-f9d4-4f43-ae2e-84da7cca6f0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_76ea4af4-8d32-4f39-8f0b-71b7fc887c6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_76ea4af4-8d32-4f39-8f0b-71b7fc887c6c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_76ea4af4-8d32-4f39-8f0b-71b7fc887c6c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_76ea4af4-8d32-4f39-8f0b-71b7fc887c6c" xlink:to="loc_us-gaap_EquityComponentDomain_76ea4af4-8d32-4f39-8f0b-71b7fc887c6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a34a63af-443e-4004-9f43-d3d08de1a020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_76ea4af4-8d32-4f39-8f0b-71b7fc887c6c" xlink:to="loc_us-gaap_EquityComponentDomain_a34a63af-443e-4004-9f43-d3d08de1a020" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_43315d29-35bb-45c7-a3f0-88714555a734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a34a63af-443e-4004-9f43-d3d08de1a020" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_43315d29-35bb-45c7-a3f0-88714555a734" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_4664dbee-c36a-45ac-b88c-a87bac3426d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_4664dbee-c36a-45ac-b88c-a87bac3426d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_b934cb63-3489-4e70-a699-4ece1bbc605e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_b934cb63-3489-4e70-a699-4ece1bbc605e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_fb8c17b9-2cc3-498d-b826-1344d5f82228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_DerivativeAssets_fb8c17b9-2cc3-498d-b826-1344d5f82228" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_97d38503-a812-4a00-a51c-17235e04fadc" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangementsasset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_Licensingarrangementsasset_97d38503-a812-4a00-a51c-17235e04fadc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b8a62755-2759-43c7-b46e-acc7fa220884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b8a62755-2759-43c7-b46e-acc7fa220884" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_2481aff9-531f-4a7f-80c8-569e18f6b959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_DerivativeLiabilities_2481aff9-531f-4a7f-80c8-569e18f6b959" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0acf7c54-eee0-4825-a66d-defd7c9f6aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0acf7c54-eee0-4825-a66d-defd7c9f6aa9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_48214024-751b-4805-a97b-7324012763ae" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangementsliability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_Licensingarrangementsliability_48214024-751b-4805-a97b-7324012763ae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_46328c38-5c0c-4ab7-9bf9-7b769762aa0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_46328c38-5c0c-4ab7-9bf9-7b769762aa0f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_b6b3ec6e-0562-4fb2-8ab4-c400dee61ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_Cash_b6b3ec6e-0562-4fb2-8ab4-c400dee61ce9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments_98550350-1ee2-44a8-b22a-c8d614729ef6" xlink:href="bsx-20210630.xsd#bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments_98550350-1ee2-44a8-b22a-c8d614729ef6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold_185b5317-d1fc-447b-a882-c56032b6f3b0" xlink:href="bsx-20210630.xsd#bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold_185b5317-d1fc-447b-a882-c56032b6f3b0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_6b6c9500-ef34-4986-8b9e-f4ae3c1d248a" xlink:href="bsx-20210630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_DiscountRateFairValueInput_6b6c9500-ef34-4986-8b9e-f4ae3c1d248a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_4bfb9551-6bbb-4f57-b592-982d882ef2af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_4bfb9551-6bbb-4f57-b592-982d882ef2af" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_d53b9c76-a2c0-4766-b423-e95938bff226" xlink:href="bsx-20210630.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_d53b9c76-a2c0-4766-b423-e95938bff226" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_482d2409-cf6d-4453-9f1c-7f4863090ad0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_PaymentsForRoyalties_482d2409-cf6d-4453-9f1c-7f4863090ad0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_7fbcf575-d15a-49f2-b428-d6c303e46987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_7fbcf575-d15a-49f2-b428-d6c303e46987" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_3de39925-c64d-459b-8b52-2c35687f0cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_DebtInstrumentFairValue_3de39925-c64d-459b-8b52-2c35687f0cba" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_caf57162-0f4a-4adc-86f8-0325c3ec28a9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:to="loc_srt_RangeAxis_caf57162-0f4a-4adc-86f8-0325c3ec28a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_caf57162-0f4a-4adc-86f8-0325c3ec28a9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_caf57162-0f4a-4adc-86f8-0325c3ec28a9" xlink:to="loc_srt_RangeMember_caf57162-0f4a-4adc-86f8-0325c3ec28a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4710b9bc-9dfa-4edc-9097-5de8b192e203" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_caf57162-0f4a-4adc-86f8-0325c3ec28a9" xlink:to="loc_srt_RangeMember_4710b9bc-9dfa-4edc-9097-5de8b192e203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_e5ff4c7a-566b-4e2b-bedc-6ce5d5433bde" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4710b9bc-9dfa-4edc-9097-5de8b192e203" xlink:to="loc_srt_WeightedAverageMember_e5ff4c7a-566b-4e2b-bedc-6ce5d5433bde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e4cedf51-6e6f-42a3-8c9c-a4d4fb4f7989" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4710b9bc-9dfa-4edc-9097-5de8b192e203" xlink:to="loc_srt_MinimumMember_e4cedf51-6e6f-42a3-8c9c-a4d4fb4f7989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_429086ec-0d3a-42ad-94b1-0b7c4de158d1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4710b9bc-9dfa-4edc-9097-5de8b192e203" xlink:to="loc_srt_MaximumMember_429086ec-0d3a-42ad-94b1-0b7c4de158d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b47fe3f4-9dc3-4238-9b62-cf6c73112396" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b47fe3f4-9dc3-4238-9b62-cf6c73112396" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b47fe3f4-9dc3-4238-9b62-cf6c73112396_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b47fe3f4-9dc3-4238-9b62-cf6c73112396" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b47fe3f4-9dc3-4238-9b62-cf6c73112396_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c77b6f03-edb4-445d-b09d-466d4a4b6ce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b47fe3f4-9dc3-4238-9b62-cf6c73112396" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c77b6f03-edb4-445d-b09d-466d4a4b6ce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_78dba5b3-7a17-42e5-b1cc-da8f8ef731b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c77b6f03-edb4-445d-b09d-466d4a4b6ce2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_78dba5b3-7a17-42e5-b1cc-da8f8ef731b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34162e83-a9c9-45fc-a63d-2b170cfc5e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34162e83-a9c9-45fc-a63d-2b170cfc5e09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34162e83-a9c9-45fc-a63d-2b170cfc5e09_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34162e83-a9c9-45fc-a63d-2b170cfc5e09" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34162e83-a9c9-45fc-a63d-2b170cfc5e09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35adeea-f166-48f1-a0eb-6440711d7d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34162e83-a9c9-45fc-a63d-2b170cfc5e09" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35adeea-f166-48f1-a0eb-6440711d7d5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_94ab452c-3311-4623-a01c-e61035592390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35adeea-f166-48f1-a0eb-6440711d7d5d" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_94ab452c-3311-4623-a01c-e61035592390" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5d351dbd-2374-4666-9ea7-753f947a12a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35adeea-f166-48f1-a0eb-6440711d7d5d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5d351dbd-2374-4666-9ea7-753f947a12a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8705b40d-28b1-4d45-b934-ea5f030aeef6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35adeea-f166-48f1-a0eb-6440711d7d5d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8705b40d-28b1-4d45-b934-ea5f030aeef6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_79841c8f-6b1b-41ae-a8ad-e77d0d235a63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_79841c8f-6b1b-41ae-a8ad-e77d0d235a63" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_79841c8f-6b1b-41ae-a8ad-e77d0d235a63_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_79841c8f-6b1b-41ae-a8ad-e77d0d235a63" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_79841c8f-6b1b-41ae-a8ad-e77d0d235a63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73d3d575-3a9d-4e8e-8e5f-f239ade28cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_79841c8f-6b1b-41ae-a8ad-e77d0d235a63" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73d3d575-3a9d-4e8e-8e5f-f239ade28cee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_fc6d0c0a-0ef5-475b-9c93-c1d95d517286" xlink:href="bsx-20210630.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73d3d575-3a9d-4e8e-8e5f-f239ade28cee" xlink:to="loc_bsx_LicensingarrangementassetsMember_fc6d0c0a-0ef5-475b-9c93-c1d95d517286" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_721af539-46c8-4f28-ae5d-ae7bb7770cf1" xlink:href="bsx-20210630.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73d3d575-3a9d-4e8e-8e5f-f239ade28cee" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_721af539-46c8-4f28-ae5d-ae7bb7770cf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EurodenominatedoutstandingdebtMember_3a3105fd-a118-4183-b119-a7f7a1b156e1" xlink:href="bsx-20210630.xsd#bsx_EurodenominatedoutstandingdebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73d3d575-3a9d-4e8e-8e5f-f239ade28cee" xlink:to="loc_bsx_EurodenominatedoutstandingdebtMember_3a3105fd-a118-4183-b119-a7f7a1b156e1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended" id="ia7721e41b10a42a989b0fd4299192bcf_ContractualObligationsandCommitmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cca4c300-5644-441e-b626-7ac502f38e98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_baf15c6b-86c9-407c-b5c2-b3c881b4c549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cca4c300-5644-441e-b626-7ac502f38e98" xlink:to="loc_us-gaap_DebtInstrumentTable_baf15c6b-86c9-407c-b5c2-b3c881b4c549" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d68ad99-8c73-4757-94e9-603e4bc01a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_baf15c6b-86c9-407c-b5c2-b3c881b4c549" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d68ad99-8c73-4757-94e9-603e4bc01a6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1d68ad99-8c73-4757-94e9-603e4bc01a6f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d68ad99-8c73-4757-94e9-603e4bc01a6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1d68ad99-8c73-4757-94e9-603e4bc01a6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4d4ff908-cd86-40d8-bb16-642b18b6c770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d68ad99-8c73-4757-94e9-603e4bc01a6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4d4ff908-cd86-40d8-bb16-642b18b6c770" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended" id="i282f061ffe89453cbead82ed27ee1eed_ContractualObligationsandCommitmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_ae937d7b-cdd4-42d0-8a54-dd6f3824f126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_ae937d7b-cdd4-42d0-8a54-dd6f3824f126" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_53375fc5-38f8-4a47-a59c-6a18e418515e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_DebtCurrent_53375fc5-38f8-4a47-a59c-6a18e418515e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_86855fc1-20ed-4c30-99e3-219b2260a196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_LongTermDebt_86855fc1-20ed-4c30-99e3-219b2260a196" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ad5f592a-7a06-498d-8815-1c2da4ab0db0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ad5f592a-7a06-498d-8815-1c2da4ab0db0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a7cec9e9-fcdc-4550-9f04-72322da4c768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a7cec9e9-fcdc-4550-9f04-72322da4c768" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3f0da088-0308-4aaf-bd80-e0f13d018d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3f0da088-0308-4aaf-bd80-e0f13d018d52" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7866e3d3-f694-4345-af8f-220a4bc46504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7866e3d3-f694-4345-af8f-220a4bc46504" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentExtensionOptionTerm_00e72bca-e0cd-4120-8a35-d90bcbf5cdae" xlink:href="bsx-20210630.xsd#bsx_DebtInstrumentExtensionOptionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_DebtInstrumentExtensionOptionTerm_00e72bca-e0cd-4120-8a35-d90bcbf5cdae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_b3448495-4b98-47a0-93af-21a1d794e474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_b3448495-4b98-47a0-93af-21a1d794e474" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_7160e76f-1a88-4543-9195-33f374afb4ef" xlink:href="bsx-20210630.xsd#bsx_MaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_MaximumLeverageRatio_7160e76f-1a88-4543-9195-33f374afb4ef" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod_e9c3f8cc-2de9-4216-b52a-bf51cdeeb5ac" xlink:href="bsx-20210630.xsd#bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod_e9c3f8cc-2de9-4216-b52a-bf51cdeeb5ac" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_8c3b31e7-6114-40a0-add0-1fa89b19e587" xlink:href="bsx-20210630.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_8c3b31e7-6114-40a0-add0-1fa89b19e587" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_ce7c1b0a-dd41-4575-a649-ab0cf11ca043" xlink:href="bsx-20210630.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_ce7c1b0a-dd41-4575-a649-ab0cf11ca043" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_72a5611b-c7b7-43a4-9519-4b1aef56c9dc" xlink:href="bsx-20210630.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_72a5611b-c7b7-43a4-9519-4b1aef56c9dc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_9b02d1a9-e1e2-453b-8120-7d42091d251e" xlink:href="bsx-20210630.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_9b02d1a9-e1e2-453b-8120-7d42091d251e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_66c5a404-f302-4cba-9333-fef8f837fe95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_66c5a404-f302-4cba-9333-fef8f837fe95" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_8ba0a08e-f256-4ece-9390-7d953574fc7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_8ba0a08e-f256-4ece-9390-7d953574fc7e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4d2db822-b6c1-4426-80ed-0cc0c08b4bad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4d2db822-b6c1-4426-80ed-0cc0c08b4bad" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_QualifiedAcquisitionConsideration_c85abdbd-c435-4f92-a54b-e0869303169e" xlink:href="bsx-20210630.xsd#bsx_QualifiedAcquisitionConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_QualifiedAcquisitionConsideration_c85abdbd-c435-4f92-a54b-e0869303169e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_27c07709-8ab1-4148-a2ed-20403114b28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:to="loc_us-gaap_DebtInstrumentAxis_27c07709-8ab1-4148-a2ed-20403114b28a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_27c07709-8ab1-4148-a2ed-20403114b28a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_27c07709-8ab1-4148-a2ed-20403114b28a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_27c07709-8ab1-4148-a2ed-20403114b28a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_27c07709-8ab1-4148-a2ed-20403114b28a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevolvingCreditFacility2021Member_41c7b649-f70a-4d54-917f-8be0af140560" xlink:href="bsx-20210630.xsd#bsx_RevolvingCreditFacility2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:to="loc_bsx_RevolvingCreditFacility2021Member_41c7b649-f70a-4d54-917f-8be0af140560" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_7720d45d-b851-4269-9af1-7debac3ecb70" xlink:href="bsx-20210630.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_7720d45d-b851-4269-9af1-7debac3ecb70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_99bb501c-a95d-4a43-8890-b9e21d9bf374" xlink:href="bsx-20210630.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_99bb501c-a95d-4a43-8890-b9e21d9bf374" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_9e71bdaa-fa58-4cb5-bff1-a7b2ff5de3e7" xlink:href="bsx-20210630.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_9e71bdaa-fa58-4cb5-bff1-a7b2ff5de3e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_855a26c6-9892-43d3-ab88-e29aa7f58a39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_855a26c6-9892-43d3-ab88-e29aa7f58a39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_855a26c6-9892-43d3-ab88-e29aa7f58a39_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_855a26c6-9892-43d3-ab88-e29aa7f58a39" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_855a26c6-9892-43d3-ab88-e29aa7f58a39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_855a26c6-9892-43d3-ab88-e29aa7f58a39" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_96782925-54b8-4bce-afac-1b4c291b0fcc" xlink:href="bsx-20210630.xsd#bsx_May2022NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_May2022NotesMember_96782925-54b8-4bce-afac-1b4c291b0fcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember_bd927af0-5484-49f9-9916-f63af16b0ee0" xlink:href="bsx-20210630.xsd#bsx_October2023NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_October2023NotesMember_bd927af0-5484-49f9-9916-f63af16b0ee0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_e4fc1c18-8df1-4c37-90d4-fab5f13e405c" xlink:href="bsx-20210630.xsd#bsx_March2024NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2024NotesMember_e4fc1c18-8df1-4c37-90d4-fab5f13e405c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember_fc53b8d5-3c1c-4bab-9b80-86c7a3a09430" xlink:href="bsx-20210630.xsd#bsx_May2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_May2025NotesMember_fc53b8d5-3c1c-4bab-9b80-86c7a3a09430" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_b9963da3-7f57-425e-9ae3-887745350f99" xlink:href="bsx-20210630.xsd#bsx_June2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_June2025NotesMember_b9963da3-7f57-425e-9ae3-887745350f99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_c2943f53-5ca5-4b6d-b5d9-77d4114de03d" xlink:href="bsx-20210630.xsd#bsx_March2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2026NotesMember_c2943f53-5ca5-4b6d-b5d9-77d4114de03d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_76cb91e5-f9ef-488a-98af-959604fb1742" xlink:href="bsx-20210630.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_December2027NotesMember_76cb91e5-f9ef-488a-98af-959604fb1742" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_ccbf50ec-a377-40d5-bc34-a840cdc13806" xlink:href="bsx-20210630.xsd#bsx_March2028NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2028NotesMember_ccbf50ec-a377-40d5-bc34-a840cdc13806" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_c9b2f041-e4a4-4ea9-bae7-065b8800a3c0" xlink:href="bsx-20210630.xsd#bsx_March2029NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2029NotesMember_c9b2f041-e4a4-4ea9-bae7-065b8800a3c0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_70b90a60-b468-489c-885e-735e3c8018c3" xlink:href="bsx-20210630.xsd#bsx_June2030NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_June2030NotesMember_70b90a60-b468-489c-885e-735e3c8018c3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_ca7543d3-7bd6-42c8-9d59-b1693c755cdc" xlink:href="bsx-20210630.xsd#bsx_November2035NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_November2035NotesMember_ca7543d3-7bd6-42c8-9d59-b1693c755cdc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_75daabde-626b-485f-b004-57fb30bd48d2" xlink:href="bsx-20210630.xsd#bsx_March2039NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2039NotesMember_75daabde-626b-485f-b004-57fb30bd48d2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_44c24957-2d5f-4f6f-bc8f-3ffb0c80abde" xlink:href="bsx-20210630.xsd#bsx_January2040NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_January2040NotesMember_44c24957-2d5f-4f6f-bc8f-3ffb0c80abde" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_70a0b4a8-b5d2-4afd-8746-7e55374eb6f4" xlink:href="bsx-20210630.xsd#bsx_March2049NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2049NotesMember_70a0b4a8-b5d2-4afd-8746-7e55374eb6f4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c2de2dc4-ce16-4b91-aea0-913570bf0c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_us-gaap_SeniorNotesMember_c2de2dc4-ce16-4b91-aea0-913570bf0c33" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cfe7ae22-9c9b-467a-9d42-6efe86549669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_us-gaap_InterestRateSwapMember_cfe7ae22-9c9b-467a-9d42-6efe86549669" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_b981bed1-1337-4ab8-adeb-c11bc50d207b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_b981bed1-1337-4ab8-adeb-c11bc50d207b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_26ef085e-ceeb-4899-ad01-26e13c449004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_us-gaap_LineOfCreditMember_26ef085e-ceeb-4899-ad01-26e13c449004" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_0e9e9a2a-29be-4eda-aedc-82b17a5c3a15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_0e9e9a2a-29be-4eda-aedc-82b17a5c3a15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_0e9e9a2a-29be-4eda-aedc-82b17a5c3a15_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0e9e9a2a-29be-4eda-aedc-82b17a5c3a15" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_0e9e9a2a-29be-4eda-aedc-82b17a5c3a15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_0f81bd7c-6cae-4818-a96f-8a08ae86a7e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0e9e9a2a-29be-4eda-aedc-82b17a5c3a15" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_0f81bd7c-6cae-4818-a96f-8a08ae86a7e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_19e23d55-d2e0-4a74-9d05-41648fd8ea98" xlink:href="bsx-20210630.xsd#bsx_The2018FacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_0f81bd7c-6cae-4818-a96f-8a08ae86a7e2" xlink:to="loc_bsx_The2018FacilityDomain_19e23d55-d2e0-4a74-9d05-41648fd8ea98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8b2f4bd7-b90e-4d3c-a0fd-8db1bcae2084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:to="loc_us-gaap_CreditFacilityAxis_8b2f4bd7-b90e-4d3c-a0fd-8db1bcae2084" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8b2f4bd7-b90e-4d3c-a0fd-8db1bcae2084_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_8b2f4bd7-b90e-4d3c-a0fd-8db1bcae2084" xlink:to="loc_us-gaap_CreditFacilityDomain_8b2f4bd7-b90e-4d3c-a0fd-8db1bcae2084_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2f2516cc-d5ce-455d-97af-58488758e8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_8b2f4bd7-b90e-4d3c-a0fd-8db1bcae2084" xlink:to="loc_us-gaap_CreditFacilityDomain_2f2516cc-d5ce-455d-97af-58488758e8b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2a1426a1-2dac-4c5e-9366-c766ae099343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2f2516cc-d5ce-455d-97af-58488758e8b7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2a1426a1-2dac-4c5e-9366-c766ae099343" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_8402ecab-6ac1-460e-8660-4dc958d2e721" xlink:href="bsx-20210630.xsd#bsx_CovenantAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:to="loc_bsx_CovenantAxis_8402ecab-6ac1-460e-8660-4dc958d2e721" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_8402ecab-6ac1-460e-8660-4dc958d2e721_default" xlink:href="bsx-20210630.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_CovenantAxis_8402ecab-6ac1-460e-8660-4dc958d2e721" xlink:to="loc_bsx_CovenantDomain_8402ecab-6ac1-460e-8660-4dc958d2e721_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:href="bsx-20210630.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_CovenantAxis_8402ecab-6ac1-460e-8660-4dc958d2e721" xlink:to="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember_6d8aa0d4-c4d4-4d99-bc4c-4ead4bd4b2ef" xlink:href="bsx-20210630.xsd#bsx_CurrentRequirementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_CurrentRequirementMember_6d8aa0d4-c4d4-4d99-bc4c-4ead4bd4b2ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_a8544a71-6375-41ab-b33b-9c31877662f1" xlink:href="bsx-20210630.xsd#bsx_ActualCovenantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_ActualCovenantMember_a8544a71-6375-41ab-b33b-9c31877662f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfJune302021Member_b238c77a-a513-459f-bcef-25f082e810cc" xlink:href="bsx-20210630.xsd#bsx_RequirementAsOfJune302021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementAsOfJune302021Member_b238c77a-a513-459f-bcef-25f082e810cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfSeptember302021Member_f6859d07-c338-4402-bcdb-0278b0e2b682" xlink:href="bsx-20210630.xsd#bsx_RequirementAsOfSeptember302021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementAsOfSeptember302021Member_f6859d07-c338-4402-bcdb-0278b0e2b682" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_654eaa82-d826-47d6-ad96-924026d72fb6" xlink:href="bsx-20210630.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_654eaa82-d826-47d6-ad96-924026d72fb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_6d076e27-f49f-4ff1-8857-05f48ac62406" xlink:href="bsx-20210630.xsd#bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_6d076e27-f49f-4ff1-8857-05f48ac62406" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_befdad71-f914-4356-a642-b0dac67c6dbb" xlink:href="bsx-20210630.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_befdad71-f914-4356-a642-b0dac67c6dbb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_b1ae7091-c440-44a1-aa9f-cf205d8fbf63" xlink:href="bsx-20210630.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_b1ae7091-c440-44a1-aa9f-cf205d8fbf63" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_782cd7ad-7b8a-4725-b194-0831755ed432" xlink:href="bsx-20210630.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_782cd7ad-7b8a-4725-b194-0831755ed432" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_e05733ab-e459-4587-98a4-a588cf71dd29" xlink:href="bsx-20210630.xsd#bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_e05733ab-e459-4587-98a4-a588cf71dd29" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_3cdafb09-bc0a-4322-9873-af51a399dffa" xlink:href="bsx-20210630.xsd#bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_3cdafb09-bc0a-4322-9873-af51a399dffa" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended" id="ia0f0c001bb9b4993ad4f7a66069b0037_SupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:href="bsx-20210630.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_25f9431b-f090-4125-ab0e-5830e045cb66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_25f9431b-f090-4125-ab0e-5830e045cb66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_30dbb9fa-19e1-437a-91a7-411431e46b15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_30dbb9fa-19e1-437a-91a7-411431e46b15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_410dd344-f86b-4f7e-ae39-6763e86a51c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_410dd344-f86b-4f7e-ae39-6763e86a51c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a946393-1e3e-447b-bd37-32ad8f1c3a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a946393-1e3e-447b-bd37-32ad8f1c3a50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9225ecd5-615d-4f1c-9da8-2e6ff155d53a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:to="loc_us-gaap_StatementTable_9225ecd5-615d-4f1c-9da8-2e6ff155d53a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a1bf1cff-d728-4540-8206-0df36461b46b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9225ecd5-615d-4f1c-9da8-2e6ff155d53a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a1bf1cff-d728-4540-8206-0df36461b46b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a1bf1cff-d728-4540-8206-0df36461b46b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a1bf1cff-d728-4540-8206-0df36461b46b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a1bf1cff-d728-4540-8206-0df36461b46b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e21a8ffc-ea51-4768-b42b-0acff7ec021a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a1bf1cff-d728-4540-8206-0df36461b46b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e21a8ffc-ea51-4768-b42b-0acff7ec021a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9a4375a2-3697-441c-9788-143940904ebb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9225ecd5-615d-4f1c-9da8-2e6ff155d53a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9a4375a2-3697-441c-9788-143940904ebb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9a4375a2-3697-441c-9788-143940904ebb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9a4375a2-3697-441c-9788-143940904ebb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9a4375a2-3697-441c-9788-143940904ebb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2a9f13be-75b9-41b8-a5a2-a292f49904b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9a4375a2-3697-441c-9788-143940904ebb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2a9f13be-75b9-41b8-a5a2-a292f49904b5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended" id="if4300211ad0c45339f60e88eabead31a_IncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5b827af8-4943-4b71-9b21-3e8a69bbc80a" xlink:href="bsx-20210630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3ec35872-211e-4b38-a13d-1589edb54eee" xlink:href="bsx-20210630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5b827af8-4943-4b71-9b21-3e8a69bbc80a" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3ec35872-211e-4b38-a13d-1589edb54eee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2c8aa1d5-c55c-412b-bf35-f7d6013d57a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3ec35872-211e-4b38-a13d-1589edb54eee" xlink:to="loc_us-gaap_VariableRateAxis_2c8aa1d5-c55c-412b-bf35-f7d6013d57a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2c8aa1d5-c55c-412b-bf35-f7d6013d57a5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_2c8aa1d5-c55c-412b-bf35-f7d6013d57a5" xlink:to="loc_us-gaap_VariableRateDomain_2c8aa1d5-c55c-412b-bf35-f7d6013d57a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9ba3c8be-c891-4b02-8aff-d85070222788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_2c8aa1d5-c55c-412b-bf35-f7d6013d57a5" xlink:to="loc_us-gaap_VariableRateDomain_9ba3c8be-c891-4b02-8aff-d85070222788" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i1b6327a028ca4752ac5cbacc20663830_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_8e322373-9ae7-4291-b7e4-9c98a3a7ba01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_8e322373-9ae7-4291-b7e4-9c98a3a7ba01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6f1b8380-bab1-49f3-bc9c-6727c8d83c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6f1b8380-bab1-49f3-bc9c-6727c8d83c69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_6fff08cb-0f47-46e1-82dc-e9899add4eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_us-gaap_LitigationSettlementExpense_6fff08cb-0f47-46e1-82dc-e9899add4eb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_f3575e17-91fd-421c-a673-5c6e15f6717c" xlink:href="bsx-20210630.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_f3575e17-91fd-421c-a673-5c6e15f6717c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_a13d8f82-8532-46b6-b810-5d80e6470dae" xlink:href="bsx-20210630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_a13d8f82-8532-46b6-b810-5d80e6470dae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedclassactionsinCanadaMesh_e1dd0d9f-d4a0-4e1e-9f9f-61c7f291b850" xlink:href="bsx-20210630.xsd#bsx_CertifiedclassactionsinCanadaMesh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_CertifiedclassactionsinCanadaMesh_e1dd0d9f-d4a0-4e1e-9f9f-61c7f291b850" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_d8d717bd-943f-446c-9a87-d37f111f22af" xlink:href="bsx-20210630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_d8d717bd-943f-446c-9a87-d37f111f22af" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_fd9df44f-810c-4bc6-a5bc-a0f05bd96aee" xlink:href="bsx-20210630.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_fd9df44f-810c-4bc6-a5bc-a0f05bd96aee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_550ae595-e5db-46c4-a672-a945612ebeb9" xlink:href="bsx-20210630.xsd#bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_550ae595-e5db-46c4-a672-a945612ebeb9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_ec482756-5c5d-4701-b532-205e6ef9b04a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_ec482756-5c5d-4701-b532-205e6ef9b04a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_a58e7347-024d-4965-88e8-6a2e1177542b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_a58e7347-024d-4965-88e8-6a2e1177542b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedClassActionsInAustraliaMesh_262a610f-c3ad-421e-8c70-619738a56cfb" xlink:href="bsx-20210630.xsd#bsx_CertifiedClassActionsInAustraliaMesh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_CertifiedClassActionsInAustraliaMesh_262a610f-c3ad-421e-8c70-619738a56cfb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_e7586733-4c31-452f-9f53-eccb77f2dd7b" xlink:href="bsx-20210630.xsd#bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_e7586733-4c31-452f-9f53-eccb77f2dd7b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_49e79929-b0bb-45cf-a395-23fb18c72601" xlink:href="bsx-20210630.xsd#bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_49e79929-b0bb-45cf-a395-23fb18c72601" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StateAGSettlementsMeshRelatedNumberOfStates_5f1d1112-e61a-4f2d-87af-fd2ffb46c4c2" xlink:href="bsx-20210630.xsd#bsx_StateAGSettlementsMeshRelatedNumberOfStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_StateAGSettlementsMeshRelatedNumberOfStates_5f1d1112-e61a-4f2d-87af-fd2ffb46c4c2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b0db25d4-f55a-4366-9cf7-61e40550080c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b0db25d4-f55a-4366-9cf7-61e40550080c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b0db25d4-f55a-4366-9cf7-61e40550080c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b0db25d4-f55a-4366-9cf7-61e40550080c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b0db25d4-f55a-4366-9cf7-61e40550080c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_26b92911-a3ad-402b-ad65-2827629017d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b0db25d4-f55a-4366-9cf7-61e40550080c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_26b92911-a3ad-402b-ad65-2827629017d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_27e5d51f-eddf-4510-ac35-d03d9c0b297d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:to="loc_us-gaap_LitigationStatusAxis_27e5d51f-eddf-4510-ac35-d03d9c0b297d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_27e5d51f-eddf-4510-ac35-d03d9c0b297d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_27e5d51f-eddf-4510-ac35-d03d9c0b297d" xlink:to="loc_us-gaap_LitigationStatusDomain_27e5d51f-eddf-4510-ac35-d03d9c0b297d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d6ee3373-59e0-4d1f-9a6b-68bb71331ddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_27e5d51f-eddf-4510-ac35-d03d9c0b297d" xlink:to="loc_us-gaap_LitigationStatusDomain_d6ee3373-59e0-4d1f-9a6b-68bb71331ddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_4050e755-74f1-4943-9359-4239febe0f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_d6ee3373-59e0-4d1f-9a6b-68bb71331ddd" xlink:to="loc_us-gaap_SettledLitigationMember_4050e755-74f1-4943-9359-4239febe0f1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e635cc22-1755-4db7-b9af-4fa632c1a3c2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:to="loc_srt_LitigationCaseAxis_e635cc22-1755-4db7-b9af-4fa632c1a3c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e635cc22-1755-4db7-b9af-4fa632c1a3c2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_e635cc22-1755-4db7-b9af-4fa632c1a3c2" xlink:to="loc_srt_LitigationCaseTypeDomain_e635cc22-1755-4db7-b9af-4fa632c1a3c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_4b61691c-a90e-48d2-a377-abc4f9c62066" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_e635cc22-1755-4db7-b9af-4fa632c1a3c2" xlink:to="loc_srt_LitigationCaseTypeDomain_4b61691c-a90e-48d2-a377-abc4f9c62066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssignedtoonejudgeinMAMember_9cf246f8-f209-4aa2-b5b1-d6ba96958956" xlink:href="bsx-20210630.xsd#bsx_AssignedtoonejudgeinMAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_4b61691c-a90e-48d2-a377-abc4f9c62066" xlink:to="loc_bsx_AssignedtoonejudgeinMAMember_9cf246f8-f209-4aa2-b5b1-d6ba96958956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9bf6a2c0-fd00-4c26-8f00-1f764676e4c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9bf6a2c0-fd00-4c26-8f00-1f764676e4c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9bf6a2c0-fd00-4c26-8f00-1f764676e4c5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9bf6a2c0-fd00-4c26-8f00-1f764676e4c5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9bf6a2c0-fd00-4c26-8f00-1f764676e4c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5c74c872-72fe-4c0c-ae2f-b8a47893fc2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9bf6a2c0-fd00-4c26-8f00-1f764676e4c5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5c74c872-72fe-4c0c-ae2f-b8a47893fc2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9c03ebfd-33fb-40d6-9db4-197de34fc11b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5c74c872-72fe-4c0c-ae2f-b8a47893fc2a" xlink:to="loc_us-gaap_SubsequentEventMember_9c03ebfd-33fb-40d6-9db4-197de34fc11b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended" id="i882d0ac1d0554ec29752703f693c44b8_StockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4ad285b3-a78b-469a-b106-3a321049fc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4ad285b3-a78b-469a-b106-3a321049fc5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_916876c7-eb5c-4374-9c0d-5dc735e3d80a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockSharesIssued_916876c7-eb5c-4374-9c0d-5dc735e3d80a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_77516509-0f3f-477f-ba06-6ca0d18af56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_77516509-0f3f-477f-ba06-6ca0d18af56e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_f5fd8676-1899-44f7-9fc4-6b006f8c8b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_f5fd8676-1899-44f7-9fc4-6b006f8c8b24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_2cc5e832-2d5c-4885-b06f-595eb303c7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_2cc5e832-2d5c-4885-b06f-595eb303c7b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_74a8670e-5553-41ba-ac2b-1f13d4430d29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_74a8670e-5553-41ba-ac2b-1f13d4430d29" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare_80ea268b-538c-47f0-a667-d333b504ae1b" xlink:href="bsx-20210630.xsd#bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare_80ea268b-538c-47f0-a667-d333b504ae1b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConvertiblePreferredStockThresholdTradingDays_cfa9a3dc-4c59-4dee-89b2-9dbf0dc06586" xlink:href="bsx-20210630.xsd#bsx_ConvertiblePreferredStockThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_bsx_ConvertiblePreferredStockThresholdTradingDays_cfa9a3dc-4c59-4dee-89b2-9dbf0dc06586" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_4f1e8f3d-12b1-44e9-982b-8f0f95929d3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_4f1e8f3d-12b1-44e9-982b-8f0f95929d3e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_0504a0a3-307b-4361-8e45-4f7bf3b7998f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PaymentsOfDividends_0504a0a3-307b-4361-8e45-4f7bf3b7998f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared_68cf68ff-ff8a-406b-b332-91acbfca2536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareDeclared_68cf68ff-ff8a-406b-b332-91acbfca2536" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f05831ab-24b0-4284-b883-01265daeccf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f05831ab-24b0-4284-b883-01265daeccf1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c0840aab-cda2-4551-9bcf-41a7ff4d4b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c0840aab-cda2-4551-9bcf-41a7ff4d4b32" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6509b7c7-0813-4500-a856-a0003a296e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6509b7c7-0813-4500-a856-a0003a296e03" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_42b4e1e3-7538-4ce3-9039-202a520c4bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_42b4e1e3-7538-4ce3-9039-202a520c4bd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_046a3e77-c6a5-45de-aac5-777a1845429d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_42b4e1e3-7538-4ce3-9039-202a520c4bd4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_046a3e77-c6a5-45de-aac5-777a1845429d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_046a3e77-c6a5-45de-aac5-777a1845429d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_046a3e77-c6a5-45de-aac5-777a1845429d" xlink:to="loc_us-gaap_ClassOfStockDomain_046a3e77-c6a5-45de-aac5-777a1845429d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d4149d37-bf6e-4072-88e2-ff0c17fd9d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_046a3e77-c6a5-45de-aac5-777a1845429d" xlink:to="loc_us-gaap_ClassOfStockDomain_d4149d37-bf6e-4072-88e2-ff0c17fd9d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_2f8c09ce-5fc6-4551-97a4-c89ade7ddab9" xlink:href="bsx-20210630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d4149d37-bf6e-4072-88e2-ff0c17fd9d5b" xlink:to="loc_bsx_A550MCPSSeriesAMember_2f8c09ce-5fc6-4551-97a4-c89ade7ddab9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d1006304-4994-4b19-a61b-f3db66f97024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d4149d37-bf6e-4072-88e2-ff0c17fd9d5b" xlink:to="loc_us-gaap_CommonStockMember_d1006304-4994-4b19-a61b-f3db66f97024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_3ad2dffa-de46-435e-8e87-2f0d1142782b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d4149d37-bf6e-4072-88e2-ff0c17fd9d5b" xlink:to="loc_us-gaap_PreferredStockMember_3ad2dffa-de46-435e-8e87-2f0d1142782b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_65aebde1-4c62-472a-88b3-cc192e4f982e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_42b4e1e3-7538-4ce3-9039-202a520c4bd4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_65aebde1-4c62-472a-88b3-cc192e4f982e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_65aebde1-4c62-472a-88b3-cc192e4f982e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_65aebde1-4c62-472a-88b3-cc192e4f982e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_65aebde1-4c62-472a-88b3-cc192e4f982e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_774bff65-d098-4a3d-98bb-51bab90e413f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_65aebde1-4c62-472a-88b3-cc192e4f982e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_774bff65-d098-4a3d-98bb-51bab90e413f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dd6fe8a0-147c-4411-a719-a0680f45f6f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_774bff65-d098-4a3d-98bb-51bab90e413f" xlink:to="loc_us-gaap_SubsequentEventMember_dd6fe8a0-147c-4411-a719-a0680f45f6f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6f9ba60b-eaa7-49b9-b35c-424455e7a93a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_42b4e1e3-7538-4ce3-9039-202a520c4bd4" xlink:to="loc_srt_RangeAxis_6f9ba60b-eaa7-49b9-b35c-424455e7a93a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f9ba60b-eaa7-49b9-b35c-424455e7a93a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6f9ba60b-eaa7-49b9-b35c-424455e7a93a" xlink:to="loc_srt_RangeMember_6f9ba60b-eaa7-49b9-b35c-424455e7a93a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1e26c428-5e66-4433-8bc9-cbeaf1febda4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6f9ba60b-eaa7-49b9-b35c-424455e7a93a" xlink:to="loc_srt_RangeMember_1e26c428-5e66-4433-8bc9-cbeaf1febda4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_859032d0-5992-4872-99b1-a9a329bc58d1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1e26c428-5e66-4433-8bc9-cbeaf1febda4" xlink:to="loc_srt_MinimumMember_859032d0-5992-4872-99b1-a9a329bc58d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b3ee9789-1766-4e5e-845f-b8ddb704cedf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1e26c428-5e66-4433-8bc9-cbeaf1febda4" xlink:to="loc_srt_MaximumMember_b3ee9789-1766-4e5e-845f-b8ddb704cedf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended" id="ic873382d1c71461d8cbfdf70319e7ba4_WeightedAverageSharesOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a2e3474-4209-4e66-aa29-4daa4a5d75eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a2e3474-4209-4e66-aa29-4daa4a5d75eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_189bcb6f-b728-4694-8e33-9c541680cd78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_189bcb6f-b728-4694-8e33-9c541680cd78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0b66ea1e-b9cf-415d-a8da-18dbe3483dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0b66ea1e-b9cf-415d-a8da-18dbe3483dc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_01950fff-40ee-4ce2-aba7-7f20e2136348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_01950fff-40ee-4ce2-aba7-7f20e2136348" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e7ab1cc5-1ed2-428c-8a11-5282a1789aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e7ab1cc5-1ed2-428c-8a11-5282a1789aa7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a27ea7aa-e4d5-44f0-8c2a-ab7be152a284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a27ea7aa-e4d5-44f0-8c2a-ab7be152a284" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_66e8433c-4bff-4c12-b18a-fc243d47ae83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_66e8433c-4bff-4c12-b18a-fc243d47ae83" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dad94f33-6776-4e51-b2ff-7d1fd6cc491e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_66e8433c-4bff-4c12-b18a-fc243d47ae83" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dad94f33-6776-4e51-b2ff-7d1fd6cc491e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_dad94f33-6776-4e51-b2ff-7d1fd6cc491e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dad94f33-6776-4e51-b2ff-7d1fd6cc491e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_dad94f33-6776-4e51-b2ff-7d1fd6cc491e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f27151c4-b8b5-4d25-bcbf-2b4bcec609a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dad94f33-6776-4e51-b2ff-7d1fd6cc491e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f27151c4-b8b5-4d25-bcbf-2b4bcec609a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8ecef7f4-ea09-477e-813d-7ae44839dda9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f27151c4-b8b5-4d25-bcbf-2b4bcec609a5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8ecef7f4-ea09-477e-813d-7ae44839dda9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_819dde9a-b3f2-451f-95aa-32f1d71d4a80" xlink:href="bsx-20210630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f27151c4-b8b5-4d25-bcbf-2b4bcec609a5" xlink:to="loc_bsx_A550MCPSSeriesAMember_819dde9a-b3f2-451f-95aa-32f1d71d4a80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_104780ea-c64b-4bd8-b4ea-e08e625bdf1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f27151c4-b8b5-4d25-bcbf-2b4bcec609a5" xlink:to="loc_us-gaap_StockCompensationPlanMember_104780ea-c64b-4bd8-b4ea-e08e625bdf1c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended" id="ia5b581a6cf1640269243fed66df861cb_SegmentReportingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_85ea4669-f9f5-428e-865c-caefecc30145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e9983b3e-d809-428e-8f67-8fd04c07cb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_85ea4669-f9f5-428e-865c-caefecc30145" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e9983b3e-d809-428e-8f67-8fd04c07cb5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_85ea4669-f9f5-428e-865c-caefecc30145" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_d2ca87b2-2984-4c03-a598-8ffe935d9e39" xlink:href="bsx-20210630.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_bsx_OperatingIncomeAllocatedToReportableSegments_d2ca87b2-2984-4c03-a598-8ffe935d9e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_90b1a59f-3c3c-4bff-b07c-19d7aff3a4cc" xlink:href="bsx-20210630.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_90b1a59f-3c3c-4bff-b07c-19d7aff3a4cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_82a79010-b16f-41fc-a990-9d06a857fdde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_82a79010-b16f-41fc-a990-9d06a857fdde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f9b85291-6f85-426a-8bc4-601edb3a087c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_us-gaap_OperatingIncomeLoss_f9b85291-6f85-426a-8bc4-601edb3a087c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_27a3e984-03cd-4bb0-bd23-7565810d94ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_27a3e984-03cd-4bb0-bd23-7565810d94ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fa7e9bff-c811-42e6-81c7-305d99aa666a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fa7e9bff-c811-42e6-81c7-305d99aa666a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales_79205b07-1844-4df6-afc2-9e6f8c50a2a7" xlink:href="bsx-20210630.xsd#bsx_SegmentOperatingIncomeasaPercentageofNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales_79205b07-1844-4df6-afc2-9e6f8c50a2a7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_49249a54-3698-477a-93c7-fa6f91970022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_85ea4669-f9f5-428e-865c-caefecc30145" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_49249a54-3698-477a-93c7-fa6f91970022" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_70c6c760-f370-485b-b13d-dac74abc872c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_49249a54-3698-477a-93c7-fa6f91970022" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_70c6c760-f370-485b-b13d-dac74abc872c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_70c6c760-f370-485b-b13d-dac74abc872c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70c6c760-f370-485b-b13d-dac74abc872c" xlink:to="loc_us-gaap_SegmentDomain_70c6c760-f370-485b-b13d-dac74abc872c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70c6c760-f370-485b-b13d-dac74abc872c" xlink:to="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_36865b4e-2940-427a-a734-2b7205f0baa9" xlink:href="bsx-20210630.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_MedsurgMember_36865b4e-2940-427a-a734-2b7205f0baa9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_0adc323d-99de-4826-b658-7ef29e95ef43" xlink:href="bsx-20210630.xsd#bsx_RhythmandNeuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_RhythmandNeuroMember_0adc323d-99de-4826-b658-7ef29e95ef43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_75e0f70a-4b16-4307-8cf7-58f138b2d1a8" xlink:href="bsx-20210630.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_CardiovascularMember_75e0f70a-4b16-4307-8cf7-58f138b2d1a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_1dc569a1-1f23-419b-b2a0-5901a310240a" xlink:href="bsx-20210630.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_BSXReportableSegmentsMember_1dc569a1-1f23-419b-b2a0-5901a310240a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_3daafae2-4ce7-4194-9bcd-f0e953996054" xlink:href="bsx-20210630.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_3daafae2-4ce7-4194-9bcd-f0e953996054" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_3f4163af-2146-40ae-8c36-96dd83bde50c" xlink:href="bsx-20210630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_3f4163af-2146-40ae-8c36-96dd83bde50c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_c8e36869-2de6-45f8-8640-ec4c64996670" xlink:href="bsx-20210630.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_c8e36869-2de6-45f8-8640-ec4c64996670" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_eef55988-c908-4acc-bb95-c8657c68f8e3" xlink:href="bsx-20210630.xsd#bsx_SpecialChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_SpecialChargesMember_eef55988-c908-4acc-bb95-c8657c68f8e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_46c08431-dace-4e54-97c9-8f1734605832" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_49249a54-3698-477a-93c7-fa6f91970022" xlink:to="loc_srt_ProductOrServiceAxis_46c08431-dace-4e54-97c9-8f1734605832" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_46c08431-dace-4e54-97c9-8f1734605832_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_46c08431-dace-4e54-97c9-8f1734605832" xlink:to="loc_srt_ProductsAndServicesDomain_46c08431-dace-4e54-97c9-8f1734605832_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_62f81378-47d7-4700-aad2-1c789eeda45f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_46c08431-dace-4e54-97c9-8f1734605832" xlink:to="loc_srt_ProductsAndServicesDomain_62f81378-47d7-4700-aad2-1c789eeda45f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended" id="i23e8e98816fd412195c3b4172b2b336e_RevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_cbdddb80-0f32-41d7-88aa-88fcbf5f8459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketstotalnumberofcountries_0c10e99e-4f28-4123-ab4b-632ad0a651ce" xlink:href="bsx-20210630.xsd#bsx_EmergingMarketstotalnumberofcountries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cbdddb80-0f32-41d7-88aa-88fcbf5f8459" xlink:to="loc_bsx_EmergingMarketstotalnumberofcountries_0c10e99e-4f28-4123-ab4b-632ad0a651ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90fe078c-6b67-4923-8462-852b09ef948a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cbdddb80-0f32-41d7-88aa-88fcbf5f8459" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90fe078c-6b67-4923-8462-852b09ef948a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_73cd1454-76bd-4b88-925f-0b41e3a6d2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cbdddb80-0f32-41d7-88aa-88fcbf5f8459" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_73cd1454-76bd-4b88-925f-0b41e3a6d2b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a1ec82c9-5d37-439e-8c49-f8d21079f089" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_73cd1454-76bd-4b88-925f-0b41e3a6d2b1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a1ec82c9-5d37-439e-8c49-f8d21079f089" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a1ec82c9-5d37-439e-8c49-f8d21079f089_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1ec82c9-5d37-439e-8c49-f8d21079f089" xlink:to="loc_us-gaap_SegmentDomain_a1ec82c9-5d37-439e-8c49-f8d21079f089_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d3eb54c6-7ab8-4ed3-a50d-6ef7c78c75f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1ec82c9-5d37-439e-8c49-f8d21079f089" xlink:to="loc_us-gaap_SegmentDomain_d3eb54c6-7ab8-4ed3-a50d-6ef7c78c75f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_d2608541-254e-4e66-af03-afe967ffb1ea" xlink:href="bsx-20210630.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d3eb54c6-7ab8-4ed3-a50d-6ef7c78c75f3" xlink:to="loc_bsx_BSXReportableSegmentsMember_d2608541-254e-4e66-af03-afe967ffb1ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2910d537-4f96-487e-9b39-6df2e1d0785c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_73cd1454-76bd-4b88-925f-0b41e3a6d2b1" xlink:to="loc_srt_ProductOrServiceAxis_2910d537-4f96-487e-9b39-6df2e1d0785c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2910d537-4f96-487e-9b39-6df2e1d0785c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_2910d537-4f96-487e-9b39-6df2e1d0785c" xlink:to="loc_srt_ProductsAndServicesDomain_2910d537-4f96-487e-9b39-6df2e1d0785c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_2910d537-4f96-487e-9b39-6df2e1d0785c" xlink:to="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_1e943221-5688-40b3-8770-cdf665167896" xlink:href="bsx-20210630.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_1e943221-5688-40b3-8770-cdf665167896" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_160654eb-0b7c-4aaa-9a64-faf8bf8c694f" xlink:href="bsx-20210630.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_160654eb-0b7c-4aaa-9a64-faf8bf8c694f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember_0cbf12f5-9a4b-41d6-b965-97c821dcf34a" xlink:href="bsx-20210630.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalCrmReportingUnitMember_0cbf12f5-9a4b-41d6-b965-97c821dcf34a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_55677475-46d4-4ee4-9757-ae3616acb0dd" xlink:href="bsx-20210630.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_55677475-46d4-4ee4-9757-ae3616acb0dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_d2d9659a-ee56-4bbb-872c-a313a3014c02" xlink:href="bsx-20210630.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_d2d9659a-ee56-4bbb-872c-a313a3014c02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_b2d259b9-3cfb-4c1b-86b5-e74499e26e34" xlink:href="bsx-20210630.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_b2d259b9-3cfb-4c1b-86b5-e74499e26e34" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_139c2738-1e83-4d23-93a9-99ba819f0b00" xlink:href="bsx-20210630.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_139c2738-1e83-4d23-93a9-99ba819f0b00" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_f8a747c2-78a1-4da0-8860-5242a4afa7db" xlink:href="bsx-20210630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_f8a747c2-78a1-4da0-8860-5242a4afa7db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ba1c42ad-2bbd-4240-9d14-c4723f3dd8e6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_73cd1454-76bd-4b88-925f-0b41e3a6d2b1" xlink:to="loc_srt_StatementGeographicalAxis_ba1c42ad-2bbd-4240-9d14-c4723f3dd8e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ba1c42ad-2bbd-4240-9d14-c4723f3dd8e6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ba1c42ad-2bbd-4240-9d14-c4723f3dd8e6" xlink:to="loc_srt_SegmentGeographicalDomain_ba1c42ad-2bbd-4240-9d14-c4723f3dd8e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ba1c42ad-2bbd-4240-9d14-c4723f3dd8e6" xlink:to="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8525ee4a-b65a-4dcc-be99-811f0fbdf5ff" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_country_US_8525ee4a-b65a-4dcc-be99-811f0fbdf5ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_ae8d5211-90b3-49c8-9101-f25e2854c3f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_us-gaap_NonUsMember_ae8d5211-90b3-49c8-9101-f25e2854c3f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_dfbefa56-6ece-4cef-936f-a65c2835990b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_us-gaap_EMEAMember_dfbefa56-6ece-4cef-936f-a65c2835990b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_edbf7192-5c32-4178-a6ec-64ef0dce60de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_srt_AsiaPacificMember_edbf7192-5c32-4178-a6ec-64ef0dce60de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_20ea4a7a-ea2e-4b45-8611-29f7604e771b" xlink:href="bsx-20210630.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_bsx_LatinAmericaandCanadaMember_20ea4a7a-ea2e-4b45-8611-29f7604e771b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_0ce4c831-a86c-4c0f-9a73-a238ff646e76" xlink:href="bsx-20210630.xsd#bsx_EmergingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_bsx_EmergingMarketsMember_0ce4c831-a86c-4c0f-9a73-a238ff646e76" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended" id="i5b18ebc6fd34408f8be98deb31602e43_ChangesinOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_52d75cf9-29f3-4867-b9e8-2dc88f98029d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_52d75cf9-29f3-4867-b9e8-2dc88f98029d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3575242a-b45f-404a-b6f0-6262183090ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3575242a-b45f-404a-b6f0-6262183090ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_937deaa3-40d4-43d4-aee9-bfcf1bd2dd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_937deaa3-40d4-43d4-aee9-bfcf1bd2dd0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a0db3efc-4f48-4cbb-9ab3-5502ebbb24ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a0db3efc-4f48-4cbb-9ab3-5502ebbb24ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_4a101514-c1f2-4084-89a4-ae22eb2e03ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_4a101514-c1f2-4084-89a4-ae22eb2e03ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_7363c405-3151-4075-8e00-dd1d54793c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_7363c405-3151-4075-8e00-dd1d54793c7e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a6b39043-2538-438d-b6a6-05910926459d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a6b39043-2538-438d-b6a6-05910926459d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_b4fa0a6e-9a54-4885-9c03-96a7a78c00ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_b4fa0a6e-9a54-4885-9c03-96a7a78c00ad" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7a1cc75b-04f8-45da-bb6f-5ae556a339e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7a1cc75b-04f8-45da-bb6f-5ae556a339e2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6d95d173-55d6-4c37-b4a4-f8ca6e19f53b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6d95d173-55d6-4c37-b4a4-f8ca6e19f53b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ffcba89e-08ac-492d-a0df-d47aeeeb5b4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ffcba89e-08ac-492d-a0df-d47aeeeb5b4c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_1b9dfd8e-6ffa-4f5a-9ddc-02ee8abc0c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_1b9dfd8e-6ffa-4f5a-9ddc-02ee8abc0c45" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_6a7a16ee-1d2d-495e-a76b-08fac70d7e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_6a7a16ee-1d2d-495e-a76b-08fac70d7e0c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_449b65ab-31dc-480a-acf8-61c2e611a1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_449b65ab-31dc-480a-acf8-61c2e611a1c5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2f60107a-6038-4029-8743-336f62898f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2f60107a-6038-4029-8743-336f62898f4d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e6c2e28c-e420-4027-886c-c3e4992e05cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e6c2e28c-e420-4027-886c-c3e4992e05cb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a9da01ad-638d-48fb-b9ab-b7ca966935b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a9da01ad-638d-48fb-b9ab-b7ca966935b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_70cd87e6-294d-4c4c-8b92-cfe33834a8da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a9da01ad-638d-48fb-b9ab-b7ca966935b6" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_70cd87e6-294d-4c4c-8b92-cfe33834a8da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_70cd87e6-294d-4c4c-8b92-cfe33834a8da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_70cd87e6-294d-4c4c-8b92-cfe33834a8da" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_70cd87e6-294d-4c4c-8b92-cfe33834a8da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_05841dc2-7735-4efb-9a63-0e2f4b84b49a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_70cd87e6-294d-4c4c-8b92-cfe33834a8da" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_05841dc2-7735-4efb-9a63-0e2f4b84b49a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_b193f14a-6cb6-4500-b3d1-482b651d6859" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_05841dc2-7735-4efb-9a63-0e2f4b84b49a" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_b193f14a-6cb6-4500-b3d1-482b651d6859" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e38d4b10-2d20-4ac3-a59f-0c42d93237fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a9da01ad-638d-48fb-b9ab-b7ca966935b6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e38d4b10-2d20-4ac3-a59f-0c42d93237fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e38d4b10-2d20-4ac3-a59f-0c42d93237fc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e38d4b10-2d20-4ac3-a59f-0c42d93237fc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e38d4b10-2d20-4ac3-a59f-0c42d93237fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f9627e0f-cbf6-4f91-9c7f-9b77cab8d27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e38d4b10-2d20-4ac3-a59f-0c42d93237fc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f9627e0f-cbf6-4f91-9c7f-9b77cab8d27c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_496ba6e1-be95-4cfa-acc5-0990d2f6b052" xlink:href="bsx-20210630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f9627e0f-cbf6-4f91-9c7f-9b77cab8d27c" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_496ba6e1-be95-4cfa-acc5-0990d2f6b052" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bsx-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:70f263dc-70b5-4726-816e-8c716916294a,g:26cfe26e-80ae-4508-82da-1214ca3ae539-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_4383cf0f-e472-4f48-b5ad-b216d5b8c4dd_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_bab2b397-e1ff-4a9a-920b-db18a8c3097f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_69a8f429-1e75-4980-a0cb-f9406d19633a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_ad2db363-6154-4f9d-90da-375a0958b39e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_386c0c13-69b0-429b-9ca9-eb4c818eed99_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_eae483db-23a1-4a11-b07d-017d58a5e118_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_45b1df96-8bdd-4f68-a8d7-58f5364e4af4_terseLabel_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20210630.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_850f5658-5c64-43fb-8e47-55f8f8fbbfd3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_c7a0a0d3-fbf2-49f6-970d-2243bed84ec6_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_bebf6c25-8346-4e3a-803c-633870d829c1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_489aa30e-523b-4e1b-9cb2-1059cee02735_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Other Comprehensive Income [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_c77453ad-bf11-4366-bac8-9008e5c7f4c3_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_20620c3b-1cc3-4731-8f2f-2e8bafb1c377_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_de913520-a5db-4254-84ed-7b031ffd9a7b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_54e32d39-1415-4857-8680-894729aab32b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_cb16aa36-318f-40de-a1a5-652614444b86_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_13f87bd2-3a23-49c2-8589-4d59b70a287b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_4f99aef0-d69e-480a-b94e-6a31f3526bf0_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39612383-1be7-4f92-9256-2cde5104835b_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_eb5cdf74-a642-4776-8887-9597ef058f2f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_d7b93284-4190-4e82-93b0-565686b0eb74_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_6b705f98-c579-430a-839e-190e5fe0c3e2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d8a1c95a-2831-4da7-ac4e-86fd225c33cf_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_92b88377-fad0-45f9-b828-74d37ab6c8b6_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_d080af3f-ad11-4f8c-910f-da62c3ba78bd_verboseLabel_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_label_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_documentation_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:href="bsx-20210630.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:to="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_bd403493-5830-4821-b386-d303d15bfcd5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_The2018FacilityDomain_be9639dd-9fae-47a9-a8e2-332630bdfa7a_terseLabel_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Member]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_label_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Domain]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_documentation_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain" xlink:href="bsx-20210630.xsd#bsx_The2018FacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_The2018FacilityDomain" xlink:to="lab_bsx_The2018FacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_ac4931d8-5d25-481f-9d27-30bddafe5bfc_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_5d4be7be-2bbc-4ab7-8066-9b8d834b5525_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_3d185b84-9871-4078-904f-5cbfd2f5f64b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees_9519f001-14e7-4e3a-9f99-3abf84595bdb_terseLabel_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of global employees</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees_label_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of global employees</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees_documentation_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of global employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:href="bsx-20210630.xsd#bsx_DivestitureAgreementTransferOfGlobalEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:to="lab_bsx_DivestitureAgreementTransferOfGlobalEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_13bd4ac8-818f-4449-9832-befe69b10347_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_de70e2c8-ce4d-4eea-a36c-91dc47871826_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_4f9a948f-3075-490a-9435-6ca342847e6a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_cf9d6594-8aad-42d7-a616-aed0bd30ff2b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f1ad3ec7-f6e2-4140-8f8d-0a78a2dc6bd7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_faae47a9-5805-4192-8ac0-b9b4d2c1bae9_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_93d216c8-ee66-47b5-b88e-18ab763cd5ff_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_39703a3d-fa16-470e-b800-fe35e7657f2a_terseLabel_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_label_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_documentation_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract" xlink:href="bsx-20210630.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherCurrentAssetsAbstract" xlink:to="lab_bsx_OtherCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_fcbc0aeb-797d-4cd3-bae0-fa613c981bd5_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_f666b1d5-0e35-4f63-8b4f-6a666d800ffb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_c97ad3d9-b0e8-4547-9b0b-69bd1e39b1bc_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_QualifiedAcquisitionConsideration_5d73ed61-279f-4558-aeb4-06532140e930_terseLabel_en-US" xlink:label="lab_bsx_QualifiedAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Acquisition Consideration</link:label>
    <link:label id="lab_bsx_QualifiedAcquisitionConsideration_label_en-US" xlink:label="lab_bsx_QualifiedAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Acquisition Consideration</link:label>
    <link:label id="lab_bsx_QualifiedAcquisitionConsideration_documentation_en-US" xlink:label="lab_bsx_QualifiedAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Acquisition Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_QualifiedAcquisitionConsideration" xlink:href="bsx-20210630.xsd#bsx_QualifiedAcquisitionConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_QualifiedAcquisitionConsideration" xlink:to="lab_bsx_QualifiedAcquisitionConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_3ce2a572-0646-42ad-8b43-075f6f09d7e7_negatedLabel_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_label_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_documentation_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration" xlink:href="bsx-20210630.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PaymentOfContingentConsideration" xlink:to="lab_bsx_PaymentOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a9f24cf9-6b62-4d12-ae63-96da81aa0d47_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_28404d76-8d4a-431a-ab43-0ea2585b41a2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_ce093d14-13f9-4115-8cc0-c7bf337cdc68_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ActualCovenantMember_b6d504a2-a2d6-420f-b858-1d19bce08a0e_terseLabel_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_label_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_documentation_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember" xlink:href="bsx-20210630.xsd#bsx_ActualCovenantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ActualCovenantMember" xlink:to="lab_bsx_ActualCovenantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_741b5ea7-d548-4039-a481-4c176dda35aa_terseLabel_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_label_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_documentation_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:href="bsx-20210630.xsd#bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:to="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_2084ca94-a443-4cd4-a2f3-1981add82434_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RevolvingCreditFacility2021Member_30617df5-906f-4fdd-893a-35aefa411938_terseLabel_en-US" xlink:label="lab_bsx_RevolvingCreditFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolving Credit Facility</link:label>
    <link:label id="lab_bsx_RevolvingCreditFacility2021Member_label_en-US" xlink:label="lab_bsx_RevolvingCreditFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility 2021 [Member]</link:label>
    <link:label id="lab_bsx_RevolvingCreditFacility2021Member_documentation_en-US" xlink:label="lab_bsx_RevolvingCreditFacility2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevolvingCreditFacility2021Member" xlink:href="bsx-20210630.xsd#bsx_RevolvingCreditFacility2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RevolvingCreditFacility2021Member" xlink:to="lab_bsx_RevolvingCreditFacility2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MedsurgMember_2273ae5b-cc4e-451a-b828-d90fb2c21d1d_terseLabel_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_label_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_documentation_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember" xlink:href="bsx-20210630.xsd#bsx_MedsurgMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MedsurgMember" xlink:to="lab_bsx_MedsurgMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_b8479610-fe71-400e-ae44-595865007ef7_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_f6d58005-0445-4baa-9c4f-e528a95cbb88_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_41ea8002-822a-4154-bfdd-65500752a4b8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f0740cc0-c927-45b4-999d-f6a01f25651f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NumberOfBusinessesDivested_d139ef09-c9f9-4b19-90dc-f25c6364dc50_terseLabel_en-US" xlink:label="lab_bsx_NumberOfBusinessesDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses Divested</link:label>
    <link:label id="lab_bsx_NumberOfBusinessesDivested_label_en-US" xlink:label="lab_bsx_NumberOfBusinessesDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses Divested</link:label>
    <link:label id="lab_bsx_NumberOfBusinessesDivested_documentation_en-US" xlink:label="lab_bsx_NumberOfBusinessesDivested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinessesDivested" xlink:href="bsx-20210630.xsd#bsx_NumberOfBusinessesDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NumberOfBusinessesDivested" xlink:to="lab_bsx_NumberOfBusinessesDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6542ae7e-8153-4994-9f69-b8fa8b573882_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_700b5c6f-7f75-4049-9ba3-f546eed56ddb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_829f6822-f6b9-4078-95b2-162f3528a0af_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SeniorNotedue2027Member_987b1704-61a9-49be-9fdb-aa08bad0dbc6_terseLabel_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_label_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_documentation_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member" xlink:href="bsx-20210630.xsd#bsx_SeniorNotedue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SeniorNotedue2027Member" xlink:to="lab_bsx_SeniorNotedue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_d7b8e1d5-c95c-4cb4-aac3-6ccc1342ca1a_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_ad2a39f9-7a65-4dae-936b-e74373acd295_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_22778a79-e470-4472-90e0-506848123a90_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_93f49460-64b9-4f43-8cc8-a3cdc58b7889_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_99bb55c1-2d2b-465a-ae5e-4c1ed333b189_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenue_05357233-383d-4549-8919-3dd041a70427_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_f0c994ce-98b7-4fa8-8b9e-99d78a291662_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of June 30, 2021 and December 31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangements_75ed03bb-e170-492c-afff-3c0c36aca47d_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_Licensingarrangements_label_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_Licensingarrangements_documentation_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangements" xlink:to="lab_bsx_Licensingarrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_ebafcfbd-2743-46ef-b8f2-ab665e9d2f61_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_69da2de3-df8b-4358-a76d-26859ba99181_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7d6baf68-9325-450d-a7bf-930f2192cd40_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8db5f341-ed5f-48a4-ba53-d293549bb0e3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_9c7cdf56-5caa-4799-8c43-f750f4d7351a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CardiovascularMember_25240f43-0c98-4faf-abf2-adc04b606296_terseLabel_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_label_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_documentation_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember" xlink:href="bsx-20210630.xsd#bsx_CardiovascularMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CardiovascularMember" xlink:to="lab_bsx_CardiovascularMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_3546fcda-f537-4943-95a3-670d29c187e5_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_34d1d457-4728-4c17-bed6-90723700213a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d45b07be-64f6-428b-957c-98cb9c1155a0_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_4a523d4c-4db6-47b4-b487-7aa7d853f7e5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_611bf05c-43fb-4dc3-8b47-064d55106c0f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalty rights</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_0782bddd-7fdd-4d9d-907b-85e060e6a779_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_FarapulseMember_7fa3e607-1993-4a12-a2c0-3e2a6c8c91c0_terseLabel_en-US" xlink:label="lab_bsx_FarapulseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Farapulse</link:label>
    <link:label id="lab_bsx_FarapulseMember_label_en-US" xlink:label="lab_bsx_FarapulseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Farapulse [Member]</link:label>
    <link:label id="lab_bsx_FarapulseMember_documentation_en-US" xlink:label="lab_bsx_FarapulseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Farapulse</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FarapulseMember" xlink:href="bsx-20210630.xsd#bsx_FarapulseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_FarapulseMember" xlink:to="lab_bsx_FarapulseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_ed6a20b4-67e0-403b-88f2-13286dcf9088_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_417b27a9-ab9b-4267-9251-ca28b3571db7_terseLabel_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_label_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_documentation_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:href="bsx-20210630.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:to="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c5b36fcb-931f-496e-ba89-aad1065d382e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rates on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_ab946751-181b-4764-9643-36e07f6292f3_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_f614290d-5c84-4e45-bb60-a4cd0cfd75ae_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_6bfa704f-f28d-480a-adf0-ab877d2595e5_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0c45b0c3-b5e2-4fb5-b277-a68d8fe39e59_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e008571-29c4-4609-ac97-a9472e8c3079_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_4e4c4ee8-ece3-4f6b-b4eb-d27d27cf7758_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_b319fe4f-e715-4134-8678-aca242206581_terseLabel_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:href="bsx-20210630.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_101cbf1d-04c7-4b69-a0b6-44e9f2527b1a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_c3a2db29-a031-43f9-a31b-331d0441c41e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_9beb7f6d-2b77-42bd-8d55-4b8b4ce7ec70_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:href="bsx-20210630.xsd#bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_df888486-fa08-45d4-aaeb-c775aae8997c_terseLabel_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology (Uro) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:href="bsx-20210630.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:to="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_26233db3-66da-49a0-a6c4-39a0199720cd_terseLabel_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:href="bsx-20210630.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:to="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_856d82fb-3f66-45e6-aa46-db69120078dc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_47d01e6f-5034-4939-ac74-5ef89b8c0bce_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_963d5657-13da-4fa7-a7db-945d459b9359_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_3b9b674c-f544-46fb-9bb1-a1fdf961fbc4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0d65b56e-7849-4309-9bea-7b2fa7190683_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_8c2e9d78-f853-4bb1-b56e-a079af65e880_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_857d7006-7758-45f6-a7c1-38a65607a8ae_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings on credit facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_16a6cac1-5ff7-4815-9ad8-7953150e06b9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance (Par value)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9ed9b4f0-5ee3-4e19-8550-795e377fdc01_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_9269f511-5ef9-408a-8c72-d3ab8c4c380b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_28d09024-c977-43c3-bcdc-e68985957ad9_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_b92a8825-87df-4bc7-af1e-5205a0b13f53_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_180b8ac0-fb81-4825-8b56-0953d987062d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantAxis_e92f1b99-64fb-471c-8653-bfbb43d70c35_terseLabel_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_label_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_documentation_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis" xlink:href="bsx-20210630.xsd#bsx_CovenantAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantAxis" xlink:to="lab_bsx_CovenantAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4f7d4519-5047-4ac9-99e4-833b311fc8f5_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_3e358ba0-fc23-414b-9091-d6fc3c0bf744_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_78c0b25b-0691-4d72-af1e-0ad142639167_verboseLabel_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate expenses and currency exchange [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_label_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_documentation_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:href="bsx-20210630.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:to="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_8d93485a-f3be-40e3-b4d9-2bab528e7170_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_8fbf1fa7-059d-4565-8113-9b4e87ca2fa2_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_f0a38e5b-4eab-445a-a9be-8f2b1abdfd83_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on borrowings from credit facilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales_0e03b61b-167a-4a4e-b4bc-d84c500a733d_terseLabel_en-US" xlink:label="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Income as a Percentage of Net Sales</link:label>
    <link:label id="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales_label_en-US" xlink:label="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Income as a Percentage of Net Sales</link:label>
    <link:label id="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales_documentation_en-US" xlink:label="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Income as a Percentage of Net Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:href="bsx-20210630.xsd#bsx_SegmentOperatingIncomeasaPercentageofNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:to="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_3f0da874-1bfc-476d-b11a-0a4618043496_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_1dcea287-042f-4e9d-a536-7d9c89f1eb40_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2028NotesMember_7dfd9575-3660-4c5e-ac48-8d8db74b0cf0_verboseLabel_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_label_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_documentation_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember" xlink:href="bsx-20210630.xsd#bsx_March2028NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2028NotesMember" xlink:to="lab_bsx_March2028NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5536f226-48f5-419c-9bfc-0c8c746e8428_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_e3c64f88-0efa-4023-9bf0-b3fbfc9fd471_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_5c7c9dbd-dd01-4a1d-961b-820de39e37b2_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_c95c0fad-c620-407a-8fe5-88091fc94821_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_570bd60e-0bb9-4668-9aa4-3054236ac315_terseLabel_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issuance (Value in excess of par)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_label_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Common stock)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_documentation_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Common stock)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:href="bsx-20210630.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:to="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7493d8d5-6963-4e0f-9a7b-957a6f0ce5c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_62127e4a-5f08-47ad-9b14-6b6cb6bc9e79_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a7208905-867d-431a-b1af-af04e60d85b5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e4f3a3b-6ee4-4c1d-b2b3-b11453499a5c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_db927a8f-9332-4b0a-b338-af800a193084_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_2f3812e0-e82c-4c53-9496-c58af2a4ee7b_terseLabel_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_label_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_documentation_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:href="bsx-20210630.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:to="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_5962a0be-45b0-4409-a274-5a304daa340c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8e434db6-3fee-4c80-9379-e13f31c94ff9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_265773ab-2c85-46ae-a155-3faf75f0cf50_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NumberOfBusinesses_f28ee5f0-3384-4242-88e1-ab934fe374ce_terseLabel_en-US" xlink:label="lab_bsx_NumberOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses</link:label>
    <link:label id="lab_bsx_NumberOfBusinesses_label_en-US" xlink:label="lab_bsx_NumberOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses</link:label>
    <link:label id="lab_bsx_NumberOfBusinesses_documentation_en-US" xlink:label="lab_bsx_NumberOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinesses" xlink:href="bsx-20210630.xsd#bsx_NumberOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NumberOfBusinesses" xlink:to="lab_bsx_NumberOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_e3ed3aef-369a-410f-946f-e9561cebed44_terseLabel_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_label_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_documentation_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember" xlink:href="bsx-20210630.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingarrangementliabilitiesMember" xlink:to="lab_bsx_LicensingarrangementliabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26cf65d8-966e-4b53-b5e7-468226bba4ba_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_19f59140-6066-4912-8d6a-8499ca6a109d_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_26b538f8-8587-434d-8531-286dc6b1b0c7_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect adjustment for adoption of ASU 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_859e5875-36b7-4492-a2cb-e250f0a43ea5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:to="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_6bf357e0-97a1-4278-8787-f66eb82e58f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5c5fb33f-daac-4b55-b55b-f813777e3a34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_3662b990-e161-4f83-aa5d-2730ad4d4cd3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_d0ade397-af35-44a4-b7c0-0ceb099a0e0e_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_7be8b459-7976-4479-ac8f-a36cbc8234dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_6feb2139-70f2-49e8-9efd-04e5fa3a2177_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL BALANCE SHEET INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_399600f7-b316-4e02-8606-5b85fe001935_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligation</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsMember" xlink:to="lab_us-gaap_CapitalLeaseObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_17f9cc0f-670c-48f9-9aaf-9ed83b828f1a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_InventoryStepUpAmortization_4b65282c-4ec2-4fbd-a386-87fd46b5c77c_terseLabel_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step-up amortization</link:label>
    <link:label id="lab_bsx_InventoryStepUpAmortization_label_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step up amortization</link:label>
    <link:label id="lab_bsx_InventoryStepUpAmortization_documentation_en-US" xlink:label="lab_bsx_InventoryStepUpAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory step up amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization" xlink:href="bsx-20210630.xsd#bsx_InventoryStepUpAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_InventoryStepUpAmortization" xlink:to="lab_bsx_InventoryStepUpAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_38ca42fd-a585-479c-a36a-50d31265157c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ae894248-0e6f-43fd-b983-b4b5bbfa0aa5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5ab45406-4547-4d42-8111-90002b570cca_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_e3ddb5ea-1667-4fd8-8d5c-de4045e67b2c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_baf0578f-53b6-47cf-aa1f-227251fbbba5_negatedTerseLabel_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_label_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_documentation_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:href="bsx-20210630.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:to="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3d8de21a-3f16-4448-a2cd-fba1b5ac7774_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_169681bd-0a15-4d33-a2f8-20d94144c39a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_25056b03-8d7a-4df3-94a6-b3a2a4039cc9_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation-related net charges (credits)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_11c29f9f-ae1b-4da7-9be8-43c019d95c77_negatedLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation-related net charges (credits)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_4a66eb82-b77c-4c33-b9ef-d2bcc7cf72b1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash equivalents included in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_137dd33d-257d-44db-8197-c7294503be20_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_10f5cc2a-5913-4f4d-ace0-35c1ef9f7280_terseLabel_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_label_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_documentation_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:href="bsx-20210630.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:to="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_6fc651c6-f21f-41cc-991e-bc62a76c4f38_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_ec05e44a-e20d-4918-bdde-567b1ba9b685_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_69d3c88b-098f-48f4-a506-350ab486d26f_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a3e2d831-3bec-4f8f-9ed8-f834d32019d4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f8a71cc3-fc22-4a2d-b3eb-8d41178de899_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_785b6d6b-5199-4a68-b6db-3b339c384200_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_296e694f-43b9-4546-9e46-8ac2dfb1ef01_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_5ea01f6b-7a29-4c75-9859-d837f302c048_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_c02de908-c13b-488d-add8-90e3f7d1458f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_307c297a-ebd1-41d0-8314-cd21eb1105b8_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_d01dd372-fef1-4e31-9289-08d56407b4ac_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_27718222-a74b-4634-9d04-94a263467275_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantDomain_0fa38363-9146-42c2-bed5-9e2aa01f4cba_terseLabel_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_label_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_documentation_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain" xlink:href="bsx-20210630.xsd#bsx_CovenantDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantDomain" xlink:to="lab_bsx_CovenantDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillMember_d0c39a52-ab51-4bcd-9fa1-d66731cf86f6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:label id="lab_us-gaap_GoodwillMember_label_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillMember" xlink:to="lab_us-gaap_GoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RhythmandNeuroMember_8edaf746-ac08-4b7f-9b6b-3dfcd2d93889_terseLabel_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:label id="lab_bsx_RhythmandNeuroMember_label_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:label id="lab_bsx_RhythmandNeuroMember_documentation_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember" xlink:href="bsx-20210630.xsd#bsx_RhythmandNeuroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RhythmandNeuroMember" xlink:to="lab_bsx_RhythmandNeuroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_ecee81e8-6250-404e-9bd8-62e30e40ab49_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_b686cc8d-21d3-4706-84d5-71bea9fcce27_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_05b4f9c3-52b9-4026-9f8a-c8f9280dc254_terseLabel_en-US" xlink:label="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</link:label>
    <link:label id="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_label_en-US" xlink:label="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</link:label>
    <link:label id="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_documentation_en-US" xlink:label="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:to="lab_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_be074676-c254-4732-adaa-f43a9f6b0426_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_f16434d0-8ef9-469f-93d9-a2b237c2f8e0_terseLabel_en-US" xlink:label="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_label_en-US" xlink:label="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_documentation_en-US" xlink:label="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases related to Greenfield Vena Cava Filter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:href="bsx-20210630.xsd#bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:to="lab_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod_d35f0ab5-8e37-4421-b745-e58a2d79de91_terseLabel_en-US" xlink:label="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Additional Revenue Payments, Period</link:label>
    <link:label id="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod_label_en-US" xlink:label="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Additional Revenue Payments, Period</link:label>
    <link:label id="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod_documentation_en-US" xlink:label="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Additional Revenue Payments, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod" xlink:to="lab_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_b047a156-e1c7-42fe-bbe5-32daf352a1d2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_790d54ea-c46a-4cdf-96f1-be83b7c9ef3b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f39cd22e-17cf-423d-8c5d-306f07268531_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_4c1fe860-7bec-42df-9ecd-5f56c5248a85_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_926639dd-66ae-4188-8e1c-dafe6a629fc8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_fe8003f3-fbbe-43ce-8cc3-0860f0b1a7ee_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d58dd7d6-95b9-454f-9391-caf703402be9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_cd0e6cdc-02d5-4c78-989d-6a6c743343aa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2d693dc0-7709-414f-a1e3-bc6ccb6433ba_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_28ad6efe-e7eb-45e8-8900-220239065559_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_f2e0bf86-3abb-4262-b627-530e4597e0b6_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_759b12f0-2a86-4af2-842c-8e6e84f4decf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_353cf085-e783-4a84-b32a-41e1e3538c42_terseLabel_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_label_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_documentation_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember" xlink:href="bsx-20210630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SpecialtyPharmaceuticalsMember" xlink:to="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_2d28ed9a-eeb0-4626-88dd-59b8d641b11a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_d2cac8ed-128f-4f0b-b975-7abd61908a2a_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_1cb06751-c483-4523-ba1f-1a45df879baa_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_d0fe0ab0-1d8b-415d-89e8-b171577bc31d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_947a0755-afb1-49f2-8a3c-e1222f776030_terseLabel_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:to="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_cdd9e6c0-d40d-4d52-a756-1a2b70612d5c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_f8a3c349-0328-4936-8e66-484194e78020_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_0cb49698-f59b-46d8-b098-ca3cd96ba9a6_terseLabel_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_label_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_documentation_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember" xlink:href="bsx-20210630.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForeigncurrencydenominatedindebtMember" xlink:to="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PreventiceMember_37dcc137-72a8-4cdf-8f81-f0b6eb1a66a5_terseLabel_en-US" xlink:label="lab_bsx_PreventiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice</link:label>
    <link:label id="lab_bsx_PreventiceMember_label_en-US" xlink:label="lab_bsx_PreventiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice [Member]</link:label>
    <link:label id="lab_bsx_PreventiceMember_documentation_en-US" xlink:label="lab_bsx_PreventiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preventice</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceMember" xlink:href="bsx-20210630.xsd#bsx_PreventiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PreventiceMember" xlink:to="lab_bsx_PreventiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_7825ea83-4115-47d0-949d-0c31bb1a171d_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT REPORTING</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b33014da-a101-4460-adb8-739445e3c9ab_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_e36fc266-82c1-4359-b872-3b784667d59a_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_6700e3be-6b14-4e7c-8af9-83b60b43bdb9_verboseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StateAGSettlementsMeshRelatedNumberOfStates_3f845fdf-b6a4-4e39-a6f3-c21929bdeaae_terseLabel_en-US" xlink:label="lab_bsx_StateAGSettlementsMeshRelatedNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State AG settlements, mesh related, number of states</link:label>
    <link:label id="lab_bsx_StateAGSettlementsMeshRelatedNumberOfStates_label_en-US" xlink:label="lab_bsx_StateAGSettlementsMeshRelatedNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State AG settlements, mesh related, number of states</link:label>
    <link:label id="lab_bsx_StateAGSettlementsMeshRelatedNumberOfStates_documentation_en-US" xlink:label="lab_bsx_StateAGSettlementsMeshRelatedNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State AG settlements, mesh related, number of states</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StateAGSettlementsMeshRelatedNumberOfStates" xlink:href="bsx-20210630.xsd#bsx_StateAGSettlementsMeshRelatedNumberOfStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StateAGSettlementsMeshRelatedNumberOfStates" xlink:to="lab_bsx_StateAGSettlementsMeshRelatedNumberOfStates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_c6f0d854-db8c-4540-b059-1eb298d9eb4e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_1c52e3c0-1e69-42a0-a216-a4e9b888cf5f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_27c07119-2ae7-4a53-b41e-046dbfdcb3e6_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_0f2a0e7b-a514-4ab4-b3c1-3534257286ba_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_45b8a06a-92ca-48cc-81fc-ed6fc43246da_terseLabel_en-US" xlink:label="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability claims, not filed, related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_label_en-US" xlink:label="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability claims, not filed, related to Greenfield Vena Cava Filter</link:label>
    <link:label id="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_documentation_en-US" xlink:label="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability claims, not filed, related to Greenfield Vena Cava Filter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:href="bsx-20210630.xsd#bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:to="lab_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_878a34d4-0bb3-4322-95d4-1aaca1bef173_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of businesses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_05f065d8-4774-4b01-9761-cfab9ccbee4c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_3296a2b9-db1d-468d-bd6e-5424bcbe35f6_terseLabel_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_documentation_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:href="bsx-20210630.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:to="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_da8a25aa-da51-4af9-9383-fa237c06e685_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_2e450bc0-1077-484c-8e1c-8f26787358f7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings, Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4fd4a320-3d06-4319-a5a0-6fb1c21108cb_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2030NotesMember_71a5a349-6ad2-4785-ba48-ab80ed4bd614_terseLabel_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_label_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_documentation_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember" xlink:href="bsx-20210630.xsd#bsx_June2030NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2030NotesMember" xlink:to="lab_bsx_June2030NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_58d669ba-b81e-4b15-83ca-c2e314763378_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_64e9360e-0211-4ec8-a2c8-0d2959bd5141_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_be016d4e-19b2-44fe-9ccc-cdf8e82dc331_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_b126e6ec-453b-4b5e-b3f1-237b605ee414_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_6d79323e-28ef-45fe-aa30-14ec1f583caf_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_893fa719-867b-43da-8788-d410f8717b85_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_476bf489-530c-4573-9e41-e48539d887f7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreference" xlink:to="lab_us-gaap_PreferredStockLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_11727ae8-fca8-4e49-bffc-7f826b610b38_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_7c822c30-ea5e-4810-9ab1-ad24e46ded1c_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_a93337fe-5d5c-427f-a638-4127715de6d9_terseLabel_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill [Line Items]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_label_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill [Line Items]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_documentation_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems" xlink:href="bsx-20210630.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems" xlink:to="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_e649a089-e32e-41c8-b22a-8d5732485f3f_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_35ddc214-b23f-422f-9627-21682b87ae24_terseLabel_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20210630.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_3a09cf7e-4ff5-4173-8c31-eee06fe0c96c_terseLabel_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_label_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_documentation_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets" xlink:href="bsx-20210630.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherOtherLongtermAssets" xlink:to="lab_bsx_OtherOtherLongtermAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_181e074e-c09a-41d6-a65b-173deb55b6ae_verboseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_5d592992-1127-4d14-97fa-8f3f7a0af62e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_cf9b909f-3f1a-44e7-8a0f-87ae466ba7eb_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_c2466615-7034-44bd-92a5-e0a45211245e_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_c3b13183-fde1-4009-aed5-c6f6e48f1a8b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_fb2a2492-9025-44a0-84b4-3b094f7db718_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average interest rate of de-recognized receivables</link:label>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_label_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable with Imputed Interest, Effective Yield (Interest Rate)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:to="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_375bfc28-95d8-46f9-80db-28a64decee56_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0939a1b2-3a14-4d60-aa75-548ea089934a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2fbed408-df0d-409c-ace7-59862a564993_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_00cdb555-7b32-4bff-9330-59f31944ce1e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) available to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_82ef9be7-fd23-4ba6-9084-ca43de5228cc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c1b80739-e470-4765-a802-f30ece4993fa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_34fe3e07-c944-4fac-affd-32c74a86fbb7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_October2023NotesMember_542f97b3-3f2b-4ede-9299-8c2b9d2c0b0c_terseLabel_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:label id="lab_bsx_October2023NotesMember_label_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:label id="lab_bsx_October2023NotesMember_documentation_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember" xlink:href="bsx-20210630.xsd#bsx_October2023NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_October2023NotesMember" xlink:to="lab_bsx_October2023NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_8b5e06ca-bed6-4d10-9714-e82e8e60eaac_negatedTerseLabel_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_label_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:label id="lab_bsx_PaymentsForRoyaltyRights_documentation_en-US" xlink:label="lab_bsx_PaymentsForRoyaltyRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for royalty rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights" xlink:href="bsx-20210630.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PaymentsForRoyaltyRights" xlink:to="lab_bsx_PaymentsForRoyaltyRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f187315-eded-414f-8f93-8b862957898c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CertifiedclassactionsinCanadaMesh_637994a0-b204-402f-974e-9f1b157f3eeb_terseLabel_en-US" xlink:label="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Canada, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedclassactionsinCanadaMesh_label_en-US" xlink:label="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Canada, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedclassactionsinCanadaMesh_documentation_en-US" xlink:label="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Canada, Mesh</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedclassactionsinCanadaMesh" xlink:href="bsx-20210630.xsd#bsx_CertifiedclassactionsinCanadaMesh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CertifiedclassactionsinCanadaMesh" xlink:to="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_8ecd2158-a0a2-4628-9e50-a7eb6530590b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_c3159a45-4d0a-406e-8691-a31fd5330e19_terseLabel_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:href="bsx-20210630.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:to="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_110d81d9-1c7d-43be-ae2a-0672ca1e545a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e6148068-154e-4744-b175-9caa22df7cdc_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_0f9d4e55-8411-46a8-90cd-2477c897d19c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_aefea529-d39f-4209-9a56-2c627b963a3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_205f9912-5ea2-4e51-92b3-d23995e19ec2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_066418d6-04f3-4ab5-92cb-57045d03835e_terseLabel_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Canada</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_label_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Canada</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_documentation_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Canada</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:href="bsx-20210630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:to="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_6f4d29b2-ac42-40cc-b756-13225a6b2bc9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_5a80998f-048a-4210-b73c-a8d2c1d2633f_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_bd1221e4-08ae-44af-9d34-ade9eff92cc2_terseLabel_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_label_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_documentation_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:href="bsx-20210630.xsd#bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:to="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_4ef8ec8d-d067-4f12-9a66-37a8c94487a6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5d0fa609-9735-416c-9f3f-732878938587_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_e1128a86-54b5-4943-9e9f-8b1c8c4a6e15_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_b5580102-da7a-4fa2-8c10-55ecb65f43d8_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (Shares Issued)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_07a147aa-6066-4c98-9fa3-5ebb9f80fb79_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (Shares Issued)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_3e9d4fd9-d144-49e7-8b0f-42b6c3aca5f2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_fa09e933-5bae-4bf6-873a-0f5d6b911411_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_8f33c896-c9be-4838-8bad-9fdfcb0267ec_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_af2ef92c-71b3-4454-8edc-1519f2d54065_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_f45260da-1c25-441a-abda-f50d16515d37_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_f682d5c7-9e5d-44f1-89e7-7eb63ea5b639_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_45449c1d-7cbd-4d06-9444-c943f1714b6e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_760a6eec-2078-4247-abe7-5d4731d8c6c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_fcba9303-78cf-4932-8f71-eb8e76f9c1cc_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_28942b4b-4c3e-42e9-b96c-2f7ae2f67aab_terseLabel_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:href="bsx-20210630.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_baf25357-d242-4d65-9413-40bdc770ad1e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_403b2260-8df9-451a-ab84-4f484225f3fe_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss)&#160;before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_39f9ddbb-3bdc-4f45-8c9c-7392670a17bf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract (less than)</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_9577e8cf-6ba1-4266-981c-219c28c238a1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_81ec9947-7704-41c3-9525-e50413a7fa72_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2af7fc2f-e59e-4f50-b7f3-33c0a94799b2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for acquisitions of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8ee2e798-c74a-422c-9bba-61e2eb0ffdda_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7a6a8e34-74b1-4cdd-9c7b-86fd8a0987a8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_873268bd-57f6-40ff-b52b-a731db546eca_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_1d2fa9ab-fc20-4aef-bf76-7d37874bc4cd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of preferred stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_239deaee-dcd6-43dd-8a46-71ee7751bae8_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of preferred stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DiscountRateFairValueInput_6c3c325b-eec3-4798-950b-e18064abfb25_terseLabel_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_label_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_documentation_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput" xlink:href="bsx-20210630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DiscountRateFairValueInput" xlink:to="lab_bsx_DiscountRateFairValueInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_3cf3c3f8-1048-48b9-9ee7-4082ebabca83_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4c67461c-5746-4f7f-8ef8-f1fe640e1ac0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingParValuePerShare_6114a94c-22c3-46df-a5a8-f5abb9e063d3_terseLabel_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:label id="lab_dei_EntityListingParValuePerShare_label_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityListingParValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingParValuePerShare" xlink:to="lab_dei_EntityListingParValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_bf41e4c3-25c0-4094-81bd-878ce447bf14_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term borrowings and debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ConvertiblePreferredStockThresholdTradingDays_412ed6b7-2c2f-4dc1-a604-bd9dad63b5bb_terseLabel_en-US" xlink:label="lab_bsx_ConvertiblePreferredStockThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Threshold Trading Days</link:label>
    <link:label id="lab_bsx_ConvertiblePreferredStockThresholdTradingDays_label_en-US" xlink:label="lab_bsx_ConvertiblePreferredStockThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Threshold Trading Days</link:label>
    <link:label id="lab_bsx_ConvertiblePreferredStockThresholdTradingDays_documentation_en-US" xlink:label="lab_bsx_ConvertiblePreferredStockThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConvertiblePreferredStockThresholdTradingDays" xlink:href="bsx-20210630.xsd#bsx_ConvertiblePreferredStockThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ConvertiblePreferredStockThresholdTradingDays" xlink:to="lab_bsx_ConvertiblePreferredStockThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ac5b2035-968e-4fe0-ba24-4d2df3ee4c31_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7c5b9c7b-0077-4f81-a146-63ee835aa49a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_839f6f39-9598-4c83-8972-d66410248123_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in defined benefit pensions and other items</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_536a4403-1f1b-4a45-9ba3-852b873a7d08_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_45a2ec43-4d70-405d-aca0-b3f9802a0836_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_5658e5c6-6fcb-416a-ba48-9fd1b1d14df1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_72ad05bb-45ad-4e25-a4f0-9cc21ce706de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent consideration recorded in purchase accounting</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EntityAbstract_06fae13c-86cf-4719-8f5a-96d7dddf3efe_terseLabel_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:label id="lab_bsx_EntityAbstract_label_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:label id="lab_bsx_EntityAbstract_documentation_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EntityAbstract" xlink:href="bsx-20210630.xsd#bsx_EntityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EntityAbstract" xlink:to="lab_bsx_EntityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ae2ae1c0-a31a-4be7-9bef-a95afb410d22_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_74886394-27d9-4abd-ac09-4354f60c08d0_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_95ed729d-2b68-4b7a-857d-7cb69170f6a4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementAsOfSeptember302021Member_acf63172-703b-4830-a3ee-53f5af92be0f_terseLabel_en-US" xlink:label="lab_bsx_RequirementAsOfSeptember302021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of September 30, 2021</link:label>
    <link:label id="lab_bsx_RequirementAsOfSeptember302021Member_label_en-US" xlink:label="lab_bsx_RequirementAsOfSeptember302021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of September 30, 2021 [Member]</link:label>
    <link:label id="lab_bsx_RequirementAsOfSeptember302021Member_documentation_en-US" xlink:label="lab_bsx_RequirementAsOfSeptember302021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of September 30, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfSeptember302021Member" xlink:href="bsx-20210630.xsd#bsx_RequirementAsOfSeptember302021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementAsOfSeptember302021Member" xlink:to="lab_bsx_RequirementAsOfSeptember302021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_a7e7159c-3f63-4255-b280-2b2fbd4b91d4_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_1748c165-09f1-4879-9799-df55037c8ff4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_f04f3aa8-8156-4be2-b6f3-23a084a97447_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_b5d62f58-ac50-48e3-a000-0cd65d5522f1_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization of allowances</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_7954b1fa-c0bc-4217-8274-b1a3d24d3c10_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_459e130b-57bc-4733-8b2f-89b5a3a05784_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC [Member]</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c40874cc-3e17-4e81-bd82-39c0336a6e07_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_22a13938-074d-493f-9008-bb26920fc775_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_08c9facb-a01e-431a-97b2-eadc775f985b_terseLabel_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_label_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_documentation_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights" xlink:href="bsx-20210630.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Noncashimpactoftransferredroyaltyrights" xlink:to="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e4e2323a-af6b-4d12-89ed-6c4802f5fe2a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_5389fe24-002d-41bf-939f-17768694d05b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_17a1d339-37c6-44c3-8c35-12e251731879_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Beginning Balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_70b0edf1-2040-40cc-a68c-c7643097532e_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Ending Balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_efecb7f7-f09f-4ec2-9863-945e9bf4ce0f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f193bdd8-a069-4d6e-a2c9-a7789ab4b2b6_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_3d79c9ab-5f56-4d4a-a9d9-43509e44fe29_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for legal matters that are probable and estimable</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock_9a76b802-d009-4a9d-8b52-5a496338cf9e_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments [Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock" xlink:href="bsx-20210630.xsd#bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock" xlink:to="lab_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_ddf59209-4134-416c-881b-abadd31cf7da_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_a277be02-d95e-4a19-a956-62e20669a593_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_477e1c07-9279-4cd1-92cc-4c64e7cbe7e9_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_d82bd869-36a2-4515-ab88-81e107b3998b_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_1de184ff-e032-4eda-a009-f32dcbaff633_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_8945723a-c7a3-4e58-ac56-5ed7f39b08e0_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_7a72ac60-78a2-4b8b-b4ad-f3358f34861b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_789e7792-3be9-42f3-b0a6-06f7214c2662_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_adc56652-a5bf-41a8-8b11-0fc7b9a1af58_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_bc54f2d9-0c22-49bc-8071-0d92bb276d14_terseLabel_en-US" xlink:label="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, third quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, third quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, third quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:href="bsx-20210630.xsd#bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_3791371e-efd9-4b9e-84e9-8d7d3f228da2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_4dc6b25f-3365-44a2-8684-da247f5afcbb_terseLabel_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:href="bsx-20210630.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f8f53b8d-dbe8-4095-8f6c-b541bd0d06dc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_1d5f48f7-c618-413d-a715-9baa928733b5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term borrowings, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_7f52c93e-4c53-43a8-ba17-f1496525994f_terseLabel_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred and prepaid income taxes</link:label>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow impact of deferred income tax expense (benefit)</link:label>
    <link:label id="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow impact of deferred income tax expense (benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:href="bsx-20210630.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:to="lab_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d7924029-0223-4b26-b313-a57e9c540cdc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_08bfb026-7d37-4c57-b02d-13f10d0eb747_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2c5f216d-4055-494d-bdc5-4cc321a9b974_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_d39a357d-927e-406e-b964-80fab208239c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_0eb3372f-bd1e-4718-aa7b-7ceead1f4bf0_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_951c7304-0edf-4660-8733-27ba9b14d01e_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_e81b624f-ff7f-4043-8db9-124715e10fe3_terseLabel_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember" xlink:href="bsx-20210630.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BSXReportableSegmentsMember" xlink:to="lab_bsx_BSXReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DebtInstrumentExtensionOptionTerm_d7f0095f-5e74-48ad-8b09-2bb2d6a46ac9_terseLabel_en-US" xlink:label="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Option, Term</link:label>
    <link:label id="lab_bsx_DebtInstrumentExtensionOptionTerm_label_en-US" xlink:label="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Option, Term</link:label>
    <link:label id="lab_bsx_DebtInstrumentExtensionOptionTerm_documentation_en-US" xlink:label="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Option, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentExtensionOptionTerm" xlink:href="bsx-20210630.xsd#bsx_DebtInstrumentExtensionOptionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DebtInstrumentExtensionOptionTerm" xlink:to="lab_bsx_DebtInstrumentExtensionOptionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_f359ed55-1375-42e1-8323-b962555dc9bb_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_a58e7f51-dada-4480-9361-1d22e56dc04a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_November2035NotesMember_81ee7956-df34-4d39-8d04-bfc3c9c6058c_terseLabel_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_label_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_documentation_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember" xlink:href="bsx-20210630.xsd#bsx_November2035NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_November2035NotesMember" xlink:to="lab_bsx_November2035NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_e1f8a8f0-6113-49e8-a7c9-727be058f332_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_70c71175-7df4-45e3-8a2d-c60d2df62d7d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_c1f8acdc-52ff-4cd2-8b13-157cb6fc6337_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_d6331058-7dba-4bda-8da9-6018ebef1295_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_1b5dedce-2bb4-42c3-b5fa-21199a8b98db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_ae018cd8-b173-4f51-be13-d00ce51517a5_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_5c3e2c30-f490-4d37-bcbd-602a1d5191d5_verboseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_e7eff8cd-ad5b-4821-85da-1319a97f1785_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_ea1eca26-0cf4-4444-a8c0-5cf97f26e17f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_156c3e69-990b-40f7-a25c-7dc9a0dd98e6_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_3ad42b01-2124-4380-8b0f-1c5520ab043e_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2ac4c515-90be-4981-ba11-e5e0ebab84b3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_4c2d5d2c-9c01-4cde-8e7f-fbd12c31065b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e3ef0f74-2c73-4d29-8ea8-c7dad8bc5071_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_39f5923b-63cb-4520-897b-8c7cd0ac294e_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b24d9eec-552b-4055-be0f-437ca1fd1351_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in derivative financial instruments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_018c4342-aff0-425c-83f0-5c86f017d715_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_ba7469d0-74d4-405b-a201-5aeed042c5d3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_70c7c3a8-9983-4e74-8f27-658f00c58475_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_e0d47900-8b5a-4266-b01e-2257912c02fd_verboseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_ec7144b5-c805-47e9-b1f0-14044ab55412_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_7ebd3096-495e-4bb6-86fc-83edfb4acf34_terseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:href="bsx-20210630.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_4a493941-a594-40ec-bdde-2ba17c2db1c6_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_c6db4cda-7fa5-4a6e-97bf-8c9a6db092e4_terseLabel_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition</link:label>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, seventh quarter following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:href="bsx-20210630.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_4a9c4a2c-123a-4978-90b8-19d94b99f415_terseLabel_en-US" xlink:label="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four succeeding quarters following qualified acquisition</link:label>
    <link:label id="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four succeeding quarters following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, four succeeding quarters following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:href="bsx-20210630.xsd#bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_bbf83308-e362-4e78-81f0-14cc5adbaa8c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_2a80453f-66b1-4d47-ba04-6c0c2ef3ac51_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_9c1dc044-d66c-4dae-a3b2-54f2f093ad5f_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_a28d179a-8f0b-46f6-9201-54e041a9f75b_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_a93c8d4a-2c6e-4ba9-a392-796bcfb745c3_verboseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:href="bsx-20210630.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_e5dbd4fb-8fa6-48a9-91f1-e486d917c99c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementAxis_7e63db98-6b1a-4d55-b4c1-04fa72d42d91_terseLabel_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_label_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_documentation_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis" xlink:href="bsx-20210630.xsd#bsx_StatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementAxis" xlink:to="lab_bsx_StatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_dc24c90b-7601-444c-83a9-0d05fc8e96a8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_77015754-9106-4f4e-bcf6-8288d86a9874_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ba8c6d0d-0b6b-4961-9f04-64af996bb9bd_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4d3dbdf8-3f2f-4866-97d6-7e971e900df7_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_26f76669-6549-4abb-9758-907b8b980901_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_056139ca-0d46-4958-a7fc-4162f7191524_verboseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3476898e-e064-4f14-870c-2ef892306f7d_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0c8f9f0d-888d-486c-89c6-7db97e7fc80c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_ecf9aa6f-9d90-48f6-b812-a97c68b2c029_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_d1ac0ffa-b249-46a4-bc25-a28b17e2ec34_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangementsasset_95ed7963-8e77-422c-8054-1afb62162dc2_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_Licensingarrangementsasset_label_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_Licensingarrangementsasset_documentation_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangementsasset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangementsasset" xlink:to="lab_bsx_Licensingarrangementsasset" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_e3cc4449-e8c7-4c6c-9eb4-ca051bd181e1_terseLabel_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_label_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_documentation_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:href="bsx-20210630.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:to="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bdfc70c7-ee83-4aa7-8190-0a64cd9b008c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0ab4c40a-4bc1-4641-b7a1-ab327a886da5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_edbaac58-d64f-4095-91fa-42dc18b249cd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_c7233a37-21ce-46b8-886c-d30f1f4045bd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_8696dc9d-2c7c-4bd2-9930-03ca10cd4dc8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_289e5209-9714-4e62-a21a-aa9572f807e6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_4bff79d4-1a2d-4ff1-b93f-5de8a60450c3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock_5000cc6b-ee98-478b-82e1-c33aaf32eb9d_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:href="bsx-20210630.xsd#bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_a1e51f27-c746-46b5-b856-71985e0d6f60_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_be614769-8fcf-42a7-bef6-beed43ab14ad_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_76229efa-a38c-4464-8422-012c92e64c7a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_87332573-83de-468f-8ede-33b3dbb241a1_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ba96bf57-e9f0-4403-9ff9-2a9be844c0cd_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration net expense (benefit)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ccb0a956-7e43-4870-8000-406b0d84cafb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration net expense (benefit)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LumenisLTDMember_37cf3e4b-962d-4e94-8702-95933054a5ca_terseLabel_en-US" xlink:label="lab_bsx_LumenisLTDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lumenis LTD</link:label>
    <link:label id="lab_bsx_LumenisLTDMember_label_en-US" xlink:label="lab_bsx_LumenisLTDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lumenis LTD [Member]</link:label>
    <link:label id="lab_bsx_LumenisLTDMember_documentation_en-US" xlink:label="lab_bsx_LumenisLTDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lumenis LTD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisLTDMember" xlink:href="bsx-20210630.xsd#bsx_LumenisLTDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LumenisLTDMember" xlink:to="lab_bsx_LumenisLTDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_0adbc6de-a021-49bb-9cf8-7427f99f53b0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_18b4c873-827f-4c64-94a5-7fa0c1efe1e3_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_80616d90-5628-4eb7-89e1-9a0a974bd149_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:href="bsx-20210630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_67ec4a43-8026-477b-8ce5-cea812756bf8_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges to expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments_6beaed2e-6810-4672-b154-cfa402ca1689_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements, Asset, Percentage Of Future Royalty Payments</link:label>
    <link:label id="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments_label_en-US" xlink:label="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements, Asset, Percentage Of Future Royalty Payments</link:label>
    <link:label id="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments_documentation_en-US" xlink:label="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements, Asset, Percentage Of Future Royalty Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments" xlink:href="bsx-20210630.xsd#bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments" xlink:to="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold_5dc68133-a3d0-4ebd-985f-d73aa8ec3dda_terseLabel_en-US" xlink:label="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements, Asset, Percentage Of Future Royalty Payments Sold</link:label>
    <link:label id="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold_label_en-US" xlink:label="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements, Asset, Percentage Of Future Royalty Payments Sold</link:label>
    <link:label id="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold_documentation_en-US" xlink:label="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements, Asset, Percentage Of Future Royalty Payments Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold" xlink:href="bsx-20210630.xsd#bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold" xlink:to="lab_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_4f59c03f-13c2-454c-b76a-3b16ab0de076_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6f0125a8-126c-46ca-a6c4-a727136406c2_verboseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_958ae3af-65e9-4085-813b-2b1f66fcd041_terseLabel_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_label_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_documentation_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity in Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:href="bsx-20210630.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:to="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_53adb4b9-3b8d-4c77-8dec-6d7aba0a18e2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_fda17c4c-6389-4842-9d38-ee28a4cb7f68_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_a763f3cf-e3e8-4e83-ab08-bb88e7261f2e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_2609b2d5-e989-414f-80aa-dd047224f2e2_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockCash" xlink:to="lab_us-gaap_DividendsPreferredStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2049NotesMember_64f215bc-e725-41fb-a15b-80bd104c5771_terseLabel_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_label_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_documentation_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember" xlink:href="bsx-20210630.xsd#bsx_March2049NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2049NotesMember" xlink:to="lab_bsx_March2049NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2039NotesMember_647cefc6-58e7-4ca4-9b5c-432382521860_terseLabel_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_label_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_documentation_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember" xlink:href="bsx-20210630.xsd#bsx_March2039NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2039NotesMember" xlink:to="lab_bsx_March2039NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_00e57e2e-1245-4fd1-90fc-acb6ea867bc1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_be399ae8-3879-4902-a464-4f542d94a081_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_48c20fb5-700b-49ec-a55a-ae242a4de62d_negatedTerseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_label_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:href="bsx-20210630.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:to="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod_16c91fed-9d4c-4a64-840c-86c9e4a2abaa_terseLabel_en-US" xlink:label="lab_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Higher Leverage Ratios Qualification, Period</link:label>
    <link:label id="lab_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod_label_en-US" xlink:label="lab_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Higher Leverage Ratios Qualification, Period</link:label>
    <link:label id="lab_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod_documentation_en-US" xlink:label="lab_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Higher Leverage Ratios Qualification, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod" xlink:href="bsx-20210630.xsd#bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod" xlink:to="lab_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EmergingMarketsMember_7650e019-0151-41fb-afe1-b50f877b14ba_terseLabel_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_label_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_documentation_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember" xlink:href="bsx-20210630.xsd#bsx_EmergingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EmergingMarketsMember" xlink:to="lab_bsx_EmergingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_ce052e2d-8a7f-4358-b29f-f053b73a235a_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_3c12d495-145e-4fc2-90dd-e082973b4806_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_fc9e77ac-dbdc-4a5f-b759-0f2f53e54680_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_d902d9d1-76fa-4599-a68b-561dc3c828b8_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_2ab14443-11fb-4e68-ae56-60bb2756fd95_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_4d1e3a16-b4f0-4dc2-9ecc-1068febcca29_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_2317b6da-51e0-4483-84b4-8bc53124ee40_terseLabel_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility</link:label>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_label_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility [Member]</link:label>
    <link:label id="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_documentation_en-US" xlink:label="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of December 31, 2021 and through remaining term of facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:href="bsx-20210630.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:to="lab_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_740b6001-d0c5-4be6-8605-5408c748c54f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ac884918-a38c-48a6-9fd1-72367e852606_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementAsOfJune302021Member_0c35adce-7c36-4377-a334-3bad32cf7c5b_terseLabel_en-US" xlink:label="lab_bsx_RequirementAsOfJune302021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, extension through the remainder of 2020 [Member]</link:label>
    <link:label id="lab_bsx_RequirementAsOfJune302021Member_label_en-US" xlink:label="lab_bsx_RequirementAsOfJune302021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of June 30, 2021 [Member]</link:label>
    <link:label id="lab_bsx_RequirementAsOfJune302021Member_documentation_en-US" xlink:label="lab_bsx_RequirementAsOfJune302021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, as of June 30, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfJune302021Member" xlink:href="bsx-20210630.xsd#bsx_RequirementAsOfJune302021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementAsOfJune302021Member" xlink:to="lab_bsx_RequirementAsOfJune302021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_94538bb5-eb50-4428-9bac-62b5982860fe_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_9acb9c4c-aa4a-4c94-abd3-80113e255bab_terseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_label_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:href="bsx-20210630.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:to="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_79c00a1f-711b-4d26-91a6-e63c1f9b16ca_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:href="bsx-20210630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_ea9eef25-d664-446a-8d84-b887eca12f4a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_9cb1789a-99b8-4901-8583-f98d46416f58_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and restricted cash equivalents included in Other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6439a6fa-41a0-4c94-bf43-a566915e4b31_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents in Other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TheCARESAct_7405bbb8-045d-40e3-8fe7-e78fb6763e90_terseLabel_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:label id="lab_bsx_TheCARESAct_label_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:label id="lab_bsx_TheCARESAct_documentation_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheCARESAct" xlink:href="bsx-20210630.xsd#bsx_TheCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TheCARESAct" xlink:to="lab_bsx_TheCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0558b69b-fbc2-4cf8-88c7-ea967ef931bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_cd34525c-5420-4e74-a6cc-d0929aad0c2c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_ae1189f6-b2ba-4ba1-9c87-2cb2f2a9ada4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_5bee5132-cc05-43e8-80fd-d1bb6f0fd825_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_43e14efd-8b12-451d-b9b9-f138363b00ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_31331f77-5473-4ccc-bea9-c9a2f3e7b4b7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_63ac33a9-e3e9-43f4-86cf-e173678fc6f6_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_6c75bf2a-e03e-4c0d-9010-91b1baa89835_terseLabel_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter following qualified acquisition</link:label>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter following qualified acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:href="bsx-20210630.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:to="lab_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_cf85735a-7c95-4399-8e1d-624157d7e5ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_a749e8ec-2094-4a6e-8046-3bea73e6ec43_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal reserves, current</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_2194e059-0741-4897-9a43-3225733fab4f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_31e702bb-bf16-43f1-9fb0-2b12b60a81ee_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_fc3d71a6-b5a1-4b00-bcba-eea84781e88e_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_df2c3542-3c8c-4556-910b-b5cce35e2e54_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_0cd49f09-0eaf-48bf-9bfe-b2d8f539208e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_b18c62ba-6ee4-4664-b0d1-f0fa0e529f6a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5b3bf9a4-f4ac-416e-96bd-04d4703b5ad1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assuming dilution</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6074be7f-bd67-4fdb-b6f5-0ab88f62a0ed_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_e639de7d-447b-48f2-a885-037eeea5cbd6_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c530d6e1-d2d1-4907-9f1f-3ba91666cfdd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)&#160;per common share &#8212; basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_20798295-d1f4-4a96-9e0e-f43c6f417201_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_7c71db8b-03b1-4093-b391-460b03e3b3f9_terseLabel_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_label_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_documentation_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:href="bsx-20210630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:to="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_d7c6603d-b776-45f1-8a0e-1414f272d6e7_terseLabel_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:href="bsx-20210630.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:to="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_08ab4b06-b7ab-442a-b396-658b6f629f9f_terseLabel_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issuance (Value in excess of par)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_label_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Preferred stock)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_documentation_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Preferred stock)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:href="bsx-20210630.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:to="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c05b17f2-93ea-46ea-8ff1-fe3f441ab138_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_8518ae02-fa32-4e7e-af8a-bdb64519f5c7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_41a56102-b88e-4e4f-aa5c-c2137d5cc225_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_33c193b5-32c7-4ad6-9b78-04508f387306_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2022NotesMember_4213afae-90cc-494a-80b8-d41098d76d7a_terseLabel_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2022NotesMember_label_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2022NotesMember_documentation_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember" xlink:href="bsx-20210630.xsd#bsx_May2022NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2022NotesMember" xlink:to="lab_bsx_May2022NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_5f6c28a8-bf7c-484c-8e4b-9726a8434c6c_terseLabel_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_label_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_documentation_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember" xlink:href="bsx-20210630.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingarrangementassetsMember" xlink:to="lab_bsx_LicensingarrangementassetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_56cb5863-486e-4d16-ba04-a010f675ab8e_terseLabel_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_label_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:href="bsx-20210630.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:to="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b5e8c8d2-0117-4a8d-8de6-1175fa5f1c12_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_fd8bfe9d-5a63-4a6b-b59c-be212460565e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IntangibleAssetsAxis_27b54fb0-e26c-4fbc-ba77-899e198456ef_terseLabel_en-US" xlink:label="lab_bsx_IntangibleAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Axis]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsAxis_label_en-US" xlink:label="lab_bsx_IntangibleAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Axis]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsAxis_documentation_en-US" xlink:label="lab_bsx_IntangibleAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsAxis" xlink:href="bsx-20210630.xsd#bsx_IntangibleAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IntangibleAssetsAxis" xlink:to="lab_bsx_IntangibleAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_52c32979-0c54-425b-8c6f-122d823b1762_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_0728a767-56a7-4c2d-97ac-675444adce0a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_61778bbc-fceb-446d-b4a6-70d634c9cf92_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,685,006,608 shares as of June 30, 2021 and 1,679,911,918 shares as of December 31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_012574af-9f7e-458e-851b-59e1cbe24f7c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7b6ec335-8ea0-4bbf-ba99-75fdceb017ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_5f630dae-acca-4a51-b69f-adb1bb813d95_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_718f6e55-d232-45b7-8a94-30f97525f40c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_December2027NotesMember_829c61ea-db71-483b-9320-264a55f470dd_terseLabel_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_label_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_documentation_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember" xlink:href="bsx-20210630.xsd#bsx_December2027NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_December2027NotesMember" xlink:to="lab_bsx_December2027NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfFacilities_bced60fc-3d13-4cfe-8c06-a70bf7b16d5f_terseLabel_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of facilities</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfFacilities_label_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of facilities</link:label>
    <link:label id="lab_bsx_DivestitureAgreementTransferOfFacilities_documentation_en-US" xlink:label="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture, agreement, transfer of facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfFacilities" xlink:href="bsx-20210630.xsd#bsx_DivestitureAgreementTransferOfFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DivestitureAgreementTransferOfFacilities" xlink:to="lab_bsx_DivestitureAgreementTransferOfFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_03a846ae-6b37-4b54-89d4-dcc08dde9ed3_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_f63999ad-009c-493f-9654-e5400a84d3e8_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_fcfd255b-c671-47d3-8139-9ae72560cf86_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_4be72c7d-3399-4b97-bc91-e281c526ef50_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IntangibleAssetsDomain_77f242d7-bd36-4738-9244-5ea9ae27df8b_terseLabel_en-US" xlink:label="lab_bsx_IntangibleAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Domain]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsDomain_label_en-US" xlink:label="lab_bsx_IntangibleAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Domain]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsDomain_documentation_en-US" xlink:label="lab_bsx_IntangibleAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsDomain" xlink:href="bsx-20210630.xsd#bsx_IntangibleAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IntangibleAssetsDomain" xlink:to="lab_bsx_IntangibleAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_66d1f08c-26d2-44c1-8a4e-f067252ae6e3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_bcafe8b8-22ca-485f-8de6-cc9e156220f4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c0443955-4d18-4b4c-9b02-f0b498bb0879_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e268b9a2-b34b-436e-9359-3c257327b5dc_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_f80bb319-68ba-4293-a352-b0844bee9dda_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_3607938c-b707-4eea-8613-4aed51fa8d31_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_8ef961e8-c7c1-48ef-8cec-18b9ce046c98_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AssignedtoonejudgeinMAMember_b325f216-a262-4c02-906f-4c40abc6aa69_terseLabel_en-US" xlink:label="lab_bsx_AssignedtoonejudgeinMAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assigned to one judge in MA [Member]</link:label>
    <link:label id="lab_bsx_AssignedtoonejudgeinMAMember_label_en-US" xlink:label="lab_bsx_AssignedtoonejudgeinMAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assigned to one judge in MA [Member]</link:label>
    <link:label id="lab_bsx_AssignedtoonejudgeinMAMember_documentation_en-US" xlink:label="lab_bsx_AssignedtoonejudgeinMAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assigned to one judge in MA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssignedtoonejudgeinMAMember" xlink:href="bsx-20210630.xsd#bsx_AssignedtoonejudgeinMAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AssignedtoonejudgeinMAMember" xlink:to="lab_bsx_AssignedtoonejudgeinMAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CertifiedClassActionsInAustraliaMesh_58cdf4b8-37cc-4cc4-9b6f-5caa9ad81f7b_terseLabel_en-US" xlink:label="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Australia, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedClassActionsInAustraliaMesh_label_en-US" xlink:label="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Australia, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedClassActionsInAustraliaMesh_documentation_en-US" xlink:label="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Australia, Mesh</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedClassActionsInAustraliaMesh" xlink:href="bsx-20210630.xsd#bsx_CertifiedClassActionsInAustraliaMesh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CertifiedClassActionsInAustraliaMesh" xlink:to="lab_bsx_CertifiedClassActionsInAustraliaMesh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf9c5e30-8d80-4a3f-b3d7-3df1edc699dc_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_93959633-6f74-45b7-889f-b9262ee18ff1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_bfbcc164-5ad4-4dab-ab04-0b7e3162183d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2fb589f2-7095-4065-bce3-1fd0dd5f683a_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2026NotesMember_327a61bf-a274-4a9a-b2a7-4283c7d7d3c0_terseLabel_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_label_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_documentation_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember" xlink:href="bsx-20210630.xsd#bsx_March2026NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2026NotesMember" xlink:to="lab_bsx_March2026NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EurodenominatedoutstandingdebtMember_596e755b-a2d3-4c98-8a6c-5d615dcc4118_terseLabel_en-US" xlink:label="lab_bsx_EurodenominatedoutstandingdebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt [Member]</link:label>
    <link:label id="lab_bsx_EurodenominatedoutstandingdebtMember_label_en-US" xlink:label="lab_bsx_EurodenominatedoutstandingdebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt [Member]</link:label>
    <link:label id="lab_bsx_EurodenominatedoutstandingdebtMember_documentation_en-US" xlink:label="lab_bsx_EurodenominatedoutstandingdebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EurodenominatedoutstandingdebtMember" xlink:href="bsx-20210630.xsd#bsx_EurodenominatedoutstandingdebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EurodenominatedoutstandingdebtMember" xlink:to="lab_bsx_EurodenominatedoutstandingdebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_6fcf80f1-c13e-4e1a-8952-edd47eb26d43_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_b7e64740-f9f0-4c25-8c6a-e67d60f13282_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_e03b418f-b60f-4493-9b40-7e53bd2b231f_terseLabel_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen denominated factoring arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:href="bsx-20210630.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SpecialChargesMember_3e0a29ec-8740-498d-92d3-3d2822e2e7f0_terseLabel_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_label_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charges [Member]</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_documentation_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember" xlink:href="bsx-20210630.xsd#bsx_SpecialChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SpecialChargesMember" xlink:to="lab_bsx_SpecialChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_25630e8d-5b66-42d8-8303-cb56e81c1c29_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_5a664450-9905-4f81-9b64-e0e7925c749a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_a9ac9d55-8f8f-40e0-876e-bcc2be4a3424_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_0f044815-9848-4a61-918a-f2e8ccd4bfc7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_d6f556bf-86e8-4560-9f69-83da5b14beab_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:href="bsx-20210630.xsd#bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_83f010b2-d27c-4013-9857-2ac9137bf157_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_dea5781b-7523-4644-8a2c-53477e766e88_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_0d6960f3-d342-42ba-b282-6adeedb86606_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11dcbd83-2bb4-4606-ac08-834d4f60aca4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_d5bcdd55-de6c-46f5-9068-864065c7d58a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_ba24020e-f040-4f66-900c-c9d9bb0f6c3b_terseLabel_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Text Block]</link:label>
    <link:label id="lab_bsx_NewAccountingPronouncementsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:href="bsx-20210630.xsd#bsx_NewAccountingPronouncementsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:to="lab_bsx_NewAccountingPronouncementsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_db6a2483-d954-47da-a1b3-1b21aacdb5bd_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_fca34de8-9808-49f2-a307-d76d54f1d88c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_09ac81e7-5baa-4cc7-b366-55196951103c_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2025NotesMember_ce8d8dfe-bb82-4da2-b0f3-54aa0fc71fab_terseLabel_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_label_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_documentation_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember" xlink:href="bsx-20210630.xsd#bsx_June2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2025NotesMember" xlink:to="lab_bsx_June2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_86647ccc-f496-446e-87cb-b5f4671412a5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_ff267b44-bc53-4506-8d21-a8c0559e14e3_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3f2e6516-e292-4af6-8fb2-997fdc2962ff_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_809a2640-a15a-4bcb-a596-d14d9a00ebc0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_64f1bb12-146c-42ad-ac88-941917ff1c86_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d249ead1-1f91-4248-bea6-3a7267069a43_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_37a188aa-d753-4021-a869-69c8a6f0cc50_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5d60dc1f-d5e3-47d2-8cb2-b65e3e96f8ee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EmergingMarketstotalnumberofcountries_2390e79d-29d9-4232-9055-61ca961a2c29_terseLabel_en-US" xlink:label="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total countries</link:label>
    <link:label id="lab_bsx_EmergingMarketstotalnumberofcountries_label_en-US" xlink:label="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:label id="lab_bsx_EmergingMarketstotalnumberofcountries_documentation_en-US" xlink:label="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketstotalnumberofcountries" xlink:href="bsx-20210630.xsd#bsx_EmergingMarketstotalnumberofcountries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EmergingMarketstotalnumberofcountries" xlink:to="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_96507df9-40a9-4ce4-ad1b-b6c63da06102_terseLabel_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product</link:label>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_label_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product</link:label>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_documentation_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims asserted related to mesh products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:href="bsx-20210630.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:to="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_a28409b8-2bcf-4cd3-b040-5ad8e631de80_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_5146d029-e375-4388-a126-948efcebae3c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_84201ab4-45fe-497f-967e-22378f41c29f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f081a7fb-8c95-4e7d-b9eb-5f4100c68679_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c2113f5f-5a79-423e-87d8-0c45ae2fd4a2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_a435670f-253c-408c-9b53-c4463c7f984f_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2024NotesMember_5cb2f678-9e89-412b-9503-e10882e22567_terseLabel_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_label_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_documentation_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember" xlink:href="bsx-20210630.xsd#bsx_March2024NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2024NotesMember" xlink:to="lab_bsx_March2024NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_0f4f8b3e-1207-46a5-a3f9-ccd23a417b60_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_dbacc53f-3da4-46f8-8ac6-2a6f7aa23620_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_04bfab87-e959-441c-9b3f-a89eb6256707_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_c96077b0-3991-4d6b-98db-09dd7fe65098_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_dcafc96f-50f7-4ee7-9ec1-aac9a1f0a4b1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_007fa548-cd69-41d1-a259-e758a7f7b4dd_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b19641b2-cd65-47da-8cab-c9b302c25239_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_7832da24-ba7f-48af-b7ce-6eb9b5c7dd66_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_8ddda57d-1dd9-46ca-bdb8-1baeba65a934_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid on preferred stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_4ec5c987-33ee-4ef4-8187-3aab319bde66_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_b502b92a-7d1a-4eb3-84fd-a1ea8cc02293_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b5b8a417-36d2-4ce1-a86e-22c9a043b85b_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8c4cc6f6-c629-4fda-b916-ff6470a3db9f_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9c8e2164-10c1-4c67-95b7-78f2462e5e82_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_7099f56a-3b6c-4328-a718-3e2b5804c25f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_940c862d-e6be-4b0a-a05f-96e1bf6e4ccf_terseLabel_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_label_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_documentation_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:href="bsx-20210630.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:to="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_4928c7bc-dbed-456c-ae59-b0e478486179_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_1408affa-c6db-4bcb-9505-40a14adb68bc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_c01a0060-ecce-49c7-abb9-da8e1185c2b2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_9db130d3-f753-46b4-aefe-9503a0208d21_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4254de18-eac4-41ac-9573-89c4bbd255ad_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0beb1f83-2863-410f-8fff-0b10b46b6cdd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_4d690742-ed0e-49d8-bc5d-bf14f456d755_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_619fc44b-41ed-461f-984c-3818a8a4215b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_b267c77f-7b29-4527-82b7-471fcf69c258_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_7b92d5bf-de1e-48f0-857c-4635f7dfad53_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_5d9ffda8-2941-4c4b-bb4f-9eebf4538d45_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_fab97f51-e061-429f-a9a7-34b76b7d2ebf_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_9dc66428-77ca-4841-bc9c-7ea073759cb8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_12f95fe8-9f1f-4782-bac1-7babf62502ea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_8bddca6a-c342-4819-9f06-048c6da36a1c_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring net charges (credits)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e8def50f-ca36-41c9-8db2-12196c050619_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_0e596263-d838-4a5d-aea6-3f3c08fa9b32_terseLabel_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_label_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_documentation_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember" xlink:href="bsx-20210630.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LatinAmericaandCanadaMember" xlink:to="lab_bsx_LatinAmericaandCanadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_7840eb32-0297-4a6a-a059-15ff76861205_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c6e0838c-1bbb-4e03-b09e-50c5270af4b3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_ed2de0b5-f732-4bfe-a9bc-dfb85b872b4d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementDomain_2a3cc5fe-b2e8-49ab-ab73-5c1c7d95a642_terseLabel_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_label_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_documentation_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain" xlink:href="bsx-20210630.xsd#bsx_StatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementDomain" xlink:to="lab_bsx_StatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeRemainingMaturity1_82caa53f-5154-483f-a56f-cca4262b6cba_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeRemainingMaturity1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Remaining Maturity</link:label>
    <link:label id="lab_us-gaap_DerivativeRemainingMaturity1_label_en-US" xlink:label="lab_us-gaap_DerivativeRemainingMaturity1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Remaining Maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeRemainingMaturity1" xlink:to="lab_us-gaap_DerivativeRemainingMaturity1" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_c02a3b9e-4a4c-4345-99d2-32b9eb5ef24b_negatedTerseLabel_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange (gain) loss</link:label>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_2c130caa-177f-4d1b-83d7-9ec91325cc6b_terseLabel_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_label_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_documentation_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss" xlink:href="bsx-20210630.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Netcurrencyexchangegainloss" xlink:to="lab_bsx_Netcurrencyexchangegainloss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_3a5c609c-06d9-4547-a831-5a1c7890de41_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d2c4579f-3f9c-425f-9f3c-864be099d428_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_aa7d3ea5-6131-483d-9e96-be5dda7cb13d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_4c073d1f-4a9b-4688-9a79-a36dc1dbec14_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_e775129b-d15b-492f-b964-498cc6cb900f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_0ff8c05c-8416-4d3d-816a-cbc2eeb92eb0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare_c026048b-aaa4-47b7-9237-5d65b5e89c56_terseLabel_en-US" xlink:label="lab_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued For Each Converted Share</link:label>
    <link:label id="lab_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare_label_en-US" xlink:label="lab_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued For Each Converted Share</link:label>
    <link:label id="lab_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare_documentation_en-US" xlink:label="lab_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued For Each Converted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare" xlink:href="bsx-20210630.xsd#bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare" xlink:to="lab_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_7dd35c71-ca0c-4111-96f7-aa0814189dc8_terseLabel_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:href="bsx-20210630.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:to="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_c3dc8b25-bbdf-41a8-9b76-dc902d5c4bdb_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_011eb906-9bba-44e9-8083-d2a1111caae4_terseLabel_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_label_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of term loan and revolving credit facility agreement compliance with debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:href="bsx-20210630.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:to="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_e3d70d78-9d92-4ab5-a8c8-056f18e026a1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_b8863b73-dd05-48b1-8a90-2ef1ad7fad42_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_3461dad0-a219-47e6-b71c-1db2f750a670_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty expense</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_bf7fc8fa-2773-4181-bd5d-7dc5d4507371_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_6661d3d4-6bff-47ab-b4f7-decc1bf84063_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_ef25ec59-5071-4be4-9817-2872ff0de733_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_f1d9831b-10a7-41a5-ab87-5ad95e8e6c9e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaximumLeverageRatio_3c4e10ab-953d-4b79-8699-18781d906822_terseLabel_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_label_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_documentation_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum leverage ratio permitted by revolving credit facility agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio" xlink:href="bsx-20210630.xsd#bsx_MaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaximumLeverageRatio" xlink:to="lab_bsx_MaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_65c7871e-b706-452d-bcb4-f3c6b706fadb_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_a75d3051-7ff7-479c-a164-4bc84daf010a_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_3d733663-73c7-4500-8aaa-c59d0d1ff643_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_6cd09ce9-57d5-4238-9861-6619accbb061_terseLabel_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:href="bsx-20210630.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:to="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_b8ec29f8-7262-433b-a850-74db92614b3b_terseLabel_en-US" xlink:label="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter following qualified acquisition and through remaining term of facility</link:label>
    <link:label id="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_label_en-US" xlink:label="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter following qualified acquisition and through remaining term of facility [Member]</link:label>
    <link:label id="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_documentation_en-US" xlink:label="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, eighth quarter following qualified acquisition and through remaining term of facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:href="bsx-20210630.xsd#bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:to="lab_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8285c962-ae94-42cf-833e-2e0ce61edecf_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance (Shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_01c2ab51-ec3c-42fd-9658-a558d5f85d40_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_06b24d51-08ae-4336-ae07-302cca8e42fc_terseLabel_en-US" xlink:label="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Australia</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_label_en-US" xlink:label="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Australia</link:label>
    <link:label id="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_documentation_en-US" xlink:label="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Australia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:href="bsx-20210630.xsd#bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:to="lab_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_c7760216-8446-4c10-81ce-aad1bff14113_terseLabel_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_label_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_documentation_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember" xlink:href="bsx-20210630.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RevenueBasedPaymentsMember" xlink:to="lab_bsx_RevenueBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_80cc82f2-43b9-44a8-bd82-1002854a67b9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:to="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_eee1ffdc-b6d1-45b3-a542-17899ac03ab3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_a7980331-de97-42b8-ba22-a0dfda2dabfa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1c841211-5cf9-4b0c-b2b6-74e76dcf2e6d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_fa8ba136-2d4d-4e31-a116-c7de0ae07295_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_b9a0484e-9b83-4cc6-8d33-966f4ade1489_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_db39bd07-daa0-452c-9e32-4b55716cc31e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a8a1cf3b-f408-4746-bb44-f7843652be48_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_5f76b76d-517d-4daa-9ed0-a7e00ccbacde_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_bc2d0931-b38b-4fcb-b883-4d0e4e97b6d9_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND STRATEGIC INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_28ee9a35-a9bf-4ab3-b4ee-fc304bc0e318_terseLabel_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember" xlink:href="bsx-20210630.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalCrmReportingUnitMember" xlink:to="lab_bsx_GlobalCrmReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_3620ef8a-238f-4487-ad03-0f0a6ef5c231_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_44bfd8a3-1ae2-4243-812b-02bb766fdf49_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_0f38b0ad-6aa1-4b9f-929e-41b493df994b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_a3d4ee21-c449-4928-b251-5db2572374bc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Investing Activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_91603f71-3b58-4134-a245-a1921015b84f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_78c5ce79-4416-478d-8055-805593ed6ffa_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_f6297720-c36f-45eb-8694-a62feb7c0cdf_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_029d90bc-9c6c-4bc9-b9b1-8aaec040aa7a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_542c1440-fe50-4814-899f-efe31ea66573_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4d218467-94a1-4f13-86f3-74b5e8ba276f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_0f96ffc5-0a8a-4b0a-be6d-3997c9edc78c_terseLabel_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_label_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_documentation_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:href="bsx-20210630.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:to="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_ec5244b6-fb56-4598-965a-c717aabb5fbf_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_1451772c-9fe3-4877-a4f4-9809cb54dda9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_801dd0da-a0d0-4521-9db8-35a216d71e88_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_4b019db5-4b10-43bf-882b-11986155bed9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e5c30b12-597f-4e95-b71b-39794b889592_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement alternative investments(1)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_72b9554b-77e2-4f07-b437-56ce3f0d366d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ea15fc1f-9310-444c-8721-207236031416_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_86e29ba6-9308-4e5e-9202-1d236b652550_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_f39ae123-ea7e-41a5-82f3-7460e44cd743_terseLabel_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:href="bsx-20210630.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:to="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareDeclared_69da61b4-814f-4a2b-8d49-0fc94b697c8a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_fab302b0-8659-462b-bf00-5e18069799bd_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CurrentRequirementMember_f6df9d8d-3775-44f8-ab5d-970028e16d10_terseLabel_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement [Member]</link:label>
    <link:label id="lab_bsx_CurrentRequirementMember_label_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement [Member]</link:label>
    <link:label id="lab_bsx_CurrentRequirementMember_documentation_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember" xlink:href="bsx-20210630.xsd#bsx_CurrentRequirementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CurrentRequirementMember" xlink:to="lab_bsx_CurrentRequirementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_24b64622-d116-40bd-b61a-7edcf42435f2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_8ff22b24-6bf9-4036-83f0-5a7e8a963983_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_efddad08-de8e-4757-a718-c56da64a6e7e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangementsliability_00c0ae7e-4b4a-4f8f-a660-fbe0cdf0e3b4_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_Licensingarrangementsliability_label_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_Licensingarrangementsliability_documentation_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangementsliability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangementsliability" xlink:to="lab_bsx_Licensingarrangementsliability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a099e51c-330c-4192-ae0c-cbb8f216daad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_b2376722-82ba-4927-b0b7-d6eb48fe304f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AccruedRebatesCurrent_0f9b26c4-9e3b-4ab5-b0ce-705c5d40c311_terseLabel_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_label_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_documentation_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent" xlink:href="bsx-20210630.xsd#bsx_AccruedRebatesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AccruedRebatesCurrent" xlink:to="lab_bsx_AccruedRebatesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_67c5d8c9-05d1-4f74-a056-a434280ca6b6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4315d27e-e12c-4fa1-9478-db201f7d7ad2_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b6ca1b0a-72cd-40ef-9e19-bd5e3dfac43a_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_eca5836e-aebb-4472-a48b-7a3ff1945bbe_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_f48bb746-0dea-436d-96e0-27e53b65b1b2_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_0158365f-d0e8-44ab-a649-19d215eef034_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_e1dd2aa3-1c28-4b1f-a0ef-7db97f9cc2b6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_ae4fa636-4235-4bfa-9aeb-cf5bd0a7782e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c616a02f-e9d9-4916-93b3-1155350a9761_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8f925750-aeab-43ac-80d3-d63b0203cb57_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherNet_10cebb8b-d312-4ae9-8dae-9f62febc74b1_terseLabel_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_bsx_OtherNet_label_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_bsx_OtherNet_documentation_en-US" xlink:label="lab_bsx_OtherNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet" xlink:href="bsx-20210630.xsd#bsx_OtherNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherNet" xlink:to="lab_bsx_OtherNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_49906f32-deaf-46f1-b253-5b328ede952b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f6fcf903-e75e-43f4-aeac-cbbde680af60_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_0f4ef35e-0a47-4a96-8cf0-2794a46a1bb4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)&#160;per common share &#8212; assuming dilution</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2029NotesMember_8f169659-d5db-4539-a03e-4a37fe19c07e_terseLabel_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_label_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_documentation_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember" xlink:href="bsx-20210630.xsd#bsx_March2029NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2029NotesMember" xlink:to="lab_bsx_March2029NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f0fe335b-7c9d-4452-9f88-1962b4363543_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_771f4806-392d-481c-b4a3-67b87fbeaa49_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_df324cd0-f10a-4b4c-b44a-c31ab31e18f4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_3e0d3df5-7745-400c-9445-bf792cce49c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_83df76ac-f921-496b-89bc-88a869b2a69f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0104838d-cd3f-43ab-840a-bbc45b61c4d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_ca839196-f5f7-4b7f-b83e-b085dd1cc55d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_9b5b7264-0ea7-4895-a9fe-97de2b3b30af_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f0234fa9-65b4-4231-ac91-df39f83b5b3d_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3df131ed-d8c9-4855-8a7b-3d41d0f011da_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_9e843df8-984c-4df5-9740-8bbce98625c0_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_19e158a1-0f52-4a40-8c1c-bddba963098b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_01961f10-b9d0-4584-902c-61c665729efb_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dfccda16-33a4-4917-a7cd-b60b20eec475_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_5073b05d-a66d-4697-9077-5355618d6e0a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_15a0970c-36e1-4c39-8cdc-0ed4f1c13b24_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_7d2e56a3-1781-45c4-9230-735c6b48cd8a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_ca6423e0-b2e5-4f6d-8381-08015928b2c4_terseLabel_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_label_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_documentation_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember" xlink:href="bsx-20210630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A550MCPSSeriesAMember" xlink:to="lab_bsx_A550MCPSSeriesAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_53a03272-20ab-494a-974c-8d52aedaa59d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_12757128-3774-436f-9ad0-d746140596c4_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_12327672-af85-444b-8616-91426295d543_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a57f1a56-3340-4e39-8551-9381ee8f7169_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_78c0062d-1804-44c1-a1ae-21dcb1bce757_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_93758578-8ba9-46f8-81af-9b5587ac5a87_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_db72636d-1b56-4f16-bf4a-cf2edefb6e7c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_eb3e4605-21f3-420d-b788-bb397a219e39_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_f06529bd-7c95-41bf-b187-b8a5ddc149e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (gain) on investments and notes receivable</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b91e1a4e-bc9b-4829-be87-9c297ea21161_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_464baf83-c6c1-4942-822f-6bf0a74b6fee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration previously established in purchase accounting</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_eb03bd7c-0239-464b-a67c-3c5123f7dd56_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate from continuing operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8833f09c-9c60-44e4-a25c-f0849705b8d8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b1983e09-136d-4fd3-acaa-e5f290f1b417_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_83015c6e-8ef3-4a68-a2a0-ed4e79867dd9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for investments and acquisitions of certain technologies</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_January2040NotesMember_6ece4918-f96a-4df3-ad6c-e1c5cd86d552_terseLabel_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_label_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_documentation_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember" xlink:href="bsx-20210630.xsd#bsx_January2040NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_January2040NotesMember" xlink:to="lab_bsx_January2040NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable_9efede17-a3ad-4a8f-817b-5a3e0b3b2c98_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable_label_en-US" xlink:label="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable_documentation_en-US" xlink:label="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:href="bsx-20210630.xsd#bsx_ScheduleofIntangibleAssetsandGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:to="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_d643aa6c-a7bc-40fe-91d3-682a587e142e_terseLabel_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_913346d9-68a0-4525-ad46-c782662e7fa7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_74fcdbb4-8c3d-4f6a-93c3-8dab64346256_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fc8ef607-77f9-4c31-9729-65e0cf0abad3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_b2a91670-9a0e-4e5c-918d-da89f4029795_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_c1ebacff-10ff-44b7-b3f5-18b54958c801_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2025NotesMember_14f41145-dd48-47d1-894e-5734a1a9a5bc_terseLabel_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2025NotesMember_label_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2025NotesMember_documentation_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember" xlink:href="bsx-20210630.xsd#bsx_May2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2025NotesMember" xlink:to="lab_bsx_May2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_478d9627-5526-41a4-8997-ec3e1cf1f350_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost - 263,289,848 shares as of June 30, 2021 and December 31, 2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_f2881cdf-fdc3-4ceb-a058-db7ff075f035_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Of Shares Outstanding [Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_7cc1b96d-d575-400c-8e22-b8a8086367ff_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_33bbeb00-daf2-43dc-8f96-764037eb520d_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_dba2a33e-28dd-4610-aade-07ee6c99764c_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ec6b4c75-8062-4ac2-b222-71444003aca9_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_96185e8e-510e-414a-bce4-795de63b8f20_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_3768fea8-4192-4053-a4ea-3d4ac6a11ae7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (Shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_d3eebf64-1529-408d-9b72-2d899276955a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f673e52a-7125-44f0-9b88-8f6006303ab3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_e7defbfe-d655-4156-ae24-277ca2883874_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockStock" xlink:to="lab_us-gaap_DividendsPreferredStockStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_501a4147-fc13-47c6-854f-9787c1e8fa6a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_92153b4d-48f9-4a73-bc8d-9f6ee5f93782_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_label_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:href="bsx-20210630.xsd#bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:to="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bsx-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:70f263dc-70b5-4726-816e-8c716916294a,g:26cfe26e-80ae-4508-82da-1214ca3ae539-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20210630.xsd#CoverDocument"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EntityAbstract_e00df01f-f08d-4680-b3c8-3946c959683b" xlink:href="bsx-20210630.xsd#bsx_EntityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_785655bc-9aca-40b0-abfe-0fc6893198f7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_EntityAbstract_e00df01f-f08d-4680-b3c8-3946c959683b" xlink:to="loc_dei_EntitiesTable_785655bc-9aca-40b0-abfe-0fc6893198f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_37a12f8e-4101-4ab9-adc0-c5e146c73267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_785655bc-9aca-40b0-abfe-0fc6893198f7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_37a12f8e-4101-4ab9-adc0-c5e146c73267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3747b1c4-c50c-432c-8e49-41371f1f89ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37a12f8e-4101-4ab9-adc0-c5e146c73267" xlink:to="loc_us-gaap_ClassOfStockDomain_3747b1c4-c50c-432c-8e49-41371f1f89ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ad8083fa-cc20-4662-a59d-ee29754d19ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3747b1c4-c50c-432c-8e49-41371f1f89ee" xlink:to="loc_us-gaap_CommonStockMember_ad8083fa-cc20-4662-a59d-ee29754d19ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_424ebbed-07f3-463a-a3a0-f3e454c5eaa6" xlink:href="bsx-20210630.xsd#bsx_SeniorNotedue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3747b1c4-c50c-432c-8e49-41371f1f89ee" xlink:to="loc_bsx_SeniorNotedue2027Member_424ebbed-07f3-463a-a3a0-f3e454c5eaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_ec561b09-281b-41bd-8fd4-6eff1b7cbecd" xlink:href="bsx-20210630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3747b1c4-c50c-432c-8e49-41371f1f89ee" xlink:to="loc_bsx_A550MCPSSeriesAMember_ec561b09-281b-41bd-8fd4-6eff1b7cbecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_785655bc-9aca-40b0-abfe-0fc6893198f7" xlink:to="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_25bd0660-2e15-47c4-9d6d-efd6eb0de7a0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentType_25bd0660-2e15-47c4-9d6d-efd6eb0de7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_e3a52393-08ca-48ba-86b4-f1214dde44bf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentQuarterlyReport_e3a52393-08ca-48ba-86b4-f1214dde44bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_64c7bbad-62a6-47b0-95e9-ee7fc77c1c70" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentPeriodEndDate_64c7bbad-62a6-47b0-95e9-ee7fc77c1c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_50b431f4-fcf6-4c86-94b0-717608782ca5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentTransitionReport_50b431f4-fcf6-4c86-94b0-717608782ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bc6bde34-e728-4ae1-9e54-01d01766efd8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityFileNumber_bc6bde34-e728-4ae1-9e54-01d01766efd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_332b48e5-b245-482a-a2b0-0b3454ef84bc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityRegistrantName_332b48e5-b245-482a-a2b0-0b3454ef84bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0b0ad7de-2128-4c2e-b728-60c0c3c999c1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0b0ad7de-2128-4c2e-b728-60c0c3c999c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bc645709-9254-4a47-b72f-de91d64aed33" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityTaxIdentificationNumber_bc645709-9254-4a47-b72f-de91d64aed33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e6ed2624-de6a-435b-81bc-33ae0acabb21" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityAddressAddressLine1_e6ed2624-de6a-435b-81bc-33ae0acabb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1b463da3-71e6-42b6-9c2e-cd24b8b5aebb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityAddressCityOrTown_1b463da3-71e6-42b6-9c2e-cd24b8b5aebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_081b6e10-a7bc-4f0d-8eb5-7d6649eae1f0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityAddressStateOrProvince_081b6e10-a7bc-4f0d-8eb5-7d6649eae1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1a387a69-a6f4-4092-9d64-08f8d25fcfb9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityAddressPostalZipCode_1a387a69-a6f4-4092-9d64-08f8d25fcfb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ea790e05-e689-45c7-8c5e-e47e3fa98ee1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_CityAreaCode_ea790e05-e689-45c7-8c5e-e47e3fa98ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2407ae2e-511d-4bd6-bbe3-b4b357642c33" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_LocalPhoneNumber_2407ae2e-511d-4bd6-bbe3-b4b357642c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_847e5c30-9912-4dab-a594-630368065ca8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_Security12bTitle_847e5c30-9912-4dab-a594-630368065ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c82ecda3-0158-41f0-8a7a-36dc000b6873" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_TradingSymbol_c82ecda3-0158-41f0-8a7a-36dc000b6873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_23501528-e977-4092-bfb3-4d57a15a9dbf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_SecurityExchangeName_23501528-e977-4092-bfb3-4d57a15a9dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c091c8f0-67e9-4613-ad4c-61fa67a93793" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityCurrentReportingStatus_c091c8f0-67e9-4613-ad4c-61fa67a93793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e37ba5a3-94c3-4e6a-a953-30df18b8acf0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityInteractiveDataCurrent_e37ba5a3-94c3-4e6a-a953-30df18b8acf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_69d866cc-5aed-40fe-a3d5-492c212a3bae" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityFilerCategory_69d866cc-5aed-40fe-a3d5-492c212a3bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9472a7b1-50e1-4358-ab63-1a7bcfee913e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntitySmallBusiness_9472a7b1-50e1-4358-ab63-1a7bcfee913e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_876defa6-3275-40d2-bc23-f49f9ac19d78" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityEmergingGrowthCompany_876defa6-3275-40d2-bc23-f49f9ac19d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_94f12349-8449-423a-aed3-09e9021e8d54" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityShellCompany_94f12349-8449-423a-aed3-09e9021e8d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_4f66c4b9-6e6c-4038-9301-b98b84c391a5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityListingParValuePerShare"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityListingParValuePerShare_4f66c4b9-6e6c-4038-9301-b98b84c391a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0642186e-bff0-47cd-85af-cf19efad129f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0642186e-bff0-47cd-85af-cf19efad129f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a53def80-b0e7-4fde-97bd-4a49f8d2b5b4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_EntityCentralIndexKey_a53def80-b0e7-4fde-97bd-4a49f8d2b5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_35c8f882-187c-468f-8b36-26c2de716ca4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_CurrentFiscalYearEndDate_35c8f882-187c-468f-8b36-26c2de716ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_78ab265f-7fac-41d7-a7dc-db2d5e65e277" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentFiscalYearFocus_78ab265f-7fac-41d7-a7dc-db2d5e65e277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9ea1f064-e004-4576-96a5-1222ed564029" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9ea1f064-e004-4576-96a5-1222ed564029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_49dbe590-a275-490f-a130-c8af6574ccc8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c1861c43-fd8f-4890-b2bc-15d72431272f" xlink:to="loc_dei_AmendmentFlag_49dbe590-a275-490f-a130-c8af6574ccc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_8812943c-81a2-4f86-89df-0d74e8d1c03f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a1acf401-efab-4c93-a6ee-673c44dc514b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8812943c-81a2-4f86-89df-0d74e8d1c03f" xlink:to="loc_us-gaap_StatementTable_a1acf401-efab-4c93-a6ee-673c44dc514b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_649a6675-c5ed-40a4-a915-4c04e7effcb7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a1acf401-efab-4c93-a6ee-673c44dc514b" xlink:to="loc_srt_StatementScenarioAxis_649a6675-c5ed-40a4-a915-4c04e7effcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0519c622-0b6b-49a3-aa40-13c8d234d3b9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_649a6675-c5ed-40a4-a915-4c04e7effcb7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0519c622-0b6b-49a3-aa40-13c8d234d3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a1acf401-efab-4c93-a6ee-673c44dc514b" xlink:to="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2c1f276-22c8-4a10-9823-8945cd2766ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2c1f276-22c8-4a10-9823-8945cd2766ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_33db0f73-bb5e-48e6-89b1-2e1ac5ad0a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_33db0f73-bb5e-48e6-89b1-2e1ac5ad0a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_562c7a67-4595-4f47-991d-3ad06261ac76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_GrossProfit_562c7a67-4595-4f47-991d-3ad06261ac76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1d584be4-62a8-4e76-902e-f885944695e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1d584be4-62a8-4e76-902e-f885944695e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9161e725-6007-4834-8e61-e682bfa027ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9161e725-6007-4834-8e61-e682bfa027ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_84786360-b602-499b-bb22-4ffa020add82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_RoyaltyExpense_84786360-b602-499b-bb22-4ffa020add82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_20c5e6d4-96e0-4e8b-aeb7-4035fcb9572e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_20c5e6d4-96e0-4e8b-aeb7-4035fcb9572e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_78dd906a-18db-4eb2-82cf-0ccc0951f657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_78dd906a-18db-4eb2-82cf-0ccc0951f657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5caa7941-c0bf-4499-a076-aab3676b7c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5caa7941-c0bf-4499-a076-aab3676b7c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a34bd3cc-254f-48e1-86ec-4d08e133fab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_RestructuringCharges_a34bd3cc-254f-48e1-86ec-4d08e133fab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_8eae0fc4-644c-49bb-b0c1-19e043a8fc11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_LitigationSettlementExpense_8eae0fc4-644c-49bb-b0c1-19e043a8fc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_6a12a7f9-0326-4e26-96fb-1180e9ecd2ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_6a12a7f9-0326-4e26-96fb-1180e9ecd2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d87d0c34-4ebc-46a2-b31e-6a61feb12fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_39aceb32-877f-4ede-bc93-8f6735bbd5ae" xlink:to="loc_us-gaap_OperatingExpenses_d87d0c34-4ebc-46a2-b31e-6a61feb12fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0464223d-66e1-4b42-8b6d-3eb6c9d3a193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_OperatingIncomeLoss_0464223d-66e1-4b42-8b6d-3eb6c9d3a193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_d9d33e08-7425-45d5-89ce-6caa99dda915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_d9d33e08-7425-45d5-89ce-6caa99dda915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_abc14f40-11f2-44be-9d3d-e9b15117d0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_d9d33e08-7425-45d5-89ce-6caa99dda915" xlink:to="loc_us-gaap_InterestExpense_abc14f40-11f2-44be-9d3d-e9b15117d0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_70fdb61c-1d8f-4ff6-ac15-c1fcd434db14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_d9d33e08-7425-45d5-89ce-6caa99dda915" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_70fdb61c-1d8f-4ff6-ac15-c1fcd434db14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd155eba-af30-4176-82eb-0ea184692a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd155eba-af30-4176-82eb-0ea184692a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5c6f85b1-4138-4a55-883f-7ca59c814e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5c6f85b1-4138-4a55-883f-7ca59c814e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bc8f6299-3314-409e-90bd-a03ff3eff62f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_ProfitLoss_bc8f6299-3314-409e-90bd-a03ff3eff62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_bd1d79ce-aa4e-4354-818c-d34ff9a192f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_DividendsPreferredStockStock_bd1d79ce-aa4e-4354-818c-d34ff9a192f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f8893cc7-122b-4744-873f-ff04837b2b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f8893cc7-122b-4744-873f-ff04837b2b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_19d22865-4a2b-4da2-898f-81236f2fce5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_EarningsPerShareBasic_19d22865-4a2b-4da2-898f-81236f2fce5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d8c6ef58-0312-4a7d-b3f2-ae9c0a9f8c3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d8c6ef58-0312-4a7d-b3f2-ae9c0a9f8c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e1e3d556-ef3f-420f-b5d6-c802181cf7f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78f1d808-32d8-4757-94f0-283849fd7738" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e1e3d556-ef3f-420f-b5d6-c802181cf7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8d2851c9-5192-4e78-b369-2e00db37f791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e1e3d556-ef3f-420f-b5d6-c802181cf7f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8d2851c9-5192-4e78-b369-2e00db37f791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8bf665b2-9947-4124-8d42-46792e42cfdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e1e3d556-ef3f-420f-b5d6-c802181cf7f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8bf665b2-9947-4124-8d42-46792e42cfdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c7209574-a641-48be-b8dd-5d155d17330a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_73b96129-43e0-4384-a1be-c6002dcf1b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c7209574-a641-48be-b8dd-5d155d17330a" xlink:to="loc_us-gaap_StatementTable_73b96129-43e0-4384-a1be-c6002dcf1b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_cefce4e8-8b6f-45d6-8f95-0386f3496faa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_73b96129-43e0-4384-a1be-c6002dcf1b5f" xlink:to="loc_srt_StatementScenarioAxis_cefce4e8-8b6f-45d6-8f95-0386f3496faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cd1300c9-a08e-474b-ae64-de7c23fefd2d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_cefce4e8-8b6f-45d6-8f95-0386f3496faa" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cd1300c9-a08e-474b-ae64-de7c23fefd2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f9e964e3-5d9e-4234-8bf8-5ada8b6c2127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_73b96129-43e0-4384-a1be-c6002dcf1b5f" xlink:to="loc_us-gaap_StatementLineItems_f9e964e3-5d9e-4234-8bf8-5ada8b6c2127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8ea6062e-bbfa-45d4-a872-d33fd45a45af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9e964e3-5d9e-4234-8bf8-5ada8b6c2127" xlink:to="loc_us-gaap_ProfitLoss_8ea6062e-bbfa-45d4-a872-d33fd45a45af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9e964e3-5d9e-4234-8bf8-5ada8b6c2127" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_77bdea1d-2a10-44ea-9a14-2b73e9b6946b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_77bdea1d-2a10-44ea-9a14-2b73e9b6946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_080c6389-c793-455a-a63a-b8988a8078e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_080c6389-c793-455a-a63a-b8988a8078e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7d655020-43bc-417a-a1bf-46d523417348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7d655020-43bc-417a-a1bf-46d523417348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85ffb71b-b8fd-42a7-97e1-fdca79a49322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_464ff76b-cc1f-44d6-a7dd-b648e9ee82e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_85ffb71b-b8fd-42a7-97e1-fdca79a49322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c864da17-b5f4-42d4-a18a-bbbab5d2c4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f9e964e3-5d9e-4234-8bf8-5ada8b6c2127" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c864da17-b5f4-42d4-a18a-bbbab5d2c4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_af89051a-e4e1-427f-9267-9d9fd15b2a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_240fb277-27f7-45d2-93ff-b426310ecdbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_af89051a-e4e1-427f-9267-9d9fd15b2a67" xlink:to="loc_us-gaap_StatementTable_240fb277-27f7-45d2-93ff-b426310ecdbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_9396d0e8-a81c-4c66-8af8-dbd83953323b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_240fb277-27f7-45d2-93ff-b426310ecdbc" xlink:to="loc_srt_StatementScenarioAxis_9396d0e8-a81c-4c66-8af8-dbd83953323b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a7e9ed8f-06b3-4806-830d-4140b4017cd2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_9396d0e8-a81c-4c66-8af8-dbd83953323b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a7e9ed8f-06b3-4806-830d-4140b4017cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e20fd705-3d4c-4b5b-9d9c-690930d510b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_240fb277-27f7-45d2-93ff-b426310ecdbc" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e20fd705-3d4c-4b5b-9d9c-690930d510b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_99ea53cf-b1cb-4b24-b27b-17799c1fef11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e20fd705-3d4c-4b5b-9d9c-690930d510b9" xlink:to="loc_us-gaap_ClassOfStockDomain_99ea53cf-b1cb-4b24-b27b-17799c1fef11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5a0275fd-46f0-4d49-ac2c-6ffa2da6d493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_240fb277-27f7-45d2-93ff-b426310ecdbc" xlink:to="loc_us-gaap_StatementLineItems_5a0275fd-46f0-4d49-ac2c-6ffa2da6d493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5a0275fd-46f0-4d49-ac2c-6ffa2da6d493" xlink:to="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8fbb3337-3e41-47a5-a063-3337edc2b81c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8fbb3337-3e41-47a5-a063-3337edc2b81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_ea5a672e-4692-4d7d-bdce-82aa405556a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_ea5a672e-4692-4d7d-bdce-82aa405556a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f81abf76-d651-4827-bed8-e0cbfd29a366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_InventoryNet_f81abf76-d651-4827-bed8-e0cbfd29a366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_2c139d75-487b-4d3e-ab32-1d49c9ecce4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_PrepaidTaxes_2c139d75-487b-4d3e-ab32-1d49c9ecce4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_9a4ae8a5-7a46-4825-a315-a81d9fc61b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_9a4ae8a5-7a46-4825-a315-a81d9fc61b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2daa3e58-85d9-42a9-a037-3dc6382a1bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2daa3e58-85d9-42a9-a037-3dc6382a1bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8274456e-4071-4e99-bcf9-ec8858e97b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14a42020-5896-426d-bbc1-a41e36d34d2b" xlink:to="loc_us-gaap_AssetsCurrent_8274456e-4071-4e99-bcf9-ec8858e97b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2dc83c4e-dcdf-40a1-b329-cc3f07259539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2dc83c4e-dcdf-40a1-b329-cc3f07259539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_67a7cf74-d6e8-453f-bfd8-d8f48a4e23cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_Goodwill_67a7cf74-d6e8-453f-bfd8-d8f48a4e23cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9077c19d-d6f1-4eb3-9d98-b22b4838b8ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9077c19d-d6f1-4eb3-9d98-b22b4838b8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_94966f0d-28d3-4d31-a828-ca8d15f93414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_94966f0d-28d3-4d31-a828-ca8d15f93414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0bc37cb0-5c34-4f78-8623-aeeb26e919a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0bc37cb0-5c34-4f78-8623-aeeb26e919a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9e205e50-a03b-4dbf-85cb-3995f1a35fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4fd6a875-9877-4358-8ff5-833a4cbbbd71" xlink:to="loc_us-gaap_Assets_9e205e50-a03b-4dbf-85cb-3995f1a35fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5a0275fd-46f0-4d49-ac2c-6ffa2da6d493" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_12f6029f-0894-4486-ac78-79c2c0113f30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:to="loc_us-gaap_DebtCurrent_12f6029f-0894-4486-ac78-79c2c0113f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6d76f315-8ba4-4166-8016-2aadf70967c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:to="loc_us-gaap_AccountsPayableCurrent_6d76f315-8ba4-4166-8016-2aadf70967c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9fd8297c-b328-4123-8a66-d5e403d43ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9fd8297c-b328-4123-8a66-d5e403d43ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_926dfbb6-ab82-43e5-8e6b-a04483ed8ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_926dfbb6-ab82-43e5-8e6b-a04483ed8ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_911895fe-a15d-4e0a-b419-cfea1db6673a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e363a545-d13d-4c49-95b1-3ba4608480b5" xlink:to="loc_us-gaap_LiabilitiesCurrent_911895fe-a15d-4e0a-b419-cfea1db6673a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_69800e57-496b-4ca2-a300-874ccdbdaa85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_69800e57-496b-4ca2-a300-874ccdbdaa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7bf8dad0-85d4-4f76-871f-5dd1b7fc525f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7bf8dad0-85d4-4f76-871f-5dd1b7fc525f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_18959151-cf56-4902-bcfa-156a81697d0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_18959151-cf56-4902-bcfa-156a81697d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b672eb1d-c3ca-43d8-904b-a8d5f40d4f69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b672eb1d-c3ca-43d8-904b-a8d5f40d4f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_79d17137-1dcb-4b69-8c82-136647c9eae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_PreferredStockValue_79d17137-1dcb-4b69-8c82-136647c9eae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c1c24027-84bc-4739-8cdc-db995e6725ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_CommonStockValue_c1c24027-84bc-4739-8cdc-db995e6725ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_feeb32aa-3a4d-4c5f-92ed-35bdd10a4bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_TreasuryStockValue_feeb32aa-3a4d-4c5f-92ed-35bdd10a4bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b6de785e-b34d-4204-9fc0-8bbbe23af00f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b6de785e-b34d-4204-9fc0-8bbbe23af00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_43b29e5d-4c2d-4aba-86a2-1f7828297194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_43b29e5d-4c2d-4aba-86a2-1f7828297194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_30acfb55-ab5f-4275-98ec-862eb18060c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_30acfb55-ab5f-4275-98ec-862eb18060c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8e8759d6-5d84-4484-9e4e-a4729e1f7f00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38f68057-8185-4f64-9a07-97f800c3e194" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8e8759d6-5d84-4484-9e4e-a4729e1f7f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0e3751a2-d85d-4bf4-9c82-400fff58bbcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ef78990d-c13a-49ec-8963-1687c2da5254" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0e3751a2-d85d-4bf4-9c82-400fff58bbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_06f31deb-f9f8-4c33-aa46-35fe561e947e" xlink:href="bsx-20210630.xsd#bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6f841f25-083e-40df-933f-eade91b1365e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_06f31deb-f9f8-4c33-aa46-35fe561e947e" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6f841f25-083e-40df-933f-eade91b1365e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2627b1de-3c22-4842-b344-2bb9fbc2b961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_06f31deb-f9f8-4c33-aa46-35fe561e947e" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2627b1de-3c22-4842-b344-2bb9fbc2b961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3357698d-aa4b-4ac6-bd0e-b2897215b60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_06f31deb-f9f8-4c33-aa46-35fe561e947e" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3357698d-aa4b-4ac6-bd0e-b2897215b60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a5124682-929c-41d5-891f-94abb88cae56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_06f31deb-f9f8-4c33-aa46-35fe561e947e" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a5124682-929c-41d5-891f-94abb88cae56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9c63bb54-58ef-419a-9215-0ea5ab2c1f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_06f31deb-f9f8-4c33-aa46-35fe561e947e" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9c63bb54-58ef-419a-9215-0ea5ab2c1f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_bbc4581d-4349-4c71-9923-94b79d482e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_06f31deb-f9f8-4c33-aa46-35fe561e947e" xlink:to="loc_us-gaap_CommonStockSharesIssued_bbc4581d-4349-4c71-9923-94b79d482e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_18e8941a-c8ff-45c7-bacf-54fc53dedc2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_06f31deb-f9f8-4c33-aa46-35fe561e947e" xlink:to="loc_us-gaap_TreasuryStockShares_18e8941a-c8ff-45c7-bacf-54fc53dedc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_cab49800-85e8-4fa3-9ee4-f252f6fe33a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_622a1c64-335e-4d8d-a0bd-61af9715f1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_cab49800-85e8-4fa3-9ee4-f252f6fe33a2" xlink:to="loc_us-gaap_StatementTable_622a1c64-335e-4d8d-a0bd-61af9715f1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c558d5f3-6869-4776-9cef-ac1cf241bd4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_622a1c64-335e-4d8d-a0bd-61af9715f1c5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c558d5f3-6869-4776-9cef-ac1cf241bd4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c558d5f3-6869-4776-9cef-ac1cf241bd4c" xlink:to="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_bfb565b3-ffcd-4026-b2f7-61177ee58d49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_PreferredStockMember_bfb565b3-ffcd-4026-b2f7-61177ee58d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a5a31f68-5b65-4a91-b24b-2f47138d20f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_CommonStockMember_a5a31f68-5b65-4a91-b24b-2f47138d20f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_73212383-a574-42c7-be2f-03b290f03878" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_TreasuryStockMember_73212383-a574-42c7-be2f-03b290f03878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4ac08fd1-382d-47dc-8913-2515a6496dd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4ac08fd1-382d-47dc-8913-2515a6496dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eaf30cdf-97f9-4bdf-8f44-733ef5125a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_RetainedEarningsMember_eaf30cdf-97f9-4bdf-8f44-733ef5125a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e67d39d3-b7e7-46be-b28e-a4a0767099a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2267b32-27ba-4556-84b0-c321a020db23" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e67d39d3-b7e7-46be-b28e-a4a0767099a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4a60b0d3-9d0d-4ca7-801e-464419b7812e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_622a1c64-335e-4d8d-a0bd-61af9715f1c5" xlink:to="loc_us-gaap_StatementLineItems_4a60b0d3-9d0d-4ca7-801e-464419b7812e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a60b0d3-9d0d-4ca7-801e-464419b7812e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_856ada8f-5eb5-445c-85f3-5c880d8587e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_856ada8f-5eb5-445c-85f3-5c880d8587e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_2649aea2-ad24-4ae6-b22e-7dc358ad107e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_SharesIssued_2649aea2-ad24-4ae6-b22e-7dc358ad107e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fed3c58e-027b-4723-a887-e099e2c58086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_ProfitLoss_fed3c58e-027b-4723-a887-e099e2c58086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_a66ff427-a2cd-4927-8131-559cef6a7d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_a66ff427-a2cd-4927-8131-559cef6a7d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_903579fa-882d-4872-b0cd-49e17f543015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_903579fa-882d-4872-b0cd-49e17f543015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_39d4b3f0-2e5e-4693-8316-15ff9f0c54e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_39d4b3f0-2e5e-4693-8316-15ff9f0c54e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_8d7a0181-d0a3-4c15-b118-152d33c041a1" xlink:href="bsx-20210630.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_8d7a0181-d0a3-4c15-b118-152d33c041a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_006d9a2e-bc7f-4e0b-af56-8f5105d4dbb5" xlink:href="bsx-20210630.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_006d9a2e-bc7f-4e0b-af56-8f5105d4dbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_74fef628-c087-4676-be28-144242a1ddb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_74fef628-c087-4676-be28-144242a1ddb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_466575f5-8fde-4ad2-a0ca-643362513731" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_DividendsPreferredStockCash_466575f5-8fde-4ad2-a0ca-643362513731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4e2be493-ad18-4e3b-8ac8-215c64745ca3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4e2be493-ad18-4e3b-8ac8-215c64745ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_59522a16-1827-4d82-a66a-2591577ffcc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_59522a16-1827-4d82-a66a-2591577ffcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_3bd91771-723b-4484-83b3-e4e56312242a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_3bd91771-723b-4484-83b3-e4e56312242a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d31708d2-587d-46d5-be2f-4bf338de5b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d31708d2-587d-46d5-be2f-4bf338de5b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_d8f9f283-1c6d-4b37-9fbe-471709b31b70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b2a92f7-80fe-43d3-8c16-30f71a66ac12" xlink:to="loc_us-gaap_SharesIssued_d8f9f283-1c6d-4b37-9fbe-471709b31b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_480ad500-bc61-4c64-ae25-e065af798aa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b5fcf3f4-3e0a-48ca-a850-b7e51386fb0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_480ad500-bc61-4c64-ae25-e065af798aa0" xlink:to="loc_us-gaap_StatementTable_b5fcf3f4-3e0a-48ca-a850-b7e51386fb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e996f87e-b255-4c5a-b466-f9c0051bcc04" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b5fcf3f4-3e0a-48ca-a850-b7e51386fb0a" xlink:to="loc_srt_StatementScenarioAxis_e996f87e-b255-4c5a-b466-f9c0051bcc04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8aed1acf-f405-4675-8354-26707613bf00" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_e996f87e-b255-4c5a-b466-f9c0051bcc04" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8aed1acf-f405-4675-8354-26707613bf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b5fcf3f4-3e0a-48ca-a850-b7e51386fb0a" xlink:to="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4fe19bfc-56cd-45fd-8cc5-cda6e773b742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_ProfitLoss_4fe19bfc-56cd-45fd-8cc5-cda6e773b742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_88620a70-546f-4f28-95ea-92d5c8e06283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_88620a70-546f-4f28-95ea-92d5c8e06283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e037a28c-44ff-4435-9d7b-38576fc5ee56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e037a28c-44ff-4435-9d7b-38576fc5ee56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_7fc00401-474e-46e9-936e-463881b9dca5" xlink:href="bsx-20210630.xsd#bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit_7fc00401-474e-46e9-936e-463881b9dca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9e36b39a-27a1-4e58-b173-9d6e347a1eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_ShareBasedCompensation_9e36b39a-27a1-4e58-b173-9d6e347a1eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f05d7460-fe3b-46aa-b059-b42b2a94ba7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f05d7460-fe3b-46aa-b059-b42b2a94ba7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_d5b3df9f-9018-4c09-9509-f6641bf5845f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_GainLossOnInvestments_d5b3df9f-9018-4c09-9509-f6641bf5845f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1d9c0aa3-f1e4-426a-8c8b-34104061d451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1d9c0aa3-f1e4-426a-8c8b-34104061d451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_InventoryStepUpAmortization_c28c8ce2-8c69-4485-b20a-0d9ae8b46106" xlink:href="bsx-20210630.xsd#bsx_InventoryStepUpAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_bsx_InventoryStepUpAmortization_c28c8ce2-8c69-4485-b20a-0d9ae8b46106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss_5a7a96f7-d0e6-4e1f-b927-111d30a8c06e" xlink:href="bsx-20210630.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_bsx_Netcurrencyexchangegainloss_5a7a96f7-d0e6-4e1f-b927-111d30a8c06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherNet_08c2f27a-d154-4032-abb3-a4132182a791" xlink:href="bsx-20210630.xsd#bsx_OtherNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_bsx_OtherNet_08c2f27a-d154-4032-abb3-a4132182a791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9548732b-1d1d-43c8-912a-663409a5d054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9548732b-1d1d-43c8-912a-663409a5d054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b448f99e-c116-4e08-bdd8-ac2f32f0a587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b448f99e-c116-4e08-bdd8-ac2f32f0a587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_efa42f98-6dd2-4d3f-b044-cdf7ff0decb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_efa42f98-6dd2-4d3f-b044-cdf7ff0decb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2d5cec5a-a53b-400a-b355-7d2704d2fc67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2d5cec5a-a53b-400a-b355-7d2704d2fc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6078469c-bce5-49ff-b1e9-3305079a9558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6078469c-bce5-49ff-b1e9-3305079a9558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_11a948db-248d-47c1-ad47-3679cb1877aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_96632010-7c56-4efe-a782-7a1a5c7c125e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_11a948db-248d-47c1-ad47-3679cb1877aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_50ab97aa-28f5-47f3-8987-1ab43cfa346e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_50ab97aa-28f5-47f3-8987-1ab43cfa346e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ec643c34-8c60-4942-b2a2-6799a5f12c30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ec643c34-8c60-4942-b2a2-6799a5f12c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_15700f27-0227-40b6-8ced-a5cadd25767e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_15700f27-0227-40b6-8ced-a5cadd25767e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_efb45fd0-bd16-419f-b4f9-89bcb68e09da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_efb45fd0-bd16-419f-b4f9-89bcb68e09da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_6078d558-a480-444c-a90c-15ea744b5c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_6078d558-a480-444c-a90c-15ea744b5c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_fb05ffc9-eefe-40bb-90bd-dd5f95d6b24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_fb05ffc9-eefe-40bb-90bd-dd5f95d6b24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_08a0f226-df6f-4c6c-881a-7697e9647129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_08a0f226-df6f-4c6c-881a-7697e9647129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_627f85e0-79c9-4dc7-8cd7-3e1b2c007399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_627f85e0-79c9-4dc7-8cd7-3e1b2c007399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e2fc9bc4-826d-4630-99df-625a31ab74dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1471067d-0f2b-49c7-9bba-fb1ad6c16d12" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e2fc9bc4-826d-4630-99df-625a31ab74dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d3997cec-8165-441a-82a4-68b2154f733b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d3997cec-8165-441a-82a4-68b2154f733b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentsForRoyaltyRights_1c453a59-9d33-4aff-95ca-a6b4828fc8ae" xlink:href="bsx-20210630.xsd#bsx_PaymentsForRoyaltyRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_bsx_PaymentsForRoyaltyRights_1c453a59-9d33-4aff-95ca-a6b4828fc8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_ee93ebf9-f31e-4886-9569-ae362088fba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_ee93ebf9-f31e-4886-9569-ae362088fba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_9450b099-0490-48ad-8df5-bc2b13fcebd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_9450b099-0490-48ad-8df5-bc2b13fcebd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_02f86f95-08f9-4e37-948a-b1aebf790f72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_02f86f95-08f9-4e37-948a-b1aebf790f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_0f6aa1e8-8279-4dad-be58-c6527b8734db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_0f6aa1e8-8279-4dad-be58-c6527b8734db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1b553430-2daa-4601-b05b-06e62b060902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_1b553430-2daa-4601-b05b-06e62b060902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_7fd47f5e-6470-4fa9-926d-4984062b4a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_7fd47f5e-6470-4fa9-926d-4984062b4a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_83de1827-a887-42df-9740-6a50328daa9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_83de1827-a887-42df-9740-6a50328daa9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_89a5327a-01d5-408b-a431-cfb23f3ec1ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_PaymentsOfDividends_89a5327a-01d5-408b-a431-cfb23f3ec1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_cad0c3cc-ea55-4217-af1c-db0b1c6de46b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_cad0c3cc-ea55-4217-af1c-db0b1c6de46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6383da9d-7607-4ca1-95de-97085ad578c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6383da9d-7607-4ca1-95de-97085ad578c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_2781508f-baa6-44e8-95e0-7ad0a099fa4a" xlink:href="bsx-20210630.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_2781508f-baa6-44e8-95e0-7ad0a099fa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_55ace21f-2115-4107-be4a-342f1fff206f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_ProceedsFromStockPlans_55ace21f-2115-4107-be4a-342f1fff206f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3a119e5d-7373-4fd1-b81e-2988d46a0e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9639fcc-189e-49f6-92bb-eb8cae40470d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3a119e5d-7373-4fd1-b81e-2988d46a0e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3c0ab44b-0bf3-4e86-94f6-bd256b0f3203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3c0ab44b-0bf3-4e86-94f6-bd256b0f3203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1efe0698-009e-4e20-8332-dbe89d2d098b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1efe0698-009e-4e20-8332-dbe89d2d098b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c948821f-bb84-4a8d-8306-c7f385b7e742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c948821f-bb84-4a8d-8306-c7f385b7e742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c7c9e18-4f06-423a-86f9-3813268f82c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c7c9e18-4f06-423a-86f9-3813268f82c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_28ac6007-3ee4-4d0b-b9d7-6f22720a5f76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27dfe090-3417-4b85-bf0b-66799eb29e70" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_28ac6007-3ee4-4d0b-b9d7-6f22720a5f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f0e91ce8-490e-44bf-8b26-8fd40e863784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_28ac6007-3ee4-4d0b-b9d7-6f22720a5f76" xlink:to="loc_us-gaap_ShareBasedCompensation_f0e91ce8-490e-44bf-8b26-8fd40e863784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_3d39445b-603b-4957-a0d0-c4035342ebc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_28ac6007-3ee4-4d0b-b9d7-6f22720a5f76" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_3d39445b-603b-4957-a0d0-c4035342ebc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_a61653a8-b30f-4505-8be8-a14857e5252e" xlink:href="bsx-20210630.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_28ac6007-3ee4-4d0b-b9d7-6f22720a5f76" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_a61653a8-b30f-4505-8be8-a14857e5252e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20210630.xsd#ConsolidatedStatementsofCashFlowsSupplementalDisclosure"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_a9018683-5545-455a-a1cc-08d470568e64" xlink:href="bsx-20210630.xsd#bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5d0c14be-8264-46cf-b41d-fb549be165d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_a9018683-5545-455a-a1cc-08d470568e64" xlink:to="loc_us-gaap_StatementTable_5d0c14be-8264-46cf-b41d-fb549be165d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_aa9e2ee6-5874-4c0e-9f45-58e7efdbefdb" xlink:href="bsx-20210630.xsd#bsx_StatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5d0c14be-8264-46cf-b41d-fb549be165d7" xlink:to="loc_bsx_StatementAxis_aa9e2ee6-5874-4c0e-9f45-58e7efdbefdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_dbcfbfe6-ad08-451e-ba2b-0adefab03b87" xlink:href="bsx-20210630.xsd#bsx_StatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementAxis_aa9e2ee6-5874-4c0e-9f45-58e7efdbefdb" xlink:to="loc_bsx_StatementDomain_dbcfbfe6-ad08-451e-ba2b-0adefab03b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5d0c14be-8264-46cf-b41d-fb549be165d7" xlink:to="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_480149f9-6474-4235-89b8-664c229ff704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_480149f9-6474-4235-89b8-664c229ff704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_44482f33-6715-41a7-b743-50359ae32c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_44482f33-6715-41a7-b743-50359ae32c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_f6975f91-77fd-4ff7-bba0-844f7ae2944f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_f6975f91-77fd-4ff7-bba0-844f7ae2944f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f7ce42ef-ad98-41ed-b0b3-8db5a62f814e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2120fc0e-34c8-43ca-bcb9-02b36b8a1885" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f7ce42ef-ad98-41ed-b0b3-8db5a62f814e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="simple" xlink:href="bsx-20210630.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ca05aff7-2ca2-424e-a442-ebdf66b467db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_25660a2c-9436-4ae8-bf0a-efa6274ec630" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ca05aff7-2ca2-424e-a442-ebdf66b467db" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_25660a2c-9436-4ae8-bf0a-efa6274ec630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="simple" xlink:href="bsx-20210630.xsd#BasisofPresentationBasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_46d6ac83-e216-475f-b01a-340fd32b323c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_739cbec8-ada7-4584-aabc-d0f4d30ad51e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46d6ac83-e216-475f-b01a-340fd32b323c" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_739cbec8-ada7-4584-aabc-d0f4d30ad51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="simple" xlink:href="bsx-20210630.xsd#AcquisitionsandStrategicInvestments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_adfc3935-f32d-4382-9c45-f3d7fa36faae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8a631f68-f461-4745-90c2-090bc41e79ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_adfc3935-f32d-4382-9c45-f3d7fa36faae" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8a631f68-f461-4745-90c2-090bc41e79ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#AcquisitionsandStrategicInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_129d1c3f-462b-4c3c-8bdb-390dbfb0b287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_129d1c3f-462b-4c3c-8bdb-390dbfb0b287" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_401a82bd-229a-41ca-b2a6-4e5aeb9fdcf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_401a82bd-229a-41ca-b2a6-4e5aeb9fdcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad4219ad-76be-41c3-8753-4a6ce10a31d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_401a82bd-229a-41ca-b2a6-4e5aeb9fdcf3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad4219ad-76be-41c3-8753-4a6ce10a31d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisLTDMember_0e117ed1-3d18-46cb-929d-817f924e8580" xlink:href="bsx-20210630.xsd#bsx_LumenisLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad4219ad-76be-41c3-8753-4a6ce10a31d6" xlink:to="loc_bsx_LumenisLTDMember_0e117ed1-3d18-46cb-929d-817f924e8580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceMember_14066c0f-de65-4050-bb8d-a22c07ade14b" xlink:href="bsx-20210630.xsd#bsx_PreventiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ad4219ad-76be-41c3-8753-4a6ce10a31d6" xlink:to="loc_bsx_PreventiceMember_14066c0f-de65-4050-bb8d-a22c07ade14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7cdc2734-536d-4df3-8e9a-9b43c9a0240b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7cdc2734-536d-4df3-8e9a-9b43c9a0240b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_633d7521-d485-40ca-8ba1-e0dada935273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7cdc2734-536d-4df3-8e9a-9b43c9a0240b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_633d7521-d485-40ca-8ba1-e0dada935273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_67e55e77-118e-4317-aad4-ee4f62f37a49" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:to="loc_srt_OwnershipAxis_67e55e77-118e-4317-aad4-ee4f62f37a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5809d990-baff-4e15-b3bd-9491c3b22e66" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_67e55e77-118e-4317-aad4-ee4f62f37a49" xlink:to="loc_srt_OwnershipDomain_5809d990-baff-4e15-b3bd-9491c3b22e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a85b37d0-7147-46c8-a62f-f967c5a4f1f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a85b37d0-7147-46c8-a62f-f967c5a4f1f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c8383dd0-d5a4-47c5-828b-8f91096ef22d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a85b37d0-7147-46c8-a62f-f967c5a4f1f5" xlink:to="loc_us-gaap_ClassOfStockDomain_c8383dd0-d5a4-47c5-828b-8f91096ef22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fce2c34d-30f6-4617-82ca-6b79864aa013" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_3a6e247f-8b30-47d6-94a6-1b9e9ec7c641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_3a6e247f-8b30-47d6-94a6-1b9e9ec7c641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_566f8c73-9bc4-48e5-adaa-f1593e89ba87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_566f8c73-9bc4-48e5-adaa-f1593e89ba87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_a12cc49a-eef5-40c9-a223-baf79240d5fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_a12cc49a-eef5-40c9-a223-baf79240d5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ee6e7341-8648-47ea-bc50-6df98c20d4fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_ee6e7341-8648-47ea-bc50-6df98c20d4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_0b5b1a1e-460c-4b27-8175-9b073a9743b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_0b5b1a1e-460c-4b27-8175-9b073a9743b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_767b7469-e8b4-4d4b-a419-eacf04b015d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab4e89b2-cc8f-4eec-8bea-859e103f365b" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_767b7469-e8b4-4d4b-a419-eacf04b015d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#AcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_fdd5a083-ba68-47f0-82a6-0cf9a1254c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_fdd5a083-ba68-47f0-82a6-0cf9a1254c0e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b4c9646a-be49-4351-84b3-167f74a256e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b4c9646a-be49-4351-84b3-167f74a256e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b6a9f44-858e-48de-bfa0-467cc4025143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b4c9646a-be49-4351-84b3-167f74a256e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b6a9f44-858e-48de-bfa0-467cc4025143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LumenisLTDMember_85f70ae8-6950-40aa-a538-544e15284cb6" xlink:href="bsx-20210630.xsd#bsx_LumenisLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b6a9f44-858e-48de-bfa0-467cc4025143" xlink:to="loc_bsx_LumenisLTDMember_85f70ae8-6950-40aa-a538-544e15284cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PreventiceMember_7665e3c4-1ca7-4977-b7f9-70fd0b44c9bb" xlink:href="bsx-20210630.xsd#bsx_PreventiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b6a9f44-858e-48de-bfa0-467cc4025143" xlink:to="loc_bsx_PreventiceMember_7665e3c4-1ca7-4977-b7f9-70fd0b44c9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_FarapulseMember_7368f867-017b-4820-bd1a-bafa0f6c2921" xlink:href="bsx-20210630.xsd#bsx_FarapulseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3b6a9f44-858e-48de-bfa0-467cc4025143" xlink:to="loc_bsx_FarapulseMember_7368f867-017b-4820-bd1a-bafa0f6c2921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ce249548-40cf-499f-bbcd-dbb1f839f92b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_srt_RangeAxis_ce249548-40cf-499f-bbcd-dbb1f839f92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e15bb5f6-a24f-4afe-a974-aeb1288a1410" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ce249548-40cf-499f-bbcd-dbb1f839f92b" xlink:to="loc_srt_RangeMember_e15bb5f6-a24f-4afe-a974-aeb1288a1410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ac498b57-77b1-49f2-906d-b9d41dcccb7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e15bb5f6-a24f-4afe-a974-aeb1288a1410" xlink:to="loc_srt_MinimumMember_ac498b57-77b1-49f2-906d-b9d41dcccb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a9172019-ca62-4e13-8613-d38ffc25a44c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e15bb5f6-a24f-4afe-a974-aeb1288a1410" xlink:to="loc_srt_MaximumMember_a9172019-ca62-4e13-8613-d38ffc25a44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_2a2fba01-3cbf-433e-b08c-4025bc4d5a6c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e15bb5f6-a24f-4afe-a974-aeb1288a1410" xlink:to="loc_srt_WeightedAverageMember_2a2fba01-3cbf-433e-b08c-4025bc4d5a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c2c900e-bab5-4c9f-a065-29c6412897fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c2c900e-bab5-4c9f-a065-29c6412897fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c88c6155-f686-4b9d-a388-b93b15baf7a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c2c900e-bab5-4c9f-a065-29c6412897fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c88c6155-f686-4b9d-a388-b93b15baf7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c1c89a73-7491-4b83-9392-070004e4e1eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c88c6155-f686-4b9d-a388-b93b15baf7a5" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c1c89a73-7491-4b83-9392-070004e4e1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_849a913a-2161-4129-9d57-0555f16b85ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c88c6155-f686-4b9d-a388-b93b15baf7a5" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_849a913a-2161-4129-9d57-0555f16b85ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f842ab53-9bf6-4999-ab27-cb795d9e2a15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f842ab53-9bf6-4999-ab27-cb795d9e2a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cc236c30-6863-424a-8ef8-64bb7dadb860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f842ab53-9bf6-4999-ab27-cb795d9e2a15" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cc236c30-6863-424a-8ef8-64bb7dadb860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_2708d4cf-a1f4-40aa-8f09-43a0d178c3ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cc236c30-6863-424a-8ef8-64bb7dadb860" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_2708d4cf-a1f4-40aa-8f09-43a0d178c3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_a730f91f-bda0-4267-9644-f5a672a70d80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_cc236c30-6863-424a-8ef8-64bb7dadb860" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_a730f91f-bda0-4267-9644-f5a672a70d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4b47e20b-8800-4ca0-b4a5-dfb959dd2a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4b47e20b-8800-4ca0-b4a5-dfb959dd2a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd1a9b4c-303b-4423-b7a3-d3e80038a329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4b47e20b-8800-4ca0-b4a5-dfb959dd2a6f" xlink:to="loc_us-gaap_SegmentDomain_cd1a9b4c-303b-4423-b7a3-d3e80038a329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d9268bdc-b1f0-48fb-b97e-b8507d73371f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d9268bdc-b1f0-48fb-b97e-b8507d73371f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_15e28607-a6c8-47b2-a25a-13841cc04193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d9268bdc-b1f0-48fb-b97e-b8507d73371f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_15e28607-a6c8-47b2-a25a-13841cc04193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_28a89f2b-1c16-41a1-bee9-ab124d76adaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_15e28607-a6c8-47b2-a25a-13841cc04193" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_28a89f2b-1c16-41a1-bee9-ab124d76adaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a9f6197b-1eac-4ac1-aa32-214bc859fe25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a9f6197b-1eac-4ac1-aa32-214bc859fe25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a3899f10-a393-4079-8d5f-25cd4a581f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a9f6197b-1eac-4ac1-aa32-214bc859fe25" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a3899f10-a393-4079-8d5f-25cd4a581f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_a01629d4-d007-4ef8-bac1-74edfd3151c8" xlink:href="bsx-20210630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a3899f10-a393-4079-8d5f-25cd4a581f54" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_a01629d4-d007-4ef8-bac1-74edfd3151c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_758e18c3-3931-440d-8ce5-b4f3e9ed0a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_758e18c3-3931-440d-8ce5-b4f3e9ed0a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f47385c8-b038-4d20-ba0c-57824c0d0505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_758e18c3-3931-440d-8ce5-b4f3e9ed0a9f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f47385c8-b038-4d20-ba0c-57824c0d0505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8c9a8803-de28-4d31-8830-1ad861837102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f47385c8-b038-4d20-ba0c-57824c0d0505" xlink:to="loc_us-gaap_SubsequentEventMember_8c9a8803-de28-4d31-8830-1ad861837102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2a20b2b4-ffff-4f6f-ac53-30b99fb714fc" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_34b10b23-b39a-46f7-9c3c-30c77a686da7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_34b10b23-b39a-46f7-9c3c-30c77a686da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinessesDivested_069efbae-e49b-428d-972b-e407a9b49cc3" xlink:href="bsx-20210630.xsd#bsx_NumberOfBusinessesDivested"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_NumberOfBusinessesDivested_069efbae-e49b-428d-972b-e407a9b49cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_288ef209-1efa-49c8-9f33-ede015ba4c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_288ef209-1efa-49c8-9f33-ede015ba4c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_b1f6cab7-83b4-4469-8843-661aaa4eb216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_b1f6cab7-83b4-4469-8843-661aaa4eb216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_19eccc62-89b5-4a94-a053-cd3b1d842794" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_19eccc62-89b5-4a94-a053-cd3b1d842794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_98f2b457-58aa-47d4-9a7b-9e6938e2a6aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_98f2b457-58aa-47d4-9a7b-9e6938e2a6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_44305485-14e5-4fc2-b57a-388e107a5caf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_44305485-14e5-4fc2-b57a-388e107a5caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8453b449-9832-476e-a872-c3b20c15fe9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8453b449-9832-476e-a872-c3b20c15fe9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b2215a8c-c21b-41b2-afe3-7a5c7c8ece19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b2215a8c-c21b-41b2-afe3-7a5c7c8ece19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod_c52d4894-0d84-4c02-aab7-431e85c78f6f" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod_c52d4894-0d84-4c02-aab7-431e85c78f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6c74ab86-876a-4765-b463-a2a81e821816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6c74ab86-876a-4765-b463-a2a81e821816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_26002a53-f7f2-43a0-87b5-2c6258c7a3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_26002a53-f7f2-43a0-87b5-2c6258c7a3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_aa684994-0d80-4978-af6c-a8a78aecd0de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_aa684994-0d80-4978-af6c-a8a78aecd0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7e8fe70a-e377-4a9e-851a-487c87f79fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_Goodwill_7e8fe70a-e377-4a9e-851a-487c87f79fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_761b8796-39ff-42a3-9e4a-903e9df4f91a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_761b8796-39ff-42a3-9e4a-903e9df4f91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b7d4434b-79b1-4fa8-9a2b-3b77d90c9cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b7d4434b-79b1-4fa8-9a2b-3b77d90c9cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5d5af037-b682-4e29-9788-8326684185de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5d5af037-b682-4e29-9788-8326684185de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_33574e5a-c1dd-4297-b392-d522ae04eba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_33574e5a-c1dd-4297-b392-d522ae04eba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ba4f0db1-8f99-4ac2-abaa-8f12dbab2e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ba4f0db1-8f99-4ac2-abaa-8f12dbab2e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_9f280472-e546-410a-8f36-0b01e02ac2cf" xlink:href="bsx-20210630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_DiscountRateFairValueInput_9f280472-e546-410a-8f36-0b01e02ac2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d9461d6e-d3bc-4ce3-9f5e-f3c097e38aac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d9461d6e-d3bc-4ce3-9f5e-f3c097e38aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfFacilities_d98a0359-2b99-4cd8-a1a8-8d80386fc8e5" xlink:href="bsx-20210630.xsd#bsx_DivestitureAgreementTransferOfFacilities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_DivestitureAgreementTransferOfFacilities_d98a0359-2b99-4cd8-a1a8-8d80386fc8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_9ff45d5b-888a-4154-b5d0-aaa25e7947d2" xlink:href="bsx-20210630.xsd#bsx_DivestitureAgreementTransferOfGlobalEmployees"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_bsx_DivestitureAgreementTransferOfGlobalEmployees_9ff45d5b-888a-4154-b5d0-aaa25e7947d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f1cfce16-56af-481e-9ad0-ac1bccb49188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3cd9dbe5-8a07-45e4-b62f-fedd8e912125" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f1cfce16-56af-481e-9ad0-ac1bccb49188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#ContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_a531fc75-d937-491f-9014-f033c9e2038c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_a531fc75-d937-491f-9014-f033c9e2038c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5f054db6-a33c-417f-9d1b-4f406869702e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:to="loc_srt_RangeAxis_5f054db6-a33c-417f-9d1b-4f406869702e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_da129bc8-d563-476b-acb8-bcfccb427099" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5f054db6-a33c-417f-9d1b-4f406869702e" xlink:to="loc_srt_RangeMember_da129bc8-d563-476b-acb8-bcfccb427099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fd5a8b36-536d-48fe-8b7e-c8e20c22d7ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_da129bc8-d563-476b-acb8-bcfccb427099" xlink:to="loc_srt_MinimumMember_fd5a8b36-536d-48fe-8b7e-c8e20c22d7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_db022b9d-59a7-4d07-a658-f6b468ec4ad0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_da129bc8-d563-476b-acb8-bcfccb427099" xlink:to="loc_srt_MaximumMember_db022b9d-59a7-4d07-a658-f6b468ec4ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_83e9ec43-d54b-404c-895a-0e65f696ab80" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_da129bc8-d563-476b-acb8-bcfccb427099" xlink:to="loc_srt_WeightedAverageMember_83e9ec43-d54b-404c-895a-0e65f696ab80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_d84ffa09-8da1-4b36-a74e-4a6da16a5de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:to="loc_us-gaap_ValuationTechniqueAxis_d84ffa09-8da1-4b36-a74e-4a6da16a5de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_8db5859e-0d2e-48d3-bb6c-cc184fd0b609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_d84ffa09-8da1-4b36-a74e-4a6da16a5de1" xlink:to="loc_us-gaap_ValuationTechniqueDomain_8db5859e-0d2e-48d3-bb6c-cc184fd0b609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_6e1d4262-3ffb-4b83-af0c-44b26715d363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_8db5859e-0d2e-48d3-bb6c-cc184fd0b609" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_6e1d4262-3ffb-4b83-af0c-44b26715d363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7262efe7-1b6f-44ec-955a-75491714d5e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7262efe7-1b6f-44ec-955a-75491714d5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dcb27828-0f99-44c2-85c2-4c483fe0ae52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7262efe7-1b6f-44ec-955a-75491714d5e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_dcb27828-0f99-44c2-85c2-4c483fe0ae52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_7376c259-83dc-44e6-b4a1-367f7bd60583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_7376c259-83dc-44e6-b4a1-367f7bd60583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_73688df4-60af-473b-b159-db00cd08adea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_7376c259-83dc-44e6-b4a1-367f7bd60583" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_73688df4-60af-473b-b159-db00cd08adea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_4be57a82-8cc1-4e05-935c-ebac78b45a8a" xlink:href="bsx-20210630.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_73688df4-60af-473b-b159-db00cd08adea" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_4be57a82-8cc1-4e05-935c-ebac78b45a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_74101217-75ab-43c4-85d1-8eb69807063c" xlink:href="bsx-20210630.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_73688df4-60af-473b-b159-db00cd08adea" xlink:to="loc_bsx_RevenueBasedPaymentsMember_74101217-75ab-43c4-85d1-8eb69807063c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2d7547aa-dbe2-44f2-8ad7-d3b8b1a94f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2d7547aa-dbe2-44f2-8ad7-d3b8b1a94f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5203e242-d2a0-4e0b-8fd4-f49a1fdc70f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2d7547aa-dbe2-44f2-8ad7-d3b8b1a94f6b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5203e242-d2a0-4e0b-8fd4-f49a1fdc70f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c559ba12-7998-4b4a-9a6d-10db98c5ded7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5203e242-d2a0-4e0b-8fd4-f49a1fdc70f6" xlink:to="loc_us-gaap_SubsequentEventMember_c559ba12-7998-4b4a-9a6d-10db98c5ded7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_a4b839b4-64b4-446d-8f34-8eee06404424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_8c08386f-b541-4ef4-a600-96029df4d750" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_a4b839b4-64b4-446d-8f34-8eee06404424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_a4b839b4-64b4-446d-8f34-8eee06404424" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b5f1ce51-5202-4aad-b7d2-537d5b2bb4d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b5f1ce51-5202-4aad-b7d2-537d5b2bb4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_da4da3b0-534c-46f1-904d-9ac6ec719f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_da4da3b0-534c-46f1-904d-9ac6ec719f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a00dfa8f-ec1c-42fb-8de7-b1d01571c3f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a00dfa8f-ec1c-42fb-8de7-b1d01571c3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_16e204f4-0511-4e3e-ba9e-93d564243132" xlink:href="bsx-20210630.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:to="loc_bsx_PaymentOfContingentConsideration_16e204f4-0511-4e3e-ba9e-93d564243132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_63a10c9c-c11e-4dc1-b69f-8431eb914d35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_4d507680-fe88-4df8-bf41-75745e4800de" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_63a10c9c-c11e-4dc1-b69f-8431eb914d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_89c55818-adaf-4738-8911-f930eba35713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_a4b839b4-64b4-446d-8f34-8eee06404424" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_89c55818-adaf-4738-8911-f930eba35713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2d413cb3-8386-4e07-b847-fa18c2080f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_89c55818-adaf-4738-8911-f930eba35713" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_2d413cb3-8386-4e07-b847-fa18c2080f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8612e309-6cd4-4909-846c-b1f59e3cd8b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_89c55818-adaf-4738-8911-f930eba35713" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8612e309-6cd4-4909-846c-b1f59e3cd8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8a52fe92-2564-405b-9d98-a2c886487ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8612e309-6cd4-4909-846c-b1f59e3cd8b4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8a52fe92-2564-405b-9d98-a2c886487ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_553d6b51-9d30-4303-9417-be6a2977815e" xlink:href="bsx-20210630.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8612e309-6cd4-4909-846c-b1f59e3cd8b4" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_553d6b51-9d30-4303-9417-be6a2977815e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_62ba9fae-6bf2-418c-a42b-a65b3486b316" xlink:href="bsx-20210630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_8612e309-6cd4-4909-846c-b1f59e3cd8b4" xlink:to="loc_bsx_DiscountRateFairValueInput_62ba9fae-6bf2-418c-a42b-a65b3486b316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_1b42e63d-feb5-4381-8a4a-8480aa7d2c95" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_a4b839b4-64b4-446d-8f34-8eee06404424" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_1b42e63d-feb5-4381-8a4a-8480aa7d2c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#StrategicInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_ccdfb24a-0f77-4755-b5d7-955257acb567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_5fd72769-3803-4c55-880c-1b1e4e9a9ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ccdfb24a-0f77-4755-b5d7-955257acb567" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_5fd72769-3803-4c55-880c-1b1e4e9a9ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6bd444b4-df87-4312-bc51-3ae6e0b167c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_5fd72769-3803-4c55-880c-1b1e4e9a9ab9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6bd444b4-df87-4312-bc51-3ae6e0b167c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f3f1e542-0ebd-43c1-9b29-0b571b8ca681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6bd444b4-df87-4312-bc51-3ae6e0b167c8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f3f1e542-0ebd-43c1-9b29-0b571b8ca681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_adbb3206-28cd-49a1-a898-0bd9d1f86f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f3f1e542-0ebd-43c1-9b29-0b571b8ca681" xlink:to="loc_us-gaap_SubsequentEventMember_adbb3206-28cd-49a1-a898-0bd9d1f86f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_5fd72769-3803-4c55-880c-1b1e4e9a9ab9" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ea270b80-5eee-4c43-a9b7-7424ab30c197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_EquityMethodInvestments_ea270b80-5eee-4c43-a9b7-7424ab30c197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d2d7db2a-d5ff-47e3-9d5b-fc315b767d7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d2d7db2a-d5ff-47e3-9d5b-fc315b767d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_822e4679-c0a4-46ce-8599-654efbeec790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_822e4679-c0a4-46ce-8599-654efbeec790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f4ea3ce6-d890-474e-9705-4a43291adc6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f4ea3ce6-d890-474e-9705-4a43291adc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e8add88d-7f20-4ecc-b5c9-b84c273e025c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_Investments_e8add88d-7f20-4ecc-b5c9-b84c273e025c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_48b697ba-c19d-45c5-93c0-01141c0f03cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_48b697ba-c19d-45c5-93c0-01141c0f03cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_070f7c2a-f5dd-47ee-be67-d9748926f205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_070f7c2a-f5dd-47ee-be67-d9748926f205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_2dd2dc70-6b24-4172-9a18-746a148680b1" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_58212444-1d7e-441e-a755-06c4f3c7fe5d" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_2dd2dc70-6b24-4172-9a18-746a148680b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="bsx-20210630.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4c834bf3-a7f2-437f-aaa3-7609968e6318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e1f8336c-56b8-4201-a634-795de927c7e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4c834bf3-a7f2-437f-aaa3-7609968e6318" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e1f8336c-56b8-4201-a634-795de927c7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#GoodwillandOtherIntangibleAssetsGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_df7d94d6-2ea8-4e6e-9685-68ae29199ba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_be13524c-368a-4ea0-bb8f-e827ea6cb988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_df7d94d6-2ea8-4e6e-9685-68ae29199ba3" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_be13524c-368a-4ea0-bb8f-e827ea6cb988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_33d6a127-48ae-4584-a601-29b2e88915b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_df7d94d6-2ea8-4e6e-9685-68ae29199ba3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_33d6a127-48ae-4584-a601-29b2e88915b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f3bd173b-3207-46de-a6d6-88cda74fda98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:href="bsx-20210630.xsd#bsx_ScheduleofIntangibleAssetsandGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f3bd173b-3207-46de-a6d6-88cda74fda98" xlink:to="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsAxis_038d3b76-003c-493c-b0ca-9aa66f022b47" xlink:href="bsx-20210630.xsd#bsx_IntangibleAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_bsx_IntangibleAssetsAxis_038d3b76-003c-493c-b0ca-9aa66f022b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsDomain_6eef8f69-467b-43ae-97fa-04e94548ffdb" xlink:href="bsx-20210630.xsd#bsx_IntangibleAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsAxis_038d3b76-003c-493c-b0ca-9aa66f022b47" xlink:to="loc_bsx_IntangibleAssetsDomain_6eef8f69-467b-43ae-97fa-04e94548ffdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_edf50cc8-b341-46d6-9b20-39eda7e826e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_edf50cc8-b341-46d6-9b20-39eda7e826e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b622dedc-f156-4201-839d-ff8f89a22239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_edf50cc8-b341-46d6-9b20-39eda7e826e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b622dedc-f156-4201-839d-ff8f89a22239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4ba9abdf-4b0b-43a1-b9bd-5cd6b3c0b161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b622dedc-f156-4201-839d-ff8f89a22239" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_4ba9abdf-4b0b-43a1-b9bd-5cd6b3c0b161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_ea34f598-35e1-4249-b434-ed95d56413c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b622dedc-f156-4201-839d-ff8f89a22239" xlink:to="loc_us-gaap_PatentsMember_ea34f598-35e1-4249-b434-ed95d56413c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_04f5704e-0739-45b0-80b0-44347e5a7bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b622dedc-f156-4201-839d-ff8f89a22239" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_04f5704e-0739-45b0-80b0-44347e5a7bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c10bd1a5-f189-4aec-9cb7-f03ffd40eaeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c10bd1a5-f189-4aec-9cb7-f03ffd40eaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_51df81cc-44da-4f9f-9115-12e97fccbe28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c10bd1a5-f189-4aec-9cb7-f03ffd40eaeb" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_51df81cc-44da-4f9f-9115-12e97fccbe28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_851a4beb-e8c6-4a5e-96a9-8c12625abeff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_51df81cc-44da-4f9f-9115-12e97fccbe28" xlink:to="loc_us-gaap_GoodwillMember_851a4beb-e8c6-4a5e-96a9-8c12625abeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1ab43daf-30a1-47e0-b4d7-e01598bd58e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_51df81cc-44da-4f9f-9115-12e97fccbe28" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1ab43daf-30a1-47e0-b4d7-e01598bd58e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_54774074-5def-41f5-962a-e786c8529930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_51df81cc-44da-4f9f-9115-12e97fccbe28" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_54774074-5def-41f5-962a-e786c8529930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4a58640e-d3e0-46dc-89ad-9d5ac98ec683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4a58640e-d3e0-46dc-89ad-9d5ac98ec683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a58640e-d3e0-46dc-89ad-9d5ac98ec683" xlink:to="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_4df8c5a2-6a32-4799-ac19-c94aa1344fc7" xlink:href="bsx-20210630.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:to="loc_bsx_MedsurgMember_4df8c5a2-6a32-4799-ac19-c94aa1344fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_6d22d7c8-bbb3-45b2-8e3c-62c766f124a8" xlink:href="bsx-20210630.xsd#bsx_RhythmandNeuroMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:to="loc_bsx_RhythmandNeuroMember_6d22d7c8-bbb3-45b2-8e3c-62c766f124a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_b22ebc5f-99e9-4020-9736-66acd32a8c2b" xlink:href="bsx-20210630.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:to="loc_bsx_CardiovascularMember_b22ebc5f-99e9-4020-9736-66acd32a8c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_d78f29db-3a93-4232-9bf8-e2983f9209a0" xlink:href="bsx-20210630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0919641c-620c-4032-91bf-a22e93d6289f" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_d78f29db-3a93-4232-9bf8-e2983f9209a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0e731150-df2d-49bc-9ea5-3b55580f2a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0e731150-df2d-49bc-9ea5-3b55580f2a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6ce3fb6d-4845-449f-a6c5-7ed63599853b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0e731150-df2d-49bc-9ea5-3b55580f2a35" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6ce3fb6d-4845-449f-a6c5-7ed63599853b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ce24272d-d1cd-4f6f-857c-e8702b7d0d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6ce3fb6d-4845-449f-a6c5-7ed63599853b" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ce24272d-d1cd-4f6f-857c-e8702b7d0d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember_22ed7451-776e-4d1f-8d95-85a232eda423" xlink:href="bsx-20210630.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6ce3fb6d-4845-449f-a6c5-7ed63599853b" xlink:to="loc_bsx_ForeigncurrencydenominatedindebtMember_22ed7451-776e-4d1f-8d95-85a232eda423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_8cc2bdb9-ca4d-43b2-8560-c20260e64cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6ce3fb6d-4845-449f-a6c5-7ed63599853b" xlink:to="loc_us-gaap_InterestRateContractMember_8cc2bdb9-ca4d-43b2-8560-c20260e64cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_83180526-0dea-4b22-973a-4d9825d0ab7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_83180526-0dea-4b22-973a-4d9825d0ab7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0866a0fb-516a-4f13-907f-7ec681985e86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_83180526-0dea-4b22-973a-4d9825d0ab7b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0866a0fb-516a-4f13-907f-7ec681985e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1ef774e1-4860-4961-8f5d-34803284c648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0866a0fb-516a-4f13-907f-7ec681985e86" xlink:to="loc_us-gaap_CashFlowHedgingMember_1ef774e1-4860-4961-8f5d-34803284c648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_5443b67c-665c-4c64-999c-a4c8d3849e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0866a0fb-516a-4f13-907f-7ec681985e86" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_5443b67c-665c-4c64-999c-a4c8d3849e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7b0404c8-f19a-421e-bfd3-2773025d850f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_HedgingDesignationAxis_7b0404c8-f19a-421e-bfd3-2773025d850f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_94659ce3-7fc4-4bfa-8c67-d35b5232f683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7b0404c8-f19a-421e-bfd3-2773025d850f" xlink:to="loc_us-gaap_HedgingDesignationDomain_94659ce3-7fc4-4bfa-8c67-d35b5232f683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0217a070-abed-4592-b810-c6f4d55287e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_94659ce3-7fc4-4bfa-8c67-d35b5232f683" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_0217a070-abed-4592-b810-c6f4d55287e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c33cabdd-872d-472d-8195-c1c6bca57683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c33cabdd-872d-472d-8195-c1c6bca57683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_781571c1-a5ab-404c-86c8-d2f1bd192f1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c33cabdd-872d-472d-8195-c1c6bca57683" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_781571c1-a5ab-404c-86c8-d2f1bd192f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_15160d0b-2b7f-4a61-9a2f-6cdb6f7deb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_781571c1-a5ab-404c-86c8-d2f1bd192f1f" xlink:to="loc_us-gaap_CostOfSalesMember_15160d0b-2b7f-4a61-9a2f-6cdb6f7deb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d596ca38-3374-448c-bc5e-9dced0c23910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_781571c1-a5ab-404c-86c8-d2f1bd192f1f" xlink:to="loc_us-gaap_InterestExpenseMember_d596ca38-3374-448c-bc5e-9dced0c23910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:href="bsx-20210630.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_ef8d8e5a-6ef8-46d4-855a-3af329a0a25e" xlink:to="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_affe6ffe-3d09-4c71-a06d-ab69d5c7edd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_affe6ffe-3d09-4c71-a06d-ab69d5c7edd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6528d3b7-5ed1-46a0-b343-c09012c68a91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6528d3b7-5ed1-46a0-b343-c09012c68a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_6dcbdfff-9e5a-49c0-81b1-785fac23554b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_GoodwillGross_6dcbdfff-9e5a-49c0-81b1-785fac23554b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4d883961-83aa-47c7-b2f3-7602247bf01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_4d883961-83aa-47c7-b2f3-7602247bf01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ceee2282-474a-4404-ba1c-1bdaf87da25e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ceee2282-474a-4404-ba1c-1bdaf87da25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_26db6142-2d18-447b-b472-237db501333b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_26db6142-2d18-447b-b472-237db501333b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_003cf006-7871-4409-873f-9f4b8c884f82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_GoodwillRollForward_003cf006-7871-4409-873f-9f4b8c884f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5cf31998-6ce5-47de-821a-006dfcea39e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_003cf006-7871-4409-873f-9f4b8c884f82" xlink:to="loc_us-gaap_Goodwill_5cf31998-6ce5-47de-821a-006dfcea39e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_883806ee-0a43-40ce-8404-f6a55608c385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_003cf006-7871-4409-873f-9f4b8c884f82" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_883806ee-0a43-40ce-8404-f6a55608c385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_dc862eef-f593-43b5-8161-c5c8d3e643ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_003cf006-7871-4409-873f-9f4b8c884f82" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_dc862eef-f593-43b5-8161-c5c8d3e643ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fd1c0c1e-c234-4371-9f12-7e6b9761377f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_003cf006-7871-4409-873f-9f4b8c884f82" xlink:to="loc_us-gaap_Goodwill_fd1c0c1e-c234-4371-9f12-7e6b9761377f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_36bbc481-c135-4c2d-9763-31dba40353a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_36bbc481-c135-4c2d-9763-31dba40353a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6123228f-0eb0-4926-bfe1-cf8c34f5727c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_6123228f-0eb0-4926-bfe1-cf8c34f5727c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_5ea8b560-9321-4957-9c13-db8100f4f92d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_5ea8b560-9321-4957-9c13-db8100f4f92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_dd7be080-1f49-446a-9875-0443ccc525bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_dd7be080-1f49-446a-9875-0443ccc525bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_830b5bfc-d685-4812-807b-ab25798ed135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_830b5bfc-d685-4812-807b-ab25798ed135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_a0bf41c0-4d5b-4b8e-b153-0d0a80cc32d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_a0bf41c0-4d5b-4b8e-b153-0d0a80cc32d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_fcddbac3-1c4a-4fdd-9d14-911b578a8559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_fcddbac3-1c4a-4fdd-9d14-911b578a8559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ffc427a1-7f28-47c8-9f93-6323fc7e1b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ffc427a1-7f28-47c8-9f93-6323fc7e1b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_284dedeb-acf9-440e-a98f-b10f32d014fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_284dedeb-acf9-440e-a98f-b10f32d014fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_f9299f2a-ee17-496a-9137-fbe990b5afd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_f9299f2a-ee17-496a-9137-fbe990b5afd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b505d966-fc35-4078-be0d-5d20e6745b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b505d966-fc35-4078-be0d-5d20e6745b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_65b71c80-8e2d-4f40-889c-223d9ddbca81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_InterestExpense_65b71c80-8e2d-4f40-889c-223d9ddbca81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_e76dc656-f84d-4235-b4ae-7dad83443f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_e76dc656-f84d-4235-b4ae-7dad83443f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_d8ce1bfa-8950-4709-8f6d-8428148999c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_d8ce1bfa-8950-4709-8f6d-8428148999c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_f611a144-e32d-4527-bf3c-ddac49e43da7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_f611a144-e32d-4527-bf3c-ddac49e43da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_b05915b6-ba63-4f70-b415-53a56b3b1243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_b05915b6-ba63-4f70-b415-53a56b3b1243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_f490a800-9593-43e5-b192-260d4846ffbc" xlink:href="bsx-20210630.xsd#bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_34288e59-7510-4ed2-965a-7f610997d67b" xlink:to="loc_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest_f490a800-9593-43e5-b192-260d4846ffbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="simple" xlink:href="bsx-20210630.xsd#HedgingActivitiesandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e24d6c21-20cf-47c7-92d5-486c94d46a07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_931d65b2-8f8f-40f9-9e27-d8c07a090cda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e24d6c21-20cf-47c7-92d5-486c94d46a07" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_931d65b2-8f8f-40f9-9e27-d8c07a090cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_c8024ee4-d6fe-4211-8cab-3e37a1036c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_931d65b2-8f8f-40f9-9e27-d8c07a090cda" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_c8024ee4-d6fe-4211-8cab-3e37a1036c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="simple" xlink:href="bsx-20210630.xsd#FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f2508f88-c8ce-4492-ac8e-44223fdab6c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_91f72f44-5f70-481f-8403-7da0db1bec48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f2508f88-c8ce-4492-ac8e-44223fdab6c9" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_91f72f44-5f70-481f-8403-7da0db1bec48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_a57f5837-27c6-46ad-ab7f-01c88fe9a962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f2508f88-c8ce-4492-ac8e-44223fdab6c9" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_a57f5837-27c6-46ad-ab7f-01c88fe9a962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b2ab9f11-b363-4748-842e-8792da51dd83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_a9b0226a-0ca9-4de3-98de-9091d37db114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b2ab9f11-b363-4748-842e-8792da51dd83" xlink:to="loc_us-gaap_DerivativeTable_a9b0226a-0ca9-4de3-98de-9091d37db114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9d386aac-03cf-4ed3-ad9f-a1e9805c52ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a9b0226a-0ca9-4de3-98de-9091d37db114" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9d386aac-03cf-4ed3-ad9f-a1e9805c52ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_acefa609-083f-4579-a998-a7853265b177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9d386aac-03cf-4ed3-ad9f-a1e9805c52ac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_acefa609-083f-4579-a998-a7853265b177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a9b0226a-0ca9-4de3-98de-9091d37db114" xlink:to="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_bc384333-e96b-42c1-aa25-04b7c923b558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_bc384333-e96b-42c1-aa25-04b7c923b558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_daee26f3-b946-4296-9911-158138fe1f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_daee26f3-b946-4296-9911-158138fe1f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_4c4ddb6e-e3d2-4f21-8f39-333398838d96" xlink:href="bsx-20210630.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_4c4ddb6e-e3d2-4f21-8f39-333398838d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_6979e601-b561-400e-9fb0-ad02192b2df6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_6979e601-b561-400e-9fb0-ad02192b2df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5bb57f7e-7a9f-452a-b4fe-f920415e9227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_01f8565b-ea39-4c9a-a622-dcb4634c4295" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5bb57f7e-7a9f-452a-b4fe-f920415e9227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7d388cd6-d26d-49d7-9a81-d23ec7c9ad16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b2ab9f11-b363-4748-842e-8792da51dd83" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_7d388cd6-d26d-49d7-9a81-d23ec7c9ad16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84049df6-8697-4154-90eb-cbe03930fb58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7d388cd6-d26d-49d7-9a81-d23ec7c9ad16" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84049df6-8697-4154-90eb-cbe03930fb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_759b9923-6732-40e5-afb1-51ffbaf2cfa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84049df6-8697-4154-90eb-cbe03930fb58" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_759b9923-6732-40e5-afb1-51ffbaf2cfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d836aa90-9b8b-4870-9f38-1d9477213cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_759b9923-6732-40e5-afb1-51ffbaf2cfa3" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d836aa90-9b8b-4870-9f38-1d9477213cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83b77747-ffba-4a5e-b4a6-611a773daa05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84049df6-8697-4154-90eb-cbe03930fb58" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83b77747-ffba-4a5e-b4a6-611a773daa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a1413602-ae41-4def-bf3f-4fe73e770814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_83b77747-ffba-4a5e-b4a6-611a773daa05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a1413602-ae41-4def-bf3f-4fe73e770814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c13ce9f8-63dd-4f89-99ec-c296f112ce60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_84049df6-8697-4154-90eb-cbe03930fb58" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c13ce9f8-63dd-4f89-99ec-c296f112ce60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_48a8273c-3b00-447e-b2b3-c570c0c94e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c13ce9f8-63dd-4f89-99ec-c296f112ce60" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_48a8273c-3b00-447e-b2b3-c570c0c94e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#HedgingActivitiesandFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_420bb63f-70bd-4dae-8fd5-16841db52943" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_420bb63f-70bd-4dae-8fd5-16841db52943" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c357ad3c-975e-4ce8-b7fc-f7c236f085d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c357ad3c-975e-4ce8-b7fc-f7c236f085d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_da2395c5-6818-4127-b1b2-b30e1bc3ed45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c357ad3c-975e-4ce8-b7fc-f7c236f085d7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_da2395c5-6818-4127-b1b2-b30e1bc3ed45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_82aabe2d-8846-46c4-b0c6-315e41fa7b52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_da2395c5-6818-4127-b1b2-b30e1bc3ed45" xlink:to="loc_us-gaap_CashFlowHedgingMember_82aabe2d-8846-46c4-b0c6-315e41fa7b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c36fdac2-60c1-4999-b355-3238102b4263" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_da2395c5-6818-4127-b1b2-b30e1bc3ed45" xlink:to="loc_us-gaap_FairValueHedgingMember_c36fdac2-60c1-4999-b355-3238102b4263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_55f44d1d-d1b3-4a58-89f6-d220af1f2ea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_da2395c5-6818-4127-b1b2-b30e1bc3ed45" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_55f44d1d-d1b3-4a58-89f6-d220af1f2ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_64d3792a-cbaf-4d1f-ac0a-a6551e28678e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_HedgingDesignationAxis_64d3792a-cbaf-4d1f-ac0a-a6551e28678e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_be4f2c15-39d4-415d-b07d-e43e0cabbe04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_64d3792a-cbaf-4d1f-ac0a-a6551e28678e" xlink:to="loc_us-gaap_HedgingDesignationDomain_be4f2c15-39d4-415d-b07d-e43e0cabbe04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_54dfc049-cd08-4dcb-ad52-1ec0da737366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_be4f2c15-39d4-415d-b07d-e43e0cabbe04" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_54dfc049-cd08-4dcb-ad52-1ec0da737366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d2eaa939-4049-48df-b1fd-fd6f6d8dc046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_be4f2c15-39d4-415d-b07d-e43e0cabbe04" xlink:to="loc_us-gaap_NondesignatedMember_d2eaa939-4049-48df-b1fd-fd6f6d8dc046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ed1ac7d8-2234-4b03-852f-50704264c2bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ed1ac7d8-2234-4b03-852f-50704264c2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ed1ac7d8-2234-4b03-852f-50704264c2bd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_970f9abf-a6db-4b49-9635-8e214df8deb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_970f9abf-a6db-4b49-9635-8e214df8deb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_14a444cf-c25b-43f9-83b0-1d16076c8ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:to="loc_us-gaap_ForeignExchangeContractMember_14a444cf-c25b-43f9-83b0-1d16076c8ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember_d94d8455-b9c6-4dd8-99f7-dca970ab9ea3" xlink:href="bsx-20210630.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:to="loc_bsx_ForeigncurrencydenominatedindebtMember_d94d8455-b9c6-4dd8-99f7-dca970ab9ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_5d2c602a-1ed6-4ba1-833e-d9d724cb9ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:to="loc_us-gaap_InterestRateContractMember_5d2c602a-1ed6-4ba1-833e-d9d724cb9ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_00338f02-84fe-403b-b980-56672404adca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_50d9f15b-88f7-4087-afc0-83ecadf88431" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_00338f02-84fe-403b-b980-56672404adca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_47a936a7-af95-4f5a-94c3-b6f5875b7bcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_47a936a7-af95-4f5a-94c3-b6f5875b7bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_47a936a7-af95-4f5a-94c3-b6f5875b7bcb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a72f1c58-e861-48f0-8db0-af9acb816b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a72f1c58-e861-48f0-8db0-af9acb816b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_44e3a441-ac10-40c0-a961-01b9be0b61ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_44e3a441-ac10-40c0-a961-01b9be0b61ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_fe384665-8378-4d62-93e9-137a1674b4b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_fe384665-8378-4d62-93e9-137a1674b4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7fb8ea92-2b5c-4b50-af41-dc04cd7a6161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ab66aa8a-8933-427b-8219-199fd8a465cc" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7fb8ea92-2b5c-4b50-af41-dc04cd7a6161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2c346a12-3671-4f21-bb10-22db36af8e27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2c346a12-3671-4f21-bb10-22db36af8e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b3e68967-5c18-45ef-9328-ee38f0d78247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2c346a12-3671-4f21-bb10-22db36af8e27" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b3e68967-5c18-45ef-9328-ee38f0d78247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_ec3f99ad-38dc-4958-a0ec-7bb4939e1bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b3e68967-5c18-45ef-9328-ee38f0d78247" xlink:to="loc_us-gaap_CostOfSalesMember_ec3f99ad-38dc-4958-a0ec-7bb4939e1bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_fc37e227-253d-484f-932c-fe9e42ee1ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b3e68967-5c18-45ef-9328-ee38f0d78247" xlink:to="loc_us-gaap_InterestExpenseMember_fc37e227-253d-484f-932c-fe9e42ee1ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_032a9190-b0f0-4b5e-80ba-97b4637772db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b3e68967-5c18-45ef-9328-ee38f0d78247" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_032a9190-b0f0-4b5e-80ba-97b4637772db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cc9d5498-ce4d-4a5c-8072-8be8b594a861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cc9d5498-ce4d-4a5c-8072-8be8b594a861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_19a7a697-84e8-4b5a-aa68-5ee78cd35cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cc9d5498-ce4d-4a5c-8072-8be8b594a861" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_19a7a697-84e8-4b5a-aa68-5ee78cd35cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_2b363741-f9d4-4f43-ae2e-84da7cca6f0a" xlink:href="bsx-20210630.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_19a7a697-84e8-4b5a-aa68-5ee78cd35cc5" xlink:to="loc_bsx_December2027NotesMember_2b363741-f9d4-4f43-ae2e-84da7cca6f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_76ea4af4-8d32-4f39-8f0b-71b7fc887c6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_76ea4af4-8d32-4f39-8f0b-71b7fc887c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a34a63af-443e-4004-9f43-d3d08de1a020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_76ea4af4-8d32-4f39-8f0b-71b7fc887c6c" xlink:to="loc_us-gaap_EquityComponentDomain_a34a63af-443e-4004-9f43-d3d08de1a020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_43315d29-35bb-45c7-a3f0-88714555a734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a34a63af-443e-4004-9f43-d3d08de1a020" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_43315d29-35bb-45c7-a3f0-88714555a734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7095f970-ec58-4472-ac36-5bd662b9b1d0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_fab56ab4-f655-4665-97a8-842617d32c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_LongTermDebt_fab56ab4-f655-4665-97a8-842617d32c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a97c4693-b8e6-43f8-aabe-6d6b6ff3637b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a97c4693-b8e6-43f8-aabe-6d6b6ff3637b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_2f4d6736-2a27-46ae-b865-966c7e9a519c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeTermOfContract_2f4d6736-2a27-46ae-b865-966c7e9a519c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_5fe6ff24-9a3b-4c8d-9d42-c8ad973ad39a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_5fe6ff24-9a3b-4c8d-9d42-c8ad973ad39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_04fd6995-faaa-4c4f-bb86-701660c20c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_04fd6995-faaa-4c4f-bb86-701660c20c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f174831d-96b8-4135-8a59-b773eec247d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f174831d-96b8-4135-8a59-b773eec247d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_0fd621c9-2e0c-4fda-a84b-f04ce3d493d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_0fd621c9-2e0c-4fda-a84b-f04ce3d493d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_e41ef2fb-23fc-470e-a23c-2c2dddc26db4" xlink:href="bsx-20210630.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_e41ef2fb-23fc-470e-a23c-2c2dddc26db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeRemainingMaturity1_214e418c-8f17-406d-ba91-8732299ef5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeRemainingMaturity1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeRemainingMaturity1_214e418c-8f17-406d-ba91-8732299ef5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_76482740-d7b1-4b05-ad2d-334dfc6a71ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_76482740-d7b1-4b05-ad2d-334dfc6a71ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_fd822de4-f7a6-4ff3-b5a3-c51f613f20fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_fd822de4-f7a6-4ff3-b5a3-c51f613f20fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_768fa5ed-dbf6-4034-b70a-4edc4b26a7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_768fa5ed-dbf6-4034-b70a-4edc4b26a7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_fda3b9fe-3364-4f63-bf43-3e77e4d4df00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_fda3b9fe-3364-4f63-bf43-3e77e4d4df00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_429a8106-0109-4c5a-af66-103d27f7fbb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_429a8106-0109-4c5a-af66-103d27f7fbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_c03a555b-7066-499c-9756-6bc8b5a3f9c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_c03a555b-7066-499c-9756-6bc8b5a3f9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_14119d43-b848-4bc0-a5bc-ebc8ca2c8181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_14119d43-b848-4bc0-a5bc-ebc8ca2c8181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_6d836b39-2ef1-47a3-a5f9-786dad43e3a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_6d836b39-2ef1-47a3-a5f9-786dad43e3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_8a1c2559-62c6-487f-a0ff-0c948ad02775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_8a1c2559-62c6-487f-a0ff-0c948ad02775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_80ffd9c9-d104-4e79-acc8-2d8f05d5f637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_80ffd9c9-d104-4e79-acc8-2d8f05d5f637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e318a0d9-b8a8-4bff-b6d6-bdb4ca0d7ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_InterestExpense_e318a0d9-b8a8-4bff-b6d6-bdb4ca0d7ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_90c7845e-376c-4476-91b4-36cc8e182175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_90c7845e-376c-4476-91b4-36cc8e182175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_ac07012b-2253-47e3-bef3-cb732a97ea3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax_ac07012b-2253-47e3-bef3-cb732a97ea3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_98b5309b-ccad-4ecc-a233-41dff56083cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax_98b5309b-ccad-4ecc-a233-41dff56083cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_8436e7c0-db0a-4388-8be8-e99fd567c25c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax_8436e7c0-db0a-4388-8be8-e99fd567c25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_4ed3caec-c763-4da2-8241-26992e44af5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_4ed3caec-c763-4da2-8241-26992e44af5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_c43101b4-05d4-4440-810e-bca615ec0de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_c43101b4-05d4-4440-810e-bca615ec0de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_790aff87-c545-4151-96fc-4f12a9f01287" xlink:href="bsx-20210630.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_790aff87-c545-4151-96fc-4f12a9f01287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_6bf8cb2d-305d-46bb-aa5f-be608143da59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_6bf8cb2d-305d-46bb-aa5f-be608143da59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0232af80-2fa5-43d8-9b38-af8444fc7665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0232af80-2fa5-43d8-9b38-af8444fc7665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss_7d8c27af-8df9-415f-807f-8d40b9259662" xlink:href="bsx-20210630.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_bsx_Netcurrencyexchangegainloss_7d8c27af-8df9-415f-807f-8d40b9259662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_81f92a56-8749-48dd-9c5c-ab3128e29c28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_81f92a56-8749-48dd-9c5c-ab3128e29c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_8416c521-5e07-4543-93cf-b4e153c42bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_8416c521-5e07-4543-93cf-b4e153c42bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_970a76ce-0b77-4b4d-8076-d8c380032ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_970a76ce-0b77-4b4d-8076-d8c380032ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_0635dba1-1cd7-4d18-9f8e-6ad678c9160c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_0635dba1-1cd7-4d18-9f8e-6ad678c9160c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_ef84cd29-e1f9-4c7f-baa7-397f325199fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_ef84cd29-e1f9-4c7f-baa7-397f325199fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0f9643b3-705e-4fe7-b762-e5db6ca1690c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_2a8b4fe1-f21a-4e48-ad8f-930b45ba2ff0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0f9643b3-705e-4fe7-b762-e5db6ca1690c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_420bb63f-70bd-4dae-8fd5-16841db52943" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_caf57162-0f4a-4adc-86f8-0325c3ec28a9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:to="loc_srt_RangeAxis_caf57162-0f4a-4adc-86f8-0325c3ec28a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4710b9bc-9dfa-4edc-9097-5de8b192e203" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_caf57162-0f4a-4adc-86f8-0325c3ec28a9" xlink:to="loc_srt_RangeMember_4710b9bc-9dfa-4edc-9097-5de8b192e203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_e5ff4c7a-566b-4e2b-bedc-6ce5d5433bde" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4710b9bc-9dfa-4edc-9097-5de8b192e203" xlink:to="loc_srt_WeightedAverageMember_e5ff4c7a-566b-4e2b-bedc-6ce5d5433bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e4cedf51-6e6f-42a3-8c9c-a4d4fb4f7989" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4710b9bc-9dfa-4edc-9097-5de8b192e203" xlink:to="loc_srt_MinimumMember_e4cedf51-6e6f-42a3-8c9c-a4d4fb4f7989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_429086ec-0d3a-42ad-94b1-0b7c4de158d1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4710b9bc-9dfa-4edc-9097-5de8b192e203" xlink:to="loc_srt_MaximumMember_429086ec-0d3a-42ad-94b1-0b7c4de158d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b47fe3f4-9dc3-4238-9b62-cf6c73112396" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b47fe3f4-9dc3-4238-9b62-cf6c73112396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c77b6f03-edb4-445d-b09d-466d4a4b6ce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b47fe3f4-9dc3-4238-9b62-cf6c73112396" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c77b6f03-edb4-445d-b09d-466d4a4b6ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_78dba5b3-7a17-42e5-b1cc-da8f8ef731b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c77b6f03-edb4-445d-b09d-466d4a4b6ce2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_78dba5b3-7a17-42e5-b1cc-da8f8ef731b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34162e83-a9c9-45fc-a63d-2b170cfc5e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34162e83-a9c9-45fc-a63d-2b170cfc5e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35adeea-f166-48f1-a0eb-6440711d7d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_34162e83-a9c9-45fc-a63d-2b170cfc5e09" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35adeea-f166-48f1-a0eb-6440711d7d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_94ab452c-3311-4623-a01c-e61035592390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35adeea-f166-48f1-a0eb-6440711d7d5d" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_94ab452c-3311-4623-a01c-e61035592390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5d351dbd-2374-4666-9ea7-753f947a12a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35adeea-f166-48f1-a0eb-6440711d7d5d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5d351dbd-2374-4666-9ea7-753f947a12a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8705b40d-28b1-4d45-b934-ea5f030aeef6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c35adeea-f166-48f1-a0eb-6440711d7d5d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8705b40d-28b1-4d45-b934-ea5f030aeef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_79841c8f-6b1b-41ae-a8ad-e77d0d235a63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_79841c8f-6b1b-41ae-a8ad-e77d0d235a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73d3d575-3a9d-4e8e-8e5f-f239ade28cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_79841c8f-6b1b-41ae-a8ad-e77d0d235a63" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73d3d575-3a9d-4e8e-8e5f-f239ade28cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_fc6d0c0a-0ef5-475b-9c93-c1d95d517286" xlink:href="bsx-20210630.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73d3d575-3a9d-4e8e-8e5f-f239ade28cee" xlink:to="loc_bsx_LicensingarrangementassetsMember_fc6d0c0a-0ef5-475b-9c93-c1d95d517286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_721af539-46c8-4f28-ae5d-ae7bb7770cf1" xlink:href="bsx-20210630.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73d3d575-3a9d-4e8e-8e5f-f239ade28cee" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_721af539-46c8-4f28-ae5d-ae7bb7770cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EurodenominatedoutstandingdebtMember_3a3105fd-a118-4183-b119-a7f7a1b156e1" xlink:href="bsx-20210630.xsd#bsx_EurodenominatedoutstandingdebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_73d3d575-3a9d-4e8e-8e5f-f239ade28cee" xlink:to="loc_bsx_EurodenominatedoutstandingdebtMember_3a3105fd-a118-4183-b119-a7f7a1b156e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8d6660-2eae-4148-93ee-b39d77b3b1d1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_4664dbee-c36a-45ac-b88c-a87bac3426d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_4664dbee-c36a-45ac-b88c-a87bac3426d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_b934cb63-3489-4e70-a699-4ece1bbc605e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_b934cb63-3489-4e70-a699-4ece1bbc605e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_fb8c17b9-2cc3-498d-b826-1344d5f82228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_DerivativeAssets_fb8c17b9-2cc3-498d-b826-1344d5f82228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_97d38503-a812-4a00-a51c-17235e04fadc" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangementsasset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_Licensingarrangementsasset_97d38503-a812-4a00-a51c-17235e04fadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b8a62755-2759-43c7-b46e-acc7fa220884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b8a62755-2759-43c7-b46e-acc7fa220884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_2481aff9-531f-4a7f-80c8-569e18f6b959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_DerivativeLiabilities_2481aff9-531f-4a7f-80c8-569e18f6b959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0acf7c54-eee0-4825-a66d-defd7c9f6aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0acf7c54-eee0-4825-a66d-defd7c9f6aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_48214024-751b-4805-a97b-7324012763ae" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangementsliability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_Licensingarrangementsliability_48214024-751b-4805-a97b-7324012763ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_46328c38-5c0c-4ab7-9bf9-7b769762aa0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_46328c38-5c0c-4ab7-9bf9-7b769762aa0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_b6b3ec6e-0562-4fb2-8ab4-c400dee61ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_Cash_b6b3ec6e-0562-4fb2-8ab4-c400dee61ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments_98550350-1ee2-44a8-b22a-c8d614729ef6" xlink:href="bsx-20210630.xsd#bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments_98550350-1ee2-44a8-b22a-c8d614729ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold_185b5317-d1fc-447b-a882-c56032b6f3b0" xlink:href="bsx-20210630.xsd#bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold_185b5317-d1fc-447b-a882-c56032b6f3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_6b6c9500-ef34-4986-8b9e-f4ae3c1d248a" xlink:href="bsx-20210630.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_DiscountRateFairValueInput_6b6c9500-ef34-4986-8b9e-f4ae3c1d248a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_4bfb9551-6bbb-4f57-b592-982d882ef2af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_4bfb9551-6bbb-4f57-b592-982d882ef2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_d53b9c76-a2c0-4766-b423-e95938bff226" xlink:href="bsx-20210630.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_d53b9c76-a2c0-4766-b423-e95938bff226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_482d2409-cf6d-4453-9f1c-7f4863090ad0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_PaymentsForRoyalties_482d2409-cf6d-4453-9f1c-7f4863090ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_7fbcf575-d15a-49f2-b428-d6c303e46987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_7fbcf575-d15a-49f2-b428-d6c303e46987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_3de39925-c64d-459b-8b52-2c35687f0cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91baae92-b318-4dfe-9226-9883c68fe25d" xlink:to="loc_us-gaap_DebtInstrumentFairValue_3de39925-c64d-459b-8b52-2c35687f0cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="simple" xlink:href="bsx-20210630.xsd#ContractualObligationsandCommitments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_092b2031-7f88-4d5d-b173-7116900a84d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_288ce523-0fb5-4837-9495-61221de4d68e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_092b2031-7f88-4d5d-b173-7116900a84d1" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_288ce523-0fb5-4837-9495-61221de4d68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_67f5eb1a-b08c-4efb-b627-9eea12d0875a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_baf15c6b-86c9-407c-b5c2-b3c881b4c549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_67f5eb1a-b08c-4efb-b627-9eea12d0875a" xlink:to="loc_us-gaap_DebtInstrumentTable_baf15c6b-86c9-407c-b5c2-b3c881b4c549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d68ad99-8c73-4757-94e9-603e4bc01a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_baf15c6b-86c9-407c-b5c2-b3c881b4c549" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d68ad99-8c73-4757-94e9-603e4bc01a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4d4ff908-cd86-40d8-bb16-642b18b6c770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d68ad99-8c73-4757-94e9-603e4bc01a6f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4d4ff908-cd86-40d8-bb16-642b18b6c770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cca4c300-5644-441e-b626-7ac502f38e98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_baf15c6b-86c9-407c-b5c2-b3c881b4c549" xlink:to="loc_us-gaap_DebtInstrumentLineItems_cca4c300-5644-441e-b626-7ac502f38e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_51426f98-03b3-4629-b9f9-603019b0594c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_67f5eb1a-b08c-4efb-b627-9eea12d0875a" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_51426f98-03b3-4629-b9f9-603019b0594c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_2c75da9c-be87-42e2-9c0b-091e9f8d1014" xlink:href="bsx-20210630.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_67f5eb1a-b08c-4efb-b627-9eea12d0875a" xlink:to="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_2c75da9c-be87-42e2-9c0b-091e9f8d1014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_e4483fe5-bc5b-4c88-b230-bc11056a83e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_67f5eb1a-b08c-4efb-b627-9eea12d0875a" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_e4483fe5-bc5b-4c88-b230-bc11056a83e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f74ba77f-49f2-4cfd-b927-fadda03d5093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f74ba77f-49f2-4cfd-b927-fadda03d5093" xlink:to="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_27c07709-8ab1-4148-a2ed-20403114b28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:to="loc_us-gaap_DebtInstrumentAxis_27c07709-8ab1-4148-a2ed-20403114b28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_27c07709-8ab1-4148-a2ed-20403114b28a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevolvingCreditFacility2021Member_41c7b649-f70a-4d54-917f-8be0af140560" xlink:href="bsx-20210630.xsd#bsx_RevolvingCreditFacility2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:to="loc_bsx_RevolvingCreditFacility2021Member_41c7b649-f70a-4d54-917f-8be0af140560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_7720d45d-b851-4269-9af1-7debac3ecb70" xlink:href="bsx-20210630.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_7720d45d-b851-4269-9af1-7debac3ecb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_99bb501c-a95d-4a43-8890-b9e21d9bf374" xlink:href="bsx-20210630.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_99bb501c-a95d-4a43-8890-b9e21d9bf374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_9e71bdaa-fa58-4cb5-bff1-a7b2ff5de3e7" xlink:href="bsx-20210630.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfc2bf92-d7d7-4df2-9bb2-6cfe80519358" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_9e71bdaa-fa58-4cb5-bff1-a7b2ff5de3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_855a26c6-9892-43d3-ab88-e29aa7f58a39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_855a26c6-9892-43d3-ab88-e29aa7f58a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_855a26c6-9892-43d3-ab88-e29aa7f58a39" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_96782925-54b8-4bce-afac-1b4c291b0fcc" xlink:href="bsx-20210630.xsd#bsx_May2022NotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_May2022NotesMember_96782925-54b8-4bce-afac-1b4c291b0fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember_bd927af0-5484-49f9-9916-f63af16b0ee0" xlink:href="bsx-20210630.xsd#bsx_October2023NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_October2023NotesMember_bd927af0-5484-49f9-9916-f63af16b0ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_e4fc1c18-8df1-4c37-90d4-fab5f13e405c" xlink:href="bsx-20210630.xsd#bsx_March2024NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2024NotesMember_e4fc1c18-8df1-4c37-90d4-fab5f13e405c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember_fc53b8d5-3c1c-4bab-9b80-86c7a3a09430" xlink:href="bsx-20210630.xsd#bsx_May2025NotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_May2025NotesMember_fc53b8d5-3c1c-4bab-9b80-86c7a3a09430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_b9963da3-7f57-425e-9ae3-887745350f99" xlink:href="bsx-20210630.xsd#bsx_June2025NotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_June2025NotesMember_b9963da3-7f57-425e-9ae3-887745350f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_c2943f53-5ca5-4b6d-b5d9-77d4114de03d" xlink:href="bsx-20210630.xsd#bsx_March2026NotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2026NotesMember_c2943f53-5ca5-4b6d-b5d9-77d4114de03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_76cb91e5-f9ef-488a-98af-959604fb1742" xlink:href="bsx-20210630.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_December2027NotesMember_76cb91e5-f9ef-488a-98af-959604fb1742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_ccbf50ec-a377-40d5-bc34-a840cdc13806" xlink:href="bsx-20210630.xsd#bsx_March2028NotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2028NotesMember_ccbf50ec-a377-40d5-bc34-a840cdc13806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_c9b2f041-e4a4-4ea9-bae7-065b8800a3c0" xlink:href="bsx-20210630.xsd#bsx_March2029NotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2029NotesMember_c9b2f041-e4a4-4ea9-bae7-065b8800a3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_70b90a60-b468-489c-885e-735e3c8018c3" xlink:href="bsx-20210630.xsd#bsx_June2030NotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_June2030NotesMember_70b90a60-b468-489c-885e-735e3c8018c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_ca7543d3-7bd6-42c8-9d59-b1693c755cdc" xlink:href="bsx-20210630.xsd#bsx_November2035NotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_November2035NotesMember_ca7543d3-7bd6-42c8-9d59-b1693c755cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_75daabde-626b-485f-b004-57fb30bd48d2" xlink:href="bsx-20210630.xsd#bsx_March2039NotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2039NotesMember_75daabde-626b-485f-b004-57fb30bd48d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_44c24957-2d5f-4f6f-bc8f-3ffb0c80abde" xlink:href="bsx-20210630.xsd#bsx_January2040NotesMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_January2040NotesMember_44c24957-2d5f-4f6f-bc8f-3ffb0c80abde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_70a0b4a8-b5d2-4afd-8746-7e55374eb6f4" xlink:href="bsx-20210630.xsd#bsx_March2049NotesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_bsx_March2049NotesMember_70a0b4a8-b5d2-4afd-8746-7e55374eb6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c2de2dc4-ce16-4b91-aea0-913570bf0c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_us-gaap_SeniorNotesMember_c2de2dc4-ce16-4b91-aea0-913570bf0c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cfe7ae22-9c9b-467a-9d42-6efe86549669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_us-gaap_InterestRateSwapMember_cfe7ae22-9c9b-467a-9d42-6efe86549669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_b981bed1-1337-4ab8-adeb-c11bc50d207b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_b981bed1-1337-4ab8-adeb-c11bc50d207b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_26ef085e-ceeb-4899-ad01-26e13c449004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_deeff61f-7373-4693-91ad-59d0cc1bea36" xlink:to="loc_us-gaap_LineOfCreditMember_26ef085e-ceeb-4899-ad01-26e13c449004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_0e9e9a2a-29be-4eda-aedc-82b17a5c3a15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_0e9e9a2a-29be-4eda-aedc-82b17a5c3a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_0f81bd7c-6cae-4818-a96f-8a08ae86a7e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0e9e9a2a-29be-4eda-aedc-82b17a5c3a15" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_0f81bd7c-6cae-4818-a96f-8a08ae86a7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_19e23d55-d2e0-4a74-9d05-41648fd8ea98" xlink:href="bsx-20210630.xsd#bsx_The2018FacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_0f81bd7c-6cae-4818-a96f-8a08ae86a7e2" xlink:to="loc_bsx_The2018FacilityDomain_19e23d55-d2e0-4a74-9d05-41648fd8ea98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8b2f4bd7-b90e-4d3c-a0fd-8db1bcae2084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:to="loc_us-gaap_CreditFacilityAxis_8b2f4bd7-b90e-4d3c-a0fd-8db1bcae2084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2f2516cc-d5ce-455d-97af-58488758e8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8b2f4bd7-b90e-4d3c-a0fd-8db1bcae2084" xlink:to="loc_us-gaap_CreditFacilityDomain_2f2516cc-d5ce-455d-97af-58488758e8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2a1426a1-2dac-4c5e-9366-c766ae099343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2f2516cc-d5ce-455d-97af-58488758e8b7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2a1426a1-2dac-4c5e-9366-c766ae099343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_8402ecab-6ac1-460e-8660-4dc958d2e721" xlink:href="bsx-20210630.xsd#bsx_CovenantAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:to="loc_bsx_CovenantAxis_8402ecab-6ac1-460e-8660-4dc958d2e721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:href="bsx-20210630.xsd#bsx_CovenantDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantAxis_8402ecab-6ac1-460e-8660-4dc958d2e721" xlink:to="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember_6d8aa0d4-c4d4-4d99-bc4c-4ead4bd4b2ef" xlink:href="bsx-20210630.xsd#bsx_CurrentRequirementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_CurrentRequirementMember_6d8aa0d4-c4d4-4d99-bc4c-4ead4bd4b2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_a8544a71-6375-41ab-b33b-9c31877662f1" xlink:href="bsx-20210630.xsd#bsx_ActualCovenantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_ActualCovenantMember_a8544a71-6375-41ab-b33b-9c31877662f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfJune302021Member_b238c77a-a513-459f-bcef-25f082e810cc" xlink:href="bsx-20210630.xsd#bsx_RequirementAsOfJune302021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementAsOfJune302021Member_b238c77a-a513-459f-bcef-25f082e810cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfSeptember302021Member_f6859d07-c338-4402-bcdb-0278b0e2b682" xlink:href="bsx-20210630.xsd#bsx_RequirementAsOfSeptember302021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementAsOfSeptember302021Member_f6859d07-c338-4402-bcdb-0278b0e2b682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_654eaa82-d826-47d6-ad96-924026d72fb6" xlink:href="bsx-20210630.xsd#bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember_654eaa82-d826-47d6-ad96-924026d72fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_6d076e27-f49f-4ff1-8857-05f48ac62406" xlink:href="bsx-20210630.xsd#bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_6d076e27-f49f-4ff1-8857-05f48ac62406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_befdad71-f914-4356-a642-b0dac67c6dbb" xlink:href="bsx-20210630.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_befdad71-f914-4356-a642-b0dac67c6dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_b1ae7091-c440-44a1-aa9f-cf205d8fbf63" xlink:href="bsx-20210630.xsd#bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember_b1ae7091-c440-44a1-aa9f-cf205d8fbf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_782cd7ad-7b8a-4725-b194-0831755ed432" xlink:href="bsx-20210630.xsd#bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember_782cd7ad-7b8a-4725-b194-0831755ed432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_e05733ab-e459-4587-98a4-a588cf71dd29" xlink:href="bsx-20210630.xsd#bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember_e05733ab-e459-4587-98a4-a588cf71dd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_3cdafb09-bc0a-4322-9873-af51a399dffa" xlink:href="bsx-20210630.xsd#bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_427ac428-c763-4823-adbb-9e8ec1082aea" xlink:to="loc_bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember_3cdafb09-bc0a-4322-9873-af51a399dffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aa178b28-8238-4439-86e1-41da1d00bfeb" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_ae937d7b-cdd4-42d0-8a54-dd6f3824f126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_ae937d7b-cdd4-42d0-8a54-dd6f3824f126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_53375fc5-38f8-4a47-a59c-6a18e418515e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_DebtCurrent_53375fc5-38f8-4a47-a59c-6a18e418515e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_86855fc1-20ed-4c30-99e3-219b2260a196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_LongTermDebt_86855fc1-20ed-4c30-99e3-219b2260a196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ad5f592a-7a06-498d-8815-1c2da4ab0db0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ad5f592a-7a06-498d-8815-1c2da4ab0db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a7cec9e9-fcdc-4550-9f04-72322da4c768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a7cec9e9-fcdc-4550-9f04-72322da4c768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3f0da088-0308-4aaf-bd80-e0f13d018d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3f0da088-0308-4aaf-bd80-e0f13d018d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7866e3d3-f694-4345-af8f-220a4bc46504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7866e3d3-f694-4345-af8f-220a4bc46504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentExtensionOptionTerm_00e72bca-e0cd-4120-8a35-d90bcbf5cdae" xlink:href="bsx-20210630.xsd#bsx_DebtInstrumentExtensionOptionTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_DebtInstrumentExtensionOptionTerm_00e72bca-e0cd-4120-8a35-d90bcbf5cdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_b3448495-4b98-47a0-93af-21a1d794e474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_b3448495-4b98-47a0-93af-21a1d794e474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_7160e76f-1a88-4543-9195-33f374afb4ef" xlink:href="bsx-20210630.xsd#bsx_MaximumLeverageRatio"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_MaximumLeverageRatio_7160e76f-1a88-4543-9195-33f374afb4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod_e9c3f8cc-2de9-4216-b52a-bf51cdeeb5ac" xlink:href="bsx-20210630.xsd#bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod_e9c3f8cc-2de9-4216-b52a-bf51cdeeb5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_8c3b31e7-6114-40a0-add0-1fa89b19e587" xlink:href="bsx-20210630.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_8c3b31e7-6114-40a0-add0-1fa89b19e587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_ce7c1b0a-dd41-4575-a649-ab0cf11ca043" xlink:href="bsx-20210630.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_ce7c1b0a-dd41-4575-a649-ab0cf11ca043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_72a5611b-c7b7-43a4-9519-4b1aef56c9dc" xlink:href="bsx-20210630.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_72a5611b-c7b7-43a4-9519-4b1aef56c9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_9b02d1a9-e1e2-453b-8120-7d42091d251e" xlink:href="bsx-20210630.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_9b02d1a9-e1e2-453b-8120-7d42091d251e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_66c5a404-f302-4cba-9333-fef8f837fe95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_66c5a404-f302-4cba-9333-fef8f837fe95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_8ba0a08e-f256-4ece-9390-7d953574fc7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_8ba0a08e-f256-4ece-9390-7d953574fc7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4d2db822-b6c1-4426-80ed-0cc0c08b4bad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4d2db822-b6c1-4426-80ed-0cc0c08b4bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_QualifiedAcquisitionConsideration_c85abdbd-c435-4f92-a54b-e0869303169e" xlink:href="bsx-20210630.xsd#bsx_QualifiedAcquisitionConsideration"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6b957511-c445-4787-9e0b-8f57244b7ead" xlink:to="loc_bsx_QualifiedAcquisitionConsideration_c85abdbd-c435-4f92-a54b-e0869303169e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="bsx-20210630.xsd#SupplementalBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_76fed669-67db-4cfa-9adf-702126024066" xlink:href="bsx-20210630.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_36c7dc6c-7c06-4076-9d01-7f39838337d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_76fed669-67db-4cfa-9adf-702126024066" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_36c7dc6c-7c06-4076-9d01-7f39838337d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_89c3c45b-5ff6-40f6-a839-f3bec705d958" xlink:href="bsx-20210630.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_f5158b58-e640-4785-8b13-d86db69d3dfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_89c3c45b-5ff6-40f6-a839-f3bec705d958" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_f5158b58-e640-4785-8b13-d86db69d3dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_19a7993e-4b46-4817-9c70-95efd4e01491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_89c3c45b-5ff6-40f6-a839-f3bec705d958" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_19a7993e-4b46-4817-9c70-95efd4e01491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_dc069960-32a7-4a51-ad40-8f24feb6a712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_89c3c45b-5ff6-40f6-a839-f3bec705d958" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_dc069960-32a7-4a51-ad40-8f24feb6a712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d01c022c-fbe8-4c0f-8a3b-595d4050fc43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_89c3c45b-5ff6-40f6-a839-f3bec705d958" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d01c022c-fbe8-4c0f-8a3b-595d4050fc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_77c6afef-aead-4fc9-9660-5c7aa7fa582f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_89c3c45b-5ff6-40f6-a839-f3bec705d958" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_77c6afef-aead-4fc9-9660-5c7aa7fa582f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_d0e04b43-727b-4b18-9baf-468494896607" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_89c3c45b-5ff6-40f6-a839-f3bec705d958" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_d0e04b43-727b-4b18-9baf-468494896607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_531ec3cd-59dd-413d-a18c-90a5932f6cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_89c3c45b-5ff6-40f6-a839-f3bec705d958" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_531ec3cd-59dd-413d-a18c-90a5932f6cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_4a677c8d-6384-4298-91c5-c69b33eb5f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_89c3c45b-5ff6-40f6-a839-f3bec705d958" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_4a677c8d-6384-4298-91c5-c69b33eb5f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:href="bsx-20210630.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9225ecd5-615d-4f1c-9da8-2e6ff155d53a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:to="loc_us-gaap_StatementTable_9225ecd5-615d-4f1c-9da8-2e6ff155d53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a1bf1cff-d728-4540-8206-0df36461b46b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9225ecd5-615d-4f1c-9da8-2e6ff155d53a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a1bf1cff-d728-4540-8206-0df36461b46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e21a8ffc-ea51-4768-b42b-0acff7ec021a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a1bf1cff-d728-4540-8206-0df36461b46b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e21a8ffc-ea51-4768-b42b-0acff7ec021a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9a4375a2-3697-441c-9788-143940904ebb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9225ecd5-615d-4f1c-9da8-2e6ff155d53a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9a4375a2-3697-441c-9788-143940904ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2a9f13be-75b9-41b8-a5a2-a292f49904b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9a4375a2-3697-441c-9788-143940904ebb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2a9f13be-75b9-41b8-a5a2-a292f49904b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:href="bsx-20210630.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9225ecd5-615d-4f1c-9da8-2e6ff155d53a" xlink:to="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_25f9431b-f090-4125-ab0e-5830e045cb66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_25f9431b-f090-4125-ab0e-5830e045cb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_30dbb9fa-19e1-437a-91a7-411431e46b15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_30dbb9fa-19e1-437a-91a7-411431e46b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_410dd344-f86b-4f7e-ae39-6763e86a51c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_410dd344-f86b-4f7e-ae39-6763e86a51c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a946393-1e3e-447b-bd37-32ad8f1c3a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_aa6f49f7-33d4-45bc-949d-e5445d60ad6f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a946393-1e3e-447b-bd37-32ad8f1c3a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract_12b952c9-c5cd-403a-8508-1d5ed624fdb7" xlink:href="bsx-20210630.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:to="loc_bsx_OtherCurrentAssetsAbstract_12b952c9-c5cd-403a-8508-1d5ed624fdb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_374b4d3c-7c72-46e9-b9ee-0fb347287669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_12b952c9-c5cd-403a-8508-1d5ed624fdb7" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_374b4d3c-7c72-46e9-b9ee-0fb347287669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_a3f8eb2f-5770-4de3-b8d3-19d747cf02a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_12b952c9-c5cd-403a-8508-1d5ed624fdb7" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_a3f8eb2f-5770-4de3-b8d3-19d747cf02a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements_50b10c75-e27b-4b39-8afc-85957eb3ff11" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_12b952c9-c5cd-403a-8508-1d5ed624fdb7" xlink:to="loc_bsx_Licensingarrangements_50b10c75-e27b-4b39-8afc-85957eb3ff11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_32dd3fad-8527-4da2-9def-a7746049c08a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_12b952c9-c5cd-403a-8508-1d5ed624fdb7" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_32dd3fad-8527-4da2-9def-a7746049c08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_efdcb5af-8783-468f-9e50-c50ae74fdd94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_12b952c9-c5cd-403a-8508-1d5ed624fdb7" xlink:to="loc_us-gaap_OtherAssetsCurrent_efdcb5af-8783-468f-9e50-c50ae74fdd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_5f125154-39b2-4e27-95d9-9469160e42cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_5f125154-39b2-4e27-95d9-9469160e42cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_d61dd56d-32fd-4092-9f31-3869605eb399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_5f125154-39b2-4e27-95d9-9469160e42cb" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_d61dd56d-32fd-4092-9f31-3869605eb399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ce5a1d83-f43e-45f5-8fa5-c017a76d3c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_5f125154-39b2-4e27-95d9-9469160e42cb" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ce5a1d83-f43e-45f5-8fa5-c017a76d3c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_a86df706-881a-4468-9c80-4c6da1516490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_5f125154-39b2-4e27-95d9-9469160e42cb" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_a86df706-881a-4468-9c80-4c6da1516490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_aff1e470-fb00-4ec5-867e-c1333d7cbe75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_aff1e470-fb00-4ec5-867e-c1333d7cbe75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_02604f22-66d1-4819-898c-a63711a16848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_aff1e470-fb00-4ec5-867e-c1333d7cbe75" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_02604f22-66d1-4819-898c-a63711a16848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_8efd7471-9912-4263-8ee9-0eaaf1722b1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_aff1e470-fb00-4ec5-867e-c1333d7cbe75" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_8efd7471-9912-4263-8ee9-0eaaf1722b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_9ed6a712-bb80-4aa0-bb6b-8c5fed7718de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_aff1e470-fb00-4ec5-867e-c1333d7cbe75" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_9ed6a712-bb80-4aa0-bb6b-8c5fed7718de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_23155beb-2d53-4596-81aa-68df225b2504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_aff1e470-fb00-4ec5-867e-c1333d7cbe75" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_23155beb-2d53-4596-81aa-68df225b2504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_d4519da2-163e-440a-b91a-2dd8f44fb89c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_aff1e470-fb00-4ec5-867e-c1333d7cbe75" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_d4519da2-163e-440a-b91a-2dd8f44fb89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_1cc980a1-24ab-43e5-be6f-23d41f0da679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:to="loc_us-gaap_InventoryNetAbstract_1cc980a1-24ab-43e5-be6f-23d41f0da679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2f156413-936e-4bcb-8291-8cc127849527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_1cc980a1-24ab-43e5-be6f-23d41f0da679" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2f156413-936e-4bcb-8291-8cc127849527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_10087c82-071b-456f-9d41-6e892a039f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_1cc980a1-24ab-43e5-be6f-23d41f0da679" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_10087c82-071b-456f-9d41-6e892a039f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_da5c451b-cf8e-4750-889f-49a3e52caba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_1cc980a1-24ab-43e5-be6f-23d41f0da679" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_da5c451b-cf8e-4750-889f-49a3e52caba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a6e37530-bcba-477d-b49f-b2eeb8ab5cf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_1cc980a1-24ab-43e5-be6f-23d41f0da679" xlink:to="loc_us-gaap_InventoryNet_a6e37530-bcba-477d-b49f-b2eeb8ab5cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_0de5a838-2b69-4648-acec-8d38fddeb870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_0de5a838-2b69-4648-acec-8d38fddeb870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_ed0dec38-2300-4e5c-9905-35c06959aec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_0de5a838-2b69-4648-acec-8d38fddeb870" xlink:to="loc_us-gaap_Land_ed0dec38-2300-4e5c-9905-35c06959aec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_48a3b1fd-5c56-4de6-8b06-d94c5b2cea9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_0de5a838-2b69-4648-acec-8d38fddeb870" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_48a3b1fd-5c56-4de6-8b06-d94c5b2cea9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross_ef1a07bd-c372-4207-969c-da314497f4da" xlink:href="bsx-20210630.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_0de5a838-2b69-4648-acec-8d38fddeb870" xlink:to="loc_bsx_EquipmentFurnitureAndFixturesGross_ef1a07bd-c372-4207-969c-da314497f4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_fd7cc488-7d3d-462a-8fbc-60688b378c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_0de5a838-2b69-4648-acec-8d38fddeb870" xlink:to="loc_us-gaap_ConstructionInProgressGross_fd7cc488-7d3d-462a-8fbc-60688b378c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2a654ee8-bcfc-4eee-a82d-3d7202c76c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_0de5a838-2b69-4648-acec-8d38fddeb870" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2a654ee8-bcfc-4eee-a82d-3d7202c76c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_971be4db-8af0-4901-b8af-3e2624d15fde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_0de5a838-2b69-4648-acec-8d38fddeb870" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_971be4db-8af0-4901-b8af-3e2624d15fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2250ae79-b2c7-48d8-81b4-529720c2cbb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_0de5a838-2b69-4648-acec-8d38fddeb870" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2250ae79-b2c7-48d8-81b4-529720c2cbb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_4df5ae77-d4e9-4324-b619-6882d48a59d1" xlink:href="bsx-20210630.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:to="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_4df5ae77-d4e9-4324-b619-6882d48a59d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_fc3c5a8f-a609-400f-8e7f-6b0bfccae9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_4df5ae77-d4e9-4324-b619-6882d48a59d1" xlink:to="loc_us-gaap_Depreciation_fc3c5a8f-a609-400f-8e7f-6b0bfccae9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_60ea5244-6d6b-420c-9d4d-334fcb4d262c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_60ea5244-6d6b-420c-9d4d-334fcb4d262c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_cfadc07b-3595-4fcb-ba3d-7ae89db28018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_60ea5244-6d6b-420c-9d4d-334fcb4d262c" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_cfadc07b-3595-4fcb-ba3d-7ae89db28018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_17c5ea13-4a3e-460b-b64f-d686bf920085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_60ea5244-6d6b-420c-9d4d-334fcb4d262c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_17c5ea13-4a3e-460b-b64f-d686bf920085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_1a756ef2-9626-433c-96fe-1f9c8e5847ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_60ea5244-6d6b-420c-9d4d-334fcb4d262c" xlink:to="loc_us-gaap_DerivativeAssets_1a756ef2-9626-433c-96fe-1f9c8e5847ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_1b25a548-a924-4d8d-9902-321dbf7524d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_60ea5244-6d6b-420c-9d4d-334fcb4d262c" xlink:to="loc_us-gaap_Investments_1b25a548-a924-4d8d-9902-321dbf7524d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_531ea314-44f8-4706-aac3-a773317ad35e" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangementsasset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_60ea5244-6d6b-420c-9d4d-334fcb4d262c" xlink:to="loc_bsx_Licensingarrangementsasset_531ea314-44f8-4706-aac3-a773317ad35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets_5f2753c8-4e9a-446b-a15c-e9219ce76997" xlink:href="bsx-20210630.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_60ea5244-6d6b-420c-9d4d-334fcb4d262c" xlink:to="loc_bsx_OtherOtherLongtermAssets_5f2753c8-4e9a-446b-a15c-e9219ce76997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_db72813b-f1fd-481c-aa9f-2df27ebc8c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_60ea5244-6d6b-420c-9d4d-334fcb4d262c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_db72813b-f1fd-481c-aa9f-2df27ebc8c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9addd166-fed8-4f5e-be62-2281d5f23e91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9addd166-fed8-4f5e-be62-2281d5f23e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_6ec7e4d7-24ab-4181-9741-88ef6d5ec432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9addd166-fed8-4f5e-be62-2281d5f23e91" xlink:to="loc_us-gaap_LitigationReserveCurrent_6ec7e4d7-24ab-4181-9741-88ef6d5ec432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_afbad847-046f-4557-ab66-e5b57837ff21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9addd166-fed8-4f5e-be62-2281d5f23e91" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_afbad847-046f-4557-ab66-e5b57837ff21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_8ccfe6b0-b822-4018-8f34-1d9804b699b3" xlink:href="bsx-20210630.xsd#bsx_AccruedRebatesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9addd166-fed8-4f5e-be62-2281d5f23e91" xlink:to="loc_bsx_AccruedRebatesCurrent_8ccfe6b0-b822-4018-8f34-1d9804b699b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_65ac3800-080b-4aa3-9e25-60d1773342ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9addd166-fed8-4f5e-be62-2281d5f23e91" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_65ac3800-080b-4aa3-9e25-60d1773342ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_feb9920a-8361-410a-be57-1060536c8b9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9addd166-fed8-4f5e-be62-2281d5f23e91" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_feb9920a-8361-410a-be57-1060536c8b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_52ff21b3-71b3-4a9c-9eda-912656d23536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9addd166-fed8-4f5e-be62-2281d5f23e91" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_52ff21b3-71b3-4a9c-9eda-912656d23536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_7f4da9f4-fd98-4814-8e99-f520465be515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:to="loc_us-gaap_OtherLiabilitiesCurrentAbstract_7f4da9f4-fd98-4814-8e99-f520465be515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_3a808abf-8832-4507-88f1-a8e997ae7983" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_7f4da9f4-fd98-4814-8e99-f520465be515" xlink:to="loc_us-gaap_DeferredRevenueCurrent_3a808abf-8832-4507-88f1-a8e997ae7983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_c796b1b4-a5cf-4c13-bbdb-4d3760f13181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_7f4da9f4-fd98-4814-8e99-f520465be515" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_c796b1b4-a5cf-4c13-bbdb-4d3760f13181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_15baf496-b767-4773-9268-ec43233cf9f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_7f4da9f4-fd98-4814-8e99-f520465be515" xlink:to="loc_us-gaap_TaxesPayableCurrent_15baf496-b767-4773-9268-ec43233cf9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_7c6d64e7-9008-4f77-ba00-8fcb26b38c12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_7f4da9f4-fd98-4814-8e99-f520465be515" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_7c6d64e7-9008-4f77-ba00-8fcb26b38c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_54670daf-c2da-4e7f-b9b8-2976ac0e5776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_7f4da9f4-fd98-4814-8e99-f520465be515" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_54670daf-c2da-4e7f-b9b8-2976ac0e5776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1b7ce301-c6b3-4e1f-82b6-e714400a59da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_7f4da9f4-fd98-4814-8e99-f520465be515" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1b7ce301-c6b3-4e1f-82b6-e714400a59da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_85f3fdbd-115f-45d2-b20a-ee7c5d169b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_a49b59fd-7ae8-4f7b-912f-30e4519f468d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_85f3fdbd-115f-45d2-b20a-ee7c5d169b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_648e088c-17be-47aa-9c34-58eff84e1826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_85f3fdbd-115f-45d2-b20a-ee7c5d169b47" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_648e088c-17be-47aa-9c34-58eff84e1826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_ef69b989-9dfe-47ed-a8cc-0d6a3a40179e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_85f3fdbd-115f-45d2-b20a-ee7c5d169b47" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_ef69b989-9dfe-47ed-a8cc-0d6a3a40179e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_59ae76a1-833a-457d-a53a-33b2468dc4b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_85f3fdbd-115f-45d2-b20a-ee7c5d169b47" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_59ae76a1-833a-457d-a53a-33b2468dc4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_5bc64ea9-59df-4706-9e6c-91e224813795" xlink:href="bsx-20210630.xsd#bsx_Licensingarrangementsliability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_85f3fdbd-115f-45d2-b20a-ee7c5d169b47" xlink:to="loc_bsx_Licensingarrangementsliability_5bc64ea9-59df-4706-9e6c-91e224813795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_05c5e08b-10d2-4ed2-a9ac-057f323558f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_85f3fdbd-115f-45d2-b20a-ee7c5d169b47" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_05c5e08b-10d2-4ed2-a9ac-057f323558f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_67c24c37-a957-4f85-a7b2-8e6b2a1ec67d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_85f3fdbd-115f-45d2-b20a-ee7c5d169b47" xlink:to="loc_us-gaap_DeferredRevenue_67c24c37-a957-4f85-a7b2-8e6b2a1ec67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_784d8254-5d09-486a-87bb-366d0f7b47e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_85f3fdbd-115f-45d2-b20a-ee7c5d169b47" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_784d8254-5d09-486a-87bb-366d0f7b47e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6a977abe-a220-4b34-b340-9028589976b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_85f3fdbd-115f-45d2-b20a-ee7c5d169b47" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_6a977abe-a220-4b34-b340-9028589976b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bsx-20210630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b4d5737d-3c75-4421-ab0e-29999d736784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_018c7612-55fc-4e7f-8abd-f63e99c2c7bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b4d5737d-3c75-4421-ab0e-29999d736784" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_018c7612-55fc-4e7f-8abd-f63e99c2c7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6ca42f22-7f41-489b-8dd8-5b07d1e91f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3ec35872-211e-4b38-a13d-1589edb54eee" xlink:href="bsx-20210630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6ca42f22-7f41-489b-8dd8-5b07d1e91f18" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3ec35872-211e-4b38-a13d-1589edb54eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2c8aa1d5-c55c-412b-bf35-f7d6013d57a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3ec35872-211e-4b38-a13d-1589edb54eee" xlink:to="loc_us-gaap_VariableRateAxis_2c8aa1d5-c55c-412b-bf35-f7d6013d57a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9ba3c8be-c891-4b02-8aff-d85070222788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_2c8aa1d5-c55c-412b-bf35-f7d6013d57a5" xlink:to="loc_us-gaap_VariableRateDomain_9ba3c8be-c891-4b02-8aff-d85070222788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5b827af8-4943-4b71-9b21-3e8a69bbc80a" xlink:href="bsx-20210630.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_3ec35872-211e-4b38-a13d-1589edb54eee" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_5b827af8-4943-4b71-9b21-3e8a69bbc80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_2445022e-fad4-48cc-83a0-381bfdbfd27e" xlink:href="bsx-20210630.xsd#bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6ca42f22-7f41-489b-8dd8-5b07d1e91f18" xlink:to="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_2445022e-fad4-48cc-83a0-381bfdbfd27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8c2052ef-44b4-4b61-bbfc-ff4ae6c19217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bf0a5f26-12fc-4824-9320-daf02347c29a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8c2052ef-44b4-4b61-bbfc-ff4ae6c19217" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bf0a5f26-12fc-4824-9320-daf02347c29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0c8baa1e-d80c-4d1e-9146-95d1b88afa8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bf0a5f26-12fc-4824-9320-daf02347c29a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0c8baa1e-d80c-4d1e-9146-95d1b88afa8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_64bf8370-2850-4386-b963-307d8edb27bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bf0a5f26-12fc-4824-9320-daf02347c29a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_64bf8370-2850-4386-b963-307d8edb27bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_1a4bf4ba-3071-4ed3-abf2-a0e592861d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bf0a5f26-12fc-4824-9320-daf02347c29a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_1a4bf4ba-3071-4ed3-abf2-a0e592861d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_9ead313c-3e29-4559-91ad-f66010147cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8c2052ef-44b4-4b61-bbfc-ff4ae6c19217" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_9ead313c-3e29-4559-91ad-f66010147cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheCARESAct_711a5c63-1f23-44a7-b373-a038e57ecb47" xlink:href="bsx-20210630.xsd#bsx_TheCARESAct"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8c2052ef-44b4-4b61-bbfc-ff4ae6c19217" xlink:to="loc_bsx_TheCARESAct_711a5c63-1f23-44a7-b373-a038e57ecb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="bsx-20210630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f6309646-2973-4de9-94cf-021d50ab60f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8ba079e2-cb49-4df0-86d3-7fac7b8db5c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f6309646-2973-4de9-94cf-021d50ab60f7" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8ba079e2-cb49-4df0-86d3-7fac7b8db5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="simple" xlink:href="bsx-20210630.xsd#CommitmentsandContingenciesCommitmentsandContingenciesPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_728c90ab-f1b9-402b-9e47-8123a6f72aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock_2f3fd00d-00fd-4202-a5ff-cb03715f58ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_728c90ab-f1b9-402b-9e47-8123a6f72aa3" xlink:to="loc_us-gaap_LegalCostsPolicyTextBlock_2f3fd00d-00fd-4202-a5ff-cb03715f58ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_90fd9d3e-8683-4b55-b147-129a4ce9c1f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_90fd9d3e-8683-4b55-b147-129a4ce9c1f1" xlink:to="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b0db25d4-f55a-4366-9cf7-61e40550080c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b0db25d4-f55a-4366-9cf7-61e40550080c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_26b92911-a3ad-402b-ad65-2827629017d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b0db25d4-f55a-4366-9cf7-61e40550080c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_26b92911-a3ad-402b-ad65-2827629017d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_27e5d51f-eddf-4510-ac35-d03d9c0b297d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:to="loc_us-gaap_LitigationStatusAxis_27e5d51f-eddf-4510-ac35-d03d9c0b297d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d6ee3373-59e0-4d1f-9a6b-68bb71331ddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_27e5d51f-eddf-4510-ac35-d03d9c0b297d" xlink:to="loc_us-gaap_LitigationStatusDomain_d6ee3373-59e0-4d1f-9a6b-68bb71331ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_4050e755-74f1-4943-9359-4239febe0f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_d6ee3373-59e0-4d1f-9a6b-68bb71331ddd" xlink:to="loc_us-gaap_SettledLitigationMember_4050e755-74f1-4943-9359-4239febe0f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e635cc22-1755-4db7-b9af-4fa632c1a3c2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:to="loc_srt_LitigationCaseAxis_e635cc22-1755-4db7-b9af-4fa632c1a3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_4b61691c-a90e-48d2-a377-abc4f9c62066" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_e635cc22-1755-4db7-b9af-4fa632c1a3c2" xlink:to="loc_srt_LitigationCaseTypeDomain_4b61691c-a90e-48d2-a377-abc4f9c62066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssignedtoonejudgeinMAMember_9cf246f8-f209-4aa2-b5b1-d6ba96958956" xlink:href="bsx-20210630.xsd#bsx_AssignedtoonejudgeinMAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_4b61691c-a90e-48d2-a377-abc4f9c62066" xlink:to="loc_bsx_AssignedtoonejudgeinMAMember_9cf246f8-f209-4aa2-b5b1-d6ba96958956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9bf6a2c0-fd00-4c26-8f00-1f764676e4c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9bf6a2c0-fd00-4c26-8f00-1f764676e4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5c74c872-72fe-4c0c-ae2f-b8a47893fc2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9bf6a2c0-fd00-4c26-8f00-1f764676e4c5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5c74c872-72fe-4c0c-ae2f-b8a47893fc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9c03ebfd-33fb-40d6-9db4-197de34fc11b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5c74c872-72fe-4c0c-ae2f-b8a47893fc2a" xlink:to="loc_us-gaap_SubsequentEventMember_9c03ebfd-33fb-40d6-9db4-197de34fc11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_80e60a02-5895-4bb4-bd38-dcfb18512e60" xlink:to="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_8e322373-9ae7-4291-b7e4-9c98a3a7ba01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_8e322373-9ae7-4291-b7e4-9c98a3a7ba01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6f1b8380-bab1-49f3-bc9c-6727c8d83c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_6f1b8380-bab1-49f3-bc9c-6727c8d83c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_6fff08cb-0f47-46e1-82dc-e9899add4eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_us-gaap_LitigationSettlementExpense_6fff08cb-0f47-46e1-82dc-e9899add4eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_f3575e17-91fd-421c-a673-5c6e15f6717c" xlink:href="bsx-20210630.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_f3575e17-91fd-421c-a673-5c6e15f6717c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_a13d8f82-8532-46b6-b810-5d80e6470dae" xlink:href="bsx-20210630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_a13d8f82-8532-46b6-b810-5d80e6470dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedclassactionsinCanadaMesh_e1dd0d9f-d4a0-4e1e-9f9f-61c7f291b850" xlink:href="bsx-20210630.xsd#bsx_CertifiedclassactionsinCanadaMesh"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_CertifiedclassactionsinCanadaMesh_e1dd0d9f-d4a0-4e1e-9f9f-61c7f291b850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_d8d717bd-943f-446c-9a87-d37f111f22af" xlink:href="bsx-20210630.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_d8d717bd-943f-446c-9a87-d37f111f22af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_fd9df44f-810c-4bc6-a5bc-a0f05bd96aee" xlink:href="bsx-20210630.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_fd9df44f-810c-4bc6-a5bc-a0f05bd96aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_550ae595-e5db-46c4-a672-a945612ebeb9" xlink:href="bsx-20210630.xsd#bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia_550ae595-e5db-46c4-a672-a945612ebeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_ec482756-5c5d-4701-b532-205e6ef9b04a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_ec482756-5c5d-4701-b532-205e6ef9b04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_a58e7347-024d-4965-88e8-6a2e1177542b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_a58e7347-024d-4965-88e8-6a2e1177542b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedClassActionsInAustraliaMesh_262a610f-c3ad-421e-8c70-619738a56cfb" xlink:href="bsx-20210630.xsd#bsx_CertifiedClassActionsInAustraliaMesh"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_CertifiedClassActionsInAustraliaMesh_262a610f-c3ad-421e-8c70-619738a56cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_e7586733-4c31-452f-9f53-eccb77f2dd7b" xlink:href="bsx-20210630.xsd#bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter_e7586733-4c31-452f-9f53-eccb77f2dd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_49e79929-b0bb-45cf-a395-23fb18c72601" xlink:href="bsx-20210630.xsd#bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter_49e79929-b0bb-45cf-a395-23fb18c72601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StateAGSettlementsMeshRelatedNumberOfStates_5f1d1112-e61a-4f2d-87af-fd2ffb46c4c2" xlink:href="bsx-20210630.xsd#bsx_StateAGSettlementsMeshRelatedNumberOfStates"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b1e57a22-e286-418d-bc3e-798719e0b92f" xlink:to="loc_bsx_StateAGSettlementsMeshRelatedNumberOfStates_5f1d1112-e61a-4f2d-87af-fd2ffb46c4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="simple" xlink:href="bsx-20210630.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_549574e8-781c-4c65-a9cf-eac609dd5775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_74a6dc92-7b7b-4366-8298-e668695c255c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_549574e8-781c-4c65-a9cf-eac609dd5775" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_74a6dc92-7b7b-4366-8298-e668695c255c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_a7fc9c73-ace4-4762-a24a-404f1ba8cc30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract_b056f258-55ad-489f-b32e-4638a2937054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_a7fc9c73-ace4-4762-a24a-404f1ba8cc30" xlink:to="loc_us-gaap_ClassOfStockDisclosuresAbstract_b056f258-55ad-489f-b32e-4638a2937054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_42b4e1e3-7538-4ce3-9039-202a520c4bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract_b056f258-55ad-489f-b32e-4638a2937054" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_42b4e1e3-7538-4ce3-9039-202a520c4bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_046a3e77-c6a5-45de-aac5-777a1845429d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_42b4e1e3-7538-4ce3-9039-202a520c4bd4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_046a3e77-c6a5-45de-aac5-777a1845429d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d4149d37-bf6e-4072-88e2-ff0c17fd9d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_046a3e77-c6a5-45de-aac5-777a1845429d" xlink:to="loc_us-gaap_ClassOfStockDomain_d4149d37-bf6e-4072-88e2-ff0c17fd9d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_2f8c09ce-5fc6-4551-97a4-c89ade7ddab9" xlink:href="bsx-20210630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d4149d37-bf6e-4072-88e2-ff0c17fd9d5b" xlink:to="loc_bsx_A550MCPSSeriesAMember_2f8c09ce-5fc6-4551-97a4-c89ade7ddab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d1006304-4994-4b19-a61b-f3db66f97024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d4149d37-bf6e-4072-88e2-ff0c17fd9d5b" xlink:to="loc_us-gaap_CommonStockMember_d1006304-4994-4b19-a61b-f3db66f97024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_3ad2dffa-de46-435e-8e87-2f0d1142782b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d4149d37-bf6e-4072-88e2-ff0c17fd9d5b" xlink:to="loc_us-gaap_PreferredStockMember_3ad2dffa-de46-435e-8e87-2f0d1142782b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_65aebde1-4c62-472a-88b3-cc192e4f982e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_42b4e1e3-7538-4ce3-9039-202a520c4bd4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_65aebde1-4c62-472a-88b3-cc192e4f982e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_774bff65-d098-4a3d-98bb-51bab90e413f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_65aebde1-4c62-472a-88b3-cc192e4f982e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_774bff65-d098-4a3d-98bb-51bab90e413f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dd6fe8a0-147c-4411-a719-a0680f45f6f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_774bff65-d098-4a3d-98bb-51bab90e413f" xlink:to="loc_us-gaap_SubsequentEventMember_dd6fe8a0-147c-4411-a719-a0680f45f6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6f9ba60b-eaa7-49b9-b35c-424455e7a93a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_42b4e1e3-7538-4ce3-9039-202a520c4bd4" xlink:to="loc_srt_RangeAxis_6f9ba60b-eaa7-49b9-b35c-424455e7a93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1e26c428-5e66-4433-8bc9-cbeaf1febda4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6f9ba60b-eaa7-49b9-b35c-424455e7a93a" xlink:to="loc_srt_RangeMember_1e26c428-5e66-4433-8bc9-cbeaf1febda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_859032d0-5992-4872-99b1-a9a329bc58d1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1e26c428-5e66-4433-8bc9-cbeaf1febda4" xlink:to="loc_srt_MinimumMember_859032d0-5992-4872-99b1-a9a329bc58d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b3ee9789-1766-4e5e-845f-b8ddb704cedf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1e26c428-5e66-4433-8bc9-cbeaf1febda4" xlink:to="loc_srt_MaximumMember_b3ee9789-1766-4e5e-845f-b8ddb704cedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_42b4e1e3-7538-4ce3-9039-202a520c4bd4" xlink:to="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4ad285b3-a78b-469a-b106-3a321049fc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4ad285b3-a78b-469a-b106-3a321049fc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_916876c7-eb5c-4374-9c0d-5dc735e3d80a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockSharesIssued_916876c7-eb5c-4374-9c0d-5dc735e3d80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_77516509-0f3f-477f-ba06-6ca0d18af56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_77516509-0f3f-477f-ba06-6ca0d18af56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_f5fd8676-1899-44f7-9fc4-6b006f8c8b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_f5fd8676-1899-44f7-9fc4-6b006f8c8b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_2cc5e832-2d5c-4885-b06f-595eb303c7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_2cc5e832-2d5c-4885-b06f-595eb303c7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_74a8670e-5553-41ba-ac2b-1f13d4430d29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_74a8670e-5553-41ba-ac2b-1f13d4430d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare_80ea268b-538c-47f0-a667-d333b504ae1b" xlink:href="bsx-20210630.xsd#bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare_80ea268b-538c-47f0-a667-d333b504ae1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ConvertiblePreferredStockThresholdTradingDays_cfa9a3dc-4c59-4dee-89b2-9dbf0dc06586" xlink:href="bsx-20210630.xsd#bsx_ConvertiblePreferredStockThresholdTradingDays"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_bsx_ConvertiblePreferredStockThresholdTradingDays_cfa9a3dc-4c59-4dee-89b2-9dbf0dc06586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_4f1e8f3d-12b1-44e9-982b-8f0f95929d3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_4f1e8f3d-12b1-44e9-982b-8f0f95929d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_0504a0a3-307b-4361-8e45-4f7bf3b7998f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PaymentsOfDividends_0504a0a3-307b-4361-8e45-4f7bf3b7998f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared_68cf68ff-ff8a-406b-b332-91acbfca2536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareDeclared_68cf68ff-ff8a-406b-b332-91acbfca2536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f05831ab-24b0-4284-b883-01265daeccf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f05831ab-24b0-4284-b883-01265daeccf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c0840aab-cda2-4551-9bcf-41a7ff4d4b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c0840aab-cda2-4551-9bcf-41a7ff4d4b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6509b7c7-0813-4500-a856-a0003a296e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_afb5511c-0e23-4660-ac52-52fdb5ceca64" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6509b7c7-0813-4500-a856-a0003a296e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="simple" xlink:href="bsx-20210630.xsd#WeightedAverageSharesOutstanding"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a2056914-37b0-450d-8bdc-608b792b90d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_46bdf9c4-e597-4306-bb8d-a5d2cc9a8591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a2056914-37b0-450d-8bdc-608b792b90d8" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_46bdf9c4-e597-4306-bb8d-a5d2cc9a8591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#WeightedAverageSharesOutstandingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4f6f9b95-aafb-4ab1-8f7c-eae7a367e0a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_2d0fcc70-2776-4ce6-91e8-dbf19fc5de0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4f6f9b95-aafb-4ab1-8f7c-eae7a367e0a1" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_2d0fcc70-2776-4ce6-91e8-dbf19fc5de0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c4a9499d-9fbf-4887-b454-e56b49960d69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4f6f9b95-aafb-4ab1-8f7c-eae7a367e0a1" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c4a9499d-9fbf-4887-b454-e56b49960d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0707104f-1979-4834-be17-242eeaa74cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_66e8433c-4bff-4c12-b18a-fc243d47ae83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0707104f-1979-4834-be17-242eeaa74cd6" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_66e8433c-4bff-4c12-b18a-fc243d47ae83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dad94f33-6776-4e51-b2ff-7d1fd6cc491e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_66e8433c-4bff-4c12-b18a-fc243d47ae83" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dad94f33-6776-4e51-b2ff-7d1fd6cc491e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f27151c4-b8b5-4d25-bcbf-2b4bcec609a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dad94f33-6776-4e51-b2ff-7d1fd6cc491e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f27151c4-b8b5-4d25-bcbf-2b4bcec609a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8ecef7f4-ea09-477e-813d-7ae44839dda9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f27151c4-b8b5-4d25-bcbf-2b4bcec609a5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8ecef7f4-ea09-477e-813d-7ae44839dda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_819dde9a-b3f2-451f-95aa-32f1d71d4a80" xlink:href="bsx-20210630.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f27151c4-b8b5-4d25-bcbf-2b4bcec609a5" xlink:to="loc_bsx_A550MCPSSeriesAMember_819dde9a-b3f2-451f-95aa-32f1d71d4a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_104780ea-c64b-4bd8-b4ea-e08e625bdf1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f27151c4-b8b5-4d25-bcbf-2b4bcec609a5" xlink:to="loc_us-gaap_StockCompensationPlanMember_104780ea-c64b-4bd8-b4ea-e08e625bdf1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_66e8433c-4bff-4c12-b18a-fc243d47ae83" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a2e3474-4209-4e66-aa29-4daa4a5d75eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a2e3474-4209-4e66-aa29-4daa4a5d75eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_189bcb6f-b728-4694-8e33-9c541680cd78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_189bcb6f-b728-4694-8e33-9c541680cd78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0b66ea1e-b9cf-415d-a8da-18dbe3483dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0b66ea1e-b9cf-415d-a8da-18dbe3483dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_01950fff-40ee-4ce2-aba7-7f20e2136348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_01950fff-40ee-4ce2-aba7-7f20e2136348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e7ab1cc5-1ed2-428c-8a11-5282a1789aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e7ab1cc5-1ed2-428c-8a11-5282a1789aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a27ea7aa-e4d5-44f0-8c2a-ab7be152a284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a2625a8-13eb-428f-b021-f99ff165cc1c" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a27ea7aa-e4d5-44f0-8c2a-ab7be152a284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="simple" xlink:href="bsx-20210630.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_efe109b6-d017-444d-8345-6a38046201ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_e7c66a2b-c8b8-4bfc-8c4e-ca98dc55b976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_efe109b6-d017-444d-8345-6a38046201ca" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_e7c66a2b-c8b8-4bfc-8c4e-ca98dc55b976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_548d17dd-6610-4d21-b085-18d4c5c865d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_213cfbf3-7bb3-4cc4-bf58-2dfee4556404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_548d17dd-6610-4d21-b085-18d4c5c865d1" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_213cfbf3-7bb3-4cc4-bf58-2dfee4556404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_44a2e3a0-7244-4465-a2f1-65244d57e923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NumberOfBusinesses_67e98e96-5af7-41b5-9717-2a5a2b4524e3" xlink:href="bsx-20210630.xsd#bsx_NumberOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_44a2e3a0-7244-4465-a2f1-65244d57e923" xlink:to="loc_bsx_NumberOfBusinesses_67e98e96-5af7-41b5-9717-2a5a2b4524e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_81cc05c0-13ce-4356-9742-01601a22cd61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_44a2e3a0-7244-4465-a2f1-65244d57e923" xlink:to="loc_us-gaap_NumberOfReportableSegments_81cc05c0-13ce-4356-9742-01601a22cd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_49249a54-3698-477a-93c7-fa6f91970022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_44a2e3a0-7244-4465-a2f1-65244d57e923" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_49249a54-3698-477a-93c7-fa6f91970022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_70c6c760-f370-485b-b13d-dac74abc872c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_49249a54-3698-477a-93c7-fa6f91970022" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_70c6c760-f370-485b-b13d-dac74abc872c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70c6c760-f370-485b-b13d-dac74abc872c" xlink:to="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_36865b4e-2940-427a-a734-2b7205f0baa9" xlink:href="bsx-20210630.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_MedsurgMember_36865b4e-2940-427a-a734-2b7205f0baa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_0adc323d-99de-4826-b658-7ef29e95ef43" xlink:href="bsx-20210630.xsd#bsx_RhythmandNeuroMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_RhythmandNeuroMember_0adc323d-99de-4826-b658-7ef29e95ef43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_75e0f70a-4b16-4307-8cf7-58f138b2d1a8" xlink:href="bsx-20210630.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_CardiovascularMember_75e0f70a-4b16-4307-8cf7-58f138b2d1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_1dc569a1-1f23-419b-b2a0-5901a310240a" xlink:href="bsx-20210630.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_BSXReportableSegmentsMember_1dc569a1-1f23-419b-b2a0-5901a310240a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_3daafae2-4ce7-4194-9bcd-f0e953996054" xlink:href="bsx-20210630.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_3daafae2-4ce7-4194-9bcd-f0e953996054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_3f4163af-2146-40ae-8c36-96dd83bde50c" xlink:href="bsx-20210630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_3f4163af-2146-40ae-8c36-96dd83bde50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_c8e36869-2de6-45f8-8640-ec4c64996670" xlink:href="bsx-20210630.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_c8e36869-2de6-45f8-8640-ec4c64996670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_eef55988-c908-4acc-bb95-c8657c68f8e3" xlink:href="bsx-20210630.xsd#bsx_SpecialChargesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5108ddf-656e-433c-b0be-81bacb9a371f" xlink:to="loc_bsx_SpecialChargesMember_eef55988-c908-4acc-bb95-c8657c68f8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_46c08431-dace-4e54-97c9-8f1734605832" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_49249a54-3698-477a-93c7-fa6f91970022" xlink:to="loc_srt_ProductOrServiceAxis_46c08431-dace-4e54-97c9-8f1734605832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_62f81378-47d7-4700-aad2-1c789eeda45f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_46c08431-dace-4e54-97c9-8f1734605832" xlink:to="loc_srt_ProductsAndServicesDomain_62f81378-47d7-4700-aad2-1c789eeda45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_85ea4669-f9f5-428e-865c-caefecc30145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_49249a54-3698-477a-93c7-fa6f91970022" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_85ea4669-f9f5-428e-865c-caefecc30145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e9983b3e-d809-428e-8f67-8fd04c07cb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_85ea4669-f9f5-428e-865c-caefecc30145" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e9983b3e-d809-428e-8f67-8fd04c07cb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_85ea4669-f9f5-428e-865c-caefecc30145" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_d2ca87b2-2984-4c03-a598-8ffe935d9e39" xlink:href="bsx-20210630.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_bsx_OperatingIncomeAllocatedToReportableSegments_d2ca87b2-2984-4c03-a598-8ffe935d9e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_90b1a59f-3c3c-4bff-b07c-19d7aff3a4cc" xlink:href="bsx-20210630.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_90b1a59f-3c3c-4bff-b07c-19d7aff3a4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_82a79010-b16f-41fc-a990-9d06a857fdde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_82a79010-b16f-41fc-a990-9d06a857fdde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f9b85291-6f85-426a-8bc4-601edb3a087c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_us-gaap_OperatingIncomeLoss_f9b85291-6f85-426a-8bc4-601edb3a087c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_27a3e984-03cd-4bb0-bd23-7565810d94ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_27a3e984-03cd-4bb0-bd23-7565810d94ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fa7e9bff-c811-42e6-81c7-305d99aa666a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fa7e9bff-c811-42e6-81c7-305d99aa666a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales_79205b07-1844-4df6-afc2-9e6f8c50a2a7" xlink:href="bsx-20210630.xsd#bsx_SegmentOperatingIncomeasaPercentageofNetSales"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_84062b43-fd58-456d-bbaf-7a04296b464e" xlink:to="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales_79205b07-1844-4df6-afc2-9e6f8c50a2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Revenue" xlink:type="simple" xlink:href="bsx-20210630.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1cff427c-504d-415a-8851-61a9e80b836a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5cf1f2e9-527d-491a-9e96-2c61c68ebdb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1cff427c-504d-415a-8851-61a9e80b836a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5cf1f2e9-527d-491a-9e96-2c61c68ebdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_50f9eb76-692d-425e-9db4-e81813114bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_97dc1265-f653-48f0-a0f5-d2f6e9e217b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_50f9eb76-692d-425e-9db4-e81813114bc1" xlink:to="loc_us-gaap_DisaggregationOfRevenueAbstract_97dc1265-f653-48f0-a0f5-d2f6e9e217b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_52877956-c93f-45a5-af21-dd5d861624a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_97dc1265-f653-48f0-a0f5-d2f6e9e217b0" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_52877956-c93f-45a5-af21-dd5d861624a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4d1f511f-fca7-4e6e-bb96-f098dc2646aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_f177d4ec-3548-4735-8c52-0745f7300bd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4d1f511f-fca7-4e6e-bb96-f098dc2646aa" xlink:to="loc_us-gaap_DisaggregationOfRevenueAbstract_f177d4ec-3548-4735-8c52-0745f7300bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_73cd1454-76bd-4b88-925f-0b41e3a6d2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_f177d4ec-3548-4735-8c52-0745f7300bd7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_73cd1454-76bd-4b88-925f-0b41e3a6d2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a1ec82c9-5d37-439e-8c49-f8d21079f089" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_73cd1454-76bd-4b88-925f-0b41e3a6d2b1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a1ec82c9-5d37-439e-8c49-f8d21079f089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d3eb54c6-7ab8-4ed3-a50d-6ef7c78c75f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1ec82c9-5d37-439e-8c49-f8d21079f089" xlink:to="loc_us-gaap_SegmentDomain_d3eb54c6-7ab8-4ed3-a50d-6ef7c78c75f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_d2608541-254e-4e66-af03-afe967ffb1ea" xlink:href="bsx-20210630.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d3eb54c6-7ab8-4ed3-a50d-6ef7c78c75f3" xlink:to="loc_bsx_BSXReportableSegmentsMember_d2608541-254e-4e66-af03-afe967ffb1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2910d537-4f96-487e-9b39-6df2e1d0785c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_73cd1454-76bd-4b88-925f-0b41e3a6d2b1" xlink:to="loc_srt_ProductOrServiceAxis_2910d537-4f96-487e-9b39-6df2e1d0785c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2910d537-4f96-487e-9b39-6df2e1d0785c" xlink:to="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_1e943221-5688-40b3-8770-cdf665167896" xlink:href="bsx-20210630.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_1e943221-5688-40b3-8770-cdf665167896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_160654eb-0b7c-4aaa-9a64-faf8bf8c694f" xlink:href="bsx-20210630.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_160654eb-0b7c-4aaa-9a64-faf8bf8c694f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember_0cbf12f5-9a4b-41d6-b965-97c821dcf34a" xlink:href="bsx-20210630.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalCrmReportingUnitMember_0cbf12f5-9a4b-41d6-b965-97c821dcf34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_55677475-46d4-4ee4-9757-ae3616acb0dd" xlink:href="bsx-20210630.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_55677475-46d4-4ee4-9757-ae3616acb0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_d2d9659a-ee56-4bbb-872c-a313a3014c02" xlink:href="bsx-20210630.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_d2d9659a-ee56-4bbb-872c-a313a3014c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_b2d259b9-3cfb-4c1b-86b5-e74499e26e34" xlink:href="bsx-20210630.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_b2d259b9-3cfb-4c1b-86b5-e74499e26e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_139c2738-1e83-4d23-93a9-99ba819f0b00" xlink:href="bsx-20210630.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_139c2738-1e83-4d23-93a9-99ba819f0b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_f8a747c2-78a1-4da0-8860-5242a4afa7db" xlink:href="bsx-20210630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_21edd16e-dec0-4277-835f-02f88d127dbb" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_f8a747c2-78a1-4da0-8860-5242a4afa7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ba1c42ad-2bbd-4240-9d14-c4723f3dd8e6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_73cd1454-76bd-4b88-925f-0b41e3a6d2b1" xlink:to="loc_srt_StatementGeographicalAxis_ba1c42ad-2bbd-4240-9d14-c4723f3dd8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ba1c42ad-2bbd-4240-9d14-c4723f3dd8e6" xlink:to="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8525ee4a-b65a-4dcc-be99-811f0fbdf5ff" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_country_US_8525ee4a-b65a-4dcc-be99-811f0fbdf5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_ae8d5211-90b3-49c8-9101-f25e2854c3f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_us-gaap_NonUsMember_ae8d5211-90b3-49c8-9101-f25e2854c3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_dfbefa56-6ece-4cef-936f-a65c2835990b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_us-gaap_EMEAMember_dfbefa56-6ece-4cef-936f-a65c2835990b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_edbf7192-5c32-4178-a6ec-64ef0dce60de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_srt_AsiaPacificMember_edbf7192-5c32-4178-a6ec-64ef0dce60de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_20ea4a7a-ea2e-4b45-8611-29f7604e771b" xlink:href="bsx-20210630.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_bsx_LatinAmericaandCanadaMember_20ea4a7a-ea2e-4b45-8611-29f7604e771b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_0ce4c831-a86c-4c0f-9a73-a238ff646e76" xlink:href="bsx-20210630.xsd#bsx_EmergingMarketsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dfb2609c-4c04-4b85-9e34-dc6f043c8cd0" xlink:to="loc_bsx_EmergingMarketsMember_0ce4c831-a86c-4c0f-9a73-a238ff646e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_cbdddb80-0f32-41d7-88aa-88fcbf5f8459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_73cd1454-76bd-4b88-925f-0b41e3a6d2b1" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_cbdddb80-0f32-41d7-88aa-88fcbf5f8459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketstotalnumberofcountries_0c10e99e-4f28-4123-ab4b-632ad0a651ce" xlink:href="bsx-20210630.xsd#bsx_EmergingMarketstotalnumberofcountries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cbdddb80-0f32-41d7-88aa-88fcbf5f8459" xlink:to="loc_bsx_EmergingMarketstotalnumberofcountries_0c10e99e-4f28-4123-ab4b-632ad0a651ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90fe078c-6b67-4923-8462-852b09ef948a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_cbdddb80-0f32-41d7-88aa-88fcbf5f8459" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90fe078c-6b67-4923-8462-852b09ef948a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract_17a19cdc-ddac-4aca-926e-f77b80ea3a23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_f177d4ec-3548-4735-8c52-0745f7300bd7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityAbstract_17a19cdc-ddac-4aca-926e-f77b80ea3a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_158d069f-c0b3-4003-8239-ee8c556a11e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_17a19cdc-ddac-4aca-926e-f77b80ea3a23" xlink:to="loc_us-gaap_ContractWithCustomerLiability_158d069f-c0b3-4003-8239-ee8c556a11e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_3296b924-7382-48c1-aa22-a9ccdd495204" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_f177d4ec-3548-4735-8c52-0745f7300bd7" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_3296b924-7382-48c1-aa22-a9ccdd495204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_33d9a52e-6c42-41b9-953c-09b2b85c42ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_3296b924-7382-48c1-aa22-a9ccdd495204" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_33d9a52e-6c42-41b9-953c-09b2b85c42ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="simple" xlink:href="bsx-20210630.xsd#ChangesinOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_6e46682d-b6b7-49e9-b1ae-e91537ca2cbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_fa3eacd2-3141-4181-bfa4-b6cfdfaa70d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_6e46682d-b6b7-49e9-b1ae-e91537ca2cbf" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_fa3eacd2-3141-4181-bfa4-b6cfdfaa70d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="simple" xlink:href="bsx-20210630.xsd#ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="bsx-20210630.xsd#ChangesinOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_2e5b279e-5567-421e-bcfe-82659cc081a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d93f8eb3-78cc-4c02-8deb-f1a116756766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_2e5b279e-5567-421e-bcfe-82659cc081a4" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d93f8eb3-78cc-4c02-8deb-f1a116756766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20210630.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_c4cdde57-ba3b-4d8d-ae85-70923859ebfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a9da01ad-638d-48fb-b9ab-b7ca966935b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_c4cdde57-ba3b-4d8d-ae85-70923859ebfd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a9da01ad-638d-48fb-b9ab-b7ca966935b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_70cd87e6-294d-4c4c-8b92-cfe33834a8da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a9da01ad-638d-48fb-b9ab-b7ca966935b6" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_70cd87e6-294d-4c4c-8b92-cfe33834a8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_05841dc2-7735-4efb-9a63-0e2f4b84b49a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_70cd87e6-294d-4c4c-8b92-cfe33834a8da" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_05841dc2-7735-4efb-9a63-0e2f4b84b49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_b193f14a-6cb6-4500-b3d1-482b651d6859" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_05841dc2-7735-4efb-9a63-0e2f4b84b49a" xlink:to="loc_us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember_b193f14a-6cb6-4500-b3d1-482b651d6859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e38d4b10-2d20-4ac3-a59f-0c42d93237fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a9da01ad-638d-48fb-b9ab-b7ca966935b6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e38d4b10-2d20-4ac3-a59f-0c42d93237fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f9627e0f-cbf6-4f91-9c7f-9b77cab8d27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e38d4b10-2d20-4ac3-a59f-0c42d93237fc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f9627e0f-cbf6-4f91-9c7f-9b77cab8d27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_496ba6e1-be95-4cfa-acc5-0990d2f6b052" xlink:href="bsx-20210630.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f9627e0f-cbf6-4f91-9c7f-9b77cab8d27c" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_496ba6e1-be95-4cfa-acc5-0990d2f6b052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a9da01ad-638d-48fb-b9ab-b7ca966935b6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_52d75cf9-29f3-4867-b9e8-2dc88f98029d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_52d75cf9-29f3-4867-b9e8-2dc88f98029d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3575242a-b45f-404a-b6f0-6262183090ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3575242a-b45f-404a-b6f0-6262183090ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_937deaa3-40d4-43d4-aee9-bfcf1bd2dd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_937deaa3-40d4-43d4-aee9-bfcf1bd2dd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a0db3efc-4f48-4cbb-9ab3-5502ebbb24ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a0db3efc-4f48-4cbb-9ab3-5502ebbb24ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_4a101514-c1f2-4084-89a4-ae22eb2e03ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_4a101514-c1f2-4084-89a4-ae22eb2e03ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_7363c405-3151-4075-8e00-dd1d54793c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_7363c405-3151-4075-8e00-dd1d54793c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a6b39043-2538-438d-b6a6-05910926459d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a6b39043-2538-438d-b6a6-05910926459d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_b4fa0a6e-9a54-4885-9c03-96a7a78c00ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_b4fa0a6e-9a54-4885-9c03-96a7a78c00ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7a1cc75b-04f8-45da-bb6f-5ae556a339e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7a1cc75b-04f8-45da-bb6f-5ae556a339e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6d95d173-55d6-4c37-b4a4-f8ca6e19f53b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6d95d173-55d6-4c37-b4a4-f8ca6e19f53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ffcba89e-08ac-492d-a0df-d47aeeeb5b4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ffcba89e-08ac-492d-a0df-d47aeeeb5b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_1b9dfd8e-6ffa-4f5a-9ddc-02ee8abc0c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_1b9dfd8e-6ffa-4f5a-9ddc-02ee8abc0c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_6a7a16ee-1d2d-495e-a76b-08fac70d7e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_6a7a16ee-1d2d-495e-a76b-08fac70d7e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_449b65ab-31dc-480a-acf8-61c2e611a1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_449b65ab-31dc-480a-acf8-61c2e611a1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2f60107a-6038-4029-8743-336f62898f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2f60107a-6038-4029-8743-336f62898f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e6c2e28c-e420-4027-886c-c3e4992e05cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f1c52d9-1e31-4491-b185-defb1633c544" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e6c2e28c-e420-4027-886c-c3e4992e05cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="bsx-20210630.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b30e796f-d347-4568-86dd-4271c1ba94a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NewAccountingPronouncementsPolicyTextBlock_f8b0e19f-cd8a-434c-860e-3c0c7a5956dd" xlink:href="bsx-20210630.xsd#bsx_NewAccountingPronouncementsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_b30e796f-d347-4568-86dd-4271c1ba94a8" xlink:to="loc_bsx_NewAccountingPronouncementsPolicyTextBlock_f8b0e19f-cd8a-434c-860e-3c0c7a5956dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="bsx-20210630.xsd#NewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_1f4a8064-9c5b-4975-a4f4-b8ad7e53c9f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_718f38a7-4877-479f-9bb5-ebf5d06e5849" xlink:href="bsx-20210630.xsd#bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_1f4a8064-9c5b-4975-a4f4-b8ad7e53c9f4" xlink:to="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_718f38a7-4877-479f-9bb5-ebf5d06e5849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_d68d8230-6c7c-4137-b9e2-750cd4eba55f" xlink:href="bsx-20210630.xsd#bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_1f4a8064-9c5b-4975-a4f4-b8ad7e53c9f4" xlink:to="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_d68d8230-6c7c-4137-b9e2-750cd4eba55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock_0d7f9a01-dc8f-4aa7-ba4c-148267a09bd8" xlink:href="bsx-20210630.xsd#bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_1f4a8064-9c5b-4975-a4f4-b8ad7e53c9f4" xlink:to="loc_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock_0d7f9a01-dc8f-4aa7-ba4c-148267a09bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock_982c3bb2-08b8-467e-81c6-caca80bb4a75" xlink:href="bsx-20210630.xsd#bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_1f4a8064-9c5b-4975-a4f4-b8ad7e53c9f4" xlink:to="loc_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock_982c3bb2-08b8-467e-81c6-caca80bb4a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b83250d0-1c80-4983-8871-48b2e719c027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_1f4a8064-9c5b-4975-a4f4-b8ad7e53c9f4" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b83250d0-1c80-4983-8871-48b2e719c027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>bsx-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bsx="http://www.bostonscientific.com/20210630"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bsx-20210630.xsd" xlink:type="simple"/>
    <context id="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1f7b6d3b742a4d51865ca65aad09fe72_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i64954d944d4b4bccab9f6197e481ec8b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8d5d572ce7ed4e2b92e847dfb3345843_I20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="i1270609d6b744578a62058c51995ce33_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iae02e9cc78ca4c7aa533a4609d180b55_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i40d4bbc844644023a5878306b022201d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79e7f5e22b45494cb5031e20d21c5988_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6ab5a160fd2842d19f763f45b6d09e89_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e6d8515e25d47aba9ea9c0df13760db_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iff4ae26c4d5d46608d3add43ad05bbb7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iacf6fa5b9d2e4cb38a2b47625e11f694_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i407e005872e847169249dc236fd723a1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibee203a2a57249aaa21381f631fdf46e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0da7317746ad4fd683a1ce1bc96f8f22_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i07039c3201414d96884a16b718546a13_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i17c0a7e09ea4403ba4b016e00d085205_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i15d4e3340e604a44a2fcefd0f1a628cd_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7f075e6862bc484dabc2a2c6cd1d7c37_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic68c9bd1b9604c838f68baa4497ef3dc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i323d08dbbf434656aa0a30682aefdeab_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibb1e17562676450a8f71a4ef6a375849_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5fdde603126345a9a39d5b631edb96c2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1dc6cd3645f6405b90a96753c13a9cb0_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idbfc05f74eb341e78530b80a19abf65b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7d53662410834885b7dbdc824ed4b103_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibca19cebdd0949a1b26b48f24eb12161_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i054fa70f408e4539865aee238d844341_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if51fbced07284741ad5b6ad72598bac1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i75faaf5aef3241e1bbf28cbd0d043d16_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i28e7fd546b52414bb22a99df2fb6e6d1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9ba117f5e9a14bee84ef83a283e82114_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i81e27f9feb6741bfbc6aa8b9c2b21974_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8023920188754b2a995080b31ccd868e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i03dcdfcf4e244a95a8ab8e736a188d92_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8652d5fb943a4587a8793dc14afb84c3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia213a6ff66974627946e8fd3a7382872_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i64d424319a394d27ad50e628661c82fd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifaf7b07ebc9642edb11f1367901401c2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0b6c5fe863db4dacb550eba84fd8836e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i850cc4a1d1c24cad88a0c8605cc8c364_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i64fe29b381c14063af8331516c517635_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7b3a8264bc9d4884896faec1361a29f2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i27c4310b23f24941bfe4832943becdd5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if3e5d0796dba4b21a297db8829d0bba0_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5adcdaba03f8425280b41743c1b6a4a8_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic49b06d7552349519467e47ae89ecc2e_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i30e29fec4ee74bcfb877317c0b851a69_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i40dc3c728f4f4406ad21325f8c547a8f_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i15add9d704da4ad1a802469251779a75_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8aa153463d4e4b10bdd112f21b499711_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib439965aa50741ed94d896621a53d24f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7422e8c7c9ac4cbfaffd4115d01b32f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b8093806ec94f8a82c561e795c452a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic09defab5a6b4fcea525bbc5a70b2eff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idb59d96b0c5240b880d48b08300df3ba_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i568faa2df0b7487aac4477602e023e13_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id4fb7a73d720449eb35e51e5c42bde88_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifffbb07e504b44f39e055b5bbe1c5ea4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5712d73ab4594b168ee2ebdc3c0b169d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic0db57ccee8d4694893d34eeb2fdfe2b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ide71e62aef2140e081c5bf792558264a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2716ea4458a542bc9c88d29a297073ed_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if96fc34936b14bdba670cff9c58d6e24_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i90fb13e8b59f4a29a69d162134fcbb7a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icc8a50967227451ab60dd06313b66069_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id5ff7d6319ec43c7a77cc183eb669155_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic42f5761199a4db4bfe046448896c355_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i23f5234796e94be18871e317e297f8f1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i103db90a98ed4fadae2e32d5e1d5d63d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4ee81bbde07a44368fcb9d1addd7d122_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia18bf18de3e5421ba842d5317c3f8f9f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id8bb9328c6444517b9390466b44fc5a6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic8bbd48792b2442d936ce7b773a35f08_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib432c787f0c944d2a88f98e14ab15f00_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie5e655ae113847fcb0d0f49867baed93_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9dd21833f22a4ead8d64d3beea08b065_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7035bd8158c64efc87cb5197cb0b1c08_D20210303-20210303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:LumenisLTDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-03</startDate>
            <endDate>2021-03-03</endDate>
        </period>
    </context>
    <context id="id3b8aa9405924b21b11a85634596952f_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="ib9c9a81fddbb4fad955c9b1435142cec_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i57c0758a66684a7982d502068215aa6f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6898b58f4aec40418ecc3bd0375059cf_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:FarapulseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="i6fdccd8db4934e95b5b9d89057e641dd_D20210806-20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:FarapulseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0a862692f9994fb897884cba9e5d394c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i42615c1dcc2b43d5bfd401f89db86ee2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2761998d541845db93a74305c87ca265_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i91ca5ff3927c42fd8cec3812dac442ed_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id114a2fef9024cbca1a1f0663c76241c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib89073632b554a279ba4e8ab72aee35b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:PreventiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibb276f2411404adb93fe59870c17c192_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i8074394ed0a841f6b6a00976ce6a3b7c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic1a8632c557548d6a28c88cdfcd4c788_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2e3062416e504886865dc878139930d2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3a1667398e9d4227ad18866f00a781a1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4ea9ee04f244471cb85a3fafa0014325_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4b1f6c1a9c3545cb8c54c62563bbe3af_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8f69f4096f2641279151434275d31698_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iafec8073344141919bf348e3f6128888_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i599a67975f864f07aebaf0697665cb54_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9b78aeabdedf468b9432e0fbf7b1d35e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b873251f0164fcc87a5f68eb8697f6b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia31b341f23ca42dd99d1f28259ed9778_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i106a39a0f8a64d958a6b4fc9ab669182_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6b198018bdf848d58391e917618a9a73_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4614798867554623b71db7e485b17073_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i66b850e1cf4c483cb4f780f209eb416e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie78944db109b43dab16a18b210d06a11_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2f4dc84c7b7d4d6784d95efacd9d16b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6c58776dd93450391e647ab995a55fa_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i96e317c9a09f414dac29a749f0646452_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f13c163b758433eb6e1965892fb50b6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic290401c00e44941bbe65f481b18918a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7879670f05dc464cace4562bebcef4af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1cd550c4b9f4493a5098816e165a726_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if893495841d548ada62dd960d69a89bc_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic0f4ff16aef048c5951b2ef3630ab4fe_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i508addd37e5f4f7ab05debf8ce4a40c5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9276b8fd7c5e459cb81f0d109ea9c590_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7c9a9df7371e47288ad47514abc3d299_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id15fe40bbc1a49598899e77eca657086_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i337a6f01680a4261a534fe13d39a19aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0484760d76d648ef90f70bb1389a147f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3139c7b655da4d49a12993d29146beea_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia68688cce8064b70bcca08cd6512a4ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ffac8f2ce0d4293b26df78d0ad2d8e0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i424e4f7e39a9410981b8ba416ccac4c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iadf7143e00714f7a9f615443b868ca37_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i61f98deb368144a69329cdfbbd8f2cc3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id3020f06cb394eccb08b9f3827b65587_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i27bdbdb9fd8a47e9b5c80577d41a1ec4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifff3446af476436f83c776f6272d3517_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7f69fa3f42484de3a5cd8686c169cf5e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2dc0aeafc5504f8491f1d7e2d12710bc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia2952dc166454f9fb8cff9b5579e82ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if744488d910741f99e4dde8ee82cf4fa_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ife61a35414c94d28863d163cb3379eee_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if0446aef545942b8b12a84b25e182179_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iba71732844214aa3859047cf4cd1b074_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic356266b05f74a6b9f1191f2b815f11b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i05caf238eba7451e935612a5c094056c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i95c41329358c426dbfde24ddb1b29c13_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i001157b3c6c14f6ab4a49a1468cbba56_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia0d946dede0f4f31a139ab6bc367b6a4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idff7731f281941c9b10a57598c4f3fa3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i88819d9575244b1f9ae25324bd55ef4f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i26eb37997b434810bb1db3a61e1958c8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i95b1b2df03b543738424133c5483532f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i413490b8a5b549428c780264cd0fca96_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7898c0ae54f649e3b3bd7531b4e96637_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e501501753d4bc3893312052f231981_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibc334024d192429bb461fc883b913f95_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i210e93bd44c944e39350884a3a028415_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5b553319bf064b3fa60f0b256efd9a1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a91e7a45fbc446c8783c08420680904_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5e8b4d9c146e4af78c9649552b795b81_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb50746f189146428dc3a086275c1f6e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i21748e73c93f404ebf1695c897f921fc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifcd5967abae8433c8e776f2d4c8e34f5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i946142230e0d45968c7d35a681ee1ca7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d5a78c050d24c3998ce9d7394914716_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia8b3a25a0021455c82d237efda98677a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28be2cc81b8646da8951fe8f886431ae_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibd3a971d105c47e3b030d7146612746b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id1d17d52c56344148e6f68416205f316_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i18328309825f40b887eb0ef197588dd3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7f8a220efc374460aac18c0864628e67_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia20c85f02adc4bdaab3ab93127fb5465_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1696ff74ab3647bb87732da6158a3427_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaff031e690ad46fcb10f2ceedfa9fcf9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i40d5ba9cb66f46eba6179aa8dc2f4775_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1b99fcb316c84c26af31432735c4acc8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iebc173f0990b4117b9314d607dba9671_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if33791e7ffab49859998b3df9fa1bafb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ied2279ddd55248389453413b491c815f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9e77807bef8c44ccb81fbc0e7ba9b799_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i20ed1fc05de34698bdf7cd17009bebce_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i600d7a0e156944d8a7e0b2f8e0296f7b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i21198075aed84d47b40aa66db088ddc3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EurodenominatedoutstandingdebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i103abe8f6cc04293824af37a171f38cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EurodenominatedoutstandingdebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i967915e4b5a34078a3ed31f7f97e8af1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie9b8b74de08d42a5b1c298735f31c874_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia41c2dcb7c86466189b28d6c0003d505_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iadb3d909cec9465983bd9071804b27c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id982ae5b53e04126a7116a0047e53636_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i113b5c1b952f4594980deebf9d2fb6a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifab91815c6bd40d0a0b1e317ea65c8da_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i38a47cf5a6694115904cfd355585ca6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d2f3b419c994bdc94530fd56efedbc8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i561c09a8d18c4e8bb44fee39130ac6ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i46ac7a01ed6b40a8b651ab864a06c209_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id0ae2e6d62514176973bc35a7110c630_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id72fc66e7aab4c62aaf40ffff524b1e0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia351226c94354547b45c1fab925a288e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5ca05e25f325480fa19833b9a5aa88d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i62a197ee399d4df089f8b6bc2882477f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i91e07d9a4bf44725bb8890bf0ddccb0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0bbf7a2beb3741228b363f15a8f99e4d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic01cfb8ffa714da4ac584f4ba607a604_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2273a18a922d4ba9bb8f7b6d48223471_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ide4c06b245c8483d952138db789ef503_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1023571c063440c1b72bde0cc574f3fc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if6c5049e8c5a466cacfec15d36c0b17c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic047224d612c40f3b5da3c6df601c6b4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iba59ff767fc24dffbfa0f7a3f3061b30_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5320ad72c40043dbadbade7185c3451d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i90a40bf358b54433a3a649f92522cdd3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i809eea6504914ca685965d4b388d35d1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8b03ff8312654acdabd6f4b180d73c5f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia44ed01226c64b529960a7be9715fdb1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if06d4aa1475745f9bd667036ca6a77e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0771aaf382b64bbbb9ca530005018dcb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibce283f07399443fbbfa2409543233c0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie78d090db6af43d5964a7c874aa66780_I20210510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-10</instant>
        </period>
    </context>
    <context id="ie5bb1bffb92d48848c682a120ac50575_D20210510-20210510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-10</startDate>
            <endDate>2021-05-10</endDate>
        </period>
    </context>
    <context id="i9e96838cdc7b44c4a1afe15baaa3ef77_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RevolvingCreditFacility2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3a4283b5db0d475db38e71d73bfd1d3c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i26601067bda84bc3b9685478594ecd99_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:CurrentRequirementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3e0d083bcc1b4a04b64d12c8d91b4941_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i20c8d3b79ea24e50b1f3b5cff5b34259_I20210510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfJune302021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-10</instant>
        </period>
    </context>
    <context id="i2386476e4d86430cb1177af6ed201651_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfSeptember302021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i73dd07304f00449f9f1e3862f53fd60c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic8cfbd87e22b48faaa5fcd00545825a2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0047d354b82246a986ea67a506f95e0f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia027378c26254f43aa24b3d62083d405_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSixthQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic85f1b8888bb425194c965e58e0b2e74_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iec922493e5094a03bf6f1519d2177851_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i11e8d32cc0a047e98a98d79bfa03d913_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7b8038e17bb14aca9760b9b13c4a71eb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id36ab86f2da34a9c8eac8655594d345f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i24cd97ee251b48559141f4a71903a86f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9ac4d1c50e424a77a8190f95382d7215_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icaaff822293a4cdd9e2c363357a949b3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9e14eaa94afa46c089e40f5f8fc742f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib85a49f2cb27434db4be4cdcf2cd10c4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2e0c97078b824377aae934b984b2c65a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9a197d277f374157b6cbffd8871e4fff_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6dcfc90377704002bd6e0af127de50c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i436cfe41ac964ae79776eea028f62811_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0e99e4069c604693bacde07aad3c5702_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iba90cf22a3284fb59a07eb50be79d5fe_I20210720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-20</instant>
        </period>
    </context>
    <context id="i77c92e5241fe49138fd00651d03d0ec6_I20210720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-20</instant>
        </period>
    </context>
    <context id="ib0ad409ecce44b268852058674771336_I20210720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bsx:AssignedtoonejudgeinMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-20</instant>
        </period>
    </context>
    <context id="i026d0c112cb44011bed4a40ce907adcb_D20171110-20171110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2017-11-10</startDate>
            <endDate>2017-11-10</endDate>
        </period>
    </context>
    <context id="ia6bc3d74e781494aa5f8d841b5dd5783_I20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-27</instant>
        </period>
    </context>
    <context id="ib072725f878d490891c935180e76efae_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="i7f1c2b882edd4e289dc69107378a5023_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7dbfe80c9a6c4f1fbd50cde474b1f462_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic6a63df2abd449589aa54a60a6aa45cb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibe8974f83a41404480fe53c20b651092_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1c82a8e57953431395abd5f8de82b993_D20210723-20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="i931d3fba103a41da93709c2ad126cda8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i80131178752d4d72933977f1f39077b2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i872461569f5c44cc9806dce827685f3e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4dd96420c83b4f6fbd2317a8063fe8e8_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i94ceea52a45242bbb3456459eec3203a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie8b39a268f3f4c688dd37a207b541d3c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if28997b0cb7f412abd0e94a0120251a4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia22d58f6c86d470aa34c0f3cdd713039_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5bcab03a819b4e56b7ba98f0bd557f87_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5dd5712978054816851d620283d3a5a1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6b8776f4806d49a896745a9a4bb90b81_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6a123b6a6d02472f84544e157b785b07_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia8ac7dde02784ed2a3c939e70748808d_I20201214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-12-14</instant>
        </period>
    </context>
    <context id="icf3d85296ff14a7fa38a4e77b4c22259_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iee7ac48795d7495bb324539450207488_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icc87b0e1aea540f5afcf25232dd8e768_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1fa95cedc94d43a78ad39a377b3b4597_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i87a9703d05a846d58b5180826ffe5050_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0ddaea5b070844abb018d02ea99642ce_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4a812afca36c4308ad9bff7ee2032b3b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i10ee3e6c967c46a4b31eb6264056e524_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9920b68656de40d1b14321411d7fbf04_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i08c5d30357d9461faac846d9a7f6f58c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib3f1a45e38524eada4c409914683546a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifbfbdc30d0ab449094a90e70fd595751_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id96d30c4d41a4cdb9fe2a6c8498a6753_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia69c68d3663c4d20b8e7aa1db007db37_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i917d4854b7a7437bbd99ae988171a69e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6987d6c22f4b44dc92c281c44ea04ff4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i875553a9513a45a38f8a905416d7829c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3e3373e787f64b69879354c4d90cb4d6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4a73a4533f85472db78cd678e9428f83_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2329374481a64746916e19c25b31e4a9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icea85ab448ac4f31a40e693d00c9232f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9425d933351842c69c2377a549b55d63_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibdbc19706ca841dab5c448ba34ebf25f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie0af53d7a56246a6a7195bfe2f410ab8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i06f6ceb4a20040a5a4fb3825accef1ad_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib2ec85ae1ab744838e2f0043d7c74fc7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3d7c3b80fe00450391af229f01a0d200_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i30338b7d70584d428b0e030a91c0bd1f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icf9a180b4192402eb3bf5e60522bf759_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic949cdc25a0746a4a459b8a0d6db3a07_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i16978436b3dc4702931fc4b84f04a48e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2aaf1372dd9946df9396ccc9020383a6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i169d8e210b0c42a7bef3c40e6e0a6e32_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i061cd56ba7464abca39e645d60f76a24_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idaedeb686cee4d8d9dab6a94ba25b3ca_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idcba7c4ff23d4a36bf3a797d17d3fc25_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia88afd4ada2e4380867080d946a426ab_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i96cfef3ea9ca4aa19b2bbb07b400eb80_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i42ab9e136af1432d93223a27751196da_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i22601e81ae894a8ead01e52c7c6c27d8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i29a590a1212940f2a9899f47bc99255f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idd29119a8cc84be69467437c76bb82de_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7af6058e474a47f6be0373df26d2c88b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5638e698e73f4b489f93a04619cb4765_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i82c8d382689b4777829b44c174c65fbc_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1373eb6d094a4864854a6d14ee507632_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i22d89029dd434509a14af75abe8b39bb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i625505b6d3a940a5bcb761bf0b3959f7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i19fc598ea5cf4543b98c31b363392b72_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8adde05e0aa442a2b88ca23ff4e546f2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7ff91ebf23ae4decb4c9ef0283823434_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i99e80edb795146f8b45480c4add3365e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5f4c3566c44c4157a5e11d70f391081a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1bce46e49184470a8222ed14bd378c26_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3f47e99793034137b15f7fa228eb0b29_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i38a51bdaccc2484c9e70993e21677ca3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7aa30fb1b39f4d348ef1434541427e01_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4a72d4a50a4d4e74b93be9e82777898f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9eab68a05c01485c92e57bee7e7e0f01_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5c54e4912e96435091d529ae0ed78f07_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibea06e5f733245528b5328dc3e82297f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5706fb2a0a0e47db92eafa5aede01ccf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9e88da73b0484cceb9e60fbd4e7e2fab_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iad77ae9479ab455da7367cecb7c17bc5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i08630dd608644cc08764c701dd22f7aa_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic338ea419c3440558697b27cc49de9db_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i690ac34917b44b20906e730e3dcdc4af_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ief8a91fe2ca84ac0b18ff0e6844a0287_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5201686b80024557a80a7f33db43a5c8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie0e96b146aad466ea7d9f8d5dcca942d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i18a4ce2ee9e8410fa314a7f39ae7cb6d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iba26343c342547479828a2dd2e8d7bd9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i947c377abd4c4941b4a244d5948eebd2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4de128567b724b5984a99d95eef02d4d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i18f2f3e5b12e432ea299981ae16b6fe8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idef0574f3eef4b9e8e842b614403cda3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id7ef4aa393984e2ebb13ebe33340a910_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i372f4fcd9ee74bd6a7b738ffb8609de3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibcf9760e631443339b33601a02bd59ce_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6d063662de5e4b32ab5ce0c83ed22b8e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6bc4e56a2f2c49849c55cba2ac3445ae_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7801f5155a6141c18f17232cef1a5392_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iec63b166a7d5454683d6ec2e2bab3b66_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i546ecb80f9f54844bc0e3f3b677fee89_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i97435401a6bf486aa47a9cc538781a9d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5d83d8f92f6647f0a79e0353d43220d2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4b1d77aa85474402b82a7b22a91d3791_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i82c87e029c8940349ae408f228d3b510_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2cdb3e06e9a64a59b0a05eddb13cb154_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i60e576728e7343f7821a9f0a44eb3d8a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7e6dacb4e8874b21b6822d368a2a953f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8e85a2c232e64290b8ebd6a6cd0bbdc4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i953e0fe9f9b847f49ab077fb9c939709_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6ec33aa8ba414dcd8d8eddba16bf0dfb_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i55ddef33ab0e4fa78d3e05af2245debc_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i705075d05b1c4df98d3f2b6311ee1876_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0149779720b14a1e9890c2e5463703cd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i48d5ab1bada04b428d1dc449d38e68aa_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i056eb40cf563486c946aa704d28fa8ab_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2a0d737980c64923b5659d62f3434702_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i999387ed85af40aa960e8fb85fe24e8f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i37862215da8c46a5911d56efc33e6a34_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9d8a9a823a7e497a910c47ea98654d1a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id9a20d757b68446898d764ace8105642_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib01f3231917a42399388b8430f7dd5c4_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia92d1f0a20454a3b9bce021d757a34e6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i89f659ee14624fde88e16586c89ce9d8_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if71b684d3c024d3886c8ef1e65dfa46d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic0734e4182c448e3a1999d0400528fb7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie1a9f292c5b94a01b78a4918d33aa51f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5fe7c0ba7c514a5aa6e493bab9893659_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4ef0989ede014a41b44c8c421e9c80b6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4a99ca748d5e4edfa719dfdea5bd3311_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia2ba737e9d8f461ba5881d87b666c936_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idf3328c2059f45a99c8ed36d5544d2c2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i27a241c1c7e14b908561f55b9bea06af_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5d4a66cacd3c409a8583c1f4d7c949a0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0f81f839a1994584aee39783ecacbdcd_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i70b422de2e4e4b18a8970d5b6f6d4282_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i10cd8488ed6a4a9f9cfca5758ddc5d1f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7a954338141045799352d36c639ad37e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8cff98864b9e45f2a169a4724b33ce66_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i009fdb9395ce49bdb5ee3d78d5dd59b5_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3f221a488db642a294dc6d9112291dc5_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaa71dec95dc94eeca8f7131ee2264446_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i80dc82869bb14419b4927d17ccb893c3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic86c037a105047ff8e30c52d263c8b1c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i73e4ecee96fe4a029361a7becb75ea87_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if876951023d64e46a24c7d835b5faa3b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i00e3dbb86db0418ca06c3632c8c1b5e7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i122407c5128c49f5a374ce6bf633b754_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i77bb9297fb7c44c6b02abde208157004_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8456f3d09026487583de79d141ac5a57_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i88135e1e5b9e48138fa29ce5f22d50a0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if7322afa2bcb4680be71b6adae30c6a0_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i719d3d1d3dfc4900a97050942bbe31de_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0eb35a14aae34796be04212920a94266_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i37162a776ece4d0bb843164a63a34546_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic8d04eeeafb94eb9bd136daeb8176cbf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ied8010a52167452ea357069eec7e9c7e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifb29b1f5e9c04d7f8e4e8c597595337c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i84fc90d4c0574d2180bf795e9ea8019a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2f7d90c59416456b8c31e32e8d530bcf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie3cc9570466e432bb34716e1723c76ed_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6d1a58b8b2a64926afbacb03ceb0e46f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4d618ba150584c2d8089fc515133c197_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6590a83019bd4768911ab6e74a8ead5f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6016cb0bcb5645e79fb9453c064d1070_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5393f9f0da0e48d99af036f07bc71c8f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iae7822dc00ec44efa94a5d7b8f0d51df_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8952d06cea3f4179a4e5e6ed3a7d7641_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i877c5d6831884713ad635096adea9fff_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icba8e95f00734703a480e7de812a5575_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic27d3ee5d397485ba3bd063f9697f20b_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="business">
        <measure>bsx:business</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="units">
        <measure>bsx:units</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="derivative_instrument">
        <measure>bsx:derivative_instrument</measure>
    </unit>
    <unit id="claims">
        <measure>bsx:claims</measure>
    </unit>
    <unit id="day">
        <measure>bsx:day</measure>
    </unit>
    <unit id="reportablesegments">
        <measure>bsx:reportablesegments</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80L2ZyYWc6YWQwYTE0YTAyNDFjNDJiYmFhYjFiNGM3YjUxYzJlZjgvdGFibGU6NjE0MWM5NjkyZTRjNDBhN2EwNGJhNWY1ZDBjNjA0MDIvdGFibGVyYW5nZTo2MTQxYzk2OTJlNGM0MGE3YTA0YmE1ZjVkMGM2MDQwMl8zLTEtMS0xLTA_44227cb7-21c4-4d08-a493-65dc1801faf5">0000885725</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80L2ZyYWc6YWQwYTE0YTAyNDFjNDJiYmFhYjFiNGM3YjUxYzJlZjgvdGFibGU6NjE0MWM5NjkyZTRjNDBhN2EwNGJhNWY1ZDBjNjA0MDIvdGFibGVyYW5nZTo2MTQxYzk2OTJlNGM0MGE3YTA0YmE1ZjVkMGM2MDQwMl80LTEtMS0xLTA_4983dd78-baf9-47ce-9b55-17b4bd7aabe8">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80L2ZyYWc6YWQwYTE0YTAyNDFjNDJiYmFhYjFiNGM3YjUxYzJlZjgvdGFibGU6NjE0MWM5NjkyZTRjNDBhN2EwNGJhNWY1ZDBjNjA0MDIvdGFibGVyYW5nZTo2MTQxYzk2OTJlNGM0MGE3YTA0YmE1ZjVkMGM2MDQwMl81LTEtMS0xLTA_499007ca-ea46-4f0e-873f-f5a1941610f3">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80L2ZyYWc6YWQwYTE0YTAyNDFjNDJiYmFhYjFiNGM3YjUxYzJlZjgvdGFibGU6NjE0MWM5NjkyZTRjNDBhN2EwNGJhNWY1ZDBjNjA0MDIvdGFibGVyYW5nZTo2MTQxYzk2OTJlNGM0MGE3YTA0YmE1ZjVkMGM2MDQwMl82LTEtMS0xLTA_b763a9e9-ee00-4b73-8bbf-c289bac549d9">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80L2ZyYWc6YWQwYTE0YTAyNDFjNDJiYmFhYjFiNGM3YjUxYzJlZjgvdGFibGU6NjE0MWM5NjkyZTRjNDBhN2EwNGJhNWY1ZDBjNjA0MDIvdGFibGVyYW5nZTo2MTQxYzk2OTJlNGM0MGE3YTA0YmE1ZjVkMGM2MDQwMl83LTEtMS0xLTA_929b2abc-f3de-4017-8523-55ee26bf9c97">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDA3_89ced2d6-b953-44cb-943e-d89da0aa4e59">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6NTY4YmEwNWI5MmI3NGU3YTkyMDZjMDQxZTE1ZTkwNDAvdGFibGVyYW5nZTo1NjhiYTA1YjkyYjc0ZTdhOTIwNmMwNDFlMTVlOTA0MF8wLTAtMS0xLTA_6a14c2aa-f270-49ed-8cc4-d1826407a9e4">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18xMjA_e3970d93-9ba8-49ef-8e60-a56d4bb5b85d">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6MjgxMzNiZjU2ZjI2NDVjOGEzNDE1Y2ZjZjgzMWQ0OTcvdGFibGVyYW5nZToyODEzM2JmNTZmMjY0NWM4YTM0MTVjZmNmODMxZDQ5N18wLTAtMS0xLTA_9a2d4662-6bd3-4cdb-95a5-8cc5bb053146">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDEz_fb8f49b8-248a-4c4a-97eb-7bd0bf716104">1-11083</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDE0_e134a143-be46-46eb-8a5e-06abe24be860">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZmRhZGFjY2Y1YTExNDYzZGJiZDIxYzRjOGJhNDJlOTcvdGFibGVyYW5nZTpmZGFkYWNjZjVhMTE0NjNkYmJkMjFjNGM4YmE0MmU5N18wLTAtMS0xLTA_770e2ea4-1cc7-4d59-90ba-d724b533f15f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZmRhZGFjY2Y1YTExNDYzZGJiZDIxYzRjOGJhNDJlOTcvdGFibGVyYW5nZTpmZGFkYWNjZjVhMTE0NjNkYmJkMjFjNGM4YmE0MmU5N18wLTItMS0xLTA_cd426034-45e3-4e00-910c-905a6c41a1b6">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDE1_c147608a-14f6-4953-b08d-5ff10d61f4da">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDA4_ce3f88f8-de16-4585-a444-b9464523aff2">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDA5_526d0100-8d55-4fa3-83be-846c62eed6e9">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDA0_4dd03ecc-c5ba-4de6-b234-79e8a8a3a89a">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDE2_b17a0f51-bf31-4ac6-a761-795323b91860">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDEw_f4caf2bd-bf56-412f-a76c-0fd6590aabc4">683-4000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i1f7b6d3b742a4d51865ca65aad09fe72_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8xLTAtMS0xLTA_713a19f3-6ddb-4cf7-87d7-aaedddc8ee0a">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i1f7b6d3b742a4d51865ca65aad09fe72_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8xLTItMS0xLTA_39f4a23a-f3b9-416d-b112-17368809b49f">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i1f7b6d3b742a4d51865ca65aad09fe72_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8xLTQtMS0xLTA_33a97913-7796-4092-8939-56da472d7939">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i64954d944d4b4bccab9f6197e481ec8b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8yLTAtMS0xLTA_39d997a1-cbdb-4287-b073-73b478ddf121">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i64954d944d4b4bccab9f6197e481ec8b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8yLTItMS0xLTA_8b9dabcf-23ea-405c-a0ad-ae7642e7d2bc">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i64954d944d4b4bccab9f6197e481ec8b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8yLTQtMS0xLTA_b562538a-f6f2-4904-a6e4-254ac78a8125">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8zLTAtMS0xLTA_47f681cf-38de-457f-90f4-c919e5d741b2">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8zLTItMS0xLTA_b8d23436-da07-43c0-830b-2d1b28e17668">BSX PR A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6ZTAzNGEzNmVjNjE3NGI4NWI4NDg1YTRhYWIwN2U3MDUvdGFibGVyYW5nZTplMDM0YTM2ZWM2MTc0Yjg1Yjg0ODVhNGFhYjA3ZTcwNV8zLTQtMS0xLTA_0ec560a1-6efe-4c0e-b66f-1a107d2bca6e">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDEx_9b717c05-7f2d-426b-956c-dd8d554a9b51">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDEy_587c40f6-c03d-4b9b-b0c7-e529147fa7a2">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6NTBiNzZmOTMyOWU5NDQyZjkwNzYzMDA5MDYyOGEwOWYvdGFibGVyYW5nZTo1MGI3NmY5MzI5ZTk0NDJmOTA3NjMwMDkwNjI4YTA5Zl8wLTAtMS0xLTA_a468ecd6-bd7d-410e-ad70-c2bd9e630a37">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6NTBiNzZmOTMyOWU5NDQyZjkwNzYzMDA5MDYyOGEwOWYvdGFibGVyYW5nZTo1MGI3NmY5MzI5ZTk0NDJmOTA3NjMwMDkwNjI4YTA5Zl8xLTMtMS0xLTA_d18ecdf7-9bc5-466f-971d-e7ba18fc0fe0">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGFibGU6NTBiNzZmOTMyOWU5NDQyZjkwNzYzMDA5MDYyOGEwOWYvdGFibGVyYW5nZTo1MGI3NmY5MzI5ZTk0NDJmOTA3NjMwMDkwNjI4YTA5Zl8yLTMtMS0xLTA_f6f3b5a4-13f0-4d16-9c4a-49b7b4f68fb4">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDA1_d77257f3-75cd-4846-b4e2-ef1fdf576fe4">false</dei:EntityShellCompany>
    <dei:EntityListingParValuePerShare
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18xOTY1_f9c9a8b8-f3fd-49ff-86e0-fd29399ce6d3"
      unitRef="usdPerShare">0.01</dei:EntityListingParValuePerShare>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i8d5d572ce7ed4e2b92e847dfb3345843_I20210730"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xL2ZyYWc6N2UwMmMxNTU0ZmQxNDk0MTg1ZmFjNTYyMjZhN2RiMjcvdGV4dHJlZ2lvbjo3ZTAyYzE1NTRmZDE0OTQxODVmYWM1NjIyNmE3ZGIyN18yMDAy_d38e1986-8b55-409f-9af8-c71a4e0acf38"
      unitRef="shares">1423852648</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMy0xLTEtMS0w_d4545ee3-a7a2-451f-a301-7ba4d51fb29c"
      unitRef="usd">3077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMy0zLTEtMS0w_ea672747-e4df-4ce4-ac9a-de5a079a3bdf"
      unitRef="usd">2003000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMy01LTEtMS0w_e80f095a-4b58-4a90-8274-c353d1dac7f4"
      unitRef="usd">5829000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMy03LTEtMS0w_9c9478f6-f536-40ef-b747-4c43ec9347e2"
      unitRef="usd">4546000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNC0xLTEtMS0w_388bb8ee-e08b-45cd-8617-f2079c14f9ba"
      unitRef="usd">945000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNC0zLTEtMS0w_394d5849-4dac-4380-b011-435a28bc4cca"
      unitRef="usd">791000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNC01LTEtMS0w_630cb986-8bfd-4dfc-8328-039d266dac6e"
      unitRef="usd">1839000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNC03LTEtMS0w_00f9dce4-f336-4feb-8948-d9153ebad8f9"
      unitRef="usd">1596000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNS0xLTEtMS0w_7484bb8c-d8fc-489c-b6bb-0ecf2bc88973"
      unitRef="usd">2132000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNS0zLTEtMS0w_84e64956-6624-4c33-a709-e936b34610a4"
      unitRef="usd">1212000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNS01LTEtMS0w_f97cf4f4-e636-454d-a8a2-439cf97d75d6"
      unitRef="usd">3990000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfNS03LTEtMS0w_44cb627a-cd68-4018-a486-75bd729d6202"
      unitRef="usd">2950000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOC0xLTEtMS0w_a001ed56-cf83-495a-803f-bf0a797f3316"
      unitRef="usd">1121000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOC0zLTEtMS0w_f607d9f5-edc4-4d38-a172-062ee6a07ec8"
      unitRef="usd">798000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOC01LTEtMS0w_e9f48709-e6d0-41c3-ad74-cd6b8070ef6f"
      unitRef="usd">2139000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOC03LTEtMS0w_44a66519-6358-4444-811d-114f18a94d70"
      unitRef="usd">1776000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOS0xLTEtMS0w_bd9b2bbf-6da7-42a4-ba86-da51d2f48e56"
      unitRef="usd">298000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOS0zLTEtMS0w_9b4f7aff-ad65-48a4-8984-b5ad8e5c32d8"
      unitRef="usd">242000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOS01LTEtMS0w_a1f9299c-081b-44a4-b042-3a948a88b105"
      unitRef="usd">574000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfOS03LTEtMS0w_eb3dc689-8f5d-492c-999b-0fe2869a772f"
      unitRef="usd">542000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:RoyaltyExpense
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTAtMS0xLTEtMA_16fc22b5-1a16-4000-b62f-a936a338a252"
      unitRef="usd">12000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTAtMy0xLTEtMA_cdead5ed-f4de-4341-98a7-65e8c1db01e7"
      unitRef="usd">8000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTAtNS0xLTEtMA_bb997f24-c124-405c-9287-7a41ab83241a"
      unitRef="usd">24000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTAtNy0xLTEtMA_f9c8bb87-176c-44a1-b5d6-c5787ba73b7f"
      unitRef="usd">20000000</us-gaap:RoyaltyExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTEtMS0xLTEtMA_7e58988d-0d79-4379-94d9-419c19b48afa"
      unitRef="usd">180000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTEtMy0xLTEtMA_39d12b1c-42b8-478c-b2be-49382f7458d0"
      unitRef="usd">197000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTEtNS0xLTEtMA_7fef2140-f447-486e-af93-c784d53c4e1f"
      unitRef="usd">365000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTEtNy0xLTEtMA_8bd25344-1e38-4994-a121-c819714acca8"
      unitRef="usd">398000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTMtMS0xLTEtMA_eee19bb6-ab38-43b0-90e0-3f3ca0f8e9ec"
      unitRef="usd">45000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTMtMy0xLTEtMA_8f87e357-772d-4d2a-99ba-fb07867fa167"
      unitRef="usd">34000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTMtNS0xLTEtMA_8fa4f25d-c82c-411c-b1b4-4f2d25e2f5ca"
      unitRef="usd">45000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTMtNy0xLTEtMA_041de048-3fd2-401b-89f7-5a7f7091e1e3"
      unitRef="usd">233000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTQtMS0xLTEtMA_ca484066-31e4-48a6-b647-eaa9610b1ac9"
      unitRef="usd">-85000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTQtMy0xLTEtMA_ad7f5282-dd5f-4ba0-bad6-aed3203b7f2e"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTQtNS0xLTEtMA_f75a4fb6-c3da-44f6-9bc2-7b8880d37178"
      unitRef="usd">-91000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTQtNy0xLTEtMA_8e5e395a-0a13-4ada-a014-0300d44037af"
      unitRef="usd">-108000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:RestructuringCharges
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTUtMS0xLTEtMA_500e7a43-d771-47ff-81c5-8b6840a93ff3"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTUtMy0xLTEtMA_8339a0ce-9ff8-42b0-9cc9-331ceba2bc49"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTUtNS0xLTEtMA_f9c3f3f7-b3a3-45fa-b74a-209a6f63db33"
      unitRef="usd">8000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTUtNy0xLTEtMA_55af64b4-338f-404e-9b15-bbb1163ad48e"
      unitRef="usd">13000000</us-gaap:RestructuringCharges>
    <us-gaap:LitigationSettlementExpense
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTYtMS0xLTEtMA_33ff8825-b310-4684-9509-902db3460373"
      unitRef="usd">298000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTYtMy0xLTEtMA_1a9564d9-c1eb-4e6d-a621-565c42da63d9"
      unitRef="usd">0</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTYtNS0xLTEtMA_4a213716-384d-4a6d-a198-bb04b3708cf1"
      unitRef="usd">302000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTYtNy0xLTEtMA_234334fb-8e67-40b4-b6e1-7312bbf24b3c"
      unitRef="usd">0</us-gaap:LitigationSettlementExpense>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTctMS0xLTEtMA_d5c150ea-5f86-4ca8-aed5-b8e2c3292ee1"
      unitRef="usd">2000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTctMy0xLTEtMA_3afb5ed9-6ff5-4f87-a76e-fb216e113d49"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTctNS0xLTEtMTk2MA_339c65d7-e2d6-4554-b80a-cfd7f559ef5f"
      unitRef="usd">9000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTctNy0xLTEtMTk2NQ_5d44ba97-de10-4b2a-bdd2-81d7c37197c2"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OperatingExpenses
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTgtMS0xLTEtMA_b2e94949-ba04-4986-beb2-9443db293d34"
      unitRef="usd">1870000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTgtMy0xLTEtMA_7853cd6a-9e79-4703-8448-bdd0f0f50f01"
      unitRef="usd">1283000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTgtNS0xLTEtMA_8f89e667-2841-4ff5-b825-b5c526281f7b"
      unitRef="usd">3358000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTgtNy0xLTEtMA_5ea2e7ae-8fc7-4376-ab1e-e4156bdace85"
      unitRef="usd">2875000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTktMS0xLTEtMA_5dc62f09-9fdb-465f-ae20-943c1e4dd053"
      unitRef="usd">262000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTktMy0xLTEtMA_1dd71e87-6580-4d92-87aa-b90dcefbcf53"
      unitRef="usd">-71000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTktNS0xLTEtMA_21018b20-c707-4303-abd3-60969d195416"
      unitRef="usd">632000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMTktNy0xLTEtMA_108c0ca2-4179-438a-920a-dfe6c075afdc"
      unitRef="usd">75000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjItMS0xLTEtMA_8be447ec-390e-49e5-b928-e51d0d6afc27"
      unitRef="usd">86000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjItMy0xLTEtMA_3c3b52a4-8b1b-482f-b607-6237d614be50"
      unitRef="usd">91000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjItNS0xLTEtMA_ac3793a8-9d24-4108-87b7-cc5065c18b06"
      unitRef="usd">168000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjItNy0xLTEtMA_8ae08704-0dbb-4e69-b28b-34467bbbc25a"
      unitRef="usd">179000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjMtMS0xLTEtMA_939dfa79-3901-4e02-b9e2-d48b64e3f8e5"
      unitRef="usd">-26000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjMtMy0xLTEtMA_13165bc7-27b8-405c-b400-ccc85c6f8f90"
      unitRef="usd">-18000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjMtNS0xLTEtMA_48e84303-2b2e-4003-80ad-42ecc7b22319"
      unitRef="usd">11000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjMtNy0xLTEtMA_f6efdd10-3385-4e94-8b4b-7ccc87b83aaa"
      unitRef="usd">-54000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjQtMS0xLTEtMA_53a092d6-edad-40ff-8b6c-879dd674861c"
      unitRef="usd">149000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjQtMy0xLTEtMA_d3203251-11be-4d90-8c48-71e1cb380a2a"
      unitRef="usd">-181000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjQtNS0xLTEtMA_3a062616-ec04-41c3-946a-89cb52dd3bf7"
      unitRef="usd">474000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjQtNy0xLTEtMA_a4b2da91-c54b-4422-9b5a-ede7911a5270"
      unitRef="usd">-159000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjUtMS0xLTEtMA_22602ada-91be-4e20-8a6a-51450829a176"
      unitRef="usd">-37000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjUtMy0xLTEtMA_2b66b067-428f-42e0-8ccd-6c5e1a0ae9f3"
      unitRef="usd">-33000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjUtNS0xLTEtMA_f4550b1b-385d-4686-9705-575c68deb84e"
      unitRef="usd">-53000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjUtNy0xLTEtMA_4d02d6f3-10e7-4450-94a0-14d321f2fabd"
      unitRef="usd">-22000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjYtMS0xLTEtMA_e207738f-9d46-427a-bc4e-087f5a985587"
      unitRef="usd">186000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjYtMy0xLTEtMA_dfcbf6cc-3621-4d5b-8d5f-a1dcadc53fd0"
      unitRef="usd">-147000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjYtNS0xLTEtMA_40791fd7-1529-4ddb-962d-19e9ec228ed5"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjYtNy0xLTEtMA_d5bf38ee-5096-4e2e-8ed5-ca964bcc430d"
      unitRef="usd">-137000000</us-gaap:ProfitLoss>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjctMS0xLTEtMA_0b62154b-e1b9-4208-82eb-db7ccf1f78f4"
      unitRef="usd">14000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjctMy0xLTEtMA_61986470-f8fc-4ed7-b0ff-bbd8b02040f1"
      unitRef="usd">5000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjctNS0xLTEtMA_3eaa83a5-c56b-4ee6-ae2e-f965913c7cce"
      unitRef="usd">28000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjctNy0xLTEtMA_5ca417ca-dac8-4354-96bb-7909d477d7eb"
      unitRef="usd">5000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjgtMS0xLTEtMA_5b6fc423-3c25-4520-88b9-d0ef94d3fb30"
      unitRef="usd">172000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjgtMy0xLTEtMA_a0c426b5-6072-4943-8e53-d08b9dff21b0"
      unitRef="usd">-153000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjgtNS0xLTEtMA_67f87e06-249e-455e-b12a-55df94f00a59"
      unitRef="usd">500000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMjgtNy0xLTEtMA_4959ced4-07d4-454d-ad8a-2941c6b16a3e"
      unitRef="usd">-142000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzAtMS0xLTEtMA_53396166-cd64-409c-9001-c1596e749ed4"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzAtMy0xLTEtMA_833702b7-3c04-49a0-b3cb-875406633ce4"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzAtNS0xLTEtMA_265ccb45-540d-420f-b2e9-25b36640d216"
      unitRef="usdPerShare">0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzAtNy0xLTEtMA_988c45c1-866c-40a9-9c22-9b22e4932fe4"
      unitRef="usdPerShare">-0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzEtMS0xLTEtMA_454f8996-bc20-4822-b3c2-932f23ec4386"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzEtMy0xLTEtMA_2637cbee-9e98-4153-8b83-01ce233bfffc"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzEtNS0xLTEtMA_b154a4a6-5fa5-4395-9f13-c8f401bf6062"
      unitRef="usdPerShare">0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzEtNy0xLTEtMA_588607b9-49be-4b7b-9bf7-65d95ffc3fe8"
      unitRef="usdPerShare">-0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzQtMS0xLTEtMA_2320625a-ceee-40b8-b7f1-639550ffdf18"
      unitRef="shares">1421300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzQtMy0xLTEtMA_0f4945ee-2336-4526-9c33-d0f547de6bf1"
      unitRef="shares">1410900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzQtNS0xLTEtMA_ad6c607c-fc1d-414e-a6aa-77c62744a8ac"
      unitRef="shares">1420000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzQtNy0xLTEtMA_a8a01bc3-23a7-4970-a416-f6ed1f21f3b0"
      unitRef="shares">1404100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzUtMS0xLTEtMA_0bef0c6d-f98e-425d-91ab-7524842a6715"
      unitRef="shares">1432500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzUtMy0xLTEtMA_9575ce05-413c-4aa6-adc6-a30ed1c7dee7"
      unitRef="shares">1410900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzUtNS0xLTEtMA_49cc078d-dc5a-4e85-a4a9-a645b02bd5e0"
      unitRef="shares">1431700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xOS9mcmFnOjMxMjE1ODg4ZTUyNjRhZjY4YWZlMGQzMmNjYTEyYzFiL3RhYmxlOjZiNDVmMjBiNDVmNDQxMDdhM2ZkMzJlOTM5NWJhYjU1L3RhYmxlcmFuZ2U6NmI0NWYyMGI0NWY0NDEwN2EzZmQzMmU5Mzk1YmFiNTVfMzUtNy0xLTEtMA_cfc93df8-2f07-4778-baae-819c9ef6eaf9"
      unitRef="shares">1404100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfMi0xLTEtMS0w_e207738f-9d46-427a-bc4e-087f5a985587"
      unitRef="usd">186000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfMi0zLTEtMS0w_dfcbf6cc-3621-4d5b-8d5f-a1dcadc53fd0"
      unitRef="usd">-147000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfMi01LTEtMS0w_40791fd7-1529-4ddb-962d-19e9ec228ed5"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfMi03LTEtMS0w_d5bf38ee-5096-4e2e-8ed5-ca964bcc430d"
      unitRef="usd">-137000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNC0xLTEtMS0w_90ecdca3-8ff0-4b10-8640-69b187ec11d5"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNC0zLTEtMS0w_df937b36-a9b6-4dc3-9c37-f9fd6762eba7"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNC01LTEtMS0w_9a9db524-7a4a-41b6-be3b-4f09b6516a0c"
      unitRef="usd">-81000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNC03LTEtMS0w_5c59a486-1607-4944-b9c0-194a15003679"
      unitRef="usd">-187000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNS0xLTEtMS0w_0c2b8e2b-d0a0-4e92-b042-71a4f326b2d6"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNS0zLTEtMS0w_2385ae75-c7eb-406e-adf3-6964dce36956"
      unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNS01LTEtMS0w_1766d2b4-3a5a-4462-9fef-1947ffe5a1bc"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNS03LTEtMS0w_85e40179-717e-44d1-96d1-6e267b22b2ed"
      unitRef="usd">48000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNy0xLTEtMS0w_cbaf9083-f7a7-40d3-9c28-e5198063a824"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNy0zLTEtMS0w_0778db11-d2bd-4282-9ad9-48bdddfb26e0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNy01LTEtMS0w_b94e4afb-ebb1-4e73-a2d2-22e4f9e3c984"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfNy03LTEtMS0w_2d8120f0-2f0b-4d00-9438-30e66c2eccf2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOC0xLTEtMS0w_19666b0c-5678-4acc-a6d6-913acbc2d327"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOC0zLTEtMS0w_a1b029c0-140e-40ab-8262-653a5fed7acd"
      unitRef="usd">-37000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOC01LTEtMS0w_d468ef56-89dc-4ec3-b3f9-4df6a40a5578"
      unitRef="usd">30000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOC03LTEtMS0w_f6a961c0-9f78-46de-93b7-765bceb60815"
      unitRef="usd">-139000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOS0xLTEtMS0w_cb94463f-ad18-41d2-8f29-f522c561d678"
      unitRef="usd">170000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOS0zLTEtMS0w_3ad00d43-f3b9-4278-9857-de79b74953ee"
      unitRef="usd">-185000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOS01LTEtMS0w_4e846a87-a56c-477b-823e-b7946572f2e8"
      unitRef="usd">558000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yMi9mcmFnOmU4OTMwZDM3OTJhNTQ2OTdiMjEwZmU3OTBkN2M4Y2EzL3RhYmxlOjA3MWZmM2E1N2YwYjQzZDZiZWM5MTA3MWI3OGFjMGNjL3RhYmxlcmFuZ2U6MDcxZmYzYTU3ZjBiNDNkNmJlYzkxMDcxYjc4YWMwY2NfOS03LTEtMS0w_4f2db1a8-164b-4e9e-b69f-cf98dbc7523f"
      unitRef="usd">-276000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNS0xLTEtMS0w_261bbf57-4cf1-4240-8ae8-13c123625cb6"
      unitRef="usd">2675000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNS0zLTEtMS0w_023e0fb9-637c-43bb-bf60-3273bf73014a"
      unitRef="usd">1734000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNi0xLTEtMS0w_24b3b3fc-9c0b-4416-93bc-e5bb7b3eb6f9"
      unitRef="usd">1675000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNi0zLTEtMS0w_a6ed1055-71d9-49c2-be9a-e9d7ab110d7b"
      unitRef="usd">1531000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNy0xLTEtMS0w_b0ddb6d5-4401-4669-93cb-ff42ebeb9efb"
      unitRef="usd">1430000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNy0zLTEtMS0w_c83c7adf-1475-4dcf-9edb-51a2c7072ae9"
      unitRef="usd">1351000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfOC0xLTEtMS0w_65d136db-6caa-435a-b150-e150b6422d50"
      unitRef="usd">202000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfOC0zLTEtMS0w_223e4bbf-6cba-43d6-9236-bf31312449ad"
      unitRef="usd">194000000</us-gaap:PrepaidTaxes>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfOS0xLTEtMS0w_5542959c-5e1a-40c2-89e7-969aab9d9a0d"
      unitRef="usd">0</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfOS0zLTEtMS0w_7f2ea96e-4918-4220-be7f-bd01a3546201"
      unitRef="usd">1133000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTAtMS0xLTEtMA_7fc16b79-6213-4b27-a294-b10bd89299d8"
      unitRef="usd">777000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTAtMy0xLTEtMA_a0fa1cc8-3a69-40c6-9c5e-67588247e0d8"
      unitRef="usd">751000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTEtMS0xLTEtMA_3ae336db-943d-45b5-a4e6-15ed13a8054a"
      unitRef="usd">6758000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTEtMy0xLTEtMA_05dc11f6-ee64-4e1b-a692-77aa157a1105"
      unitRef="usd">6694000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTItMS0xLTEtMA_7fca81e1-a627-4c11-b075-f90d2c530cda"
      unitRef="usd">2082000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTItMy0xLTEtMA_d156e724-b7b9-41ca-a4a1-5bfbdebf5f91"
      unitRef="usd">2084000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTMtMS0xLTEtMA_43b70f5c-15e3-44ce-88e6-2a758531c7b1"
      unitRef="usd">10874000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTMtMy0xLTEtMA_2c0bf3a3-ac1f-44eb-9a87-14a1f795c704"
      unitRef="usd">9951000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTQtMS0xLTEtMA_deedb56b-b3c8-4a78-9f39-d44d17917e45"
      unitRef="usd">5788000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTQtMy0xLTEtMA_91c02709-6159-42a4-b2f0-cab5c3a0492c"
      unitRef="usd">5917000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTUtMS0xLTEtMA_47934a8e-7576-4c7f-9bdd-2b440af0fe2c"
      unitRef="usd">4036000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTUtMy0xLTEtMA_8edcbaab-9e86-44ad-b738-1586912746de"
      unitRef="usd">4210000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTYtMS0xLTEtMA_2cda3337-efda-4fc0-9bdf-de5e49b22bd4"
      unitRef="usd">1629000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTYtMy0xLTEtMA_1587f87f-86e4-4b07-aac2-f4f1081ae541"
      unitRef="usd">1921000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTctMS0xLTEtMA_597d2ff9-9cd0-4ba5-a17b-5f66ae2ab482"
      unitRef="usd">31168000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMTctMy0xLTEtMA_c86a6009-b425-48f7-8c02-3ce262c7cb4e"
      unitRef="usd">30777000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjEtMS0xLTEtMA_6c4dfbca-ba43-4a5d-a8f6-692b68b38daf"
      unitRef="usd">262000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjEtMy0xLTEtMA_9ed2ccf0-b2e8-4c24-b6e0-19341f8a33d6"
      unitRef="usd">13000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjItMS0xLTEtMA_e0749006-4b92-41f0-9207-da9e35ea42f7"
      unitRef="usd">689000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjItMy0xLTEtMA_83993019-c376-447f-92a0-d3032ceee169"
      unitRef="usd">513000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjMtMS0xLTEtMA_c0068945-5a05-4e0d-936f-c9531f0227b6"
      unitRef="usd">2442000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjMtMy0xLTEtMA_7b08c458-015f-4521-9588-77aa6122790b"
      unitRef="usd">2197000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjQtMS0xLTEtMA_3314ff25-c336-4472-bb15-567724de5d8e"
      unitRef="usd">680000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjQtMy0xLTEtMA_6d1468e0-1a13-4270-b67f-b4642645af8f"
      unitRef="usd">958000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjUtMS0xLTEtMA_e7729bcb-f005-402d-863b-a64cffca7a97"
      unitRef="usd">4073000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjUtMy0xLTEtMA_e0f0cf14-9046-452c-9595-27671fb201d0"
      unitRef="usd">3681000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjYtMS0xLTEtMA_9f630e87-48ef-4576-86d2-dc80c0f783a5"
      unitRef="usd">8847000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjYtMy0xLTEtMA_47f06938-1163-4987-9fb8-66c424dcaad3"
      unitRef="usd">9130000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjctMS0xLTEtMA_0ea38e4d-d09a-4ca9-9aa3-8aad079f2c85"
      unitRef="usd">115000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjctMy0xLTEtMA_e622af29-c1d9-4855-8645-76950afff139"
      unitRef="usd">330000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjgtMS0xLTEtMA_e7a8a2d1-1409-4d37-b805-a600b0944b37"
      unitRef="usd">2190000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMjgtMy0xLTEtMA_08e27f17-94f8-446c-babe-065624d7d2c9"
      unitRef="usd">2309000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzAtMS0xLTEtMA_ee8b8915-0477-4b9f-a96a-753ce42798fa"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzAtMy0xLTEtMA_301200b2-3f0b-4679-93fe-64c6d690227b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzIx_638c9e21-f9f2-4ca5-a4da-8008610b9bea"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzIx_e6411676-0d5b-4fde-958d-c2b196e67567"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzQ3_86321d61-8218-49fc-bacc-ab08546f2391"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzQ3_f851dc18-a4ec-47dc-8cc2-e448b8c67707"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzY2_073c99aa-93f8-4ebe-b981-014969309452"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjJhYWJlMTY5YWFkMzQ0YWZiYzU1NWE1NTcxNzcxZDA5XzY2_453169d3-7d53-4c99-90eb-2be7e1f590a6"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMS0xLTEtMA_380cf9d6-87a5-49c9-9c33-48ac34e5e9ba"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzMtMy0xLTEtMA_7c204165-360a-43a0-8c7b-0afdf6e025fd"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzE4_12c06763-db96-42dc-9a4a-aecb74fb81e3"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzE4_80616609-2877-4aba-8de4-a30291a0440a"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzQ0_3a8aa065-1beb-4490-adac-beb56e96b6a7"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzQ0_f5c31350-af91-4d65-a040-08de3e656fc7"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzYz_e134bdbe-efd1-43fd-8856-4aea69dd9fa8"
      unitRef="shares">1685006608</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmMzZThkNjdiYzc2MzQ4NjM5ZTkzYjBkN2VhM2NkMDMyXzk4_b9dab216-9f58-43aa-96c8-2f1bad1ac424"
      unitRef="shares">1679911918</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMS0xLTEtMA_56e768bf-aafe-4817-afbe-ea69be4ddb4f"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzQtMy0xLTEtMA_3e0c78f6-a8f9-4531-a372-bbee373e3baa"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockShares
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjg3YjQ1MjU0Zjc5MTQzNDk5YTM4NDVlZWMxYWI5MDVjXzMw_4505e2d9-07fa-427a-872d-b35483d0dd52"
      unitRef="shares">263289848</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjg3YjQ1MjU0Zjc5MTQzNDk5YTM4NDVlZWMxYWI5MDVjXzMw_fd4e366f-7b1e-4d71-87f5-a244bb428aa4"
      unitRef="shares">263289848</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzUtMS0xLTEtMA_82b46ad0-6a78-4cf0-8290-831dfa4bcb9b"
      unitRef="usd">2251000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzUtMy0xLTEtMA_35f4f6a9-94ab-46e8-b89d-b907d02568ff"
      unitRef="usd">2251000000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzYtMS0xLTEtMA_c2c9bc3a-2be2-45d4-8350-29bfbe84e853"
      unitRef="usd">19817000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzYtMy0xLTEtMA_03524d78-c2db-4491-bdb1-13bedd310819"
      unitRef="usd">19732000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzctMS0xLTEtMA_3ada8418-05d6-4be2-b7b3-0af6bb939253"
      unitRef="usd">-1878000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzctMy0xLTEtMA_b27fdb05-faf2-465e-b27c-7c83b2685951"
      unitRef="usd">-2378000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzgtMS0xLTEtMA_dff9b5fb-c2a5-425c-9dcd-064c7a0afbc5"
      unitRef="usd">237000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzgtMy0xLTEtMA_be6b8fed-c3ef-4986-b6ad-5f5702adc2f6"
      unitRef="usd">207000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzktMS0xLTEtMA_6bb30b3c-aefa-4a42-a145-12e625987f97"
      unitRef="usd">15942000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfMzktMy0xLTEtMA_c42d0775-12a9-4d2d-963b-7e6def1ec6bc"
      unitRef="usd">15326000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNDAtMS0xLTEtMA_92feb875-9c68-405e-be36-06ad55d72983"
      unitRef="usd">31168000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yNS9mcmFnOjc4ZjUyYTY0MzIwODQzOGI4ZTc3MDhjM2UxNWZlY2RkL3RhYmxlOjQ3ZDc3NzExMjk3YzRhYmM4NzRmNzRmZjIwYzk3ZTAyL3RhYmxlcmFuZ2U6NDdkNzc3MTEyOTdjNGFiYzg3NGY3NGZmMjBjOTdlMDJfNDAtMy0xLTEtMA_d6a195bf-35d0-4716-9d1c-2f7742e59360"
      unitRef="usd">30777000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i79e7f5e22b45494cb5031e20d21c5988_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtMS0xLTEtMA_899a5209-2bea-4eeb-8b12-e084d06f469f"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79e7f5e22b45494cb5031e20d21c5988_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtMy0xLTEtMA_ce37dfe9-e7b7-4f6c-88be-0d6b7c514623"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i6ab5a160fd2842d19f763f45b6d09e89_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtNS0xLTEtMA_0b4c5041-9f3d-4a22-9388-1a9b6c1ebd46"
      unitRef="shares">1642488911</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ab5a160fd2842d19f763f45b6d09e89_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtNy0xLTEtMA_3d623e06-0574-491d-b1b4-bbf2207ec041"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e6d8515e25d47aba9ea9c0df13760db_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtOS0xLTEtMA_b5c02d8b-0d47-442b-a661-d9e4a86cf784"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff4ae26c4d5d46608d3add43ad05bbb7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtMTEtMS0xLTA_33605216-34e9-4480-8239-595d19f73c20"
      unitRef="usd">17561000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iacf6fa5b9d2e4cb38a2b47625e11f694_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtMTMtMS0xLTA_8ff80fbe-37e1-4ddf-a723-57f6192cce60"
      unitRef="usd">-2253000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i407e005872e847169249dc236fd723a1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzYtMTUtMS0xLTA_5ed0b45e-368a-439e-aabb-5efb5aff9563"
      unitRef="usd">270000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ibee203a2a57249aaa21381f631fdf46e_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzctMTMtMS0xLTA_163f2c08-ec38-434f-b638-d25ce4d2d720"
      unitRef="usd">11000000</us-gaap:ProfitLoss>
    <us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal
      contextRef="ibee203a2a57249aaa21381f631fdf46e_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzgtMTMtMS0xLTA_718492d0-f09f-4387-bb64-5bec0d286f05"
      unitRef="usd">-10000000</us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0da7317746ad4fd683a1ce1bc96f8f22_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfMzktMTUtMS0xLTA_3de45282-458f-4d08-9877-f33892443c30"
      unitRef="usd">-101000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i07039c3201414d96884a16b718546a13_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDAtNS0xLTEtMA_dde4529b-a53e-4890-8201-79a7a5084fea"
      unitRef="shares">4388331</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i17c0a7e09ea4403ba4b016e00d085205_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDAtMTEtMS0xLTA_41470aeb-f377-413f-9343-4cd42fc8974a"
      unitRef="usd">28000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i15d4e3340e604a44a2fcefd0f1a628cd_I20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtMS0xLTEtMA_1ab7aab3-22cc-4ab7-8a5e-51dbdffe49ae"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15d4e3340e604a44a2fcefd0f1a628cd_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtMy0xLTEtMA_dcb53882-bc05-4e80-8a64-32c389e57250"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i7f075e6862bc484dabc2a2c6cd1d7c37_I20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtNS0xLTEtMA_781bb128-881d-4283-a42d-4ba01862729d"
      unitRef="shares">1646877242</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f075e6862bc484dabc2a2c6cd1d7c37_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtNy0xLTEtMA_525b4a75-5c9d-4906-8b27-bd8025449fbd"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic68c9bd1b9604c838f68baa4497ef3dc_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtOS0xLTEtMA_15e533fb-7d29-4009-8758-41e55b68dbf8"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i323d08dbbf434656aa0a30682aefdeab_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtMTEtMS0xLTA_d3ed3d61-9322-4d00-be51-473b247416f6"
      unitRef="usd">17589000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb1e17562676450a8f71a4ef6a375849_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtMTMtMS0xLTA_d78a8fd3-b5e0-4de2-9282-a965b4cdada0"
      unitRef="usd">-2252000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5fdde603126345a9a39d5b631edb96c2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDEtMTUtMS0xLTA_a02ed34b-8a74-458a-be11-86c89e2b2c3f"
      unitRef="usd">168000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i1dc6cd3645f6405b90a96753c13a9cb0_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDItMTMtMS0xLTA_a742211e-94e4-427b-926c-dbd0daf8bc80"
      unitRef="usd">-147000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idbfc05f74eb341e78530b80a19abf65b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDMtMTUtMS0xLTA_e8d78ba0-681a-4a49-8fd8-7a0e5ae8cbc4"
      unitRef="usd">-37000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i7d53662410834885b7dbdc824ed4b103_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDQtMS0xLTEtMA_6236f011-ce6c-4af8-a2a9-137948432b01"
      unitRef="shares">10062500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i7d53662410834885b7dbdc824ed4b103_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDQtMy0xLTEtMA_a7d732b3-a880-42b0-b40c-b018d0b8f382"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock
      contextRef="ibca19cebdd0949a1b26b48f24eb12161_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDQtMTEtMS0xLTA_a49eb18c-71e4-466b-8285-0bdc4f5f36de"
      unitRef="usd">975000000</bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i054fa70f408e4539865aee238d844341_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDUtNS0xLTEtMA_d120e811-1931-4b1e-82cd-958f16632013"
      unitRef="shares">29382500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i054fa70f408e4539865aee238d844341_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDUtNy0xLTEtMA_3416b281-eced-490d-9d13-c619f31707ff"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock
      contextRef="ibca19cebdd0949a1b26b48f24eb12161_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDUtMTEtMS0xLTA_dd08a5f2-caf8-4bf6-a6df-03a12db79abf"
      unitRef="usd">975000000</bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock>
    <us-gaap:DividendsPreferredStockCash
      contextRef="i1dc6cd3645f6405b90a96753c13a9cb0_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDYtMTMtMS0xLTA_de49d7b8-d6b5-4eea-a5cd-e6e1aaa1c208"
      unitRef="usd">-5000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i054fa70f408e4539865aee238d844341_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDctNS0xLTEtMA_8c3b78c7-3f82-4b7a-ad33-506a65ed9b9d"
      unitRef="shares">493824</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ibca19cebdd0949a1b26b48f24eb12161_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDctMTEtMS0xLTA_31c781f3-996e-4874-97c8-7a3bf156c15f"
      unitRef="usd">50000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="if51fbced07284741ad5b6ad72598bac1_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtMS0xLTEtMA_32150295-f995-49aa-99bb-3692a4a677a4"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if51fbced07284741ad5b6ad72598bac1_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtMy0xLTEtMA_7f85f45e-e6b2-4994-b834-abe34a85cf5d"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i75faaf5aef3241e1bbf28cbd0d043d16_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtNS0xLTEtMA_affae8b9-8752-4d32-b10d-6bfc9c438aa5"
      unitRef="shares">1676753566</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i75faaf5aef3241e1bbf28cbd0d043d16_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtNy0xLTEtMA_89228f96-e6ce-41d9-9e26-bad7ce699654"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28e7fd546b52414bb22a99df2fb6e6d1_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtOS0xLTEtMA_5d1de9c3-cbe4-4f5a-94f6-700c2f2cfe6a"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ba117f5e9a14bee84ef83a283e82114_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtMTEtMS0xLTA_d0ad8dcd-d991-4495-b5cf-de37f06720ac"
      unitRef="usd">19590000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81e27f9feb6741bfbc6aa8b9c2b21974_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtMTMtMS0xLTA_6a0be187-e23d-4e96-87c1-bc24cb63e353"
      unitRef="usd">-2405000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8023920188754b2a995080b31ccd868e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDgtMTUtMS0xLTA_9912b5f5-38b6-4be3-a91b-4b7d945bdf30"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i03dcdfcf4e244a95a8ab8e736a188d92_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNDktMTMtMS0xLTA_897e53f5-f726-49c1-9593-61e49f62cd25"
      unitRef="usd">-155000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8652d5fb943a4587a8793dc14afb84c3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTAtMTUtMS0xLTA_1eec3698-cb48-4248-a220-44335e99ffbf"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsPreferredStockCash
      contextRef="i03dcdfcf4e244a95a8ab8e736a188d92_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTEtMTMtMS0xLTA_0d64cbe3-eb02-4b43-9a4f-fa1f7930777c"
      unitRef="usd">-14000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="ia213a6ff66974627946e8fd3a7382872_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTItNS0xLTEtMA_71a05827-17a8-4363-b6d8-b5e333e5e36e"
      unitRef="shares">2674643</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i64d424319a394d27ad50e628661c82fd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTItMTEtMS0xLTA_4d482594-7ae6-473c-92bf-aea63e127762"
      unitRef="usd">97000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="ifaf7b07ebc9642edb11f1367901401c2_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtMS0xLTEtMA_5cb9454b-7414-482e-9a4d-9db687e47734"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifaf7b07ebc9642edb11f1367901401c2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtMy0xLTEtMA_1dd43ddd-efc4-4005-8b0f-b7aba20f47b1"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i0b6c5fe863db4dacb550eba84fd8836e_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtNS0xLTEtMA_45fb72cf-4294-4fbd-b029-1bdb0e8fe150"
      unitRef="shares">1679428209</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b6c5fe863db4dacb550eba84fd8836e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtNy0xLTEtMA_a8b61108-ca0f-47db-abd0-833b2926d863"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i850cc4a1d1c24cad88a0c8605cc8c364_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtOS0xLTEtMA_38dca218-65c3-4f96-b3ca-fdc87e28ebf2"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64fe29b381c14063af8331516c517635_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtMTEtMS0xLTA_589a003d-7ee2-453f-9e70-ae7639fb53d9"
      unitRef="usd">19687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b3a8264bc9d4884896faec1361a29f2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtMTMtMS0xLTA_2cfc0f01-80ea-4be7-969d-68b75a46ddc5"
      unitRef="usd">-2574000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27c4310b23f24941bfe4832943becdd5_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTMtMTUtMS0xLTA_5312d00b-2dc1-4efb-bca2-552d97d4c6c8"
      unitRef="usd">151000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="if3e5d0796dba4b21a297db8829d0bba0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTQtMTMtMS0xLTA_97e8df83-91ac-4af8-8c7d-23062edc9417"
      unitRef="usd">210000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5adcdaba03f8425280b41743c1b6a4a8_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTUtMTUtMS0xLTA_100998bb-a119-450d-988a-a1ce759e809f"
      unitRef="usd">56000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsPreferredStockCash
      contextRef="if3e5d0796dba4b21a297db8829d0bba0_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTYtMTMtMS0xLTA_7b836c2b-b8a9-4c7e-a3e8-da1fc859921d"
      unitRef="usd">-14000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic49b06d7552349519467e47ae89ecc2e_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTctOS0xLTEtMA_ff61d9e4-4d50-4f80-903f-3e213c84fdd9"
      unitRef="usd">-535000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i30e29fec4ee74bcfb877317c0b851a69_D20201001-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTgtNS0xLTEtMA_939c17af-f301-4d1d-b5c2-6100ea588124"
      unitRef="shares">483709</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i40dc3c728f4f4406ad21325f8c547a8f_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTgtMTEtMS0xLTA_e0bc8ba3-b869-4639-87f9-d1c9804953f5"
      unitRef="usd">45000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i15add9d704da4ad1a802469251779a75_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktMS0xLTEtMA_7a8438de-8d7f-4d0f-81b8-7556744ff7df"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15add9d704da4ad1a802469251779a75_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktMy0xLTEtMA_99657c2f-007a-4eb7-8924-150af02fd58c"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i8aa153463d4e4b10bdd112f21b499711_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktNS0xLTEtMA_38e3b56c-8a72-43de-9e06-f99c3a033921"
      unitRef="shares">1679911918</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8aa153463d4e4b10bdd112f21b499711_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktNy0xLTEtMA_01fc3423-d929-4781-987c-3d36b4d669a0"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib439965aa50741ed94d896621a53d24f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktOS0xLTEtMA_16ea6642-d0e0-47aa-878f-f87c8f97130e"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7422e8c7c9ac4cbfaffd4115d01b32f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktMTEtMS0xLTA_f8e6410d-307e-42bf-8cdc-418ca0571578"
      unitRef="usd">19732000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8b8093806ec94f8a82c561e795c452a6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktMTMtMS0xLTA_73377add-955e-4d2b-8d2f-55d4ea5228bf"
      unitRef="usd">-2378000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic09defab5a6b4fcea525bbc5a70b2eff_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNTktMTUtMS0xLTA_6c7cb85a-bce8-47e1-9b43-78710b32ef42"
      unitRef="usd">207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="idb59d96b0c5240b880d48b08300df3ba_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjAtMTMtMS0xLTA_19f0adec-fbc6-49bb-aaa0-224b20b1e6f6"
      unitRef="usd">341000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i568faa2df0b7487aac4477602e023e13_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjEtMTUtMS0xLTA_d07bab5b-20ba-4b44-b6ed-b830b58aaa57"
      unitRef="usd">47000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsPreferredStockCash
      contextRef="idb59d96b0c5240b880d48b08300df3ba_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjItMTMtMS0xLTA_18f6902b-3062-41e7-9149-d07517190f83"
      unitRef="usd">-14000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="id4fb7a73d720449eb35e51e5c42bde88_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjMtNS0xLTEtMA_634e54c4-5bf2-4326-93a6-ff9cd5b16a9d"
      unitRef="shares">3949308</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ifffbb07e504b44f39e055b5bbe1c5ea4_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjMtMTEtMS0xLTA_ad773637-913a-40fa-9177-f0e5a4c480ca"
      unitRef="usd">19000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i5712d73ab4594b168ee2ebdc3c0b169d_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtMS0xLTEtMA_bbf669b5-3728-4af0-8392-3864aa514afc"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5712d73ab4594b168ee2ebdc3c0b169d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtMy0xLTEtMA_252d6258-3b3b-46ca-ac6e-26ea543a9799"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="ic0db57ccee8d4694893d34eeb2fdfe2b_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtNS0xLTEtMA_46fc6605-848d-4e11-b8da-12f0d5d91bde"
      unitRef="shares">1683861226</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0db57ccee8d4694893d34eeb2fdfe2b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtNy0xLTEtMA_0d47ddd2-150b-4618-9413-fed9aa86fb27"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide71e62aef2140e081c5bf792558264a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtOS0xLTEtMA_8bae3fcc-b1ea-48f3-842c-0b3833e2c7c5"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2716ea4458a542bc9c88d29a297073ed_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtMTEtMS0xLTA_537fb14a-b4e3-4cb0-b1b7-8c67204f2608"
      unitRef="usd">19750000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if96fc34936b14bdba670cff9c58d6e24_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtMTMtMS0xLTA_54d41308-c92a-403e-98d1-350e9de4b92c"
      unitRef="usd">-2050000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90fb13e8b59f4a29a69d162134fcbb7a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjQtMTUtMS0xLTA_d56df7e1-b63e-43db-94cd-1551c7599ac9"
      unitRef="usd">254000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="icc8a50967227451ab60dd06313b66069_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjUtMTMtMS0xLTE0ODU_24c342bf-4225-4a16-a0ab-86bed5b8596f"
      unitRef="usd">186000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id5ff7d6319ec43c7a77cc183eb669155_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjYtMTUtMS0xLTE0OTU_37109f87-21eb-4b1c-8a96-5da2f5422026"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsPreferredStockCash
      contextRef="icc8a50967227451ab60dd06313b66069_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjctMTMtMS0xLTE0OTA_b5967895-45de-463f-82d7-49df41153e26"
      unitRef="usd">-14000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="ic42f5761199a4db4bfe046448896c355_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjgtNS0xLTEtMTQ3Ng_986b026a-7ab0-43c1-a0cb-2bf44864b5fd"
      unitRef="shares">1145382</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i23f5234796e94be18871e317e297f8f1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjgtMTEtMS0xLTE0ODA_d90414ad-cd01-48d0-960b-ca65c2bdc8a8"
      unitRef="usd">66000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i103db90a98ed4fadae2e32d5e1d5d63d_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktMS0xLTEtNDM_4af4242c-fb2d-4f30-b666-c6adccf4f1d4"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i103db90a98ed4fadae2e32d5e1d5d63d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktMy0xLTEtNTE_2ff35398-73a6-4654-8394-ffbfcfb0c9b1"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i4ee81bbde07a44368fcb9d1addd7d122_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktNS0xLTEtNTU_4b903d24-b44e-426e-99b7-709deaf9bae3"
      unitRef="shares">1685006608</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4ee81bbde07a44368fcb9d1addd7d122_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktNy0xLTEtNjE_4687bd53-1bb4-4cad-adf7-32bb4a2302f8"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia18bf18de3e5421ba842d5317c3f8f9f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktOS0xLTEtNzA_e72d85ca-aa16-46e6-8bab-6ae3290969cf"
      unitRef="usd">-2251000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id8bb9328c6444517b9390466b44fc5a6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktMTEtMS0xLTc0_134f94d8-7850-4e85-bfa5-1fc2ecee1b16"
      unitRef="usd">19817000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8bbd48792b2442d936ce7b773a35f08_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktMTMtMS0xLTg2_f6a697dc-6ab5-42c5-866d-6fb167d31cf0"
      unitRef="usd">-1878000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib432c787f0c944d2a88f98e14ab15f00_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8yOC9mcmFnOjE3Zjk2ODNiNzE3NzQ5OTFiMzc4MWJlYjEwOTBjNjU0L3RhYmxlOmE2ZjBlYTBmMmNiYzQ3NDdhNTg1ZWEwMjQyZDVlN2FmL3RhYmxlcmFuZ2U6YTZmMGVhMGYyY2JjNDc0N2E1ODVlYTAyNDJkNWU3YWZfNjktMTUtMS0xLTkw_a6d7c66b-93b9-42b2-a1ab-d770cada44ad"
      unitRef="usd">237000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMi0xLTEtMS0w_4dfd7f6f-87a7-4c74-b29e-03d856a58f2a"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMi0zLTEtMS0w_c6b531a4-09ef-414c-8131-7d1661c3eedd"
      unitRef="usd">-137000000</us-gaap:ProfitLoss>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNC0xLTEtMS0w_e47c00a4-f95b-4d00-b1b6-425f793622d5"
      unitRef="usd">8000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNC0zLTEtMS0w_78d3b88c-90ef-4e19-a56d-b5be01e59834"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNS0xLTEtMS0w_a146df38-c11c-473a-b501-1158252ddde2"
      unitRef="usd">531000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNS0zLTEtMS0w_2b4f6a94-8816-4145-a432-64567567265f"
      unitRef="usd">552000000</us-gaap:DepreciationDepletionAndAmortization>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNi0xLTEtMS0w_edaf1eb6-dc72-45d3-b81e-b36f995ecd72"
      unitRef="usd">-88000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNi0zLTEtMS0w_9b995892-0fa8-4ad9-8455-62536c08c327"
      unitRef="usd">15000000</bsx:CashFlowImpactOfDeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNy0xLTEtMS0w_cd0dea13-2144-4e5a-995e-ea4251f13465"
      unitRef="usd">94000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNy0zLTEtMS0w_91075e81-7eec-48a9-a7a5-8d9259ac0025"
      unitRef="usd">88000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfOC0xLTEtMS0w_52106e57-cafe-4558-bd6f-1a99b2816ef4"
      unitRef="usd">45000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfOC0zLTEtMS0w_b3862fd7-a54e-4f4e-86e4-9808d9df2f19"
      unitRef="usd">233000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:GainLossOnInvestments
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfOS0xLTEtMS0w_d8b26daf-9293-42ad-b7b5-ee8808be93d6"
      unitRef="usd">22000000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfOS0zLTEtMS0w_20c273ce-642b-4c77-bf4a-492caadb11d3"
      unitRef="usd">-34000000</us-gaap:GainLossOnInvestments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTAtMS0xLTEtMA_2cd55d29-6582-4202-bb33-1f4c2b3a0e0c"
      unitRef="usd">-91000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTAtMy0xLTEtMA_fdf295e2-b7bd-40fe-8879-610bebda80b5"
      unitRef="usd">-108000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:InventoryStepUpAmortization
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTEtMS0xLTEtMA_66676466-ba50-4a1f-8b19-fbc3f14aeabf"
      unitRef="usd">8000000</bsx:InventoryStepUpAmortization>
    <bsx:InventoryStepUpAmortization
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTEtMy0xLTEtMA_c36dfb83-db11-41a3-9f5e-56cc11276917"
      unitRef="usd">30000000</bsx:InventoryStepUpAmortization>
    <bsx:Netcurrencyexchangegainloss
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTItMS0xLTEtMA_8667c007-afcb-4473-97a9-9e031adff8f8"
      unitRef="usd">-9000000</bsx:Netcurrencyexchangegainloss>
    <bsx:Netcurrencyexchangegainloss
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTItMy0xLTEtMA_9f5db0df-c539-489a-a7b7-74fd9750f275"
      unitRef="usd">-12000000</bsx:Netcurrencyexchangegainloss>
    <bsx:OtherNet
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTMtMS0xLTEtMA_163f9900-2bb8-4011-9285-cd9430284303"
      unitRef="usd">26000000</bsx:OtherNet>
    <bsx:OtherNet
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTMtMy0xLTEtMA_778ac084-907d-4d70-90da-d9683f14e307"
      unitRef="usd">35000000</bsx:OtherNet>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTUtMS0xLTEtMA_74c024dd-72bc-48c4-b8ed-00a53d534119"
      unitRef="usd">145000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTUtMy0xLTEtMA_857b52c2-dc8d-4abb-b5cd-ec361461ebee"
      unitRef="usd">-365000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTYtMS0xLTEtMA_54bbe2e4-8e6f-4a32-8040-61c8b141d1d5"
      unitRef="usd">100000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTYtMy0xLTEtMA_92f1a83c-6254-4d8e-8652-3042b4b135f7"
      unitRef="usd">36000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTctMS0xLTEtMA_12f520a2-2823-4428-ac77-ddd29eec34a9"
      unitRef="usd">200000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTctMy0xLTEtMA_8ed841ca-3050-46b2-bc02-3501f6f05b8d"
      unitRef="usd">179000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTgtMS0xLTEtMA_6c7f2617-d449-43bc-816e-4f8819b23655"
      unitRef="usd">187000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTgtMy0xLTEtMA_ec534472-a2bb-4a80-b05e-ba9ffe7d8221"
      unitRef="usd">-531000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTktMS0xLTEtMA_25fa9317-ec50-4c04-99e4-15738e4f8412"
      unitRef="usd">153000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMTktMy0xLTEtMA_88fd2481-3897-432c-9df1-ca3c0dae0744"
      unitRef="usd">-181000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjAtMS0xLTEtMA_9656a0ad-4719-4c27-a412-fe9ea6faa679"
      unitRef="usd">927000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjAtMy0xLTEtMA_03e2a3b1-680a-4404-9d72-2572c780cb18"
      unitRef="usd">192000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjMtMS0xLTEtMA_c7a2cdfe-7b92-496a-8138-74dba7a307f4"
      unitRef="usd">181000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjMtMy0xLTEtMA_e4648d6d-41b5-418f-aa11-c32a437f961a"
      unitRef="usd">168000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjQtMS0xLTEtMA_d74fe039-db26-4751-afe0-e0f79d1c73a5"
      unitRef="usd">7000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjQtMy0xLTEtMA_1b6d668d-7be4-4467-a984-34365a9335c4"
      unitRef="usd">4000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjUtMS0xLTEtMA_a9b4d677-813c-4190-a56b-dac5d15e9629"
      unitRef="usd">706000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjUtMy0xLTEtMA_d831f379-821e-4bcc-967a-f8a7fffe6f05"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjYtMS0xLTEtMA_fc59eeb5-4682-45d8-99d1-6dc5a28e071a"
      unitRef="usd">-43000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjYtMy0xLTEtMA_b2a14a8a-ce9a-4a5c-a07b-fb39758b8d88"
      unitRef="usd">-45000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjctMS0xLTEtMA_12a6e247-157b-49c2-a5d9-22906ee5d564"
      unitRef="usd">30000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjctMy0xLTEtMA_b80515bd-6d00-418e-8783-fca3124a7108"
      unitRef="usd">29000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjgtMS0xLTEtMA_84ab85ac-d3ae-4492-8efc-c7273dcc631d"
      unitRef="usd">122000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjgtMy0xLTEtMA_615b4705-af02-403a-8677-fa122bbc6a1d"
      unitRef="usd">0</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjktMS0xLTEtMA_97ce59b7-fc43-4901-80c9-d1d81e167ae9"
      unitRef="usd">801000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMjktMy0xLTEtMA_a8725fa2-8391-4912-8e8e-4c8c70893145"
      unitRef="usd">15000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzAtMS0xLTEtMA_2c2d9d86-9c45-4eec-ae3b-f314c8389396"
      unitRef="usd">15000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzAtMy0xLTEtMA_d78ca090-5367-417c-a56b-d9909b6c4c61"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzEtMS0xLTEtMA_2443b2b4-9b11-4d4e-9c9b-ccb58379d10b"
      unitRef="usd">71000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzEtMy0xLTEtMA_8e4287bb-2bf5-4690-a585-7aa42c3658c2"
      unitRef="usd">-135000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzQtMS0xLTEtMA_9cf37e5c-e37e-4a20-9139-b9a403c20664"
      unitRef="usd">14000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzQtMy0xLTEtMA_fc0cac01-2fa1-434c-b2e3-9ed16d4986e5"
      unitRef="usd">38000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <bsx:PaymentsForRoyaltyRights
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzUtMS0xLTEtMA_114fe186-8ce5-4691-be06-aa754fb24a7e"
      unitRef="usd">42000000</bsx:PaymentsForRoyaltyRights>
    <bsx:PaymentsForRoyaltyRights
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzUtMy0xLTEtMA_5fb345e3-867d-41ed-8d96-89a0e02892b1"
      unitRef="usd">52000000</bsx:PaymentsForRoyaltyRights>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzYtMS0xLTEtMA_b655ae31-db58-4634-99c3-c9b6d2d93cc1"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzYtMy0xLTEtMA_56bfda7a-272f-43ca-97b0-c127c4ae67fe"
      unitRef="usd">2700000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzctMS0xLTEtMA_e7f1fc71-3e92-4f71-b0ae-794a8f1ef5b7"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzctMy0xLTEtMA_7cf9c471-ce00-45cb-9db7-a01fa35e8b0e"
      unitRef="usd">2245000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzgtMS0xLTEtMA_8d1c3cfe-455b-4bea-a5ca-2f561a6c8463"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzgtMy0xLTEtMA_b271e88f-4d86-4f3a-b1fb-eaa0f54838f9"
      unitRef="usd">-714000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzktMS0xLTEtMA_459c04eb-f3ca-4f61-a1d2-a3307d6bf8c0"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfMzktMy0xLTEtMA_44ab61c7-70d1-4e3a-8451-47ddacd3d053"
      unitRef="usd">1919000000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDAtMS0xLTEtMA_d7fddaa1-57f5-420c-a3ea-e0440cbacfee"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDAtMy0xLTEtMA_76696b18-361e-4e89-939e-fe6b73c5687b"
      unitRef="usd">1916000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDEtMS0xLTEtMA_44e9c226-6878-431d-b96d-c0a2082d46ea"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDEtMy0xLTEtMA_bab69f41-f67b-44f9-90fe-a026788ac4ff"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDItMS0xLTEtMA_5e4a4d46-0c05-461b-8a6f-5de35c562ab0"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDItMy0xLTEtMA_bd63fee0-6c48-4e08-8fda-2c1c04d42f81"
      unitRef="usd">1683000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDMtMS0xLTEtMA_c767cd0f-0993-421e-9084-bee8f1e21e07"
      unitRef="usd">28000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDMtMy0xLTEtMA_2c2ffc50-faee-4a53-a8fd-948c91c2b52f"
      unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDQtMS0xLTEtMA_be2cfab0-3dcf-4736-b943-45e377d26cb3"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDQtMy0xLTEtMA_917c35ba-ced1-4a26-b824-9309b70a8b93"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDUtMS0xLTEtMA_2ed11375-02d4-4eeb-9cb1-ac947a7d13c6"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDUtMy0xLTEtMA_80062daf-36cb-4a40-9770-ace7b51017e7"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDYtMS0xLTEtMA_771b1378-4ff7-4dc7-a7c6-6f06b6b11fd0"
      unitRef="usd">47000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDYtMy0xLTEtMA_052d9e8b-7849-47e2-9bb5-b67ad2426410"
      unitRef="usd">57000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDctMS0xLTEtMA_ddedafa1-55e6-4662-81b6-3ab3a304523e"
      unitRef="usd">38000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDctMy0xLTEtMA_13031040-0bfc-44c6-bee1-c6c5d17c248f"
      unitRef="usd">48000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDgtMS0xLTEtMA_74736466-741c-442d-bf5c-20336c7d406d"
      unitRef="usd">-93000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNDgtMy0xLTEtMA_f7e24f6a-edc0-42ad-985a-d68c32a8aa47"
      unitRef="usd">1361000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTAtMS0xLTEtMA_7b30eb18-ba6d-499c-86d0-f6774619470c"
      unitRef="usd">-2000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTAtMy0xLTEtMA_47f18c2d-8929-4539-ab5b-8287aa378377"
      unitRef="usd">-9000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTItMS0xLTEtMA_dd9813fd-f70d-456f-bb21-5fe93bb325a3"
      unitRef="usd">903000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTItMy0xLTEtMA_9d4c8130-d05d-4345-a45c-4873934e72c7"
      unitRef="usd">1409000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTMtMS0xLTEtMA_a21e6116-25e6-4e3a-b234-bedc273e0f17"
      unitRef="usd">1995000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTMtMy0xLTEtMA_455a07d6-db6c-46fa-a2d0-0468dc4154ee"
      unitRef="usd">607000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTQtMS0xLTEtMA_2d487bfe-845e-4567-8d36-70009b60b71b"
      unitRef="usd">2898000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjUxNGIzMmMwODg4NTQ1NzNhMjNhYjkzNDE0MWEyMzczL3RhYmxlcmFuZ2U6NTE0YjMyYzA4ODg1NDU3M2EyM2FiOTM0MTQxYTIzNzNfNTQtMy0xLTEtMA_4dc023ae-04d3-4976-8835-07da498d32e7"
      unitRef="usd">2016000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ShareBasedCompensation
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfMy0xLTEtMS0w_83146702-fa29-4613-b1e3-a153226b51af"
      unitRef="usd">94000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfMy0zLTEtMS0w_587ccbbe-36f3-4716-b9de-3738aba92096"
      unitRef="usd">88000000</us-gaap:ShareBasedCompensation>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfNC0xLTEtMS0w_872856bd-61ff-4a9c-97fa-18cd324c8310"
      unitRef="usd">221000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfNC0zLTEtMS0w_3ebe597f-6f22-4253-99d3-d1b350d159cc"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <bsx:Noncashimpactoftransferredroyaltyrights
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfNS0xLTEtMS0w_22dfb21d-8d10-42d5-b435-9e1ac086cb1c"
      unitRef="usd">-43000000</bsx:Noncashimpactoftransferredroyaltyrights>
    <bsx:Noncashimpactoftransferredroyaltyrights
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjhmOWY5YWVhMzVkZTRiM2Y5YzIyYWM5MzljNWMzYjdkL3RhYmxlcmFuZ2U6OGY5ZjlhZWEzNWRlNGIzZjljMjJhYzkzOWM1YzNiN2RfNS0zLTEtMS0w_44888a40-dae9-4501-967c-ade3faf38ec5"
      unitRef="usd">-45000000</bsx:Noncashimpactoftransferredroyaltyrights>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfMi0xLTEtMS0w_261bbf57-4cf1-4240-8ae8-13c123625cb6"
      unitRef="usd">2675000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfMi0zLTEtMS0w_f30817e4-3bd6-4b00-9c13-e8fecef6b4ce"
      unitRef="usd">1724000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfMy0xLTEtMS0w_e9e062f2-7869-49d6-babb-ae044850838d"
      unitRef="usd">167000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfMy0zLTEtMS0w_7e150ba4-0092-4701-95f8-ea8bb141ef49"
      unitRef="usd">245000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfNC0xLTEtMS0w_b0940d04-41f0-4676-8840-5c16b06e69f4"
      unitRef="usd">57000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfNC0zLTEtMS0w_a7f21e03-d45f-4611-855d-11ba204eb7a5"
      unitRef="usd">46000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfNS0xLTEtMS0w_0c9546b0-a895-4ec9-a1aa-72274d9d712e"
      unitRef="usd">2898000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfNS0xLTEtMS0w_ff55b2b2-4d6b-43de-8dc3-d9593d899508"
      unitRef="usd">2898000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zMS9mcmFnOjUyOTA2YjdmY2E0OTQ2ZDFiN2QxMjUxODhmODFmNGE2L3RhYmxlOjliMTQwNGFjNDYzNDRkOWE4M2Q0MWJlZmZmOGYxYjljL3RhYmxlcmFuZ2U6OWIxNDA0YWM0NjM0NGQ5YTgzZDQxYmVmZmY4ZjFiOWNfNS0zLTEtMS0w_d678ee41-a082-4efd-a0ca-36f79d26cbf8"
      unitRef="usd">2016000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zNy9mcmFnOjhmMTM4ODc1MTdmOTRhYjJiZTgyZDNkZGNhZWFkM2NhL3RleHRyZWdpb246OGYxMzg4NzUxN2Y5NGFiMmJlODJkM2RkY2FlYWQzY2FfMTgxMw_994169ab-bcc8-4277-9bf0-e08d340defcc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE A &#x2013; BASIS OF PRESENTATION &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X, and they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three and six months ended June&#160;30, 2021 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2021. Accordingly, our unaudited consolidated financial statements and footnotes thereto should be read in conjunction with our audited consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions, Divestitures and Strategic Investments, Note H &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8zNy9mcmFnOjhmMTM4ODc1MTdmOTRhYjJiZTgyZDNkZGNhZWFkM2NhL3RleHRyZWdpb246OGYxMzg4NzUxN2Y5NGFiMmJlODJkM2RkY2FlYWQzY2FfMTgxNw_489ba846-2423-47cb-a882-9f326d83c4b6">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions, Divestitures and Strategic Investments, Note H &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzYwOQ_dbdbb207-173d-4e72-98e7-964ab27cf3df">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE B &#x2013; ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accompanying unaudited consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We completed one acquisition and one divestiture in the first six months of 2021 and did not complete any significant acquisitions or divestitures during the first six months of 2020. We have not presented supplemental pro forma financial information for completed acquisitions or divestitures given their results are not material to our accompanying unaudited consolidated financial statements. Further, transaction costs were immaterial to our accompanying unaudited consolidated financial statements and were expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 3, 2021, we announced our entry into a definitive agreement to acquire the global surgical business of Lumenis LTD. (Lumenis), a privately-held company that develops and commercializes energy-based medical solutions, for an upfront cash payment of approximately $1.070 billion subject to closing adjustments. The global surgical business of Lumenis includes innovative laser systems, fibers, and accessories used for urology and otolaryngology procedures. The acquisition is expected to close during the second half of 2021, subject to customary closing conditions. Following the closing of the acquisition, we plan to integrate the Lumenis business into our Urology and Pelvic Health division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, we completed the acquisition of Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. The transaction consisted of an upfront cash payment of $925 million and up to an additional $300 million in a potential commercial milestone payment. We have been an investor in Preventice since 2015 and held an equity stake of approximately 22 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests, which resulted in a $195 million gain recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the first quarter of 2021. The transaction price for the remaining stake consisted of an upfront cash payment of $706 million, net of cash acquired, and up to approximately $230 million in an additional future revenue-based payment. The Preventice business is being managed by our Cardiac Rhythm Management division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 6, 2021, we completed our acquisition of the remaining shares of Farapulse, Inc. (Farapulse), a privately-held company that has developed a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias in which we previously held an equity stake of approximately 27 percent. The transaction price consists of $450 million upfront, or approximately $295 million after adjustments for our prior equity stake, debt and other closing adjustments; up to $125 million upon achievement of certain clinical and regulatory milestones, or $92 million for the portion not previously owned; and additional revenue-based payments over the next three years. The valuation studies necessary to determine the fair value of the various purchase price components are currently in process.  Once completed, we will remeasure the fair value of our previously held equity interest and recognize a gain of at least $150 million within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other income (expense)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; during the third quarter of 2021.  The Farapulse business will be integrated into our Electrophysiology division.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary purchase price for acquisitions completed during the first six months of 2021 was comprised of the amounts presented below, which represent the preliminary determination of the fair value of identifiable assets acquired and liabilities assumed. The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary purchase price allocation for acquisitions completed during the first six months of 2021 was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the preliminary purchase price for acquisitions completed during the first six months of 2021 to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies and is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021 Divestiture&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of approximately $800 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;million, subject to certain adjustments including cash on hand at the closing of the transaction. The agreement included the transfer of five facilities and approximately 280 employees globally. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classified the assets and liabilities of the Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet as of December 31, 2020 at their respective carrying values, which approximated fair value, less costs to sell. Assets within the disposal group are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and liabilities are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;within our consolidated balance sheet as of December 31, 2020. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note C &#x2013; Assets and Liabilities Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information. In the second quarter and first six months of 2021, we recognized a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gain on disposal of business&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; associated with the transaction of $2 million and $9 million respectively, within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our contingent consideration liability during the first six months of 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount recorded related to current year acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our completed acquisitions was $751 million, which includes amounts related to our recent acquisition of Preventice. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information. In the second quarter of 2021 we recorded a contingent consideration net benefit of $85 million.  The benefit related to certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$290 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Projected contingent payment amounts related to research and development (R&amp;amp;D), commercialization-based and revenue-based milestones are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of June&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Strategic Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held equity securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;616&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter and first six months of 2021, we recorded losses of $8 million and $154 million, respectively, on our investment in Pulmonx Corporation presented in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt; associated with the partial disposition of our ownership and remeasurement of our remaining investment to fair value based on observable market prices. On March 1, 2021, we completed our acquisition of Preventice, in which we previously held an equity interest of approximately 22 percent. In addition, on August 6, 2021, we completed the acquisition of the remaining shares of Farapulse, in which we previously held an equity stake of approximately 27 percent.  As of June&#160;30, 2021, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $314 million, which represents amortizable intangible assets, in-process research and development (IPR&amp;amp;D), goodwill and deferred tax liabilities.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTc1OTIxODYwNjU0NDg_2164a1f7-3e1e-4f96-991b-5c6eb8d78a9d"
      unitRef="business">1</us-gaap:NumberOfBusinessesAcquired>
    <bsx:NumberOfBusinessesDivested
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTc1OTIxODYwNjU0NTY_a769f012-a2ec-4572-91f8-1cfa97ac2206"
      unitRef="business">1</bsx:NumberOfBusinessesDivested>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTc1OTIxODYwNjU0NjQ_b069aa0b-39c2-456d-8bd0-05e3ce6e07a2"
      unitRef="business">0</us-gaap:NumberOfBusinessesAcquired>
    <bsx:NumberOfBusinessesDivested
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTc1OTIxODYwNjU0NjQ_cf540816-d26d-4dd5-b189-6a5739ab38a7"
      unitRef="business">0</bsx:NumberOfBusinessesDivested>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i7035bd8158c64efc87cb5197cb0b1c08_D20210303-20210303"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfODYy_6fdacd36-8655-4044-bfd6-3bdc8d15f340"
      unitRef="usd">1070000000.000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="id3b8aa9405924b21b11a85634596952f_D20210301-20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTY1Mg_f170df61-270d-4c69-87d4-57f7a5e71aae"
      unitRef="usd">925000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest
      contextRef="ib9c9a81fddbb4fad955c9b1435142cec_I20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTY3OQ_6add0f0a-bf7d-4056-83f4-dcf4ef6cdc48"
      unitRef="usd">300000000</bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="ib9c9a81fddbb4fad955c9b1435142cec_I20210301"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTgxOQ_a0b6004d-394d-4f9a-b084-7b3b126ef397"
      unitRef="number">0.22</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i57c0758a66684a7982d502068215aa6f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjAzNw_804997eb-66f7-4b56-a944-9ca76a1f3dc9"
      unitRef="usd">195000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="id3b8aa9405924b21b11a85634596952f_D20210301-20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjE3NA_42fb5861-ec2b-4b51-b62f-8639458f9fd2"
      unitRef="usd">706000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ib9c9a81fddbb4fad955c9b1435142cec_I20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjIyNA_11577549-a222-41de-8ee7-685a8639fc58"
      unitRef="usd">230000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i6898b58f4aec40418ecc3bd0375059cf_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4OTk2OQ_1f98d82f-592d-4513-83ad-cb477ff4fda8"
      unitRef="number">0.27</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="i6fdccd8db4934e95b5b9d89057e641dd_D20210806-20210806"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4OTk0OA_27e0ac37-7e29-4d3f-a6b4-febee73699bb"
      unitRef="usd">450000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i6fdccd8db4934e95b5b9d89057e641dd_D20210806-20210806"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4OTk2NQ_f7d0316c-524c-4d87-9e6d-52567856b59a"
      unitRef="usd">295000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest
      contextRef="i6898b58f4aec40418ecc3bd0375059cf_I20210806"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4OTk5OQ_dbe589c1-ca93-4d02-8a56-0a27c2888499"
      unitRef="usd">125000000</bsx:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i6898b58f4aec40418ecc3bd0375059cf_I20210806"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA5MDAzMQ_21432617-0a55-40cc-9d74-05390de4783f"
      unitRef="usd">92000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <bsx:BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod
      contextRef="i6fdccd8db4934e95b5b9d89057e641dd_D20210806-20210806"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTc1OTIxODYwNjU0NzQ_62867048-330a-4236-90c4-a4bca623d40d">P3Y</bsx:BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i6fdccd8db4934e95b5b9d89057e641dd_D20210806-20210806"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA5MDAxNg_2d4cb9f1-2147-4407-b8a0-dbda754ff1df"
      unitRef="usd">150000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzYxMw_70bd2c2f-d59f-492c-aa39-a15999a61c76">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjhiNDNjYWVmMmFhMjQ2YmRiNGJkNjExMDY4MWQ3NzFiL3RhYmxlcmFuZ2U6OGI0M2NhZWYyYWEyNDZiZGI0YmQ2MTEwNjgxZDc3MWJfMS0xLTEtMS0w_9a99ae60-7b89-430a-94fa-9cc4225e477d"
      unitRef="usd">706000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjhiNDNjYWVmMmFhMjQ2YmRiNGJkNjExMDY4MWQ3NzFiL3RhYmxlcmFuZ2U6OGI0M2NhZWYyYWEyNDZiZGI0YmQ2MTEwNjgxZDc3MWJfMi0xLTEtMS0w_5fe4b179-c9bf-44ca-9a49-87ddb855280b"
      unitRef="usd">221000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjhiNDNjYWVmMmFhMjQ2YmRiNGJkNjExMDY4MWQ3NzFiL3RhYmxlcmFuZ2U6OGI0M2NhZWYyYWEyNDZiZGI0YmQ2MTEwNjgxZDc3MWJfMy0xLTEtMS0w_e1144d62-6bb6-4517-9144-4aacde3cd40e"
      unitRef="usd">269000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjhiNDNjYWVmMmFhMjQ2YmRiNGJkNjExMDY4MWQ3NzFiL3RhYmxlcmFuZ2U6OGI0M2NhZWYyYWEyNDZiZGI0YmQ2MTEwNjgxZDc3MWJfNC0xLTEtMS0w_b54ab460-436b-474f-a85d-dfd777a8dbc6"
      unitRef="usd">1197000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzYzNQ_ac52f389-480c-4da6-9fbd-b3bcbbf8bb87">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjNhNzVjY2IzYWI4YjQxOTNhMmQ0OTdmNjhhMDFiMTBiL3RhYmxlcmFuZ2U6M2E3NWNjYjNhYjhiNDE5M2EyZDQ5N2Y2OGEwMWIxMGJfMS0xLTEtMS0w_382c83b5-1c64-4624-9231-ec353f2bedb1"
      unitRef="usd">926000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjNhNzVjY2IzYWI4YjQxOTNhMmQ0OTdmNjhhMDFiMTBiL3RhYmxlcmFuZ2U6M2E3NWNjYjNhYjhiNDE5M2EyZDQ5N2Y2OGEwMWIxMGJfMi0xLTEtMS0w_90bb3bd3-4256-4590-ad6b-41e218c565eb"
      unitRef="usd">237000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjNhNzVjY2IzYWI4YjQxOTNhMmQ0OTdmNjhhMDFiMTBiL3RhYmxlcmFuZ2U6M2E3NWNjYjNhYjhiNDE5M2EyZDQ5N2Y2OGEwMWIxMGJfNC0xLTEtMS0w_f5767ba4-f104-4a40-9f54-fed157934be8"
      unitRef="usd">65000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjNhNzVjY2IzYWI4YjQxOTNhMmQ0OTdmNjhhMDFiMTBiL3RhYmxlcmFuZ2U6M2E3NWNjYjNhYjhiNDE5M2EyZDQ5N2Y2OGEwMWIxMGJfNi0xLTEtMS0w_97cb0c54-ee11-460e-a7d7-90ca716400d8"
      unitRef="usd">32000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjNhNzVjY2IzYWI4YjQxOTNhMmQ0OTdmNjhhMDFiMTBiL3RhYmxlcmFuZ2U6M2E3NWNjYjNhYjhiNDE5M2EyZDQ5N2Y2OGEwMWIxMGJfOC0xLTEtMS0w_8423429e-0977-48e5-9c97-02c4ce37aff8"
      unitRef="usd">1197000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="i90f104f7be4946ecaeca51b7eecbdc7e_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzY4MQ_fe04bb2d-498b-4644-9b27-6d995eda6c6a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i0a862692f9994fb897884cba9e5d394c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfMi0xLTEtMS0w_448ecc9a-d08e-4ba0-9bd4-28bd6bcd2eef"
      unitRef="usd">215000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i42615c1dcc2b43d5bfd401f89db86ee2_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfMi0zLTEtMS0w_5ce94c09-f578-4ed1-bd43-e53070178b41">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i2761998d541845db93a74305c87ca265_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfMi03LTEtMS0w_c8bfdd40-2fa9-443e-8337-5b2ea3df66dc"
      unitRef="number">0.10</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i91ca5ff3927c42fd8cec3812dac442ed_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfNC0xLTEtMS0w_13fc0c82-c2fe-4b30-8d72-d3a47454b53f"
      unitRef="usd">22000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id114a2fef9024cbca1a1f0663c76241c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfNC0zLTEtMS0w_8b0f366d-2c3f-4d99-b7b7-a6364b8085be">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="ib89073632b554a279ba4e8ab72aee35b_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfNC03LTEtMS0w_1e6575b5-4535-4364-a67d-352d0ae02cde"
      unitRef="number">0.10</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i07a5ff06eb0d4cb3872ad600010a3efb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOmQ4ZGJlN2NiMDEyNzRjZmRhZTg0MDlhMmY1MGQwODlhL3RhYmxlcmFuZ2U6ZDhkYmU3Y2IwMTI3NGNmZGFlODQwOWEyZjUwZDA4OWFfNy0xLTEtMS0w_f739c57f-9d1b-45dd-884c-1604fca0dd0f"
      unitRef="usd">237000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ibb276f2411404adb93fe59870c17c192_I20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMzg3Mg_fff00f1e-7470-4ccb-aa87-c68ce58b2312"
      unitRef="usd">800000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <bsx:DivestitureAgreementTransferOfFacilities
      contextRef="ibb276f2411404adb93fe59870c17c192_I20210301"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNDAwNA_8047693e-134d-4bd8-8f14-2877e52b3bdf"
      unitRef="units">5</bsx:DivestitureAgreementTransferOfFacilities>
    <bsx:DivestitureAgreementTransferOfGlobalEmployees
      contextRef="ibb276f2411404adb93fe59870c17c192_I20210301"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNDAzNg_0f84b5c8-c0ee-4101-8fd1-e8ee0813d96a"
      unitRef="units">280</bsx:DivestitureAgreementTransferOfGlobalEmployees>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i8074394ed0a841f6b6a00976ce6a3b7c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4MDQwNw_b1a97289-982f-4048-b37d-1b6c3eead28f"
      unitRef="usd">2000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ic1a8632c557548d6a28c88cdfcd4c788_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4MjI3Ng_6f986a36-70fe-4671-9a48-9216ee49eca8"
      unitRef="usd">9000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzYyNw_e0de5576-a08d-412c-8659-ca4808819c55">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our contingent consideration liability during the first six months of 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount recorded related to current year acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjUzNWU0ZWE4ODY0ZjQ1ZmE4MGUzZmJjNTJlMmUzZjg2L3RhYmxlcmFuZ2U6NTM1ZTRlYTg4NjRmNDVmYTgwZTNmYmM1MmUyZTNmODZfMS0xLTEtMS0w_ad17c138-e3b5-491b-91a6-d78f3078f2bf"
      unitRef="usd">196000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjUzNWU0ZWE4ODY0ZjQ1ZmE4MGUzZmJjNTJlMmUzZjg2L3RhYmxlcmFuZ2U6NTM1ZTRlYTg4NjRmNDVmYTgwZTNmYmM1MmUyZTNmODZfMi0xLTEtMS0w_cabacdde-4f9d-45ab-89b9-b5ae9eb18ed0"
      unitRef="usd">221000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjUzNWU0ZWE4ODY0ZjQ1ZmE4MGUzZmJjNTJlMmUzZjg2L3RhYmxlcmFuZ2U6NTM1ZTRlYTg4NjRmNDVmYTgwZTNmYmM1MmUyZTNmODZfNC0xLTEtMS0w_58edc17f-46c4-434c-95df-b9922e85355a"
      unitRef="usd">-91000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:PaymentOfContingentConsideration
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjUzNWU0ZWE4ODY0ZjQ1ZmE4MGUzZmJjNTJlMmUzZjg2L3RhYmxlcmFuZ2U6NTM1ZTRlYTg4NjRmNDVmYTgwZTNmYmM1MmUyZTNmODZfNS0xLTEtMS0w_29c9a7f5-c961-4ca8-b4b7-3837a35cb36f"
      unitRef="usd">14000000</bsx:PaymentOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjUzNWU0ZWE4ODY0ZjQ1ZmE4MGUzZmJjNTJlMmUzZjg2L3RhYmxlcmFuZ2U6NTM1ZTRlYTg4NjRmNDVmYTgwZTNmYmM1MmUyZTNmODZfNi0xLTEtMS0w_b24a1cb5-0253-41c1-b5fa-bebce8047a09"
      unitRef="usd">312000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNTA4Nw_313868a4-bb5d-42fb-bd1a-4c14578edd41"
      unitRef="usd">751000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA4MjQ5MA_ca484066-31e4-48a6-b647-eaa9610b1ac9"
      unitRef="usd">-85000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzYzMg_9379e8f3-15bf-43e8-ab24-ce941a90bc96">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$22 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$290 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2e3062416e504886865dc878139930d2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfMS0xLTEtMS0w_0da63de6-dad1-4e17-a62e-44de8abd78bc"
      unitRef="usd">22000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="i2e3062416e504886865dc878139930d2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfMS00LTEtMS0w_617e762b-5d26-4f77-8670-4a3dccf79bf1"
      unitRef="number">0.02</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i3a1667398e9d4227ad18866f00a781a1_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfMS03LTEtMS0w_f7942656-f829-4bd9-9876-3ab7cb8ebdf7"
      unitRef="number">0.02</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i2e3062416e504886865dc878139930d2_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfMi00LTEtMS0w_b1e0c55c-97e3-4d06-85c2-23d3607a9752"
      unitRef="number">0.20</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i3a1667398e9d4227ad18866f00a781a1_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfMi03LTEtMS0w_f7d5bdf1-b53f-4bbc-944e-3ad2d2ed2c28"
      unitRef="number">0.20</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4ea9ee04f244471cb85a3fafa0014325_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNC0xLTEtMS0w_46b2171a-c9a3-4073-a999-bfdd5c742962"
      unitRef="usd">290000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="i4b1f6c1a9c3545cb8c54c62563bbe3af_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNC00LTEtMS0w_b4d4e4dc-64b8-46ed-957e-455d93648b85"
      unitRef="rate">0.04</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i8f69f4096f2641279151434275d31698_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNC02LTEtMS0w_0ed4b3e8-5639-4a53-91d7-8fdc92307f80"
      unitRef="number">0.14</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="iafec8073344141919bf348e3f6128888_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNC03LTEtMS0w_dc81d9fe-91b0-4848-8126-e18c58bf43ab"
      unitRef="rate">0.06</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i4b1f6c1a9c3545cb8c54c62563bbe3af_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNS00LTEtMS0w_314c744f-6c00-4a8c-84ae-b1e5c431e75d"
      unitRef="number">0.80</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i8f69f4096f2641279151434275d31698_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNS02LTEtMS0w_76e3044e-9dbc-4f05-8291-e2811744e488"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="iafec8073344141919bf348e3f6128888_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjFkYTJhMDhhOGNmZjRmMTJhMTYyMGQwYTdkN2M4ZTBkL3RhYmxlcmFuZ2U6MWRhMmEwOGE4Y2ZmNGYxMmExNjIwZDBhN2Q3YzhlMGRfNS03LTEtMS0w_d3467207-6d7b-4138-88f5-a9d4882ddaf4"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzY1MQ_02132d4b-c525-40da-a82b-60cfb9e343a2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held equity securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;616&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfMi0xLTEtMS0w_735ec0ec-5a23-4001-b65d-4307d059cba0"
      unitRef="usd">264000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfMi0zLTEtMS0w_51eb1188-eb39-446f-9d5f-25d340495736"
      unitRef="usd">319000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfMy0xLTEtMS0w_6b9d182d-0087-4237-9da0-38c8000dc995"
      unitRef="usd">175000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfMy0zLTEtMS0w_0899e22a-5750-4e33-ad03-660a28675fc5"
      unitRef="usd">183000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNC0xLTEtMS0w_efa36aa2-9f8f-412d-9aa2-3cdebeda4766"
      unitRef="usd">176000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNC0zLTEtMS0w_d9e5955c-230b-4bf6-8d82-40389e074926"
      unitRef="usd">414000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNS0xLTEtMS0w_bae4d7a6-91cc-4798-9e27-2a3fdb24536c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNS0zLTEtMS0w_f6c02e93-5e1d-4482-a192-d3ecd098df83"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:Investments
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNi0xLTEtMS0w_6069fbcd-a01a-4566-b9c1-31a84224b89d"
      unitRef="usd">616000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RhYmxlOjI4OWE2NTgwOThiNDQ4MjM4MzQ2ZmUwZDcwY2E2MWFmL3RhYmxlcmFuZ2U6Mjg5YTY1ODA5OGI0NDgyMzgzNDZmZTBkNzBjYTYxYWZfNi0zLTEtMS0w_49f96ebd-27e1-4e27-bdad-a06aba75bb9a"
      unitRef="usd">918000000</us-gaap:Investments>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMTA5OTUxMTYzNTU5Nw_9788e169-1aae-4212-9af9-b4ccb75e2e04"
      unitRef="usd">-8000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNjk5Mg_7b2977d7-b8c4-407d-8847-4f3f36478346"
      unitRef="usd">-154000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="ib9c9a81fddbb4fad955c9b1435142cec_I20210301"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA5MDg4NA_a0b6004d-394d-4f9a-b084-7b3b126ef397"
      unitRef="number">0.22</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i6898b58f4aec40418ecc3bd0375059cf_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfMjc0ODc3OTA5MDA2OA_1f98d82f-592d-4513-83ad-cb477ff4fda8"
      unitRef="number">0.27</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80My9mcmFnOmY0Yzg2MDU2M2M1NzRlNDg5YTlhNjkxZmM5OGRiNTliL3RleHRyZWdpb246ZjRjODYwNTYzYzU3NGU0ODlhOWE2OTFmYzk4ZGI1OWJfNzQ2OA_59e905e0-a4de-4b07-876f-86d891461f46"
      unitRef="usd">314000000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfNDcwMg_f09d0fa6-01d5-4692-a47b-c635963d2015">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE C &#x2013; GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,774&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,924&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;330&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;377&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In the fourth quarter of 2020, we recorded goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of June 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The increase in our balance of goodwill and intangible assets is primarily related to our acquisition of Preventice in the first quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives. Our IPR&amp;amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents our goodwill balance by global reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,951&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations and other changes in carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,057&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,874&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the divestiture on March 1, 2021, we presented the Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Intangible Asset Impairments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not record any goodwill impairment charges in the second quarter or first six months of 2021 or 2020. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of&#160;2021, we performed our annual goodwill impairment test for all of our reporting units using the quantitative approach described in FASB ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Othe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r (FASB ASC Topic 350). We identified the following reporting units in our 2021 annual goodwill impairment test: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health and Neuromodulation. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350.  We determined that the fair value of each reporting unit exceeded its carrying value and concluded that goodwill was not impaired or at risk of impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of  $45 million in the second quarter and first six months of 2021, $34 million in the second quarter of 2020 and $233 million in the first six months of 2020. We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life.  We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets.  In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist.  During the second quarter of 2021, we determined it was more likely than not that one of our indefinite-lived intangible assets was impaired based on our qualitative assessment of impairment indicators.  We tested the intangible asset for recoverability and recorded an impairment charge associated with incremental time and cost to complete the associated in-process research and development (IPR&amp;amp;D) project.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impairment charges recorded in the first six months of 2020 were primarily associated with amortizable technology-related intangible assets that were initially established following our acquisition of nVision. These charges were recorded as a result of management&#x2019;s decision to change commercial launch plans or discontinue certain R&amp;amp;D programs based on cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfNDY5Ng_1d37f1a4-1a03-45fb-8e54-f1c59f4169af">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,774&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,924&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;330&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;377&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In the fourth quarter of 2020, we recorded goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of June 30, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i599a67975f864f07aebaf0697665cb54_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMi0xLTEtMS0w_89ea4822-ec33-47bd-9889-4a5c7e166078"
      unitRef="usd">11284000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i599a67975f864f07aebaf0697665cb54_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMi0zLTEtMS0w_e9e5a98d-7c25-42f3-b75c-77b447a0a08e"
      unitRef="usd">6475000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9b78aeabdedf468b9432e0fbf7b1d35e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMi01LTEtMS0w_3cc68668-d9d9-4931-a268-3836cc55c21b"
      unitRef="usd">11059000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9b78aeabdedf468b9432e0fbf7b1d35e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMi03LTEtMS0w_c7e720fb-05be-4764-b4c8-4389229a434f"
      unitRef="usd">6179000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6b873251f0164fcc87a5f68eb8697f6b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMy0xLTEtMS0w_65dd1ed3-fa40-4929-b158-1c61298c5980"
      unitRef="usd">497000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6b873251f0164fcc87a5f68eb8697f6b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMy0zLTEtMS0w_a6df428c-7761-46b9-8fae-7a0539fdec97"
      unitRef="usd">397000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia31b341f23ca42dd99d1f28259ed9778_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMy01LTEtMS0w_f84d9794-d955-40bd-9a54-7ef7c07fb938"
      unitRef="usd">511000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia31b341f23ca42dd99d1f28259ed9778_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMy03LTEtMS0w_74596438-d2cc-447b-9e8e-f8f7c912659e"
      unitRef="usd">407000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i106a39a0f8a64d958a6b4fc9ab669182_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNC0xLTEtMS0w_b22410dd-8933-4bc1-8d9f-7f1ed8f9acd3"
      unitRef="usd">1826000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i106a39a0f8a64d958a6b4fc9ab669182_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNC0zLTEtMS0w_5b815e30-9603-48f6-bb08-d8450994f87e"
      unitRef="usd">1278000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6b198018bdf848d58391e917618a9a73_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNC01LTEtMS0w_ea117e63-9483-4249-975b-9e16e395b022"
      unitRef="usd">1775000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6b198018bdf848d58391e917618a9a73_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNC03LTEtMS0w_b63b7a34-13e7-4244-8f86-4d06b00ac856"
      unitRef="usd">1220000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNS0xLTEtMS0w_857c8535-ee8f-4de9-a5ec-f3ee77d0a8a6"
      unitRef="usd">13607000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNS0zLTEtMS0w_fd956a88-2c40-42d2-a647-de25425afffd"
      unitRef="usd">8150000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNS01LTEtMS0w_67c8db57-fa5f-4cf9-b527-c261517083da"
      unitRef="usd">13345000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNS03LTEtMS0w_40e97ee9-15d9-416f-af77-8b25bff13a2d"
      unitRef="usd">7806000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:GoodwillGross
      contextRef="i4614798867554623b71db7e485b17073_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNy0xLTEtMS0w_c4606122-1e86-4433-ba1b-638b8a2a44b0"
      unitRef="usd">20774000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i4614798867554623b71db7e485b17073_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNy0zLTEtMS0w_0697b056-c05c-4307-83b6-3cb448ef3efb"
      unitRef="usd">9900000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillGross
      contextRef="i66b850e1cf4c483cb4f780f209eb416e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNy01LTEtMS0w_f3940379-59da-4653-ac6d-abb4cbe7cb9d"
      unitRef="usd">19924000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i66b850e1cf4c483cb4f780f209eb416e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfNy03LTEtMS0w_ea3f56af-85c6-4cc5-9b7a-e47df7934c52"
      unitRef="usd">9973000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie78944db109b43dab16a18b210d06a11_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfOS0xLTEtMS0w_99b2c116-f2ee-4910-8154-5f1e44c45fc5"
      unitRef="usd">210000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2f4dc84c7b7d4d6784d95efacd9d16b7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfOS01LTEtMS0w_30ec309d-18c3-4d84-ab15-bab6a1e54521"
      unitRef="usd">257000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="if6c58776dd93450391e647ab995a55fa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMTAtMS0xLTEtMA_0a4442fa-952d-42ee-9699-678be9000ad7"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i96e317c9a09f414dac29a749f0646452_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMTAtNS0xLTEtMA_8d9e244b-deb9-4ee8-bb72-d6582f71967b"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMTEtMS0xLTEtMA_8eafba4f-a94b-44b2-82eb-1d612569274c"
      unitRef="usd">330000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOjE4OGFlMDI0ZTcwYTRiNzJhMjliNWNmY2Y0ZGRiMzIzL3RhYmxlcmFuZ2U6MTg4YWUwMjRlNzBhNGI3MmEyOWI1Y2ZjZjRkZGIzMjNfMTEtNS0xLTEtMA_6e2f1a1e-e781-4081-97ef-bdf153e63dcf"
      unitRef="usd">377000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4f13c163b758433eb6e1965892fb50b6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfMjk5_10d353ea-6b41-48d1-aeb5-c1ab0856e005"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4f13c163b758433eb6e1965892fb50b6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfNTcx_10d353ea-6b41-48d1-aeb5-c1ab0856e005"
      unitRef="usd">73000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfNDcyNA_aef2bd2a-9684-4c72-9567-92bee912338d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents our goodwill balance by global reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,951&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations and other changes in carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,057&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,698&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,874&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ic290401c00e44941bbe65f481b18918a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfMS0xLTEtMS0w_2e5818d7-a9a7-4414-a2a0-d05cb7314ad6"
      unitRef="usd">2059000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7879670f05dc464cace4562bebcef4af_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfMS0zLTEtMS0w_c47d95e7-420a-493d-93dd-3fd98498d3e2"
      unitRef="usd">2194000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic1cd550c4b9f4493a5098816e165a726_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfMS01LTEtMS0w_f0f1bcba-585c-4139-9143-f8b5b80f1f7f"
      unitRef="usd">5697000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfMS05LTEtMS0w_7a286fb4-1204-4d88-b06d-ca45259656c3"
      unitRef="usd">9951000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="if893495841d548ada62dd960d69a89bc_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNC0xLTEtMS0w_904f4c46-f93e-4150-94ca-c1de48b34592"
      unitRef="usd">-2000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNC0zLTEtMS0w_6f529d8d-c6e9-4071-8d85-15669bf85329"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNC01LTEtMS0w_491825ec-ffd5-41f5-9e1a-18eb0baf07f6"
      unitRef="usd">1000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNC05LTEtMS0w_c0db8b7f-59e6-4017-8546-06da7e17f1b3"
      unitRef="usd">-2000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="if893495841d548ada62dd960d69a89bc_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNS0xLTEtMS0w_5a27b57c-fe04-4c36-b951-9a595134179e"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNS0zLTEtMS0w_3c88cf2d-94f0-488c-9100-ccced185f434"
      unitRef="usd">926000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNS01LTEtMS0w_d4bc4dc8-883e-45e8-952d-31320db9ce43"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNS05LTEtMS0w_9480512c-e954-4178-ac42-1d42092d8c1c"
      unitRef="usd">926000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="ic0f4ff16aef048c5951b2ef3630ab4fe_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNy0xLTEtMS0w_6893a2f9-0114-4457-9778-02023dfe5a39"
      unitRef="usd">2057000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i508addd37e5f4f7ab05debf8ce4a40c5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNy0zLTEtMS0w_7df9bbc3-280e-4d0a-a3b8-3c5c31e72d01"
      unitRef="usd">3120000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9276b8fd7c5e459cb81f0d109ea9c590_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNy01LTEtMS0w_860ffb48-755b-4e48-bcf8-857a7d983681"
      unitRef="usd">5698000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RhYmxlOmVmZDJkODAwODIyZDRkMmI5ZmI0Y2FmZDU1MmNjYjU5L3RhYmxlcmFuZ2U6ZWZkMmQ4MDA4MjJkNGQyYjlmYjRjYWZkNTUyY2NiNTlfNy05LTEtMS0w_48bbdf81-1ac2-4eac-be11-0cb21145466e"
      unitRef="usd">10874000000</us-gaap:Goodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfMTA5OTUxMTYzNDg5NA_1ace8909-c829-4f93-99a0-117b3edb4d6d"
      unitRef="usd">45000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfMTA5OTUxMTYzNDkyNQ_fe06dc6f-0ef7-404e-b2fa-403c645d50ca"
      unitRef="usd">34000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF80OS9mcmFnOjVjNDdjZTAwOTY2MzQyNDc5OTA0Y2IwZGY4Nzk5YzIxL3RleHRyZWdpb246NWM0N2NlMDA5NjYzNDI0Nzk5MDRjYjBkZjg3OTljMjFfMTA5OTUxMTYzNDk3OQ_786486f6-c449-4e17-8283-ce29a1b9d993"
      unitRef="usd">233000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTg0MDY_bccbd6ef-8437-4937-908f-0cc2750ab74f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE D &#x2013; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Currency Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Management Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities, forecasted intercompany and third-party transactions, and net investments in certain subsidiaries. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in Euro, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Designations and Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net change in derivative financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax (OCI)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our accompanying unaudited consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax (AOCI)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. For these derivative instruments, we elected to use the spot method to assess hedge effectiveness. We also elected to exclude the spot-forward difference, referred to as the excluded component, from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. As such, we defer recognition of foreign currency gains and losses within the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Foreign currency translation adjustment (CTA)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and we reclassify amortization of the excluded component from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to current period earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of June&#160;30, 2021 and December&#160;31, 2020, we designated as a net investment hedge a portion of our &#x20ac;900 million in aggregate principal amount of 0.625% senior notes issued in November 2019 and due in 2027. For these nonderivative instruments, we defer recognition of the foreign currency remeasurement gains &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and losses within the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; CTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We reclassify these gains and losses to current period earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our accompanying unaudited consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our accompanying unaudited consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Interest Rate Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Management Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Designations and Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no interest rate derivative instruments designated as cash flow hedges outstanding as of June&#160;30, 2021 and December&#160;31, 2020. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was a $27 million loss as of June&#160;30, 2021&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and a $29 million loss as of December&#160;31, 2020. We recognized immaterial gains and losses in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the amortization of our terminated cash flow hedges in the current and prior periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no interest rate derivative instruments designated as fair value hedges outstanding as of June&#160;30, 2021 and December&#160;31, 2020. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our accompanying unaudited consolidated balance sheets into earnings as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which generally offset. The balance of the deferred gains on our terminated fair value hedges within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was immaterial as of June&#160;30, 2021 and December&#160;31, 2020. We recognized immaterial gains in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the amortization of the terminated fair value hedges in the current and prior periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#x20ac;900 million debt principal designated as a net investment hedge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining time to maturity as of June&#160;30, 2021 is within 60&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next year. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited consolidated statements of operations. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note M &#x2013; Changes in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the total amounts relating to derivative and nonderivative instruments presented within our accompanying unaudited consolidated statements of comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; CTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Balance Sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;322&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#x20ac;900 million debt principal designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Inputs to the valuation methodology are unobservable inputs based on management&#x2019;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;322&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,189&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,998&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,605&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;662&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,865&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $2.379 billion invested in money market funds and time deposits as of June&#160;30, 2021 and $1.584 billion as of December&#160;31, 2020, we held $296 million in interest-bearing and non-interest-bearing bank accounts as of June&#160;30, 2021 and $150 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions, Divestitures and Strategic Investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#x2122; Drug. We recognized a financial asset and associated liability for our licensing arrangements at fair value in our accompanying unaudited consolidated balance sheets using the fair value option in accordance with FASB ASC Topic 825, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We own the contractual right to receive 50 percent of the future royalty payments from the licensee and remit such payments to the inventors associated with the intellectual property. Royalty payments we receive reduce the fair value of the financial asset and are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and payments we remit to inventors reduce the fair value of the financial liability and are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Payments for royalty rights&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our unaudited consolidated statements of cash flows. We sold our right to receive and retain the other 50 percent of the future royalty payments in 2019 for an upfront cash payment, which we accounted for as a secured borrowing in accordance with FASB ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Although we sold these rights, we continue to recognize at fair value the future royalty payments as a financial asset and associated liability. Royalty payments associated with the rights we sold no longer impact our cash flows, and we present this activity as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-cash impact of transferred royalty rights&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the supplemental information to our unaudited consolidated statements of cash flows. We reduce the fair value of the financial asset and associated liability when such non-cash activity occurs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have recorded the fair value of the financial asset and associated liability using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of June&#160;30, 2021.  However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains and losses from the licensing arrangement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2021 include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average (1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$311 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$350 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash impact of transferred royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash impact of transferred royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;350&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Non-Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions, Divestitures and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our strategic investments and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note C &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of the fair values of our intangible assets including goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our outstanding debt obligations was $10.431 billion as of June&#160;30, 2021, including $1.085 billion relating to our euro-denominated December 2027 Notes, and $10.774 billion as of December&#160;31, 2020, including $1.118 billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our debt obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzNzM_46970bd1-b9de-4c98-a32e-81693dca667c">Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfNDY0OA_067e34e9-4261-4113-bfe8-f6a209bb059a"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfNDY4NA_97e4c152-9d82-4793-adc7-408e7d9a664a"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DerivativeTermOfContract
      contextRef="id15fe40bbc1a49598899e77eca657086_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM2ODQ_c79c229a-f1f4-4f0a-91f4-e9f0ecc9ba7f">P1Y</us-gaap:DerivativeTermOfContract>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i337a6f01680a4261a534fe13d39a19aa_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MjQ_2654df20-1eff-4cc3-b5fd-e99cb98ec4b4"
      unitRef="derivative_instrument">0</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i0484760d76d648ef90f70bb1389a147f_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MjQ_d8308761-8392-4462-a818-163976a17769"
      unitRef="derivative_instrument">0</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i3139c7b655da4d49a12993d29146beea_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfNzM3Ng_9fa589e0-89c6-4b18-a2b0-ac569961657b"
      unitRef="usd">-27000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ia68688cce8064b70bcca08cd6512a4ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfNzM5OQ_7ba43100-5ffc-4e40-a3d2-f2e96e443fc7"
      unitRef="usd">-29000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i6ffac8f2ce0d4293b26df78d0ad2d8e0_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MTY_245a0d8b-d4df-4841-9bbf-f3cfa024c6ce"
      unitRef="derivative_instrument">0</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i424e4f7e39a9410981b8ba416ccac4c3_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MTY_fc41e181-ab35-4dab-a5af-8d3eecff7a1c"
      unitRef="derivative_instrument">0</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTg0MTQ_2b49b85d-7b6d-4361-81a1-dd09554cbc6c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#x20ac;900 million debt principal designated as a net investment hedge.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iadf7143e00714f7a9f615443b868ca37_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfMi00LTEtMS0w_8d433ff6-6825-485e-9d42-bcf89bae55d2"
      unitRef="usd">4725000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i61f98deb368144a69329cdfbbd8f2cc3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfMi02LTEtMS0w_b10c262b-7934-4319-8192-719f6089c2ba"
      unitRef="usd">4531000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id3020f06cb394eccb08b9f3827b65587_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfMy00LTEtMS0w_409c4c5a-2fac-4e89-8626-c4cc85e04abf"
      unitRef="usd">493000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i27bdbdb9fd8a47e9b5c80577d41a1ec4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfMy02LTEtMS0w_7600e480-06ed-420a-8f2a-f3cb9584dc88"
      unitRef="usd">1004000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ifff3446af476436f83c776f6272d3517_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNC00LTEtMS0w_d7627040-d42c-49fb-b504-2f03c64a5731"
      unitRef="usd">997000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7f69fa3f42484de3a5cd8686c169cf5e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNC02LTEtMS0w_155a65ea-d458-4a13-b337-c209cc7511a0"
      unitRef="usd">868000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2dc0aeafc5504f8491f1d7e2d12710bc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNS00LTEtMS0w_57a50ece-51dd-4519-8efa-af9803d3e360"
      unitRef="usd">5125000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia2952dc166454f9fb8cff9b5579e82ac_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNS02LTEtMS0w_132f48d4-fa90-486b-934b-9f00eebcf447"
      unitRef="usd">4946000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNy00LTEtMS0w_71509962-b824-41a2-98ee-51a4e45422c6"
      unitRef="usd">11340000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjcwY2ZiZGM5YmUxMzQ0ZjViZGYwNTgzZGYxNDY0MmEwL3RhYmxlcmFuZ2U6NzBjZmJkYzliZTEzNDRmNWJkZjA1ODNkZjE0NjQyYTBfNy02LTEtMS0w_10a53779-1216-4f0c-a32d-3ae0b7c56852"
      unitRef="usd">11349000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfODgwNw_067e34e9-4261-4113-bfe8-f6a209bb059a"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <bsx:ForwardCurrencyContractsTimetoMaturity
      contextRef="if744488d910741f99e4dde8ee82cf4fa_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfODkxNA_1205fb5e-57ec-44f0-9717-31ec789e13ae"
      unitRef="units">60</bsx:ForwardCurrencyContractsTimetoMaturity>
    <us-gaap:DerivativeRemainingMaturity1
      contextRef="id15fe40bbc1a49598899e77eca657086_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MDE_f2d38532-4b4c-4407-b00e-eeb402081001">P1Y</us-gaap:DerivativeRemainingMaturity1>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzNjc_88444bea-8eb4-4fe3-b529-f80f2dc71316">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; CTA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS0xLTEtMS0w_991eb754-054d-4c3f-b3b3-b241bbf91839"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS0yLTEtMS0w_3bfa2ead-3ae5-4dce-aba0-e2a5b2c944f6"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS0zLTEtMS0w_bfccbaba-cac2-4066-99b5-7712c7e11780"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS02LTEtMS0w_1ea0b65f-3c8d-4020-b8b6-9f20ed1f6b4b"
      unitRef="usd">945000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS04LTEtMS0w_95d2cfe6-316f-40c3-af6d-09161342dade"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS05LTEtMS0w_adee0f43-81b3-425d-8ec7-ffb61304fc70"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i355d35d8a50147c58c1b9393d0c23590_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNS0xMC0xLTEtMA_42a40994-41ee-4ee0-ba05-343f9f69fe54"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi0xLTEtMS0w_252782e9-0ec7-4e3d-8cf6-4e45490a458c"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi0yLTEtMS0w_ac22e943-2ec8-4860-9e00-eb576c3bab29"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi0zLTEtMS0w_1061ab01-6da0-48f5-8027-102188a8a00b"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi02LTEtMS0w_e04a22a4-52f7-418f-b9f9-936e1ec40a47"
      unitRef="usd">86000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi04LTEtMS0w_6bf34dd8-5294-479f-b0bb-57eb26199d52"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi05LTEtMS0w_16c441ff-b16f-47f3-b216-5e279fd7a919"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="ie8e0f8100dda4ba4804c26879cb8f359_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfNi0xMC0xLTEtMA_2bf097ba-8f2d-44b9-9a38-674679d8d381"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC0xLTEtMS0w_6e9beff1-0dbf-4f0c-bd26-fa244b27fa7b"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC0yLTEtMS0w_a8637ee3-4b33-4e54-9308-9ab75e7acd28"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC0zLTEtMS0w_dcebc427-c8dd-4fd3-90a8-c4ccab8d63eb"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC02LTEtMS0w_4eca890b-1c3c-43b3-a379-54db5a8de2a3"
      unitRef="usd">26000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC04LTEtMS0w_cdc0b017-afcb-4f99-beb8-cf509a23e2e5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC05LTEtMS0w_5bff0805-d718-44bf-bcc4-1ade3eb31fe5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="id9a4e43ec60d4358beff545e75d725be_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfOC0xMC0xLTEtMA_56b8a2eb-55e3-49ec-927a-ef00ce3d96c1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtMS0xLTEtMA_e0264a3b-6d0e-43e3-b672-bb2830aa047c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtMi0xLTEtMA_a77bd999-1b1a-41fc-8bde-48f759e599c2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtMy0xLTEtMA_f44d56dd-8969-4d92-a1c4-58357c4da15a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtNi0xLTEtMA_e04a22a4-52f7-418f-b9f9-936e1ec40a47"
      unitRef="usd">86000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtOC0xLTEtMA_acb1f94b-f990-4e2e-ae6a-bab3d07786d9"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtOS0xLTEtMA_019ac6a9-3958-412d-a94a-50331248d3f5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ife61a35414c94d28863d163cb3379eee_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTAtMTAtMS0xLTA_89a8f566-19cd-4101-b746-940781d92a0b"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtMS0xLTEtMA_6d0ed58d-0301-442e-b80e-26a6ca4f488f"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtMi0xLTEtMA_940464ec-999f-4f8a-82d0-cdd023ce4b4c"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtMy0xLTEtMA_dd508aef-bd76-4aa9-bd55-7f528efa43de"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtNi0xLTEtMA_e13c179b-840b-4ff9-9fdd-c77218c21875"
      unitRef="usd">791000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtOC0xLTEtMA_dbcb4b09-ea09-4bff-b5bf-f45e392a5771"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtOS0xLTEtMA_10822c3d-9aac-4a95-85d5-ba7d6cfc2c49"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ibcbc612af7f04d7b91ca54a87aae6222_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTMtMTAtMS0xLTA_82aea098-54f5-44e8-baea-3a262935f54b"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtMS0xLTEtMA_c7215688-cd22-4162-8a8f-c2c649adb335"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtMi0xLTEtMA_9cb31f61-ce30-4f82-b453-091dcb9f8c94"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtMy0xLTEtMA_e17caf78-a40e-4620-9701-466ec8561f5b"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtNi0xLTEtMA_a03cfe2a-7064-4a60-bcc1-68b6368d68e3"
      unitRef="usd">91000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtOC0xLTEtMA_b348ae12-773a-4273-87d2-eae7bfec9530"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtOS0xLTEtMA_2c11c7df-ff76-4207-8a97-8d315766a5f8"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="i803788ce65214fe69e9b5f6236cf8ee6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTQtMTAtMS0xLTA_efa8cc1e-bacc-4355-bc86-c8b88f28f166"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtMS0xLTEtMA_a984509e-16c4-4367-bc7f-e5381466c3e7"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtMi0xLTEtMA_f13dd8e8-749c-4ea6-8da0-c2240db60863"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtMy0xLTEtMA_6029087d-2f57-45c0-9411-a802ba52e524"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtNi0xLTEtMA_9703e017-162c-4b79-9f7a-64e11e3cc06c"
      unitRef="usd">18000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtOC0xLTEtMA_2f905414-cf2d-4c8c-8588-b5968af01bdb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtOS0xLTEtMA_7840ae80-ccd3-4f5b-a290-af264bc34bdc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="i60b7b1b530754b3a930184d6dbacd26c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTYtMTAtMS0xLTA_d6f28370-7c7e-43a4-b3cb-39f18b0d5304"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtMS0xLTEtMA_0e1f4574-8c30-4654-a307-3abce24ee875"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtMi0xLTEtMA_187eefc5-4c33-449c-a318-d2d41575ec64"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtMy0xLTEtMA_acdf74b9-a372-4c92-a3ec-0a0c80aafdad"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtNi0xLTEtMA_a03cfe2a-7064-4a60-bcc1-68b6368d68e3"
      unitRef="usd">91000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtOC0xLTEtMA_a73d3a3e-fd12-4204-8002-1847a35aa49f"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtOS0xLTEtMA_923ea147-fb88-4117-a9da-96b4c9b313e2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="iabbf9023c2174bb7a5e9a2006f4126a9_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMTgtMTAtMS0xLTA_83ec2ced-2244-414e-bfa3-a29ce75ada89"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtMS0xLTEtMA_2e6e524c-d5de-4f27-b953-2f2e501cf0fa"
      unitRef="usd">156000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtMi0xLTEtMA_9c07a64f-9ae1-4557-bb97-1e7025e624eb"
      unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtMy0xLTEtMA_1b64f36f-ef0d-4f27-986b-adffc2cc103f"
      unitRef="usd">121000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtNi0xLTEtMA_cb45645d-2fe4-4394-9b09-5e92140c07d1"
      unitRef="usd">1839000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtOC0xLTEtMA_51706250-b5a0-43d1-9919-c53bd003d4ff"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtOS0xLTEtMA_18a4b8e6-73c8-4296-8e04-d28092ed4580"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i1a6c71d531dd4670b9e4af0d801a079e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjEtMTAtMS0xLTA_8eac0ce8-c368-4c94-afa7-c73a6bb67b78"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItMS0xLTEtMA_67be6ed1-4e98-4282-8bec-220ad73f6230"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItMi0xLTEtMA_b23590a2-3b9d-49a4-85e0-6eebd947b2cb"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItMy0xLTEtMA_818f2b40-f24e-4ea8-9e74-4415cd27625a"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItNi0xLTEtMA_66aae967-2831-4749-bd0c-387703f44ac8"
      unitRef="usd">168000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItOC0xLTEtMA_d5ad9aef-f4a1-4eef-9522-796480f59d6e"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItOS0xLTEtMA_dc6f51f4-4eb0-4985-9677-a01c0236d54f"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="i19dd2038e5c94312a220ca7dc5252ce5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjItMTAtMS0xLTA_4f55966f-9270-464a-964a-3371933dd92c"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtMS0xLTEtMA_febdf0bc-82a2-4334-8466-17c1658db4aa"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtMi0xLTEtMA_e807478c-4c93-4e4e-bf45-08557e892822"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtMy0xLTEtMA_bdc0274d-d739-477b-b141-7db2f51592c2"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtNi0xLTEtMA_a1943abd-edb9-4d5c-8bbe-434b0779a4ef"
      unitRef="usd">-11000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtOC0xLTEtMA_22c300fe-595b-4458-bc1c-d52f279db06d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtOS0xLTEtMA_5eec4e18-2e89-4f02-964d-428b91cbfe78"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="ie691e9973e4c4fd0a67b4b7ceebf8e30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjQtMTAtMS0xLTA_c9ca9b22-d728-4bdb-914e-b667d439c0d7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtMS0xLTEtMA_994d720a-a4bc-4920-bfb0-cfec124e4c15"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtMi0xLTEtMA_32f22dff-ee37-4f03-b27b-b8b67e5d9364"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtMy0xLTEtMA_81274602-2f9b-4a33-a9ea-fe6fc493ba3c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtNi0xLTEtMA_66aae967-2831-4749-bd0c-387703f44ac8"
      unitRef="usd">168000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtOC0xLTEtMA_a4584259-56d3-411c-9f27-043d8464f146"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtOS0xLTEtMA_2098315f-549e-4a8c-94c3-9b4cc1ec84a8"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ie1bb7c50f7d04dea85248a0569ab38fa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjYtMTAtMS0xLTA_6652bb89-5f1c-4565-abac-375c5ae80ef3"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktMS0xLTEtMA_9eaa7fd8-d653-4231-be26-3359f1e66572"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktMi0xLTEtMA_1b1489b5-2f5d-4a79-b369-8d7c582279d9"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktMy0xLTEtMA_f50906d5-da8a-4683-873b-3b338a9f4f59"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktNi0xLTEtMA_8c560163-dc37-4d04-9037-52a200d3f7ff"
      unitRef="usd">1596000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktOC0xLTEtMA_9664e9a3-ca17-44a6-88db-41f385e4a76f"
      unitRef="usd">-51000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktOS0xLTEtMA_a5f1cc5b-6363-4027-af53-98a86c38f44a"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i763ebb1cc10045159d6c3807131d4da5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMjktMTAtMS0xLTA_427b1aa5-c568-41cf-826f-c4c3b907774d"
      unitRef="usd">-39000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtMS0xLTEtMA_14967330-9251-451b-b0ca-66b309905255"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtMi0xLTEtMA_7b32db53-702d-4d8f-8f47-255e6e4766bb"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtMy0xLTEtMA_c997a784-7b9d-4eeb-9d8d-9d51c5288caf"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtNi0xLTEtMA_c81a8fbd-8f2c-46fa-ab79-e6bac39ed182"
      unitRef="usd">179000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtOC0xLTEtMA_09c4fed4-b000-42b3-9a4f-65cdfaa06e9d"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtOS0xLTEtMA_871e01a2-ba2f-4d48-96cc-c0231ce306f1"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="ia361cf49a83a49148d0d417784f0cafd_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzAtMTAtMS0xLTA_a2d6ee0a-04e5-4dc6-bdbe-79abe0e8288a"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMS0xLTEtNTg5_230badf6-95cf-47cb-9bd9-df0befc63d15"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMi0xLTEtNTg5_c3c03e9b-2237-4bcf-a184-60bb358b4440"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMy0xLTEtNTg5_5325378b-1f97-4960-8798-273f150bf8ac"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItNi0xLTEtNjAz_a9cc47fb-e532-4a5d-9c9a-8d4a6e7003d7"
      unitRef="usd">54000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
      contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItOC0xLTEtNTk2_8ec74b2c-df9f-4144-9030-9cf1cb6fa46d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
      contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItOS0xLTEtNTk2_3d721657-1b44-459d-9bb6-947a4d57350c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
      contextRef="i13200394ceca4498a424ec29d1b93ef1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMTAtMS0xLTU5Ng_823c9f53-c3ca-47a7-8c1b-a89fc527bd03"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMS0xLTEtMA_bf74968f-930e-4224-b741-b3be7ceac950"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMi0xLTEtMA_919b29f8-15bb-441d-8656-7160025eadbd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMy0xLTEtMA_20fe9f3b-fc78-4fbf-bae5-3b4e2dc83885"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItNi0xLTEtMA_c81a8fbd-8f2c-46fa-ab79-e6bac39ed182"
      unitRef="usd">179000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItOC0xLTEtMA_8c0fdc44-4a8b-4797-b123-d0b876daaafa"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItOS0xLTEtMA_7f8be863-70d2-40b3-9004-8fbee3a0ad2f"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i76da37a6619346f7a5eee5204d86feb8_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjUyY2VmN2NhMDhiYzQ4MDA5YWJlM2Y5OWQzMDg2ZWI5L3RhYmxlcmFuZ2U6NTJjZWY3Y2EwOGJjNDgwMDlhYmUzZjk5ZDMwODZlYjlfMzItMTAtMS0xLTA_cffea55a-4add-4a5a-a171-7749d613963a"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="if0446aef545942b8b12a84b25e182179_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MzI_5f1a7ad7-0f72-406a-bdd5-9beb8ee0880e"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="iba71732844214aa3859047cf4cd1b074_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MzI_67d09de3-0f27-4504-b6d6-80f6ab87b1f9"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ic356266b05f74a6b9f1191f2b815f11b_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MzI_f8a1fcca-0769-4728-892d-160bd16ba8de"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i05caf238eba7451e935612a5c094056c_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc1OTIxODYwNjM3MzI_fdc18186-e36d-459e-869a-8b01baa84757"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzODM_f40a95cf-9ad8-4cf0-b15e-875a9d69db83">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="i95c41329358c426dbfde24ddb1b29c13_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjZmYWUyZWRlNjhmYTRmNzE4MTZhN2RiYTdhMTM0M2IwL3RhYmxlcmFuZ2U6NmZhZTJlZGU2OGZhNGY3MTgxNmE3ZGJhN2ExMzQzYjBfMS02LTEtMS0w_8a33686e-ef7e-4daa-866e-5b8a386fcebd"
      unitRef="usd">75000000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet
      contextRef="i001157b3c6c14f6ab4a49a1468cbba56_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjZmYWUyZWRlNjhmYTRmNzE4MTZhN2RiYTdhMTM0M2IwL3RhYmxlcmFuZ2U6NmZhZTJlZGU2OGZhNGY3MTgxNmE3ZGJhN2ExMzQzYjBfMi02LTEtMS0w_996cdfea-54ba-488e-9c28-f092d15a7639"
      unitRef="usd">7000000</bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="ia0d946dede0f4f31a139ab6bc367b6a4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjZmYWUyZWRlNjhmYTRmNzE4MTZhN2RiYTdhMTM0M2IwL3RhYmxlcmFuZ2U6NmZhZTJlZGU2OGZhNGY3MTgxNmE3ZGJhN2ExMzQzYjBfMy02LTEtMS0w_98e7352d-d038-4852-907d-39da2b6174e8"
      unitRef="usd">-5000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzNjE_ae074bb5-8233-45b8-a704-49412c1e5be0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="idff7731f281941c9b10a57598c4f3fa3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMi00LTEtMS0w_7ed426d9-b49f-4088-9bf0-70b45dde74d9"
      unitRef="usd">-1000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i88819d9575244b1f9ae25324bd55ef4f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMi02LTEtMS0w_345430d9-7ec6-4410-95af-c0d08e297c89"
      unitRef="usd">6000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i26eb37997b434810bb1db3a61e1958c8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMi04LTEtMS0w_b1f28df4-a4d3-4479-9fa2-482d4d859c1a"
      unitRef="usd">-2000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i95b1b2df03b543738424133c5483532f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMi0xMC0xLTEtMA_aa578989-95d3-4175-b4cb-8375121f7313"
      unitRef="usd">-9000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="idff7731f281941c9b10a57598c4f3fa3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMy00LTEtMS0w_4f2e1edd-3c75-440d-a104-7922deb68fa5"
      unitRef="usd">-5000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i88819d9575244b1f9ae25324bd55ef4f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMy02LTEtMS0w_247b4705-3609-4009-abf8-89fca62a0367"
      unitRef="usd">-11000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i26eb37997b434810bb1db3a61e1958c8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMy04LTEtMS0w_4eb7080e-40b8-4923-a12e-41e1112fbbad"
      unitRef="usd">-6000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i95b1b2df03b543738424133c5483532f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfMy0xMC0xLTEtMA_44da5ebc-26bf-4bb2-8e11-03abafa54a9c"
      unitRef="usd">-3000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <bsx:Netcurrencyexchangegainloss
      contextRef="idff7731f281941c9b10a57598c4f3fa3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfNC00LTEtMS0w_aef9db64-64bd-4fe4-9f39-db041b87ea18"
      unitRef="usd">-7000000</bsx:Netcurrencyexchangegainloss>
    <bsx:Netcurrencyexchangegainloss
      contextRef="i88819d9575244b1f9ae25324bd55ef4f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfNC02LTEtMS0w_76c10f90-2c4b-4a44-abb2-5fc7c2474d3c"
      unitRef="usd">-5000000</bsx:Netcurrencyexchangegainloss>
    <bsx:Netcurrencyexchangegainloss
      contextRef="i26eb37997b434810bb1db3a61e1958c8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfNC04LTEtMS0w_b0d38794-97f3-4ec6-8d76-a91ff5532d28"
      unitRef="usd">-9000000</bsx:Netcurrencyexchangegainloss>
    <bsx:Netcurrencyexchangegainloss
      contextRef="i95b1b2df03b543738424133c5483532f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmVjYmY0ZjEwOGQ2NDRjMmQ4MzM4NjUxODk2ODc3NDVlL3RhYmxlcmFuZ2U6ZWNiZjRmMTA4ZDY0NGMyZDgzMzg2NTE4OTY4Nzc0NWVfNC0xMC0xLTEtMA_ddd5b089-49cc-44da-9eef-dca6ff8c833f"
      unitRef="usd">-12000000</bsx:Netcurrencyexchangegainloss>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzOTc_df1d1ed0-6169-45fd-be60-88c08fa063ae">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzOTQ_98aabb27-d837-4627-959e-259c1bf40629">The following are the balances of our derivative and nonderivative assets and liabilities:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Consolidated Balance Sheets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;322&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#x20ac;900 million debt principal designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i413490b8a5b549428c780264cd0fca96_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNC00LTEtMS0w_745f93f1-d9ae-4f47-9f9d-cc9e4bd9bac5"
      unitRef="usd">128000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i7898c0ae54f649e3b3bd7531b4e96637_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNC02LTEtMS0w_ef4394d3-2c65-4dcb-be73-0011042c7c48"
      unitRef="usd">53000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i1e501501753d4bc3893312052f231981_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNS00LTEtMS0w_1eca8546-364f-4f06-95ee-85e2a5cd9d39"
      unitRef="usd">156000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ibc334024d192429bb461fc883b913f95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNS02LTEtMS0w_1f057bd5-774a-449d-a334-064f2650f099"
      unitRef="usd">109000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i210e93bd44c944e39350884a3a028415_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNi00LTEtMS0w_0bb42a90-1f85-453b-baf4-b5ebbbcb8e69"
      unitRef="usd">284000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i5b553319bf064b3fa60f0b256efd9a1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfNi02LTEtMS0w_581552ac-1f3d-468c-ad03-be4e55a3e742"
      unitRef="usd">162000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i7a91e7a45fbc446c8783c08420680904_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfOC00LTEtMS0w_bab33cc7-8a03-4af7-b63a-166f03ba9335"
      unitRef="usd">38000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i5e8b4d9c146e4af78c9649552b795b81_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfOC02LTEtMS0w_12e08e0e-c8b6-4065-9712-3b40ed27f6d5"
      unitRef="usd">79000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTAtNC0xLTEtMA_a6423abe-b483-46e2-b8d1-f5e5e02f200c"
      unitRef="usd">322000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTAtNi0xLTEtMA_6e54a1af-ca9a-4c40-bc1d-11f5d05adfe1"
      unitRef="usd">242000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ieb50746f189146428dc3a086275c1f6e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTQtNC0xLTEtMA_c742ff15-ee63-46a9-90f5-b83fc9c0ade9"
      unitRef="usd">37000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i21748e73c93f404ebf1695c897f921fc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTQtNi0xLTEtMA_13be6d9e-1e96-4373-9239-1c1dade2d294"
      unitRef="usd">44000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ifcd5967abae8433c8e776f2d4c8e34f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTUtNC0xLTEtMA_2c8524f0-80c9-4025-81cc-276904c23a72"
      unitRef="usd">16000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i946142230e0d45968c7d35a681ee1ca7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTUtNi0xLTEtMA_b820a557-76d2-4c8b-8e2f-92aefe7e0806"
      unitRef="usd">54000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i2d5a78c050d24c3998ce9d7394914716_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTYtNC0xLTEtMA_d7b97673-c4da-478a-a72b-7e53d620bfd4"
      unitRef="usd">1058000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ia8b3a25a0021455c82d237efda98677a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTYtNi0xLTEtMA_0f253fc8-13c2-414d-a44e-6bb911f29721"
      unitRef="usd">1094000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i210e93bd44c944e39350884a3a028415_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTgtNC0xLTEtMA_7e29eef0-9514-418e-a9f4-5da6c9c4b945"
      unitRef="usd">1111000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i5b553319bf064b3fa60f0b256efd9a1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMTgtNi0xLTEtMA_ec8c4602-ad5e-4626-94ac-0ae337e705d8"
      unitRef="usd">1191000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i28be2cc81b8646da8951fe8f886431ae_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMjAtNC0xLTEtMA_6b1fbc1d-68a2-4a46-8d3c-91b9602fffa2"
      unitRef="usd">51000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="ibd3a971d105c47e3b030d7146612746b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMjAtNi0xLTEtMA_4d604062-0167-41fb-8916-0214e4a7c625"
      unitRef="usd">71000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMjEtNC0xLTEtMA_69ad0ee1-ed5f-40fe-ba1f-270da93d52a0"
      unitRef="usd">1163000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmJkZTQ4ZmRkOTYwNDQ5ZDI4ZTQ3ZDYzMTYxMjZiY2M5L3RhYmxlcmFuZ2U6YmRlNDhmZGQ5NjA0NDlkMjhlNDdkNjMxNjEyNmJjYzlfMjEtNi0xLTEtMA_489214a8-5f8a-450e-899e-de629d9b73b7"
      unitRef="usd">1262000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LongTermDebt
      contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTI0ODY_067e34e9-4261-4113-bfe8-f6a209bb059a"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgzOTU_8bf78683-799c-4060-b752-a939b9617435">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;322&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,189&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,998&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,605&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;662&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,865&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2021 include the following significant unobservable inputs:&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average (1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$311 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$350 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;365&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash impact of transferred royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash impact of transferred royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;350&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC0xLTEtMS0w_fc486bba-21d3-4409-b127-f1aba5563e3f"
      unitRef="usd">2379000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="id1d17d52c56344148e6f68416205f316_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC0zLTEtMS0w_a30088b4-ee29-486f-bfed-021b038e2a04"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i18328309825f40b887eb0ef197588dd3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC01LTEtMS0w_89f3108a-1ee8-493e-8e10-954eb0ee4bb0"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i7f8a220efc374460aac18c0864628e67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC03LTEtMS0w_c69927e2-322b-4dfa-9cb3-f6e0d557a9a5"
      unitRef="usd">2379000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC05LTEtMS0w_644c5b1e-7588-4943-9017-955d6780abd6"
      unitRef="usd">1584000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC0xMS0xLTEtMA_0c1b45d4-4f9d-42bd-b111-7106f03e8404"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC0xMy0xLTEtMA_84e19eb7-021e-494e-ba7d-d1a5a8aad9e0"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNC0xNS0xLTEtMA_8048db0c-ba6b-4972-8fb2-2ad029b55851"
      unitRef="usd">1584000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS0xLTEtMS0w_95f9d179-bcbb-43e6-a191-698555bec51f"
      unitRef="usd">176000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id1d17d52c56344148e6f68416205f316_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS0zLTEtMS0w_d1ea4731-e42e-41ab-9f74-292d4d9d13f7"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i18328309825f40b887eb0ef197588dd3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS01LTEtMS0w_8b6d8614-74e9-4a83-baa4-4607fe8ea18e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7f8a220efc374460aac18c0864628e67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS03LTEtMS0w_04bfc84e-bcd5-49ff-a57b-eae5203efd15"
      unitRef="usd">176000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS05LTEtMS0w_c50769e4-54d8-416f-b0c5-33fc8530ae5f"
      unitRef="usd">414000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS0xMS0xLTEtMA_6befafe0-a61c-45f4-b987-452a89fd151f"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS0xMy0xLTEtMA_9978b4c4-fd7c-4369-b09d-a35ca16b11d1"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNS0xNS0xLTEtMA_95bb586c-021e-484c-8087-55845e30239a"
      unitRef="usd">414000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi0xLTEtMS0w_414b4c11-0549-4a75-b1a3-ed366647252e"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id1d17d52c56344148e6f68416205f316_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi0zLTEtMS0w_5bad3be6-58ea-4260-9183-c0a348b4d1ee"
      unitRef="usd">322000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i18328309825f40b887eb0ef197588dd3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi01LTEtMS0w_5d480719-dd59-4e08-96dc-a6cbdd2f375f"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i7f8a220efc374460aac18c0864628e67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi03LTEtMS0w_317c912e-09ce-4fe0-84cf-f771deae7e52"
      unitRef="usd">322000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi05LTEtMS0w_52aa409b-c04e-4bf4-9cca-3757e4132802"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi0xMS0xLTEtMA_cb6d15b4-08d8-455d-acbc-1c783b07e31a"
      unitRef="usd">242000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi0xMy0xLTEtMA_3c17218a-45df-4ead-add4-78628188589b"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNi0xNS0xLTEtMA_ee071d6a-d22a-4c42-b6dd-d69b686ecf50"
      unitRef="usd">242000000</us-gaap:DerivativeAssets>
    <bsx:Licensingarrangementsasset
      contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy0xLTEtMS0w_e1da296e-6919-4795-9623-d6d69b4c0673"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="id1d17d52c56344148e6f68416205f316_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy0zLTEtMS0w_420add8a-a14b-41d6-8536-1d01d5b96db7"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i18328309825f40b887eb0ef197588dd3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy01LTEtMS0w_5f4ab9ac-ad8b-4bfc-8064-6ec6255543a5"
      unitRef="usd">311000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i7f8a220efc374460aac18c0864628e67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy03LTEtMS0w_284d743f-a984-41de-bfbb-ad32ea5b92f0"
      unitRef="usd">311000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy05LTEtMS0w_856054a3-3d60-4cb3-93ad-4e95746390f3"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy0xMS0xLTEtMA_687062f3-f8e4-4060-919e-ac9337f08a0f"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy0xMy0xLTEtMA_2fceb99c-a58b-4744-bc3f-37b6bc53bc49"
      unitRef="usd">365000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfNy0xNS0xLTEtMA_531da08d-c71b-46b7-8783-54cb37e230bd"
      unitRef="usd">365000000</bsx:Licensingarrangementsasset>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC0xLTEtMS0w_904e10b5-5595-48f5-bde5-2e753c3217f8"
      unitRef="usd">2556000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id1d17d52c56344148e6f68416205f316_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC0zLTEtMS0w_cd893a99-41aa-4650-84fa-8101841e4665"
      unitRef="usd">322000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i18328309825f40b887eb0ef197588dd3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC01LTEtMS0w_30d5d746-0cc8-4fde-a32e-f12961c45e0a"
      unitRef="usd">311000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7f8a220efc374460aac18c0864628e67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC03LTEtMS0w_bbba3b97-f732-4a45-aca2-60b233cc87be"
      unitRef="usd">3189000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC05LTEtMS0w_a2254a9e-f564-4209-a2da-5f9861f88808"
      unitRef="usd">1998000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC0xMS0xLTEtMA_625fe5fb-d8e6-45b8-8f14-299bed75d0da"
      unitRef="usd">242000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC0xMy0xLTEtMA_cd00a508-f338-4a16-854c-ad28a98f51f7"
      unitRef="usd">365000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfOC0xNS0xLTEtMA_d1eabee5-b13d-4bcd-8956-3682fa23e896"
      unitRef="usd">2605000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtMS0xLTEtMA_853a2051-c5eb-4291-9e0e-85e3fb77bb39"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id1d17d52c56344148e6f68416205f316_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtMy0xLTEtMA_58734b57-07b6-47de-920b-3c28da4b482d"
      unitRef="usd">1163000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i18328309825f40b887eb0ef197588dd3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtNS0xLTEtMA_31ac34ce-2792-42a3-9ab2-76ba2cb480b3"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i7f8a220efc374460aac18c0864628e67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtNy0xLTEtMA_7b280743-469c-4853-a96f-113b54edd81a"
      unitRef="usd">1163000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtOS0xLTEtMA_81c3339f-0e7c-4e13-9f91-c2017e76b58d"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtMTEtMS0xLTA_e0af9e0f-67f9-4a25-ba5d-7e7baba57597"
      unitRef="usd">1262000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtMTMtMS0xLTA_415b9a09-cf8e-4528-970c-171dc7aae1bd"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTAtMTUtMS0xLTA_83c9228a-8d1b-4da8-98db-d49a8f0848be"
      unitRef="usd">1262000000</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtMS0xLTEtMA_5c4db3b9-b285-4129-a729-fa7565cc3304"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id1d17d52c56344148e6f68416205f316_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtMy0xLTEtMA_932c8da9-7987-41ab-9a08-7fe7b61386e9"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i18328309825f40b887eb0ef197588dd3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtNS0xLTEtMA_5b16dd2f-4da7-4a85-a812-31902ece6175"
      unitRef="usd">312000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7f8a220efc374460aac18c0864628e67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtNy0xLTEtMA_c0d9150b-5921-490f-af01-d999ccac4ef6"
      unitRef="usd">312000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtOS0xLTEtMA_148f7a7f-94eb-44e0-b330-aae36cddf5bf"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtMTEtMS0xLTA_c7656389-b712-4729-be4c-610c53b53e3c"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtMTMtMS0xLTA_b0a15904-1097-46c8-aff7-d6b539e74122"
      unitRef="usd">196000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTEtMTUtMS0xLTA_05a138d6-6a78-404d-8190-09f105000aab"
      unitRef="usd">196000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:Licensingarrangementsliability
      contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItMS0xLTEtMA_d920cf25-3dcb-477f-9ba7-d461603cdda3"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="id1d17d52c56344148e6f68416205f316_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItMy0xLTEtMA_71e00b47-a0cf-45f2-ab5a-434c03a03e1b"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i18328309825f40b887eb0ef197588dd3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItNS0xLTEtMA_8bd55583-7823-4589-82f8-1b17992091f1"
      unitRef="usd">350000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i7f8a220efc374460aac18c0864628e67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItNy0xLTEtMA_27dfe8b0-b6e6-4e21-a1b6-03d1f42eb51d"
      unitRef="usd">350000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItOS0xLTEtMA_e2fe8f6a-6277-473d-b18f-529cc15cc45f"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItMTEtMS0xLTA_d59d57f1-3220-4878-88e0-cf3be323fde8"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItMTMtMS0xLTA_e42584b8-d5af-4a4b-88aa-6d41f9ba2095"
      unitRef="usd">407000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTItMTUtMS0xLTA_c55108ba-1820-472a-aa2f-159d16ad0628"
      unitRef="usd">407000000</bsx:Licensingarrangementsliability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtMS0xLTEtMA_8b6e5a67-b483-49fa-8277-94a8eabc7f28"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id1d17d52c56344148e6f68416205f316_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtMy0xLTEtMA_55160e3a-9bb8-46b0-9ed8-0a1e39d902ca"
      unitRef="usd">1163000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i18328309825f40b887eb0ef197588dd3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtNS0xLTEtMA_d1179ce2-15d0-441f-b4be-5063494b95d1"
      unitRef="usd">662000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7f8a220efc374460aac18c0864628e67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtNy0xLTEtMA_b422fee9-fe1d-4c2e-9926-84b049f8538c"
      unitRef="usd">1825000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtOS0xLTEtMA_6e7a56df-e98c-4c70-9ba7-b86cf6b00de2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i888c9e5c58b94bb2a463c44ac2e2ac45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtMTEtMS0xLTA_6be413ff-e211-4e37-bbae-857aea2500c9"
      unitRef="usd">1262000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtMTMtMS0xLTA_d4be7b76-1b57-4a9a-a3d3-1de0eff3f46c"
      unitRef="usd">603000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1696ff74ab3647bb87732da6158a3427_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjU1ODk1YTJkYjM3ODRkNGZiMjA3MTk2MjBkMTVkZjFiL3RhYmxlcmFuZ2U6NTU4OTVhMmRiMzc4NGQ0ZmIyMDcxOTYyMGQxNWRmMWJfMTMtMTUtMS0xLTA_23eee5f0-d86f-4b7a-ba3f-7e4953536ba1"
      unitRef="usd">1865000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="ifc32bd7cafef4dbfad9887aed3e2ba12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTQxODg_fc486bba-21d3-4409-b127-f1aba5563e3f"
      unitRef="usd">2379000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i3f7c41cbb0224ee39d19c3468d3298ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTQyNTM_644c5b1e-7588-4943-9017-955d6780abd6"
      unitRef="usd">1584000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:Cash
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTQyNzQ_90932876-3414-4301-b527-e8b746b77660"
      unitRef="usd">296000000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTQzNDk_ddeddbbb-ea20-4ebc-b061-5dc2b74e2da9"
      unitRef="usd">150000000</us-gaap:Cash>
    <bsx:LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMjc0ODc3OTA4OTExMw_c56e2464-3117-4266-9988-3840af10aba5"
      unitRef="number">0.50</bsx:LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments>
    <bsx:LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMjc0ODc3OTA4OTUzMg_cb3f785d-d5fa-4c01-80f8-f89cc5c7c776"
      unitRef="number">0.50</bsx:LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold>
    <bsx:Licensingarrangementsasset
      contextRef="iaff031e690ad46fcb10f2ceedfa9fcf9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfMS0xLTEtMS0w_1f53eaf0-0f52-44d5-a703-c9733b8c1696"
      unitRef="usd">311000000</bsx:Licensingarrangementsasset>
    <bsx:DiscountRateFairValueInput
      contextRef="i40d5ba9cb66f46eba6179aa8dc2f4775_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfMS00LTEtMS0w_8a4e95c5-4dc0-4c6c-95ff-c397054c2402"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i1b99fcb316c84c26af31432735c4acc8_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfMS03LTEtMS0w_0ffeda7a-1040-406e-aa8c-9255999ea70f"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:Licensingarrangementsliability
      contextRef="iaff031e690ad46fcb10f2ceedfa9fcf9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfNC0xLTEtMS0w_05f42270-5f28-4050-996b-25f5f6e37a3f"
      unitRef="usd">350000000</bsx:Licensingarrangementsliability>
    <bsx:DiscountRateFairValueInput
      contextRef="iebc173f0990b4117b9314d607dba9671_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfNC00LTEtMS0w_2ca6d882-efd9-42cd-9d8a-6503c5ee198c"
      unitRef="number">0.12</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="if33791e7ffab49859998b3df9fa1bafb_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfNC02LTEtMS0w_1200c783-1020-482b-ab5f-a63879fdf2b0"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="ied2279ddd55248389453413b491c815f_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjQ2MzYzNjg3NjZhZDQxYWU5MDhhN2FiZTc3MGRhYWI4L3RhYmxlcmFuZ2U6NDYzNjM2ODc2NmFkNDFhZTkwOGE3YWJlNzcwZGFhYjhfNC03LTEtMS0w_be2b0112-abe9-430f-89b7-e9bb606ac02e"
      unitRef="number">0.13</bsx:DiscountRateFairValueInput>
    <bsx:Licensingarrangementsasset
      contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmNjYjExNzcxM2Q3NTRhMzBiNDlkMzE0OTI4ZTVlNzMwL3RhYmxlcmFuZ2U6Y2NiMTE3NzEzZDc1NGEzMGI0OWQzMTQ5MjhlNWU3MzBfMS0xLTEtMS0w_5bfb400d-4009-4e62-a076-041956881eda"
      unitRef="usd">365000000</bsx:Licensingarrangementsasset>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="i9e77807bef8c44ccb81fbc0e7ba9b799_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmNjYjExNzcxM2Q3NTRhMzBiNDlkMzE0OTI4ZTVlNzMwL3RhYmxlcmFuZ2U6Y2NiMTE3NzEzZDc1NGEzMGI0OWQzMTQ5MjhlNWU3MzBfMy0xLTEtMS0w_75d23b36-a83b-4bea-8517-c8044cccc140"
      unitRef="usd">43000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <bsx:Noncashimpactoftransferredroyaltyrights
      contextRef="i40d5ba9cb66f46eba6179aa8dc2f4775_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmNjYjExNzcxM2Q3NTRhMzBiNDlkMzE0OTI4ZTVlNzMwL3RhYmxlcmFuZ2U6Y2NiMTE3NzEzZDc1NGEzMGI0OWQzMTQ5MjhlNWU3MzBfNS0xLTEtMS0w_5f1b5fa2-9c7e-44ef-a7e3-3557ba5afd88"
      unitRef="usd">-43000000</bsx:Noncashimpactoftransferredroyaltyrights>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="i9e77807bef8c44ccb81fbc0e7ba9b799_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmNjYjExNzcxM2Q3NTRhMzBiNDlkMzE0OTI4ZTVlNzMwL3RhYmxlcmFuZ2U6Y2NiMTE3NzEzZDc1NGEzMGI0OWQzMTQ5MjhlNWU3MzBfNi0xLTEtMS0w_adc5ddda-558b-4c21-9061-74474386734c"
      unitRef="usd">31000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:Licensingarrangementsasset
      contextRef="i18328309825f40b887eb0ef197588dd3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOmNjYjExNzcxM2Q3NTRhMzBiNDlkMzE0OTI4ZTVlNzMwL3RhYmxlcmFuZ2U6Y2NiMTE3NzEzZDc1NGEzMGI0OWQzMTQ5MjhlNWU3MzBfNy0xLTEtMS0w_79056c2e-3ce0-477a-98b6-54871ebe6508"
      unitRef="usd">311000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsliability
      contextRef="ia20c85f02adc4bdaab3ab93127fb5465_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjdhZTYwNmI0Y2VlNTQwNDZhYzM3ZjBkYmFhYjBiZmI5L3RhYmxlcmFuZ2U6N2FlNjA2YjRjZWU1NDA0NmFjMzdmMGRiYWFiMGJmYjlfMS0xLTEtMS0w_f1f3d48d-3c2d-4643-8666-20990c89a79f"
      unitRef="usd">407000000</bsx:Licensingarrangementsliability>
    <us-gaap:PaymentsForRoyalties
      contextRef="i20ed1fc05de34698bdf7cd17009bebce_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjdhZTYwNmI0Y2VlNTQwNDZhYzM3ZjBkYmFhYjBiZmI5L3RhYmxlcmFuZ2U6N2FlNjA2YjRjZWU1NDA0NmFjMzdmMGRiYWFiMGJmYjlfMy0xLTEtMS0w_84a14513-5441-41fc-9d44-6fceba6a758a"
      unitRef="usd">42000000</us-gaap:PaymentsForRoyalties>
    <bsx:Noncashimpactoftransferredroyaltyrights
      contextRef="i600d7a0e156944d8a7e0b2f8e0296f7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjdhZTYwNmI0Y2VlNTQwNDZhYzM3ZjBkYmFhYjBiZmI5L3RhYmxlcmFuZ2U6N2FlNjA2YjRjZWU1NDA0NmFjMzdmMGRiYWFiMGJmYjlfNi0xLTEtMS0w_9c2b1522-5bf1-4006-8867-6b0e53c862a4"
      unitRef="usd">-43000000</bsx:Noncashimpactoftransferredroyaltyrights>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="i20ed1fc05de34698bdf7cd17009bebce_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjdhZTYwNmI0Y2VlNTQwNDZhYzM3ZjBkYmFhYjBiZmI5L3RhYmxlcmFuZ2U6N2FlNjA2YjRjZWU1NDA0NmFjMzdmMGRiYWFiMGJmYjlfNy0xLTEtMS0w_30f6238e-66fc-4c28-bdf4-299c46ce2b15"
      unitRef="usd">28000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:Licensingarrangementsliability
      contextRef="i18328309825f40b887eb0ef197588dd3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RhYmxlOjdhZTYwNmI0Y2VlNTQwNDZhYzM3ZjBkYmFhYjBiZmI5L3RhYmxlcmFuZ2U6N2FlNjA2YjRjZWU1NDA0NmFjMzdmMGRiYWFiMGJmYjlfOC0xLTEtMS0w_8c29d907-3f77-488a-a75e-5f4e92263c3b"
      unitRef="usd">350000000</bsx:Licensingarrangementsliability>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc5Mjg_aba47dae-e318-4fa0-a4fa-3104cda8490f"
      unitRef="usd">10431000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i21198075aed84d47b40aa66db088ddc3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc5NTE_8fbe7b46-c5ee-4fd8-87c6-831324212419"
      unitRef="usd">1085000000.000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTc5OTU_0e183312-5c81-4f6e-be9c-f72c206e2d6a"
      unitRef="usd">10774000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i103abe8f6cc04293824af37a171f38cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF81NS9mcmFnOjk1MWI1ZTA3MGEyODQzMTJhZTdmMjcwYjc1NjNkZTdlL3RleHRyZWdpb246OTUxYjVlMDcwYTI4NDMxMmFlN2YyNzBiNzU2M2RlN2VfMTgwMTg_91ea671b-6e9a-4d42-83df-afbafe4e522f"
      unitRef="usd">1118000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMzI5ODUzNDg5NzAxMw_c4cca33c-9d27-4b6e-bdc4-70ccc9f1f3f5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE E &#x2013; CONTRACTUAL OBLIGATIONS AND COMMITMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Borrowings and Credit Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had total debt outstanding of $9.109 billion as of June&#160;30, 2021 and $9.143 billion as of December&#160;31, 2020, with current maturities of $262 million as of June&#160;30, 2021 and $13 million as of December&#160;31, 2020. The debt maturity schedule for our long-term debt obligations is presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, &lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.125%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;and Deferred Financing Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Gain on Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,847&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)   As of June 30, 2021 the outstanding balance is presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Current Debt Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our unaudited consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 10, 2021 we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were no amounts outstanding under the 2021 Revolving Credit Facility as of June&#160;30, 2021 or under the 2018 Revolving Credit Facility as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of and through June&#160;30, 2021, we were in compliance with the financial covenant required by the credit facilities described above: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.25 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.06 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The 2021 Revolving Credit Facility includes the following financial covenant requirement for all of our credit arrangements (i)  maintain the maximum permitted leverage ratio of 4.25 times for the second quarter of 2021, with a step-down for each succeeding fiscal quarter end, beginning with the third quarter of 2021, to 4.00 times and 3.75 times for the fourth quarter of 2021 and through the remaining term of the 2021 Revolving Credit Facility. The agreement provides for higher leverage ratios for the period following a qualified acquisition, at our election, for which consideration exceeds $1.000 billion.  In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted leverage ratio is 4.75 times.  It steps down for the fifth, sixth and seventh succeeding quarters to 4.50 times, 4.25 times  and 4.00 times, respectively.  Thereafter, a maximum leverage ratio of 3.75 times is required through the remaining term of the 2021 Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreements, through maturity, of any non-cash charges and up to  $500 million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of June&#160;30, 2021, we had $467 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed  $1.455 billion in the aggregate. As of June&#160;30, 2021, we had $1.303 billion of the litigation exclusion remaining.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any inability to maintain compliance with this covenant could require us to seek to further renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable&lt;/span&gt;&lt;span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our commercial paper program is backed by the 2021 Revolving Credit Facility, as discussed above, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. We did not have any commercial paper outstanding as of June&#160;30, 2021 or December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Notes &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had senior notes outstanding of $9.168 billion as of June&#160;30, 2021 and $9.205 billion as of December&#160;31, 2020. Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Arrangements &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts de-recognized for accounts and notes receivable, which are excluded from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our accompanying unaudited consolidated balance sheets, are aggregated by contract denominated currency below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Renminbi denominated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Contractual Obligations and Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had outstanding letters of credit of $135 million as of June&#160;30, 2021 and $124 million as of December&#160;31, 2020, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of June&#160;30, 2021 and December&#160;31, 2020, none of the beneficiaries had drawn upon the letters of credit or guarantees, and accordingly, we have not recognized a related liability for our outstanding letters of credit in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNzk_623a70cd-aa78-441d-b1fd-065b064ec636"
      unitRef="usd">9109000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfOTU_7f12e15a-d3a8-4804-91aa-8241d8cbbbee"
      unitRef="usd">9143000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTM1_ac277396-494f-4899-92d6-fc524ac830ce"
      unitRef="usd">262000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTUx_f38e27a3-00d2-4298-aae8-13a49fbe111a"
      unitRef="usd">13000000</us-gaap:DebtCurrent>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNjAxNA_9a0d0171-766d-40c9-8df3-30876ed1a70e">&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, &lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.125%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;and Deferred Financing Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Gain on Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,847&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)   As of June 30, 2021 the outstanding balance is presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Current Debt Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our unaudited consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i967915e4b5a34078a3ed31f7f97e8af1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMi02LTEtMS0w_73ce400f-4102-4aab-ba84-b9d7eae35b92"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie9b8b74de08d42a5b1c298735f31c874_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMi04LTEtMS0w_0e10eb86-ddec-4de0-b3d9-62468b4a62e2"
      unitRef="usd">250000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i967915e4b5a34078a3ed31f7f97e8af1_I20210630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMi0xMC0xLTEtMA_c15ce4ce-2c44-4b24-ae97-07afb9737c0d"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia41c2dcb7c86466189b28d6c0003d505_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMy02LTEtMS0w_1ed1bf8a-5ca3-444f-9a45-6741232ce7ea"
      unitRef="usd">244000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iadb3d909cec9465983bd9071804b27c8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMy04LTEtMS0w_abef792f-fd98-4490-be5f-77446f09c0ab"
      unitRef="usd">244000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia41c2dcb7c86466189b28d6c0003d505_I20210630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMy0xMC0xLTEtMA_08d2c108-3571-4f60-81df-fcd4f048ffe8"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id982ae5b53e04126a7116a0047e53636_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNC02LTEtMS0w_fdd941bb-4175-47e0-b2e2-719e0fcd7ab6"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i113b5c1b952f4594980deebf9d2fb6a3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNC04LTEtMS0w_2e32a79b-4923-495a-9835-ab683f0c2a44"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id982ae5b53e04126a7116a0047e53636_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNC0xMC0xLTEtMA_32113cd5-96a5-476d-b90c-c5a3906f7645"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ifab91815c6bd40d0a0b1e317ea65c8da_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNS02LTEtMS0w_87c63e8a-9b75-44dd-a550-b1029058a289"
      unitRef="usd">523000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i38a47cf5a6694115904cfd355585ca6a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNS04LTEtMS0w_75e472d2-bb9f-48a5-a800-357c2fdf045b"
      unitRef="usd">523000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifab91815c6bd40d0a0b1e317ea65c8da_I20210630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNS0xMC0xLTEtMA_a26f4e2d-bb73-4770-9eb1-29e242f04e26"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i9d2f3b419c994bdc94530fd56efedbc8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNi02LTEtMS0w_b1d36ed3-bfc7-4cff-8992-d44147b52289"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i561c09a8d18c4e8bb44fee39130ac6ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNi04LTEtMS0w_0a5d527c-b467-4e39-b314-f07749f0b7bd"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9d2f3b419c994bdc94530fd56efedbc8_I20210630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNi0xMC0xLTEtMA_4ef807ab-1682-4be4-9131-6200c0eeea6e"
      unitRef="number">0.01900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i46ac7a01ed6b40a8b651ab864a06c209_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNy02LTEtMS0w_1f791372-8195-47fc-aefc-e9d0a96432aa"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id0ae2e6d62514176973bc35a7110c630_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNy04LTEtMS0w_62e282f4-c863-4373-b094-23d01daec4c7"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i46ac7a01ed6b40a8b651ab864a06c209_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfNy0xMC0xLTEtMA_b8c73163-e981-405e-860a-bb1acb6447aa"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOC02LTEtMS0w_8a541254-ca4d-46de-8b49-59f022007abc"
      unitRef="usd">1068000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id72fc66e7aab4c62aaf40ffff524b1e0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOC04LTEtMS0w_9bfda7d6-a993-4978-b2b5-6e24fa17e6ab"
      unitRef="usd">1105000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7c9a9df7371e47288ad47514abc3d299_I20210630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOC0xMC0xLTEtMA_64dd6e6e-cf0d-4c8e-a40d-5cf045200ac5"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia351226c94354547b45c1fab925a288e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOS02LTEtMS0w_50598f99-ffce-47f9-a6cc-77e64ad59c27"
      unitRef="usd">434000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5ca05e25f325480fa19833b9a5aa88d6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOS04LTEtMS0w_1192aeea-9bd3-4fcb-bbe4-51c4adf9da31"
      unitRef="usd">434000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia351226c94354547b45c1fab925a288e_I20210630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfOS0xMC0xLTEtMA_75dcb723-e76f-4a65-b596-0f2a496f2b62"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i62a197ee399d4df089f8b6bc2882477f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTAtNi0xLTEtMA_29870ec5-9728-4ca4-94e8-0a9d6960c516"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i91e07d9a4bf44725bb8890bf0ddccb0c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTAtOC0xLTEtMA_a226da5e-d5c3-497f-9a48-7fa41262bfb4"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i62a197ee399d4df089f8b6bc2882477f_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTAtMTAtMS0xLTA_be18d88a-058b-45b3-a7cf-455b450b01a0"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0bbf7a2beb3741228b363f15a8f99e4d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTEtNi0xLTEtMA_4a272fb0-d185-432c-b55b-5646ef3d9bbc"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic01cfb8ffa714da4ac584f4ba607a604_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTEtOC0xLTEtMA_fb4acda2-1a71-4f14-b7df-2f642a5ace35"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0bbf7a2beb3741228b363f15a8f99e4d_I20210630"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTEtMTAtMS0xLTA_fbf72558-363d-4365-b6a2-85f2491161ca"
      unitRef="number">0.02650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2273a18a922d4ba9bb8f7b6d48223471_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTItNi0xLTEtMA_3c7666b1-cd6d-4f6a-978b-3c36e5a1244f"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ide4c06b245c8483d952138db789ef503_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTItOC0xLTEtMA_10c87010-1087-4a6e-893f-cde7b6d44823"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2273a18a922d4ba9bb8f7b6d48223471_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTItMTAtMS0xLTA_a8dda4fd-d424-46c7-b78c-3e0a11442fad"
      unitRef="number">0.07000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1023571c063440c1b72bde0cc574f3fc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTMtNi0xLTEtMA_f5acd0bb-ef91-4368-813c-7b61b03cddb8"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if6c5049e8c5a466cacfec15d36c0b17c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTMtOC0xLTEtMA_548a715a-23f8-4b3a-be4f-3ee46f7352c4"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1023571c063440c1b72bde0cc574f3fc_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTMtMTAtMS0xLTA_ad7bce35-274e-42ae-b4cd-40151b8f062a"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ic047224d612c40f3b5da3c6df601c6b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTQtNi0xLTEtMA_48563624-7949-49bb-a42a-e7cae9cd3026"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iba59ff767fc24dffbfa0f7a3f3061b30_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTQtOC0xLTEtMA_a246d7cc-2fd4-424b-8405-f247e6ebf6ab"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic047224d612c40f3b5da3c6df601c6b4_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTQtMTAtMS0xLTA_ef47d023-d4a0-4cb2-b733-24bfc2957229"
      unitRef="number">0.07375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5320ad72c40043dbadbade7185c3451d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTUtNi0xLTEtMA_2a1816a5-d430-4eb0-bb53-9c7a083eaba6"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i90a40bf358b54433a3a649f92522cdd3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTUtOC0xLTEtMA_4b190b9b-b712-4de3-8f6a-0a3d79d9db43"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5320ad72c40043dbadbade7185c3451d_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTUtMTAtMS0xLTA_706cd27d-d6a7-402c-b123-3c8ab527ce54"
      unitRef="number">0.04700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i809eea6504914ca685965d4b388d35d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTYtNi0xLTEtMA_53237542-a018-4843-8958-f4f9ca472105"
      unitRef="usd">-82000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i8b03ff8312654acdabd6f4b180d73c5f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTYtOC0xLTEtMA_09f32223-5815-41e2-a61d-0d4bb027cdbb"
      unitRef="usd">-88000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="ia44ed01226c64b529960a7be9715fdb1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTctNi0xLTEtMA_dc64b091-0af5-41f3-9a6a-97f7c1d462b5"
      unitRef="usd">4000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if06d4aa1475745f9bd667036ca6a77e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTctOC0xLTEtMA_5d5b8abf-1cf3-47cf-b66c-283ce84c00ff"
      unitRef="usd">5000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0771aaf382b64bbbb9ca530005018dcb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTgtNi0xLTEtMA_301992e6-f482-48df-a2e0-3fa18d706ef9"
      unitRef="usd">6000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibce283f07399443fbbfa2409543233c0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTgtOC0xLTEtMA_e577715b-2dcd-4b0b-b3f1-aa303680cb19"
      unitRef="usd">7000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTktNi0xLTEtMA_b3922d38-f031-4966-9a8d-523f10fca5b2"
      unitRef="usd">8847000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjMxMDM1MWMyNDU4NjQyNjg4OGZjYzVlNzk3MzRkZWMxL3RhYmxlcmFuZ2U6MzEwMzUxYzI0NTg2NDI2ODg4ZmNjNWU3OTczNGRlYzFfMTktOC0xLTEtMA_dfb4dbf9-0697-4856-a05a-5bcb3627c034"
      unitRef="usd">9130000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie78d090db6af43d5964a7c874aa66780_I20210510"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTA5OTUxMTYzNTc4Mg_dff319ca-7b63-481f-9eda-a35abeb5679b"
      unitRef="usd">2750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <bsx:DebtInstrumentExtensionOptionTerm
      contextRef="ie5bb1bffb92d48848c682a120ac50575_D20210510-20210510"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTc1OTIxODYwNTUzMjU_501408fa-a52f-4e83-8498-e2d5a94c15cb">P1Y</bsx:DebtInstrumentExtensionOptionTerm>
    <us-gaap:LongTermDebt
      contextRef="i9e96838cdc7b44c4a1afe15baaa3ef77_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTc1OTIxODYwNTUzMjg_0e1ab228-19cf-4be6-9639-0e5b4113b1cf"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3a4283b5db0d475db38e71d73bfd1d3c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTc1OTIxODYwNTUzMjg_af5a3d9a-d141-4655-b478-15d80c8c11dd"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNTk5Mw_7122d4ee-da12-4b63-a68c-cf18085a85bd">&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.25 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.06 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;</bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock>
    <bsx:MaximumLeverageRatio
      contextRef="i26601067bda84bc3b9685478594ecd99_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjdlMjhiMTE4NTM3ODRkNjBhMmVmYTI3YzBhOWU2ZTIwL3RhYmxlcmFuZ2U6N2UyOGIxMTg1Mzc4NGQ2MGEyZWZhMjdjMGE5ZTZlMjBfMi0yLTEtMS0w_d94985b8-6d04-407b-ae6d-c9f1025aac1d"
      unitRef="number">4.25</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i3e0d083bcc1b4a04b64d12c8d91b4941_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOjdlMjhiMTE4NTM3ODRkNjBhMmVmYTI3YzBhOWU2ZTIwL3RhYmxlcmFuZ2U6N2UyOGIxMTg1Mzc4NGQ2MGEyZWZhMjdjMGE5ZTZlMjBfMi00LTEtMS0w_d502904f-7432-4a28-88c5-1a22fc9a0087"
      unitRef="number">3.06</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i20c8d3b79ea24e50b1f3b5cff5b34259_I20210510"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjE0MA_a04c3004-3586-46a5-b8da-88190c6e3838"
      unitRef="number">4.25</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i2386476e4d86430cb1177af6ed201651_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTA5OTUxMTYzNjE2OA_abe53960-a40b-4c4f-8f18-bf1d327731d9"
      unitRef="number">4.00</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i73dd07304f00449f9f1e3862f53fd60c_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMTA5OTUxMTYzNjI3OA_973836ca-7307-452f-ade9-ae866ef3a5c2"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:QualifiedAcquisitionConsideration
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA3ODg2MQ_ef4d1e14-64eb-466d-8326-7a11b7f44cfb"
      unitRef="usd">1000000000.000</bsx:QualifiedAcquisitionConsideration>
    <bsx:MaximumLeverageRatio
      contextRef="ic8cfbd87e22b48faaa5fcd00545825a2_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA4Mjk5MA_f9e5b3ac-a630-452d-899d-fcc08b7742fe"
      unitRef="number">4.75</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i0047d354b82246a986ea67a506f95e0f_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA4MzAwMw_607c0273-c8b7-4b6f-bc7e-c8f40975b67c"
      unitRef="number">4.50</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="ia027378c26254f43aa24b3d62083d405_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA4MzAxNg_6d99a4c0-9b0e-4772-a001-03c7c5aadb44"
      unitRef="number">4.25</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="ic85f1b8888bb425194c965e58e0b2e74_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA4MzAzMA_6048f3a9-29e4-4eba-9064-eebaa0055f5c"
      unitRef="number">4.00</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="iec922493e5094a03bf6f1519d2177851_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjc0ODc3OTA4MzA0Mw_c6185041-3e51-4398-b412-1aea821d165d"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:ExclusionFromEbitdaForRestructuringCharges
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjU3NA_d52a53aa-1ace-4f20-abcd-ac5e9078db55"
      unitRef="usd">500000000</bsx:ExclusionFromEbitdaForRestructuringCharges>
    <bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMjcwOA_e35997a8-2757-4c8c-b779-cb121ee96363"
      unitRef="usd">467000000</bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <bsx:LitigationAndDebtExclusionFromEbitda
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMzA0MA_aa17080c-5dc8-4cac-8627-f72a70776e8e"
      unitRef="usd">1455000000</bsx:LitigationAndDebtExclusionFromEbitda>
    <bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfMzA3OA_5df0186b-71af-4b32-ae63-0b9f08e86781"
      unitRef="usd">1303000000</bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <us-gaap:LongTermDebt
      contextRef="i809eea6504914ca685965d4b388d35d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNDI2OA_036ef291-0434-4676-aa23-851d6883ed35"
      unitRef="usd">9168000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8b03ff8312654acdabd6f4b180d73c5f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNDI4NA_e324c8e6-403e-4b74-aec6-9fa783611383"
      unitRef="usd">9205000000</us-gaap:LongTermDebt>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNTk5NA_48d0d7c3-a1d5-4d3f-8b47-83548a61acc8">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Renminbi denominated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i11e8d32cc0a047e98a98d79bfa03d913_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMi0xLTEtMS0w_ffc8dfca-5f01-4c90-9410-3ea77f8e4d92"
      unitRef="usd">160000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i7b8038e17bb14aca9760b9b13c4a71eb_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMi0zLTEtMS0w_d5904be1-65a4-44a3-8f66-92b6d0f101bb"
      unitRef="number">0.022</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="id36ab86f2da34a9c8eac8655594d345f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMi01LTEtMS0w_062832be-1c86-438f-b80b-b1cd52ae50c5"
      unitRef="usd">148000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i24cd97ee251b48559141f4a71903a86f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMi03LTEtMS0w_760f2410-8928-4fd2-82ee-28059a10ca57"
      unitRef="number">0.019</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i9ac4d1c50e424a77a8190f95382d7215_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMy0xLTEtMS0w_d0263136-9c73-45cb-bac0-c971ddc61698"
      unitRef="usd">213000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="icaaff822293a4cdd9e2c363357a949b3_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMy0zLTEtMS0w_ac729c9a-1fce-4aa9-be10-17ffd82b1d9e"
      unitRef="number">0.006</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i9e14eaa94afa46c089e40f5f8fc742f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMy01LTEtMS0w_f81ca6d2-8799-45e1-8895-02ebad7d9627"
      unitRef="usd">240000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="ib85a49f2cb27434db4be4cdcf2cd10c4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfMy03LTEtMS0w_c38894e8-8128-4081-88c1-8144a5c5097b"
      unitRef="number">0.006</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i2e0c97078b824377aae934b984b2c65a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfNC0xLTEtMS0w_0e155cc4-c10c-45d1-93d3-db9cc7f3fe41"
      unitRef="usd">0</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i9a197d277f374157b6cbffd8871e4fff_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfNC0zLTEtMS0w_6e0a4ed0-4179-46f8-ad91-96e208d37c4d"
      unitRef="number">0.031</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i6dcfc90377704002bd6e0af127de50c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfNC01LTEtMS0w_fd1ade6d-365e-4d6a-af93-ce8df30f205f"
      unitRef="usd">0</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i436cfe41ac964ae79776eea028f62811_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RhYmxlOmVjNTkyYTkyY2FiYzQwNjY4Y2ZhOTdjMDlmZThjMDkzL3RhYmxlcmFuZ2U6ZWM1OTJhOTJjYWJjNDA2NjhjZmE5N2MwOWZlOGMwOTNfNC03LTEtMS0w_cf5c6658-dc11-4776-a636-fdecbcb2c0b1"
      unitRef="number">0.035</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNTM5Mg_10f189af-d722-4188-acee-e2e14ce4a320"
      unitRef="usd">135000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF82MS9mcmFnOmQ3YTUwNTE0MDBiNTQwNWNiMTcyMWZkNDU2NThhZGZmL3RleHRyZWdpb246ZDdhNTA1MTQwMGI1NDA1Y2IxNzIxZmQ0NTY1OGFkZmZfNTQwOA_36b4ac0c-9459-4a37-aaff-9db902b81981"
      unitRef="usd">124000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU5OA_54334634-e513-4f63-989d-10352e5a8747">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE F &#x2013; SUPPLEMENTAL BALANCE SHEET INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions in our accompanying unaudited consolidated balance sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,675&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,531&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect adjustment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Effective January 1, 2020, we adopted FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note R &#x2013; New Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 326, we record credit loss reserves to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when we establish &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, we have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers and office-based laboratories. Many of these customers are smaller than those we have historically done business with and may have limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions based on collection trends.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,430&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,082&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,084&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $83 million&#160;for the second quarter of 2021, $78 million for the second quarter of 2020, $166 million for the first six months of 2021 and $154 million for the first six months of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,629&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,921&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,442&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;958&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,190&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,309&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU0Ng_380bb1bd-600b-4131-9b65-b124d14e6342">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,675&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,531&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect adjustment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;107&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Effective January 1, 2020, we adopted FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note R &#x2013; New Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfMi0xLTEtMS0w_8aca5a30-3378-4208-a805-23eb3e29fb14"
      unitRef="usd">1781000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfMi0zLTEtMS0w_95c0897d-6d2a-4d6f-817d-78a6a3f9e546"
      unitRef="usd">1637000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfMy0xLTEtMS0w_3eecdb20-d355-4932-b83f-e25cdd37e38e"
      unitRef="usd">107000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfMy0zLTEtMS0w_1675d202-b50d-48c4-87bf-1d981b5c5c3d"
      unitRef="usd">105000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfNC0xLTEtMS0w_6e5052f4-7efc-48d0-8557-5ca3a4f72815"
      unitRef="usd">1675000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjZmNTQ5MDBjZWFlOTQyNTU5MmM3MjAxNDFkNTUwOTlkL3RhYmxlcmFuZ2U6NmY1NDkwMGNlYWU5NDI1NTkyYzcyMDE0MWQ1NTA5OWRfNC0zLTEtMS0w_2c59fee8-3e83-4fae-a0b5-7baaef23281a"
      unitRef="usd">1531000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfMi0xLTEtMS0w_c875b042-4f49-45f5-a76e-b78cb5d7758c"
      unitRef="usd">101000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0e99e4069c604693bacde07aad3c5702_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfMi0zLTEtMS0w_c6ca7fab-3ad8-498b-ab45-ea25064e96f5"
      unitRef="usd">87000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfMi01LTEtMS0w_2bb9e8e1-e499-4395-9ae4-4efabfd0fea0"
      unitRef="usd">105000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfMi03LTEtMS0w_4f8b396f-7f2f-4aa7-875d-103f368d11cd"
      unitRef="usd">74000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfMy03LTEtMS0w_f11503cc-edad-4322-800a-6a07a639ad4d"
      unitRef="usd">10000000</us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNC0xLTEtMS0w_3bd617e2-85fc-4378-a887-02e327e95f21"
      unitRef="usd">9000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNC0zLTEtMS0w_18d92f5f-7ee8-49a4-8f75-24cb4a94c325"
      unitRef="usd">14000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNC01LTEtMS0w_f26fa44d-abfa-455e-bb9c-d73b09f55f30"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNC03LTEtMS0w_77225e6b-267e-4411-a83c-7b0fb6e9d426"
      unitRef="usd">22000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNS0xLTEtMS0w_c8b671e5-f6b7-4fa5-a098-9c5b86b0b4c8"
      unitRef="usd">4000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNS0zLTEtMS0w_5484a138-23e5-4776-be06-4c81c6ffbadf"
      unitRef="usd">7000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNS01LTEtMS0w_3b0f7ab9-caab-4201-8bc3-d655143b8f1d"
      unitRef="usd">10000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNS03LTEtMS0w_2f70f6fb-2da5-4d19-8c8d-7c45deca86f7"
      unitRef="usd">13000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNi0xLTEtMS0w_55e34d8a-ef47-462f-ba12-c4a42902310d"
      unitRef="usd">107000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNi0zLTEtMS0w_b1d9759b-50b6-4d45-867b-a3966aae87f2"
      unitRef="usd">94000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNi01LTEtMS0w_33799c91-2dc0-4905-83f4-5e1b6bc5efcc"
      unitRef="usd">107000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmMzYzMyYWY3ZDBmZjRkNGJhN2I2NTBlMTI0MDMzOTg2L3RhYmxlcmFuZ2U6YzNjMzJhZjdkMGZmNGQ0YmE3YjY1MGUxMjQwMzM5ODZfNi03LTEtMS0w_33e86180-9a71-4eb7-a214-0f9559697272"
      unitRef="usd">94000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU4MQ_5978aaa1-2ea9-490b-b22c-663c14059feb">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,430&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfMi0xLTEtMS0w_d061694d-0659-4802-bc64-427a027086e5"
      unitRef="usd">933000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfMi0zLTEtMS0w_e0c3b0ba-03f8-423c-a849-be2ed3068204"
      unitRef="usd">893000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfMy0xLTEtMS0w_1f26f61b-832b-459d-b58c-758d7e9adbbd"
      unitRef="usd">121000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfMy0zLTEtMS0w_1a625b9f-eb74-49f1-ba9e-5512ca282899"
      unitRef="usd">109000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfNC0xLTEtMS0w_91b9ff26-d52c-410f-a5d0-85aa88307125"
      unitRef="usd">376000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfNC0zLTEtMS0w_85125834-f5b5-42c7-af2f-bae2c2bbf7ca"
      unitRef="usd">349000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfNS0xLTEtMS0w_4b58df28-cf5e-4a22-b97e-9e857cae83f0"
      unitRef="usd">1430000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjI2ZWUyNzU2MDI0NDQzYjliYjU3NDg5ZDg3MDljNjY4L3RhYmxlcmFuZ2U6MjZlZTI3NTYwMjQ0NDNiOWJiNTc0ODlkODcwOWM2NjhfNS0zLTEtMS0w_681d7913-6f69-461f-8771-efa6fe09edac"
      unitRef="usd">1351000000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU2Nw_ab72a698-74ad-4865-9bed-64e63500fad9">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfMi0xLTEtMS0w_cdd8ebf7-1c0e-49d4-a5a5-95e06a3c9fff"
      unitRef="usd">167000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfMi0zLTEtMS0w_21573428-da84-486f-bf1b-9b5ed74a7a12"
      unitRef="usd">208000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfMy0xLTEtMS0w_13821ace-3bb3-47c0-b9e4-9d901c7c7fb9"
      unitRef="usd">167000000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfMy0zLTEtMS0w_3858b735-f14d-450b-8cd3-51c5ea316153"
      unitRef="usd">133000000</us-gaap:DerivativeAssetsCurrent>
    <bsx:Licensingarrangements
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNC0xLTEtMS0w_4cfb2602-6b08-4fc0-8261-ce99581593e9"
      unitRef="usd">145000000</bsx:Licensingarrangements>
    <bsx:Licensingarrangements
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNC0zLTEtMS0w_18afc017-60f2-4358-ab6a-e9da4beea16e"
      unitRef="usd">148000000</bsx:Licensingarrangements>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNS0xLTEtMS0w_5da43297-0724-4539-953e-c4eb82a78fbb"
      unitRef="usd">299000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNS0zLTEtMS0w_cd00612f-2ffe-42a9-a36c-c50e79e0e8dd"
      unitRef="usd">263000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNi0xLTEtMS0w_d8a740c2-ee47-447e-ac9d-a14266d8313f"
      unitRef="usd">777000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmZmOTZiMTZjM2U3NDQ4YjJiZDI3ZDVhZjFjZmMxNTEyL3RhYmxlcmFuZ2U6ZmY5NmIxNmMzZTc0NDhiMmJkMjdkNWFmMWNmYzE1MTJfNi0zLTEtMS0w_0478fe33-b3d3-4cc3-9c8b-239371ac4c5e"
      unitRef="usd">751000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU3OA_d654a392-9fe5-4d80-9b99-31c13ce40985">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,082&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,084&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfMi0xLTEtMS0w_b52f6b3b-27cd-44ba-b6ad-d51a18b85d7d"
      unitRef="usd">104000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfMi0zLTEtMS0w_f37f1057-d915-49ea-a82a-e1418b319a03"
      unitRef="usd">104000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfMy0xLTEtMS0w_2efbb467-9d02-487c-8bda-0ce55b84db2b"
      unitRef="usd">1342000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfMy0zLTEtMS0w_a9cbe0c1-c243-43ab-af7d-e4da6092a83a"
      unitRef="usd">1292000000</us-gaap:BuildingsAndImprovementsGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNC0xLTEtMS0w_ff7e8226-12dc-4ab8-be75-b645c840f6c8"
      unitRef="usd">3517000000</bsx:EquipmentFurnitureAndFixturesGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNC0zLTEtMS0w_3ea75f29-8c52-4d27-9f73-ac76122698d1"
      unitRef="usd">3465000000</bsx:EquipmentFurnitureAndFixturesGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNS0xLTEtMS0w_7ac7f6f4-8569-4f84-87c7-6c61147f381b"
      unitRef="usd">432000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNS0zLTEtMS0w_8d21650d-9dbb-482b-a4b1-8813e4536046"
      unitRef="usd">446000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNi0xLTEtMS0w_c5993314-cf5d-4bfd-9e99-657cc628aeb1"
      unitRef="usd">5395000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNi0zLTEtMS0w_eefff5ef-fa1b-4cf3-9569-e7e657c0705f"
      unitRef="usd">5308000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNy0xLTEtMS0w_1c208d01-5535-4a97-b83b-9d9b6ddcfaee"
      unitRef="usd">3313000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfNy0zLTEtMS0w_8ff80da3-cfcf-4879-a10b-2889b4b9f6e0"
      unitRef="usd">3224000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfOC0xLTEtMS0w_8cb15c7f-43dc-4c0c-bda9-ae777b4f30e7"
      unitRef="usd">2082000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmJkYzA4MTNhM2Y5NzRmMzI4MDhiMDc0NTNiODA4ODRkL3RhYmxlcmFuZ2U6YmRjMDgxM2EzZjk3NGYzMjgwOGIwNzQ1M2I4MDg4NGRfOC0zLTEtMS0w_ac854f6e-5f3f-4dc9-a0b9-f77a1090b440"
      unitRef="usd">2084000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjM1Ng_88632efc-e399-48b6-8440-4d92c934f801"
      unitRef="usd">83000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjM4OA_ce3336ed-8d83-4b0e-9c45-0f62b4832953"
      unitRef="usd">78000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMTA5OTUxMTYzMDQxNA_a3dd630d-8f42-464f-99e5-d38f5ad6376d"
      unitRef="usd">166000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMTA5OTUxMTYzMDQzOA_d224b474-5561-4ae5-ab2d-413e0bd709de"
      unitRef="usd">154000000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU4NA_96bd607b-16b2-4ee5-813b-76b161aee2ce">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,629&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,921&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfMi0xLTEtMS0w_77e84c83-fe10-4923-8727-46434fc1003e"
      unitRef="usd">57000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfMi0zLTEtMS0w_062e1349-1b88-4b20-8552-029acd4b83ce"
      unitRef="usd">52000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfMy0xLTEtMS0w_330835df-86fa-47b8-b5d5-160b11baacb1"
      unitRef="usd">411000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfMy0zLTEtMS0w_7bffe4ed-89de-46d3-bbfb-4b80eb6b8f68"
      unitRef="usd">458000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DerivativeAssets
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNC0xLTEtMS0w_dbef00fd-61af-47b4-8ef4-ad0f51f6e9c4"
      unitRef="usd">156000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNC0zLTEtMS0w_2cb76fe0-f55d-474e-9a74-eb8af506beb9"
      unitRef="usd">109000000</us-gaap:DerivativeAssets>
    <us-gaap:Investments
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNS0xLTEtMS0w_920391a3-5899-4dd4-a882-635ea038633a"
      unitRef="usd">616000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNS0zLTEtMS0w_da747f78-5f94-420d-ac07-4b1086125d38"
      unitRef="usd">918000000</us-gaap:Investments>
    <bsx:Licensingarrangementsasset
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNi0xLTEtMS0w_949b0e2e-44e5-4088-be73-ef0f6e29ef4a"
      unitRef="usd">166000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNi0zLTEtMS0w_089a538a-a485-40d8-acd5-f6a084c67eaf"
      unitRef="usd">218000000</bsx:Licensingarrangementsasset>
    <bsx:OtherOtherLongtermAssets
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNy0xLTEtMS0w_96635c3f-8432-4783-881c-ef59617ae248"
      unitRef="usd">224000000</bsx:OtherOtherLongtermAssets>
    <bsx:OtherOtherLongtermAssets
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfNy0zLTEtMS0w_7e1784ac-504f-4644-8e20-bc2c8d293db5"
      unitRef="usd">166000000</bsx:OtherOtherLongtermAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfOC0xLTEtMS0w_cab297bf-3b40-4b58-b389-b23bdf82da94"
      unitRef="usd">1629000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjk0YzZkNTZhZjc1YTQ1MzQ5MzM0MTBiNTU4MzEyODRiL3RhYmxlcmFuZ2U6OTRjNmQ1NmFmNzVhNDUzNDkzMzQxMGI1NTgzMTI4NGJfOC0zLTEtMS0w_35bd63dd-d982-4df4-8029-15cd8b2a37dc"
      unitRef="usd">1921000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjUzMw_00196f3b-b41a-4d88-b315-c202688c2e96">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,442&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:LitigationReserveCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfMi0xLTEtMS0w_6aa7d901-230c-40ea-9992-c5e628ad2bed"
      unitRef="usd">417000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfMi0zLTEtMS0w_424fff99-1a80-4012-aaf5-3b4261264110"
      unitRef="usd">505000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfMy0xLTEtMS0w_aedd16d3-784f-45b2-8d3b-3bce10f8e23a"
      unitRef="usd">801000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfMy0zLTEtMS0w_773bf2ae-6c8f-4dd4-aeae-4e46238ec09d"
      unitRef="usd">681000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNC0xLTEtMS0w_40183612-55e8-4ed3-a1eb-c131971d02ec"
      unitRef="usd">354000000</bsx:AccruedRebatesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNC0zLTEtMS0w_8c08419b-0d88-4c1a-bde3-e9b0b0635e78"
      unitRef="usd">331000000</bsx:AccruedRebatesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNS0xLTEtMS0w_56015557-ed51-42c4-952d-5b433f34c232"
      unitRef="usd">258000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNS0zLTEtMS0w_0fcc0637-99ac-4bda-ac3d-a5473f5ea661"
      unitRef="usd">26000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNi0xLTEtMS0w_5049b120-ec63-4b1e-a6fe-63bd53acab83"
      unitRef="usd">612000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNi0zLTEtMS0w_44c62be2-e6f5-4686-ba6c-2472b9cae3fd"
      unitRef="usd">656000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNy0xLTEtMS0w_97bf8b19-8413-49af-afc3-c824f0e1dd60"
      unitRef="usd">2442000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmEwNzg3NzU1OGQzMjQ5MmU4OGU3MjFhNTIyYTcxODQ1L3RhYmxlcmFuZ2U6YTA3ODc3NTU4ZDMyNDkyZTg4ZTcyMWE1MjJhNzE4NDVfNy0zLTEtMS0w_8a5e38ec-0c9f-4e10-b7cf-0d764991ca33"
      unitRef="usd">2197000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjUzNA_8992c95d-7e97-434e-8e1d-9d2e93533d79">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;958&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfMi0xLTEtMS0w_59d436f1-fa25-4c0f-9af5-3bad983b2f5a"
      unitRef="usd">141000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfMi0zLTEtMS0w_0232c834-09f3-4525-899c-ea034806e49f"
      unitRef="usd">138000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfMy0xLTEtMS0w_87ed8bea-7aa8-4332-a808-14b2156661a1"
      unitRef="usd">151000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfMy0zLTEtMS0w_56ca17df-1666-40b3-8958-34e5bfe308de"
      unitRef="usd">153000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNC0xLTEtMS0w_89e82e4f-72e7-454c-937a-74a537db7fe2"
      unitRef="usd">121000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNC0zLTEtMS0w_c4ee441f-0cb5-4e0d-b4dd-bf66f3890653"
      unitRef="usd">158000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNS0xLTEtMS0w_130ae793-b9a3-4fd3-b677-0fcf44fa8bea"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNS0zLTEtMS0w_31ff75de-e75a-44f3-9cd6-bc6159274707"
      unitRef="usd">200000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNi0xLTEtMS0w_e7c11fa5-46eb-47a7-b8ec-d1882f91aa10"
      unitRef="usd">268000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNi0zLTEtMS0w_01cbe10a-336a-468e-b9c2-5b074db04b3f"
      unitRef="usd">307000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNy0xLTEtMS0w_e7935ea9-4e0e-4bae-823f-c84ceb2f74ea"
      unitRef="usd">680000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOmViZGQ2NzgwNmNkODQzM2M4ZGE5M2UzOTZlYTEwNmEwL3RhYmxlcmFuZ2U6ZWJkZDY3ODA2Y2Q4NDMzYzhkYTkzZTM5NmVhMTA2YTBfNy0zLTEtMS0w_cbc2109f-84c9-4bb5-a083-7d304972c189"
      unitRef="usd">958000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RleHRyZWdpb246YzgwYWNmMGQ5ZDljNDAzYWEzZGNlYmYxMWQ0MmI2ODNfMjU1MQ_8872571c-fbd2-4535-a292-324bf6db0027">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,190&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,309&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfMi0xLTEtMS0w_32d4f1be-7a96-4784-a22f-46f9b7788188"
      unitRef="usd">535000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfMi0zLTEtMS0w_da6c05e8-8537-4cb6-b33d-682e9a55115f"
      unitRef="usd">547000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfMy0xLTEtMS0w_0f107903-6dba-48b9-a04e-0ccb4cc33fc5"
      unitRef="usd">200000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfMy0zLTEtMS0w_9c39ff1b-bf8a-4bff-99c3-0af5c8bb5d5c"
      unitRef="usd">64000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNC0xLTEtMS0w_de3ed60a-92b9-47e4-8c31-507ea8450fc8"
      unitRef="usd">54000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNC0zLTEtMS0w_10b2f57c-ebd3-4e19-beb9-6e565e41567d"
      unitRef="usd">171000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <bsx:Licensingarrangementsliability
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNS0xLTEtMS0w_8f612a2a-bfea-40a0-95a7-40e102ffccdb"
      unitRef="usd">199000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNS0zLTEtMS0w_ab1f6589-21c0-4e3f-a519-3f69bc5c4cde"
      unitRef="usd">253000000</bsx:Licensingarrangementsliability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNi0xLTEtMS0w_874969ae-1802-41e3-8df9-ec77afc26541"
      unitRef="usd">359000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNi0zLTEtMS0w_391b0c9c-7d8a-4568-8ba0-d12d16558110"
      unitRef="usd">401000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredRevenue
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNy0xLTEtMS0w_fbc607fc-20fb-4fc2-8074-afaa04b48f55"
      unitRef="usd">283000000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfNy0zLTEtMS0w_fa7a9369-4204-472b-b2c1-5f01b581a56c"
      unitRef="usd">257000000</us-gaap:DeferredRevenue>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfOC0xLTEtMS0w_ca604f38-7c92-46f3-9177-372e9f480099"
      unitRef="usd">560000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfOC0zLTEtMS0w_f6f15047-1333-4717-9c64-edf440907517"
      unitRef="usd">615000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfOS0xLTEtMS0w_c3dd474c-0fb8-4c9c-bb84-396789c93165"
      unitRef="usd">2190000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF83My9mcmFnOmM4MGFjZjBkOWQ5YzQwM2FhM2RjZWJmMTFkNDJiNjgzL3RhYmxlOjU3YjQ3MGZlOGVhNDQ3MWM5ZGI4OGJlZmQzNGY4NzBjL3RhYmxlcmFuZ2U6NTdiNDcwZmU4ZWE0NDcxYzlkYjg4YmVmZDM0Zjg3MGNfOS0zLTEtMS0w_73271f44-e9f0-4a8b-ba05-97153251586e"
      unitRef="usd">2309000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfMjE4NQ_1421934a-14e4-43b4-be3e-aed145fa6c95">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE G &#x2013; INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective tax rate from continuing operations is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in our reported tax rates for the second quarter and first six months of 2021, as compared to the same periods in 2020, relates primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These receipts and charges include acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credit), litigation charges, investment portfolio net losses (gains), as well as certain discrete tax items primarily related to changes in foreign tax rates, and changes in tax laws adopted in the second quarter of 2021, as well as the impacts of the Coronavirus Aid, Relief and Economic Security (CARES) Act in the second quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, we had $280 million of gross unrecognized tax benefits, of which a net $195 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2020, we had $261 million of gross unrecognized tax benefits, of which a net $183 million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to positions on new entities we acquired through recent acquisitions and restructuring activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that within the next 12 months, we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $24 million.&lt;/span&gt;&lt;/div&gt;Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act, enacted on March 27, 2020, provided an estimated $2.2 trillion in COVID-19 pandemic-related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes incurred in 2020. This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments and is expected to be paid in full by the end of 2022 as permitted by the legislation.</us-gaap:IncomeTaxDisclosureTextBlock>
    <bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfMjE4Ng_5068bdaa-6af2-4205-9923-cdae3e1cd479">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RhYmxlOmJjYTkwOTcyMjcxOTRjY2RiNDljYjAwMTMxMWM2MjgxL3RhYmxlcmFuZ2U6YmNhOTA5NzIyNzE5NGNjZGI0OWNiMDAxMzExYzYyODFfMi0xLTEtMS0w_2729658f-4e93-4dbe-8239-be6c81ba8d0f"
      unitRef="number">-0.249</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RhYmxlOmJjYTkwOTcyMjcxOTRjY2RiNDljYjAwMTMxMWM2MjgxL3RhYmxlcmFuZ2U6YmNhOTA5NzIyNzE5NGNjZGI0OWNiMDAxMzExYzYyODFfMi0zLTEtMS0w_e0155aba-a3ef-47b1-b155-3b2bf2c1bd88"
      unitRef="number">0.184</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RhYmxlOmJjYTkwOTcyMjcxOTRjY2RiNDljYjAwMTMxMWM2MjgxL3RhYmxlcmFuZ2U6YmNhOTA5NzIyNzE5NGNjZGI0OWNiMDAxMzExYzYyODFfMi01LTEtMS0w_121a799d-7e73-4db7-8efa-14244f28a266"
      unitRef="number">-0.112</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RhYmxlOmJjYTkwOTcyMjcxOTRjY2RiNDljYjAwMTMxMWM2MjgxL3RhYmxlcmFuZ2U6YmNhOTA5NzIyNzE5NGNjZGI0OWNiMDAxMzExYzYyODFfMi03LTEtMS0w_3c3ae7e7-3f84-4d04-89f8-d8a404952162"
      unitRef="number">0.137</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfNjk5_40b74ab4-6099-4426-a2af-272ee0256a6c"
      unitRef="usd">280000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfNzUz_f41a3cd4-3054-4797-bccf-134fe4aee5b9"
      unitRef="usd">195000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfODI2_c5e21387-f9b7-41fc-aa54-246e60887848"
      unitRef="usd">261000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfODgw_badd64fb-19ab-4df9-b44c-60356dd4991d"
      unitRef="usd">183000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfMTMyMg_53d325c1-3610-4822-b4e3-5e5c24299b59"
      unitRef="usd">24000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <bsx:TheCARESAct
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-11"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84Mi9mcmFnOjEwZDE3YmQ1MmQzZjQ5N2Y5NDE4OWEzMTU4MTEzY2E5L3RleHRyZWdpb246MTBkMTdiZDUyZDNmNDk3Zjk0MTg5YTMxNTgxMTNjYTlfMTU1NQ_25cf4c0d-0bc3-4999-8c0e-3387a90fd92b"
      unitRef="usd">2200000000000</bsx:TheCARESAct>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTc1Nzg_a1677eb2-8477-45f8-b0f5-8ed1f7c69328">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;NOTE H &#x2013; COMMITMENTS AND CONTINGENCIES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accrual for legal matters that are probable and estimable was $617 million as of June&#160;30, 2021 and $569 million as of December&#160;31, 2020 and includes certain estimated costs of settlement, damages and defense. The increase in our legal accrual was mainly due to product liability cases or claims related to transvaginal surgical mesh products. A portion of our legal accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $167 million as of June&#160;30, 2021 and $208 million as of December&#160;31, 2020. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note F &#x2013; Supplemental Balance Sheet Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded litigation-related net charges of $298 million during the second quarter of 2021 and $302 million during the first six months of 2021, related primarily to transvaginal surgical mesh products.  We did not record any litigation-related net charges during the first six months of 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;in our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our accompanying unaudited consolidated statements of operations. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Patent Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, &#x201c;Cook&#x201d;) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#x2019;s Instinct&#x2122; Endoscopic Hemoclip. The case was transferred to the District Court for the Southern District of Indiana. Cook filed seven Inter Partes Review (&#x201c;IPR&#x201d;) requests with the U.S. Patent and Trademark Office (USPTO) against the four asserted patents. All IPRs have concluded and Cook and the Company both appealed the Patent Office&#x2019;s IPR decisions to the Federal Circuit Court of Appeals. On April 30, 2020, the U.S. Court of Appeals ruled that claims from two of the Company's patents remain valid, remanding two of the patents for further review by the USPTO&#x2019;s Patent Trial and Appeal Board. In November 2020, the Patent Office issued remand rulings invalidating several additional claims. The district court stayed the case pending the appeals court decision on the IPRs, which is now complete. The case is proceeding before the United States District Court for the Southern District of Indiana, with the Company asserting three patents against Cook. Trial is anticipated in October 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 23, 2021, Nevro Corp. (&#x201c;Nevro&#x201d;) filed a complaint against the Company in the United States District Court for the District of Delaware (21-cv-258). The complaint alleges infringement of five Nevro patents by certain of the Company&#x2019;s spinal cord stimulation systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Liability Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of July 20, 2021, approximately 54,500 product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. As of July 20, 2021, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately 52,500 cases and claims, adjusted to reflect the Company&#x2019;s analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately 52,500 cases and claims, approximately 49,000 have met the conditions of the settlement and are final. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. The pending cases are in various federal and state courts in the U.S. Generally, the plaintiffs allege personal injury associated with use of our transvaginal surgical mesh products. The plaintiffs assert design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. Over 3,100 of the cases were specially assigned to one judge in state court in Massachusetts. On February 7, 2012, the Judicial Panel on Multi-District Litigation (MDL) established MDL-2326 in the U.S. District Court for the Southern District of West Virginia and transferred the federal court transvaginal surgical mesh cases to MDL-2326 for coordinated pretrial proceedings. The Court issued an Order closing the MDL on February 11, 2021, as all cases that had been pending were dismissed or remanded to courts of primary jurisdiction. Outside the United States, there are fewer than 75 claims in the United Kingdom and Ireland. In the first quarter of 2021, two class actions were filed against the Company in Australia.  In the second quarter of 2021, one of these class actions was permanently stayed, while the other is proceeding.  At this time, the Company is aware of fewer than 125 claims in Australia. There are also fewer than 10 cases in Canada, inclusive of one certified class action, which has settled and received Court approval. On April 16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#x2019;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. In April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records. The Company has notified our insurer and retained counsel to respond to the demand.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. In the second quarter of 2021, we increased the accrual associated with this matter by $298 million to account for increased, post-COVID-19 settlement and litigation activity related to the remaining cases and claims the Company faces, our revision of the per-case settlement amount for these cases based on recent settlement and litigation activity, and changes to our expectations regarding the rate of incoming cases and claims.  We continue to engage in discussions with plaintiffs&#x2019; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest the cases and claims asserted against us that do not settle and expect that more cases will go to trial through 2023.  The final resolution of the cases and claims is uncertain and could have a further material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are currently named as a defendant in 147 filed product liability cases involving our Greenfield Vena Cava Filter, which we discontinued marketing and active selling in the fourth quarter of 2018, alleging various injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional 521 claims, none of which have been filed.  As of June 24, 2021, we have entered into master settlement agreements in principle or are in the final stages of entering with certain plaintiffs&#x2019; counsel to resolve approximately 200 cases. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Governmental Investigations and Qui Tam Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 5, 2014, we were served with a subpoena from the U.S. Department of Health and Human Services, Office of the Inspector General. The subpoena seeks information relating to the launch of the Cognis&#x2122; CRT-D and Teligen&#x2122; ICD line of devices in 2008, the performance of those devices from 2007 to 2009 and the operation of our Physician Guided Learning Program. We are cooperating with this request. On May 6, 2016, a qui tam lawsuit in this matter was unsealed in the United States District Court for the District of Minnesota. At the same time, we learned that the U.S. federal government and the State of California had earlier declined to intervene in that lawsuit on April 15, 2016. The complaint was served on us on July 21, 2016. On October 7, 2016, the plaintiff/relator served an amended complaint that dropped the allegations relating to our Physician Guided Learning Program. We filed a motion to dismiss the amended complaint on December 7, 2016 and the court &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;heard our motion to dismiss on April 5, 2017. On August 29, 2017, the Court granted the motion to dismiss, without prejudice and on September 19, 2017, the relator filed a Second Amended Complaint.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We filed a motion to dismiss the Second Amended Complaint on October 10, 2017 and the Court denied that motion on December 13, 2017. On July 31, 2018, the relator filed a motion seeking leave to file a Third Amended Complaint. The Court denied the motion on October 30, 2018.  In February 2021, we filed a motion for summary judgment, which the relator opposed, and on April 29, 2021, the Court held a hearing on that motion.  The motion remains pending.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 4, 2020 Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against the Company, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#x2122; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all other similarly situated, filed a second, materially similar class action complaint against the Company, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. Subsequently, on March 30, 2021, the Court consolidated the two actions, and appointed Mariano Errichiello as the lead plaintiff. Under the terms of the Court-approved Scheduling Order, Counsel for Mr. Errichiello was required to file an Amended Complaint on or before June 4, 2021, which it did, and, in response the Company brought a Motion to Dismiss the Amended Complaint by July 19, 2021.  On December 15, 2020, the Securities and Exchange Commission&#x2019;s Boston Regional Office (Boston SEC) notified the Company that it was conducting an investigation related to the Company&#x2019;s decision to retire the LOTUS System, and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company is cooperating fully with the investigation. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#x2019;s Board of Directors conduct an investigation into actions by the Company&#x2019;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System. The Trust subsequently agreed to stay its demand, pending the outcome of any dispositive motion against the Amended Complaint in the class action complaint described above.  The Company received letters on behalf of the Union Excavators Local 731 Pension Fund and Diane Nachbaur, two stockholders of the Company, on July 26, 2021 and July 29, 2021, respectively, each demanding access to certain books and records of the Company, pursuant to 8 Delaware Section 220, regarding the business, operations, effectiveness and commercial viability of the LOTUS system, and related items.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Matters Concluded Since December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 23, 2015, a judge for the Court of Modena (Italy) ordered a trial for the Company and three of its employees, as well as numerous other defendants charged in criminal proceedings. The charges arose from allegations that the defendants made improper donations to certain healthcare providers and other employees of the Hospital of Modena in order to induce them to conduct unauthorized clinical trials, as well as related government fraud in relation to the financing of such clinical trials. A trial began on February 24, 2016. On November 10, 2017, the Court issued a ruling that convicted one Company employee but acquitted two others and levied a fine of &#x20ac;245 thousand against us and imposed joint and several civil damages of &#x20ac;620 thousand on all defendants. We continue to deny these allegations, and timely appealed the decision on May 10, 2018. On November 9, 2020, the Court of Appeal in Bologna reversed the judgements against the Company and its employee and acquitted them of all charges. This judgment of acquittal became final as to the Company and its employee on April 15, 2021 when the prosecution chose not to appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general regarding our transvaginal surgical mesh products and related alleged violations of states&#x2019; consumer protection statutes. On December 12, 2019, the Mississippi Attorney General filed suit against us in a Mississippi state court alleging violations of the Mississippi Consumer Protection Act. In the fourth quarter of 2020 and the first quarter of 2021, we reached settlements with 48 states, including Mississippi, and the District of Columbia. These settlements were finalized in March of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On &lt;/span&gt;&lt;/div&gt;May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders. On April 8, 2021, the parties settled the dispute, and, on April 12, 2021, the parties filed stipulations with the court to dismiss the remaining legal proceedings. The settlement did not result in any material benefit or liability to the Company.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTc1NzQ_1d1a99da-d6f1-4866-accd-36d4207e57b9">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.&lt;/span&gt;</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMzkxNA_168888b2-a944-49a4-86df-8db558157a68"
      unitRef="usd">617000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMzkzMA_1df77cd6-b14c-419b-b5df-dbf74448a8dd"
      unitRef="usd">569000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfNDM3NQ_e9e062f2-7869-49d6-babb-ae044850838d"
      unitRef="usd">167000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfNDM5MQ_4f6ac7cc-754d-4ca4-89be-e2df5a420351"
      unitRef="usd">208000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:LitigationSettlementExpense
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfNDQ5Mg_33ff8825-b310-4684-9509-902db3460373"
      unitRef="usd">298000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTA5OTUxMTY0NTM5OQ_4a213716-384d-4a6d-a198-bb04b3708cf1"
      unitRef="usd">302000000</us-gaap:LitigationSettlementExpense>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfNzYxNQ_aa37ccd8-7dc9-463b-bb58-0dac0ff3d3b8"
      unitRef="claims">54500</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i77c92e5241fe49138fd00651d03d0ec6_I20210720"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfNzk5Mg_66fa81d1-bb7d-4f72-b5de-65afc4a9f3af"
      unitRef="claims">52500</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i77c92e5241fe49138fd00651d03d0ec6_I20210720"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfODM2MA_66fa81d1-bb7d-4f72-b5de-65afc4a9f3af"
      unitRef="claims">52500</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct
      contextRef="i77c92e5241fe49138fd00651d03d0ec6_I20210720"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfODM5NQ_da8e9d7e-edfe-48bf-a3a3-7647458b94f9"
      unitRef="claims">49000</bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="ib0ad409ecce44b268852058674771336_I20210720"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfODk2OA_5df21256-4168-42b2-b310-94ba4b66b1bd"
      unitRef="claims">3100</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom
      contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfOTU0Ng_0ab19013-db23-4baa-9078-b305839ca63d"
      unitRef="claims">75</bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom>
    <bsx:CertifiedClassActionsInAustraliaMesh
      contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfOTYwOQ_3c078e93-e525-43bc-8551-3cf4467f7604"
      unitRef="claims">2</bsx:CertifiedClassActionsInAustraliaMesh>
    <bsx:ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia
      contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfOTY5OA_392ad6c7-9891-405c-9771-1e74cc63bbd3"
      unitRef="usd">125</bsx:ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia>
    <bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada
      contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfOTczNQ_22aed736-5457-4682-916e-3039306f4edf"
      unitRef="claims">10</bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada>
    <bsx:CertifiedclassactionsinCanadaMesh
      contextRef="iba90cf22a3284fb59a07eb50be79d5fe_I20210720"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfOTc2OA_a10a9486-43a7-4209-854c-5ac2d26b4381"
      unitRef="claims">1</bsx:CertifiedclassactionsinCanadaMesh>
    <us-gaap:LitigationSettlementExpense
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMjc0ODc3OTA5ODE0Nw_33ff8825-b310-4684-9509-902db3460373"
      unitRef="usd">298000000</us-gaap:LitigationSettlementExpense>
    <bsx:ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTE3ODA_e42547a8-eb21-4a1b-a487-ab29153e00d4"
      unitRef="claims">147</bsx:ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter>
    <bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTIyMDU_3be7905b-b624-4977-a383-b474d8ed1fb7"
      unitRef="claims">521</bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter>
    <bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTc1OTA_f1a11c6a-93b2-4168-bc67-43ca5f720ea2"
      unitRef="claims">521</bsx:ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i026d0c112cb44011bed4a40ce907adcb_D20171110-20171110"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTY1MTA_228d8b3c-5cc1-4d4a-a84c-ab3e39b55edd"
      unitRef="eur">245000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i026d0c112cb44011bed4a40ce907adcb_D20171110-20171110"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTY1NzE_136051a9-1553-4418-928f-7b9c0790449e"
      unitRef="eur">620000</us-gaap:LossContingencyDamagesPaidValue>
    <bsx:StateAGSettlementsMeshRelatedNumberOfStates
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF84OC9mcmFnOjFjZTYzMmUzMTc4MDRhZDM5OWM0MzBkMmM4YThiYWIxL3RleHRyZWdpb246MWNlNjMyZTMxNzgwNGFkMzk5YzQzMGQyYzhhOGJhYjFfMTc0NTg_f7932904-3c6b-4271-97ec-056ed0c30e1c"
      unitRef="units">48</bsx:StateAGSettlementsMeshRelatedNumberOfStates>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNDAxMw_97bd69a4-7490-4948-8c92-9958600edca1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE I &#x2013; STOCKHOLDERS' EQUITY&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975&#160;million after deducting underwriting discounts and commissions and offering expenses. As of June&#160;30, 2021, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of 5.50% of the liquidation preference of $100 per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $100 per share plus accumulated and unpaid dividends.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between 2.3834 and 2.9197 shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In the second quarter of 2021, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared and we paid a cash dividend of $1.375 per MCPS share to holders of our MCPS as of May 15, 2021, representing a dividend period from March through May 2021. On July 23, 2021, the Committee declared a cash dividend of $1.375 per MCPS share to holders of our MCPS as of August 15, 2021, representing a dividend period from June through August 2021. We have presented cumulative, unpaid dividends within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; within our unaudited consolidated balance sheet as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note L &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for information on the pertinent rights and privileges of our outstanding common stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNTI_e0653631-14ef-4b41-b8f6-db57551e236e"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia6bc3d74e781494aa5f8d841b5dd5783_I20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNDY4_73d500ce-c820-44a9-8d98-c7041d68952f"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNDgx_e2d4405a-4e62-43c4-915c-84b3afba62a2"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="ia6bc3d74e781494aa5f8d841b5dd5783_I20200527"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNTky_3ccbbf44-18c5-401e-9380-0bb5a30d215e"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="ib072725f878d490891c935180e76efae_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfNjYz_af4e6eb9-3371-4f93-a25e-148ddcee0c6e"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="i7f1c2b882edd4e289dc69107378a5023_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfODA0_9585caa6-47d3-4deb-bc71-e4ecff15dfc0"
      unitRef="usd">1006000000.000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMTAyNw_e2d4405a-4e62-43c4-915c-84b3afba62a2"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i7f1c2b882edd4e289dc69107378a5023_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMTA2Mw_b5f29578-aaab-4263-ad2b-a961074863bb"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i7f1c2b882edd4e289dc69107378a5023_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMjE2NQ_b5f29578-aaab-4263-ad2b-a961074863bb"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <bsx:ConvertiblePreferredStockSharesIssuedForEachConvertedShare
      contextRef="i7dbfe80c9a6c4f1fbd50cde474b1f462_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMjM4MA_3de64436-66f0-4ace-a977-16dac665d597"
      unitRef="number">2.3834</bsx:ConvertiblePreferredStockSharesIssuedForEachConvertedShare>
    <bsx:ConvertiblePreferredStockSharesIssuedForEachConvertedShare
      contextRef="ic6a63df2abd449589aa54a60a6aa45cb_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMjM4Nw_1e9a2d8d-3d34-4b26-9529-30599ad495ec"
      unitRef="number">2.9197</bsx:ConvertiblePreferredStockSharesIssuedForEachConvertedShare>
    <bsx:ConvertiblePreferredStockThresholdTradingDays
      contextRef="ib49698e97e504d60869e1ddaf5b2bb12_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMTc1OTIxODYwNDg1NzQ_87669335-f7ff-4f47-a2a8-22319c2944ed"
      unitRef="day">20</bsx:ConvertiblePreferredStockThresholdTradingDays>
    <us-gaap:PreferredStockDividendsPerShareCashPaid
      contextRef="ibe8974f83a41404480fe53c20b651092_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMzMyNg_b3175982-2bd1-4e8d-b6f6-ff532f8f4ead"
      unitRef="usdPerShare">1.375</us-gaap:PreferredStockDividendsPerShareCashPaid>
    <us-gaap:PreferredStockDividendsPerShareDeclared
      contextRef="i1c82a8e57953431395abd5f8de82b993_D20210723-20210723"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF85NC9mcmFnOjBmYTkyMDkxZmUwNDQ5ZWI5NGU0YzNkMDMzZmEzZGNlL3RleHRyZWdpb246MGZhOTIwOTFmZTA0NDllYjk0ZTRjM2QwMzNmYTNkY2VfMzUyNA_665cb2d9-574a-4ed8-a300-1a1da5a2e30a"
      unitRef="usdPerShare">1.375</us-gaap:PreferredStockDividendsPerShareDeclared>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzIwNjA_be8e3f8b-98d2-4282-9a1d-6b01351b6439">&lt;div style="margin-top:20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE J &#x2013; WEIGHTED AVERAGE SHARES OUTSTANDING &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,420.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,432.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,410.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,431.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,404.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in the second quarter and first six months of 2020 due to our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; position in those periods.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We base &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss)&#160;per common share - assuming dilution&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the second quarter and first six months of 2021, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; was reduced by cumulative &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Preferred stock dividends&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, as presented in our accompanying unaudited consolidated statements of operations, for purposes of calculating &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net income available to common stockholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. &lt;/span&gt;&lt;/div&gt;We issued approximately one million shares of our common stock in the second quarter of 2021 and 2020, and five million shares in the first six months of 2021 and 2020, following the exercise of stock options, vesting of deferred stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first six months of 2021 or 2020. On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock. As of June&#160;30, 2021, we had the full amount remaining available under the authorization.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzIwNTU_01add682-8aa6-4bb9-bb11-3d4439561d50">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,421.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,420.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,432.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,410.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,431.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,404.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzItMS0xLTEtMA_2320625a-ceee-40b8-b7f1-639550ffdf18"
      unitRef="shares">1421300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzItMy0xLTEtMA_0f4945ee-2336-4526-9c33-d0f547de6bf1"
      unitRef="shares">1410900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzItNS0xLTEtMA_ad6c607c-fc1d-414e-a6aa-77c62744a8ac"
      unitRef="shares">1420000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzItNy0xLTEtMA_a8a01bc3-23a7-4970-a416-f6ed1f21f3b0"
      unitRef="shares">1404100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzMtMS0xLTEtMA_ea87f80d-3dd0-43d5-9ec1-364ec64ea919"
      unitRef="shares">11200000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzMtMy0xLTEtMA_2078f186-cd0e-4dbf-b62f-4674dc31ff2c"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzMtNS0xLTEtMA_2ce95a15-656a-44c2-9354-a2b90581628b"
      unitRef="shares">11700000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzMtNy0xLTEtMA_cd9de47c-ce3a-42aa-8ada-d4442c3656cc"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzQtMS0xLTEtMA_0bef0c6d-f98e-425d-91ab-7524842a6715"
      unitRef="shares">1432500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzQtMy0xLTEtMA_9575ce05-413c-4aa6-adc6-a30ed1c7dee7"
      unitRef="shares">1410900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzQtNS0xLTEtMA_49cc078d-dc5a-4e85-a4a9-a645b02bd5e0"
      unitRef="shares">1431700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo4N2VlZTEyZTk4NmM0MGY1YTcyNjQ1YzI5NTljYWJiZi90YWJsZXJhbmdlOjg3ZWVlMTJlOTg2YzQwZjVhNzI2NDVjMjk1OWNhYmJmXzQtNy0xLTEtMA_cfc93df8-2f07-4778-baae-819c9ef6eaf9"
      unitRef="shares">1404100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzIwNTg_234ba696-3b2b-4b27-9dc4-0b73824ede7f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in the second quarter and first six months of 2020 due to our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; position in those periods.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i931d3fba103a41da93709c2ad126cda8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzItMS0xLTEtMA_62c645f1-5749-48a2-89de-8e9505f05db9"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i80131178752d4d72933977f1f39077b2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzItMy0xLTEtMA_6254409a-0cce-4816-a5b7-1df1f1e04e4a"
      unitRef="shares">13000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i872461569f5c44cc9806dce827685f3e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzItNS0xLTEtMA_f7fd0526-fbfd-4823-b4a3-57d4c1511595"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4dd96420c83b4f6fbd2317a8063fe8e8_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzItNy0xLTEtMA_7cce6ce6-36b7-4f87-9e99-8c5826b7e611"
      unitRef="shares">14000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i94ceea52a45242bbb3456459eec3203a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzMtMS0xLTEtMA_60193747-9a71-456d-9426-26b3efe07ba2"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie8b39a268f3f4c688dd37a207b541d3c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzMtMy0xLTEtMA_8ca46bff-1575-4126-a88c-6a5db15e5ab7"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if28997b0cb7f412abd0e94a0120251a4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzMtNS0xLTEtMA_06b645c7-ff9c-4a8d-821a-4814fb68cb6c"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia22d58f6c86d470aa34c0f3cdd713039_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzMtNy0xLTEtMA_c5f9f9af-0b14-4791-8e80-a27941d8e612"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5bcab03a819b4e56b7ba98f0bd557f87_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzQtMS0xLTEtMA_c6bd7625-00a2-4ee8-bc29-62f055fb9952"
      unitRef="shares">24000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5dd5712978054816851d620283d3a5a1_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzQtMy0xLTEtMA_c19632ae-e912-4f01-ade4-983f89d37ab9"
      unitRef="shares">9000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6b8776f4806d49a896745a9a4bb90b81_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzQtNS0xLTEtMA_40a94842-aab6-467a-92ae-379364c7f26a"
      unitRef="shares">24000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6a123b6a6d02472f84544e157b785b07_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90YWJsZTo5MjkxZTMwNjJmZWU0MGZiOTUzNDQyNDI4ZDY3OWNlOC90YWJsZXJhbmdlOjkyOTFlMzA2MmZlZTQwZmI5NTM0NDI0MjhkNjc5Y2U4XzQtNy0xLTEtMA_85bf603e-2d01-4d70-9e2e-17d2e2aced75"
      unitRef="shares">5000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzE1MDU_4bdd1ca0-7982-44a1-8e05-3ac71c40bfa5"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzEwOTk1MTE2MzAwNTU_75a0b948-57aa-42c1-884b-29308f8a96a8"
      unitRef="shares">5000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ia8ac7dde02784ed2a3c939e70748808d_I20201214"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDAvZnJhZzo3OGU3MjVmNjhhYmQ0ZTc5OTY1MTIwNmRjZGE2MjZhMS90ZXh0cmVnaW9uOjc4ZTcyNWY2OGFiZDRlNzk5NjUxMjA2ZGNkYTYyNmExXzEwOTk1MTE2MzAzMzU_4644f733-1099-49d3-a568-6d60775a41a6"
      unitRef="usd">1000000000.000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90ZXh0cmVnaW9uOjFkN2M4MGE4ZWYwNTQ4MGE5ZGJiN2E1ODFkODgwY2E2XzE2NDY_920b822a-e600-4992-bd5f-8c1fd2a67ee8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE K &#x2013; SEGMENT REPORTING &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our seven core businesses are organized into three reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. Operating income of reportable segments as a percentage of net sales of reportable segments is defined as operating income of reportable segments divided by net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits); and certain litigation-related net charges (credits) and European Union (EU) Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in our accompanying unaudited consolidated statements of operations and are included in the reconciliation below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,228&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,935&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,437&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,546&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits) and EU MDR implementation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(327)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;474&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1) On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income margin of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <bsx:NumberOfBusinesses
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90ZXh0cmVnaW9uOjFkN2M4MGE4ZWYwNTQ4MGE5ZGJiN2E1ODFkODgwY2E2XzE3NTkyMTg2MDQ2MDgy_449df45b-6b4c-445b-8f2b-69ad02433282"
      unitRef="business">7</bsx:NumberOfBusinesses>
    <us-gaap:NumberOfReportableSegments
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90ZXh0cmVnaW9uOjFkN2M4MGE4ZWYwNTQ4MGE5ZGJiN2E1ODFkODgwY2E2XzU1_d244b7c0-85f5-489f-8d5b-47cd81457a8a"
      unitRef="reportablesegments">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90ZXh0cmVnaW9uOjFkN2M4MGE4ZWYwNTQ4MGE5ZGJiN2E1ODFkODgwY2E2XzE2NDU_61cf1a87-26b9-4d4d-843d-2502c10308b7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,228&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,935&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,437&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,546&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(222)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits) and EU MDR implementation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(327)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;149&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;474&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1) On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income margin of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf3d85296ff14a7fa38a4e77b4c22259_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzItMS0xLTEtMA_0d52c459-6a5b-448d-809f-6b0c7093544c"
      unitRef="usd">948000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee7ac48795d7495bb324539450207488_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzItMy0xLTEtMA_aebde2a5-83b8-4ec0-bc41-e18ab0716e6a"
      unitRef="usd">576000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if893495841d548ada62dd960d69a89bc_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzItNS0xLTEtMA_55761d5c-1a82-4a5c-94f9-8aeebc27d34d"
      unitRef="usd">1808000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc87b0e1aea540f5afcf25232dd8e768_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzItNy0xLTEtMA_cc2cd4ab-a6f3-48ae-a6aa-8b2456a78abb"
      unitRef="usd">1350000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fa95cedc94d43a78ad39a377b3b4597_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzMtMS0xLTEtMA_49e9a8df-d0b5-43be-83fd-f21745641ac9"
      unitRef="usd">866000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87a9703d05a846d58b5180826ffe5050_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzMtMy0xLTEtMA_4395f499-9509-4f28-85b3-90ec67eb05bc"
      unitRef="usd">525000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzMtNS0xLTEtMA_20f7b7ae-3ec0-478c-bb08-a4df6bdfb9d7"
      unitRef="usd">1617000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ddaea5b070844abb018d02ea99642ce_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzMtNy0xLTEtMA_90e03b19-e90b-4e2b-96fe-72c3378307a8"
      unitRef="usd">1228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a812afca36c4308ad9bff7ee2032b3b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzQtMS0xLTEtMA_37e20ebf-5dce-4e97-8207-7ba788608e8a"
      unitRef="usd">1263000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10ee3e6c967c46a4b31eb6264056e524_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzQtMy0xLTEtMA_9c49758e-5bf3-4268-aae3-08e125582436"
      unitRef="usd">834000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzQtNS0xLTEtMA_a0c65c3c-f474-48ed-be59-1a15f96fb80e"
      unitRef="usd">2392000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9920b68656de40d1b14321411d7fbf04_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzQtNy0xLTEtMA_4eaab294-4eef-4f1c-9eb8-22de76f4be48"
      unitRef="usd">1860000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08c5d30357d9461faac846d9a7f6f58c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzUtMS0xLTEtMA_1db9666f-57d7-4f34-abbd-d25a5aee345d"
      unitRef="usd">3077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3f1a45e38524eada4c409914683546a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzUtMy0xLTEtMA_e3392733-d5c6-4394-8fd0-c175d6fa0300"
      unitRef="usd">1935000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifbfbdc30d0ab449094a90e70fd595751_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzUtNS0xLTEtMA_109a5089-c3ee-4349-8531-bc13a0f93664"
      unitRef="usd">5816000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id96d30c4d41a4cdb9fe2a6c8498a6753_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzUtNy0xLTEtMA_111f702c-2a06-4d4f-a76d-577ef48611a4"
      unitRef="usd">4437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia69c68d3663c4d20b8e7aa1db007db37_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzYtMS0xLTEtMA_a53bae81-7e6b-4e32-bdd7-7e7d64028268"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i917d4854b7a7437bbd99ae988171a69e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzYtMy0xLTEtMA_a02775d1-9058-4d73-b02d-42ba4ef962bd"
      unitRef="usd">68000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6987d6c22f4b44dc92c281c44ea04ff4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzYtNS0xLTEtMA_ce7c31db-6a6a-431c-96a8-c2fa1851c34d"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i875553a9513a45a38f8a905416d7829c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzYtNy0xLTEtMA_6d16b149-c26b-44e6-b247-87e4e1f33110"
      unitRef="usd">109000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzctMS0xLTEtMA_fb8a89f2-739c-44be-8a28-4df266742888"
      unitRef="usd">3077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzctMy0xLTEtMA_23b44335-629c-4398-acf0-48eec0ee9bd9"
      unitRef="usd">2003000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzctNS0xLTEtMA_197404df-1def-4780-bc31-d994c996cb5d"
      unitRef="usd">5829000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzctNy0xLTEtMA_86130f99-db38-4f28-9c66-8bcae76c45b5"
      unitRef="usd">4546000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="icf3d85296ff14a7fa38a4e77b4c22259_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzExLTEtMS0xLTA_a3cc1305-db0d-45d3-8c79-1106c2b28d00"
      unitRef="usd">363000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="iee7ac48795d7495bb324539450207488_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzExLTMtMS0xLTA_179f162b-f48b-48f3-8b57-f37a8f387bce"
      unitRef="usd">173000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="if893495841d548ada62dd960d69a89bc_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzExLTUtMS0xLTA_54c5c41b-c757-43fc-a83d-3232c2bf50e4"
      unitRef="usd">695000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="icc87b0e1aea540f5afcf25232dd8e768_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzExLTctMS0xLTA_50e5ce41-ea92-4c96-8d4c-b3d7dba96c66"
      unitRef="usd">432000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i1fa95cedc94d43a78ad39a377b3b4597_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEyLTEtMS0xLTA_a54422a5-fdb7-4623-9901-adf58755c664"
      unitRef="usd">168000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i87a9703d05a846d58b5180826ffe5050_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEyLTMtMS0xLTA_eb158363-3e84-45ea-b133-04082a12c87f"
      unitRef="usd">32000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEyLTUtMS0xLTA_2d97c369-7607-406e-8bef-01fc1970992f"
      unitRef="usd">316000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i0ddaea5b070844abb018d02ea99642ce_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEyLTctMS0xLTA_b7df0e26-2068-4406-9a20-aaea1d50a1cc"
      unitRef="usd">131000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i4a812afca36c4308ad9bff7ee2032b3b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEzLTEtMS0xLTA_e8e01c4d-5c0e-4868-9ee7-fd0a6c6a4cb5"
      unitRef="usd">418000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i10ee3e6c967c46a4b31eb6264056e524_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEzLTMtMS0xLTA_4e66a785-731a-46e8-9104-fc89818b579f"
      unitRef="usd">186000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEzLTUtMS0xLTA_1f869c39-5d5c-4ca6-8acc-82ce87986a76"
      unitRef="usd">756000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i9920b68656de40d1b14321411d7fbf04_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzEzLTctMS0xLTA_c05d0bde-d0d2-407e-97c4-186eb0dede4b"
      unitRef="usd">385000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3e3373e787f64b69879354c4d90cb4d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE0LTEtMS0xLTA_a0c92ed5-e207-43d7-b79d-c91e4e3354f5"
      unitRef="usd">949000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4a73a4533f85472db78cd678e9428f83_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE0LTMtMS0xLTA_a997164b-4fa3-4a8e-87e8-4ae55ed8fd9d"
      unitRef="usd">391000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2329374481a64746916e19c25b31e4a9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE0LTUtMS0xLTA_3e80cdad-44fa-49a7-95d0-f6ea42f76a39"
      unitRef="usd">1767000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icea85ab448ac4f31a40e693d00c9232f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE0LTctMS0xLTA_dc0cc128-0c49-427c-b44c-2c524d71715a"
      unitRef="usd">947000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9425d933351842c69c2377a549b55d63_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE1LTEtMS0xLTA_dbb05998-b2ad-4403-9321-0247119d40c3"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibdbc19706ca841dab5c448ba34ebf25f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE1LTMtMS0xLTA_48c25aad-6510-427b-b8ff-b24390c57177"
      unitRef="usd">49000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie0af53d7a56246a6a7195bfe2f410ab8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE1LTUtMS0xLTA_5f000346-ae42-498d-8ca8-fef2fba191b4"
      unitRef="usd">4000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i06f6ceb4a20040a5a4fb3825accef1ad_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE1LTctMS0xLTA_8a7d8a1f-b9bf-4e63-a245-6890d1a21b7d"
      unitRef="usd">75000000</us-gaap:OperatingIncomeLoss>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="ib2ec85ae1ab744838e2f0043d7c74fc7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE3LTEtMS0xLTA_83ddb412-a788-4cb1-85b5-db43701b5814"
      unitRef="usd">176000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i3d7c3b80fe00450391af229f01a0d200_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE3LTMtMS0xLTA_c0a63c0a-f868-41c2-9800-a344a6eb9870"
      unitRef="usd">189000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i30338b7d70584d428b0e030a91c0bd1f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE3LTUtMS0xLTA_1fce3d07-0162-4797-afbc-f94d14bafd08"
      unitRef="usd">329000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="icf9a180b4192402eb3bf5e60522bf759_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE3LTctMS0xLTA_bfc316cc-139b-486a-bf77-c0c34ac3a1e3"
      unitRef="usd">222000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="ic949cdc25a0746a4a459b8a0d6db3a07_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE4LTEtMS0xLTA_127379e8-2a47-40e4-a826-a463d5789691"
      unitRef="usd">331000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i16978436b3dc4702931fc4b84f04a48e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE4LTMtMS0xLTA_bc232bc4-ea19-4466-9b84-29da22436c7e"
      unitRef="usd">125000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i2aaf1372dd9946df9396ccc9020383a6_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE4LTUtMS0xLTA_3f47aecc-559c-4f29-aea1-e096bce6f117"
      unitRef="usd">445000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i169d8e210b0c42a7bef3c40e6e0a6e32_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE4LTctMS0xLTA_3e60d0e9-74b5-4ac7-b215-9f68020278f1"
      unitRef="usd">327000000</bsx:OperatingIncomeUnallocatedToSegment>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE5LTEtMS0xLTA_1825d519-467d-40f5-871e-b49f116f9523"
      unitRef="usd">180000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE5LTMtMS0xLTA_8f751189-7cb8-463e-b57e-f776551f1a2e"
      unitRef="usd">197000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE5LTUtMS0xLTA_9f1b6a7d-9308-4ef5-abb4-c0c3fc256375"
      unitRef="usd">365000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzE5LTctMS0xLTA_9ed0bd93-970d-4f7b-ad21-6124b2962e01"
      unitRef="usd">398000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIwLTEtMS0xLTA_a6f50650-2913-4036-9d81-cab4fc89dd57"
      unitRef="usd">262000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIwLTMtMS0xLTA_04c5f2b8-e689-442e-a67b-189f8d664494"
      unitRef="usd">-71000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIwLTUtMS0xLTA_3afe4885-5a8c-4d5f-a457-43f4c3924785"
      unitRef="usd">632000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIwLTctMS0xLTA_66c760d8-219a-4511-9926-8f0bd09e2c09"
      unitRef="usd">75000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIxLTEtMS0xLTA_ff750897-71cb-4756-9ba9-3d5216648c7b"
      unitRef="usd">-113000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIxLTMtMS0xLTA_a912dca5-1061-42b8-97b8-54e51820a766"
      unitRef="usd">-110000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIxLTUtMS0xLTA_802711e0-9474-474e-9fa2-e884d17ca087"
      unitRef="usd">-157000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIxLTctMS0xLTA_32210ee8-a989-4aab-9b29-bb0cbaf4d81e"
      unitRef="usd">-234000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIyLTEtMS0xLTA_bb63c78d-e326-4aea-bb86-56e3c2aa2fd6"
      unitRef="usd">149000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIyLTMtMS0xLTA_c3b03dfd-9061-42d5-975f-4a129e6679b9"
      unitRef="usd">-181000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIyLTUtMS0xLTA_b6e3a4f0-fc7f-4215-8c87-6b2cc248422d"
      unitRef="usd">474000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzIyLTctMS0xLTA_47657c5d-a913-4d34-9f5f-5b1241545b82"
      unitRef="usd">-159000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="icf3d85296ff14a7fa38a4e77b4c22259_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI3LTEtMS0xLTA_17e9f9c0-9209-4fb2-a0fb-2a5b78e4de82"
      unitRef="number">0.383</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="iee7ac48795d7495bb324539450207488_D20200401-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI3LTMtMS0xLTA_b848d24a-1d4b-40df-8136-302a6592868e"
      unitRef="number">0.301</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="if893495841d548ada62dd960d69a89bc_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI3LTUtMS0xLTA_7890be3d-d895-43ee-ad13-6a75183d41e1"
      unitRef="number">0.385</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="icc87b0e1aea540f5afcf25232dd8e768_D20200101-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI3LTctMS0xLTA_1861681d-f7a8-499f-9080-e89499430266"
      unitRef="number">0.320</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="i1fa95cedc94d43a78ad39a377b3b4597_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI4LTEtMS0xLTA_8daebcd9-6903-44ff-96f3-cd5cb49afac4"
      unitRef="number">0.193</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="i87a9703d05a846d58b5180826ffe5050_D20200401-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI4LTMtMS0xLTA_cacddc58-dfaa-4d7a-965b-693390172d60"
      unitRef="number">0.061</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="id2ea91faa9974792975202e8cda6e40b_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI4LTUtMS0xLTA_c909aa52-33de-4f39-8ba2-2b9a9ab912d2"
      unitRef="number">0.195</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="i0ddaea5b070844abb018d02ea99642ce_D20200101-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI4LTctMS0xLTA_3f168e29-9d13-479c-ba86-e5afa8768ae5"
      unitRef="number">0.107</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="i4a812afca36c4308ad9bff7ee2032b3b_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI5LTEtMS0xLTA_05b4c9d4-3f0d-4456-9551-79b736341b3c"
      unitRef="number">0.331</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="i10ee3e6c967c46a4b31eb6264056e524_D20200401-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI5LTMtMS0xLTA_bb8b7c90-4bd8-454f-994e-6246e813f9b0"
      unitRef="number">0.223</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="ib88b6425ce754e46bc57f0af51d23660_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI5LTUtMS0xLTA_6e017aed-f8f3-4c9c-9170-a85f4286400f"
      unitRef="number">0.316</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="i9920b68656de40d1b14321411d7fbf04_D20200101-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDYvZnJhZzoxZDdjODBhOGVmMDU0ODBhOWRiYjdhNTgxZDg4MGNhNi90YWJsZTpjMDUzNTFlMzAwMTQ0ODZiODA0YjNkOGE2NzUwZjEwNS90YWJsZXJhbmdlOmMwNTM1MWUzMDAxNDQ4NmI4MDRiM2Q4YTY3NTBmMTA1XzI5LTctMS0xLTA_18644a88-d1c2-4c8d-8f8a-493eec47f3a2"
      unitRef="number">0.207</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzM5NTk_e4d46601-d32c-4f05-a22b-68fd5effaa21">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE L &#x2013; REVENUE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our accompanying unaudited consolidated statements of operations. The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,277&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,003&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,939&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,546&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA (Europe, Middle East and Africa)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC (Asia-Pacific)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LACA (Latin America and Canada)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,003&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,546&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;359&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;268&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;676&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation which had an immaterial impact on previously reported Emerging Markets net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities are classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our accompanying unaudited consolidated balance sheets. Our deferred revenue balance was $424 million as of June&#160;30, 2021 and $395 million as of December&#160;31, 2020. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#x2122; Patient Management System within our Cardiac Rhythm Management (CRM) business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#x2122; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $38 million in the second quarter and $74 million in the first six months of 2021 that was included in the above contract liability balance as of December&#160;31, 2020. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzM5NjM_490075e2-580b-4a27-bfa9-1f4661e0877f">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,277&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,003&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Int'l&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,939&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,546&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA (Europe, Middle East and Africa)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC (Asia-Pacific)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LACA (Latin America and Canada)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,003&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,829&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,546&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;359&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;268&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;676&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation which had an immaterial impact on previously reported Emerging Markets net sales.</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i061cd56ba7464abca39e645d60f76a24_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtMS0xLTEtMA_8a247c45-7a64-4760-b182-59872f723ae8"
      unitRef="usd">316000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idaedeb686cee4d8d9dab6a94ba25b3ca_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtMy0xLTEtMA_d5ebcd17-6507-4a00-81c1-b8659137df02"
      unitRef="usd">235000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idcba7c4ff23d4a36bf3a797d17d3fc25_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtNS0xLTEtMA_10efeae1-4efc-428e-9827-c1c43da862ef"
      unitRef="usd">551000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia88afd4ada2e4380867080d946a426ab_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtNy0xLTEtMA_3f255c33-8a10-4af9-959f-a9722310744a"
      unitRef="usd">190000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96cfef3ea9ca4aa19b2bbb07b400eb80_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtOS0xLTEtMA_8321d8f0-652e-469c-a840-a392912911ad"
      unitRef="usd">158000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42ab9e136af1432d93223a27751196da_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzMtMTEtMS0xLTA_06df3a28-3312-4c13-9043-13fbc6f56b19"
      unitRef="usd">348000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22601e81ae894a8ead01e52c7c6c27d8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtMS0xLTEtMA_1a9a39ef-7e1c-4852-92a6-526c8af943b1"
      unitRef="usd">285000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29a590a1212940f2a9899f47bc99255f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtMy0xLTEtMA_684abaee-925f-48b7-acf9-0c13216e0a52"
      unitRef="usd">112000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd29119a8cc84be69467437c76bb82de_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtNS0xLTEtMA_78b0a89b-b99b-4109-989d-ebb2c825916d"
      unitRef="usd">397000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7af6058e474a47f6be0373df26d2c88b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtNy0xLTEtMA_13c03df7-2dab-4860-8a4f-d555d6446f5b"
      unitRef="usd">162000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5638e698e73f4b489f93a04619cb4765_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtOS0xLTEtMA_420c12d2-4783-4f36-acc6-6d9e8780fc03"
      unitRef="usd">66000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82c8d382689b4777829b44c174c65fbc_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzQtMTEtMS0xLTA_db09defa-627c-4fd4-9271-e2ab74be387b"
      unitRef="usd">228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1373eb6d094a4864854a6d14ee507632_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtMS0xLTEtMA_e53e5cfb-088f-42c8-b874-f3351aae622a"
      unitRef="usd">314000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22d89029dd434509a14af75abe8b39bb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtMy0xLTEtMA_95ced925-1eb6-4c06-824d-a1e00f3bed48"
      unitRef="usd">210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i625505b6d3a940a5bcb761bf0b3959f7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtNS0xLTEtMA_ef9c331d-20b4-494d-90f4-d868014a6e79"
      unitRef="usd">524000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19fc598ea5cf4543b98c31b363392b72_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtNy0xLTEtMA_d34672c8-b2c9-42f0-b1aa-182aa24d66ac"
      unitRef="usd">208000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8adde05e0aa442a2b88ca23ff4e546f2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtOS0xLTEtMA_bf05ce31-543a-49a6-999c-370b88c8e55b"
      unitRef="usd">143000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ff91ebf23ae4decb4c9ef0283823434_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzUtMTEtMS0xLTA_2f093cd2-9793-41c6-8f66-649aba4c2d0c"
      unitRef="usd">351000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99e80edb795146f8b45480c4add3365e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtMS0xLTEtMA_c10aaf39-5a6b-48c6-945f-85432ec9c5d9"
      unitRef="usd">34000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f4c3566c44c4157a5e11d70f391081a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtMy0xLTEtMA_7a12ed22-2c8e-4511-977b-11aa372b7ae7"
      unitRef="usd">62000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1bce46e49184470a8222ed14bd378c26_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtNS0xLTEtMA_0a409529-c20f-4447-9fb0-57fd886cb654"
      unitRef="usd">95000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f47e99793034137b15f7fa228eb0b29_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtNy0xLTEtMA_31b02c02-cddc-45b9-9031-be9b01aa9774"
      unitRef="usd">22000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38a51bdaccc2484c9e70993e21677ca3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtOS0xLTEtMA_905a5f79-de15-44fd-ad7a-b5ff1b5e98e4"
      unitRef="usd">30000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7aa30fb1b39f4d348ef1434541427e01_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzYtMTEtMS0xLTA_e820ceeb-aefd-46a6-af44-defeacb3c301"
      unitRef="usd">51000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a72d4a50a4d4e74b93be9e82777898f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctMS0xLTEtMA_ebc4c3d7-55d6-4d2e-842b-a6e515d7bd04"
      unitRef="usd">194000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9eab68a05c01485c92e57bee7e7e0f01_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctMy0xLTEtMA_f05adbfd-78e9-46c4-8a80-f0f192c187e2"
      unitRef="usd">53000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c54e4912e96435091d529ae0ed78f07_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctNS0xLTEtMA_b4646c03-da75-4f0b-8726-6c152913d605"
      unitRef="usd">247000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibea06e5f733245528b5328dc3e82297f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctNy0xLTEtMA_924ce05c-6215-4c01-a525-dd258b33d827"
      unitRef="usd">100000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5706fb2a0a0e47db92eafa5aede01ccf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctOS0xLTEtMA_5db90d8f-4a09-4f52-a7e4-56a75c19e945"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e88da73b0484cceb9e60fbd4e7e2fab_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzctMTEtMS0xLTA_1ce36a51-9497-4c3f-9922-6996f75305e0"
      unitRef="usd">122000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad77ae9479ab455da7367cecb7c17bc5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtMS0xLTEtMA_ee6b5ca4-e1db-4768-b98e-52411c5e634c"
      unitRef="usd">398000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08630dd608644cc08764c701dd22f7aa_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtMy0xLTEtMA_72db1ab8-03aa-49f5-b491-061940a9b713"
      unitRef="usd">392000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic338ea419c3440558697b27cc49de9db_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtNS0xLTEtMA_014e2177-af64-45c6-924c-380d41fe90ba"
      unitRef="usd">790000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i690ac34917b44b20906e730e3dcdc4af_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtNy0xLTEtMA_69cb83b4-9548-48cd-8ea4-4297df45d226"
      unitRef="usd">189000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief8a91fe2ca84ac0b18ff0e6844a0287_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtOS0xLTEtMA_d81a1859-add5-4922-8499-c6a0197f9d7c"
      unitRef="usd">306000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5201686b80024557a80a7f33db43a5c8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzgtMTEtMS0xLTA_2d1930ba-89d5-47b6-b09d-646a9bfb8307"
      unitRef="usd">495000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0e96b146aad466ea7d9f8d5dcca942d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktMS0xLTEtMA_167ccf01-3df0-4396-acd3-90e4fec0348c"
      unitRef="usd">260000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18a4ce2ee9e8410fa314a7f39ae7cb6d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktMy0xLTEtMA_1ec255d9-93dc-4609-bdcc-b0d1f9a97bda"
      unitRef="usd">213000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba26343c342547479828a2dd2e8d7bd9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktNS0xLTEtMA_7d70c7ed-cbc5-4104-9db5-5c0747ab705a"
      unitRef="usd">473000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i947c377abd4c4941b4a244d5948eebd2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktNy0xLTEtMA_b1c5db5f-dac1-4b05-9ecc-562fd3a6f7fe"
      unitRef="usd">189000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4de128567b724b5984a99d95eef02d4d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktOS0xLTEtMA_0d99ed4b-c170-4589-ac42-901d8597fe1a"
      unitRef="usd">151000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18f2f3e5b12e432ea299981ae16b6fe8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzktMTEtMS0xLTA_2f79912d-02c2-4236-8316-a2bf1d8bb560"
      unitRef="usd">340000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idef0574f3eef4b9e8e842b614403cda3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTEtMS0xLTA_812df141-df6d-4bda-a288-484d6a1d0a60"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7ef4aa393984e2ebb13ebe33340a910_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTMtMS0xLTA_1bf3088b-b1eb-4f65-a417-87168b291c99"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia69c68d3663c4d20b8e7aa1db007db37_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTUtMS0xLTA_940e496e-0fb0-4815-ac5a-b6f2df7cc267"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i372f4fcd9ee74bd6a7b738ffb8609de3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTctMS0xLTA_1f03340f-bd8e-4c5f-ac2f-e4de2c570a6d"
      unitRef="usd">60000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcf9760e631443339b33601a02bd59ce_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTktMS0xLTA_e8743a52-c49f-4c3b-9be9-f6e51e2939c3"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i917d4854b7a7437bbd99ae988171a69e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzEwLTExLTEtMS0w_d3e38333-9068-48e4-85d9-4cc977f41e39"
      unitRef="usd">68000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d063662de5e4b32ab5ce0c83ed22b8e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTEtMS0xLTA_b5bae5af-01df-4872-a119-e3aa20156574"
      unitRef="usd">1800000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6bc4e56a2f2c49849c55cba2ac3445ae_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTMtMS0xLTA_b951897e-a468-4e99-b65f-881437678a81"
      unitRef="usd">1277000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTUtMS0xLTA_fb8a89f2-739c-44be-8a28-4df266742888"
      unitRef="usd">3077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7801f5155a6141c18f17232cef1a5392_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTctMS0xLTA_39089f89-008b-4416-80e4-2b0f0c7369ea"
      unitRef="usd">1118000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec63b166a7d5454683d6ec2e2bab3b66_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTktMS0xLTA_2062bce2-d424-4a41-ad59-4538e98f1b82"
      unitRef="usd">885000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpmNDc2ZWJmYjM0N2E0ZTFiYjdlMDNlMTY3MzdhZmVjNS90YWJsZXJhbmdlOmY0NzZlYmZiMzQ3YTRlMWJiN2UwM2UxNjczN2FmZWM1XzExLTExLTEtMS0w_23b44335-629c-4398-acf0-48eec0ee9bd9"
      unitRef="usd">2003000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i546ecb80f9f54844bc0e3f3b677fee89_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtMS0xLTEtMjIz_3a40a2cc-edfc-45f1-b801-8f6f582e5c39"
      unitRef="usd">596000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97435401a6bf486aa47a9cc538781a9d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtMy0xLTEtMjIz_95617f20-1896-49a9-ac85-7ed8ac27db2c"
      unitRef="usd">454000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d83d8f92f6647f0a79e0353d43220d2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtNS0xLTEtMjIz_e19bc07c-66f5-402e-931f-1d85afca8d08"
      unitRef="usd">1050000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b1d77aa85474402b82a7b22a91d3791_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtNy0xLTEtMjIz_684e43bb-305f-4754-99b3-60ceb8c5265f"
      unitRef="usd">445000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82c87e029c8940349ae408f228d3b510_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtOS0xLTEtMjIz_b9b87a30-da8d-41a8-9af3-f8d9fa773495"
      unitRef="usd">345000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cdb3e06e9a64a59b0a05eddb13cb154_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzMtMTEtMS0xLTIyMw_dcf9d25e-9335-466a-bfec-51f16494b638"
      unitRef="usd">790000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60e576728e7343f7821a9f0a44eb3d8a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtMS0xLTEtMjIz_1f87f016-99e3-4abe-9bc3-7b4a6fc60a19"
      unitRef="usd">542000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e6dacb4e8874b21b6822d368a2a953f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtMy0xLTEtMjIz_e2553051-6683-46a9-9a0e-1e116efa345b"
      unitRef="usd">216000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e85a2c232e64290b8ebd6a6cd0bbdc4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtNS0xLTEtMjIz_447046e8-b730-44be-8170-a945f6d2c926"
      unitRef="usd">758000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i953e0fe9f9b847f49ab077fb9c939709_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtNy0xLTEtMjIz_eb72f87c-6cf5-4026-9e1a-305c1bc5a52f"
      unitRef="usd">400000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ec33aa8ba414dcd8d8eddba16bf0dfb_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtOS0xLTEtMjIz_73d11911-b815-41ed-96ac-a9038ac50efd"
      unitRef="usd">161000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i55ddef33ab0e4fa78d3e05af2245debc_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzQtMTEtMS0xLTIyMw_66c6a71d-379e-4fe1-ac86-c6068c4b68d9"
      unitRef="usd">560000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i705075d05b1c4df98d3f2b6311ee1876_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtMS0xLTEtMjIz_4014ed9b-0c5c-4aa4-be6e-7bba41657c75"
      unitRef="usd">590000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0149779720b14a1e9890c2e5463703cd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtMy0xLTEtMjIz_4651f9e7-191a-482e-bc53-a1f85ea55933"
      unitRef="usd">403000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48d5ab1bada04b428d1dc449d38e68aa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtNS0xLTEtMjIz_508ddaa6-e11e-47b3-8f15-9898f000475d"
      unitRef="usd">993000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i056eb40cf563486c946aa704d28fa8ab_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtNy0xLTEtMjIz_a5f2d4d2-a11d-4d22-8985-13ec89be8a7c"
      unitRef="usd">463000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a0d737980c64923b5659d62f3434702_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtOS0xLTEtMjIz_ed92845e-fae8-4be0-9704-852695c1b933"
      unitRef="usd">325000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i999387ed85af40aa960e8fb85fe24e8f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzUtMTEtMS0xLTIyMw_397c6854-620f-46c7-9896-ec81d08d856c"
      unitRef="usd">788000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37862215da8c46a5911d56efc33e6a34_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtMS0xLTEtMjIz_9f3f7379-152e-4772-9a4a-d709cf1a3064"
      unitRef="usd">64000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d8a9a823a7e497a910c47ea98654d1a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtMy0xLTEtMjIz_1582c2d8-0094-4f21-a130-5dcd21c64f49"
      unitRef="usd">115000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9a20d757b68446898d764ace8105642_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtNS0xLTEtMjIz_64697759-3a97-4dc4-a3b4-38e1b907d02d"
      unitRef="usd">179000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib01f3231917a42399388b8430f7dd5c4_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtNy0xLTEtMjIz_97fc0936-f4ce-4efe-9b44-f7f785d3d117"
      unitRef="usd">53000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia92d1f0a20454a3b9bce021d757a34e6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtOS0xLTEtMjIz_0c6fdf65-96f6-4a1a-8afe-7fe727e0883b"
      unitRef="usd">72000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89f659ee14624fde88e16586c89ce9d8_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzYtMTEtMS0xLTIyMw_0f12c6d2-8182-420d-b796-d01bf961b91f"
      unitRef="usd">126000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if71b684d3c024d3886c8ef1e65dfa46d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctMS0xLTEtMjIz_08259949-d619-48af-a3da-2337d4504f67"
      unitRef="usd">345000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0734e4182c448e3a1999d0400528fb7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctMy0xLTEtMjIz_5af0a7de-7913-4dbb-8dc7-3622cbad72c0"
      unitRef="usd">99000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1a9f292c5b94a01b78a4918d33aa51f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctNS0xLTEtMjIz_39e03c9a-919a-4248-a84f-695bc22ef556"
      unitRef="usd">444000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5fe7c0ba7c514a5aa6e493bab9893659_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctNy0xLTEtMjIz_d78a1f43-a58e-41b5-9590-cd58365cd501"
      unitRef="usd">250000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ef0989ede014a41b44c8c421e9c80b6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctOS0xLTEtMjIz_11796524-6752-4009-8802-d0706eb76d3b"
      unitRef="usd">63000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a99ca748d5e4edfa719dfdea5bd3311_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzctMTEtMS0xLTIyMw_fc7a7385-0742-4846-93ef-13fad4ab8bf0"
      unitRef="usd">313000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2ba737e9d8f461ba5881d87b666c936_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtMS0xLTEtMjIz_b062d81c-0f3a-4b02-857d-2e08ac1000d8"
      unitRef="usd">741000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf3328c2059f45a99c8ed36d5544d2c2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtMy0xLTEtMjIz_f76c8c55-c0ea-4c93-8e3f-d90860bd190a"
      unitRef="usd">745000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27a241c1c7e14b908561f55b9bea06af_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtNS0xLTEtMjIz_8508f65e-af55-42ae-8f09-108f848a9525"
      unitRef="usd">1486000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d4a66cacd3c409a8583c1f4d7c949a0_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtNy0xLTEtMjIz_c983f86a-fce1-44ce-9bf0-09db609739b1"
      unitRef="usd">486000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f81f839a1994584aee39783ecacbdcd_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtOS0xLTEtMjIz_c32d128c-385e-49e4-8670-cc5eb0859c1d"
      unitRef="usd">642000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70b422de2e4e4b18a8970d5b6f6d4282_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzgtMTEtMS0xLTIyMw_78b01121-646c-4a96-9344-cb3b52e060a9"
      unitRef="usd">1128000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10cd8488ed6a4a9f9cfca5758ddc5d1f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktMS0xLTEtMjIz_a124abd4-395e-4ed0-8597-e332fb731939"
      unitRef="usd">498000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a954338141045799352d36c639ad37e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktMy0xLTEtMjIz_4d4ed06d-baa4-4e5d-b341-5e071d859f49"
      unitRef="usd">407000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8cff98864b9e45f2a169a4724b33ce66_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktNS0xLTEtMjIz_0aceef74-abe5-46b3-973d-b155e15bdadf"
      unitRef="usd">906000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i009fdb9395ce49bdb5ee3d78d5dd59b5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktNy0xLTEtMjIz_cf0953d0-5c8a-41c3-99b1-c6806428f177"
      unitRef="usd">413000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f221a488db642a294dc6d9112291dc5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktOS0xLTEtMjIz_52b834f7-7a62-4ec3-adfd-56b96cef849d"
      unitRef="usd">319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa71dec95dc94eeca8f7131ee2264446_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzktMTEtMS0xLTIyMw_1c3109b6-6d4e-4653-90be-1570a2a99d8f"
      unitRef="usd">732000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80dc82869bb14419b4927d17ccb893c3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTEtMS0xLTIyMw_95b44638-cf54-49d2-b1eb-18fb0b291780"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic86c037a105047ff8e30c52d263c8b1c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTMtMS0xLTIyMw_67a1213f-8c24-4ea6-914b-00d3191d3858"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6987d6c22f4b44dc92c281c44ea04ff4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTUtMS0xLTIyMw_ce7c31db-6a6a-431c-96a8-c2fa1851c34d"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73e4ecee96fe4a029361a7becb75ea87_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTctMS0xLTIyMw_72da4e61-7a47-46ce-a951-ba2b4a21790f"
      unitRef="usd">97000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if876951023d64e46a24c7d835b5faa3b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTktMS0xLTIyMw_b6800e82-db3f-476a-bba2-8b2952daed45"
      unitRef="usd">12000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i875553a9513a45a38f8a905416d7829c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzEwLTExLTEtMS0yMjM_1900799a-9ee5-4142-99c2-750c66b8f3ed"
      unitRef="usd">109000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00e3dbb86db0418ca06c3632c8c1b5e7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTEtMS0xLTIyMw_15b96da5-5878-4e9d-8b81-c30794c5d990"
      unitRef="usd">3386000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i122407c5128c49f5a374ce6bf633b754_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTMtMS0xLTIyMw_808ee0f8-0c79-4fc5-8326-57d4a9696c89"
      unitRef="usd">2443000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTUtMS0xLTIyMw_197404df-1def-4780-bc31-d994c996cb5d"
      unitRef="usd">5829000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77bb9297fb7c44c6b02abde208157004_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTctMS0xLTIyMw_a0e117e9-8080-4bd9-99e1-814a0faa3d87"
      unitRef="usd">2607000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8456f3d09026487583de79d141ac5a57_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTktMS0xLTIyMw_3118d34a-c402-42e6-88c4-aea1c5559dd1"
      unitRef="usd">1939000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTpkNjFiM2RiMmQ2NTQ0Y2UxYmViNzU1MTVlNjk0ZmEyMi90YWJsZXJhbmdlOmQ2MWIzZGIyZDY1NDRjZTFiZWI3NTUxNWU2OTRmYTIyXzExLTExLTEtMS0yMjM_86130f99-db38-4f28-9c66-8bcae76c45b5"
      unitRef="usd">4546000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88135e1e5b9e48138fa29ce5f22d50a0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzItMS0xLTEtMA_30eff467-a515-4e18-8077-0904068271e2"
      unitRef="usd">1800000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7322afa2bcb4680be71b6adae30c6a0_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzItMy0xLTEtMA_ac34a59b-efc2-416b-8830-e55332c53fa7"
      unitRef="usd">1058000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i719d3d1d3dfc4900a97050942bbe31de_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzItNS0xLTEtMA_eb40e0aa-f017-49fa-9a38-2fb6672718cc"
      unitRef="usd">3376000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0eb35a14aae34796be04212920a94266_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzItNy0xLTEtMA_f2076442-3740-44ef-9e41-058f1f033a3f"
      unitRef="usd">2510000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37162a776ece4d0bb843164a63a34546_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzMtMS0xLTEtMA_9950c112-ceec-4eb8-b5b7-3670ff7ade9a"
      unitRef="usd">662000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8d04eeeafb94eb9bd136daeb8176cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzMtMy0xLTEtMA_1010a2d8-6347-45da-80cc-0405abab1269"
      unitRef="usd">416000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied8010a52167452ea357069eec7e9c7e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzMtNS0xLTEtMA_2944cf63-0675-415a-8b13-512d6cec2441"
      unitRef="usd">1266000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb29b1f5e9c04d7f8e4e8c597595337c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzMtNy0xLTEtMA_34d5aaaf-2c05-483c-a68b-6d424082e880"
      unitRef="usd">968000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84fc90d4c0574d2180bf795e9ea8019a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzQtMS0xLTEtMA_94c0a04a-40de-4b50-94ff-50bb89677866"
      unitRef="usd">520000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f7d90c59416456b8c31e32e8d530bcf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzQtMy0xLTEtMA_1332a4b9-c6d1-44b6-a0e2-431c348eaca3"
      unitRef="usd">410000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3cc9570466e432bb34716e1723c76ed_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzQtNS0xLTEtMA_83ba9333-7cd1-4395-b89c-d2cd799c0340"
      unitRef="usd">994000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d1a58b8b2a64926afbacb03ceb0e46f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzQtNy0xLTEtMA_6c165d71-5b3d-4d64-9ce9-4d63c41a5174"
      unitRef="usd">819000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d618ba150584c2d8089fc515133c197_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzUtMS0xLTEtMA_4c786cb9-e09b-48eb-a247-7f41ee5d1f29"
      unitRef="usd">95000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6590a83019bd4768911ab6e74a8ead5f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzUtMy0xLTEtMA_903efe49-795f-4061-a593-7ef7c6c21423"
      unitRef="usd">51000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6016cb0bcb5645e79fb9453c064d1070_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzUtNS0xLTEtMA_7fbf2c76-72a7-4d94-ac8e-7dcef2ca6727"
      unitRef="usd">180000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5393f9f0da0e48d99af036f07bc71c8f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzUtNy0xLTEtMA_2c7dac59-764f-41a5-ae68-17502daa9d3a"
      unitRef="usd">140000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08c5d30357d9461faac846d9a7f6f58c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzYtMS0xLTEtMA_67b2acd3-345a-4b20-b6ac-a1a4992538e1"
      unitRef="usd">3077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3f1a45e38524eada4c409914683546a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzYtMy0xLTEtMA_8d207d38-f06d-47d6-a6bf-fd16961161a1"
      unitRef="usd">1935000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifbfbdc30d0ab449094a90e70fd595751_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzYtNS0xLTEtMA_e008ef75-1e39-4037-9c7c-18b927de8615"
      unitRef="usd">5816000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id96d30c4d41a4cdb9fe2a6c8498a6753_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzYtNy0xLTEtMA_315faf52-b358-4a41-8791-d2ce06da37d7"
      unitRef="usd">4437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idef0574f3eef4b9e8e842b614403cda3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzctMS0xLTEtMA_812df141-df6d-4bda-a288-484d6a1d0a60"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i372f4fcd9ee74bd6a7b738ffb8609de3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzctMy0xLTEtMA_1f03340f-bd8e-4c5f-ac2f-e4de2c570a6d"
      unitRef="usd">60000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80dc82869bb14419b4927d17ccb893c3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzctNS0xLTEtMA_95b44638-cf54-49d2-b1eb-18fb0b291780"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73e4ecee96fe4a029361a7becb75ea87_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzctNy0xLTEtMA_72da4e61-7a47-46ce-a951-ba2b4a21790f"
      unitRef="usd">97000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7ef4aa393984e2ebb13ebe33340a910_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzgtMS0xLTEtMA_1bf3088b-b1eb-4f65-a417-87168b291c99"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcf9760e631443339b33601a02bd59ce_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzgtMy0xLTEtMA_e8743a52-c49f-4c3b-9be9-f6e51e2939c3"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic86c037a105047ff8e30c52d263c8b1c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzgtNS0xLTEtMA_67a1213f-8c24-4ea6-914b-00d3191d3858"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if876951023d64e46a24c7d835b5faa3b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzgtNy0xLTEtMA_b6800e82-db3f-476a-bba2-8b2952daed45"
      unitRef="usd">12000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia69c68d3663c4d20b8e7aa1db007db37_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzktMS0xLTEtMA_940e496e-0fb0-4815-ac5a-b6f2df7cc267"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i917d4854b7a7437bbd99ae988171a69e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzktMy0xLTEtMA_d3e38333-9068-48e4-85d9-4cc977f41e39"
      unitRef="usd">68000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6987d6c22f4b44dc92c281c44ea04ff4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzktNS0xLTEtMA_a6e5eb85-dede-4912-b6fe-a201c78e32a0"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i875553a9513a45a38f8a905416d7829c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzktNy0xLTEtMA_1900799a-9ee5-4142-99c2-750c66b8f3ed"
      unitRef="usd">109000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEwLTEtMS0xLTA_fb8a89f2-739c-44be-8a28-4df266742888"
      unitRef="usd">3077000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEwLTMtMS0xLTA_b1ad0a0b-c1db-4e25-af90-37012e9e36b0"
      unitRef="usd">2003000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEwLTUtMS0xLTA_d16f65f3-4f43-4442-ba2a-8d783b119fb3"
      unitRef="usd">5829000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEwLTctMS0xLTA_3bd09140-8a11-40e6-bf97-d0fef2e8f85e"
      unitRef="usd">4546000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEwLTctMS0xLTA_772bf79b-02f6-47d5-8efe-7732b7411f1a"
      unitRef="usd">4546000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae7822dc00ec44efa94a5d7b8f0d51df_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEyLTEtMS0xLTA_ad63d0c7-a77b-4200-947d-e13ea31d7d22"
      unitRef="usd">359000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8952d06cea3f4179a4e5e6ed3a7d7641_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEyLTMtMS0xLTA_87b90c3f-367c-47f0-9ae7-30b8291e3f67"
      unitRef="usd">268000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i877c5d6831884713ad635096adea9fff_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEyLTUtMS0xLTA_07632403-c45b-44da-bb4a-02a770469efe"
      unitRef="usd">676000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icba8e95f00734703a480e7de812a5575_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90YWJsZTo3MThlNWFkYjBkY2I0OGNkYjBiNWUzZmVlMzUyODcwYy90YWJsZXJhbmdlOjcxOGU1YWRiMGRjYjQ4Y2RiMGI1ZTNmZWUzNTI4NzBjXzEyLTctMS0xLTA_f009a9c4-4dc6-4143-b15b-ac5b8ae43e60"
      unitRef="usd">542000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bsx:EmergingMarketstotalnumberofcountries
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzU1Mg_668d7529-3267-48b2-b205-d97d5ca0e936"
      unitRef="units">20</bsx:EmergingMarketstotalnumberofcountries>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzEzOTM_01b4aa61-629f-430e-bf61-6871253793e3"
      unitRef="usd">424000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzE0MDk_18bf8814-d230-4e53-a9bd-23a9e64d3a98"
      unitRef="usd">395000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzE5Nzg_e3d4b1c4-12e7-453d-8b50-0d02c4ef9803"
      unitRef="usd">38000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMDkvZnJhZzo2ZDE5Mjk3ODBjYjc0YzUxODc3ZDE1YTBmMzUzYjhlNy90ZXh0cmVnaW9uOjZkMTkyOTc4MGNiNzRjNTE4NzdkMTVhMGYzNTNiOGU3XzEwOTk1MTE2MzE4MDQ_7591dc7d-5f0f-4539-8d1e-fceb81e43c6e"
      unitRef="usd">74000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90ZXh0cmVnaW9uOmRmMzc1ODMwMjUwYjQwOGY4NTY4NTUxNDRmMmRhMTA5XzkxNQ_1e49b1db-6d3b-4874-b52e-baf31447f857">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE M &#x2013; CHANGES IN OTHER COMPREHENSIVE INCOME&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;134&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;168&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;131&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In connection with the completion of the divestiture of the Specialty Pharmaceuticals business in the first quarter of 2021, we released $127 million of cumulative translation adjustments associated with the disposed business from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;131&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further detail on our net investment hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and our cash flow hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net change in derivative financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt; were reduced by immaterial income tax impacts in the second quarter and first six months of 2021 and 2020.</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90ZXh0cmVnaW9uOmRmMzc1ODMwMjUwYjQwOGY4NTY4NTUxNDRmMmRhMTA5XzkwOQ_973c0f0d-3f84-40be-b8aa-63d4f2c5a1fc">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;134&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;168&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;131&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;207&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In connection with the completion of the divestiture of the Specialty Pharmaceuticals business in the first quarter of 2021, we released $127 million of cumulative translation adjustments associated with the disposed business from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;131&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzEtMS0xLTEtMA_c19018ca-4521-483b-be98-e80e8c6f1697"
      unitRef="usd">134000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzEtMy0xLTEtMA_661b6f93-7bde-4173-958f-448e84f15e86"
      unitRef="usd">165000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzEtNy0xLTEtMA_e19f6dcc-b395-4d61-a1e7-2470f9560e07"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0c6a8ca2ac8f44369c94a92e480c676d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzEtOS0xLTEtMA_a62a129d-e5b7-414a-856b-5c5065b419a6"
      unitRef="usd">254000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzItMS0xLTEtMA_1d718e29-1cd0-4ce6-8de2-bcf9d109572e"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzItMy0xLTEtMA_6eff805e-dbc5-4104-849f-ca254ab2c9fe"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzItNy0xLTEtMA_73a82307-72ca-4426-b423-94b628012a25"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzItOS0xLTEtMA_6d9528f7-e4fc-47c1-9a66-3876bc0a1d8c"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzMtMS0xLTEtMA_8508f02f-b7ef-492b-b91d-7842a2dfa010"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzMtMy0xLTEtMA_5a00c920-a70b-46e3-bd45-970118b6e27c"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzMtNy0xLTEtMA_e247cb48-dcc7-4039-bc4f-c88bb2497c61"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzMtOS0xLTEtMA_3f05757b-5606-4b0a-b207-ad6a0890363a"
      unitRef="usd">9000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzQtMS0xLTEtMA_02be1fcf-85a5-4266-b9c0-446859a1be27"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzQtMy0xLTEtMA_2376e930-9439-4114-bc7b-058648395099"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzQtNy0xLTEtMA_c9947aa9-6792-46c1-9a8e-b4c77c9dfa3e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1270609d6b744578a62058c51995ce33_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzQtOS0xLTEtMA_adfa1b5b-2184-433c-ae56-c7b4ad35f391"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzUtMS0xLTEtMA_6c74384e-cc5c-43e4-8665-c3a4e8c8008d"
      unitRef="usd">136000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzUtMy0xLTEtMA_ca5c847b-a490-4b3d-b957-6730f505072e"
      unitRef="usd">146000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzUtNy0xLTEtMA_0da173dc-6c58-47e8-b3b3-c1db1304a9a8"
      unitRef="usd">46000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NWQzODk4NTc5YTY0YzAwYjY3NjU0NDYzODQ3YmM3MC90YWJsZXJhbmdlOjY1ZDM4OTg1NzlhNjRjMDBiNjc2NTQ0NjM4NDdiYzcwXzUtOS0xLTEtMA_372487a9-991c-42cb-8cf2-d115f4942bf8"
      unitRef="usd">237000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i0e99e4069c604693bacde07aad3c5702_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzEtMS0xLTEtMA_528b3eb1-ec45-406d-8fd0-e5a55cd3500d"
      unitRef="usd">-35000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i0e99e4069c604693bacde07aad3c5702_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzEtMy0xLTEtMA_609fc39c-d292-420f-b638-6a3b1206a65d"
      unitRef="usd">248000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i0e99e4069c604693bacde07aad3c5702_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzEtNy0xLTEtMA_65873ce0-8e4d-441f-9c5f-e82fa45acf0a"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0e99e4069c604693bacde07aad3c5702_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzEtOS0xLTEtMA_57bf5c3a-b90b-42fd-8fa1-39954f8ec47f"
      unitRef="usd">168000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzItMS0xLTEtMA_4d4bdeb1-ebd8-4b5b-9a4f-8a00746d6cdb"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzItMy0xLTEtMA_d87a6f85-dfda-4ca1-8169-35169a71dd5b"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzItNy0xLTEtMA_a8efebac-6ab7-43a3-a9ea-dea8ff5096cd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzItOS0xLTEtMA_cc87967e-a6ca-40c3-b4a5-75b5d7b2a920"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzMtMS0xLTEtMA_2f4ef7a3-f8e8-466e-8919-0cf14ff12b7e"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzMtMy0xLTEtMA_2f898758-afc0-4138-a128-7f87d00be1f7"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzMtNy0xLTEtMA_2108fa29-b6b7-4fb9-a47e-6459c08eef3a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzMtOS0xLTEtMA_0f77f68d-ef37-4c24-9e67-e7417cb0662f"
      unitRef="usd">25000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzQtMS0xLTEtMA_bc892e39-000e-4b07-8644-ba4918b76c8a"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzQtMy0xLTEtMA_689e6b91-ded2-41f2-896d-34c48e6ba0c2"
      unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzQtNy0xLTEtMA_de270eb4-21aa-45c5-9135-dcbbe0c84e34"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f71de323ed1485cb8bbc22ea72fbbf3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzQtOS0xLTEtMA_ead6e3df-ca5a-4179-87a0-86a280581b58"
      unitRef="usd">-37000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzUtMS0xLTEtMA_b80ef3a9-6e20-417d-aa6d-f9cb8ca673a7"
      unitRef="usd">-46000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzUtMy0xLTEtMA_51526e21-0f83-4adf-ab77-fe89a8b7cb76"
      unitRef="usd">222000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzUtNy0xLTEtMA_70f14582-057c-4887-99a9-d16d6478b807"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTplZDJjNGIzNzg5M2I0OWE2YjhiZjQ4ODQ4OTJlNmMzYS90YWJsZXJhbmdlOmVkMmM0YjM3ODkzYjQ5YTZiOGJmNDg4NDg5MmU2YzNhXzUtOS0xLTEtMA_03a55be6-4fa4-498a-b79f-0c8297287558"
      unitRef="usd">131000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzEtMS0xLTEtMjA0_1cd4b085-6f7c-4db9-a485-f4134ff47883"
      unitRef="usd">218000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzEtMy0xLTEtMjA0_d3bf31fb-a6ea-4da0-bc52-f0f22a72d32e"
      unitRef="usd">36000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzEtNy0xLTEtMjA0_b468e42e-f771-48c9-b0f8-a4dd27313a2a"
      unitRef="usd">47000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i40d4bbc844644023a5878306b022201d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzEtOS0xLTEtMjA0_c7b7d9db-2a3f-4a98-93ec-5ba61822018b"
      unitRef="usd">207000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzItMS0xLTEtMjA0_9ca23491-673c-4237-9832-730706028ae9"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzItMy0xLTEtMjA0_e76bbf0c-04ac-42c8-8ba7-d59549bed3af"
      unitRef="usd">121000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzItNy0xLTEtMjA0_3d87c1bb-7565-4abb-882b-d99d0d7ae4b1"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzItOS0xLTEtMjA0_b4360556-0503-4b9f-beb6-d3f8d9e40322"
      unitRef="usd">174000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzMtMS0xLTEtMjA0_6e7e9c08-9a8c-427b-93af-0b1e6f313185"
      unitRef="usd">134000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzMtMy0xLTEtMjA0_8a2e1cc4-d6ff-4ce5-812c-abd50a38a009"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzMtNy0xLTEtMjA0_834c3241-3b04-4edf-92c3-a710f8990ae6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzMtOS0xLTEtMjA0_bfbc6f10-f21a-46f6-a984-db66019440ca"
      unitRef="usd">144000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzQtMS0xLTEtMjA0_1ae5a677-2110-4a0f-9200-6811a05e40fd"
      unitRef="usd">-81000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzQtMy0xLTEtMjA0_69e34c95-dda2-44c9-b9a9-5f1ed629ef5f"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzQtNy0xLTEtMjA0_e21d03bf-aafb-4af7-af72-248d15841614"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzQtOS0xLTEtMjA0_63d9cffa-870a-47f7-b824-78934f8d3aef"
      unitRef="usd">30000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzUtMS0xLTEtMjA0_05c1e823-7b14-4a40-9b46-0f4ac9b06e10"
      unitRef="usd">136000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzUtMy0xLTEtMjA0_cd61dcce-146f-4306-b464-f0918df149ca"
      unitRef="usd">146000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzUtNy0xLTEtMjA0_8e5090de-8b6c-4ede-8985-45a260d168f8"
      unitRef="usd">46000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iae02e9cc78ca4c7aa533a4609d180b55_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo2NjZhMTc4NDI2YTc0YTMzYTA5OWVjMDc3ZTA2ODM1OS90YWJsZXJhbmdlOjY2NmExNzg0MjZhNzRhMzNhMDk5ZWMwNzdlMDY4MzU5XzUtOS0xLTEtMjA0_15b5316a-e7de-414f-bf5b-c8a27b7ad25d"
      unitRef="usd">237000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="ic27d3ee5d397485ba3bd063f9697f20b_D20210301-20210301"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90ZXh0cmVnaW9uOmRmMzc1ODMwMjUwYjQwOGY4NTY4NTUxNDRmMmRhMTA5XzI3NDg3NzkwNzA1MzI_ed5f3e7c-b3cb-4ea2-ab55-501b9f593c38"
      unitRef="usd">127000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzEtMS0xLTEtMjA0_d8341936-c4f6-4ac7-a707-36ac81b278c3"
      unitRef="usd">142000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzEtMy0xLTEtMjA0_59223cb5-54b1-4b97-98eb-be295cd37722"
      unitRef="usd">173000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzEtNy0xLTEtMjA0_029bd92a-ac7c-48af-80bd-05f22a2525eb"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie5e655ae113847fcb0d0f49867baed93_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzEtOS0xLTEtMjA0_10526d0a-5fc2-49b5-b931-c19a46ec5452"
      unitRef="usd">270000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzItMS0xLTEtMjA0_d9fdaa44-c772-411d-ab7e-01fc3ae03f76"
      unitRef="usd">-178000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzItMy0xLTEtMjA0_23ac03ff-3b71-4006-a9a7-a7fa71ce675c"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzItNy0xLTEtMjA0_733fc135-1bcb-40de-9260-bb787a2e54ca"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzItOS0xLTEtMjA0_5406c275-d416-4a21-8433-fc0c147ffda2"
      unitRef="usd">-92000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzMtMS0xLTEtMjA0_f6110195-8edc-4072-b9b0-84412714beff"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzMtMy0xLTEtMjA0_437924ef-1ac6-406d-a888-b8eb05299c19"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzMtNy0xLTEtMjA0_93abedac-5d87-48f2-8734-71c8fbe584f9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzMtOS0xLTEtMjA0_bc973988-344b-4fb1-890b-f3b53f81d67c"
      unitRef="usd">47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzQtMS0xLTEtMjA0_4b315bde-8fea-4bab-9f5f-194ad8bc3a09"
      unitRef="usd">-187000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzQtMy0xLTEtMjA0_92b30116-0646-40e6-a0bd-c89d2b0b9635"
      unitRef="usd">48000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzQtNy0xLTEtMjA0_49d0eb8a-f1e8-4503-af5b-01a173425233"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i897d997064224d39a60cae4e0d9ce232_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzQtOS0xLTEtMjA0_1005a2ce-6948-4719-a9e4-962815235a48"
      unitRef="usd">-139000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzUtMS0xLTEtMjA0_c94b2505-5878-4511-ae18-ed6fed7c31f8"
      unitRef="usd">-46000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzUtMy0xLTEtMjA0_c57557c1-8e88-4491-b336-aae5e4edc204"
      unitRef="usd">222000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzUtNy0xLTEtMjA0_3c1337a2-18f0-4781-8652-d7b69dd24a18"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9dd21833f22a4ead8d64d3beea08b065_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMTUvZnJhZzpkZjM3NTgzMDI1MGI0MDhmODU2ODU1MTQ0ZjJkYTEwOS90YWJsZTo3MjkzMDYzZDk3ZmI0ZmM5OWNmZDhmNGRmODFlNDVlYy90YWJsZXJhbmdlOjcyOTMwNjNkOTdmYjRmYzk5Y2ZkOGY0ZGY4MWU0NWVjXzUtOS0xLTEtMjA0_dfb005c4-2dd6-4ce6-b46f-a624daff4176"
      unitRef="usd">131000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <bsx:NewAccountingPronouncementsPolicyTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMjEvZnJhZzo1ZDE5OTIyYWM5NTE0NjEzODM2MmEyN2QxMWZiZGIzYS90ZXh0cmVnaW9uOjVkMTk5MjJhYzk1MTQ2MTM4MzYyYTI3ZDExZmJkYjNhXzI3NDg3NzkwNzM1MDI_afead29d-0336-4d26-a11e-7e8b0f0cb0b4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE N &#x2013; NEW ACCOUNTING PRONOUNCEMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our accompanying unaudited consolidated financial statements. During the first quarter of 2021, we implemented the following standards, which did not have a material impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-10&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In October 2020, the FASB issued ASC Update No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-06&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASC Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 470-20) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 815-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2019-12 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, the FASB issued ASC Update No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. The purpose of Update No. 2019-12 is to continue the FASB&#x2019;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"&gt;Standards to be Implemented&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2021-05&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the FASB issued ASC Update No. 2021-05, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842): Lessors&#x2014;Certain Leases with Variable Lease Payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases.  Such classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We have the option to apply the amendments retrospectively to leases that commenced or were modified on or after the adoption of FASB ASC Topic 842, or prospectively.  We are currently in the process of determining the effect that the adoption will have on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our accompanying unaudited consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</bsx:NewAccountingPronouncementsPolicyTextBlock>
    <bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMjEvZnJhZzo1ZDE5OTIyYWM5NTE0NjEzODM2MmEyN2QxMWZiZGIzYS90ZXh0cmVnaW9uOjVkMTk5MjJhYzk1MTQ2MTM4MzYyYTI3ZDExZmJkYjNhXzI1MTQ_1f95e837-8c6e-4cc8-8abd-a16c3bdf04ee">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-10&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In October 2020, the FASB issued ASC Update No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock>
    <bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMjEvZnJhZzo1ZDE5OTIyYWM5NTE0NjEzODM2MmEyN2QxMWZiZGIzYS90ZXh0cmVnaW9uOjVkMTk5MjJhYzk1MTQ2MTM4MzYyYTI3ZDExZmJkYjNhXzI1Mjc_cec684a5-c0ff-41ed-ac1c-1f2eaf3863af">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-06&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASC Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt - Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 470-20) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Subtopic 815-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock>
    <bsx:ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMjEvZnJhZzo1ZDE5OTIyYWM5NTE0NjEzODM2MmEyN2QxMWZiZGIzYS90ZXh0cmVnaW9uOjVkMTk5MjJhYzk1MTQ2MTM4MzYyYTI3ZDExZmJkYjNhXzI1MTU_69345bca-cb20-46b6-ba93-85a2f59f3480">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2019-12 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, the FASB issued ASC Update No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. The purpose of Update No. 2019-12 is to continue the FASB&#x2019;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock>
    <bsx:ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock
      contextRef="i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjgyNzQ2YzFhZDkyMDQ5YjE4MWE4Nzc4NzNhNmNjMzE4L3NlYzo4Mjc0NmMxYWQ5MjA0OWIxODFhODc3ODczYTZjYzMxOF8xMjEvZnJhZzo1ZDE5OTIyYWM5NTE0NjEzODM2MmEyN2QxMWZiZGIzYS90ZXh0cmVnaW9uOjVkMTk5MjJhYzk1MTQ2MTM4MzYyYTI3ZDExZmJkYjNhXzI3NDg3NzkwNzM1MDE_2b29784a-448a-4376-972f-60a9f5fff2e9">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2021-05&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the FASB issued ASC Update No. 2021-05, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842): Lessors&#x2014;Certain Leases with Variable Lease Payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases.  Such classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We have the option to apply the amendments retrospectively to leases that commenced or were modified on or after the adoption of FASB ASC Topic 842, or prospectively.  We are currently in the process of determining the effect that the adoption will have on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357412899160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Document - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jul. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingParValuePerShare', window );">Entity Listing, Par Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,423,852,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member', window );">Senior Note due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX PR A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357507968168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,077<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="nump">$ 5,829<span></span>
</td>
<td class="nump">$ 4,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">945<span></span>
</td>
<td class="nump">791<span></span>
</td>
<td class="nump">1,839<span></span>
</td>
<td class="nump">1,596<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">1,212<span></span>
</td>
<td class="nump">3,990<span></span>
</td>
<td class="nump">2,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">1,121<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="nump">2,139<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expenses</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">574<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="nump">398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="num">(85)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring net charges (credits)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation-related net charges (credits)</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">302<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on disposal of business</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">1,870<span></span>
</td>
<td class="nump">1,283<span></span>
</td>
<td class="nump">3,358<span></span>
</td>
<td class="nump">2,875<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">262<span></span>
</td>
<td class="num">(71)<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(86)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss)&#160;before income taxes</a></td>
<td class="nump">149<span></span>
</td>
<td class="num">(181)<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="num">(159)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">186<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="nump">527<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Preferred stock dividends</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) available to common stockholders</a></td>
<td class="nump">$ 172<span></span>
</td>
<td class="num">$ (153)<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="num">$ (142)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss)&#160;per common share &#8212; basic</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="num">$ (0.10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss)&#160;per common share &#8212; assuming dilution</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="num">$ (0.10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">1,421.3<span></span>
</td>
<td class="nump">1,410.9<span></span>
</td>
<td class="nump">1,420.0<span></span>
</td>
<td class="nump">1,404.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Assuming dilution</a></td>
<td class="nump">1,432.5<span></span>
</td>
<td class="nump">1,410.9<span></span>
</td>
<td class="nump">1,431.7<span></span>
</td>
<td class="nump">1,404.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409519576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 186<span></span>
</td>
<td class="num">$ (147)<span></span>
</td>
<td class="nump">$ 527<span></span>
</td>
<td class="num">$ (137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change in defined benefit pensions and other items</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income (loss)</a></td>
<td class="nump">$ 170<span></span>
</td>
<td class="num">$ (185)<span></span>
</td>
<td class="nump">$ 558<span></span>
</td>
<td class="num">$ (276)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357414864424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,675<span></span>
</td>
<td class="nump">$ 1,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,675<span></span>
</td>
<td class="nump">1,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,430<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">777<span></span>
</td>
<td class="nump">751<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,758<span></span>
</td>
<td class="nump">6,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,082<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,874<span></span>
</td>
<td class="nump">9,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">5,788<span></span>
</td>
<td class="nump">5,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">4,036<span></span>
</td>
<td class="nump">4,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">1,629<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">31,168<span></span>
</td>
<td class="nump">30,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">262<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">689<span></span>
</td>
<td class="nump">513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,442<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">680<span></span>
</td>
<td class="nump">958<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,073<span></span>
</td>
<td class="nump">3,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">8,847<span></span>
</td>
<td class="nump">9,130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">2,190<span></span>
</td>
<td class="nump">2,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of June 30, 2021 and December 31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,685,006,608 shares as of June 30, 2021 and 1,679,911,918 shares as of December 31, 2020</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 263,289,848 shares as of June 30, 2021 and December 31, 2020</a></td>
<td class="num">(2,251)<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">19,817<span></span>
</td>
<td class="nump">19,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,878)<span></span>
</td>
<td class="num">(2,378)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">15,942<span></span>
</td>
<td class="nump">15,326<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 31,168<span></span>
</td>
<td class="nump">$ 30,777<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357414684824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract', window );"><strong>Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,685,006,608<span></span>
</td>
<td class="nump">1,679,911,918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">263,289,848<span></span>
</td>
<td class="nump">263,289,848<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357508105736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Preferred Stock</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss) [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">$ (1,717)<span></span>
</td>
<td class="nump">$ 17,561<span></span>
</td>
<td class="num">$ (2,253)<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (Shares Issued) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,642,488,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASU 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,388,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,589<span></span>
</td>
<td class="num">(2,252)<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,646,877,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,561<span></span>
</td>
<td class="num">(2,253)<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (Shares Issued) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,642,488,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASU 2016-13</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">19,590<span></span>
</td>
<td class="num">(2,405)<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,676,753,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,589<span></span>
</td>
<td class="num">(2,252)<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (Shares Issued) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,646,877,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="num">(37)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock', window );">Preferred stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock', window );">Common stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issuance (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">29,382,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">19,590<span></span>
</td>
<td class="num">(2,405)<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,676,753,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,674,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">19,687<span></span>
</td>
<td class="num">(2,574)<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,679,428,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">15,326<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">19,732<span></span>
</td>
<td class="num">(2,378)<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,679,911,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,949,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">19,750<span></span>
</td>
<td class="num">(2,050)<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,683,861,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2020</a></td>
<td class="nump">15,326<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">19,732<span></span>
</td>
<td class="num">(2,378)<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (Shares Issued) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,679,911,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2021</a></td>
<td class="nump">15,942<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">19,817<span></span>
</td>
<td class="num">(1,878)<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,685,006,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="nump">19,750<span></span>
</td>
<td class="num">(2,050)<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (Shares Issued) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,683,861,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,145,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2021</a></td>
<td class="nump">$ 15,942<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">$ (2,251)<span></span>
</td>
<td class="nump">$ 19,817<span></span>
</td>
<td class="num">$ (1,878)<span></span>
</td>
<td class="nump">$ 237<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,685,006,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues (Common stock)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues (Preferred stock)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121321822&amp;loc=d3e3913-113898<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121323062&amp;loc=d3e15009-113911<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in stockholders' equity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357414797144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash provided by (used for) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 527<span></span>
</td>
<td class="num">$ (137)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain on disposal of businesses</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">531<span></span>
</td>
<td class="nump">552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit', window );">Deferred and prepaid income taxes</a></td>
<td class="num">(88)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net loss (gain) on investments and notes receivable</a></td>
<td class="num">(22)<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="num">(91)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_InventoryStepUpAmortization', window );">Inventory step-up amortization</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Netcurrencyexchangegainloss', window );">Foreign exchange (gain) loss</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherNet', window );">Other, net</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade accounts receivable</a></td>
<td class="num">(145)<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(200)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">187<span></span>
</td>
<td class="num">(531)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">153<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash provided by (used for) operating activities</a></td>
<td class="nump">927<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(181)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property, plant and equipment</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions of businesses, net of cash acquired</a></td>
<td class="num">(706)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Proceeds from royalty rights</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Payments for investments and acquisitions of certain technologies</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Proceeds from sale of investments</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from disposal of businesses</a></td>
<td class="nump">801<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Payments for Hedge, Investing Activities</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash provided by (used for) investing activities</a></td>
<td class="nump">71<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration previously established in purchase accounting</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PaymentsForRoyaltyRights', window );">Payments for royalty rights</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Payments on short-term borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,700)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings, net of debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Net increase (decrease) in commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(714)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Payments on borrowings from credit facilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,919)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from borrowings on credit facilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Payments on long-term borrowings and debt extinguishment costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from long-term borrowings, net of debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends paid on preferred stock</a></td>
<td class="num">(28)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock in connection with public offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Paymenttonetsharesettleemployeeequityawards', window );">Cash used to net share settle employee equity awards</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash provided by (used for) financing activities</a></td>
<td class="num">(93)<span></span>
</td>
<td class="nump">1,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rates on cash</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="nump">903<span></span>
</td>
<td class="nump">1,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</a></td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</a></td>
<td class="nump">2,898<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Fair value of contingent consideration recorded in purchase accounting</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Noncashimpactoftransferredroyaltyrights', window );">Non-cash impact of transferred royalty rights</a></td>
<td class="num">$ (43)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash flow impact of deferred income tax expense (benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_InventoryStepUpAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory step up amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_InventoryStepUpAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Netcurrencyexchangegainloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net currency exchange gain (loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Netcurrencyexchangegainloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Noncashimpactoftransferredroyaltyrights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash impact of transferred royalty rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Noncashimpactoftransferredroyaltyrights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other, net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentsForRoyaltyRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for royalty rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentsForRoyaltyRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Paymenttonetsharesettleemployeeequityawards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment to net share settle employee equity awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Paymenttonetsharesettleemployeeequityawards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357414303304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Supplemental Disclosure) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,675<span></span>
</td>
<td class="nump">$ 1,734<span></span>
</td>
<td class="nump">$ 1,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and restricted cash equivalents included in Other current assets</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents included in Other long-term assets</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 2,898<span></span>
</td>
<td class="nump">$ 1,995<span></span>
</td>
<td class="nump">$ 2,016<span></span>
</td>
<td class="nump">$ 607<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357407570856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; BASIS OF PRESENTATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X, and they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three and six months ended June&#160;30, 2021 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2021. Accordingly, our unaudited consolidated financial statements and footnotes thereto should be read in conjunction with our audited consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this Quarterly Report on Form 10-Q are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments, Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357407519160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Strategic Investments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS AND STRATEGIC INVESTMENTS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accompanying unaudited consolidated financial statements include the operating results for acquired entities from the respective dates of acquisition. We completed one acquisition and one divestiture in the first six months of 2021 and did not complete any significant acquisitions or divestitures during the first six months of 2020. We have not presented supplemental pro forma financial information for completed acquisitions or divestitures given their results are not material to our accompanying unaudited consolidated financial statements. Further, transaction costs were immaterial to our accompanying unaudited consolidated financial statements and were expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2021, we announced our entry into a definitive agreement to acquire the global surgical business of Lumenis LTD. (Lumenis), a privately-held company that develops and commercializes energy-based medical solutions, for an upfront cash payment of approximately $1.070 billion subject to closing adjustments. The global surgical business of Lumenis includes innovative laser systems, fibers, and accessories used for urology and otolaryngology procedures. The acquisition is expected to close during the second half of 2021, subject to customary closing conditions. Following the closing of the acquisition, we plan to integrate the Lumenis business into our Urology and Pelvic Health division. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the acquisition of Preventice Solutions, Inc. (Preventice), a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors, to cardiac event monitors and mobile cardiac telemetry. The transaction consisted of an upfront cash payment of $925 million and up to an additional $300 million in a potential commercial milestone payment. We have been an investor in Preventice since 2015 and held an equity stake of approximately 22 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the allocation of the purchase price according to priority of equity interests, which resulted in a $195 million gain recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the first quarter of 2021. The transaction price for the remaining stake consisted of an upfront cash payment of $706 million, net of cash acquired, and up to approximately $230 million in an additional future revenue-based payment. The Preventice business is being managed by our Cardiac Rhythm Management division. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, we completed our acquisition of the remaining shares of Farapulse, Inc. (Farapulse), a privately-held company that has developed a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias in which we previously held an equity stake of approximately 27 percent. The transaction price consists of $450 million upfront, or approximately $295 million after adjustments for our prior equity stake, debt and other closing adjustments; up to $125 million upon achievement of certain clinical and regulatory milestones, or $92 million for the portion not previously owned; and additional revenue-based payments over the next three years. The valuation studies necessary to determine the fair value of the various purchase price components are currently in process.  Once completed, we will remeasure the fair value of our previously held equity interest and recognize a gain of at least $150 million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the third quarter of 2021.  The Farapulse business will be integrated into our Electrophysiology division.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price for acquisitions completed during the first six months of 2021 was comprised of the amounts presented below, which represent the preliminary determination of the fair value of identifiable assets acquired and liabilities assumed. The final determination of the fair value of certain assets and liabilities will be completed within the measurement period in accordance with Financial Accounting Standards Board (FASB)&#160;Accounting Standards Codification&#160;(ASC) Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary purchase price allocation for acquisitions completed during the first six months of 2021 was comprised of the following components:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the preliminary purchase price for acquisitions completed during the first six months of 2021 to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies and is not deductible for tax purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Divestiture</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business to Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, for a purchase price of approximately $800 </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million, subject to certain adjustments including cash on hand at the closing of the transaction. The agreement included the transfer of five facilities and approximately 280 employees globally. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classified the assets and liabilities of the Specialty Pharmaceuticals business (disposal group) as held for sale within our consolidated balance sheet as of December 31, 2020 at their respective carrying values, which approximated fair value, less costs to sell. Assets within the disposal group are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and liabilities are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">within our consolidated balance sheet as of December 31, 2020. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Assets and Liabilities Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information. In the second quarter and first six months of 2021, we recognized a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain on disposal of business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the transaction of $2 million and $9 million respectively, within our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability during the first six months of 2021 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded related to current year acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our completed acquisitions was $751 million, which includes amounts related to our recent acquisition of Preventice. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information. In the second quarter of 2021 we recorded a contingent consideration net benefit of $85 million.  The benefit related to certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$290 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to research and development (R&amp;D), commercialization-based and revenue-based milestones are discounted back to the current period, primarily using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of June&#160;30, 2021. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.787%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">616</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter and first six months of 2021, we recorded losses of $8 million and $154 million, respectively, on our investment in Pulmonx Corporation presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span> associated with the partial disposition of our ownership and remeasurement of our remaining investment to fair value based on observable market prices. On March 1, 2021, we completed our acquisition of Preventice, in which we previously held an equity interest of approximately 22 percent. In addition, on August 6, 2021, we completed the acquisition of the remaining shares of Farapulse, in which we previously held an equity stake of approximately 27 percent.  As of June&#160;30, 2021, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $314 million, which represents amortizable intangible assets, in-process research and development (IPR&amp;D), goodwill and deferred tax liabilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357510539080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill are as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,475)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,150)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,774</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,924</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,973)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">330</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">377</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In the fourth quarter of 2020, we recorded goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of June 30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in our balance of goodwill and intangible assets is primarily related to our acquisition of Preventice in the first quarter of 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives. Our IPR&amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,059</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,697</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,951</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and other changes in carrying amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,057</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,698</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,874</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the divestiture on March 1, 2021, we presented the Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Asset Impairments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not record any goodwill impairment charges in the second quarter or first six months of 2021 or 2020. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of&#160;2021, we performed our annual goodwill impairment test for all of our reporting units using the quantitative approach described in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Othe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r (FASB ASC Topic 350). We identified the following reporting units in our 2021 annual goodwill impairment test: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health and Neuromodulation. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350.  We determined that the fair value of each reporting unit exceeded its carrying value and concluded that goodwill was not impaired or at risk of impairment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of  $45 million in the second quarter and first six months of 2021, $34 million in the second quarter of 2020 and $233 million in the first six months of 2020. We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life.  We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets.  In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist.  During the second quarter of 2021, we determined it was more likely than not that one of our indefinite-lived intangible assets was impaired based on our qualitative assessment of impairment indicators.  We tested the intangible asset for recoverability and recorded an impairment charge associated with incremental time and cost to complete the associated in-process research and development (IPR&amp;D) project.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impairment charges recorded in the first six months of 2020 were primarily associated with amortizable technology-related intangible assets that were initially established following our acquisition of nVision. These charges were recorded as a result of management&#8217;s decision to change commercial launch plans or discontinue certain R&amp;D programs based on cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409256504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities, forecasted intercompany and third-party transactions, and net investments in certain subsidiaries. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in Euro, Japanese yen, Chinese renminbi and Australian dollar. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax (OCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax (AOCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. For these derivative instruments, we elected to use the spot method to assess hedge effectiveness. We also elected to exclude the spot-forward difference, referred to as the excluded component, from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. As such, we defer recognition of foreign currency gains and losses within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and we reclassify amortization of the excluded component from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designate certain euro-denominated debt as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro. As of June&#160;30, 2021 and December&#160;31, 2020, we designated as a net investment hedge a portion of our &#8364;900 million in aggregate principal amount of 0.625% senior notes issued in November 2019 and due in 2027. For these nonderivative instruments, we defer recognition of the foreign currency remeasurement gains </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and losses within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We reclassify these gains and losses to current period earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations only when the hedged item affects earnings, which would occur upon disposal or substantial liquidation of the underlying foreign subsidiary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as cash flow hedges outstanding as of June&#160;30, 2021 and December&#160;31, 2020. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was a $27 million loss as of June&#160;30, 2021</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and a $29 million loss as of December&#160;31, 2020. We recognized immaterial gains and losses in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of our terminated cash flow hedges in the current and prior periods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as fair value hedges outstanding as of June&#160;30, 2021 and December&#160;31, 2020. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated balance sheets into earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which generally offset. The balance of the deferred gains on our terminated fair value hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was immaterial as of June&#160;30, 2021 and December&#160;31, 2020. We recognized immaterial gains in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of the terminated fair value hedges in the current and prior periods.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.430%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,340</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,349</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;900 million debt principal designated as a net investment hedge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of June&#160;30, 2021 is within 60&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next year. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note M &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our accompanying unaudited consolidated statements of comprehensive income (loss).</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:28.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.655%"/><td style="width:0.1%"/></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.911%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">322</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,163</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;900 million debt principal designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,556</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">322</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,189</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,998</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,605</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,163</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">662</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,865</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $2.379 billion invested in money market funds and time deposits as of June&#160;30, 2021 and $1.584 billion as of December&#160;31, 2020, we held $296 million in interest-bearing and non-interest-bearing bank accounts as of June&#160;30, 2021 and $150 million as of December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability. In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, including the contractual right to receive future royalty payments related to the Zytiga&#8482; Drug. We recognized a financial asset and associated liability for our licensing arrangements at fair value in our accompanying unaudited consolidated balance sheets using the fair value option in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own the contractual right to receive 50 percent of the future royalty payments from the licensee and remit such payments to the inventors associated with the intellectual property. Royalty payments we receive reduce the fair value of the financial asset and are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proceeds from royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and payments we remit to inventors reduce the fair value of the financial liability and are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our unaudited consolidated statements of cash flows. We sold our right to receive and retain the other 50 percent of the future royalty payments in 2019 for an upfront cash payment, which we accounted for as a secured borrowing in accordance with FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Although we sold these rights, we continue to recognize at fair value the future royalty payments as a financial asset and associated liability. Royalty payments associated with the rights we sold no longer impact our cash flows, and we present this activity as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-cash impact of transferred royalty rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the supplemental information to our unaudited consolidated statements of cash flows. We reduce the fair value of the financial asset and associated liability when such non-cash activity occurs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recorded the fair value of the financial asset and associated liability using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of June&#160;30, 2021.  However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains and losses from the licensing arrangement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2021 include the following significant unobservable inputs:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (1)</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$311 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$350 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">350</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $10.431 billion as of June&#160;30, 2021, including $1.085 billion relating to our euro-denominated December 2027 Notes, and $10.774 billion as of December&#160;31, 2020, including $1.118 billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357407711944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE E &#8211; CONTRACTUAL OBLIGATIONS AND COMMITMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings and Credit Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total debt outstanding of $9.109 billion as of June&#160;30, 2021 and $9.143 billion as of December&#160;31, 2020, with current maturities of $262 million as of June&#160;30, 2021 and $13 million as of December&#160;31, 2020. The debt maturity schedule for our long-term debt obligations is presented below: </span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, <br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.125%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Deferred Financing Costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,847</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)   As of June 30, 2021 the outstanding balance is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Current Debt Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our unaudited consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2021 we entered into a new $2.750 billion revolving credit facility (2021 Revolving Credit Facility) with a global syndicate of commercial banks and terminated our previous facility (2018 Revolving Credit Facility). The 2021 Revolving Credit Facility will mature on May 10, 2026, with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. There were no amounts outstanding under the 2021 Revolving Credit Facility as of June&#160;30, 2021 or under the 2018 Revolving Credit Facility as of December&#160;31, 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through June&#160;30, 2021, we were in compliance with the financial covenant required by the credit facilities described above: </span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:32.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.158%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25 times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.06 times</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 2021 Revolving Credit Facility includes the following financial covenant requirement for all of our credit arrangements (i)  maintain the maximum permitted leverage ratio of 4.25 times for the second quarter of 2021, with a step-down for each succeeding fiscal quarter end, beginning with the third quarter of 2021, to 4.00 times and 3.75 times for the fourth quarter of 2021 and through the remaining term of the 2021 Revolving Credit Facility. The agreement provides for higher leverage ratios for the period following a qualified acquisition, at our election, for which consideration exceeds $1.000 billion.  In the event of such an acquisition, for the four succeeding quarters immediately following, including the quarter in which the acquisition occurs, the maximum permitted leverage ratio is 4.75 times.  It steps down for the fifth, sixth and seventh succeeding quarters to 4.50 times, 4.25 times  and 4.00 times, respectively.  Thereafter, a maximum leverage ratio of 3.75 times is required through the remaining term of the 2021 Revolving Credit Facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreements, through maturity, of any non-cash charges and up to  $500 million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of June&#160;30, 2021, we had $467 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed  $1.455 billion in the aggregate. As of June&#160;30, 2021, we had $1.303 billion of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this covenant could require us to seek to further renegotiate the terms of our credit arrangements or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all 2021 Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our 2021 Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program, which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our commercial paper program is backed by the 2021 Revolving Credit Facility, as discussed above, and outstanding commercial paper directly reduces borrowing capacity under the 2021 Revolving Credit Facility. We did not have any commercial paper outstanding as of June&#160;30, 2021 or December&#160;31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $9.168 billion as of June&#160;30, 2021 and $9.205 billion as of December&#160;31, 2020. Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts de-recognized for accounts and notes receivable, which are excluded from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying unaudited consolidated balance sheets, are aggregated by contract denominated currency below (in millions):</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.912%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $135 million as of June&#160;30, 2021 and $124 million as of December&#160;31, 2020, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of June&#160;30, 2021 and December&#160;31, 2020, none of the beneficiaries had drawn upon the letters of credit or guarantees, and accordingly, we have not recognized a related liability for our outstanding letters of credit in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2021 and December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409594488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">SUPPLEMENTAL BALANCE SHEET INFORMATION</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in our accompanying unaudited consolidated balance sheets are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,675</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,531</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Effective January 1, 2020, we adopted FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note R &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 326, we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability, including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We closely monitor outstanding receivables for potential collection risks, including those that may arise from economic conditions. Our sales to government-owned or supported customers, particularly in southern Europe, are subject to an increased number of days outstanding prior to payment relative to other countries. More recently, we have seen an increase in the volume of our U.S. business conducted in ambulatory surgery centers and office-based laboratories. Many of these customers are smaller than those we have historically done business with and may have limited liquidity. We have adjusted our estimates of credit loss reserves for these customers, regions and conditions based on collection trends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,430</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">777</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,082</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,084</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $83 million&#160;for the second quarter of 2021, $78 million for the second quarter of 2020, $166 million for the first six months of 2021 and $154 million for the first six months of 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,629</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,921</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,442</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">958</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,190</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,309</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409229624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in our reported tax rates for the second quarter and first six months of 2021, as compared to the same periods in 2020, relates primarily to the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These receipts and charges include acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credit), litigation charges, investment portfolio net losses (gains), as well as certain discrete tax items primarily related to changes in foreign tax rates, and changes in tax laws adopted in the second quarter of 2021, as well as the impacts of the Coronavirus Aid, Relief and Economic Security (CARES) Act in the second quarter of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, we had $280 million of gross unrecognized tax benefits, of which a net $195 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2020, we had $261 million of gross unrecognized tax benefits, of which a net $183 million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to positions on new entities we acquired through recent acquisitions and restructuring activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12 months, we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $24 million.</span></div>Economic stimulus legislation has been enacted in many countries in response to the COVID-19 pandemic. In the U.S., the CARES Act, enacted on March 27, 2020, provided an estimated $2.2 trillion in COVID-19 pandemic-related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes incurred in 2020. This allowed us to preserve cash generated from operations to service our debt obligations and other near-term commitments and is expected to be paid in full by the end of 2022 as permitted by the legislation.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409270952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">NOTE H &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accrual for legal matters that are probable and estimable was $617 million as of June&#160;30, 2021 and $569 million as of December&#160;31, 2020 and includes certain estimated costs of settlement, damages and defense. The increase in our legal accrual was mainly due to product liability cases or claims related to transvaginal surgical mesh products. A portion of our legal accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $167 million as of June&#160;30, 2021 and $208 million as of December&#160;31, 2020. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note F &#8211; Supplemental Balance Sheet Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related net charges of $298 million during the second quarter of 2021 and $302 million during the first six months of 2021, related primarily to transvaginal surgical mesh products.  We did not record any litigation-related net charges during the first six months of 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in our accompanying&#160;unaudited consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying unaudited consolidated statements of operations. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2015, the Company filed suit against Cook Group Limited and Cook Medical LLC (collectively, &#8220;Cook&#8221;) in the United States District Court for the District of Delaware (1:15-cv-00980) alleging infringement of certain Company patents regarding Cook&#8217;s Instinct&#8482; Endoscopic Hemoclip. The case was transferred to the District Court for the Southern District of Indiana. Cook filed seven Inter Partes Review (&#8220;IPR&#8221;) requests with the U.S. Patent and Trademark Office (USPTO) against the four asserted patents. All IPRs have concluded and Cook and the Company both appealed the Patent Office&#8217;s IPR decisions to the Federal Circuit Court of Appeals. On April 30, 2020, the U.S. Court of Appeals ruled that claims from two of the Company's patents remain valid, remanding two of the patents for further review by the USPTO&#8217;s Patent Trial and Appeal Board. In November 2020, the Patent Office issued remand rulings invalidating several additional claims. The district court stayed the case pending the appeals court decision on the IPRs, which is now complete. The case is proceeding before the United States District Court for the Southern District of Indiana, with the Company asserting three patents against Cook. Trial is anticipated in October 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2021, Nevro Corp. (&#8220;Nevro&#8221;) filed a complaint against the Company in the United States District Court for the District of Delaware (21-cv-258). The complaint alleges infringement of five Nevro patents by certain of the Company&#8217;s spinal cord stimulation systems.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 20, 2021, approximately 54,500 product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. As of July 20, 2021, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately 52,500 cases and claims, adjusted to reflect the Company&#8217;s analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately 52,500 cases and claims, approximately 49,000 have met the conditions of the settlement and are final. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. The pending cases are in various federal and state courts in the U.S. Generally, the plaintiffs allege personal injury associated with use of our transvaginal surgical mesh products. The plaintiffs assert design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. Over 3,100 of the cases were specially assigned to one judge in state court in Massachusetts. On February 7, 2012, the Judicial Panel on Multi-District Litigation (MDL) established MDL-2326 in the U.S. District Court for the Southern District of West Virginia and transferred the federal court transvaginal surgical mesh cases to MDL-2326 for coordinated pretrial proceedings. The Court issued an Order closing the MDL on February 11, 2021, as all cases that had been pending were dismissed or remanded to courts of primary jurisdiction. Outside the United States, there are fewer than 75 claims in the United Kingdom and Ireland. In the first quarter of 2021, two class actions were filed against the Company in Australia.  In the second quarter of 2021, one of these class actions was permanently stayed, while the other is proceeding.  At this time, the Company is aware of fewer than 125 claims in Australia. There are also fewer than 10 cases in Canada, inclusive of one certified class action, which has settled and received Court approval. On April 16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#8217;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. In April 2021 the Company's Board of Directors received a shareholder demand under section 220 of the Delaware General Corporation Law, for inspection of books and records. The Company has notified our insurer and retained counsel to respond to the demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. In the second quarter of 2021, we increased the accrual associated with this matter by $298 million to account for increased, post-COVID-19 settlement and litigation activity related to the remaining cases and claims the Company faces, our revision of the per-case settlement amount for these cases based on recent settlement and litigation activity, and changes to our expectations regarding the rate of incoming cases and claims.  We continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims. We continue to vigorously contest the cases and claims asserted against us that do not settle and expect that more cases will go to trial through 2023.  The final resolution of the cases and claims is uncertain and could have a further material impact on our results of operations, financial condition and/or liquidity. Trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently named as a defendant in 147 filed product liability cases involving our Greenfield Vena Cava Filter, which we discontinued marketing and active selling in the fourth quarter of 2018, alleging various injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional 521 claims, none of which have been filed.  As of June 24, 2021, we have entered into master settlement agreements in principle or are in the final stages of entering with certain plaintiffs&#8217; counsel to resolve approximately 200 cases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governmental Investigations and Qui Tam Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2014, we were served with a subpoena from the U.S. Department of Health and Human Services, Office of the Inspector General. The subpoena seeks information relating to the launch of the Cognis&#8482; CRT-D and Teligen&#8482; ICD line of devices in 2008, the performance of those devices from 2007 to 2009 and the operation of our Physician Guided Learning Program. We are cooperating with this request. On May 6, 2016, a qui tam lawsuit in this matter was unsealed in the United States District Court for the District of Minnesota. At the same time, we learned that the U.S. federal government and the State of California had earlier declined to intervene in that lawsuit on April 15, 2016. The complaint was served on us on July 21, 2016. On October 7, 2016, the plaintiff/relator served an amended complaint that dropped the allegations relating to our Physician Guided Learning Program. We filed a motion to dismiss the amended complaint on December 7, 2016 and the court </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">heard our motion to dismiss on April 5, 2017. On August 29, 2017, the Court granted the motion to dismiss, without prejudice and on September 19, 2017, the relator filed a Second Amended Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We filed a motion to dismiss the Second Amended Complaint on October 10, 2017 and the Court denied that motion on December 13, 2017. On July 31, 2018, the relator filed a motion seeking leave to file a Third Amended Complaint. The Court denied the motion on October 30, 2018.  In February 2021, we filed a motion for summary judgment, which the relator opposed, and on April 29, 2021, the Court held a hearing on that motion.  The motion remains pending.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Proceedings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 4, 2020 Enrique Jevons, individually and on behalf of all others similarly situated, filed a class action complaint against the Company, Michael F. Mahoney and Daniel J. Brennan, stemming from the recall and retirement of the LOTUS Edge&#8482; Aortic Valve System (LOTUS System) in United States District Court for the Eastern District of New York. On December 14, 2020, the parties agreed to transfer the case to the United States District Court for the District of Massachusetts. On December 16, 2020, Mariano Errichiello, individually and on behalf of all other similarly situated, filed a second, materially similar class action complaint against the Company, Michael F. Mahoney, Joseph M. Fitzgerald, and Daniel J. Brennan in the United States District Court for the District of Massachusetts. Subsequently, on March 30, 2021, the Court consolidated the two actions, and appointed Mariano Errichiello as the lead plaintiff. Under the terms of the Court-approved Scheduling Order, Counsel for Mr. Errichiello was required to file an Amended Complaint on or before June 4, 2021, which it did, and, in response the Company brought a Motion to Dismiss the Amended Complaint by July 19, 2021.  On December 15, 2020, the Securities and Exchange Commission&#8217;s Boston Regional Office (Boston SEC) notified the Company that it was conducting an investigation related to the Company&#8217;s decision to retire the LOTUS System, and issued a voluntary request for documents and information related to that decision. On February 10, 2021, the Boston SEC issued a second voluntary request for additional documents and information. The Company is cooperating fully with the investigation. On February 8, 2021, the Company received a letter from The Vladimir Gusinsky Revocable Trust, a shareholder, demanding that the Company&#8217;s Board of Directors conduct an investigation into actions by the Company&#8217;s directors and executive officers regarding statements made about the effectiveness and commercial viability of the LOTUS System. The Trust subsequently agreed to stay its demand, pending the outcome of any dispositive motion against the Amended Complaint in the class action complaint described above.  The Company received letters on behalf of the Union Excavators Local 731 Pension Fund and Diane Nachbaur, two stockholders of the Company, on July 26, 2021 and July 29, 2021, respectively, each demanding access to certain books and records of the Company, pursuant to 8 Delaware Section 220, regarding the business, operations, effectiveness and commercial viability of the LOTUS system, and related items.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Matters Concluded Since December 31, 2020</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2015, a judge for the Court of Modena (Italy) ordered a trial for the Company and three of its employees, as well as numerous other defendants charged in criminal proceedings. The charges arose from allegations that the defendants made improper donations to certain healthcare providers and other employees of the Hospital of Modena in order to induce them to conduct unauthorized clinical trials, as well as related government fraud in relation to the financing of such clinical trials. A trial began on February 24, 2016. On November 10, 2017, the Court issued a ruling that convicted one Company employee but acquitted two others and levied a fine of &#8364;245 thousand against us and imposed joint and several civil damages of &#8364;620 thousand on all defendants. We continue to deny these allegations, and timely appealed the decision on May 10, 2018. On November 9, 2020, the Court of Appeal in Bologna reversed the judgements against the Company and its employee and acquitted them of all charges. This judgment of acquittal became final as to the Company and its employee on April 15, 2021 when the prosecution chose not to appeal.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general regarding our transvaginal surgical mesh products and related alleged violations of states&#8217; consumer protection statutes. On December 12, 2019, the Mississippi Attorney General filed suit against us in a Mississippi state court alleging violations of the Mississippi Consumer Protection Act. In the fourth quarter of 2020 and the first quarter of 2021, we reached settlements with 48 states, including Mississippi, and the District of Columbia. These settlements were finalized in March of 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On </span></div>May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders. On April 8, 2021, the parties settled the dispute, and, on April 12, 2021, the parties filed stipulations with the court to dismiss the remaining legal proceedings. The settlement did not result in any material benefit or liability to the Company.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357407752600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; STOCKHOLDERS' EQUITY</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975&#160;million after deducting underwriting discounts and commissions and offering expenses. As of June&#160;30, 2021, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of 5.50% of the liquidation preference of $100 per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $100 per share plus accumulated and unpaid dividends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between 2.3834 and 2.9197 shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the second quarter of 2021, the Audit Committee of our Board of Directors (the Committee), pursuant to authority delegated to such committee by our Board of Directors, declared and we paid a cash dividend of $1.375 per MCPS share to holders of our MCPS as of May 15, 2021, representing a dividend period from March through May 2021. On July 23, 2021, the Committee declared a cash dividend of $1.375 per MCPS share to holders of our MCPS as of August 15, 2021, representing a dividend period from June through August 2021. We have presented cumulative, unpaid dividends within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within our unaudited consolidated balance sheet as of June&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note L &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for information on the pertinent rights and privileges of our outstanding common stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357407669304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Weighted Average Number Of Shares Outstanding [Text Block]</a></td>
<td class="text"><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,432.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,410.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,431.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,404.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been anti-dilutive:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in the second quarter and first six months of 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> position in those periods.&#160;&#160;&#160;&#160;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the beginning of the reporting period to the extent that the effect is dilutive. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the second quarter and first six months of 2021, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, as presented in our accompanying unaudited consolidated statements of operations, for purposes of calculating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net income available to common stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span></div>We issued approximately one million shares of our common stock in the second quarter of 2021 and 2020, and five million shares in the first six months of 2021 and 2020, following the exercise of stock options, vesting of deferred stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first six months of 2021 or 2020. On December 14, 2020, our Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $1.000 billion of our common stock. As of June&#160;30, 2021, we had the full amount remaining available under the authorization.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409187016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our seven core businesses are organized into three reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. Operating income of reportable segments as a percentage of net sales of reportable segments is defined as operating income of reportable segments divided by net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits); and certain litigation-related net charges (credits) and European Union (EU) Medical Device Regulation (MDR) implementation costs. Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in our accompanying unaudited consolidated statements of operations and are included in the reconciliation below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages): </span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,228</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,935</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,816&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,437</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,546</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits) and EU MDR implementation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(327)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(181)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">474</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(159)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1) On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income margin of reportable segments</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357414009304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; REVENUE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our accompanying unaudited consolidated statements of operations. The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,277</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,118</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">885</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,939</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">359</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">676</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation which had an immaterial impact on previously reported Emerging Markets net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited consolidated balance sheets. Our deferred revenue balance was $424 million as of June&#160;30, 2021 and $395 million as of December&#160;31, 2020. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System within our Cardiac Rhythm Management (CRM) business, for which revenue is recognized over the average service period based on device and patient longevity. Our contractual liabilities also include deferred revenue related to the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, also within our CRM business, for which revenue is recognized over the average service period based on device longevity and usage. We recognized revenue of $38 million in the second quarter and $74 million in the first six months of 2021 that was included in the above contract liability balance as of December&#160;31, 2020. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit. We base our estimate for sales returns upon historical trends and record the amount as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls and variation in product utilization all affect our estimates related to sales returns and could cause actual returns to differ from these estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. We estimate rebates for products where there is sufficient historical information available to predict the volume of expected future rebates. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409062872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Income (Loss) Note [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">134</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">248</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">168</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In connection with the completion of the divestiture of the Specialty Pharmaceuticals business in the first quarter of 2021, we released $127 million of cumulative translation adjustments associated with the disposed business from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span> were reduced by immaterial income tax impacts in the second quarter and first six months of 2021 and 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409626232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NewAccountingPronouncementsPolicyTextBlock', window );">New Accounting Pronouncements, Policy</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our accompanying unaudited consolidated financial statements. During the first quarter of 2021, we implemented the following standards, which did not have a material impact on our financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-10</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2019-12 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-05</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Lessors&#8212;Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases.  Such classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We have the option to apply the amendments retrospectively to leases that commenced or were modified on or after the adoption of FASB ASC Topic 842, or prospectively.  We are currently in the process of determining the effect that the adoption will have on our financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our accompanying unaudited consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NewAccountingPronouncementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>New Accounting Pronouncements, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NewAccountingPronouncementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409080056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our accompanying unaudited consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions, Divestitures and Strategic Investments, Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357406578952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives, Policy [Policy Text Block]</a></td>
<td class="text">Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409183112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies Commitments and Contingencies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Costs, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409878824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock', window );">ASC Update No. 2020-10 Codification Improvements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-10</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock', window );">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock', window );">ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2019-12 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock', window );">ASC Update No. 2020-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2021-05</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the FASB issued ASC Update No. 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Lessors&#8212;Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The amendments in Update No. 2021-05 revise lessor lease classification guidance and require accounting for certain leases with variable lease payments that do not depend on a reference index or rate as operating leases.  Such classification is required if the lease would have been classified as a sales-type or direct financing lease in accordance with guidance in FASB ASC Topic 842 and the lessor would have otherwise recognized a day-one loss. Update No. 2021-05 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We have the option to apply the amendments retrospectively to leases that commenced or were modified on or after the adoption of FASB ASC Topic 842, or prospectively.  We are currently in the process of determining the effect that the adoption will have on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2020-10 Codification Improvements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357413733608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Strategic Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability during the first six months of 2021 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount recorded related to current year acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$290 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock', window );">Investment [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.787%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">616</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceMember', window );">Preventice</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_PreventiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357408996792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill are as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,475)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,150)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,806)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,774</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,924</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,973)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">330</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">377</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In the fourth quarter of 2020, we recorded goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $73&#160;million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of June 30, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,059</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,697</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,951</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and other changes in carrying amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,057</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,698</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,874</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357415056568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.430%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,340</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,349</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;900 million debt principal designated as a net investment hedge.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss) [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Consolidated Statements of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current and prior period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> CTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock', window );">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:28.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.655%"/><td style="width:0.1%"/></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</a></td>
<td class="text">The following are the balances of our derivative and nonderivative assets and liabilities:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.911%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Consolidated Balance Sheets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">322</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,163</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Foreign currency-denominated debt is the portion of the &#8364;900 million debt principal designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,556</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">322</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,189</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,998</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,605</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,163</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">662</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,262</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,865</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The recurring Level 3 fair value measurements of our licensing arrangements recognized in our accompanying unaudited consolidated balance sheets as of June&#160;30, 2021 include the following significant unobservable inputs:<div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of June 30, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (1)</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$311 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$350 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">350</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357414143128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, <br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.125%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Deferred Financing Costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 - 2049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,847</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)   As of June 30, 2021 the outstanding balance is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Current Debt Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our unaudited consolidated balance sheet.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock', window );">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:32.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.158%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25 times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.06 times</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio of total debt to consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock', window );">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.912%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of term loan and revolving credit facility agreement compliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357412269496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Trade accounts receivable, net [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,675</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,531</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">107</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Effective January 1, 2020, we adopted FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note R &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory Disclosure [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,430</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,351</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">777</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment, net [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,082</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,084</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,629</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,921</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,442</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Current Liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">958</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other long-term liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,190</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,309</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409014088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems', window );"><strong>Schedule of Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock', window );">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ScheduleofIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409750040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,421.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,432.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,410.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,431.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,404.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been anti-dilutive:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in the second quarter and first six months of 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> position in those periods.&#160;&#160;&#160;&#160;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409134168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited consolidated statements of operations is as follows (in millions, except percentages): </span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,808&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,228</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,935</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,816&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,437</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,546</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), and certain litigation-related net charges (credits) and EU MDR implementation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(327)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(181)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">474</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(159)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1) On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales and income (loss) before income taxes for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income margin of reportable segments</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357510419928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Disaggregation of Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,277</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,118</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">885</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. Our consolidated net sales for the first six months of 2021 include Specialty Pharmaceuticals up to the date of the closing of the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Int'l</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,939</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,003</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,829</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">359</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">676</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2021, modified our list to include the following countries: Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Taiwan, Thailand, Turkey and Vietnam. We have revised prior period amounts to conform to the current year's presentation which had an immaterial impact on previously reported Emerging Markets net sales.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357409146088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Other Comprehensive Income [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">134</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">248</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">168</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In connection with the completion of the divestiture of the Specialty Pharmaceuticals business in the first quarter of 2021, we released $127 million of cumulative translation adjustments associated with the disposed business from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357413111592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 06, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 03, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 01, 2021 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>business</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>business</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of Businesses Acquired | business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NumberOfBusinessesDivested', window );">Number Of Businesses Divested | business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 706<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DivestitureAgreementTransferOfFacilities', window );">Transfer of facilities | units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DivestitureAgreementTransferOfGlobalEmployees', window );">Divestiture, agreement, transfer of global employees | units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember', window );">Lumenis LTD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceMember', window );">Preventice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceMember', window );">Preventice | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceMember', window );">Preventice | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceMember', window );">Preventice | Weighted Average [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceMember', window );">Preventice | Weighted Average [Member] | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_FarapulseMember', window );">Farapulse | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</a></td>
<td class="nump">$ 125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="nump">$ 92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod', window );">Business Combination, Consideration Transferred, Additional Revenue Payments, Period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Additional Revenue Payments, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DivestitureAgreementTransferOfFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture, agreement, transfer of facilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DivestitureAgreementTransferOfFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DivestitureAgreementTransferOfGlobalEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture, agreement, transfer of global employees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DivestitureAgreementTransferOfGlobalEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NumberOfBusinessesDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Businesses Divested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NumberOfBusinessesDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_LumenisLTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_PreventiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_PreventiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_FarapulseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_FarapulseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357418561464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Fair value of contingent consideration recorded in purchase accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration net expense (benefit)</a></td>
<td class="num">$ (85)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="num">$ (108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PaymentOfContingentConsideration', window );">Payment of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="nump">751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">$ 290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration liability, probability of payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ContingentConsiderationLiabilityProbabilityOfPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of contingent consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357417564072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">$ 319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Measurement alternative investments(1)</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Notes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">616<span></span>
</td>
<td class="nump">$ 918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Equity Securities, FV-NI, Gain (Loss)</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</a></td>
<td class="nump">$ 314<span></span>
</td>
<td class="nump">$ 314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357410106968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 13,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(8,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,806)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">$ 233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">10,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">945<span></span>
</td>
<td class="nump">791<span></span>
</td>
<td class="nump">1,839<span></span>
</td>
<td class="nump">1,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other Operating Income (Expense), Net</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeigncurrencydenominatedindebtMember', window );">foreign currency denominated in debt [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">2,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember', window );">Rhythm and Neuro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">3,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">5,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember', window );">Goodwill [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, Gross</a></td>
<td class="nump">20,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="num">(9,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,973)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">11,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(6,475)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,475)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,179)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(397)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(397)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(407)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">1,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">$ (1,278)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,278)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,220)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_IntangibleAssetsandGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Intangible Assets and Goodwill [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_IntangibleAssetsandGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeigncurrencydenominatedindebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeigncurrencydenominatedindebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357396419976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>derivative_instrument </div>
<div>units</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>derivative_instrument </div>
<div>units</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;) </div>
<div>derivative_instrument </div>
<div>units</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>derivative_instrument</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="nump">$ 146,000,000<span></span>
</td>
<td class="nump">$ 222,000,000<span></span>
</td>
<td class="nump">$ 146,000,000<span></span>
</td>
<td class="nump">$ 222,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,000,000<span></span>
</td>
<td class="nump">$ 36,000,000<span></span>
</td>
<td class="nump">$ 248,000,000<span></span>
</td>
<td class="nump">$ 173,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">11,340,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,340,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,349,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="nump">121,000,000<span></span>
</td>
<td class="nump">86,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="nump">945,000,000<span></span>
</td>
<td class="nump">791,000,000<span></span>
</td>
<td class="nump">1,839,000,000<span></span>
</td>
<td class="nump">1,596,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="nump">86,000,000<span></span>
</td>
<td class="nump">91,000,000<span></span>
</td>
<td class="nump">168,000,000<span></span>
</td>
<td class="nump">179,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other Operating Income (Expense), Net</a></td>
<td class="nump">26,000,000<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
<td class="nump">54,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Netcurrencyexchangegainloss', window );">Net currency exchange gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Asset, Fair Value, Gross Asset</a></td>
<td class="nump">322,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liability, Fair Value, Gross Liability</a></td>
<td class="nump">1,163,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,163,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">156,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">166,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">312,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">199,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">296,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 296,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments', window );">Licensing Arrangements, Asset, Percentage Of Future Royalty Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold', window );">Licensing Arrangements, Asset, Percentage Of Future Royalty Payments Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Noncashimpactoftransferredroyaltyrights', window );">Non-cash impact of transferred royalty rights</a></td>
<td class="num">(43,000,000)<span></span>
</td>
<td class="num">(45,000,000)<span></span>
</td>
<td class="num">$ (43,000,000)<span></span>
</td>
<td class="num">(45,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">10,431,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,431,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,774,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 1,068,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,068,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,105,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember', window );">Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from Royalties Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (43,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Noncashimpactoftransferredroyaltyrights', window );">Non-cash impact of transferred royalty rights</a></td>
<td class="num">$ (43,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember', window );">Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Noncashimpactoftransferredroyaltyrights', window );">Non-cash impact of transferred royalty rights</a></td>
<td class="num">(43,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Payments for Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_EurodenominatedoutstandingdebtMember', window );">Euro-denominated outstanding debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">1,085,000,000.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,085,000,000.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,118,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">311,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">2,379,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,379,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,584,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">322,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">311,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">3,189,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,189,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,605,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">1,163,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,163,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">312,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">1,825,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,825,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,865,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">2,379,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,379,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,584,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">2,556,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,556,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,998,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">322,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">322,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">1,163,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,163,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">1,163,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,163,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">311,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">311,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">312,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">662,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">662,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">603,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">284,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">1,111,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,111,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,191,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">$ 1,058,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,058,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,094,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ForwardCurrencyContractsTimetoMaturity', window );">Forward Currency Contracts, Time to Maturity | units</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">$ 128,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Noncurrent Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">156,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign Currency Transaction Gain (Loss), before Tax</a></td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Netcurrencyexchangegainloss', window );">Net currency exchange gain (loss)</a></td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">5,125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,946,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</a></td>
<td class="nump">38,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</a></td>
<td class="nump">$ 51,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative, Term of Contract (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeRemainingMaturity1', window );">Derivative, Remaining Maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Foreign Exchange Contract [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="num">$ (5,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of Interest Rate Derivatives Held | derivative_instrument</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 4,725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,531,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(15,000,000)<span></span>
</td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="nump">156,000,000<span></span>
</td>
<td class="nump">111,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="num">(35,000,000)<span></span>
</td>
<td class="num">(25,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="nump">121,000,000<span></span>
</td>
<td class="nump">86,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="num">(28,000,000)<span></span>
</td>
<td class="num">(16,000,000)<span></span>
</td>
<td class="num">(51,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="num">(21,000,000)<span></span>
</td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="num">(39,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Rate Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="num">(27,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (29,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of Interest Rate Derivatives Held | derivative_instrument</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Foreign Exchange Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet', window );">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">493,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,004,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="nump">17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="num">(25,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</a></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</a></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | foreign currency denominated in debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">997,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">997,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 868,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | foreign currency denominated in debt [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(12,000,000)<span></span>
</td>
<td class="num">(22,000,000)<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="num">(17,000,000)<span></span>
</td>
<td class="nump">27,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ForwardCurrencyContractsTimetoMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forward Currency Contracts, Time to Maturity in Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ForwardCurrencyContractsTimetoMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing Arrangements, Asset, Percentage Of Future Royalty Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing Arrangements, Asset, Percentage Of Future Royalty Payments Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsasset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsasset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsliability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsliability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Netcurrencyexchangegainloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net currency exchange gain (loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Netcurrencyexchangegainloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Noncashimpactoftransferredroyaltyrights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash impact of transferred royalty rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Noncashimpactoftransferredroyaltyrights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeRemainingMaturity1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeRemainingMaturity1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_EurodenominatedoutstandingdebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_EurodenominatedoutstandingdebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeigncurrencydenominatedindebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeigncurrencydenominatedindebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357411563800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 10, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,109,000,000<span></span>
</td>
<td class="nump">$ 9,143,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term Debt and Capital Lease Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,847,000,000<span></span>
</td>
<td class="nump">9,130,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ExclusionFromEbitdaForRestructuringCharges', window );">Exclusion from EBITDA for Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">467,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LitigationAndDebtExclusionFromEbitda', window );">Litigation and Debt Exclusion from EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,455,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Legal payments remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,303,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,000,000<span></span>
</td>
<td class="nump">124,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_QualifiedAcquisitionConsideration', window );">Qualified Acquisition Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_CurrentRequirementMember', window );">Current Requirement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_ActualCovenantMember', window );">Actual, Covenant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.06<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementAsOfJune302021Member', window );">Requirement, extension through the remainder of 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="nump">4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementAsOfSeptember302021Member', window );">Requirement, as of September 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember', window );">Requirement, as of December 31, 2021 and through remaining term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember', window );">Requirement, fifth quarter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember', window );">Requirement, sixth quarter following qualified acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember', window );">Requirement, seventh quarter following qualified acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember', window );">Requirement, eighth quarter following qualified acquisition and through remaining term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember', window );">Requirement, four succeeding quarters following qualified acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain', window );">the 2018 Facility [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 2,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember', window );">May 2022 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember', window );">October 2023 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 244,000,000<span></span>
</td>
<td class="nump">244,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember', window );">March 2024 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember', window );">May 2025 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 523,000,000<span></span>
</td>
<td class="nump">523,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.85%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember', window );">June 2025 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember', window );">March 2026 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,068,000,000<span></span>
</td>
<td class="nump">1,105,000,000<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember', window );">March 2028 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 434,000,000<span></span>
</td>
<td class="nump">434,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember', window );">March 2029 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember', window );">June 2030 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.65%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember', window );">November 2035 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember', window );">March 2039 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember', window );">January 2040 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.375%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember', window );">March 2049 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,168,000,000<span></span>
</td>
<td class="nump">9,205,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82,000,000)<span></span>
</td>
<td class="num">(88,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember', window );">Finance Lease Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_RevolvingCreditFacility2021Member', window );">2021 Revolving Credit Facility | Line of Credit | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DebtInstrumentExtensionOptionTerm', window );">Debt Instrument, Extension Option, Term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember', window );">Euro Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160,000,000<span></span>
</td>
<td class="nump">$ 148,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember', window );">Yen Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 213,000,000<span></span>
</td>
<td class="nump">$ 240,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember', window );">Renminbi Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DebtInstrumentExtensionOptionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Option, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DebtInstrumentExtensionOptionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ExclusionFromEbitdaForRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exclusion from EBITDA for Restructuring Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ExclusionFromEbitdaForRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal payments remaining to be excluded from calculation of consolidated EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LitigationAndDebtExclusionFromEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LitigationAndDebtExclusionFromEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum leverage ratio permitted by revolving credit facility agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_QualifiedAcquisitionConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Qualified Acquisition Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_QualifiedAcquisitionConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_CurrentRequirementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_CurrentRequirementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_ActualCovenantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_ActualCovenantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementAsOfJune302021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementAsOfJune302021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementAsOfSeptember302021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementAsOfSeptember302021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_RevolvingCreditFacility2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_RevolvingCreditFacility2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357412868056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems', window );"><strong>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 2,675<span></span>
</td>
<td class="nump">$ 1,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,675<span></span>
</td>
<td class="nump">$ 1,724<span></span>
</td>
<td class="nump">$ 1,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted Cash Equivalents in Other long-term assets</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">2,898<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,898<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">$ 607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherCurrentAssetsAbstract', window );"><strong>Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangements', window );">Licensing arrangements</a></td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Other Assets, Miscellaneous, Current</a></td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets, Current</a></td>
<td class="nump">777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract', window );"><strong>Trade accounts receivable, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Less: allowance for doubtful accounts</a></td>
<td class="num">(107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>Allowance for doubtful accounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charges to expenses</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Utilization of allowances</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td>
<td class="nump">933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Inventory, Work in Process, Net of Reserves</a></td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Inventory, Raw Materials, Net of Reserves</a></td>
<td class="nump">376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and improvements</a></td>
<td class="nump">1,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EquipmentFurnitureAndFixturesGross', window );">Equipment, furniture and fixtures</a></td>
<td class="nump">3,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Capital in progress</a></td>
<td class="nump">432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">5,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="nump">3,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract', window );"><strong>Supplemental Balance Sheet Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents included in Other long-term assets</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherOtherLongtermAssets', window );">Other, Other Long-term Assets</a></td>
<td class="nump">224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets, Noncurrent</a></td>
<td class="nump">1,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Legal reserves, current</a></td>
<td class="nump">417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related liabilities</a></td>
<td class="nump">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AccruedRebatesCurrent', window );">Accrued Rebates, Current</a></td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Business Combination, Contingent Consideration, Liability, Current</a></td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="nump">2,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred Revenue, Current</a></td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Accrued Royalties, Current</a></td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes Payable, Current</a></td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Disposal Group, Including Discontinued Operation, Liabilities, Current</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other Sundry Liabilities, Current</a></td>
<td class="nump">268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Liabilities, Current</a></td>
<td class="nump">680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued income taxes</a></td>
<td class="nump">535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Estimated Litigation Liability, Noncurrent</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business Combination, Contingent Consideration, Liability, Noncurrent</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="nump">560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">$ 2,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AccruedRebatesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Rebates, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AccruedRebatesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EquipmentFurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equipment, furniture and fixtures Gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EquipmentFurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsasset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsasset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsliability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsliability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherOtherLongtermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other, Other Long-term Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherOtherLongtermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357414675928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Percent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate from continuing operations</a></td>
<td class="num">(24.90%)<span></span>
</td>
<td class="nump">18.40%<span></span>
</td>
<td class="num">(11.20%)<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</a></td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in Unrecognized Tax Benefits is Reasonably Possible</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TheCARESAct', window );">The CARES Act</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TheCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TheCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357508936584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 10, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>units </div>
<div>claims</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>claims</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 20, 2021 </div>
<div>claims </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrual for legal matters that are probable and estimable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 617,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 617,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 569,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,000,000<span></span>
</td>
<td class="nump">$ 245,000,000<span></span>
</td>
<td class="nump">167,000,000<span></span>
</td>
<td class="nump">$ 245,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 208,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation-related net charges (credits) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (298,000,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (302,000,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Loss Contingency, Damages Awarded, Value | &#8364;</a></td>
<td class="nump">&#8364; 245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Loss Contingency, Damages Paid, Value | &#8364;</a></td>
<td class="nump">&#8364; 620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter', window );">Product liability cases related to Greenfield Vena Cava Filter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter', window );">Product liability claims, not filed, related to Greenfield Vena Cava Filter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StateAGSettlementsMeshRelatedNumberOfStates', window );">State AG settlements, mesh related, number of states | units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada', window );">Product liability cases or claims related to mesh product - Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CertifiedclassactionsinCanadaMesh', window );">Certified class actions in Canada, Mesh</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom', window );">Product liability cases or claims related to mesh product - United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia', window );">Product liability cases or claims related to mesh product - Australia | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CertifiedClassActionsInAustraliaMesh', window );">Certified class actions in Australia, Mesh</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bsx_AssignedtoonejudgeinMAMember', window );">Assigned to one judge in MA [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct', window );">Total Product liability cases and claims settled related to Mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CertifiedClassActionsInAustraliaMesh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Certified class actions in Australia, Mesh</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CertifiedClassActionsInAustraliaMesh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CertifiedclassactionsinCanadaMesh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Certified class actions in Canada, Mesh</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CertifiedclassactionsinCanadaMesh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - Australia</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases related to Greenfield Vena Cava Filter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability claims, not filed, related to Greenfield Vena Cava Filter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims asserted related to mesh products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Productliabilitycasesorclaimsrelatedtomeshproduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - Canada</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - United Kingdom</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_StateAGSettlementsMeshRelatedNumberOfStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State AG settlements, mesh related, number of states</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_StateAGSettlementsMeshRelatedNumberOfStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Product liability cases and claims settled related to Mesh product</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bsx_AssignedtoonejudgeinMAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bsx_AssignedtoonejudgeinMAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357415007352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 23, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 27, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of Dividends | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred Stock, Liquidation Preference Per Share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred Stock, Liquidation Preference, Value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ConvertiblePreferredStockThresholdTradingDays', window );">Convertible Preferred Stock, Threshold Trading Days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareCashPaid', window );">Preferred Stock, Dividends, Per Share, Cash Paid | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare', window );">Convertible Preferred Stock, Shares Issued For Each Converted Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare', window );">Convertible Preferred Stock, Shares Issued For Each Converted Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.9197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareDeclared', window );">Preferred Stock, Dividends Per Share, Declared | $ / shares</a></td>
<td class="nump">$ 1.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Shares Issued For Each Converted Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ConvertiblePreferredStockThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ConvertiblePreferredStockThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357539258984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 14, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">1,421,300<span></span>
</td>
<td class="nump">1,410,900<span></span>
</td>
<td class="nump">1,420,000<span></span>
</td>
<td class="nump">1,404,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">11,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">1,432,500<span></span>
</td>
<td class="nump">1,410,900<span></span>
</td>
<td class="nump">1,431,700<span></span>
</td>
<td class="nump">1,404,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Payment Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357412801592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>business</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>business </div>
<div>reportablesegments</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NumberOfBusinesses', window );">Number Of Businesses | business</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | reportablesegments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 3,077<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="nump">$ 5,829<span></span>
</td>
<td class="nump">$ 4,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="num">(180)<span></span>
</td>
<td class="num">(197)<span></span>
</td>
<td class="num">(365)<span></span>
</td>
<td class="num">(398)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">262<span></span>
</td>
<td class="num">(71)<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(113)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
<td class="num">(234)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss)&#160;before income taxes</a></td>
<td class="nump">149<span></span>
</td>
<td class="num">(181)<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="num">(159)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">948<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="nump">1,808<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeAllocatedToReportableSegments', window );">Operating Income Allocated to Reportable Segments</a></td>
<td class="nump">$ 363<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 695<span></span>
</td>
<td class="nump">$ 432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SegmentOperatingIncomeasaPercentageofNetSales', window );">Segment Operating Income as a Percentage of Net Sales</a></td>
<td class="nump">38.30%<span></span>
</td>
<td class="nump">30.10%<span></span>
</td>
<td class="nump">38.50%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember', window );">Rhythm and Neuro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 866<span></span>
</td>
<td class="nump">$ 525<span></span>
</td>
<td class="nump">$ 1,617<span></span>
</td>
<td class="nump">$ 1,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeAllocatedToReportableSegments', window );">Operating Income Allocated to Reportable Segments</a></td>
<td class="nump">$ 168<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 316<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SegmentOperatingIncomeasaPercentageofNetSales', window );">Segment Operating Income as a Percentage of Net Sales</a></td>
<td class="nump">19.30%<span></span>
</td>
<td class="nump">6.10%<span></span>
</td>
<td class="nump">19.50%<span></span>
</td>
<td class="nump">10.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 1,263<span></span>
</td>
<td class="nump">$ 834<span></span>
</td>
<td class="nump">$ 2,392<span></span>
</td>
<td class="nump">$ 1,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeAllocatedToReportableSegments', window );">Operating Income Allocated to Reportable Segments</a></td>
<td class="nump">$ 418<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="nump">$ 756<span></span>
</td>
<td class="nump">$ 385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SegmentOperatingIncomeasaPercentageofNetSales', window );">Segment Operating Income as a Percentage of Net Sales</a></td>
<td class="nump">33.10%<span></span>
</td>
<td class="nump">22.30%<span></span>
</td>
<td class="nump">31.60%<span></span>
</td>
<td class="nump">20.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 3,077<span></span>
</td>
<td class="nump">$ 1,935<span></span>
</td>
<td class="nump">$ 5,816<span></span>
</td>
<td class="nump">$ 4,437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember', window );">Total allocated to reportable segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">949<span></span>
</td>
<td class="nump">391<span></span>
</td>
<td class="nump">1,767<span></span>
</td>
<td class="nump">947<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember', window );">Corporate expenses and currency exchange [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Operating Income Unallocated to Segment</a></td>
<td class="num">(176)<span></span>
</td>
<td class="num">(189)<span></span>
</td>
<td class="num">(329)<span></span>
</td>
<td class="num">(222)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember', window );">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Operating Income Unallocated to Segment</a></td>
<td class="num">$ (331)<span></span>
</td>
<td class="num">$ (125)<span></span>
</td>
<td class="num">$ (445)<span></span>
</td>
<td class="num">$ (327)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NumberOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Businesses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NumberOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeAllocatedToReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income Allocated to Reportable Segments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeAllocatedToReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeUnallocatedToSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income Unallocated to Segment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeUnallocatedToSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SegmentOperatingIncomeasaPercentageofNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Operating Income as a Percentage of Net Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SegmentOperatingIncomeasaPercentageofNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357410585416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EmergingMarketstotalnumberofcountries', window );">Emerging Markets total countries | units</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,077<span></span>
</td>
<td class="nump">$ 2,003<span></span>
</td>
<td class="nump">$ 5,829<span></span>
</td>
<td class="nump">$ 4,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Change in Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">3,386<span></span>
</td>
<td class="nump">2,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,277<span></span>
</td>
<td class="nump">885<span></span>
</td>
<td class="nump">2,443<span></span>
</td>
<td class="nump">1,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember', window );">Emerging Markets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="nump">542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">551<span></span>
</td>
<td class="nump">348<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">316<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="nump">445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology (Uro) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="nump">758<span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology (Uro) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">542<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology (Uro) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">351<span></span>
</td>
<td class="nump">993<span></span>
</td>
<td class="nump">788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="nump">463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">444<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">790<span></span>
</td>
<td class="nump">495<span></span>
</td>
<td class="nump">1,486<span></span>
</td>
<td class="nump">1,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">398<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">741<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="nump">745<span></span>
</td>
<td class="nump">642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">473<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="nump">732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="nump">319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">3,077<span></span>
</td>
<td class="nump">1,935<span></span>
</td>
<td class="nump">5,816<span></span>
</td>
<td class="nump">4,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">3,376<span></span>
</td>
<td class="nump">2,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | EMEA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">662<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
<td class="nump">968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | APAC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">520<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="nump">994<span></span>
</td>
<td class="nump">819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | Latin America and Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 95<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EmergingMarketstotalnumberofcountries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Emerging Markets total number of countries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EmergingMarketstotalnumberofcountries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_EmergingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140357411638056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="num">$ (92)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(144)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (47)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</a></td>
<td class="num">$ (127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=116690757&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e709-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 40<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116633155&amp;loc=d3e31531-110899<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>62
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%%9!G@\4D-"F!O/-A!_7$Y*."3^7^2GRO3XB'L&6X9?NX5=L#L-Q-=S;'SX
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M75 ;X*S(JO8G>NAL@Q&:K:JZ6'2#=02+-%__CK]U$[$U %/' -(-(/T!PC&
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M7EFW36Q9!W8XA'#<EW4@J$A2TI=UR!N585_6 3X&#E1SPT9^$!O]CU%@6><
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M(!5?L5UM?I=/O_#!H<*V5\I:=W_)TV";7)!RIXW<#C>#@JUH^O_LV] 11S=
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MMSA>X<%AA=],>LF;'X+<R:3W&<0#EAPWW <M#D&A,^X%Q^ZT7/V@/F"^)H5
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M75Y;?-IK5DEUK@JG32&LFKW;&@]?GQW0>![PLU;W+OI;D"938[[1AZOTW=:
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M- #O9P8L%#[0!LUWG]__/U!+ P04    " !UA 93'$JWLP0+  #&'   &0
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MI@VJ?I8E6I7HK&OJD= >Y0O?T+DN,^M3.\/CGX[76-\[99Z@WV\*\)$OD;E
MW3",ES$4IU,JC@W>[.7,!+:8;]HF6<:.;SJ2;5([8I!NGC("1#J14C/LM.1\
M>\[?K$%3C5F#.G76^R*&@XULHO9+T6A$'FU+1#S" XTM4U-E#='6P7-D"&%?
M=#3)["A?G?;?B-72_RQ;.X#=;/0^^^8-S)S-O+$;W4BV?;B9B%?]LY^<K\=#
MIO.JU^]O;M]#NU.K\T07D2^_[:BY E>Y;ZT=12!+14-F:"L]37. V5C!&2/9
MIC7";@-L3IB><@-0.V=N*Y,U6*U63;M!:'TT;=O6B5JO-/KGL[@D/)8,\P0
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M+_#I#Q^M><*D*VY6*N@2&3P(@K6TS)0 H$%#*S)3+(^\LGE4NI$$V@D@G8.
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M$E\4.H5&0<5RJTWIQ$2<B"]MQ-D7T\YT=(+_;SK]Z.JWC%Q>S@%4<@Y/B=2
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MMB,H,>H[I%GQZNYV*3 &F*,19M\ O>@%P()L>T&/"%3JUP/U"K 04'M?/0=
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M'/?(M%?YMN'TRE^?9]KA,NX_EU+@L,@"&)]K[38-GF#[?\K1'U!+ P04
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MQ@>PGUF\H#4/;*#[>'7Z/U!+ P04    " !UA 93GYX=I!D#  #B!@  &0
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M:W-H965T<R]S:&5E=#(T+GAM;)56P6[;.!#]E8%/NT#6=IRD6Q2. 3O9H+M
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M^/*(F16@6EQ(QW<OML-7,%I0UIV[ZP+-:. :J$AR/]<U+54+V:)&%K46-;+
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M9F"<28+4'K%WL]L+-KN]9'=J)2,V\4)@R\C[C),CS@@NJ$]4ZH/GD4CG0K/
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MP_W+O\YQX96&"; _U2A?S0<K6%^AS_X#4$L#!!0    ( '6$!E.#)3W(QP8
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MJ/_\\;B\_XKTBS!X][/ O89HL)=CV#7]AYG^C].M_QARK9W3M;_<2KS?&EZ
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M^%2]MR5'A7N4I5'VEEH_,WD4J>0(*[)##;T563/4EZ/(6&AG$*4MS+2!24[
M7,.3%*;0\" RS%[[1Y92QRO9\YHF9P&_5B*$0?P!DCCIG\$;='D./-[@!-[2
M=G-6,029PR%G6!"#L,!4BI0R2GRC/'^SOO!HD.N7,Y&'7>2ACSQ\1^2'/$??
MAO]QR)7D,+,UI**B8@/?2U2>CH9G_RJPPIV!*9/I]N6M]SE/8E4HQ%=O!+;"
MZ"N\I+L3-Z[V;HF/I$,*QG)7'??TP%T>N/>28?CQ$BZ@?QL.[=;K]\/$ZX/P
M!B[>*F]TU,P<U<:/K+;XE3!-7W>GW:]PWPS#P;SY4IZ(VE#+@F%N7>/PYBH
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MZA:.]EN$2YFI$J&W9"N!IC\=6(KI+ =9XW]1^X^?\3^"#TK:PL"/,L?\L?V
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MVHZS;0*6)[DDL042AGN9R;U@0F ._)X#7QL>>""X*=F_3&(\QM5<%PJ"ON=
MRV[?\P5=I$71LG@19W&14"@D!Y+U0> @V#8TY1EY:G0-Q];G*B[J+-Y(,!8
MK]=5LF0RJIVWY;IHVLL[G_^'J836'Z 0%6['VIMJ6'&%.YH!&5[A>?+/.JW8
M7 O757LUU[1*2SB=(YDLK)CQ"/,KP6;WBV5Q_<VZV/:T>P%HZGNB1YO!(@"F
MN?<\[R&BM6>CP"[+G"T3EJU^?V!YKDC*G%IO/K(L]/;8NHSKI16Q%8'U"YTO
M*$M/;/W0_WI'V6J#6C<TR>*Z3N_3I'.?8RN^;UC/G^,GD!LB>PG"0CB 0*[(
MGHQ!& D1 0#Y*D_@.1SID_AE67<1<565\W7" F%=9I C7FS[V;MS4N@#0%Z
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MR[N76XBG\ZK!.O(,Z$6Q_G2X9G7TFO43G=^NJX5)'G>XGG/0R'G<X6+',=S
M:+3AU %J<5-'42ARN%!Q]+6V47><.M!S8L45<KGCZ.7.2W:<.L8JPMG93Z]7
M$<_8;^I N^$<<7%LA(I@E.J^\RSOZ+/\S?)+L\R[&_T;75>ET;3A^= 9^QFC
MP[.'H\\>SYPV0 4"!8H-9PZ/S([99O%QIHWQ"M[ET= UW4EN/FM<>4&LW*?M
M\A#JFNT8-Y@W+K#Q"4G[2(U0$8!2WWB7!VU7'[0OF1^GY4-<)^LLKDQFC<MC
ML3OVHM'E4=0UBZ)FL\:5XZ?C!HJ'W"X/H:Y9"!UEUKC =F+%!>X<(])'Q1?-
M&N/UA,OCIZM?3SQGS@ %;3<0-V<9H2(8I;KM/&*[^HA]NZ))&F?-%^MZ&5=Y
MG-!UPP1I9K1WUN4QV1U[[ZS'PZEG&DYW#F%]A,\&1IX<1SW%HLGC8=0S#*,&
MG'D\G'E8R]DXIRT]'N(\4[FI/%GIR2(23SWIL(X9+ )@* BP(@]X/)YZIJIT
MXQ!TOG^D<MA-+CPYR)X$P51,=V:P"(8I_8[';$\?LZ\*Z[HJ$UK7;#59TYC%
MZ<Y'0OI LW*U5U;5N0B/P9[[+5QRYU#EP*G*\<Z.>L!!"O'!66@"BB"0HSH^
MR@.QIP_$GVFR+,JL7'PYN6#)%C+5Y%;RB.SI(_(XM]+G4=K71^D1;Z4/'"60
ME*@)*!H [9O*TX&O3P?CW$J?)PK_6R0*GR<*7Y\H7GPPWP<"/L*^F#[,8!$(
M4RZ_?9X^_,/>._"<T_D^$/E=VQ.W-9C!(A"F/)WF\SSBZ_/(-;.E,/1*GBO\
M;Y$K?)XK?'VN>+E7 J?E [$@9 ** )"C.AG@[YRJ'SA -Z8_ J5P(AMK@HH@
ME#U5)$*?)R;?I+#^HI 9\&P43+^!<P8\)03ZE/!BYPSD4@GRQ1.@H1$J@E">
MI]C0$_#T$^C++F/ZYW:HW8</)PA[XI+9#!;!,"G!3W;>TY33:M&]4:NVNF+'
MYN4X_;?]6[O.NW=5"=]?H/>7"/@^1.]GFW=R\>XWKPC[%%>+M*BMC-ZSH:;O
M6L%?;=ZZM?G0E*ON+5%W9=.4>??GDL9S6K4 ]OM]639?/[0#].\^._L_4$L#
M!!0    ( '6$!E.F-8&KNA4  "NP   9    >&PO=V]R:W-H965T<R]S:&5E
M=#0Q+GAM;,U=:W/;.++]*RS?N[<R57%,\,UL)E6V) \]%2>I)#/[86OK%BW1
M-N](HI>D\JC:'W]!BA) H=$-RK+B_;#CV(< N]% 'SQX\.9;4?Y5W6=9;7U?
MS)?5KR?W=?WP^NRLFMYGB[1Z53QD2_Z7VZ)<I#7_9WEW5CV463IK'UK,SQS;
M#LX6:;X\>?NF_=W'\NV;8E7/\V7VL;2JU6*1EC\NLGGQ[=<3=K+YQ:?\[KYN
M?G'V]LU#>I=]SNH_'CZ6_%]GVU)F^2);5GFQM,KL]M>3<_;Z=\?VFB=:R)]Y
M]JV2?K8:6VZ*XJ_F'U>S7T_LYI6R>3:MFS)2_I^OV2B;SYNB^(O\NROU9%MI
M\Z#\\Z;TR]9Z;LU-6F6C8OZ/?%;?_WH2G5BS[#9=S>M/Q;<DZRSRF_*FQ;QJ
M_]_ZUF'M$VNZJNIBT3W,WV"1+]?_3;]WGI >\$+- T[W@+/S@,,T#[C= ZYI
M#5[W@&=:@]\]X)O6$'0/!*8UA-T#X6X-CN:!J'L@,JTA[AZ(31]@]J;E[#:"
MUDW>QLLXK=.W;\KBFU4V>%Y>\T,;=.WS/$SR9=-!/M<E_VO.GZO?)MGL+E_>
M6>=-G.9UGE56NIQ9EVE>6G^F\U5F76=IM2HSWBGJRGHQSNHTGU>_6/_S7Y$;
M>'^W\J5UG<_G/-:K-V<U?Z.FW+-I5_O%NG9'4[MK71?+^KZR)LM9-@.>'^//
M!\CS9]P36W<X&W=<.&B!OZ^6KRS7?FDYML/^^#RV7OSW+[.LS+^F33?^WWQ9
MU>6J<<5JF=>0P2/S\NVN?,CL)W[+R4'>\G+ 6T[^^&2]Z&)FV+O^AM=RG9:\
M%M;S!5!*@I<RSJ;;4FS,HT#15^8OB#CS=^,79#%82B_>W6WW=]MB76VQ&QNM
MJZV-U4OK-YY:K1?OBHKW]'^^XP]95W6VJ/Z%5.EMJ_3:*CU-E><?1E<OK5%:
MW5N7/#U;S0B4\5^L%JOY^DVDRE]:Z6V=E=:7]#LTNJQK"MN:&BKP]2WS KO]
MWYNSKW*W5)&.XT#(L7&9$^,R?P/*#'P(F:A(%ZS\"JC<BR#D[T#EH;N#[+6D
MOVU)'VU)$3POK?=%0W?2N76^*%9@-[E8%Q;([\%<SP8;80 V@;$Q9F&PM3!
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M'ZM\UF;#YB_XR 'P$9A:C\VA"0!E.%%D@N<PG.CH6GB.F@G0CQC,;6-S: )
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MSZ&1@^GZYD5-CC;!6'C@A;#PP8 )!$7G18XD0>K8SX!,XGQ]\XK8YH\!9FR
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M'$" HWG]X0D'$ 5 ?:W/%9),'MB9W!2:05V $CG"ZOF0$XI"J#$V%'2!Y._
MSM]WRR4_B" /=Q;/A4JF#NQ,O6 ;D0WPKE(?()N)=/X,M%+!!40!4&@Z;P@D
M$P?VMOFWY)476=8D;)RU^6B6)D]IEE:&,CX ^N-J$WWF J( *!H97!Y*T@\O
M=K\;ES^P)Z&._5PPU.F3A.IN= %1"&0Z.0DE$X>7"FX1+$7!@";%[BG-F]Q0
M*%3D-3O7"9/X6*:KAJ[K7Q:=ZU[M6@/][5!-#UU % (90E H>3IT.*T&YZU3
M:N2KY8(+B$*@T#1Q2<ZAG9R/*V\A-Y#=#SK'XD!KD#BA*(3RQX:SUE 2=FAO
M7G?$!BCDEJN'O2?R[$PZ96LF!-?[]IGE!V:W',!]@1J#7$ 4 A%#6A!*%@WM
M+'J*0<5KDEU>!P#WA9HV#B *@@P]^5"2:'CA4#KYR4HDJ*([2;1H AP@:^UW
M%Q"%0*82()3,'5ZHL=-R7Y2"O"DO#ON!J.'K(K#.1\4ORR:LUF[K"J!^1+WH
M0YV>U<[V90@%(-@SG+"&DN1#.\FWF_CQD*_XJ[M"P -BD482#B *@(CI^;](
MTGQDIWES9 (?.M7I.1JI#G(!40 T-BW,2!)]Y#O$6=F!,.9@Y_(EIT9V3CT&
MI#1?%CN&JGI'@W;2B3$D:O_4!40A4&#RNJ38Z,*I<EFENR9+70CC;-IF62_K
ML1<L$4"2GK8*'$ 4 $6&ME@DR3:R5\>_D.U=T!MH9:M9K@.& A@_-B2YD63^
MZ$)'W- 4..Z!5U E@+>U1Q-=0!0 81-G1KVGY2_4T6H/S=U9.H>34-/, 40!
M4."9W"6S@<B>#:B)&J@#](2Y>F+A J(0*#2%$9D'1/8\H.MR0/GZ!>< 57BD
M11 '$ 5 D6^HYR-)]9$+U3OP2*>._AR;J!HT?5Q0%$(1K>,Y[+TUN&-\T[Q!
M6J+F@;7V7:O3U=-;JG?-NYG*]7O_X]0'KL_\C_/V'50IOGTE]FO"-VE>HHRM
MQ:V\#['8^+Q]R[3]4A7[YIW%IZ*JBEWS<<L2$6]K@/A]7135\4M]@].[OK?_
M!5!+ P04    " !UA 939XU2540#  "4"@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970T-"YX;6RE5EUOVC 4_2M6M$FMM)%/ JL B4^MDRHANFX/TQY,<D.L
M.3:S36GWZV<[(:4T3='6AQ([]YQSS\V-<P=[+G[)'$"AAX(R.71RI;97KBN3
M' HL.WP+3-_)N"BPTDNQ<>56 $XMJ*!NX'FQ6V#"G-' [BW%:,!WBA(&2X'D
MKBBP>)P Y?NAXSN'C179Y,ILN*/!%F_@%M3==BGTRJU94E( DX0S)" ;.F/_
M:M$W\3;@&X&]/+I&QLF:\U]F<9T.'<\D!!0291BP_KF'*5!JB'0:ORM.IY8T
MP./K _O">M=>UEC"E-/O)%7YT.D[*(4,[ZA:\?UGJ/QT#5_"J;3_T;Z,C4,'
M)3NI>%&!=08%8>4O?JCJ< 30/,V H ($IX#H%4!8 <)S%:(*$)VKT*T W7,!
M<06(;>W+8ME*S[#"HX'@>R1,M&8S%_9Q6;0N,&&FL6Z5T'>)QJG1-4MX >@K
M?@")+F:@,*'R$GU$=[<S=/'N$KU#A*$;0JGN SEPE=8T2#>I^"<E?_ *?XAN
M.%.Y1'.60MJ G[7CXQ:\J[W6AH.#X4G02OAEQSHH]#Z@P O\AGRFY\.])CO_
MIS[_/_5%.WP&B8;[3?!GM0SKY@DM7_@*WSS+P)X,Z*F-T HK0"M(.$L()=B<
M'Q_0$D0"3*$?X[540A\G/UODHUH^LO+1F_)*ZPJCFPE>("VM"-L1MD'Z !8V
MA<;6;:>_"*+.)^_]95.3M"/]?B?RWC=UQQN*OM\)FA7G;RB&G=ZIXK.:=NN:
M=EN)[IC0CV[#R!]([>.< (.,J,;ZE50]2V6^8/>CH*_[ZO[8\1DQBX:8V*]C
MGOF(:Q_QO_E *L<*?><[FJ+K8JM;$3WUT:%_F\R6>O%1DOZG[HG9,V(6\0NS
M?C]L-MNKS?9:S>KW6@\5$LQ1_;IQ(O5KB25G>$T?T9)+2=:TT6KOA8T@.G':
M&O+,1+\VT6\U\34'-!VOYK=HG*BFK/HONT2/3_KO)+6WX\K\W*.O9@%B8^<;
MJ4^/'5/E&5COUB/4V$X.)_L3_VKJ-^S/_*MY.2$]T9?SV@T6&\(DHI!I*:_3
MTV^ *&>@<J'XUGZSUUSI"<!>YGIL!&$"]/V,<W58&(%Z$!W]!5!+ P04
M" !UA 937.S\GS@%  !X%0  &0   'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6RU6&USVC@0_BL:KG/3S*0!"["A1YBA(2^]:^XR29/[T+D/PA:@JVQ1289V
MYG[\K63'!FRK-&GR@?A%N_OL:O4\DD<;(3^K):4:?8UYHDY;2ZU7;]MM%2YI
M3-2)6-$$WLR%C(F&6[EHJY6D)+)&,6_C3L=OQX0EK?'(/KN1XY%(-6<)O9%(
MI7%,Y+=WE(O-:<MK/3ZX98NE-@_:X]&*+.@=U?>K&PEW[<)+Q&*:*"82).G\
MM#7QWE[AOC&P(QX8W:BM:V12F0GQV=R\CTY;'8.(<AIJXX+ OS4]HYP;3X#C
M2^ZT5<0TAMO7C]XO;/*0S(PH>B;XWRS2R]/6H(4B.B<IU[=B<T7SA"S 4'!E
M?]$F&QOX+12F2HLX-P8$,4NR_^1K7H@M ^PU&.#< .\9='&#03<WZ!X:H9<;
M]/8-@@:#?F[0/S2"GQOXAT8(<H/@T B#W&!@9S>;#CN74Z+)>"3%!DDS&KR9
M"]L0UAJFD"6F=^^TA+<,[/3X3,0QT]",6B&21.A,))HE"YJ$C"KT>DHU85P=
MH5]_&73]WF^()>CC4J0*QJI16P,"XZ<=YM'>9=%P0[0_Q?H$>9UCA#M><'Y_
MBU[G?H]J?)VY??V>)B>H:WUA[_YNBEZ_.DH3IE7("8OKP$T/=]C)'=9X.?]Q
M6(V(+GX*HLOO>>$GX"%#E$%I]G7E]C6E(2#R'(C:T(!%%^*B"[%UVVUP^T$H
MM==ZGS[ &/1>TUC]XXC0+2)T;81>0X1)&,J4< 1LCSA=P!7PGJ92(;TD&A%)
MT4J*&9EQ:M<!59K%]NX_]*JN.;-P@0UG!&(]]KV@8_]&[?5VOQP\\JHZLN\/
M]T;N9-\KLN\YL[^%="0+-84%3M0R6^GFXOQ+RM:$V^4/2_LOO:02:$=*>(*(
M4A2>-Q0@B^AO@?7\VK2FO4I:N->O+=7!/B\.]GE5,[(S<!6U7Q2U[RSJ!Z;9
M@A@%?B,I)Z:X"6PVPB61"\.=H:01T-%14P'[%6!O\' ?65;!ZM#]RM4XZ\(2
MK2N=R]E.(?RB$+Z[$+NK]]LQFI*8F!I,-D1&-#I&#X2G9BGE=%^G'%F,X>Z,
MU@,+"F#!$X'=$'88JJ""RL<-Y1H4J 9.5#=21&FH$6=DQCC3WU (FR^%'IM(
M"W0I*4WFC/((/="$P%I=$W3!.!!672<-JLNF%^PUB'O,3B+#(I'ACR9BU>48
M)4*C.>-FYI^>U;""N(^]O:S<8W:R\CKEEJCCS.M. V(TN41 ?YI3NSDZ1C$%
MOLRS@0S3> 94*>9(F=&&)>WFHW8?TZF@[ T:0&[MVSPWR'2FZ)?4\/3YVOQ^
MNJ8&DDLLO5*/O9<29*]49,\MR4WK !0ZZZ/MWK'57V46M5N@;K43C" TE+D4
M3L^MG$\&B=Y ?R<D(K5H:X2N"6HI1YY;C\ZHU R65V20P?01>SJTNIXA.4;7
M + 63[^*IP%.*0J>6Q6>4[E[6$KPX@_HODC$M8C]"N*@02V\4BX\MUX\!_($
MSFJ2@&6#W%_FL7=JC)L@EUKBN<7$,>D%(L>\5U4!-R J1<%SJ\)$*;9(LAH)
M8(Q_TVA!#9[K2<%14*.G\!<N*1QW7HB_<,G V,W /Y6_\EC;,]'UFN@+;YVK
ML%LEK()%J-RK/GL.2G['W9>:@Y*>\0O1<^T<5%FYCQLU!)?$C-W$_%%H.&\V
M035GL1RKRF=K"_/U]S!7F;LWK!YMVEM?B,PWR6LXHS"@"4[G8-<Y"<"-S#[S
M93=:K.Q'HYG06L3V<DE)1*49 ._G0NC'&_,=JOC8.OX?4$L#!!0    ( '6$
M!E.#FW*'XP0  &45   9    >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;,U8
M46^C.!#^*U;4T^U*4< FA&:51MHF;;>GS2EJMGL/JWMPP"E6 :>V29K3_?BS
M@0))@-!*D:X/*>"9S_-YQO-A1EO&GX5/B 2O81")JXXOY?J+80C7)R$6/;8F
MD1I9,1YBJ6[YDR'6G& O<0H# YGFP @QC3KC4?)LSL<C%LN 1F3.@8C#$//=
M-0G8]JH#.V\/'NB3+_4#8SQ:XR>R(/)Q/>?JSLA1/!J22% 6 4Y65YVO\,L=
M&FB'Q.(G)5M1N@::RI*Q9WUS[UUU3!T1"8@K-016_S9D0H) (ZDX7C+03CZG
M=BQ?OZ'?)N05F2469,*"OZ@G_:O.90=X9(7C0#ZP[3>2$;(UGLL"D?R";69K
M=H ;"\G"S%E%$-(H_8]?LX4H.:!^C0/*'-"!@S6H<; R!^O0P:EQZ&<._0.'
M?AT'.W.P#SG &H=!YC X#*EN!B=S<))DI:N;I&:*)1Z/.-L"KJT5FKY(\IMX
MJXS02)?B0G(U2I6?'"\D<Y]]%GB$B]_!S4M,Y0Y\FA*):2 ^@PM@ .%C3@2@
M$7B,J!1=]5!=SV@0J%H2(T.J,#28X6937J=3HIHI_XB#'D!6%R 3P6*""J!)
M,] ,[P!R$ASS<3$%GRX^%W"UH--3T44]8)EI=.U1;]Z/ZN%="^#;]L!OBU"!
M<M>,,B6N0H$I2G-0ABJPO,I07F4HP;=J\"<!%@*P%4C*#?SZKL;!O22A^+L!
MW<K1K02]7X,^5]V+<$Z\%+X+%FG%?HVESSC]1PW\6U]DTQ1\D(#KSKT9VV;Z
M-S(VY12W-;QK8;A'M)\3[7^(Z+T0\0F2_:.0H!(K9!^1;&MXU\)PCZ2=D[0;
M2?ZI]'?-F4N()\"*LQ!010]'+M$%M,Z70"2EI#J1RZ(H$[8ME3Y8Q\N NLI8
M&=+H22W+1=6&3:-P2O$?,+P]MA@Z=C6Y04YNT)Q!O%,Z+I.],*4;ZI%(L:R)
M<' T/[H\"/'8I&;UG3Q IS' "0M#M9 ?VDC.444@TZS>2NU-[UJ9[G&]S+E>
MOH/K''/ N+K#4O'\B8.8@#GAZ1KH%#4IU32=R2XGHF?" ]9MC.Y.&.TQ'>9,
MAXU,[9YM_@9FD_E"Y53M"IU3\&M&PB7A31T8FL5KA'F&#@]+KRGP3*UODB&W
M[U2PD#6(_@^]:I*%T:H5P4(VX3MU\ZTC@0>U![JZ^EW5K-2)I/*%IQD\*;FF
MU!>B!]^I>M^I>DWU<+**Z2#1*]YZLTZR"9W]BMC?A],V1C<GC/89%PH(FR6P
M)>-NUJ6JBV8*C_5+U_TA@Q-6^Q0*G8/-0C=AT89P29<! 4=T?O@J,?K0 7YP
M[.FZG^*=ED'U2EQ9:H,*#:B)L! ZV*QTM=4OND4I=<$$"U]I _5.2D V'X3E
MI>Q9M?NTD"G8K%.-W5N%-:,1#>.P54,O% ,.S]#042$8R/QX@>PW]ULERS?8
M]4'FH^VT056I9+-"5*Z5GG5I]:NS@ H%0LT*=#(+^+5M%E#IW'2.@Q,J)  U
M=^ES9<&JRL(0#IV:+!1B@)K%X%06%O%2D)=8R1:XV>C?-NDH&C.RSY&.HFNB
M$\>#VIY4;DGJM!Y@3DYVI.MLMI,=R2A]/](?(&>8/]%(@("LE)_9<]2J\/2;
M7GHCV3KYI+1D4K(PN?0)]@C7!FI\Q9A\N]%?J?(OJ^/_ %!+ P04    " !U
MA 93F0:/=RP$  "0$0  &0   'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6S-
M6-MNVS@0_96!T05:P+5$W9P$C@'?@DVQ;HUXNWTH]H&1:(L;2?225)SNUY>4
M%/DB6C&V19$72Z1GS@P/CV9$#;:,/XB8$ E/:9*)ZTXLY>;*LD08DQ2+'MN0
M3/VS8CS%4@WYVA(;3G!4.*6)Y=AV8*689IWAH)A;\.& Y3*A&5EP$'F:8OYM
M3!*VO>Z@SO/$'5W'4D]8P\$&K\F2R,^;!5<CJT:):$HR05D&G*RN.R-T=8/Z
MVJ&P^(N2K=B[![V4>\8>]. VNN[8.B.2D%!J"*PNCV1"DD0CJ3S^K4 [=4SM
MN'__C'Y3+%XMYAX+,F')%QK)^+IST8&(K'">R#NV_9U4"_(U7L@24?S"MK*U
M.Q#F0K*T<E89I#0KK_BI(F+/0>&8'9S*P3EV\$XXN)6#>VX$KW+PSHW@5P[^
MN0Y!Y1 4W)=D%4Q/L<3# 6=;X-I:H>F;8KL*;T4PS;2REI*K?ZGRD\,O!?4D
M@M$CX4I*L(PQ)P(^Y5)(G$4T6\/;*9&8)N(=O(?/RRF\??,.1&E&,_@S9KE0
MEJ(+;_1X3I-$:48,+*GRTU&LL,IE7.;BG,C%A3G+9"Q@ED4D,OA/V_V#%G]+
M\5*3XSR3,W9: 3_D60]<NPN.[2!#/I/SW6W3<GXL^NS'HM^TNT])V /DF=P/
MN'1KH;D%GGL";Y1)&M$DUX4$EB3,.954*6CV%":YVBY8<9;"A*6;7.*BZ+ 5
MS##/E (%+ @OE0E?_U# <"M)*OYN2<NKT_**M+QS]?\Q3^]5,!6\^21T88P%
M#4W*+J,$111=S1^'R'.0:ROJ'O<58[)#]N6QW=2(9]O'=C.3G:T0=W8'M/@U
M+?[_HF6J=U!-&ZK$*/I'E2O5=*2)'[^9)W(:[#2MCGDQX?0;K+3A'/ 1U'P$
M/U,F%4TF(@+#AKF.WZ#"9&<2BA'/0(G)KD4H_9J8?BLQU>IOA<A)U*W(J*[O
M=<N/8(&_:57 B'.<K8F^[P)>246?>CE8$2IS3DQ4]9LI-QZ :=/(MT\MZJ)>
MU$7[HB0+'^".;'(>QFH-L.!LS7':A5$N8\;I?UH)*<N-6K\IP?NG\CY(Z;).
MZ?)EGML(_;311;.E(B)[]TI@OZ92C?;>55 K"3\IL>[IO1M7&>SKR6V(;F*P
M"IK2/,MJ]I+5(5?.CBNGE2N_Y]N_P7RR6*JGD7!-TPB^SHDN6ZV[L6OHZ%5U
M=+1KZ:B]I_\*F33[KN,9=-(TNS3HY"RPF<'L=*E#NTZ/VEO]"Y6E;4=VW1,%
MKTHJN^Z%VMO7KY!*LT,U9&+H=,VJ,WT9:69"\IHBL?8.C"GAZ^)H+R#4:RA?
MZ>O9^O/!J#@T'\V/T=4$&>:GZ&I6?AS8P9??*N:8KVDF("$K%<KN]94Z>7G\
M+P>2;8KCZCV3ZO!;W,8$1X1K _7_BC'Y/- !ZH\PP^]02P,$%     @ =80&
M4\B=1U%=!P  <"8  !D   !X;"]W;W)K<VAE971S+W-H965T-#@N>&ULS5K;
M;N,V$/T5PMT662")15*2I30)D-@NFF*S&\2;ML"B#[1,VT)U\9)4+D4_OI0L
MFS9%T6[7#?*2R/*9"V?(.:.QSI]R]B>?4RK <YID_*(S%V)QUNWR:$Y3PD_S
M!<WD-].<I43(CVS6Y0M&R:022I,N<AR_FY(XZUR>5_?NV.5Y7H@DSN@= [Q(
M4\)>KFF2/UUT8&=UXSZ>S45YHWMYOB S.J+B87''Y*?N6LLD3FG&XSP#C$XO
M.E?P;.AZI4"%^#6F3WSC&I1+&>?YG^6'F\E%QRD]H@F-1*F"R'^/M$^3I-0D
M_?A:*^VL;9:"F]<K[3]5BY>+&1-.^WGR6SP1\XM.T $3.B5%(N[SIY]IO:#*
MP2A/>/47/-58IP.B@HL\K86E!VF<+?^3YSH0&P(H;!% M0#2!6"+ *X%L";@
M]EH$W%K W=>"5PM42^\NUUX%;D $N3QG^1-@)5IJ*R^JZ%?2,EYQ5FZ4D6#R
MVUC*B<L1G<FT"W!/%SD3<38#1P,J2)SP]^ =B#-P&R>)S"@_[PIIKA3J1K7J
MZZ5JU*(:@]L\$W,.AMF$3@SR [N\;Y'ORF6NUXI6:[U&5H6_%-DIP,XQ0 Z"
M#Z,!.'KW?EQPB>*FY?7WU^;4VDR+_.\^L2HG9)Q0OLR2R<OAMWJY%4J\WC:X
M4HOWWC9?KL9<,'GN_["H=]?JW4J]VZ+^8Y&.*0.?IN"ZC@7EX&]@2=;U4J%?
M*2RKX^-E[[S[N)D(&V++2V_MI;>/E_D4J$R!5:JDNWOE;^ UW,)FM_RU6_Z_
MR\VQO'RD64'E_RC/HC@I$W8C: J^?)#"U26WY:VW-MVS1F1E9\KR%/3EZ2TW
MA*QH8@[Z52VC[!@,GZ.DF)0N7)5YY70"/I-G4TZ7QGJ;H7%Z6EK[39 D2:SE
MO@GR A1N@X9-D.NYOCD9P3HB@349ZXB3BA?E7OFTH(Q41^:.Y=-8@*,/.9?5
MMHK9:+5[1%[&C^=)/"%"1FBOXQ6NG0JM:;I*RXWQU](E^BR;#DY-\0\;6_,$
M!HX6?Q,HU,^> 81]3XN_"10&YOA#1Q&<8UVLBG><17('@J.DC+>1SYR&!\A'
MVGH-H),>U-9K /E8TS0T@'I>RW(W^!S:EROFLB;523T&&17&E4)#UB#6EVI$
M.?I:32BOIR_6@$+8;5DN4LM%UN7>;.;TA^^@[_PXIK)_IJML"_),S<T+:C@$
MW5"/0!,DCT CVTV4VW/U )A4>6%+ !010VP-P"V=C HF^?>6EFQD*P]0T2]T
M7YM"H&)5:*?5 Y,(;!)LZ 9ZGIL@K^?K:6Z"9#D,]#P;4-AS6O*L2!W:6?U5
MB00JPH=VQE=.U"?Q*DGRJ+(D+=^KOFC4W@)=0P/1^XUBU 3!GL[S!I ?ZCQC
M +D;Q7D[$HKH86"-Q.K,-")"."#@CK)(?BN?O<O4?:0"C$C24ICL=G!PBIWO
M3<\KNP2=4V@4'.RVZ!D%A[L$T:FC"VY'5W4LT-ZRW,]?Q#P%))O(X!4LWZ?>
M(=4C(.>UZQU2C(WLC'W@>E=;V]S=@:^5LKX!Y"'MG P,(.A#G=A-*(1:VC:D
MB!VAMU/OD*);9*?;@]2[VL9V8'5*,H#T#G)@PD!?3Y#!&H8M^5$M K(_HA^L
MW.VP \.V<K=#T&^K=KL-ME2[78+.:<]:[9!J@9"]!>H3-HGS1\*C(B%LKUJG
M&@GTZN,!I-H%]*H# F3H"5"C<S"@ NSJ1\DP1\"A_LAF,ACX+<T=4KT#>D-3
M J1(%]E)]S#%+FQV6[!1[)H@&5<]14U0SVM4NR8(!RU/U5@U"-@^1#A8M=MA
M!^.6JM7?(8A02YD<[+((3WUSN=ME<5>YPZH#PO8.Z'KTNVDW[5/WL&HHL+VA
M^!_J'MX8E]O;A@/7/6S@_>9DU(""(=:[/ /*"QI-A 'ENKAE@(Y5%X'MG/DY
M%R0!9+.LF&;I^VP$1:[8>SO%%BM>QOZAYI2UINV1ACZZ,H!PJ$^N#"#8\_46
MWVBO+?>J%\#V7F"TH%%,$O$"[N:$I22BA8@CDNR7;L6M^ UQ*U;<BO?EUMWI
M;@[&]2&\ :)OB($)HR>Z"6F;2+N*.UT[4?1S)D^TC.%J*LVKQ_BH8(QFT8N\
M&\U))KESC[2[BE-<^';2[BH6<NWSZD8#\9!M5;_:#^,OG*8!LCZD[!M1@;X7
M3"C<^$',A$*H95+F*C)T[61X(UNE;!:7%9Y(EA,@3A<D9A4[RZW 9I0? Q)]
M+6(>E\GK3N)'RD4L"D9/&$VJ6&52[JA&OP<1HY-82#$F@:R()%3&^*3::-NW
M=L@/'\#MX+[T**&E0\O=$^5<+'=M(CV:53?MFFR;9>-7</L8_G7WL")0U_YT
M^BU[V&NT$2<80WT/&U"P,9XRH5Q7'_8:+2*=O+H;;]#(7FQ6O;K$9=Z+3"S?
MBEC?7;\>=56]%*3=OX9G?6BX/X!GP^7+3TK]\EVL6[EQXHR#A$ZE*=E42X?9
M\O6FY0>1+ZKW=\:YD(UB=3FG9$)9"9#?3_-<K#Z4!M8OF5W^ U!+ P04
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M'$(AI/<\@"+$YYHN "C,7:^#(N4)B%C/\G-2R"RI>[.4Z.^W<OLH,VL'*A=
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M\WV8,ZJ<@]J=X]><#5!3JN2<3AS04"7<=$1 0X%0!>D< B#LZMX(@)@^L0T
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M,G3"9.7,PR1<A?WX;6WW<J?>[^6V-GRY8W9\N>8N6F.E"00RK@TA4*G<!KL
MBNIB.VL]%:#:RE4_OR$_;(L^[.(^?GI\2,1U_60$[?,;]'&.@,\7Z&-P> *$
MJO[P1(K;L-HYECNQ?"J;<C]4D51V>,;#X4V1[NIG$CRF19%NZY<;&:YD5@'*
M[Y_2M'A]4S5P?-3&U?\!4$L#!!0    ( '6$!E,20!B$]04  )P>   9
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MDH"*#*#^7W(N7VZR]VC;%]+COP%02P,$%     @ =80&4_)(7N%# P  \!,
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M@J"G\D%3")J6#Y(QRC@F2+K!FD!K0:Z%P&M!L(5 ;$&RA<!L0;2%0&U!MH7
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M;%!+ 0(4 Q0    ( '6$!E-&4&IM[@   "L"   1              "  :\
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M2P$"% ,4    " !UA 93 ;AG9VP#  "9"P  &               @(&(%0
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ =80&4SD ZC]C
M!@  CAD  !@              ("!*AD  'AL+W=O<FMS:&5E=',O<VAE970T
M+GAM;%!+ 0(4 Q0    ( '6$!E.E;^K*P0(  -X(   8              "
M@<,?  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " !UA 93
MJ8]>$%T)  !V.P  &               @(&Z(@  >&PO=V]R:W-H965T<R]S
M:&5E=#8N>&UL4$L! A0#%     @ =80&4^%+;D,>"0  Y2@  !@
M     ("!32P  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (
M '6$!E/CH_KVP (  #4(   8              " @:$U  !X;"]W;W)K<VAE
M971S+W-H965T."YX;6Q02P$"% ,4    " !UA 932)W)/9P%  #J#   &
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M970Q,RYX;6Q02P$"% ,4    " !UA 93H)K+D6\)  "^%@  &0
M    @(&S@P  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (
M '6$!E,JV_,VG00  .H*   9              " @5F-  !X;"]W;W)K<VAE
M971S+W-H965T,34N>&UL4$L! A0#%     @ =80&4\MD5%^G'0  LE,  !D
M             ("!+9(  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"
M% ,4    " !UA 93O:-AC7((  !N%   &0              @($+L   >&PO
M=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( '6$!E,HO^KQG 4
M .L-   9              " @;2X  !X;"]W;W)K<VAE971S+W-H965T,3@N
M>&UL4$L! A0#%     @ =80&4PSO/@JA!@  6Q$  !D              ("!
MA[X  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " !UA 93
MTAQ$2SD+  "/&@  &0              @(%?Q0  >&PO=V]R:W-H965T<R]S
M:&5E=#(P+GAM;%!+ 0(4 Q0    ( '6$!E-::/T^% 4  #40   9
M      " @<_0  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%
M  @ =80&4]D(SU"5!P  R!(  !D              ("!&M8  'AL+W=O<FMS
M:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !UA 93GYX=I!D#  #B!@
M&0              @('FW0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+
M 0(4 Q0    ( '6$!E/ ='=M>@0  *X*   9              " @3;A  !X
M;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ =80&4QC8MNT
M P  <P8  !D              ("!Y^4  'AL+W=O<FMS:&5E=',O<VAE970R
M-2YX;6Q02P$"% ,4    " !UA 93%7U;UK(&  !Z$@  &0
M@($>Z0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( '6$
M!E/Z7])__08  +D3   9              " @0?P  !X;"]W;W)K<VAE971S
M+W-H965T,C<N>&UL4$L! A0#%     @ =80&4[T<6&7;!   K L  !D
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M=#,R+GAM;%!+ 0(4 Q0    ( '6$!E/=(D)<.00  &,*   9
M  " @:P8 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @
M=80&4_0'TYPJ!0  J L  !D              ("!'!T! 'AL+W=O<FMS:&5E
M=',O<VAE970S-"YX;6Q02P$"% ,4    " !UA 93&Y$=J%L%  #)"P  &0
M            @(%](@$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4
M Q0    ( '6$!E.98>O)900  $\.   9              " @0\H 0!X;"]W
M;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ =80&4V?*'>KC!P
MURP  !D              ("!JRP! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6Q02P$"% ,4    " !UA 936G59A,H%  "P(@  &0              @('%
M- $ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( '6$!E/?
MB4(?0P,  ' *   9              " @<8Z 0!X;"]W;W)K<VAE971S+W-H
M965T,SDN>&UL4$L! A0#%     @ =80&4RX:<7)*"P  !TT  !D
M     ("!0#X! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4
M" !UA 93IC6!J[H5   KL   &0              @('!20$ >&PO=V]R:W-H
M965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( '6$!E-'PT93C0L  ,=+   9
M              " @;)? 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L!
M A0#%     @ =80&4[\_W$#K"@  ]SL  !D              ("!=FL! 'AL
M+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " !UA 939XU2540#
M  "4"@  &0              @(&8=@$ >&PO=V]R:W-H965T<R]S:&5E=#0T
M+GAM;%!+ 0(4 Q0    ( '6$!E-<[/R?. 4  '@5   9              "
M@1-Z 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ =80&
M4X.;<H?C!   914  !D              ("!@G\! 'AL+W=O<FMS:&5E=',O
M<VAE970T-BYX;6Q02P$"% ,4    " !UA 93F0:/=RP$  "0$0  &0
M        @(&<A $ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0
M   ( '6$!E/(G4=170<  ' F   9              " @?^( 0!X;"]W;W)K
M<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ =80&4V^ 5DCE"0  =D,
M !D              ("!DY ! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q0
M2P$"% ,4    " !UA 93$D 8A/4%  "<'@  &0              @(&OF@$
M>&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( '6$!E/R2%[A
M0P,  / 3   -              "  =N@ 0!X;"]S='EL97,N>&UL4$L! A0#
M%     @ =80&4Y>*NQS     $P(   L              ( !2:0! %]R96QS
M+RYR96QS4$L! A0#%     @ =80&4]YF=YA !   ?2$   \
M ( !,J4! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( '6$!E,X@V\FQ $
M  T>   :              "  9^I 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( '6$!E. A/B=P $    >   3              "
M 9NK 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     Z #H S0\  (RM 0
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>443</ContextCount>
  <ElementCount>454</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>112</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CoverDocument</Role>
      <ShortName>Cover Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Consolidated Statements of Cash Flows (Supplemental Disclosure)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure</Role>
      <ShortName>Consolidated Statements of Cash Flows (Supplemental Disclosure)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Acquisitions and Strategic Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments</Role>
      <ShortName>Acquisitions and Strategic Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - Hedging Activities and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</Role>
      <ShortName>Hedging Activities and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Contractual Obligations and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</Role>
      <ShortName>Contractual Obligations and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2118106 - Disclosure - Supplemental Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</Role>
      <ShortName>Supplemental Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2121107 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2124108 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2127109 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2129110 - Disclosure - Weighted Average Shares Outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</Role>
      <ShortName>Weighted Average Shares Outstanding</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2132111 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2135112 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2138113 - Disclosure - Changes in Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</Role>
      <ShortName>Changes in Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2142114 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2212202 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies</Role>
      <ShortName>Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2225203 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies</Role>
      <ShortName>Commitments and Contingencies Commitments and Contingencies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2243205 - Disclosure - New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Acquisitions and Strategic Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables</Role>
      <ShortName>Acquisitions and Strategic Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables</Role>
      <ShortName>Goodwill and Other Intangible Assets Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables</Role>
      <ShortName>Hedging Activities and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2316304 - Disclosure - Contractual Obligations and Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</Role>
      <ShortName>Contractual Obligations and Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2319305 - Disclosure - Supplemental Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</Role>
      <ShortName>Supplemental Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2322306 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2330307 - Disclosure - Weighted Average Shares Outstanding (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</Role>
      <ShortName>Weighted Average Shares Outstanding (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2333308 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReporting</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2336309 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/Revenue</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2340310 - Disclosure - Changes in Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</Role>
      <ShortName>Changes in Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsDetails</Role>
      <ShortName>Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContingentConsiderationDetails</Role>
      <ShortName>Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Strategic Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StrategicInvestmentsDetails</Role>
      <ShortName>Strategic Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Goodwill and Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2414405 - Disclosure - Hedging Activities and Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails</Role>
      <ShortName>Hedging Activities and Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2417406 - Disclosure - Contractual Obligations and Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails</Role>
      <ShortName>Contractual Obligations and Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2420407 - Disclosure - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2423408 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2426409 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2428410 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/StockholdersEquity</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2431411 - Disclosure - Weighted Average Shares Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails</Role>
      <ShortName>Weighted Average Shares Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2434412 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReportingTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2437413 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/RevenueTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="bsx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2441414 - Disclosure - Changes in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Changes in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bsx-20210630.htm">bsx-20210630.htm</File>
    <File>bsx-20210630.xsd</File>
    <File>bsx-20210630_cal.xml</File>
    <File>bsx-20210630_def.xml</File>
    <File>bsx-20210630_lab.xml</File>
    <File>bsx-20210630_pre.xml</File>
    <File>exhibit311-ceo302q22021.htm</File>
    <File>exhibit312-cfo302q22021.htm</File>
    <File>exhibit321-ceo906q22021.htm</File>
    <File>exhibit322-cfo906q22021.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>67
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bsx-20210630.htm": {
   "axisCustom": 1,
   "axisStandard": 29,
   "contextCount": 443,
   "dts": {
    "calculationLink": {
     "local": [
      "bsx-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bsx-20210630_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "bsx-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20210630.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 661,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 5
   },
   "keyCustom": 60,
   "keyStandard": 394,
   "memberCustom": 58,
   "memberStandard": 49,
   "nsprefix": "bsx",
   "nsuri": "http://www.bostonscientific.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Document",
     "role": "http://www.bostonscientific.com/role/CoverDocument",
     "shortName": "Cover Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Acquisitions and Strategic Investments",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments",
     "shortName": "Acquisitions and Strategic Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - Hedging Activities and Fair Value Measurements",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
     "shortName": "Hedging Activities and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Contractual Obligations and Commitments",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitments",
     "shortName": "Contractual Obligations and Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118106 - Disclosure - Supplemental Balance Sheet Information",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation",
     "shortName": "Supplemental Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121107 - Disclosure - Income Taxes",
     "role": "http://www.bostonscientific.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124108 - Disclosure - Commitments and Contingencies",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127109 - Disclosure - Stockholders' Equity",
     "role": "http://www.bostonscientific.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129110 - Disclosure - Weighted Average Shares Outstanding",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding",
     "shortName": "Weighted Average Shares Outstanding",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132111 - Disclosure - Segment Reporting",
     "role": "http://www.bostonscientific.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i1270609d6b744578a62058c51995ce33_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Statements of Operations (Unaudited)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i1270609d6b744578a62058c51995ce33_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135112 - Disclosure - Revenue",
     "role": "http://www.bostonscientific.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138113 - Disclosure - Changes in Other Comprehensive Income",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome",
     "shortName": "Changes in Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:NewAccountingPronouncementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142114 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:NewAccountingPronouncementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation Basis of Presentation (Policies)",
     "role": "http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies",
     "shortName": "Basis of Presentation Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2212202 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)",
     "role": "http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies",
     "shortName": "Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalCostsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2225203 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies",
     "shortName": "Commitments and Contingencies Commitments and Contingencies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalCostsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "bsx:NewAccountingPronouncementsPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2243205 - Disclosure - New Accounting Pronouncements (Policies)",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies",
     "shortName": "New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "bsx:NewAccountingPronouncementsPolicyTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Acquisitions and Strategic Investments (Tables)",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
     "shortName": "Acquisitions and Strategic Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables",
     "shortName": "Goodwill and Other Intangible Assets Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables",
     "shortName": "Hedging Activities and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i1270609d6b744578a62058c51995ce33_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i1270609d6b744578a62058c51995ce33_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316304 - Disclosure - Contractual Obligations and Commitments (Tables)",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables",
     "shortName": "Contractual Obligations and Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319305 - Disclosure - Supplemental Balance Sheet Information (Tables)",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables",
     "shortName": "Supplemental Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322306 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330307 - Disclosure - Weighted Average Shares Outstanding (Tables)",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables",
     "shortName": "Weighted Average Shares Outstanding (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333308 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.bostonscientific.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336309 - Disclosure - Revenue (Tables)",
     "role": "http://www.bostonscientific.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340310 - Disclosure - Changes in Other Comprehensive Income (Tables)",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables",
     "shortName": "Changes in Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Acquisitions (Details)",
     "role": "http://www.bostonscientific.com/role/AcquisitionsDetails",
     "shortName": "Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i40d4bbc844644023a5878306b022201d_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Contingent Consideration (Details)",
     "role": "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
     "shortName": "Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bsx:PaymentOfContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Strategic Investments (Details)",
     "role": "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
     "shortName": "Strategic Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i40d4bbc844644023a5878306b022201d_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
     "shortName": "Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Goodwill and Other Intangible Assets (Details)",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i40d4bbc844644023a5878306b022201d_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414405 - Disclosure - Hedging Activities and Fair Value Measurements (Details)",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
     "shortName": "Hedging Activities and Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i40d4bbc844644023a5878306b022201d_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417406 - Disclosure - Contractual Obligations and Commitments (Details)",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
     "shortName": "Contractual Obligations and Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420407 - Disclosure - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails",
     "shortName": "Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i40d4bbc844644023a5878306b022201d_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i1270609d6b744578a62058c51995ce33_D20210401-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423408 - Disclosure - Income Taxes (Details)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i1270609d6b744578a62058c51995ce33_D20210401-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426409 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i40d4bbc844644023a5878306b022201d_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428410 - Disclosure - Stockholders' Equity (Details)",
     "role": "http://www.bostonscientific.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "ia6bc3d74e781494aa5f8d841b5dd5783_I20200527",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i1270609d6b744578a62058c51995ce33_D20210401-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431411 - Disclosure - Weighted Average Shares Outstanding (Details)",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails",
     "shortName": "Weighted Average Shares Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i1270609d6b744578a62058c51995ce33_D20210401-20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "bsx:NumberOfBusinesses",
      "reportCount": 1,
      "unitRef": "business",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434412 - Disclosure - Segment Reporting (Details)",
     "role": "http://www.bostonscientific.com/role/SegmentReportingDetails",
     "shortName": "Segment Reporting (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegments",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "bsx:EmergingMarketstotalnumberofcountries",
      "reportCount": 1,
      "unitRef": "units",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437413 - Disclosure - Revenue (Details)",
     "role": "http://www.bostonscientific.com/role/RevenueDetails",
     "shortName": "Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i40d4bbc844644023a5878306b022201d_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i1270609d6b744578a62058c51995ce33_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441414 - Disclosure - Changes in Other Comprehensive Income (Details)",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
     "shortName": "Changes in Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i1270609d6b744578a62058c51995ce33_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i79e7f5e22b45494cb5031e20d21c5988_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
     "shortName": "Consolidated Statements of Stockholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "ibee203a2a57249aaa21381f631fdf46e_D20200101-20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "iae02e9cc78ca4c7aa533a4609d180b55_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Consolidated Statements of Cash Flows (Supplemental Disclosure)",
     "role": "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
     "shortName": "Consolidated Statements of Cash Flows (Supplemental Disclosure)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://www.bostonscientific.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20210630.htm",
      "contextRef": "i4cc580a493d24ee1af41820f69ad4df0_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 112,
   "tag": {
    "bsx_A550MCPSSeriesAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.50% MCPS, Series A",
        "label": "5.50% MCPS, Series A [Member]",
        "terseLabel": "5.50% MCPS, Series A [Member]"
       }
      }
     },
     "localname": "A550MCPSSeriesAMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]",
        "label": "ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]"
       }
      }
     },
     "localname": "ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity\u2019s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity\u2019s Own Equity",
        "label": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity\u2019s Own Equity (Subtopic 815-40) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity\u2019s Own Equity (Subtopic 815-40)"
       }
      }
     },
     "localname": "ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2020-10 Codification Improvements",
        "label": "ASC Update No. 2020-10 Codification Improvements [Policy Text Block]",
        "terseLabel": "ASC Update No. 2020-10 Codification Improvements"
       }
      }
     },
     "localname": "ASCUpdateNo202010CodificationImprovementsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments",
        "label": "ASC Update No. 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments [Text Block]",
        "terseLabel": "ASC Update No. 2020-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments"
       }
      }
     },
     "localname": "ASCUpdateNo202105LeasesTopic842LessorsCertainLeasesWithVariableLeasePaymentsTextBlock",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_AccruedRebatesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Rebates, Current",
        "label": "Accrued Rebates, Current",
        "terseLabel": "Accrued Rebates, Current"
       }
      }
     },
     "localname": "AccruedRebatesCurrent",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ActualCovenantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actual Covenant.",
        "label": "Actual, Covenant [Member]",
        "terseLabel": "Actual, Covenant [Member]"
       }
      }
     },
     "localname": "ActualCovenantMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AssignedtoonejudgeinMAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assigned to one judge in MA [Member]",
        "label": "Assigned to one judge in MA [Member]",
        "terseLabel": "Assigned to one judge in MA [Member]"
       }
      }
     },
     "localname": "AssignedtoonejudgeinMAMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BSXReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BSX Reportable Segments [Member]",
        "label": "BSX Reportable Segments [Member]",
        "terseLabel": "BSX Reportable Segments [Member]"
       }
      }
     },
     "localname": "BSXReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Additional Revenue Payments, Period",
        "label": "Business Combination, Consideration Transferred, Additional Revenue Payments, Period",
        "terseLabel": "Business Combination, Consideration Transferred, Additional Revenue Payments, Period"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredAdditionalRevenuePaymentsPeriod",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High, Including Prior Interest"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHighIncludingPriorInterest",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CardiovascularMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiovascular [Member]",
        "label": "Cardiovascular [Member]",
        "terseLabel": "Cardiovascular [Member]"
       }
      }
     },
     "localname": "CardiovascularMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]",
        "verboseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_CashFlowImpactOfDeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash flow impact of deferred income tax expense (benefit)",
        "label": "Cash flow impact of deferred income tax expense (benefit)",
        "terseLabel": "Deferred and prepaid income taxes"
       }
      }
     },
     "localname": "CashFlowImpactOfDeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CertifiedClassActionsInAustraliaMesh": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certified class actions in Australia, Mesh",
        "label": "Certified class actions in Australia, Mesh",
        "terseLabel": "Certified class actions in Australia, Mesh"
       }
      }
     },
     "localname": "CertifiedClassActionsInAustraliaMesh",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_CertifiedclassactionsinCanadaMesh": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certified class actions in Canada, Mesh",
        "label": "Certified class actions in Canada, Mesh",
        "terseLabel": "Certified class actions in Canada, Mesh"
       }
      }
     },
     "localname": "CertifiedclassactionsinCanadaMesh",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]",
        "label": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]",
        "terseLabel": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]"
       }
      }
     },
     "localname": "CondensedConsolidatedBalanceSheetParentheticalAbstract",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]",
        "label": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]",
        "terseLabel": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bsx_ContingentConsiderationLiabilityProbabilityOfPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration liability, probability of payment",
        "label": "contingent consideration liability, probability of payment",
        "terseLabel": "contingent consideration liability, probability of payment"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityProbabilityOfPayment",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_ConvertiblePreferredStockSharesIssuedForEachConvertedShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Shares Issued For Each Converted Share",
        "label": "Convertible Preferred Stock, Shares Issued For Each Converted Share",
        "terseLabel": "Convertible Preferred Stock, Shares Issued For Each Converted Share"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedForEachConvertedShare",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bsx_ConvertiblePreferredStockThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Threshold Trading Days",
        "label": "Convertible Preferred Stock, Threshold Trading Days",
        "terseLabel": "Convertible Preferred Stock, Threshold Trading Days"
       }
      }
     },
     "localname": "ConvertiblePreferredStockThresholdTradingDays",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_CorporateExpensesincludinghedgingactivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Expenses including hedging activities [Member]",
        "label": "Corporate Expenses including hedging activities [Member]",
        "verboseLabel": "Corporate expenses and currency exchange [Member]"
       }
      }
     },
     "localname": "CorporateExpensesincludinghedgingactivitiesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CovenantAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Axis]",
        "terseLabel": "Covenant [Axis]"
       }
      }
     },
     "localname": "CovenantAxis",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_CovenantDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Domain]",
        "terseLabel": "Covenant [Domain]"
       }
      }
     },
     "localname": "CovenantDomain",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CurrentRequirementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Requirement.",
        "label": "Current Requirement [Member]",
        "terseLabel": "Current Requirement [Member]"
       }
      }
     },
     "localname": "CurrentRequirementMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DebtInstrumentExtensionOptionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Extension Option, Term",
        "label": "Debt Instrument, Extension Option, Term",
        "terseLabel": "Debt Instrument, Extension Option, Term"
       }
      }
     },
     "localname": "DebtInstrumentExtensionOptionTerm",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_DebtInstrumentHigherLeverageRatiosQualificationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Higher Leverage Ratios Qualification, Period",
        "label": "Debt Instrument, Higher Leverage Ratios Qualification, Period",
        "terseLabel": "Debt Instrument, Higher Leverage Ratios Qualification, Period"
       }
      }
     },
     "localname": "DebtInstrumentHigherLeverageRatiosQualificationPeriod",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bsx_December2027NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 2027 Notes [Member]",
        "label": "December 2027 Notes [Member]",
        "terseLabel": "December 2027 Notes [Member]"
       }
      }
     },
     "localname": "December2027NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "label": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "label": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DiscountRateFairValueInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount Rate, Fair Value Input",
        "label": "Discount Rate, Fair Value Input",
        "terseLabel": "Discount Rate, Fair Value Input"
       }
      }
     },
     "localname": "DiscountRateFairValueInput",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_DivestitureAgreementTransferOfFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture, agreement, transfer of facilities",
        "label": "Divestiture, agreement, transfer of facilities",
        "terseLabel": "Transfer of facilities"
       }
      }
     },
     "localname": "DivestitureAgreementTransferOfFacilities",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_DivestitureAgreementTransferOfGlobalEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture, agreement, transfer of global employees",
        "label": "Divestiture, agreement, transfer of global employees",
        "terseLabel": "Divestiture, agreement, transfer of global employees"
       }
      }
     },
     "localname": "DivestitureAgreementTransferOfGlobalEmployees",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_EmergingMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets [Member]",
        "label": "Emerging Markets [Member]",
        "terseLabel": "Emerging Markets [Member]"
       }
      }
     },
     "localname": "EmergingMarketsMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EmergingMarketstotalnumberofcountries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets total number of countries",
        "label": "Emerging Markets total number of countries",
        "terseLabel": "Emerging Markets total countries"
       }
      }
     },
     "localname": "EmergingMarketstotalnumberofcountries",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_EntityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity [Abstract]",
        "label": "Entity [Abstract]",
        "terseLabel": "Entity [Abstract]"
       }
      }
     },
     "localname": "EntityAbstract",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bsx_EquipmentFurnitureAndFixturesGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment, furniture and fixtures Gross.",
        "label": "Equipment, furniture and fixtures Gross",
        "terseLabel": "Equipment, furniture and fixtures"
       }
      }
     },
     "localname": "EquipmentFurnitureAndFixturesGross",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_EuroDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Factoring Arrangements [Member]",
        "label": "Euro Denominated Factoring Arrangements [Member]",
        "terseLabel": "Euro Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "EuroDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EurodenominatedoutstandingdebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro-denominated outstanding debt [Member]",
        "label": "Euro-denominated outstanding debt [Member]",
        "terseLabel": "Euro-denominated outstanding debt [Member]"
       }
      }
     },
     "localname": "EurodenominatedoutstandingdebtMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ExclusionFromEbitdaForRestructuringCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusion from EBITDA for Restructuring Charges",
        "label": "Exclusion from EBITDA for Restructuring Charges",
        "terseLabel": "Exclusion from EBITDA for Restructuring Charges"
       }
      }
     },
     "localname": "ExclusionFromEbitdaForRestructuringCharges",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_FarapulseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Farapulse",
        "label": "Farapulse [Member]",
        "terseLabel": "Farapulse"
       }
      }
     },
     "localname": "FarapulseMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ForeigncurrencydenominatedindebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "foreign currency denominated in debt [Member]",
        "label": "foreign currency denominated in debt [Member]",
        "terseLabel": "foreign currency denominated in debt [Member]"
       }
      }
     },
     "localname": "ForeigncurrencydenominatedindebtMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ForwardCurrencyContractsTimetoMaturity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Currency Contracts, Time to Maturity in Months",
        "label": "Forward Currency Contracts, Time to Maturity",
        "terseLabel": "Forward Currency Contracts, Time to Maturity"
       }
      }
     },
     "localname": "ForwardCurrencyContractsTimetoMaturity",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_GlobalCrmReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global CRM Reporting Unit [Member]",
        "label": "Global CRM Reporting Unit [Member]",
        "terseLabel": "Global CRM Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalCrmReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalElectrophysiologyEpReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Electrophysiology (EP) Reporting Unit [Member]",
        "label": "Global Electrophysiology (EP) Reporting Unit [Member]",
        "terseLabel": "Global Electrophysiology (EP) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalElectrophysiologyEpReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalEndoscopyEndoReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "label": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "terseLabel": "Global Endoscopy (Endo) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalEndoscopyEndoReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalInterventionalCardiologyIcReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Interventional Cardiology (IC) Reporting Unit [Member]",
        "label": "Global Interventional Cardiology (IC) Reporting Unit [Member]",
        "terseLabel": "Global Interventional Cardiology (IC) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalInterventionalCardiologyIcReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalNeuromodulationNmReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "label": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "terseLabel": "Global Neuromodulation (NM) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalNeuromodulationNmReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalPeripheralInterventionsPiReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "label": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "terseLabel": "Global Peripheral Interventions (PI) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalPeripheralInterventionsPiReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalUrologyandPelvicHealthReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "label": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "terseLabel": "Global Urology (Uro) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalUrologyandPelvicHealthReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_IntangibleAssetsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets [Axis]",
        "label": "Intangible Assets [Axis]",
        "terseLabel": "Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IntangibleAssetsAxis",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_IntangibleAssetsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Intangible Assets [Axis]",
        "label": "Intangible Assets [Domain]",
        "terseLabel": "Intangible Assets [Domain]"
       }
      }
     },
     "localname": "IntangibleAssetsDomain",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_IntangibleAssetsandGoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Intangible Assets and Goodwill [Table]",
        "label": "Intangible Assets and Goodwill [Line Items]",
        "terseLabel": "Intangible Assets and Goodwill [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsandGoodwillLineItems",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_InventoryStepUpAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory step up amortization",
        "label": "Inventory step up amortization",
        "terseLabel": "Inventory step-up amortization"
       }
      }
     },
     "localname": "InventoryStepUpAmortization",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_January2040NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2040 Notes [Member]",
        "label": "January 2040 Notes [Member]",
        "terseLabel": "January 2040 Notes [Member]"
       }
      }
     },
     "localname": "January2040NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2025 Notes",
        "label": "June 2025 Notes [Member]",
        "terseLabel": "June 2025 Notes [Member]"
       }
      }
     },
     "localname": "June2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2030NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2030 Notes",
        "label": "June 2030 Notes [Member]",
        "terseLabel": "June 2030 Notes [Member]"
       }
      }
     },
     "localname": "June2030NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LatinAmericaandCanadaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America and Canada [Member]",
        "label": "Latin America and Canada [Member]",
        "terseLabel": "Latin America and Canada [Member]"
       }
      }
     },
     "localname": "LatinAmericaandCanadaMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "label": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "terseLabel": "Legal payments remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Arrangements, Asset, Percentage Of Future Royalty Payments",
        "label": "Licensing Arrangements, Asset, Percentage Of Future Royalty Payments",
        "terseLabel": "Licensing Arrangements, Asset, Percentage Of Future Royalty Payments"
       }
      }
     },
     "localname": "LicensingArrangementsAssetPercentageOfFutureRoyaltyPayments",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Arrangements, Asset, Percentage Of Future Royalty Payments Sold",
        "label": "Licensing Arrangements, Asset, Percentage Of Future Royalty Payments Sold",
        "terseLabel": "Licensing Arrangements, Asset, Percentage Of Future Royalty Payments Sold"
       }
      }
     },
     "localname": "LicensingArrangementsAssetPercentageOfFutureRoyaltyPaymentsSold",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_LicensingarrangementassetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangement assets [Member]",
        "label": "Licensing arrangement assets [Member]",
        "terseLabel": "Licensing arrangement assets [Member]"
       }
      }
     },
     "localname": "LicensingarrangementassetsMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LicensingarrangementliabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangement liabilities [Member]",
        "label": "Licensing arrangement liabilities [Member]",
        "terseLabel": "Licensing arrangement liabilities [Member]"
       }
      }
     },
     "localname": "LicensingarrangementliabilitiesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Licensingarrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements",
        "label": "Licensing arrangements",
        "terseLabel": "Licensing arrangements"
       }
      }
     },
     "localname": "Licensingarrangements",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Licensingarrangementsasset": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements, asset",
        "label": "Licensing arrangements, asset",
        "terseLabel": "Licensing arrangements, asset"
       }
      }
     },
     "localname": "Licensingarrangementsasset",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Licensingarrangementsliability": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing arrangements, liability",
        "label": "Licensing arrangements, liability",
        "terseLabel": "Licensing arrangements, liability"
       }
      }
     },
     "localname": "Licensingarrangementsliability",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LitigationAndDebtExclusionFromEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusion of litigation payments and any debt Issued to fund tax deficiency payments",
        "label": "Litigation and Debt Exclusion from EBITDA",
        "terseLabel": "Litigation and Debt Exclusion from EBITDA"
       }
      }
     },
     "localname": "LitigationAndDebtExclusionFromEbitda",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LumenisLTDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lumenis LTD",
        "label": "Lumenis LTD [Member]",
        "terseLabel": "Lumenis LTD"
       }
      }
     },
     "localname": "LumenisLTDMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2024NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2024 Notes [Member]",
        "label": "March 2024 Notes [Member]",
        "terseLabel": "March 2024 Notes [Member]"
       }
      }
     },
     "localname": "March2024NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2026NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2026 Notes [Member]",
        "label": "March 2026 Notes [Member]",
        "terseLabel": "March 2026 Notes [Member]"
       }
      }
     },
     "localname": "March2026NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2028NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2028 Notes [Member]",
        "label": "March 2028 Notes [Member]",
        "verboseLabel": "March 2028 Notes [Member]"
       }
      }
     },
     "localname": "March2028NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2029NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2029 Notes [Member]",
        "label": "March 2029 Notes [Member]",
        "terseLabel": "March 2029 Notes [Member]"
       }
      }
     },
     "localname": "March2029NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2039NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2039 Notes [Member]",
        "label": "March 2039 Notes [Member]",
        "terseLabel": "March 2039 Notes [Member]"
       }
      }
     },
     "localname": "March2039NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2049NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2049 Notes [Member]",
        "label": "March 2049 Notes [Member]",
        "terseLabel": "March 2049 Notes [Member]"
       }
      }
     },
     "localname": "March2049NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum leverage ratio permitted by revolving credit facility agreement.",
        "label": "Maximum Leverage Ratio",
        "terseLabel": "Maximum Leverage Ratio"
       }
      }
     },
     "localname": "MaximumLeverageRatio",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bsx_May2022NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2022 Notes [Member]",
        "label": "May 2022 Notes [Member]",
        "terseLabel": "May 2022 Notes [Member]"
       }
      }
     },
     "localname": "May2022NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_May2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "May 2025 Notes [Member]",
        "label": "May 2025 Notes [Member]",
        "terseLabel": "May 2025 Notes [Member]"
       }
      }
     },
     "localname": "May2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MedsurgMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MedSurg [Member]",
        "label": "MedSurg [Member]",
        "terseLabel": "MedSurg [Member]"
       }
      }
     },
     "localname": "MedsurgMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Netcurrencyexchangegainloss": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net currency exchange gain (loss)",
        "label": "Net currency exchange gain (loss)",
        "negatedTerseLabel": "Foreign exchange (gain) loss",
        "terseLabel": "Net currency exchange gain (loss)"
       }
      }
     },
     "localname": "Netcurrencyexchangegainloss",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_NewAccountingPronouncementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Accounting Pronouncements, Policy",
        "label": "New Accounting Pronouncements, Policy [Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_Noncashimpactoftransferredroyaltyrights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash impact of transferred royalty rights",
        "label": "Non-cash impact of transferred royalty rights",
        "terseLabel": "Non-cash impact of transferred royalty rights"
       }
      }
     },
     "localname": "Noncashimpactoftransferredroyaltyrights",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_November2035NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2035 Notes [Member]",
        "label": "November 2035 Notes [Member]",
        "terseLabel": "November 2035 Notes [Member]"
       }
      }
     },
     "localname": "November2035NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_NumberOfBusinesses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Businesses",
        "label": "Number Of Businesses",
        "terseLabel": "Number Of Businesses"
       }
      }
     },
     "localname": "NumberOfBusinesses",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_NumberOfBusinessesDivested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Businesses Divested",
        "label": "Number Of Businesses Divested",
        "terseLabel": "Number Of Businesses Divested"
       }
      }
     },
     "localname": "NumberOfBusinessesDivested",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_October2023NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2023 Notes [Member]",
        "label": "October 2023 Notes [Member]",
        "terseLabel": "October 2023 Notes [Member]"
       }
      }
     },
     "localname": "October2023NotesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_OperatingIncomeAllocatedToReportableSegments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income Allocated to Reportable Segments",
        "label": "Operating Income Allocated to Reportable Segments",
        "terseLabel": "Operating Income Allocated to Reportable Segments"
       }
      }
     },
     "localname": "OperatingIncomeAllocatedToReportableSegments",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OperatingIncomeUnallocatedToSegment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income Unallocated to Segment",
        "label": "Operating Income Unallocated to Segment",
        "negatedTerseLabel": "Operating Income Unallocated to Segment"
       }
      }
     },
     "localname": "OperatingIncomeUnallocatedToSegment",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OtherCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Assets [Abstract]",
        "label": "Other Current Assets [Abstract]",
        "terseLabel": "Other Current Assets [Abstract]"
       }
      }
     },
     "localname": "OtherCurrentAssetsAbstract",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_OtherNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other, net",
        "label": "Other, net",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNet",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OtherOtherLongtermAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other, Other Long-term Assets",
        "label": "Other, Other Long-term Assets",
        "terseLabel": "Other, Other Long-term Assets"
       }
      }
     },
     "localname": "OtherOtherLongtermAssets",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PaymentOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of contingent consideration",
        "label": "Payment of contingent consideration",
        "negatedLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentOfContingentConsideration",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PaymentsForRoyaltyRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for royalty rights",
        "label": "Payments for royalty rights",
        "negatedTerseLabel": "Payments for royalty rights"
       }
      }
     },
     "localname": "PaymentsForRoyaltyRights",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Paymenttonetsharesettleemployeeequityawards": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment to net share settle employee equity awards",
        "label": "Payment to net share settle employee equity awards",
        "negatedTerseLabel": "Cash used to net share settle employee equity awards"
       }
      }
     },
     "localname": "Paymenttonetsharesettleemployeeequityawards",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PreventiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preventice",
        "label": "Preventice [Member]",
        "terseLabel": "Preventice"
       }
      }
     },
     "localname": "PreventiceMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - Australia",
        "label": "Product liability cases or claims related to mesh product - Australia",
        "terseLabel": "Product liability cases or claims related to mesh product - Australia"
       }
      }
     },
     "localname": "ProductLiabilityCasesOrClaimsRelatedToMeshProductAustralia",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases related to Greenfield Vena Cava Filter",
        "label": "Product liability cases related to Greenfield Vena Cava Filter",
        "terseLabel": "Product liability cases related to Greenfield Vena Cava Filter"
       }
      }
     },
     "localname": "ProductLiabilityCasesRelatedToGreenfieldVenaCavaFilter",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability claims, not filed, related to Greenfield Vena Cava Filter",
        "label": "Product liability claims, not filed, related to Greenfield Vena Cava Filter",
        "terseLabel": "Product liability claims, not filed, related to Greenfield Vena Cava Filter"
       }
      }
     },
     "localname": "ProductLiabilityClaimsNotFiledRelatedToGreenfieldVenaCavaFilter",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_Productliabilitycasesorclaimsrelatedtomeshproduct": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims asserted related to mesh products",
        "label": "Product liability cases or claims related to mesh product",
        "terseLabel": "Product liability cases or claims related to mesh product"
       }
      }
     },
     "localname": "Productliabilitycasesorclaimsrelatedtomeshproduct",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - Canada",
        "label": "Product liability cases or claims related to mesh product - Canada",
        "terseLabel": "Product liability cases or claims related to mesh product - Canada"
       }
      }
     },
     "localname": "ProductliabilitycasesorclaimsrelatedtomeshproductCanada",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - United Kingdom",
        "label": "Product liability cases or claims related to mesh product - United Kingdom",
        "terseLabel": "Product liability cases or claims related to mesh product - United Kingdom"
       }
      }
     },
     "localname": "ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_QualifiedAcquisitionConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Qualified Acquisition Consideration",
        "label": "Qualified Acquisition Consideration",
        "terseLabel": "Qualified Acquisition Consideration"
       }
      }
     },
     "localname": "QualifiedAcquisitionConsideration",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RDRegulatoryandCommercializationbasedMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "label": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "terseLabel": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]"
       }
      }
     },
     "localname": "RDRegulatoryandCommercializationbasedMilestoneMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RenminbiDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Renminbi Denominated Factoring Arrangements",
        "label": "Renminbi Denominated Factoring Arrangements [Member]",
        "terseLabel": "Renminbi Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "RenminbiDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, as of December 31, 2021 and through remaining term of facility",
        "label": "Requirement, as of December 31, 2021 and through remaining term of facility [Member]",
        "terseLabel": "Requirement, as of December 31, 2021 and through remaining term of facility"
       }
      }
     },
     "localname": "RequirementAsOfDecember312021AndThroughRemainingTermOfFacilityMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementAsOfJune302021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, as of June 30, 2021",
        "label": "Requirement, as of June 30, 2021 [Member]",
        "terseLabel": "Requirement, extension through the remainder of 2020 [Member]"
       }
      }
     },
     "localname": "RequirementAsOfJune302021Member",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementAsOfSeptember302021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, as of September 30, 2021",
        "label": "Requirement, as of September 30, 2021 [Member]",
        "terseLabel": "Requirement, as of September 30, 2021"
       }
      }
     },
     "localname": "RequirementAsOfSeptember302021Member",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, eighth quarter following qualified acquisition and through remaining term of facility",
        "label": "Requirement, eighth quarter following qualified acquisition and through remaining term of facility [Member]",
        "terseLabel": "Requirement, eighth quarter following qualified acquisition and through remaining term of facility"
       }
      }
     },
     "localname": "RequirementEighthQuarterFollowingQualifiedAcquisitionAndThroughRemainingTermOfFacilityMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, four succeeding quarters following qualified acquisition",
        "label": "Requirement, four succeeding quarters following qualified acquisition [Member]",
        "terseLabel": "Requirement, four succeeding quarters following qualified acquisition"
       }
      }
     },
     "localname": "RequirementFourSucceedingQuartersFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementSeventhQuarterFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, seventh quarter following qualified acquisition",
        "label": "Requirement, seventh quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, seventh quarter following qualified acquisition"
       }
      }
     },
     "localname": "RequirementSeventhQuarterFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementSixthQuarterFollowingQualifiedAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, sixth quarter following qualified acquisition",
        "label": "Requirement, sixth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, sixth quarter following qualified acquisition"
       }
      }
     },
     "localname": "RequirementSixthQuarterFollowingQualifiedAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, fifth quarter following qualified acquisition [Member]",
        "label": "Requirement, fifth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, fifth quarter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementfifthquarterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Requirement, third quarter following qualified acquisition [Member]",
        "label": "Requirement, third quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, third quarter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementthirdquarterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.",
        "label": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA",
        "terseLabel": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RevenueBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "revenue-based payments [Member]",
        "label": "revenue-based payments [Member]",
        "terseLabel": "revenue-based payments [Member]"
       }
      }
     },
     "localname": "RevenueBasedPaymentsMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RevolvingCreditFacility2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility 2021",
        "label": "Revolving Credit Facility 2021 [Member]",
        "terseLabel": "2021 Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacility2021Member",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RhythmandNeuroMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rhythm and Neuro [Member]",
        "label": "Rhythm and Neuro [Member]",
        "terseLabel": "Rhythm and Neuro [Member]"
       }
      }
     },
     "localname": "RhythmandNeuroMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]",
        "label": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Line Items]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Line Items]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationLineItems",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Table]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Table]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationTable",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_ScheduleofIntangibleAssetsandGoodwillTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets and Goodwill [Table]",
        "label": "Schedule of Intangible Assets and Goodwill [Table]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleofIntangibleAssetsandGoodwillTable",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_SegmentOperatingIncomeasaPercentageofNetSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Operating Income as a Percentage of Net Sales",
        "label": "Segment Operating Income as a Percentage of Net Sales",
        "terseLabel": "Segment Operating Income as a Percentage of Net Sales"
       }
      }
     },
     "localname": "SegmentOperatingIncomeasaPercentageofNetSales",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_SeniorNotedue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Note due 2027 [Member]",
        "label": "Senior Note due 2027 [Member]",
        "terseLabel": "Senior Note due 2027 [Member]"
       }
      }
     },
     "localname": "SeniorNotedue2027Member",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SpecialChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits",
        "label": "Special Charges [Member]",
        "terseLabel": "Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits"
       }
      }
     },
     "localname": "SpecialChargesMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SpecialtyPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty Pharmaceuticals [Member]",
        "label": "Specialty Pharmaceuticals [Member]",
        "terseLabel": "Specialty Pharmaceuticals [Member]"
       }
      }
     },
     "localname": "SpecialtyPharmaceuticalsMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StateAGSettlementsMeshRelatedNumberOfStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State AG settlements, mesh related, number of states",
        "label": "State AG settlements, mesh related, number of states",
        "terseLabel": "State AG settlements, mesh related, number of states"
       }
      }
     },
     "localname": "StateAGSettlementsMeshRelatedNumberOfStates",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_StatementAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "statement [Axis]",
        "label": "statement [Axis]",
        "terseLabel": "statement [Axis]"
       }
      }
     },
     "localname": "StatementAxis",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_StatementDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for statement [Axis]",
        "label": "statement [Domain]",
        "terseLabel": "statement [Domain]"
       }
      }
     },
     "localname": "StatementDomain",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, New Issues (Common stock)",
        "label": "Stock Issued During Period, Value, New Issues (Common stock)",
        "terseLabel": "Common stock issuance (Value in excess of par)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesCommonStock",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, New Issues (Preferred stock)",
        "label": "Stock Issued During Period, Value, New Issues (Preferred stock)",
        "terseLabel": "Preferred stock issuance (Value in excess of par)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesPreferredStock",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of term loan and revolving credit facility agreement compliance with debt covenants.",
        "label": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]",
        "terseLabel": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_SupplementalBalanceSheetInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information.",
        "label": "Supplemental Balance Sheet Information [Abstract]",
        "terseLabel": "Supplemental Balance Sheet Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationAbstract",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bsx_SupplementalBalanceSheetInformationTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information.",
        "label": "Supplemental Balance Sheet Information (Textuals) [Abstract]",
        "verboseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationTextualsAbstract",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_The2018FacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the 2018 Facility",
        "label": "the 2018 Facility [Domain]",
        "terseLabel": "the 2018 Facility [Member]"
       }
      }
     },
     "localname": "The2018FacilityDomain",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TheCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The CARES Act",
        "label": "The CARES Act",
        "terseLabel": "The CARES Act"
       }
      }
     },
     "localname": "TheCARESAct",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_TotalAllocatedToReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total allocated to reportable segments [Member]",
        "label": "Total allocated to reportable segments [Member]",
        "terseLabel": "Total allocated to reportable segments [Member]"
       }
      }
     },
     "localname": "TotalAllocatedToReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Product liability cases and claims settled related to Mesh product",
        "label": "Total Product liability cases and claims settled related to Mesh product",
        "terseLabel": "Total Product liability cases and claims settled related to Mesh product"
       }
      }
     },
     "localname": "TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_YenDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yen denominated factoring arrangements.",
        "label": "Yen Denominated Factoring Arrangements [Member]",
        "terseLabel": "Yen Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "YenDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20210630",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "verboseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.",
        "label": "Entity Listing, Par Value Per Share",
        "terseLabel": "Entity Listing, Par Value Per Share"
       }
      }
     },
     "localname": "EntityListingParValuePerShare",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "APAC [Member]"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r356",
      "r359",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r536",
      "r576",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]",
        "verboseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r356",
      "r359",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r536",
      "r576",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]",
        "verboseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r207",
      "r332",
      "r336",
      "r537",
      "r575",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r207",
      "r332",
      "r336",
      "r537",
      "r575",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r344",
      "r356",
      "r359",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r536",
      "r576",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r344",
      "r356",
      "r359",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r536",
      "r576",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r208",
      "r209",
      "r332",
      "r337",
      "r578",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r208",
      "r209",
      "r332",
      "r337",
      "r578",
      "r589",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r289",
      "r357",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "verboseLabel": "Statement, Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r509",
      "r511",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average [Member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r33",
      "r65",
      "r213",
      "r214",
      "r559"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Trade accounts receivable, net",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal": {
     "auth_ref": [
      "r228"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.",
        "label": "Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)",
        "terseLabel": "Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)",
        "verboseLabel": "Cumulative effect adjustment for adoption of ASU 2016-13"
       }
      }
     },
     "localname": "AccountsReceivableChangeInMethodCreditLossExpenseReversal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r213",
      "r214"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r29",
      "r544",
      "r561"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Accrued Liabilities, Current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r18",
      "r19",
      "r56"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Accrued Royalties, Current"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r51",
      "r273"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r79",
      "r84",
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedTerseLabel": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r74",
      "r81",
      "r83",
      "r84",
      "r473"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r36",
      "r81",
      "r83",
      "r84",
      "r563",
      "r584",
      "r585"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r80",
      "r84",
      "r88",
      "r144",
      "r145",
      "r146",
      "r416",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r75",
      "r84",
      "r88",
      "r416",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r362",
      "r363",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r38",
      "r215",
      "r227"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedLabel": "Less: allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r126",
      "r255",
      "r263"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization expense",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r135",
      "r191",
      "r197",
      "r203",
      "r225",
      "r412",
      "r418",
      "r475",
      "r542",
      "r560"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r11",
      "r13",
      "r68",
      "r135",
      "r225",
      "r412",
      "r418",
      "r475"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r3",
      "r4",
      "r5",
      "r270",
      "r277"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r216",
      "r218",
      "r234",
      "r547"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Notes receivable"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r433",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r16",
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r355",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r355",
      "r358",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1": {
     "auth_ref": [
      "r389",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination",
        "terseLabel": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r125",
      "r407"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration net expense (benefit)",
        "verboseLabel": "Contingent consideration net expense (benefit)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r399",
      "r400",
      "r404"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Business Combination, Contingent Consideration, Liability Ending Balance",
        "periodStartLabel": "Business Combination, Contingent Consideration, Liability Beginning Balance",
        "terseLabel": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r399",
      "r401"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r399",
      "r401"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "verboseLabel": "ACQUISITIONS AND STRATEGIC INVESTMENTS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r394",
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLeaseObligationsMember": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A borrowing recorded for a lease meeting the criteria for capitalization. A lease is defined as an agreement conveying the right to use property, plant, or equipment (land or depreciable assets) usually for a stated period of time.",
        "label": "Capital Lease Obligations [Member]",
        "terseLabel": "Finance Lease Obligation"
       }
      }
     },
     "localname": "CapitalLeaseObligationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r48",
      "r586",
      "r587"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r48",
      "r128"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r120",
      "r128",
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period",
        "periodStartLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r120",
      "r482"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease)\u00a0in cash, cash equivalents, restricted cash and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock Disclosures [Abstract]",
        "terseLabel": "Class of Stock Disclosures [Abstract]"
       }
      }
     },
     "localname": "ClassOfStockDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r133",
      "r135",
      "r160",
      "r161",
      "r162",
      "r164",
      "r166",
      "r175",
      "r176",
      "r177",
      "r225",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r61",
      "r288",
      "r549",
      "r567"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r285",
      "r286",
      "r287",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r144",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,685,006,608 shares as of June 30, 2021 and 1,679,911,918 shares as of December 31, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r91",
      "r93",
      "r98",
      "r411",
      "r422",
      "r552",
      "r571"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r97",
      "r107",
      "r551",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Income (Loss) Note [Text Block]"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Capital in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r321",
      "r322",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability [Abstract]",
        "terseLabel": "Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r334"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r101",
      "r537"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold",
        "verboseLabel": "Cost of Goods and Services Sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r548",
      "r569"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current",
        "verboseLabel": "Current debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "CONTRACTUAL OBLIGATIONS AND COMMITMENTS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r26",
      "r27",
      "r28",
      "r543",
      "r545",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r59",
      "r137",
      "r311",
      "r314",
      "r315",
      "r316",
      "r494",
      "r495",
      "r497",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r304",
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Decrease in Unrecognized Tax Benefits is Reasonably Possible"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r369",
      "r370"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r369",
      "r370"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred Revenue, Current"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r126",
      "r271"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r126",
      "r186"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r70",
      "r71",
      "r474"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Current",
        "terseLabel": "Derivative Asset, Current"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r69",
      "r72",
      "r436",
      "r517"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative Asset, Fair Value, Gross Asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r69",
      "r72",
      "r436",
      "r517"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Derivative Liability, Fair Value, Gross Liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r434",
      "r437",
      "r446",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r431",
      "r434",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r431",
      "r434",
      "r446",
      "r452",
      "r453",
      "r457",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Assets, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Assets, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Liabilities, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Liabilities, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r70",
      "r71",
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r425",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeRemainingMaturity1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Remaining Maturity",
        "terseLabel": "Derivative, Remaining Maturity"
       }
      }
     },
     "localname": "DerivativeRemainingMaturity1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r424",
      "r426",
      "r427",
      "r431",
      "r432",
      "r440",
      "r446",
      "r454",
      "r456",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Term of Contract",
        "terseLabel": "Derivative, Term of Contract (less than)"
       }
      }
     },
     "localname": "DerivativeTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r132",
      "r138",
      "r424",
      "r426",
      "r431",
      "r432",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]",
        "terseLabel": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r332",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r268",
      "r269",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that either has been sold or is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r126",
      "r269",
      "r275"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "negatedTerseLabel": "Gain on disposal of businesses",
        "terseLabel": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r355",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPreferredStockCash": {
     "auth_ref": [
      "r317",
      "r556"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Preferred Stock, Cash",
        "verboseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "DividendsPreferredStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStockStock": {
     "auth_ref": [
      "r317",
      "r556"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.",
        "label": "Dividends, Preferred Stock, Stock",
        "negatedTerseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "DividendsPreferredStockStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA [Member]"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r99",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r157",
      "r160",
      "r164",
      "r165",
      "r166",
      "r171",
      "r172",
      "r553",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income (loss)\u00a0per common share \u2014 basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r99",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r160",
      "r164",
      "r165",
      "r166",
      "r171",
      "r172",
      "r553",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income (loss)\u00a0per common share \u2014 assuming dilution"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r167",
      "r169",
      "r170",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Weighted Average Number Of Shares Outstanding [Text Block]"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of foreign exchange rates on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate from continuing operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and related liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r148",
      "r154",
      "r156",
      "r174",
      "r226",
      "r310",
      "r317",
      "r362",
      "r363",
      "r364",
      "r379",
      "r380",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "terseLabel": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r49",
      "r192",
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r222"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Equity Securities, FV-NI, Gain (Loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Measurement alternative investments(1)"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r461",
      "r462",
      "r463",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r354",
      "r462",
      "r506",
      "r507",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r461",
      "r462",
      "r465",
      "r466",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r345",
      "r346",
      "r351",
      "r354",
      "r462",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r345",
      "r346",
      "r351",
      "r354",
      "r462",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r354",
      "r462",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r467",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Fair value of contingent consideration recorded in purchase accounting"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r354",
      "r506",
      "r507",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r469",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r219",
      "r220",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r236",
      "r237",
      "r238",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r256",
      "r259",
      "r262",
      "r265",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "verboseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r262",
      "r539"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r256",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r476",
      "r478",
      "r480",
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign Currency Transaction Gain (Loss), before Tax"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r345",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": {
     "auth_ref": [
      "r434",
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.",
        "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments",
        "terseLabel": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r104",
      "r126",
      "r217"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedTerseLabel": "Net loss (gain) on investments and notes receivable"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r126",
      "r417"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain on disposal of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r242",
      "r244",
      "r541"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill Ending Balance",
        "periodStartLabel": "Goodwill Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r245",
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Goodwill, Gross"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r245",
      "r250"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedTerseLabel": "Goodwill, Impaired, Accumulated Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r126",
      "r243",
      "r247",
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill [Member]",
        "terseLabel": "Goodwill [Member]"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r248",
      "r249",
      "r388"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Translation and Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r100",
      "r135",
      "r191",
      "r196",
      "r199",
      "r202",
      "r205",
      "r225",
      "r475"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r431",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r126",
      "r266"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairment charges",
        "verboseLabel": "Impairment of Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r126",
      "r266"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development [Member]",
        "verboseLabel": "In Process Research and Development [Member]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r96",
      "r191",
      "r196",
      "r199",
      "r202",
      "r205",
      "r540",
      "r550",
      "r555",
      "r573"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss)\u00a0before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r355",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r373",
      "r377",
      "r378",
      "r381",
      "r383",
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r155",
      "r156",
      "r189",
      "r371",
      "r382",
      "r384",
      "r574"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Trade accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).",
        "label": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option",
        "terseLabel": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r258",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]",
        "verboseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r258",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "verboseLabel": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r254",
      "r260"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r95",
      "r185",
      "r493",
      "r496",
      "r554"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest Expense",
        "verboseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense [Member]"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r345",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest Rate Contract [Member]"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap [Member]"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r40",
      "r239"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Inventory, Finished Goods, Net of Reserves"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r66"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r42",
      "r239"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Inventory, Raw Materials, Net of Reserves"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r41",
      "r239"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Inventory, Work in Process, Net of Reserves"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.",
        "label": "Investment Holdings, Schedule of Investments [Table Text Block]",
        "terseLabel": "Investment [Table Text Block]"
       }
      }
     },
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r568"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r15",
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalCostsPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r132",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
        "label": "Legal Costs, Policy [Policy Text Block]",
        "terseLabel": "Legal Costs, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "LegalCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r37",
      "r135",
      "r225",
      "r475",
      "r546",
      "r565"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r57",
      "r135",
      "r225",
      "r413",
      "r418",
      "r419",
      "r475"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r3",
      "r4",
      "r5",
      "r270",
      "r277"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities, Current"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r54",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r61",
      "r288",
      "r297"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Legal reserves, current"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r61",
      "r288"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Estimated Litigation Liability, Noncurrent"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "negatedLabel": "Litigation-related net charges (credits)",
        "terseLabel": "Litigation-related net charges (credits)"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r28",
      "r305",
      "r545",
      "r562"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term Debt and Capital Lease Obligations",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r59",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r296",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "verboseLabel": "Accrual for legal matters that are probable and estimable"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r288",
      "r291",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Loss Contingency, Damages Awarded, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r288",
      "r291",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Loss Contingency, Damages Paid, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money Market Funds, at Carrying Value"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "verboseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash provided by (used for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Cash provided by (used for) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r120",
      "r123",
      "r127"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r152",
      "r157",
      "r158",
      "r163",
      "r166",
      "r191",
      "r196",
      "r199",
      "r202",
      "r205"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income (loss) available to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of Businesses Acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r425",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of Interest Rate Derivatives Held"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r191",
      "r196",
      "r199",
      "r202",
      "r205"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r500"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r499"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r6",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "verboseLabel": "BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r56"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other Accrued Liabilities, Noncurrent"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "totalLabel": "Other Assets, Current"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Current",
        "terseLabel": "Other Assets, Miscellaneous, Current"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Other Assets, Noncurrent",
        "verboseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets, Noncurrent [Abstract]"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r76",
      "r81",
      "r477",
      "r479",
      "r484"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r84",
      "r94",
      "r485",
      "r487",
      "r491"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r77",
      "r81"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "verboseLabel": "Net change in derivative financial instruments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r77",
      "r81"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r77",
      "r81",
      "r435",
      "r441",
      "r458"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r81",
      "r85"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r81",
      "r85",
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": {
     "auth_ref": [
      "r78",
      "r81",
      "r85",
      "r444"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax": {
     "auth_ref": [
      "r78",
      "r81",
      "r85",
      "r444"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax": {
     "auth_ref": [
      "r78",
      "r81",
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax": {
     "auth_ref": [
      "r78",
      "r81",
      "r442",
      "r458"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax": {
     "auth_ref": [
      "r78",
      "r81",
      "r442",
      "r458"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
     "auth_ref": [
      "r81",
      "r85",
      "r86",
      "r87",
      "r483"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r90",
      "r93",
      "r94",
      "r97",
      "r310",
      "r485",
      "r490",
      "r491",
      "r551",
      "r570"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Total other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]",
        "terseLabel": "Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r79",
      "r81"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r79",
      "r81"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "terseLabel": "Net change in defined benefit pensions and other items",
        "totalLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": {
     "auth_ref": [
      "r81",
      "r85",
      "r87",
      "r352"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Other Current Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r17",
      "r18",
      "r56"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "totalLabel": "Other Liabilities, Current",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "totalLabel": "Other long-term liabilities",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "verboseLabel": "Other long-term liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense) [Member]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "terseLabel": "Other Operating Income (Expense), Net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r56",
      "r302"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other Sundry Liabilities, Current"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of contingent consideration previously established in purchase accounting"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r110",
      "r113",
      "r139"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Proceeds from royalty rights"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "negatedTerseLabel": "Payments for Royalties"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash dividends paid on preferred stock",
        "terseLabel": "Payments of Dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r111",
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Payments for acquisitions of businesses, net of cash acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedTerseLabel": "Payments for investments and acquisitions of certain technologies"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Preferred Stock, Dividend Rate, Percentage"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockDividendsPerShareCashPaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of preferred stock outstanding.",
        "label": "Preferred Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Preferred Stock, Dividends, Per Share, Cash Paid"
       }
      }
     },
     "localname": "PreferredStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockDividendsPerShareDeclared": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding.",
        "label": "Preferred Stock, Dividends Per Share, Declared",
        "terseLabel": "Preferred Stock, Dividends Per Share, Declared"
       }
      }
     },
     "localname": "PreferredStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r31",
      "r133",
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "terseLabel": "Preferred Stock, Liquidation Preference Per Share"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred Stock, Liquidation Preference, Value",
        "terseLabel": "Preferred Stock, Liquidation Preference, Value"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, Shares Issued",
        "verboseLabel": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of June 30, 2021 and December 31, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r11",
      "r46",
      "r47"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r10",
      "r12",
      "r240",
      "r241"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from disposal of businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeInvestingActivities": {
     "auth_ref": [
      "r110",
      "r124"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Proceeds from Hedge, Investing Activities",
        "terseLabel": "Payments for Hedge, Investing Activities"
       }
      }
     },
     "localname": "ProceedsFromHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net proceeds from issuance of common stock in connection with public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "terseLabel": "Net proceeds from issuance of preferred stock in connection with public offering",
        "verboseLabel": "Net proceeds from issuance of preferred stock in connection with public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-term Debt",
        "terseLabel": "Proceeds from long-term borrowings, net of debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Proceeds from borrowings on credit facilities"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r115",
      "r117",
      "r129"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "Net increase (decrease) in commercial paper"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRoyaltiesReceived": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for royalties during the current period.",
        "label": "Proceeds from Royalties Received",
        "negatedTerseLabel": "Proceeds from Royalties Received"
       }
      }
     },
     "localname": "ProceedsFromRoyaltiesReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "terseLabel": "Proceeds from sale of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings, net of debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r89",
      "r92",
      "r119",
      "r135",
      "r147",
      "r155",
      "r156",
      "r191",
      "r196",
      "r199",
      "r202",
      "r205",
      "r225",
      "r411",
      "r414",
      "r415",
      "r421",
      "r422",
      "r475",
      "r555"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r50",
      "r272"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r23",
      "r24",
      "r274",
      "r566"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r23",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Property, plant and equipment, net [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.",
        "label": "Receivable with Imputed Interest, Effective Yield (Interest Rate)",
        "verboseLabel": "Average interest rate of de-recognized receivables"
       }
      }
     },
     "localname": "ReceivableWithImputedInterestEffectiveYieldInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r84",
      "r88",
      "r94",
      "r485",
      "r489",
      "r491"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r84",
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "terseLabel": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r196",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "verboseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r195",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "negatedTerseLabel": "Payments on borrowings from credit facilities"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedTerseLabel": "Payments on long-term borrowings and debt extinguishment costs"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedTerseLabel": "Payments on short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r367"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r22",
      "r128",
      "r130"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted Cash and Cash Equivalents in Other current assets",
        "verboseLabel": "Restricted cash and restricted cash equivalents included in Other current assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r14",
      "r25",
      "r130",
      "r590"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash equivalents included in Other long-term assets",
        "verboseLabel": "Restricted Cash Equivalents in Other long-term assets"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r126",
      "r280",
      "r282",
      "r283"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "verboseLabel": "Restructuring net charges (credits)"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r35",
      "r317",
      "r365",
      "r564",
      "r583",
      "r585"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r148",
      "r154",
      "r156",
      "r226",
      "r362",
      "r363",
      "r364",
      "r379",
      "r380",
      "r580",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r182",
      "r183",
      "r195",
      "r200",
      "r201",
      "r207",
      "r208",
      "r211",
      "r331",
      "r332",
      "r537"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales",
        "verboseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r335",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "verboseLabel": "Trade accounts receivable, net [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r84",
      "r490",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Changes in Other Comprehensive Income [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "verboseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r59",
      "r137",
      "r311",
      "r314",
      "r315",
      "r316",
      "r494",
      "r495",
      "r497",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "verboseLabel": "Schedule of Long-term Debt Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r434",
      "r446",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "verboseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "verboseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r461",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r251",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r21",
      "r43",
      "r44",
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventory Disclosure [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r445",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r62",
      "r133",
      "r175",
      "r176",
      "r307",
      "r308",
      "r309",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of Weighted Average Number of Shares [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r178",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r211",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r178",
      "r180",
      "r181",
      "r191",
      "r194",
      "r199",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r210",
      "r211",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "SEGMENT REPORTING"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation [Member]"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending Balance (Shares Issued)",
        "periodStartLabel": "Beginning Balance (Shares Issued)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r178",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r211",
      "r251",
      "r278",
      "r281",
      "r284",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Statement, Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r133",
      "r135",
      "r160",
      "r161",
      "r162",
      "r164",
      "r166",
      "r175",
      "r176",
      "r177",
      "r225",
      "r310",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r64",
      "r144",
      "r145",
      "r146",
      "r148",
      "r154",
      "r156",
      "r174",
      "r226",
      "r310",
      "r317",
      "r362",
      "r363",
      "r364",
      "r379",
      "r380",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]",
        "verboseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r174",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Share-based Payment Arrangement"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
     "auth_ref": [
      "r360",
      "r366"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r31",
      "r32",
      "r310",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Stock issuance (Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the number of shares issued.",
        "label": "Stock Issued During Period, Shares, Period Increase (Decrease)",
        "terseLabel": "Stock-based compensation (Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r31",
      "r32",
      "r310",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r135",
      "r144",
      "r145",
      "r146",
      "r148",
      "r154",
      "r225",
      "r226",
      "r317",
      "r362",
      "r363",
      "r364",
      "r379",
      "r380",
      "r409",
      "r410",
      "r420",
      "r475",
      "r485",
      "r486",
      "r491",
      "r581",
      "r582"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r317",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r310",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in stockholders' equity during the period.",
        "label": "Stockholders' Equity, Period Increase (Decrease)",
        "terseLabel": "Stock issuance (Par value)"
       }
      }
     },
     "localname": "StockholdersEquityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r492",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r492",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r492",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent Events, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "verboseLabel": "SUPPLEMENTAL BALANCE SHEET INFORMATION"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes Payable, Current"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets [Member]"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized",
        "verboseLabel": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r219",
      "r220",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r63",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r63",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r63",
      "r318",
      "r319"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost - 263,289,848 shares as of June 30, 2021 and December 31, 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r310",
      "r317",
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r368",
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r140",
      "r143"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charges to expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedLabel": "Utilization of allowances"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Valuation Technique, Discounted Cash Flow [Member]"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r166"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Weighted Average Number Diluted Shares Outstanding Adjustment"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r159",
      "r166"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted",
        "verboseLabel": "Assuming dilution"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted-average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r157",
      "r166"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3581-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3098-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27405-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117546-209714"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2599-110228"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121321822&loc=d3e3913-113898"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121323062&loc=d3e15009-113911"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r601": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r602": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r603": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r604": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r605": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e709-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>68
<FILENAME>0000885725-21-000036-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000885725-21-000036-xbrl.zip
M4$L#!!0    ( '6$!E-EXS17G#\# !:N*  0    8G-X+3(P,C$P-C,P+FAT
M;>R]6YL;1;(N?+]^!1_7N\=YB,R,X)EA/\8V+-;&AL',FL7<K"<B(](MIMWR
M2&ICSZ__,MO=/F%C [)4)<M@:'65JJ1ZX_!&9&3$G__ODX=GGSRVU7JQ//_+
MI_Y/[M-/_N_G?_[_3D[^YXOOO_GD]K)>/+3SS2>W5L8;TT]^7FQ./_F[VOJ?
MG[35\N$G?U^N_KEXS"<GE^^YM7ST=+5X<+KY)+C@7SNX^JRX%G+4>E*<I!,H
M(9^@SW:"M?A,/@<"_C\//@NY-@OC]X[M!)+#$PS*)SYXJ!S94J3_HY]A*)"K
M9Z7@@,2C9RP%2^1<:_0X;GNZZ=^N?\/S]6<7ZY,'S(_^\NGI9O/HLQLW&J_E
M3\O5@QM7!V[TC^Q.G#^)_M.KM]3EQ?EF]?3Y6Y[(ZNQ/:ZM_>K!\?./JX!O>
M-DY;/'_3SS___*?+-XY[!>?BC<7Y>L/GU:[//UN<__-73A^'A=?/3W^R?O7B
M/\?K<_V-_[G[S?UZ:@_YY/6;J"W>_#WZ@;=\!WWM'5=WR3>>';P^5=9/7OD\
MLEQOEN?KNNARLVB+^J>Z?#CNX%V.[OGU?_&EK[Z&)Z(;ET>O3UT\>=O#\>-9
M]E-MR.K5Z6^_YI"%ZVNN5YM?"D+_Y1N>Q.+)YJ0_JU>N>_WL7MS]QF;%Y^NV
M7#WD3=>D\>'221?<5Z[SYN_QKHN$DY"?7V2]A.#+KPG7LS.NWW"Q6;WU9+K1
MCUZ>^-D9GS_XRZ=V?O*W^Y]VK3'6S__\T#;\R7CKB?WK8O'X+Y_>6IYO.J8G
M/SQ]U,6J/GOUET\W]F1SX_+AWOC\/_[C/_Z\66S.[/,N%2?7H/_YQK/?_?G&
MLRO+4I]^_F==//YDO7EZ9G_Y5!?K1V?\]+/SY;GU^R^>?#9.M-6S'Q>J=G[Y
M8S]^K]NCU:(^N_V3S??6_O+I FI-W5@ 10U@YKF!Q^!:)E;0YO[W]N5'Z?^<
MO!#$<WXX;FV+S^YT0=T\O=6_S8K/OCY7>_+_[.FGGRRT7UKC?S^5V\O'WX3O
M'_\8[U[H3W<>_^,K^NG;GQX\O??OOX8?__WEZ3]N__/IW=M_33_^= ?N_OT.
MW/MW[7_OG=Y[>.^GN_^^ ]_$>V<__GL)=W^J[M[#NT]^_/M?T]V?;KIO__[U
MDV]O?WGZ[>T:^]]___C#/W[Z\=]WGWS[);IOPC^>_OCWFONY/__XPQWWXP\W
MG]Z[_>5/]V[_U^+'AU^>_OC3EXM[7]V-/_[TMR<__ON_SO[QTX/'^M67"_GJ
M;_G>3W?<W;_?3?=^^N?3?_SP?7_/%Z?WPIV?[WWU7Z?W_OZC_\?M+WZZU^]_
M]_;75^_Y[WZO=/Z/'Y;A[@]_[=?[9_CVA_\ZZ]=W=[^Z$_N]W8\/[_A__/3?
M_[S[U=W0O^O/=\_PW]_\<&=S][Y[\LT/-_\7((12I9P$7^$$M,O^P.,D)ZT>
MG6_<TJ>?N_X',960_GSC%3RW#^\S->KO?K+Y3+OO>MBO>*K\]&7@;UVL5AWU
M+Q?KRF<_&J_NG.OM?NX1^W=A[U[!GC"J%CP1;M3]>K43DI1.?!$0+<QB^.GG
M/MR(_H/#_@+<:^[R MTO^V_61VS?A:U_%5MRKE0^,89\ LUU6E9B.VF)/8'/
MWK7XZ>?C^>\-VN_Z]9=Z!/>]P TO@RLE1R:C$S/G3D!*/$&1=E(#DG!-0$J?
M?O[7L$-H;W9<]1+;,WYPA/-=<,:7X:1 $ECJ28O: R?GRPFF$$]2LAY/2:-*
MY=//&Y^M[1>(WGB5::VL67>-U=9OX(>#G7^VOHPS.N:?7++USS:=%?[ET_7B
MX:.S$71<_NYT-43B92KXIR=K[5>X\>HEGMW^Q3VO/L)Z>;&Z?'4947UV)6;/
M9.+WB-GUA>R2[UV_6NBS0,56GUQ^('LCU;_U]?][E;Z\_N;/KW_UZM4?71JG
MZU<])EMM!L.XM)@CT'#^^GTOCCW_F/K2J?ED$.E7CUR_OK[)C5<>U!N?FV]%
MLD8I$!@T><RI<D[,ZJA9"7MX;E=?WQX,M7_V4OO-GCPZ6]3%YJX]E'X+7?2C
MSY(45P'[9_<W@];U]]PZX_7ZVW9_LZS_O/EDL?[T\^M3;BT?=MYW>>#9=?Y\
MXXV7?_[HGG^*68"9@1(H 2ATIE4K"[7LJ1B@MXIR&&!V^_'9?3M?+%?WEAO3
M"^O?I1PBG *4":WCEQQH=IC)O&J/G"2(^ /1S0'GS93<W5O?W;_?'XZM;QX(
MF!?GBV=(7JRUD]+[I[RRYP#IXG%_L"^?>NE[>;-\_I@?&J\O5O;Y50[GL[_=
MOWU]I^M#UZ_?^/[QR]MVOGRX.'_39:^^_?A4ZU^[[BN7N/'JIW_IM%]\ZV=7
M_O3WWO:-*H&:M,MFM6(*%H2"(11M$B,DA/B_7U]J0IF$=W^6<]U<R5%Y28ZN
MC_QV.?K%XWQ/X7BS\P_%94>:N_N'5)!S< EK\D2I6HQ7!@:F39I@]WZV%:\6
M0S3U@*E*CY)J",8EM!XO/7MN[OJYN2D^-_?^S\UM[;DA%27J,@<A@$;B["H;
MF%.J%F*X>FY^VL_M?7W']IX;FPM&M1:L#+4PIQ@9AN9Z=)+2E=6;QN-ZU>KE
MWVWU7@WO7*>T4A$@ [@0.6'!Z+*X$(+S>OD$G _13^L)N!,?3J+?PA,H9*4E
M"T$@ 4&5Y*+OU%>#KXD0QQ/PM(LG\(<YX)U_78SUE>7#1\OS_G+]:HSVW67<
MOS+]0&':"W0\;0V=S)+89]<T( 3UU$J.#5*/K1T9TL&@\T$CZ \"#5E63+ZK
M3E(H+$S&5)TV'TMV*@<#S0^K2][W=$[@M 9L(5?HO!YR#W$ULBKT_[@D(N5@
MP+FINAB+^'SV'2_TZ_-;_&BQX;.9P,2UY<9)2(-UUQ.1NQLJ.23SOF6"@X'I
M>]OPXMST#J_.%^</UC/!!UPQUT.W<AD.^TP!2&N(N6GI9,D?##XW:[UX>'$V
M:L^^W9S::IRWLM-QM<?V]7E=/K290";6R5ODP/U) C%S\!&[,D7?M$&VUV.A
M.'OL/KQN_8%(+;Z$ZA^(U)QRB;X4R*S0-&-7OFI>*N6&+?PBPIT_JGO1R D
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MW,'@,X'DR98@LV0Y)3;O(T+I=,&I:T"8B[!U!=O='+/?] 2V.:U2-7B,L87
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MO;;-^HNG=_FGY>K6&:]?3^);/3U?GBT?//V"U[]\XTZL]>QD!4+VJ?KNPX-
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M25&$;!(+41&(@'[,PE.)G+UYZI$.SBAX/8K5E*+E$1=K<U$2Q!(10H^>8TV
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M1MM+^?4PE'PRD,017$&.IM&WTJ@8<IMPB'J-T3?+\P<;6SV\W1_Z#T\?V0N
M[O+3_N'#O>5F-F;-2% *J#E4")S$UT!8XJ@5JEA@^BHS 3BVF!"'_ORU2JFC
M7")[) FHN?8G%S6Y&:18WP['MW6S[&_J7R#.24-8)2HYJE8)<B*,TE\6CPXD
ME*NLZDPU9*>0;$]+E#"P)4G1'/B0N7B?V3DHEF*.,ZAQ_#6CM:JG_>/#G'3$
M^RBI>J$4VIB]UIFRFDDC#4TRQSGKR X!V6(9.0MY]*EF47#JV(FWZ(MQ3A65
MYZTAPZVG.>E'1!X3ZE(/& F\'P/K:M.84L)4.<]@W]P$X-AB#-+-4A3P5(E
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M;T7NO6[Q]MJ K\Z6PF=WSG6YKLM'3\</SQ8F.OOZV_GU]0[+3RN;VMB$4,U
M44E9,A,(C^7%.H=VA^^0FVLS<6]Y_K=WJ?Y1@'Z[ -5N<RJT%J("=\+7(A<J
MZHO&UOG\3 3H".JKS4:06X=3.1A$=)B+0S=VM3"$S#(#]OZQ>Y/][&@;\X5;
M-*;:0WCV)*.#KBL"SIG@')*Q1V^R3P'JH8B0^9A[M DQ*,40(H=2DO>4=0Y[
MK8Z@_B)W$++SAIX-"1B-M;],H9:::R@ZA[$=[P/JWU;+L^6#IWRNW]E9/^$_
MC<\VI[\%W1TXM5G2D4"<R+$//A"X%IB0J$&12A12:C,1H"FYE3\NK+.4)-5
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M#X!7'JB_V$\2G)V66 A=S4 A2LJ)-(<V)M04%^8O+8?N+_8B-D04L9AB#S/
M,5-VADTP-0M@V&8B-D<HQX8)S"'XI(RUNXI$WFMW(:W&:)GCH:0I#W_VQ'[2
MH(I,C"%RL1YYC*U9%8HQ84Z@?B[$<4K^8_\#<'8O1DH<.A%)14:7K(R$6C)P
M-?2=S\+!5'9]A-"*\RV&Z,D7AA '<4!!B*X5U50/ILSBX/W+7M@)4U#?7+<.
MD("CD%3KTCE,1><FEF<B/4?_LN=B06H]KC7SD ,T-43S.6&N2-4ZAYF)&!VA
M_26TK8P:'=!87>C_Q0&J-6\Y:6/(<\EX?^P3*/;"3:HKW8F QU !T")[(E('
MSJ6 3<I,9&=*WF7?(W!V+T0V*DP#A9J$@)V7@CR&M.HH[TA^+A6#1V!?!S8U
M*]4)EYH\<&(>PW>CL!!2['3B0$C#H7N6O; 2L.:ZF%R.,@(>'1:A8H7@C2HZ
M.<8M,S- ^Q$B)JI<QN*\@74Z6SQICUXX27<N?BY;XX[ _B*K$;I7B65$G@VR
M%TZ(7K%(SKEVWW(@E.&C&3.QGYQYBS%@#2Y1@S1,!9K&K"D!:*ASR9E/R<5,
M8PC!7J0I% ZCDTXMYD'(8<J^I1[27$[XY$.)8CYBA),"=_?"56,%1XP)8_4-
MM%0"XKELF#XZG7TR%]?0-XPT,F60$-@L4L%H7:Y$J\Y$B(Y.9Q+25)Q "&JA
MAS<@'AFI.$V26U8(.)?JPR/";V_L[JHB8&>FF7LXVZBVRJDD5*U)#R8Y^K%,
MFMC/EGRF!#&B!^\@%:*8QH[\FKL;TAY%ST2&IN1S)C&(8#^[\FMKA)C'$ )(
M+;#/Q#!&F,18+1]*ZN7C!=@Y:BH4*54#$I74*:J6,4]/$TDZ$$[QL7B<_=3$
MMQ \=]JBDB%P(-":E;P/@;S6N<C0T>-,09B8BU>KE+026 ^4L14?O5D(&0#F
MLA1X!/BME,)IQ8"91#R )P$*17VI59!BC;.G%(<[<F0_56>8JXN%O4L.2FMH
MT=4>TH0<*XJO,Y&7:7B7_<TVVD,@' VLFE%N-D;)4\R>BUB5DHR?#Y:?KR<Y
M7$.SG])H+)F2=R%J!H/, 6I1C$E28XX'T K@\ W-?E9Y7 ^913"K./!8V>4:
M<PP5J^_Q] '411\JM^@1*KA1L!JP K7$L4"U+"W'V+W$7'9S;TGE9PEA*2(4
MJ#0I%:!F<8%%+3CTJ3@WEPV3'Z&_14BY177D>F2/)6%4*Z0>/-?$:2[\;"+*
MMQ\(T<=DWM)8'N@_8^- U5(+09/C.<R=O<;H.8Q?7*P7Y[9>WW]VB?4+3O/%
M_?]YEIUA.;/KP_,GVWL92==*#(&[N$@5R.C$QL9$5A[1?7Y>7C7EP69'R=G+
M/+51U1_5][^M<S;GF$;/3X(@8M'K'-:WCY*SG[5.DYC8 W<C X6RF(/@ X4N
M0Q#R')86CI*SIZY?/@<N)5LU& ,)$*+/P#ER'&,YCSQG6U3YSMT[-S]\F+I[
MOE-1'9@9-R$P(5$?<V<[@K[D*NW(=V8D0?L9!:S871.GX'.!%(QC*BZ362U&
M=19U?4<)VBO_:1)(?$M=7!QH:6A@6!.51"G&,H?)!T<)VG/*KE5R"M6E AI\
MC]M;H2Y0QMTX$<^ ![T#P7'XYGK!WW'M-ZA_5%X^L+S.D@J%5I1<MSO0*73*
M@C5ZB\%04W12YT"%CD*T=S84:Z5.@"!G@QA$>D3OL_D28NUAVESZF!V%:)^$
M**OGA((2>+3SSSTXXRHN5ANSH?)<^K(?A6B?G @T>Q3VR26$&GJ4AM1J\LG'
M6#V5&7"BB;/J<=]O>+,XO_FPPU*9S_46G[/R(;*CG,@QQLZF1:%D).]9LA5@
M--8T!W9T%*?I\*3L?.XN3:JD3K:MT,@_IEA=!O6NN!GPI*,X38<QI4BQ47/*
MG2"A$G%S,3=7I!9?9S')YBA.T^%.;&7,BZ_.606PQ@2<M AV"4M>VPRXTWO
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MO_R?X8S7+MF7\8E[3A\?>SWPO:M(XV/9GHVQU;60E'%G1>$HMN=KRIX.G2)
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MB_^"RQ"EXS?%<._!HR(R&'X+A@DCCPDY(^$&2)@&0A 5J,9$@Q"-SVCV\&@
M(80!$H1+"96A*M16WF[_.Z_R)UGE%[<_DHR]O/-Q*@XV)A)X8>.*'QL(GZ9
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M]I5K*^VS?!SXX =I)V?B?=F.<QR7SNJ3^6$R,+(&<Q=43#48(QTFE'#@-!2
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M>-BY&*275\)"K00BLTJ0>U2]'F658"%5 D8G*@')*L'B"((T:Y]2RM7VJ,P
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MDF)>I0EN!I$%VAEXJ9B?L]&?,?^PF)^:_$(R8AW70/E4C$1  B2E,NDA,,#
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M<0"&0P$X)L)Q1(UG,!<K>+[8G']UU(S->V%SQFFI+1&*: E4G!M $91 "B-
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MVJ-[Y69YYA3W<'$19]0U<?F^'4]&IJ=;T=/G61<)QAQB[310I<634K'$"=.
M(<J@Q$HCP6LK1%3#\YMW:Q;-Q9'!>F^PSI1\,YP;F*J]X52U'?ODGK .<,NB
MQ0FU5X%$L%Y.X)K!^BS .@<G0P;K@X)UQE,0*&,PG0HBDKE4UIR#:/<QP 2S
M7#IO)/6U%9;!^DS!^M"6?@;KO<$ZE:S40>QX( !!'\5KU'V!HAH"%&<.HX"#
M-JZV@BM2RO E!$ T_&@.V5!?>!;GN0<Z?!ST(]/DK$NW9IN=6:,[6ME"D*C"
M*T=YU..%!L92#Z 4@6DE&9,B;3->/H90Q0S-5=I!6$0\5\-<S\B^.[)G @B"
M-8%;"PC'"%#'#) NY3A&SFIG&0DN>?OI??QI&=0+ .JG#!W(4+XSE&</,T"A
M4' "((95A+(S0''L %)>^<BYTCL6[7=\&<I92#\_/%?#\L_(OCNR9X0TBYJ2
M]!XPJ'C:\_(@@1E8K3@UUE("H[&/[K7IM4BU4<;[\17W!WP<^. ' Y_&O&^_
M%Z[]H^U\S]WM#,1D(%XL1<W=,;!^.AUG\[2=IJG\D;GJ5EQE9UT%T$1#(D4.
M>62B%H)3$B/L#7!&6!M0$#*D4JUS.)E5#?UCCOL++Q;<<T\8F,$]3W!/%1&.
ME.140!!DL%$1B<:&28>4C''2Q)FA,*!H8F1L9VP_F+,@8WN.V)X]*."UED1'
MJX+QE.#,\U3HS(.@.%.(V"B^?6T%SR%K20;W<P'WW!,69G#/$]PS15:MIDA8
M#9RV$E#"*%#<&"!4M*FH$$YXLP""^WG%$8B;Q1$4^H=N=[3I^&+4C]WN=ON]
ML4]AK]^)@WW)H?"PQYDJ-V#_]7#]KPI37]WQIW2?Q%4Z/;^U>KI 6_VU<GEN
MSZS.MWK8MIF[;\7=W\XEA3 \6(H)(!8S0%DZ\2"- @[ZH*+4#8:D+5IQ.=;K
M%!A/H48\[].CF6)?!L56(]0ED^T#D^W,Z5<8J98;!C@4&%!%"9">D4BVD7)=
M"!B9\O3K?:+@,]=EKJL@USVE4R\SW,,RW(R?CXL@A8<<8*I\5">9!P9A#1AS
M49T,$&JF:BL,PJQ.9HK-%/MDZN3#!65ELGU@LITYIJ58G"U' 13Q!V74 >VD
M!EA19+E!7!.?HB'N<T[KD9.IG#;D=&'36U6KONFNRPV>,=-A$KOD^H?)17JQ
MQT]=US:W\DE;^2)W#,;*TH$?G.T6[.F!+_[G'Q(C_*8PB=7O4Y3JF6H9"Z1(
M_$J/^.@'VVF^Y[L%@"]J$1MZT(NC-3Q]W7E= 69=X?>ZPLGJ^>3/1''$.;".
M1UT!*@M4U.^ 14QQ+Z*UYFAM!2ZCY^#H7R#C*S-?E?KV2Q/J&NJ[IV<>7VM)
M90Z<"P?.5-DD1$!L!"!EMEJE(3#$&B %HY!S0JP?<^#S*E"=*6B1*.@.#'1/
MAWE6OAZ$>&:\XI@S:PUE(/),JO\% S#8*X"9(9S'SS#BB7C(Y1BYK'QEYGLA
MS'<7Y>N>?NRL?#TP!TZ5+R6EI<PB(#FWT0#5"BA;IO^.NG(473A,E*_+6X.+
M7..\TFQR6]^>'@X/N[%SA6MW#M/4W"?=VW,CW*NZ6&W"K:"?;STM+.\RT=Z*
M:#=F/7V4T2"5XL!8# &5D6.CE1N)-E(L)MY2(OGB>_JJE^PU<]\B<5^E/7V9
M!>_(@C/)X3D1UG@/E%<24,0(D$82 %&R"XB)R]7>V]>722B3T#/S]67JN1OU
MS'C[#&)44\T!"YH!2A0#*B "K Q1-)C (<>+[^W+W)>Y[]EZ^S(+WI$%9Y("
M2,FA2%FZ5"JE980!R@0!.'.*1>6+!"_O[>^;(PG-)0#UIOE"\S.>US.>O[-X
MW+3(I?UQ^=37L3-^D*ZJK7PI+_,.Z-A>_<V/O<;#HG\X&HYT+_7PVK24CQ3<
MFY_Q2,]X7B'15VO*;Z\*<3[K[ UR02]@XJ9KM;4QUN><$835BM ?=/4H/NMH
M]+IWV'7]T>3[B[K;*?NLCLFG<=@U?M ,I1XW;$XI*!\WNKU&]^E<<52"H^7*
M-(B+.&ITT$A@1$" 1PN7P1!<0%&C0TL4H^7+)]@7/I@D WR.Z2@RP"L#\*G)
M!@-5E$5L8T)XR@7$@;(DI:<(C KGN4D)6"/ $5R^7* ] _PY ?R^21@RP*L"
M\!G/M';<<B@L"!8Y0!'U0'.M@1"6XZBI::GM6(+#Y<MNF0SPYP3P^V8 R "O
M#,!G$DQ)#9&Q)$IP+0"-TPLT11P$'O6T@%$@98*I)0KI\N6-[Z<#^//RGUT-
MS]7?!4_>B)YNNI>UZ/14 0_"9!/H$DME@KH507T^7\#%!VBY T%)#RAF#BBD
M#1 ,4TFQY@*QDJ (7KZ\/;[P6]09XM7R(62(SPOB,P<]F(@,#5FT+X@%5&L.
MM+/Q!X%QHJUPWHNY>1$RQ"L-\0IX$3+$YP3QV6*PREHHI /.,@VHERR:&5H!
MS2DS$!O'_-C,(&CYW@5A,\0K#?$*^!$RQ.<%\:D4M\%&T@X2X  %H$)(8+3V
M0")EE0_<ZZ#FYDF8=QC7GZ.4<S+^[=H_5OX9?YR^>N99^X?#43L<3S"V\D\S
M^/,L_/;YW?>('((3AVQ[7_3ZH_C 4;\8[?E((OK0M2-*$WN4Z2-U^D=H]W3/
MMG4G-C!^T/6]T7"Y6.W&U3$:%EU]G)X2"2+^<(=EB9IRX<15LGSM($P:0O&R
M8+&Q!_UANXQ8&OB.'K5_^#<_VVZT=TIV,S>.5])K.+U%F]C4R"W7WG)Q<3[1
M<)/S@S'[,S6V)#^)!>46::<PI,H@B;2,L!9$<VL)DE\QKIW>M'<6!WD0>1:8
M@=??@0XC/WBM.S_U\;#VY[EAZ+9[X,*P7QRQ:P<FA <;F%\%K?U35Z8MQ=X@
MB=)__'Z*HN'4*FLU]4.QEJ1P1,D__]0K5TW_K\;\01?CV^9VJ]DHMM<V-QJM
MS7>;:\5:<^MC<VNUM1D_7FVL%]N?WVYOKF^N;FUN;%>?R]::C>WFA\WUU=9&
M;'HK_E6/'=LNFN]BQ^H?MS;^M='8WOQ[H]ALQ']O%*\^-+>W_RA>?6ZL?E[?
MC#?],3>>CV*TG/XSPBI3EL:!Z.B#H7]]^LL;UQX>=/3QZW:O[$YYTYNN'GR+
M.)VP7,+H!4E:MF;\]12^RW ,X8EW?O+FR=?+Y5<7Y/OX.\J6)5;7?@V7T;7?
M_>JQ""US=+?'_OH[1JY_:6YL%1N+Z8T>^YN]I=\:>>K2I5=8<38RL1]4*%X[
M"HHH57Q1C]?M#8N-*&Q<R2E_'?9\0>#2#2*RG^W0;+>/;C@P-UP\%=E_+)_X
MNCV*;[,W,/1?M7M%?%$G:B/#2V=NKG*4W"()?,570/(VSJO'-XFA?U8C!^?!
M'<]U</*RFL^RNNM!DKN.2>7B12XEYWHQE7BO'H\74-?GEO[X1ZC$^W'0#^U1
M*N53%6?Z<;T]<:9W/]-FJ_YS=[U.FJV_]AJM3[C9<NWZ_L;/W>[G^-G;[PU<
MISMXXV3J3%\E]2^[W3K>0 V\\W-G_]/)[OIN>_=+G=5;Z;M-TGS_;K_^OK%_
MT9E>7[='N]V=V);/9+=TQC>^-[I_Q?9_/TK?[>Q;NO.E_G,'-T*]/7&D;\.?
M7SV&0A 9@'*4 XJ%!L92#Z 4@6DE&9-I0USR.07DY;IDF;^JU/%JE+G-3'97
M)CLY8S(7K G<6D X1H Z9H!T+ "-G-7.,A)<VO>GE_?\JU=P+)-8)K&'4<+F
M7K\V4]==J0N=41>%0J'@!$ ,JTA=S@#%L0-(>>6CA)'>L=H*P_<.5\K\E?FK
M@OQ5C>*PF<GNRF1DJH2QJ =+[P&#*IJ3'GN0R M8K3@UUE("753"R"(H82_A
MW%=SM#?.IW\P\'N^-VS_\.?]>DM%SX]21,=('[W.B9)>R#/FE"AI+'7Q,F85
MA\&[_B#^LU?8P\' ]^QQ,1K$IW7*6*A"NQ3^DJ+_<EJE1_/MEL2T-LM+T\+M
MD]E:FTQ6*\W5N(FK/=>:SMSJV<0U_*@96OHH"_9;"/;&VHR?6$%OG=4$R! @
MH 9!(#F%@*=(0.$M0LE$N5RU(>=EJ#;&J^'_S&BO MIG?:F*"$,XT,I$-=Y9
MDI(M"1!4<%QP[(U.NT+/JQ1I1OH\O809Z15&^M3UJ+1RAF$*A*8:4!3A;CPQ
M@ 88H<\0U]#65F1&^C-%^L.YTS+2JX#TJ6N.6:8TE1Q$A3RE7Z(4&&4A0(IJ
MQ" D7*1#DW(.KKD*>=\6Q@61(NKLGNY]2PZXB+!!^T=Y('#F%&*[-QP-#KOC
M<U4O*CW3;1AM#JZ(.S#:FA[NO>OT?_[+NV_^O6[WTH>KZ5#BEK<=/1RV0QS,
M4X;+/'8['MN>\41 BXWTV  '-034*PP,I!@(I&D@F!OL>.*Q:E3NR%D=GH<7
M(N/[8?$]]3U@(IGV@@$K?+1#(/= NT  5YRZ2.!<L8AO?#D@->.[LOA^R@"E
MC.JG0_74SX $YPX;"HA.69DHQT %'Y+U(4+P3".3LCM?X5+,&9F>#;;GX&S(
MV*X*MJ>>!<E\U+:$BBJX\!';#@'%XP_N,1<&8X.]JZW0RQKY$V=BNMZ[<)JB
M(C;6_YH-\I7GKWQID2,7W38A7N$*XWOQMU%QD$BIWQL6NN>*?AEKU1[Y[MW<
M-XOKD'Y<[\ULQKX3/^B[* AN(S@^CB<M2H7RJH_]X6C@1^U!F0#L[7AF/W;B
M<&3O]/UDR/&,5\<:'124! 21B@- EW:<L00^SKR,LZPEIJD,M,0(O\E1)L^7
M .;@WLD$L# $,'7[0"&D,PB!:"4Z0+&,!J)V"E!IG'/!8)[2]F8">/8$\#2Q
M)QGSCX;YJ5/(*.JI#@9X8Q"@7A"@L<,@TCT-RA.K9!3Z5:H%E-%>/9=0%O<+
M _VISP@[B2*IPY3"VP#J( 2*$@D(])Q;[*T-N(KB_B4<"FOU1[HS<5?\XFC8
M?6)0[G=RMWJ,5_T E4Q9=Z"LYNP1&*0XYP9:P+B0@&IK@>:. X6(MM%&=02G
MH/@Y;$Q7YGS^''>V7C+BGR9D)2/^;HB?^B0T,A"7,;(4>D"A-D!BC@%G1+/@
MG=#6U5;N=9@](WYA$%_5():,\[OA?.J'<)1+'Q@'4CD+J+<$&!)2)I[ =80]
MBUI:Q/F]JXYGL"\,V*M_AB;#_FZPG_H@(K@51U&\JY 4>NX\4,0((#@SUAL.
M95GOEUPN!%H]^3ZGN(N*^"6N*1I1^B5NX9&X80JA2=$9$H?>]0]3"9O3OBQL
M@K&K!_"N"<;F,4!5H?NK1^8I4YU<P>^GW![_U3E,8_BQ/R@C%4>C0=L<EB63
M6OU&OY=:-NAW8H>^;::T^7XXRO+@-O)@^UP,BJ*4DP"T0U$>((>!#%B!P#"V
MC"/'DQJ(Q&4]\!173Z&IW"L%Y!R0O1@Y(C/'OWB.KX;'+K/]D[+]U+E'M(/0
M40(",2I5/I! 22: \T)%T:X8\3Z=(V5S2U69R3:3[4LAVZ=TEF:*?5**G<EK
M[B7E6@J@&;>I3GO:/R$>&*$H9U&48A\5:L8NGPS*"G7F^(HP6>;X>2C4#^<C
MSVS_I&P_=:?3@)U!6@+$J4F)62+1<Q6 #4HZ8P7#)-16L+A/@$QER+;TM_]9
MKJ25^Y=.S_?E^_)]^;Y\7[XOWY?O>W;W/:(-CY-ILNU]T>N/X@-'_6*TYZ-I
MHJ,E,/+)1NZ5ZJ!._Y@FUQR.X@=E;LWE8K4;=<[1L.CJX_24(O3C#W?HT\-*
M=31JC\O7#L*D(10OBY2]XJ _;"<M]_7 =\J,GF]^MMUH[]1/-G/C1)V%TUNT
MB4T]'%U_RT6E]8F&FYX?C-F?J;&E'26QH-PB[12&-%6-B*:"$%(0S:TE2'[%
MK'9ZT][@M <'^ELT(P9>?P<ZY>YYK3L_]?&P]N>Y8>BV>^#"L%\<L6L')H0'
M&YBQ31&MV/Z@3#3T.BX=/TA7Q3;IRK2EV!LD&_T?OY\B45MI)9,G%81:2^9]
MF8I6KUPU_;\:\P==C&^;VZUFH]A>V]QHM#;?;:X5:\VMC\VMU=9F_'BUL5YL
M?WZ[O;F^N;JUN;%=?2Y;:S:VFQ\VUU=;&^O%V]4/JXVUC6+[7QL;K>L;W]6#
M;Q$3$T:AI8.O-%:G7%,:R+$/'7TP]*]/?WESFM2GW2M;4M[TYOSC$KPN&,?E
M8(V_GB!/J67)2 +?)"IM\N()+I=+7%ZP]\??<;R,V/5?PV5T[7>_>BSBRPK*
M.SWVU]\Q@A^DL>AF8_";R+]*!/BI>SC>S_JD;M(GZY,?[VEZ=;67='48V?)<
MIQ9JQLH'OFZ/XLOL3>*FV[TBOJ>3LEXM%?[(^N1^V],#7^; .O"#R;^B_J6O
M/T(ZLW]Q"T]>M1?"7X<]7Q"X5*1=S'GU_":E_Y[-"*Y[Z[LF+B&"RE&$MX'5
M78=AP5ARL>?]&E(YL]YNPAB/ (T%6!,+?2#@AI)U>WM6![[''GBE.GM?V-\Y
M&<VS'["%3MYQLUZ/2RJ-"CT<^M%P+A6;%Z#7]P#' Y127LP!FV?F7C'VP55X
M %)V\-(BL>D7_Y_#]@_=N:JRTFVZ_\0!33?K^:WCF:H0D72SKMTB'DE[B+VR
M5DBKJ15:,T(T3>>ZD(2&L:^;-TDOW#OLNOYH\OVEP*2XLE9[+OVU,5U?JZ,U
M/1@<QP']6W<.?67"C1K;DW"C?4MW]S\?[[1V8/UD\V=S_=-)\_TFW6U94E_?
MVZ_CST>-+[N=';SU?1IN](GLQF<V3C:.ZOO?R<Y)^KP>V[3537]V]S=_[IQ\
M)[NMU>.+X4:-=?<]MI_46QO'S9;;;[Q_U]XY^48:[W?BG]UN??_M?OR\4U__
MZWP=*,R1,8$)0&U @&(*@=1> D0LPH1C9DVJ$[/$Q>4(_H5/()A9Z5FR$H6.
M&F,EI9Q2B(EF4D@"N8$88XA<R4HP+F^46:E*K#23QA@3#X-1@!-A 27& !,X
M! 0+8H(@$%%=6T%+@M *L=(\BVU67_=K#;3SA;9VO,L_\-9'')B.7RIZ?O1<
M2FLNHLJT.IF31@K=B"SUH1][MG4V/PT_FMBWF:!N0U#M6;6)&F)(L$#9E'B5
M(IZ2GEC@F3'"$&]X2&6 YZ$VY5)<E<7R(R@:&<L/A.69_(3<.P09 P*E2@G*
M8F"\TL K)[1!"#IA$I89J5)9O9?E:-KL_8AKO#]H^V=3]6D1-8O3:3B.O),)
MYS:$,UNER4#G#'<LZ@T0 <JYBLJ#-2 $BKWQ1OE0$@Z]?Z[$ZOE<,EP?3WG(
M<+T[7*?Z@94DLJD+ %$1,>ML ,H[ QC2V HHL/:EKD]8E6JLO"QGQ,>!/]!M
M=YK(<*2/[J@HO 2SY>Z*PGEZF0QZ*PUVII=;T,NY@@B<.41XY!-NM0:4, T,
M8A#X^,.D@_Z.P=I*G)$*&1_9D5 572 C<EZ(G I\C(F/TQ$B(DU"9*I.@@D'
M)A!$$*94:1<%OKKWWD-V!]P16JME7%:QYSLN:</%,"[T[!=X4+_ =37AQE/1
M#.OMX4$_SL/[.+X'9RECXJ>I+>W>H7?- S\^-)<]EG<@J-F@#<8H5DQ9P#R*
M! 4M!E)Y 1176AOEE(:NBF7?L@NA*FK#S?<?,KP?"=Y3_4,$[+7B'E"5,FC'
MJ03&BP",@T@31GF<T^1P0(14"-POR^'0'-=U/!<GGAT.C^-PV#@Z\+VA/RTU
M.Z:HS#JW9YUZ:S4QSEBQ6(V\8Q$W0@&.$0'48 $T5A08!(V3"BOE9&U%B,N5
MVK(GXKE =<Z>B S5>4+U^ RJ&@:-K)6 :*Z2!<"!LLP#+IB4F H/2ZC>?T>B
M>BZ**FL%D]I*]]<*SF?HK'X]N JI#+<T;3(9W86,-F;U!J(]*7<P%"4.4&88
MT-1S@)AWB&@)68K6YDOBBA3E]TH37ODLX!GKE7)C9*S?$>M3Q0,R9Q$*''C/
M*: >&1 U$ Q$I&C$A$8(LH1U?O_=D<?"^@LXS_YQT#^(K3E>*@XZ.FDF/5>>
MUCU(J1KS>8TG5D1.9^=CFIMH*FV<SDP.V[HM5VU>\&=HB3R*#(73 5>$@(&"
M@:"@PY81:)U.9UNAS+$5SQ? CZ!=9 #/$\!39<,AQKW %!B1BLLAJZ-AH1%@
M)ACG36!!H3& GV$H1I7UB??]OOO9[G1RS,73:0VG<Y )YE8$4Y_5$"@Q @9F
MDZN" $JM!U)Z#K 63#*"K#!IIQ4N25&E@^8YCF+A5(2,UKNB=:H.8 M-()H
M;5&(:/4&J%07$46=( C%K("TMJ*6U',\B%%E=6 <#-'NC73O6SNE1Q_O?&3'
MPI,?USR=D;'_,YHC&T>3T*U,2'<BI$^SZH/SWAG&#3#$2D!U*GX=B *.4H>$
M0L)35EMA2T+>>^,C.Q@J"^1'.<B9@3Q_($\U"X4LQ (JP!%+5>PU!08'"*PV
MS!(-J<(V 3E"ND) ?@&.AG4?_&#@73K1.8=XBF?-0X^@4)Q.Q[A <$L?G=%1
M9I];L<_G<UX(H0C5T@/!! =QZ@)0QCF 390G.L#@$_O0)4@N%_W-3HCG M]'
M4",R?.<'WZGR(+VS1FL#E)<1OE0[8 21 #')%4K%X)Q/\(W<6R'XOABW1*??
M^P9&?M#-IS2>7'^8"0)O]'LVAV/=@7MV9E4';)TFA C@@]. !@N3ZA" \\Q3
M93 VCI9Y*+&JD.&2/1 +ISIDY,X%N5.M(6H'(L3_ \D]!=1  ;2V& 0:$)1(
M>T;+0YX*YS,<CUH/J]5LK7XHKJZ*]; QW%4;B5M7$[AY]RO"O%?WNUHZTYAT
M,]7>BFKMK)+$E' X! 64=3!2K69 (V$ "YQKC[6A$M=6"%I"_/(^S2D&GD #
MJ&B\_",57\E<^L*X]-&. 64NO2V73M56*[GF$"I@*&: RB" M! #8CWFV IK
MJ(]<"I>N2A.0N?0:??JT(:=-IB53/D'QQ9D.D]@EUS],X3QW*9==L5:^ ,/E
MP^;JV\T/FZW-C>UBM;%>;+>::__O7\T/ZQM;VV4N,/&FV/CT>;.UDXO]YF*_
MN=COQ6*_G;8V[4Y[U/:YXN^CTOEB#]C+RKQZ"A;GS:CHF]B>,N=?+OC[,DIK
MSBN3VWI</CD;PQVLL?USF5>XI2X8JX'1E "JF0-:!@ZXPH9+0Z33H;82#;,*
M!1[DVKV98!X^_UPFF'L0S$Q@M'?8V@"!P5X":M-9;.XA0(I0%*0FQ/':"LIY
M:)\L$_YI_=T#?9P*0N;HI@?67$X'_.-XO#/'W(5CSJ5I\5!0!2$'U"@,(JU
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MLW5L.T=QM[,7!\?=L-6+84A.=KZ=QDX_OHW0A_WLY2Y<90:N<C3%5131W-"
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M$0<C1HYCC\"8=0"RF)BF-Z==KHY)ES;JV<9SAUKG8;?FHPL!&VXL<50ZKA-
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MJJA(E-3&1 G'$6OBA4O*4"$TE=S>#+)%]V-)@'A"ATX[&UGR'CD2+>(Z,6#
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MJ/:2<RZ(@A<&<RES^3POK+R;F[: :_W =1P^X/&G+(UC>-!(:8$1CUH@EZQ
M)'D:?8S$$5F)^^G"H@N\UPG+"KP_+/\"\#UPK0QUE .!-DSZJ)Q2S#*1L"XL
M>@6 _B)YXXA^2M)*HX('WNP$XM0+I*4,2"9 >!48\0EGI[=65YW=A487G"TX
M>R\:[3BC7FF5L#><!VJU3D9'PJTC +.X.)MK#J$7F>I?OGZR,B@/.R!DF#,
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M"&,K6!",DYP+0*Y)ZRG!MW4UV%I$NQ3#?0S#'=--+903U%,4O :Z:9U#3OB
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M/"3#$>FFB?$8#<=P- HNS8)+!Q.DA-*0'"4!Z4"R2&<0R'$FD $*ZK&6WA'
M)?X0N=[Z.7F*L3X\RKP8ZU,9ZYA$<*ZUSE4,@XU970U8HI'*(QLB2S8Q';T
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MR;+/8#()V53R3ZI?L8E?6-D.(9_^GM.2;?D%@HD!&[Q5FP$L2ZWN<W[G_1S
M&=B^5M"/U5GAPNZ%[MZE? A$>M;N:=S=87&&J>+1".>06/\"([O;ZD=_G1[N
M1;]5O_V^"W>^*%K?X#C:5[# =CE9&KDDQ.:L^^;:O8ORF. 3,-3Q .$],0;H
MBK.K:AYUQ]GPR)!B5KJC@L(/J'L!.CY..L3JXPMU%1:.ROT%L,7W5B<\.OH_
M2Y2-\#C-M!4T$R9GSAO!C<ZHA']C34TL*O4MC5,R^N'.]2-ORP7W3WN5()Z
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MY4V&'6[2GZCD4U:='X9 =E"PAZ[RK(^5<H2VFO(]<>7U04]'3"L+BD*M%*I
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M^]'X^/I;$%L&Q.H!,!EK4/-M2EB2H8]9Q@0.5A-&74*%R?+,80 LG7>*K&T
M;&1SP&+=SHW*Z*(KGT-TK:S*F,FNWH;5-@G\PA$V>MVJ;JW\QA8&EX#!*>^P
MSWC.M6($/5*$*183Z3-L'F%IQF7*M!,[^_E\X?7:1MH>& 4W4!7\:[Z2Y)DI
M@+]M. C6_K*%OF6@;TH#Q!E!!K#..4K!C(T=4=QR+-56G.9 .1;[J,]W 9AS
M]SU[W>_6R0O3%OWB*-WU]OY:>_9^-6UAE5NS+NB[35C8XO)M</FDKI(*EJ0L
MD8[$DG/"A,N(-)*3.#',N)0K[\432%A8(;]O:*K"0Z<<?!RG%81.H:/>/:-1
M#_=62U[-KL"1YEC7/.=^C7!%9^7P.=6O<A,V*QWA-8ZC='^UO@6%]:A;#:@L
M_S+Q5\ZHMOVWJAA,RGMK"/S<LQ/8\=]?O(N9UM@^5 H-^BE.D= ))[F5,G-6
MY297&YN=D&5[2<Q6GYV0[$F>W^FV-W^6I;?+>;B_Q:Y<Z5^3#1"/M@&WS$^9
M-6Y6F,KRD_X*CZ&<'X0>)Q$@-2REYABZ33^(=<[,*9NV+YF?\^1/^V/X!?28
M UBT.G/1*$P<-*.RH=^&DD!HK/?0YU_NPUI9V^]:_:_D(+3;A7,^;/5#QYTH
MZ.SO0/&L!A[C,+^?=;!Z;CEKUR+D]9D4+VZ1"OAK6W0+ EW:7_<8B_QEY>5Y
MOOB* E3!7\#+*3+KP6R+D?S4F68W]!4D84K0$MU3;AN>6KMW7KK4;2U]O[^>
M?:!$GN0R\5)*YK4 4T$PHY5TF4TE,]O4JQ4X>#M_L\]O_MUN)(W6\>$K6.>[
M\\^==\W/IV?Q\6&[>=SY1(_?_'V)KHI9!^_GP^;73YT/Z:?DZ/+X]"AMO&ET
M/K]YW3XYA.L_OKKZ?/[A\O/A 3OY^'HZ]8HQ[)8N%;&Q<(1I%1.I+2.)T#;7
MQB8 MSO["?WEI(,5AM]65-6[HI2"1U4S;V3LA0Y&EN0T,]0:DVB6VDQ[RV+J
MA;1:Y,XE"QV,"_J6HTH_R]TC=GU]O;]Q9.14-LZ'OO/#]E\M[[:,>QO&_3%I
M&F(<X&XLB<^X(,Q92H!O4^*R-.8QY4(S&D;>S882[J 2/W=&NN5LL(3G5$IA
M,T8%RZR6J>(LC3,CN%%)GBT6DDF]]?_()$1C<-R]XJA[,9S$,#=UI-=#LTHZ
M9A4C .0 Y4CBE22,I8Z(-.4DTXE3J?5Y;LW./IUO:_Y_ES&V[\.&6K\K5Y29
MO"DFSZAU_"IJ-)Y%FK*D!K-$4IEPPQ)OA7$F%32QRC"6.+LU%#8'1*>2DVGJ
M36Q$0DSBT5!(8R(L3XA-%>,L8SK#.3W)?(;>XR4G/X)?:B/5FX5V@J64*3AJ
M+^,$+'VCJ*(^SO/4\#QAU&SMA'7FVXF=('3L4]!P2&)23YB5DFBN.5%YFC,M
M8I%I$.[B#G;"QCF--Y(Y;VE[:"%CGN9IHK,,^)9+K9@32O-$.9=FUR1G;FV/
M^V&_B>U!79[Q3&>$96F&;9\8<!ZW),T2&RL7)\:Z6]@>CZ#*KY_M\9ROW![6
MNO5U?*:E$:O<FG6Q>A^Q-.(AK-[RXN#*.&VJ[M-JNO)00KW>$]?S5)J,>R(M
MU2#9K248#B5@Z#)O5&QM[!?W*]B@FH@5,OH&!OK6)FEF$]]M1;4L#UV3,@+&
MT*;RH@"4+N AD>OCF[3ZS5!BXK"$I'_5=<49UHC@-%&#R7SP5^W""%WXQ1>]
M3M1VP7>!)2DXG--];_7#<+W>134ZH;^+)2:7#IX(_ZTF4H=1@&%$D6_W+G$*
M\+DS9:6+ZO=[IJ5&TP C/QR$X;^CM)Q0LP+?;O7##&SK[!"^B;P:1F2K[UA+
M<]'KN_[>4^UE6@(,B-A>N<4O@ M<@5<!'F/]SV'K&YQG"S?NJ>[!SOY)-SI6
MA6E&=#=4/861T9,Z*2R LI-]&!5=O<>:*-4>7$5OFZKH*..& 9K[D^&S0.3O
M!ZKX&H5>^Z6"HMK17\/OT?N]@[UW>W_M[082?/_JW9_1^X/W\)OWH)>$W%9X
M#OX=_A:]&A; !K@SXX=>3#TT0@2[V"W+O69KP'!&]05PQG=@T8$#%EUF4+76
M"<]]PBAE,5,8I?4NDX+'AG)#95+I:FE,[US&>@B8V.NK]AM\AZ.N:0\1=X-_
M!6>H#)T]&6' U"R53=?([CZ,^L=9>GSV!814''OJ"&<\)LP83902G)A<&)<)
MG:0TV=D7\8(!U#.YY?!QM=>JU+MJ;%JQ"DO*\".<5*@D?!%R&H$MJGJJR@BH
M?;'2@>+)5Y0&C6<XN/XKL_K.(P$"^I>F]J?V;[.8Y-*?.:(+I[X2Y8&_7ZCV
MI;KJ[_QCNN*QU24S6SC[]M>^I/>/@OS_5&NSEJA9( K]3TLDG.6&*BN3F$E-
M!05*YX*G*C<FI>(+W]D/E9>(=CA["=MB__,?:G_12<Z0>PD>VG I:2+A51E3
M6:9-YJ@0UF4)8Y;3G6@,1P>(:LRK..:6JYAG3&'&9\S3)$XS@$)%17XM93^N
ML*O*BW:C_E"CJH1":CQ=.91:A&%[./^]Q.%2NX)=:J*D4N6$:-,&GD;EK)2%
M@P)65&)+.=A9G16NG+A<WJ<2H^$Z7\YMOUX&P0_]E4BA!2$V$$278(3U77?:
MES\6[P>CE9]6:SWQKY69[5@3/S.)TS@\N&P<?!$QX[E,':$ILX1I*XCP%--?
M.0<^P:Z$8,E[V,UYD>/'NQA4GFF-Y&&(X;8'_J;=TZK]"A3 WI5[WJ?^HW'V
M)?:"Z<P(8F+G",,8MO"6$B><BP5-K<P5V MB@9[A1GL8G84];5\M-=^[E RM
M+KKR7J3YQ6##+(N/B)1@AX;)!@$!KQE@?WN;XC=;:<NERO\[VL)-U[9!]8<_
ME^/L <S1B,8QD.AC"D8P;'\8=P^6N1O@U^"AA\XX#(]&:6G[Q!7 MPHPL-'8
M0 T/)$!17"'<A^EN8(=?-EM@+M58&!X_GOZV"Z9\'QM-] ?!!.J#Q;X7E5[5
MT>)*FZK^(I$J0B.+/H:6[>BZ>W8 WKXV,QQG]0Y3V_U(+LJPGCDRVH ]+%,$
MJQ:84XM_S)W\)9[9BT NP>] Z^NUUXW>P$4OH__W/R*A](\1"R+1U/LH_FM$
MSN\?FYQA _$$%.B= 5):7=A\P$-8")Q&J9>B)E!Z#>&\CN"OI9]>X,G@ESL
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M1[UCA&JS^&OYA)C'W,#UT]INVTC@KENU6=2T"K?R7;9B[10_( OV>!STI#0
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M9^YM5]N?1"@R*57.)<^\R)F/N7):^3@'0RC/C,[8"B(4KUOP>/<72)LY%VW
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M>&RS/YI@A9^5<_,^XB /G%"S8"K!M3?V$0X?B:Z<*JK19 <71:L=T3 H9++
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MZSTBKSN[VN@]N/&-48%8J&I?IV(':.D#9T\B"NBB!R08H,=Z%#0$F&Y73G%
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M;#"G>?8^B[DMPK*87N=?^_TX1+?Q31K\TPUI^ 975.7;.?EVNE"*B<"T]<0
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MZQ?E[NAO)D3<.4;N.(9@$[+ ]1@UL[Z"]OSSZ/SQ_(/1[7QGCLG#LPF81PM
MTJPCA9B<D1R,HU)9YX7)[AYL@MH&?[5FP-OI#+RU@/J?.N+ !P*64^*SIR3D
M%!@'M R97+85, _ [LG.KYC?&,Q7P"\ ^$G 7?#,><R9I"1T<=P%\;PD"(U7
M.LEHA8(*^ KX]@"^>ON+HGYZ3SS7H"@G/%M/P E!G$V.Y*1R "N\$V'347_[
MT6;?O:0EC$^[[6VWN^Q@F1OO'S7EUHWY+2/'-6[,?XC$6/&_<I.K]DIO"75,
ME3 XD :XM$2J*,H8^D!LF;M#040#"C(#M;6SK%9#U8]J6<7A$E"]JB;"%=@+
M 'MJ/"BU: S(3"38A Z306!#$,1ZM.18"@9?FC7$?NZRQ(KIJJAK._#5Q#^F
MJAV4DMQ[@XHZHXX&J21Q"  BM S2)4-3%LOK]7$?H)Z=U;U%COA6\]U;%IV8
M72?QIONELXN?.AAV7O9BBIW?3GNI(^B3#D*37GIH<U>-7'Z2<PNK;24EO_0'
MG]T@7O1JN&,IR3S264(PK9Z@GN!>3S!WR4R;B\P6*YF9YU;KX)N-L6^U$LE[
M5J8!4RA[0:,*PE#-!(L0W:AK%CVW;^G]#8"NI3SSV[B?+I7R).=TCH9$)04!
M+ACQB2LBA+29);2 -2];Z5HV_KGRS.;PS#RQL240S;)B8[60:&ETTYV:-L_
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M0$B$:\O1('*"6.<YT<H['I"#J%]>=[]*0Y6&6M\ N!I$]\M%$X-(>VZH!D%
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M%4IOC*V5L)U]"$V(%,(83K#G3&D (N.=,M%1R> W,,I*@1N%MD?!Z^M"W,,
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M X8Q=54K%K2%=V:Y',$E^E27'ZD%V)A=X:$4*6@3JP#1BVM@^ 9F&?#=D;K
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MW,=>FLZE_Y6Z7F^Q_N==-CG%7JLN2GAW8=+.VL<!>/'"2TA$/9=0$/ X.D*
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M*.KZ-&014=QU"&4.)XQ&(6'<C1W?4[8MZ:O7#ET![F7BK;>52BZ*AV;_+3P
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M*0IKOX)6@ZGQN)' YZ+,%BW.J%VNN%A&#:@!XG0L$D552T89X6-HI6JKLB[
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M-*:&9BBS20L.#K@C&3;9"^UIE!>8UN2)LDQGJK=@12# ]#2;F&H3+;=+36.
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MGW=-\) +CR:QXAW9+5(GY@4&9K4$1YQHK-"=:U7)Q9.%W?=4+MH=WVNY=6\
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MZ801PR]BPX3)U^?[,Q'^.?OV:DW--"+^])"F5E;I.5;7)#T+_;>V]Q>0%E1
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M$LQS[4B9L8H%+A,#&1!R\4:&M+!DSLDK;%D%-PPKXQU1:92R0 !(T<LHG8@
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M=F%)FI,))ZWESN-MN7/'AO"$'IA^:EB_#:P?FL$<HBZ2+.!L7 W?RLS0D%I
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M-U#TW"-JR91*F4%1GKF DLG@T6.H;7-DIWA<VPW4R*.1QUGDP5.J?IS +7<
M& (7+O'**-Z C+DY<WI$'G.-18HP+DO/?/4<$^M'%M 9EC49+,X:AUD3>?#%
MD\V GBAYW% ;T%[[:W[&<1J._L9)W-W \=WW_7Q O ?HA,0249D(BCM,/I1B
M<Y9<R:!"\];TA?>.#(#D.D#T"9@J=;@.U :@6@MF?;#**!!!Q84EI6XL9/_@
M>>_!]$U\0.11>WJI;*(W-H)!"$KD8*0!KDW6$IJWID?D,9?O$URP9'8Q",DQ
MT%"8]Y"9D6"R$ZKXP!>6I+RQ-,-&'HT\3I!'<"Z0::5CMAHRF!"U+1R+%DDJ
M8\YK-='(XR[)X]!=8S(7%G-BQ16RN")97%Y8SM#I M(1]_-"FH=8-(T\&GG<
M%GEX+WDPSFB3,O D@@ E!0B1; F%0W/7](@\CN3> %F<CB41)9&'2\P5APR\
MRCF"+0IE+8BZOKOFL9!'YZ[Y1U?53'^GX=]+^RNSLKM)7Q!/_ILN.E;:"G(Z
MKV5[-!G6Q7P^SAMTU/_./WT9IIWU?03.O7&Z L_YX5LP3$8;NSMGO^7XHM[]
M\LEZ2TH=K-]TM>;^K'?;8=9)"R8*3$0CX(-P IVUSBHT,2KA_A)UHL[L7>L'
ME<+;1 4LC#-^9EAV\O@Y;GS!O<G"/XXLQ.9PBQU;^.-K=N;2E')K2S,]]<2!
MHVDKE^>$ECRN5]$]86_N9; ^K@S_;^?OD5U86NVJ_4=E4%O53 O^<>FT_3\"
MD1MH>7:T;<[;_'?>VLW[/7,J9;T?[JS_O#LA$.7Q*GW7/S=&\?.]2XS/^Q)#
M?GSYBJ[_3-?\\],'^HP/W]Y]K>^AWXL/E;V_O?OVX=/ZQLJ>YQ__9YW'S3^W
M\+W???/IX^?EU<][;U9CE2C#E6]O/ZVLUOM+]/L_UY=_^4!2967XYI=WZG^^
M+>N5U<]_94A "KU@2<G(H'#-4,K C"M)$TLC2C&5[T-:Q?1BI[H64'DA8X1H
M.00N F@R#D+DL2@5-&U!)D&\77EGO)O/0=5ME>]VA+/R9O75X+\'__??G!3B
MI\';5W^^6GGWZIZZI'5W-#B*@(.56>I:(IQX\10"_T0G=UCV[HG"W^?!6MZJ
MVE@>C*?0&FR/274;TW<-"J&L:X=26[14[-<6*1N9[4[R8#.G*L9)T_M[&&?]
M6[;'>4+4</!)M;M+?5?7X&7:P*7V#]D=#S#6?C*XM5?;B^QNX6X:UG8P1WK#
M3';HKZZW2/V0T4%?K,7!+7/,R^$$U];&>6TVJW[&.1T#/FF"^;3\%WC.K<Z2
MT2('!B@M"P4]$X5X1V1.<J,<)QBPCLP&993U"!DA$*]H)YV$B)#B"8)9K0U^
M1AL;HR_U='0*V620#C<E=T=H_Y!UAS3.9,%D\(6DP2#.Q,%D$/8.V@]U1Y0,
MC+4Q;J_3L:'/JM;/#W0D"5D;]6C]^/RDRC</87IM]FC=T9@>@?,?[^ARJ&AD
MX8%S)P"$!>^Y)XM*VU2D EG.U/4.J6+6>N=(?P:BC W<GN3G^S_\1$NVO8%[
MSX=;'?"[-_TT;>+#9EIGU9B.:>3=%TY?/E2F%OE4H9I%,V??/'MYL7OIF)TP
M?4W915(ISGR9+XHS7_O>Q[I%X_65/O7[KRG7[K7=ZU._5\LO?#^G>-OV68=(
M])RNK>W*HU>>DR]R?LN>$SU[9BS_T-OVG&S%-KA$&[;[W12A'VDCI=MO0?5H
ME^XBK<T>+#WU*VOM]#WXY\PD.#GAZW'W/WNW^,?BK</V4:[<ZZV=_]AH2W<E
MZ3W:P8LLW=-<G0;)!LG>0K)_2LA#N?+)-Q8E,VTTB:/MO5OKX7'AT2OWN@X7
M'X5UZ>?O=W+%)::L<"-BTB:@!0,8(BJ?#>AD>+$&9\G-EYFA>DZ4^-77.B2
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M[V$<_%?&C9WU-EKA+.*7TG"1G< ZJ 1=QD3_U#+::**TR37/9>^(__?Y>+1
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M7,R"="92J)5@1,!U<A4:YKV/3%E>M])EW04>H2?#,QN(;R5[H!1/YE2I782
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M+A.&U;73?AJ&^XMA2V83+T$$Y0LD!2[7KE&@08"TF8N&X1YB>#Y.D9WD,>?
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MY]X+C2TW+% >([$IU]3!21H;>$BX _G[!O)+NZ'$*(YA'A$),7M?-4;.,X*
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M\5(')G/>DD"QTU%92X+#6($47"770^<76 4@^["<[1%';F1$.#F,N"8"62\
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M5(";G/"$7!(.>6VI<LH&*L+:)F4/*''8RE8::YZ ,CP^87(9,YO:8_5'O4$
M#O$$$5U@_4:GP'QM!FAA8>3G>A+._]T>9%P8Q!HP3GJ3PPK$N$1?]F/Y;)C*
M)]#U")V:3$>Q_>CU<<P%:B:GU<M#.SJR/D[+:(XK-QU#(\;C7%4E_S+U1N-)
M]=^I'8$=GB_/X+)>G>2,9?UHQS%4__@&\/)4!1:C",PHKH6SS 6 JF2D48EB
MU^P#LG8?$%Y\Z<S&8'H4AI/F^^Y0Z(\#SW?_.<3^Z,^!_<M,]XY>'>U\]@1
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M:QL(65YLHSA;(W920N[+=AQPU Q')473--\ZU3!H1]G1 *LM,XU,49LU-I.
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MLP%?)J0^=E;[59KF5C\]>_Y_X!&_;/]<'>1U7R^RO"0I_H6]>9E'&G@M*Y_
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M4L7-_+*98Z0VW3_&F3,+?@>B[VQV5#:*M0A\.EN=)/6SK\XVA\1GU"+$\>(
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MIBJ,J'Q/^H-!C2I\GO%<CJP*/FF)6U=I[N:^&U3M&XH=34[LBNYU/&=NL_U
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M;AOLOSWTC1."(3G-$WH$0L++Z1LOE5'^;$5VM9OPR6ET!LKF4=MV0JAXIWE
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M9,4_[L).-.:C 1P^:\#AC4EC=87QW>[',B"^!L37@/@:$-\U'3R+NVA ?'?
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M3(186N,0^$/^/>]^SKZ'=Y<*4^!5_T )"7O^J_"32(T+#\AQ-SHC7URSJK=
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M<?[PP'QZO"C>_0 ;ZU;[FCW.K/<177-V(+LMC[?.R@;\1$;R>AN(6N_!@;I
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M6'3>QD"O8@8Z[H<47_K,5+@-FD7FXF_ENG88(L.FJ9R7[RJ?9WNCLH%NBME
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MO6F"J0@K7B".1->[@\QDB>DQ<<SQ;/P^<PV:S]@9<M=H>'^O:/@+^L^(:]P
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MRK M-)'/]G0'LSDD<1XI]284F+IIW]FN1]DNNF4\*T# !T"L<Q6A!9:4KSM
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M=V2]2Y.K<-W7Z.B5$?8L^H7$B*+??&'/ /[DDW:8'37D^XAZ"?F1KC6]35M
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MGS(%)Y OHS/'D)T'[PW>]V0<<5;=FJ80Y<T!Y32A]H%X+E:V'0!<'7, CSF
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M5+E<H%,]+MLVW00A9K& 58/7TY& XQ>_W'R^?K/[D/A#[=M2':'$=P*!D "
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MKU\42$J42((@K0XX(R?=B22B/EP**%05"L5?_OKJ>]8S9IS0X-.1_:%[9.'
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M<+%75V1MQ#^/][\<B\'@S@+[Z/-/_P]02P,$%     @ =80&4\KO7F8])0
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MNQ*[^'&M!!A5"Z1N%'P0=;<DZ[JWWJ^+%2X)SNM%F%]I:%QWW3:9GU*TCK9
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M$"-*B"I*;8T2J1,'?/6Y3Y[1@PRYAM6#]LG>8[H8TPBYB!_ZTP'V'$E))\G
M>RY Y1 A:*_ 2":-8T:GT,4^V>ISGSRK!QER#:L';91]&(>:!/3^VUD<#7K)
M"4S5V6-<4PA/*SRX8 -(DQ-C+!IGNWA1;SSTR?.YOPG7D'G0IMA26;]\39_"
M\"/.-NF$U 1%.$!O[7Q-CR5*TIFV@>O@<R='D.N>_>2I/=B@:QCN8*/KQ<5X
MC,/I_.RD2H]<]PL:)?,\.1*<L4AKON$20E8)#"_!V."E]=WM<ZW'\.09[\S
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M)#6^T7C^TO@#Z*)!&95MK-ISNI1H>:1WL&3RY8(%;Y%#R2E8'Y27HDD=G6W
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M02?G6';:66RBKJ>ZA]]4)8TV]G>@N$7L]BD0C%>3R07FGJA-XK$F_V=R&U1
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MP^!=S9J]P.4;.>^$V$M:9.7(S679S2I6T2AJV*8D1T<#<66UZ_0.<<P^B$Y
M< ](T6VA^>--BY?MFGHF616B,^"LJ6ZKT;7^OX0@@B/0@KMC[@/=B?4$]'8L
MIM9L7!]<7FE_/_3R[CSO"<.8"!2F%UO(<9"U:+&E^%U0)*]=LD&&8RVU.X,_
M;?VUY7*-(#N[<G=M$+?+0H5;!71^&XWRE_Y@L+9 %+FZO1",4WX^BS-0WCIR
M%TPB#S=8%S!EEIL4J&XTGM.6[=$97Z/D@P]\E@![%EU!RP*@M+9N:B(XS6LK
M+O)3;;&^8)/#OR6 $]+*7C9=0^[!=83V%.U:L5X5!9OTK.'166] ^IHU*X($
MCRJ 9Y*B[Z**Y\?:/.YB/"<DO<? ^!HEMSCSV'M<;Z:?<'S5TF+^+WK19J6D
MBF!]Y*!*<.!K-649K<V>)4]3\6/7]-J1_:7N1BI8H_,69RE[C_#:=WHZZU"8
MM&1K1PXS"@_D:CAP4AAR0+C3C\JQO&\\?VFZ4\;7*/G@ Y<V*]'\AV?O[H=/
M87CI:4FI;:W3 8GG3.N3MS5[4D#60@1D"F-H4JO[J*/\2_5'4,>:=^'@0Z,E
M_&M5=U=!_Q-KOW(:X6<<AX_XYP3+Q>!UOV O!E58IM7(%>\IB$@"0@R!ON0B
MQQ %KA;[Z$;:AX ^(:4>C;LUPCOH_*?V.!U=#*?OPO1JZVQ6];;GBW!,60&H
ME0'%644D#;#(.#)!,-,VYSF;GW "_'=HPC7,'GS@0M#.1Y,P^&T\NCB_S%.;
M :Z;^1?DX)XO]O%O;.KWLE>&9X.094R@$E(D5S1"D8EYB]*%T*2,];Z 3T!*
M1^5L35+X05="YK<7^M.+,3[_.,9YF[#%N>2;\FM(2X<S>S*)U!Y$K'-=R@X"
MI_C)9<>D,R6YU0W$#9/*=L\[ 5TT,^\:#1Q40.YND+\-1C$,?CD['XR^(2'U
MI2B*/B(XYVH=/4VFT)E!"$%HM%[9+ X6PLI#OPLU'&+H-9(X^.S@QGSVQVBZ
M=B:KR7^O1Y/)F^'RQWN%IY*0&] F%%".(_A0<2<>4XK*<^>:+T';XST!;1V3
ML35*.[P+ZZY%($00+(JHH)2Z7UU,(:Q:@F0T>Y9H>:-F'4^R=/<ABFK*S&,O
MW1U5\D:9 !$5K<E24Z"GH@1N;+&*)F&#?Y7N/E0#6Y;NWH6+!RG"O W OTIW
M[\?GSM68]R'C050CHPF^* 5.UT)7+B/$$A@H8U-23&BNCC;%/-[2W6W%L@L'
MK4MW.UTL"^C >$T(6 @0M'2@52U>)IQ*T6P17#V%TMT[F?VNTMV[V*QUZ6YK
MC$:9%/ 4;,WWLA!M\6!9R2PJTG$\E=+=^_)WD,TZ?O]^#>-P?C&87$*1QA5G
M+,V8-M*8:.Z,F8=:/C"P8I+P@F]!W\K'GA)[AUBLPX(6M=CC[%;.;'U(*)37
MM94?2^1PDI,),:8,.49>G/3%BVW.T+8JE'GYU)-VQ_>W;PN2%UK;!D;7U6ZO
M/?_XE6[W9&"5PP/,UW&%V^MP:&V.41<#02B"$PI"[4,( 2,7S@6N^#89>8^#
MQ3LJVW9+XBY6ZYB\W\E29Q=G"R A*>^BMF!M3:7S18!G)D/T6?&<4HJVLSGW
MQI./MYH>9/M1%X;KT%V= 0E?KP/QW K&/:1@:@H9E^ ,_9*E*R4)'<CUZHS!
MZT]^@@SN;;B.W\&57)0%(%KA2PS5XBG2L*0D9XZY!-6/BTEE'4QG3*Y%\/08
M/=R0+1J;;TY"^OG;[^'_C,:SJK6SQ40FD3QC!##4*D6)%I/ C ;ADU$T=&]+
MD[RQ'3">M(?<FK,6?<<W0[T"^D<XNXP1MX#;<DM[1[P/L\'=C/_M==89>0VV
MP'>%G9Q+AFL-Q3@#BIPB"-(Y\HYDK 4RBPU-[BD^"JW=LSW^6*6V"V<-)#;K
M>3\:C#Y^^SE,UD!>1+\\.1^L!*L\N=W12? U29Q9QIA"\N*PR7JY%;KC[Q V
MY7C4FJ .XZ(ER-FU@@W0G/+D\\L @AN"QNMEFTP1'--:%VZBT]CD>M4=F$Y;
M,5V1T:09W\+86T[$Q2E!4S").=9^-=Y["%%8H##?Z^Q1!-YD0=L1YW?AJ[?D
MKD$EV'O@KGWKMH'<MG?HSI@?JJ-H0RWLIKO.B#S^=+=^YD]"FB09T,0O00D5
MP&%Q8%2,-H<<G6ERU_[1:._>/J6/6WJ[\-=$<F_'HT0KP3N<('WRI^?#_!(_
MXV!T7K,]EUMUEKFL$LW^O*AYUH<KS,^J165N79+8I$C)5NB.[YTUY_F6KKHF
MZ<@^/44:K'A>(.::]B",!6\4N14Z&"N"K06;3MZG/[9JNB*D9:_.I1_Z?IY<
M/I^"5506R?$$YQB!2X0PJJ AE^BUSUF$U1*I'??K7(?JN_#9N^.E06W\!9;%
MF[$-F):^]PTT#]RM\W"V5G5PL*E;3!HW0*7,:Y^OVLI-1E"J]GBSH9X+(Z&4
M+DC1I 3I$7C?MD5G8]IWL7 #NF_<KYNMB[4#9KC,4\]>&!=S@L@+#=25"-%;
MA.@TL]E*:7F35>(>7-_%.M$E-PT:5-P!;Z'M;0"V7#WN1?@P*TJGO&ZOF0-(
M.>[$LP#*-0IRO"V$V@59V=J)0.@ 7#K%4V**^R87B1Y(-?>L1P\KFEVX:"V6
MVIOOU]'X?:!I>#S_&\PT(7^KW]ET17P9D@D7G"\B D^\5L$)'")BW7WB0F5K
M0F[31:RS$1P_HNY8'7=I[VC4-MB9>36LG52NW,8P",.$[S\A3I\/KW7#J&,8
MC&JG*?(7;HQ^<G>%G;GG&7PQW%L:)894"W1Q".0C@N J)J=]P38MO8\SO._"
MKWN$2FG0=VHGP-<VX[:!?32G<7O<#W7D]_BD=-<$WU@'K5V/7>!+1Q,!9Q"D
MEZ"8]>"R+B!TRBIHQXM6)R_?>T\-3U>].]#?\0W@]^>8^F$P_?;V4QB?A807
M4W+7!I>'$HP;X;."S&KMG'K.$:M)K,)<LN2:IY5:5FLO!-_]E ?V4EL1-6IB
MY0;.Z/N+.,'_NJ"7ZI=Z,_T#_;/9JV"U0^X2^2E><E"*97 ):W.L(M%C9O2N
M--G/78_GNW#WNN"BPTZ+=\!:O!+; &MZZ+,)V0,= '7!W_V:.,#X+8Z!-@(L
MRDJG*<Z/3%*PGVMYA, 2:.N$2BPSS9H$H$=6Q7W'0T<5Q2XV;R^&9=9R\L$Y
M)ND-$A44C=<YR8"'[ QWTG(FCB"$AW(X.F+K;@WL8>J-WL2__[ABF]?TY>PO
M9M^O8W^'Y5G]_<]WKR[M].7+E[_%T61*"V/JS]L<I+^1W_[CS%@;.G&^Q&GH
M#R8W,4WZ9^<#O,>WO.<#?[P"?',@BT^]07%WT/'K%(<9\P_/^OFG'_I%"&W(
M$X@%K5(40C@K++D"SF#1Q$;OGL_NO ;;QH:HRXJ9H=X^\>3 &$6_*&5RK?ZN
MP"$B,XHI)9J$HWM@?9B&YR\^U3^^&CX_J_7SWY1-_R1.IN.0ICV5-;/&,2CH
MZBM9'?RBR,'7MM8C=>QXC2^[']VC*._4J::[Z9K>4B0-HL!].B='73@Y+!PT
M"1!4"!FBS0)H6LN:0J!(8WI873^"'M>/2#4=-,O>A?(6]ZF7?4I^QU#W^*K-
M_MF??OIS.")?:/RY!N"S%B:3VG!I6/L++-LO78S'-+*?PZ0_N1S.VXMQ^A0F
MM0%!4#G(R&@@*H$RA8-G*H,/R6"RW!?7I%U[JP']I?<U%[L?@W@:U$UI:OG+
MX?)>(..6X I@XC1,42*XC!8BSXQKRY,L3:OU-A[?7Z_,D5V?/:7586F864'6
M\*V"WHBRQPT*IHH"ICD'A;4J4FUV[676AMQ&R>4V'5_N>\Y?\ELIE-LE+PVN
M)^_C/1D9>&VS"XES)%LD#M'X H[ 8O1<9?DX'>9C+4J7JG$^:>VX@Y!K3Q8K
M'3A/-!<O&<8@:4YX1&O-7[%P UH;=B38#?VLX-Z;\N9B6E,0)C,7\A_]CY]Z
M(BLN4Y3@9*WQ@8P6+*<LE,!=$LRQXIO<>.EV&$]EX=E/1)WHMQ,%M R'%XV$
M;S007D0Y^<U* ',KW+D9[5R9V7"!DGDP*=,TX>E/3IE9TKCV*%-VL<DV<,M!
M?5=:?S3J>-"8]\K[<D&+@EZ (/\0%-,1?/9D6I&<,\K9%)H<0A[1^ZJ.\WV?
M_78\BHL_OBD++[NGM<PF:DX6D0R49!*\XC2;H0G"6^NXON\T;M]G/T MKT?S
M8HR.2%N';^$][:.-H$"L! 03BP!%2R$$)2($HZ-4SD3)MVGC\Y@Z<#]*R71$
M0<<;*MVZ6)?9F6_'_5$MGH%CG$Q[/"J!1F8H6 M\2L?!A5J+0SD6@LTB^6WZ
M,1\#Z^D&A8^2[0;.Q@XIH!O&/L\,=8G5.*% U*KN6!5%[R-CX T3/A>5K6Y2
M=*<C_ _8SK7IGL9#T/O0S5]OMF;1A6F5HX$@9:+5PA9R*'@$510SSGC+Q#8)
M*B?70:H[NM<VEMK%[ U;$6T#XT0;2^W$P(:>1/N8KR&;.7#A8W*0=2U09@TY
M?2DZB*G49N;"LJTV)1\'BULUENJ"Q%VLUK2Q5,DZN"@-:$EKF'(%P46+D!P*
MEH3(%K>Y=?.4&DOM9/N-C:5V,5S3QE(Y,B%JO6_M:T///*MUH!T4$Y5QF%3(
MG75V>R2-I?9F<&_#':6QE*O7,)*2-"Q%TPE3"9S7 1@:78PW(6Y5)/,I-I;:
ME]'##=D@?JOAY=QQJZT8^O]U,5\WLE.EA+K90J,%5>>.8!6""H:^88+.R+>@
M=^=P;#V<[]$=[I"@H\AF619K"UPM+SUN O8P=QZ[(.]>/1Q@^0;GKAOQN1RU
MTQZ!93'K*RTA1I,@)4[(,XN&-<D(.*XB[KGO>$Q![&+PXPAAL2>/^468?/IU
M,/JR6 ,-\JR$$2!+B?,&/Z$PBE=4%,9RG:5IDM&T/<3C;U1W0^O]6NF"DX9W
M;J[WJ9]=#"9(6- "C[2>*H4)O"9WR6KEN>4J:VR:5[2"YWOV3+J@J$$ORW6P
MZA_'>%D;8 N +7V4>Q$^C+/2"9];:.1P,AJF/VX&FE,4U@D'-7&-@"8!3M,O
M*BDG"[* NFF*S)'5<H\C\S!BV86#!B+9,)7^_.VJ;H6T)@E-CIS,=:U$4PN:
M$Z?&%ANS8=HU\63N1?8]+U3=TM;@OL2FD5\K9[,%P)9+UKT('V;)ZIC9[71S
M("W'FY=N #7.T6L"ALUS92-$3KAS9"QEYD)NTQ/K@71SS^+U\++9GHV.JQJ^
M>_D./UX,ZD]\"\/\8G1V1I-Y/PSZ_SU#&6L?WM_[ ZSE7I9[U"JBML'18DM!
M9DWEU^"E3H Q).NBTL&MJ&=M1MD^SSY^X-TQ?:,CVK[#.'R&%S_C\ )GK9D7
M6;7+NHQ6<<8%M^37A0A*)D6.6.;@,!KOF"7>TS:*V/B$D^*]&SL>ISS=;/H3
MY$XI&P(-#<F[5H7D%[*%+*.+/'A53).6Z$^WOF4SY[4+BEKT-]M8MFT;8'^5
MO=R-OZTK'.YC_*.6O=2"211*0!:UER/6WE\E*RC*!UYRLJPT*2;S-,I>MA'%
M+C8_6MG+I+6/@0NPWCM0Y%V##R8#9SEZEW3&;(\@A,=7]G(GMK8J>[F+J8];
M]O+]E)9)_-A/KX:?R>N=>4;[U[R\Z],Z+'BY->B5:I<B965$-%8&H:0C1A+3
M:&/*)J=@L7?7!W=U2^/:1[^^O"&@G>!"*04\6Z1IAR,$JS4PDU21R1;4N>WE
MBW6P#IUW?B'G;/KM=YQ^&N5KG]_#4(N,.@8:$>O6L83@([G@M6-QE"QQWV3F
MV8#G >:>[M2P.@%U8?,&I\ES6._K#<39K<1:VFQ4[QR&W!]\HW<,QV?]8?75
MKRXSSFKX]#(MR3D*6I%UK5AO48+/.D))DNMHC<VV222T-^(3E%-KWAKX/*O
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M1!9SCB7@D:-"'WR(33++-T,Z5E&1AA->1_9^Z)(@]YW;F)C)0%%!+LZ"DEQ
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M&%K!E3&!?,N^?M5]3,_#G6IDS4V\V=$4/?VI&]#DU4AI942.]&THIZL':5E
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M7,08H@Y!0=;%@;7<ALBY<B=;O&>'FPJ8G=;__TR<^@IGR^ESL_ETE.:8ZQ_
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MU,S(FHU"CW][W>F\1&,$.:8<I6+:VGJ":,@[D25'DS"!U3T^O;5H=EU=/A!
MG$XQ+Q[[Z12F.'MU,3^=3$?_@_E$0Y;>1,7 ^5H\$(!%X@Q3H(@[.I1DNG0%
M>1C6_M>;W9EP=ZUIJ/@.@<HZ=+_.9A>$+ CKG4V.8:P-BY2K_3EX9B8GIPRJ
M?*^A83]*+"$=*QV>H/ ._L>'Z:1.&)S]0EJHB&JWT_>%PK2O-8&<XK/;T$^<
M,\(:BJYYJ96.SM'>"\1<FX!GX:$8V^7:84N<QT&:?J;I<'=]&\U/HZ^C3-M\
M;5[V :>ICBW\C"?%E.S)5V?"A\"T+H[18J>9C9S;XI./LLON.@3<<7"FL1$Z
MS.*YC?'MB%RZO#@B7/X!$LU/9$H&?:U/RW55]-ZP2-B8"0:CXBJY/CVM!V [
M/IKL;H(.9V@#("Y+UYP&(G.=VFB,JGVX@?0@(Q-%J*RUXO?F7.^-*@>J(3P(
M7[8W1N->&ALWQIONUB^3Z<^03E=_E_Y"_;-Z! W2DB=NE">JNT*JL;:V;U J
M&JX![QZWK"\N?#*"E\R1/>J^<>N,C:A_)R//ZHG#[U.HP[=_@F^SDU0@@,J$
M,=74CXS(?(BRGA85GA.WQ@^YF]OJI4?+BYTUW+ %QL.^TXP<IP53:SO"6C!]
MHHM 7VK7;ED;#VH,+'A:XWSA)9@@0U:=0J!!^%XR9WJ:HD/WBP_P;5'C]KY<
M03SA=<WBH)CB+M;\=,$\:E-GLL:BH@O!]SE3NX_E*)BPHXH[]+)XA)P_83JC
M'_*)]:E87PHKQ0/3W$86%?G304"*)8$TJLM$^('XCH(='4S1LKW%E>23\_.:
MI[KN++APXY6 R*2.G&GI-8O>*S*LM"8#IE2ZM*A^ -,Q4*.5REOVO5B#[0-,
MWT\7!='+3BR7U#U)W&L.A#%ED$R3'EB(J5!,!:X4G7540[)\=Z'%)FQ'1H\F
M)FC9\N+JPKJB6\9./UU,R4LF9*/),FZ:O<,_%W\T.ZEGOM$EQ[@7I ;#20W>
M6 :<<P4R6.2J2[+ ('C'0)8.AFC9V^(*YFH0T4KVU]\6FEAFV6D9:V=3Q1S%
MV11@T<\"5Z':%HSD2<?<Y>#] 4S[:FW0@0^-%/U<6AM<35B]J:I%SA77%A0Z
MQY(%<K!-1@:D)N:< ^&UT11B]5E;-B ZV!#:5B:_M[2T4'V'B^&;>%;)5T,0
M]4Q>O0_I0%FK;6QVUR-IH_#]4"%KH4-6CL5BD0(J)VN_0$GQ%4_"U5ZVIDN"
MXKXH\%B*ZKX8L(V>6Q>J&,-_>_/ATR?R=2AZ6J5+RN(3#PF9*<FN?&('N@XD
M@XPN9QC4\'?MPP_K*CY%XY.6ZNJ0Z'4CRED!RH)70VBF0Z#_1!$86!%943E:
M6X+C?1(P[B%YL<9NH]LNJ5PW#\-6F!1DF4L!VM4T$5 99!Z]8[+P+(26SO=I
MK+L.S(LW^<X:[I!VM:E:PAK F%&0/VHETTX"R1D52TD$B;H$+_OT!WA>16?=
M_/8&:M\/&U:\'P+L1^79=O8;7&3T%.7OM?+,.1U+L;512J!/ 51FP<?(C(CD
MH7#40G6YM7P9E6=]2+&-SO=6>9:S+>B!,Z%=8EK75FBN.C+<>EZT*;;LHU;Y
M^56>;66M095GVZBZ<5>9CS#^O*)V"1$LCPP!'#FN,;"H:KZGU!2MH(.@AM1[
M#&HQ<?768W$&GJ[*QOUC%B!6M!H"HW7+F!OOWW^7F"=:X*X-=U!?XWXP-^$(
ME#9IZ9E!2]&%5HKYF )+$:&(0ML2#(G7GX<5'^CZTM:(VVBML?%^(TV=7YRO
M@'A#BXC,G)D0R'.HE<LA1%KH R@98C(^#TGN&&2^6V_>;YN7)^M^TD)QC3?'
MW^"O&T"B0@S.!R9<%0=K>$][,XL^Y^@X;11YB&<\S((WW_P"+?ADQ6W\!KL4
MUO\GCCZ?SC&_^HI3^(S+:_SW%_/9',:+9.0GE]D/?7+#HOLG"7.G!#]YIY27
M620GM!79IUAR<5R)@"Z"/AGZDMTBDE<D6QZ=7<Q'7_$3IHLIJ05G/_^5SBX(
M:RV#?#,Y_W(Q7U2>O"\_PW1,[[[*]GM[=;?O0%IIP#.A,-;\+F(=F8F5$$H1
MUE#<UJ4E?RL!=@WM[ICK:N[&7;.]AMDH56VATDZ3HFK7K/K- \B:@ ^@P61G
ML,L1\58H]Q\*'H2-=R/'?I;L<-NT%NQ/586K8I^;B%_E_[J8S>L=ZHGPM*%'
M2VIQM.EH&S3S2)M.2$8+BH53=GYO!'P<[P\J=K-NAV.N#5_0)N G/%J+()#%
ML$CU-)F!S\"$SY$^+J]RZI*.O27.'R1L;LT.US$[ZNS5^>2"OB N@N&E$'Z.
MM>D52@:18F-7)$<IE"5!GJ$[LT3_G1)U_Y;OT*GAP;SGQ7_)[\!<)<'Q;"'*
M"3J((B7#!&99E9:8!R&8D5Z"H'@0P.T]&WT]UN^4FKVMVJ.A:H7\$;]<3-,I
M8?LPG7R>POEU1<_R<Q$G(!V" V"HLZF=33CS20)]-"ZB,!*D[Y/E/@S?]TRX
MQM9KV#SB_NW0CEI;7BB1X^&U4HG5>T-:NX5D47A@)4FMLG: OD]93E,Q]E6D
M\3R(>C@&/)=2D!T%?_UM_0,6-SL9<M"%0C_KW.)$6+ H23,NBY)M2CKT&5G3
M4:;#WV3OGZEM/=UFC.EP=K >V3LXOTP*&8*O9U+=8P /DUOW;!@QB*D[FO,0
MM"O2"2-2K5J/=1Z*-"RF6)B,.B9,E@?HDJ1U&+H]DK3W8MFVC14[L.SG\R]G
MDV^("^_\_9<;X\X\)BRN:(90KQ&<0^:%RHRV :V]"CE#EXYZ&Q$]E[CIJ<:;
M]-!\PPN<S?5+7M [L;:G5J6V0*C3] Q%:$H6D9W(&CR_387G7.[5Q:IME-<C
MP;?2Z^8ISH<SN"2:X-K5SGLL64U14LR>14V_1.Z1PJ>82Y\;\@<P'0D=6FM_
MXZU$GYD3RRCR(WZ93.<[I<)L>E++>1-#P-Y)=0$3C1=@4Q%6<VD#!3@%L[6Y
M>"M2/-GTT%VGN-Y^ZD?\BN,+,A"%\6E$_^IS/;VX/L7P!D%;&U@)Q=13#-H(
MK$DL 19,27&A^Z3A;X=SUR5J]?BEDS:>3R'-_W,T/WUS028_Q^G2B:O7R;,9
MTO_R[_#7"8;@5504)ONZ1RY44ZRC_V2N$W<IFBXM*9Z ]0#U"QUY=G>%ZVV\
M#ADJ5WI8!0/OO^ 4JIX^3"=E-*\3ZJHX*RW.?I^08+/)66UVC/E5G"V$//&:
M6]H"%"O9>-K7;68Q D4%P+4,-FJKNYQC-4%_[)S<MX$;=UVX OSKF/8Y?'6V
M^.OT\4R6^JO'=9?H3[),X%V43 :OZS0LQ< $3U]3P:!,#JB&-&/8YIW[I\\!
M3#K9@SWZ\N:/,5PC7>$["3P*PE.82I='O9&67$9ABH-2%.B4MJ?+NE=]YRS9
M6?L]4I'.Z^K[/ROU_#J>P_AS[<M==V>BKI?@ A><16%KHE2IDWD#9R%S"]ZX
M0I%LER/%!V%]3SSJ8*@.*4%WF%[U<5)"]$8&P6SQ=<.V4.M%-+-<8(X*N'==
M#A/68/D>";.K23KDZ[R;C">W4?W\5ST(P1/I0&'=';E*N4Y[)B)G6:MN+<7E
M/ >=NLR7VXCH>V1,&_-T2,&Y9O!E5#D:7Q#(E8I(#Z^Q3*:X_'L44-:+'M('
MO7\TANFW10!!TM7D"#+)(K88SW&*L_E) 8>A[KK)"T&?!%KF17),<7+, H"U
MM@OS.LKT/7+WN5"D\2R:E<;NK.4P@^NY;9/R#N>?X QG)RY(;LA[9,)K"C1R
ML0Q*DBQ@G=]F.,B[2;9K/?FM7OH]D:VO13K,KKFKJAMG<^O5LVIZ$:0.8#13
MMC8U<0Y84$3X K8$$1SGLDN3^:?!W5<NXB$/K#H8[KFD%EXU37U],2/=S6:7
M BY2+1Q/-CG+65&.,^U-I A'998A.0VQ#GWO="/Y *I#I??M@Q6;&E'O;)T>
M5]E++)>MF : Z=K*[B:: [>@WMU:=WFPLZJ[VS\9P7W.A5E36WC6O-7(8TV5
MB9!B .5$GV9U_>T^M.]T9[-OH^'&!]F_89Y=3#]?-E>UM)-&C4P&72?UT(H&
M3FDFHR-_J_ (=U/1UCJZMQYZL!NPIRAWTD(SC5/%/IY^FY^>PSB_PXOI9(6'
M0TY*UJYX(9-47EH6+3G<#HL,& P6K098:MVS7ZK!=M93XT_K#5 ,//D*LW1Q
M!M,5'F>0%\>A]JNN[8LIA/&I.&9\$<I'F07X 79;]^R7:K>=]=3P^J;B>?WI
M_[M_V7B92I:3L0$$$Z6.L1&!UGP)M6T6%Z $EYK# /,]\(J7:L566FMXB5)A
M_3Z9P]F#U\B7"WP&*("REGV[BE'7Z6.9%4ZKA K!<J,'6';H^UZJF;OHL^&5
MR.(HZ0NF$9S-OWTXA>DY)+R8CQ*<72$K6E@%A4E1.\AS(*F3LBS8G+V*&0T?
M<B__\%M>JGT;ZJ[AA<5RN/64J$:L6UV>D$>^RG@[Q?R9?H T'WU=Y!2OP":/
MU6T+3&:LTT"*9]Z2]X9))ZN)@M8-R:;?^L4OU?9]-=SZ!'])U#=$T\]7>!"+
M,<%[E@*O7:,321Z#88F<=Y>L+X1W^*=]Z]DOU:@[ZZGA\7GM6OEA.LD7:?Y^
M^@FG7T=IV816VSK\4XD:.V,M_*+-PJ7 R-FC(,O6^;%##L8'=?U<!^ [.'AL
MHON&GO8-/+-7X[Q"-%NQ?0BHUEVU-Z+9?X_MW0UUW^J-M-RX?_-F<%86+Y2K
M_,[D0+HZWA6R9"(Y'Q ST';S0DW_0&/N/5E^&^7NMUOP:@E\>B74G0<T+(!Z
M"-J=NB>IT"-ML,*6K(44P205M7 RRJB4Q9,[S]KMO/ZGT0P^?Y[BY]O;R-NK
M*],4<\[1$^V+HHA,D,V]ASI6I:18R&W3IDN)\6/ =G$ ?S[':75*?X/I?^.<
M;$:!Z7C1H'!24NUP5&M#3W@2%' &^FI*;8<II&(0=6162<@<K!'I,4(-?MG^
M7<2FAK_I-;97;I?RHNTKH@(OR)U/S$9;QQT09*^M9-[(R .6H'V7M+074<[6
MA4[[LE:'>] -^E@ZX4ZE+#1MQ<[&FKM)T520IC!.ZSPJL%G&+IUK'P*UKY2=
MKD1IIO67D8D# I.7Y,V9.B93JU"/U'1@Q6?:A%PHW'?9FY]E)DX[VV^5;[.-
M#;KG6PP!\UWGVVQEK0<3+YZBZN[VSPJCT<DR!Y&\*LRUK)%G9K$X"L^2,Z5/
M)\MGGF_3SNS;:+AQ4L!#UZ196NZ-%DP:C:MY$J46M18,UI42!;[PR^6M%#_P
M<GD;K34>7;7VL$8&P;.I#"W!UE%:R$)4@=E<)(I,[JP9DEG[XLZRFV_=332\
MMQ/K(:"^MQ/KK0PUZ-SR*5K>VXFU%)BSL/2U8%KD"%+0HRK)9?$^"^ER'#+9
MZ3F:?ML3ZPZ6WT*YC??L?S^;1#C[>9PGLS3Y\JW^Y*I8Y0_2[M4<OZ"5E((9
M2\N;YE$Q[QQG*1=KC;#.!SM@^Q[VMOV.*VQDEDE7G39.NUTB_(-4-/G\#<;Y
M YZ1X/^!<#8_70O5<DL>2*0]K<Z7!@ 6P&I6H/A8?+)!E\'F'_S:X^!!'RUW
M60;>3,_7X>(I%B&+(32UQZ#(EL5@3;VG\U+D5)0>XKL_]([C,'4#_37.]UTM
M16>8YM/)E]-OM.-5,O[\91U.8ZQSVAFF;=84;6"]BC6. 2HK+*3(<QZ^R ]Z
MYW'8O8-^&Z<*+W$NB@?.20=GBSCFW5JV9IF)G $8HK&U;T-DM=J'@1(*:@%J
MXG(P"X:\\3@XT%RWC1.'ER@7_0F^UMO_R9C6JT5U0B7LKVD=W"BS-'5JNDHE
MUED.!-=&P]!I'0)*BVI(WO@37GT<G.BG[<;YQTNX=7C7EU.<W@8^^S!:ZZRH
MD*13G@GTJC8T5BPH"'6T.G@1"H]\2 +R]F\^#FITTW6?5.1-.?/% ^UH23+G
M0=3AP)QY;SDS4DO04("T\(+J#?I8O*$.&R<L7UU*_#O606I?3BNNQ2%'!)'H
M]9G)6 \UI:YMX81F23NIBLK9XYV _^GG/1M1'-5Q;QM=-_0+%Z"6]PTW(:W(
M/@14ZS/?C6CV?^;;R%J37JIN?/"[&5PN45H>4NU!JRO=*6XE1X3E9 O7*OF4
M^0NU_P,'O_LT_S8:;FCV9:KCMY,_/IUX(PU%HU#+QX%VH%HR@R$P+T3A)>9B
MRIIT]-FEFF>8_OYY\O4?JR<N[;SZQ5TS7[]UO[MZ(_5/=M)=ASS1=Y/Q'Y>.
M!*#/1@K!0CU+UB'1SB1(]8402F]T4F7(GOV4AIA_',15:VO4757:8[#6;S]?
M3@ BB6@',)993(OYW85B %L86),DN:&!$/8P[C6$8[#M$Q7:^*;]U6P$'R#5
M"HS+HL4<BQ-!,I,6.:7.$PY,S&HL/">T?%#/[$&[[+VWOV3#[J[.QB>M;VN'
MQU?G%-XG@'%^ V/(L((E.5) YX A2*)<U(9Y2XN+#,59KM$Y,21:?N 5+]F4
M+;77^/#T3LG(U;T.ZN258.#M0E):0< I!E+Y4JRVZ(9<BJ]]^$LWY.X:VWC$
MV:4T[\TIC#_7K@#OYZ<XK</6IGA: X6OJ_:_3R_:^__;N[*>1HX@_)[_TE+?
MQTLDEA6[*ZT ;9+GJ(_J74=>F_A01'Y]JCU@"WPPQM-CQ_""Q!CA^KJ^KJGJ
MH[[6_[K#ZWRO@_/LHI\*S$) 1R<A);798F)K$P3!-.4@Q9^MO^5 O8D8YS_+
MO@JD;5]4&OA^7=[0T)E%Q9,C#)!K4CI6-*A5J?@#TT)$)66-7&E?0P]64-CQ
M)4WKZF\0AWXZ+>1H.EI?P^PFE^M'.#Y&Q>Q*^,3,UFI#@@-+>(K69F<I=U6T
MSPZP^0BRCC69MR:^T),WZXBA/3&L7(1K,7:7\\D$0U?9"QFG)1:AS&+IF^ ;
M/A-)%[5UID1SS9D5U-%-JQ&==)+N#,294_5H_JY08^\:K:6-3I@$WN/4HN7H
MAL ?'L"1D&-F(?&4:._1\HUPK7/_U%#$:C<@2W,]34% QA0X2XMY< B8!P=!
ME,+$*H3 *TG7[&GGF3.KIM=JZ&5ML?$*,X/!]U$37./][Q,_FI9N9NBG45K\
MUAQ)^H0.*'@N)H-I42.>3XK^Q=-8+#VC3)7M#%9TQJF5Q#I?)A-'B!RH@#KZ
M6_6QG3F93XT=%:3 =@UB6YC/,Y>+]-=\.BN+'XL<YN;RRS?PP\&_D/ZX&X^*
M(,O-Y.O@[WEI45:.]3T.A1%:1$D5$EFAJZA1Q *E)"66E#2E95D5D<,3&H,W
M.J%.G6T5M-2Z&(H5]-7[5 ?AJ!2$*X'O4V$3)OY>$ZH<HXYKJ?I?@G@]G/?I
M4)L#'1YMW',(-P'<"BG([*G70!9M+*4M2^9%O]EI;[RQD5)?A=85L)PYIX_M
M_0KJ;;MP7/KICZOA^)_/D+[#8[ZW>67Q(L]@LGCS>!:C48%0F8OD7?(D!)V)
M\J"4]D(XJ"+KUC&.,R?R,;V^3F+;.XFW M')J<1,J=&3QI)=&!(D5BS91IRC
MS&4EJIR:Z0S!.W$K>'J=LJYWRBX,7T,S6K0&S#D&;QT0:GTLK0$3\31EDJ3Q
M !!4D+VNPKP&Q#MQZ_A[PP[(P=MW%^,X6#/\LAE,1/8$0K&7!9=RLD!TSI[(
MK#QQ*45".8#U(=*X4BGM-,/=S\XSIV!-KVU@6=6-MMOF3#[.A\5?W8ZGLPG,
M!I.F8QJ,T'>SVR'FW:N,>TL*L_Q\M6Y?,F^F 0A+.+.D4T"\T9C<V.RCH<G
M<U&<^N&T)N SY_W_@D<;)M#!NXR[@+^\TMAZ:%;+_=*52PT!>8UA0EKJB8]8
M#V@6.6C&L$BH$N9[QOF&I\NQ6;-AEE3;)GUE>%CBXEE31HTGFI:52LH=L48*
M(H3.FEMGL^Q]M?H /&^8]7VQ8 .[#]X#;3F('XL_(3V"V07XZ>P%C;.4VTA
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M%@^K[S5)<L14RJ$06$&<QJRN7B]II'DBDEC&TI57W[0\-@XUPMT9X3I,^K>
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M?;$*;J2Y]#V\*>:!R$&#R^?]#L7$V4(6\U=6BI<I6ZPK>J4)CFSD9B0HL:$
M&C)NG=I21)AG4990YXO?ASH8G<'T1L8.EYD/HGCZM.Y<;/HV>WJ!Q:.D]IGP
M#%4PVQ,FOT+8+1BTE;D^]-IP1:Q;A'Y3HKKMN6X&F37NJO&^5^)Q5OSC1:U.
MD\SF+]-",JA3E$-,#;O1E"&8Y9'9&HJ8Y,KK<N6QCL;&;1LYP>7S\V+.Q&-=
MX6 M=<=3NZ,XN]E5(=#KF?W.!\[;@CJ%2DB+Z6A?@UI(IS3>M8A./G_&-N[P
M]6"$92QQ:B@C3XB]6)%#KF0&:90G*(\,\:(N&[>S[Q"_^U:MP[[L,,(&71[E
M7,$,ZPSBA'##S+F E ANB#E.4Q9YG98&P7>08],!T/78Y_['N-<^S'WV82^R
MC^4&N__5]3[NK*]CW>O3A7OVK;[S^%DM)YBE"9)80"RYX8J<8\@QR6'.6"Y)
MBK2G%7>\J['9<9L;%DOV#;!*RFY73@Z@ZL818;#JF2,V,*V.+NU9Y3JEXN>0
MV<I/H]''%94#O;W+;97C6A^[N-+R1L<[+.Q[%=GY\WSQ93$72LGR9R-OQ4HW
M,UM6H9@]7(IE\5JQTR2+8ZXCF\ +:6[X0R!(.,YAE&&9IF;[+"(]F:D'>T1P
M[W'-Q4\,IZE"ZZFR)TQ_TV8M.K!##A;S[VRZ_ X6-M>D)\WX#HL;]_2!\D W
M6U:2 SU?@!_>X/PCJ"V:C0)@JT' *R_=H MZ'<93A&&ORG3#9^\:3<=FNI&?
M;7%FQOW[W^:+O]_,JAY701BK.MGE),I)PJ64,+=%9K&DTFY:.22IBK)(92S/
MO9(#./0Y-J-I(_(%L$*#8@968F^"F=:B^[&<"_YNS!88U9[9+ 2@W@SF 5%(
MUG+I=E"F\L!AEYU\7O4_1/R9+=CSR[14JR.>7#.DLBB'YGM"$+,X@2P1$40J
M89D@@L;"N2+?3MMC8YB->.ZG8KMHG3XG/ .#GOE@(UF'T\%='-P/!L_ 8Z S
MP=.?A=<IX!&%6PX =]\8[.SOB*C-8[]CCW0SA=;%2FYG.W61/ZI%\6K&V8:I
MELM%->SEY_ER??]'R<MR=26H\<!$R8PE$<<PRU4$<82,Q61O],4H(9D4FD:$
M^)A-@>4;&P$VRZ//9_NEU;=:@H86-A<ZV"IJTR6L;\DUGO*SR4)_"&[VVSL.
M;\_<_BXCZVT<]H1_2$,RM(B#&IT]X;MKH/;5C;\Q^_7C5_5@RU8;:YG-I(TA
M5@M1L&GQ[Y71P%FIY*_%U.SHY[.U[8+CG"<YHY!QRB%.LAS2)(VA8 GA*,UC
MR9V27W458&RKPM?_S)Z>_^O'"[!5I<[+MZL,K+0!&W4ZV)&=!NRTT=WW,/3,
MWJ,? 7=SO^^1&&A/T..(>&TFSH&S9<?1J=G!MB7G*-W<NYS53K<-SK762BQO
M]?4W\6CSF7PUB][MS!9LM/^[_L>+61^G=M'[:CI=%,(LB?87ES/Y]@>-)R<B
MY2C3@D.*8@TQS93YZ(A9OI@THYI*1!+EL\GI0<:Q+6FUBM;#J5>6L%HI"Q9&
MV]+:R,*HX+=IZ6-PW38N[SQD/2]_V]%:ZP>L@G:0K-"KZKH-V2TMK]6J?VFY
M>?=GC1?";6%Z'(F0VY@^Q!QT*],CSKO;F3Z[ZGIWNMH=";M(50< #V:ZE;\L
MS)YK8C8M.,O-=B4FL=F]Y!F&-,,(HDQ%N<X2FFC/.]-'^QH;JZ\3A1<S\+R2
MT_=.]'%<W8@X$%H]$VI3RM6Q7R7G!:@D#7GO^20<8>\['^]NX'O.)_7>O]]\
M^I4SXPML>*#.8IS02,)4$ RQPBGD/(L@PT)&0LL\9<HO!+[9O,\W/DS0^UHZ
M[S#L-ZAE7-NDYQKJA$B(2<0@D]J@QDF>RR2EJ0U5=0]K[XK9$('L81#S#)@8
M5^!I(S(B:)SI(75[B7(8/);TD&9'XQ;.CQ==94ZW05F&-ZMT-'\KEH]7+V:G
M;O;PQE*;OD@;HU66AD25O&??)I&P=U,$@CQ5"<2:&^9+\ARRC$BB%:(J]0JA
MZB##V PF&^53&HO4<Z)W03]64432/(8)%6;=R2(*F: &?8KS1!&!HMRSE%#/
M^ ^S/*V4J$-UUVJ /XP>8*W(!=BH M:ZV%#X_L?,C<-['H>^7>L]#(#WNG &
MA"&7CRYB#+K*G('3[F)T3E/GU RN+DS\6I1"3<UWJ.8OY=7J<I^QQ056BD E
M%#+K4\8AQXI#F1@+,Q<ZSU.O6)43_8UM+5H5NEU=[WDC\<4J3J%3N>#C@+O1
M6T 8>Z:RLQ#L6"GX)"[AZP0?[_(=J@2?U/]PC>#3K_G'.ER_+.8?U6S^5%21
M%#\;1IO;ZI&7C<SYJ^-:CF*JE=G.JCQ.(8X1AB3+B;'(6(*3),I2XI3HWJ_;
ML3&.E1PT1 <;V4%3^ YGZ!Y#<3IVH1^ ^SZR&0.V[E$)_6 \4"Q",*R](@_\
M(6N)-_!H;+ H W\%F[$%'=[N9E9NB@FO"@?;EG]>J'^\5 %W=1Z?.(H%U[&$
M$18YQ#PSF^_(WKG'BNHD37(>,Q_3TJ'/L9%]L[)W0VJP$;MC[B07^-T,S<"@
M]DSP'3'T-C,]4 EI:KIT.ZBYZ8'#KLGI\VK'<N+%3-WJJX62Q=(PG<TA\OWR
M6U%.!&*)Y(FE&Q3;R_KF;RCF$*%81AC' L=>H4G'.AH;VWQ2,VD3MYI'P.]6
M0$]6.0JH&Y6$@*EG_O! R+_\] GU@Q:</M;7L"6F3VB\5U3ZU//^V\_+NZO?
MGJ6Q=3[/+51Q=#67A2Y$9?S>/#TOYJ^UU?-E/BW$]T8V;:YXKFU%)9X;XR3A
M$A*9FFTI)QP+E2N1.U\P[2K$V/C#Z %J1<#G^9^KVK(PCD!3&]!4QWW[U'F8
M3F]4AP"_9U;RQ1W\7NOBG^/\K+%PW]@.,28#;7.#S0FO;>ZY +9L>CLW/=@6
M^%SEFQOBL]OR7Y)^F<XYF_YFM)T_V #_+VKZ6HB_*C9=/GY5S_.%3>/RVZQ8
MKOU%FA""208UBPC$J<20,<6AR//4_(50F@O7E<BS[[$M0+7X8"4_^,'\Y4>P
MD1M8P3OX[GP'Y/2:TR/,/2\U.PC; /5:>%!+/SS:[JM*CZ@/M)@$1]]K4>F(
M7\M:XMOB8$M(1U6;*T?7)KHN&+;LV?.C6K#IS6QIT^G,[+=8?BD.39HD2Q"2
M',$LDPQBRB+(,H$A,G\S7V&>1$+ZK1D^W8]TV=BJ -[H '[X<A-L&?$:)M>5
MI"_PAUE,QH>[[YK2%_[#+BMAQZ'#TM(%QI.KBU>C R\P713>7V,ZM=+-9?[A
MI2QFJBPOQ3]>BK*P_50.7I)FDB2:0Z2SS.Q!5&;V(#B#DF<T-MCD1#KM04[T
M,[:%8RTF:,C9R7-^#%<WQWD M'IF^BY >3O03\ 0TG]^K*M!W><G]-WUGI]Z
MW(\1RL5R<J<>[.KTBYH_+-CS8R'8='5VC',9Q2K3,(T0-O8ELG'S.8:ITH1R
M(B(NG$[06GL9&QLT)?0\EV]'LYT%@F'4M[7G!8_S['=2OV7NF_<;\][\:W?.
MMW<PR(QWTG$]W]T>[EH7XT JK)N9S7ZERD8ACLOEYOA^0C,DTRS-88SL7E.S
M'+)<<DBMJS*EG"*_&TP=9!@;4QS)6U?,0*W%Q=L2,VP)MH% OB4W_ ?,S>CH
M>1AZ)J->1J!#!8_.&(8M[>$OQL U/SKCM%\,I'M3W3BS*OEMN_EDS*\;\]=R
M@CCE68X%U"FVUPK-QHER'D,6:ZEI%FLNL \E[G<Q-L;;2 A^MS*"2DC/3=(!
M(-VHZCQX>F8B3V2\.>:X\B$IY$ O@S+$<2UW":#ER8[S6SPJ^3)5M_IRMBQD
M,7VQ['*GQ,NB8I+Z4IZ2]:6]I^>7VIUWJZ_98E;,'LHO:G'WR!:-RO"1S%*>
M9@KF!%.(440-/R@&<YX8\RFF44:\LN&$%W%T_++2T*;;:NH(MDJ"M9;K6[,;
M/:L<72M-K1<45+IZDE/XK\"1W-YU;/LFQ_##"GZO*M<[Q3[YDVUO@Q&4K,-+
M.2S9]X;RWF+17T\=<ZA-65G>ZKNE:6KE'2(B453F!&J2(HBM'5FM'2S**=-9
MJ@AQBD0]WL78R+Z2T,[N2L:.5V .(.E&N.?ATS-A^D+CGQOMJ/9!4Z+M]S)L
M)K2C6NXE0#O^9,>BDHW2;9_FLX=[M7BRIFJYCGR?D#27>11ET.96@#C5&62Y
M,!@2EJ59E#/"O*ZGG.QQ;//_;:E(/E\LYG]4B[S-?UM)#'1]/< [&]AI]-U(
M(BBF/7/&6S@_;6J!5_):+JDE#E@/TA6<H!4@3W8Z;,U'5PSVJCPZO]C57668
M['$^-6^4-O?K\KN-+YC;ZKD+Q4KU4=5_3N*,98(9WDFUSB$F<0HIDP3F-$5Q
M&JDHXUY^?=>.Q\9&]4I;E.4+,R,/?OC"%N#5^@U_]'5O.0+OZO0*#V?OKK"M
MR/\%U$)?@%ILL)8;_+"6_#B^'9QD?F"%=9TY]CVP0\T/D7TWF^?[YP4DF<T7
MMSD+S.;+)L8RUH":+6URVL*T5?UX[=O__MD L,JE1)6D'.L(ILHFKU(QA21-
M(TMA"N6YEB)RRB@31)JQ\=HF9J>AS078Z@/>*+0],+/I1S=*=0N#ZC::;KPX
MV!CU3);]#D_GX*NS8.TC1*N;0.\2R'46=L?"O<YK],PCS\K5.J%)1G4:QS;\
MBT(<$0:)R!,H$>-$8(%(Q#L==U;-CXTW&P=ZE7Q=3SEK[#Q/.+T1&>YT\P08
MW0\VW^C<RZ%FW</['&B^T>[H8>;;I_Q#.;_:]$Y5R'%"9$2C!$-!;6(#9%-/
M"RF@R@@E*4US)IVV=6]:'=L<K03SBM1^"U+[K.RL^@"3L2B750!F,Q-2J$#L
M@WJ?&WJY;7"P4,L]'9JAE?N_['B2LY\FA].$$9*DD.120\Q%#IF.%4R3*&41
MCY%._8K@C#[C4"TA6(O8Z>Y$YWQ#H\XTY(F,_SG.('F&WCO#D'MNH6!9A;:!
MAGRY#3'<1M?&QM@E3$10<Q)#7$UWGF8PHBF2E.11ECA=O3W1S]AFNA6S$6I[
MT8BG!1^+4DSG=CGR#6X^#+';] \ 7,\<<"9F'<*16Q$)&W)\N*N!PXI;]=T/
M'6Y_W/_F_M7\5<W8;%DM6HHF.N:4P@QK6P(O%I!DJ;&^-><8R3P2*'6]D]]L
M>&Q,L);-:['?0ZM]CI^#0=\+>Q#UW6^H=X5AH+OG:_'^'.8B^2%M6ZZ(OWE\
ML,O?AX1L7NL^^/NNT21*JX6Q;:KSF"H4K;PIRQ<E)UCG$J<QA6F$S4:?"0HI
M51@2A#B*8RV(3OUJ&QWOS.?#&Z:$T4;6.E+JH@X.+4$MKV_0R%&0D4(IX<Q8
M>R)!$,>80QK1&,I,"R0BKG/L==,C#,3#!.D, K";K1<&MIY7AHZ(=0B_.05&
MV+B;H[T-''!S2NO]2)N3;W0Q^1;/<UNM_?K;LYJ5JBQFJYI-CTH^F#^86!:O
M5>3:*AE-;J_+)RF'46:( \L\J;U"$9,Q3C)$XRQWX^E._8^/NC<J +72H<J$
M5A]=B>_FIZMRZ_ZY@OQ'Q\4.[1'QWHW5-=1KX<%&>K 2'VSE'P1Q'].W1^0'
MLX\#CX"G.=T1P5:;V[?- 0WSCNJ^M=Z[-G)&A;Y5(:[&!>;J1'![F8Q(BC!)
M&=2(*X@CA2#'DL*$,YXF1.6Q6[YRKU['9I/6M>964C=O^/M<"CMC$-R,U>#0
M]KQ(!$&U6R4_5Y2"U_,[V?'P5?U<L3A8V\_YY8ZE5HR!-B&:Z]BF?XE2*B%.
MLQ22.$:0<JQ(+EBB6>)55L4T.C:&L3)Y%DVQT+@1@Z_"/<_[5EW]RY\TE M:
MZL2V.VQ9DX8F>R5,FK_K6D7^F7VOTI;<ZL-7E'3$$%%FQX@5,__!9M5GU*SZ
M1"<\9EQJ2=!DIAYLB;=[G]+Q)SIV^C9I_6WN==^C7V4EM;T>UK@L5MUV.O.Z
MV.FQ<)O98: =JO;X\P90/<1U,6=PPE85/]7IP#7$'3'8KQCN^J*_+VN59>[V
MN0HDGCW<S,3\2;&2?5'F6S-;XP<UUY_5\HY-53F)5(1X%G,89SF#F&%E=B!<
M0$FP2*.(Y0@YYQSWZGEL-L)*>+"1'M3B U8"!K8:V+ED= "5$NX>%;]1.>V_
MZ@WKGGEJ5#"[.ZUZ@WL@AU58V+V\59V@:_%4^;4WF)>JDYI-#U6W!L[-CO4W
M53P\&I/O\M5T^Z ^OUC?UZVNSU5V'"5(1Y*1',.8:P%QGDG(XYC!B.$L)A%&
MF&;=$F!Y2#&Z=:.1#&FM!ECI 6I%JLP?]:GAN1ZM;@/G9N[V/AQ]+RU]C<09
M":<Z(-E/3BD?0=XI;50'K(YGANK2F/\%G9U>5F=AL12*)22'$4ZTV>Y3"5F*
M,IA+*@C5L>+8R:M_M(>Q<>#>;/,[<3R.9#MQ!<&G9U+RA\;K8D^K^N=>\CG<
M^& 7?EIU:U[^:7_0?P?]JWGZT>!!/L^7VX /J25-\Q2B+(N@V1PKR 0FD$@B
M>8YY)'3D'O!QJ(OQQ7144MKJJ 14<G:()#B(Y>GM[;GX]#RK^P+&?4-Z+D #
M[3O]@?+:6[:AT+*%//C:8#O%-J&;&\+6Y\Z)2I@_/2_4HYJ55;YUN\O\-"_+
M*U8^_CR=_U$E7?^%%3/[PZ]*V%1ZF^*Z'Y2>+]0]^S9)C46CDR2#F.@4XI@*
M2.VV,!)$Y#A3!"?$/W0AA&ACLXY6)_%-U=;>EQ^L(C]> *L@L!K6A0XN@%5R
M\]M=32\ KW0%1MDN 1%!QM]M3_D^H]HS^[_/@':,Q0B)??B C2#2O4-41TA4
M#X=^!.TA6!JO\I*7RP43RXE"(L.:$!@IS2".$ALRHB/(D3;+ -42Y^=FZ=IT
M-C9&/Y3ER9@V:W$[EAD\"+,;S88"KV?B[(Q;B,17>X#TG-=JV]][IZW:T]PA
M*]7^.WX<(E4QN9XMB^7WNR<VG:Y[F*0B%U1R":4T*&(62TCM\3-)(JD052CG
M3N%F1]H?&U/4(H)*1K 6THT>CB'8S@@!<.F9!/P@<9[Y)Q3?3O9R/=M+)?[\
M,'_]R;Q93W3SE]WY?:S50:;T"976L_C48V=L%7<.(U>Q\Y_5<B)H*B+-)!29
M 0Q'.8-$JQ02$M'8K/^8)%[+?WMW8YO6]0Y@[S#]AY7$QL0W0G?8FAW'VV.[
M%03%0;9070'LMA4ZB4OP[<WQ'H??LIS4_N VY/1;'0+4[,7-^LKFQY>%:;O.
M05RE[?BL_JA^8TV1I_FL>G22YA&76:1@Q#F%.,L(I(QAB*(4)RAC L7..3A\
M.Q\;\]2B@7(GO7F=?J:8V6N6JJXU\LP6CKG..PW*:1]^GU#W3$]U]OA:=E +
MO\IX?E%G^K'\]$?]0 E^: Y*GYA[Q*OUB/U0(6M]C(%?Y%I'$-N"UWR;'"Y^
MK:.R;T+8NK;1S43=S5I_,]O/;_]U/IW^/%_\P19RDF.*))$IS&AF$\M'VJPC
M.8<V?6JF(Z%2X66S>O8_MJ7D0.T&NX(<JO< ?K=Z@)4BGOXMWV%R,W5[!+_G
MQ:4'W+T-XH[HA;20?448U&3NB,^N#=VUF>[)+;<9"+?AGUD2)[G"#*8Z(A#G
M9M=.>8QAQC/!,RZHRJE?3JDC/8TO@N7J]O/]U\NK^]\N/X';#Y]N?KF\O[G]
M? <N/W\$5[>__GIS_^OUY_L[_PR7AW!V(ZX V/5,4%6&RZV(X/=>@F1/X! Z
MK^6AK@;/:]FB[Z&\EFV/=Z.(37[,1J;Q<O/#OQ9FM[\0C]]7I3=9GD2$1BDD
M62XA1C&#/&8:,AUAE462I-QIX]VI][&92XTTKQM)JQ1'GR__K6.U4[_1R!36
MB"$.,Z4PQ"*6D"<<V3L8.$684I8*/QKO;3R&(??MB%PT,^>7;U+R;L=JB#%R
M6P)ZP[WGA>&\*>"]0G2"*>2ZX2? H*M))VQVUYANC9Q?0?=FY;>\U6^\6YPF
M.2-F4XY0 C&/S&J#$#&K#8DB%E,4$<^LG"=Z'-L*8R]>/K\I^[IQ\,XU$&\\
MOS/S[]E,">N# W\4RT?P_,*GA3!/:F5=+]TK[!X>'3=F"XIYSVSVML+N30/J
ME2^Q$KB? KNMV/158/=PI^]68+<5@[8"N^TO^A](77\3TY?23"3;^#4OEI*9
M#?E799/*BV7ER+QZ9(L'54X2C4B<J @JD@A["P1!BFD&14J83AA6*G<JFN;7
M[=B(:B-Y/76N/]S<?[P$>KX ;Z0'*_'=3T0\1N+T^5,_^/9,2F. UOV8J1^(
M!SI@"@6UUYF2/V(MITD>C0UVCN2O8/,$J</;W<S17^9S^4<QG38/'E*:)2RR
MB3A3'D&,(PI9DF.8,A1AR1C"D? Q0 _T,38F7XMXU@'/(2S=S,4S$>J9BWW!
M\;8(6]0/:0,>ZF90JZ]%SUT[K^U1_PCD2[.,R*HNT)0]3(C""$N>0:25F>2"
M1&:KF5.H8J11+"C6VJF(YE[+8YO5&^& E<X]W/@M7.U3^"P0>IZXCOI[Q18?
MU/6,J.*W[0T63WQ0C68D\>$'NBVRK4DX;E^6Y9+-; KNS6V7)$OS'#$.$T%2
MB#.F((O3U$Q8IO-41T*GCI?LNXHP/B_W6@/(5ADDRCJ!S7PKO-]R[3TJ;FMY
MGTCWS!>GLP4UY+\ 'XOIBWVZCXM+75$,:2]XRS"H,=$5H5U+HW,[_@ZF==OK
MJQEFCZT3HI1A-(@0P1 G.(&$J!@R3A'6"N58*%='TG[S8S-(5O/I5H.MC.ZN
MBP/PG?;^G =*SX03' ]WE\UYN SDFO'"Q\O_<ES]%C_+@9<&\Z<<%[CI-VEY
MRI^N/A7"WCN?/;#%PI9LL@,^W=8@6.6J44A)Q)2&**,,XMA&T^),0T73+!:*
M*^E61,^YQ[&1VD9HT) :3)N5-KRS KE!?YK]@@/:,R&^'Y;NS!D<TX'(- "V
M7A3KA5,+Z[JU,Q@1>ZG5Y&:_%SO&]16S8JD^%:]*WI@/:O90\*FZ-.O LOR5
M_:_YXLHF"/EL/I)5G%*2"9VEDD":90IB;BM:IRHW6VZ2)!GG#'/F%=GGU__8
MJ+P6'U;R@ZT"H-;@ E0Z@$H)8+7H&DOF.4IN&^\>L>^9]</#[A]CU@V\H%%F
MGB(,&V?6#9^]2+..S71CPZOYS-Y9-CQK_E86LKK#/)_=F]96,RNF.J4QCF 6
M91G$-#;;;YDQ2#"E@F4LCJA3V0OG'L?&>%N!P1N)@16Y([V=AMV-T(*"V3.%
MG8FC-U\Y8Q.2H4YW.B@G.6.PRT+N+W;CG4LAYB^SI4W(IHI7FV3\JJIY?#/[
M52T?Y[*N[6-3MJT2*7Q5KV:NLZFQQXP)1C2!)"7&"D-8FK^A&"8DDR+C,8^$
M8SGILV49WPG(U<O3R]2,U*L"2FLEEH#)__52+JM]C(W787+^7$VZN0:7=[^!
M)(HS&",_]NH^>"2ER@R;30W-S>!AFD"6" Y5DD8Z8A@IYG5-9I"A&^0<>J4(
MV&IR 6I=; 1SK<W%JC09L JMZRF#']8Z.>93.'\4W=:F0<:F[^/Q7H?%>TD[
M&]*02UUW809= L_&;'=I/+_!\W*,7HI_O!1E85G\R"K]R3QWLU1/Y23C&J6Y
MBB#-60QQDIME,S?+ILXRQ4EBN%AW2CWJ(</8F':36;.APP4X:IS^;A4!E28=
MDY7ZC)<;L_8\"CUS:A\#T#GK:0<(^TB&ZB/&N^1([8#3L=2I79HZMW:;X>KY
MPZSX=R5OI.FMT(62M4^EDL8P]N5,-HJ'F]^]/"FY4QPL%:GF"&DH&1/6%9Q"
M\S\.-8E1GN<*,>1U[2ZP?&-CVF:5L:V"8*OARGL)UCI6%V0;6H*5F@%KP87Y
M$-QH^AV'MV<*?Y>1/:.V7%#\^ZDZ%T;$=ZI'%Q3?XY7JPG9S1K)?LP58O*AF
M5U<OBX41:8*R+.&41E#%F3&X-4&0L53")$<1DUAB(9%WLM^CW8V-\2MI.R3S
M/8ZG&].&0ZEGXJR3^:XD;1*B,8!K80-G\CT)2O!,OL=['#Z3[TGM#V;R/?U6
M1Y_W7!1[E4FV'MMUC9)+;::JK1LD#6,H1'/(S"8>8LPPY+DPP O%(TI9I"*G
MP->._8^-7"YOKVX.E MJN+S?5 YB5@W_ND^^@^3H"^T/^KX]H*%1]W=Z=L,N
MJ*O34X1A'9S=\-ES:W9L)EQVM2_S:2&^U__=[K5RK@C'*84YS3/#@CF%3! -
M&<H$%R1!6'K%'SCW/#;^:Z24:HA^ 6JQP>^K/SMODMV'Q(WS>@&Z9[8+B'&0
M'%ZM>/6=O^MPY^^>NZL5$Y>\7>T-='0UOCP_3ZO6V?0#F]J<.W>/2C7R4I:-
M++-:\21&AM(BG4!,%8%4:0DCK%+-$$OBW#.$P:?[\44MW/WVY<NG:YM>]O(3
M^'#YZ?+SU36X^^OU]3VX^?SS[==?JU2TGBX_GP%Q].?U!'+?SKJ&V& E-Z@$
M;V2N+7M*7=L%LZ .-I_^A_6>=4!FSS76I8V.@:+LN3"]?+*YN6_YM'BH:]^M
MKH8@2K,HTCGD*,YLO8 $DBS*8,I)JE44Q11YQ?6T]C8ZPZR857.JDA9LQ?4,
M"6T%V(VA@L'6,R6MY-Q#+.3]&B],@H: MG8X;/BGB^Y[H9].+W5CD=WZNS9W
ME=UXKAQL=1&4SVIYJ\T6\W*Y7!3\95FY[^=?6.40CG--A8@TS/)(V(KJU%:X
MTL: D@1QDA =>UW'.5NBL;'1KD)URK:5&Z=6:E,<R*91G6OKKKD 3=W <@YJ
M[?PX[/SA=>.Y00>M9RX<:+R\>3,8QB&Y]7RA!N7?8!CN<G2XAOWOO-_,7DT#
M\\7WNZ5Z_NWY\FF^6!;_7E\*QCQ+DRK?JQ)F9ZNYA R1#))<2YSQ5.2Y4U[
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M/2#5EG81IC!""3%$C#)[()E!3'!,L<J)^5XGR_F230<"=-M7WW#64CJ5I?8
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M_N8P?$Y\TH&/":/!=ZS:V(@5]7[U\+BM/QB[<IGNHB4(4IIR8]=IB3)#>:R
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M5N80(Y5"DJ',GJ^C/,^EH&[)?RZ#S8U[#Q'\G;2@%7=7""NP@_$YF-VVQK'
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M&7ZHU:-Z9[3\JNZ;X(Z[]>OUJEXO*VF(6C:Q0HL,EP6A1$&5%!ABG6)(RD1
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M/&;T!<T)4QG3L,@5A3@A.32;< X13W51:"$3[-SWV6W(N1DG.ZD/#<WV<M\
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MC(66TBL+]U@K4_O:JYJLM@30N\5JL_GECW^(<?3G1ZLPOWIX*':W;?3Z'_]
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M=V%NB)OO4^02IH8 S02(YI +&D.5D%AD"58ZB[PBH'U:G]J7O4_9KLTO-(M
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MG!H?U4:#RFI0F UV]KH'!+D!WLY#@\ X^%3H*(++W1'B8%BZAUL%QW2D *P
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MMJ6I+9U*8XOBO"_-!:6]OD5*3P'<3AY!81MZLZHK8AV*EIY!HW?ITE//'[F
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M-Z'$UBK4J8 $(ZXB,W=&B5=FZ*C63XWI:N=!P_L+L/<?- $ I5.@AJ (T6J
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M ?=[\\9&W:N[I;C7S3;FZ]_;<A0_KM?JM^6]?6<E+RDB&G M[%035X4-L*@
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MR13 N"P ,Y0"R$@A,"*H]%-\/-?XW)BLMB^K#<P:"_W>U+/ ]=/74#A&IJX
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M6(%R4*%2$H$MO].@.8%OQW/C[<[)V8.-7>&_ME)2["ZS]WCXT>X8*(],K>D
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MZ;(W<0ZP=KO)90D!0Q1J34T%"?,[:'_2=L@K-<UY^OUL*2Q2.P6MHC+/2:$
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M#$D$J.+"AF>8%'X)C2<MSXU=6N.RQCI_\>VG</73Q" 01B8#3_^#!+7/^CI
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MV.XRD!4$W124W5!,LVVSQ<OKO/2_/JQTAO(;]SS#.@GE>RWKX<D0K'^;AT5
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M7V%6;X6=K36OG;?*<A8METR'$,E]E#6?6TGGD+.730!X@XQQG:]&F-I?T!W
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M77[ U024CEFEQ*31M?@(!?,6$].9T[^5*K#5D>8^P<L=8L;IAML\*CE,Z%U
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MWX$_>,GB^4+^&>>XJ=!+MG@319T27HM_#9D*KPIS"4Q(7E \W? .W1UZQLV
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M)( 31%UOE3!O:FNV F2J$#4KTLAB"RH%3892;T7=P',\K90@DM6,XAQD.M=
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MJLO(Y,UF3[\MUXD*64=5.)-8<P@VD. 4"4Z84D+AR>@VO?&W)7#<M-VXT<4
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M4RBB3)P[%9KC[R'BNJR9/@8 !]%6!PC<7H03E&378]+,R]H$T"K.0LB%66E
M"8B.F!TW,]YE#74K-#;27+^G-B^G<YBG^P59@E6A)/*.?<!Z6&I9D.1[8/0)
M4'/M>#XB-A\A==PTT'%.;8;25 ?V\3Q$>[E8?NNNRSU,3S(9>Y>0G!!AZ_A@
M\D2\!,VLCU(879Q2L6&$O1_579[L# :I^T/P(^AW_!B]EL]?2WN]77R%V?KK
MV^F'CQ2XB:2- A-8R$HQ#:6P8&K/-!NUE[XD#]O<67GH^5T>RPP-JL$$/#Y6
M+B3W%C^=,_2ZO/NX6*[IT2<O,*XGB$%A+($5)4A WI. C T,4%G)O2\1FK2N
M>9"B+@]86MFM8?32#\YNY)IN\!.TX9&'P+@F)T5[R,SG0DY*DE&HDC#F]F?.
M.^/LV,<DS?;'0?32@R-WC9'KBZ<.-,1EFL+L#7S"Y83+XFT)AG%/:TAC;75/
MS#&*R&A5N<"+:]6A<!OZNCP?.0;XAM)9!U"\SLIOB_F'NJ1J/%8YVTQ5G_!B
M 01Z\B9=32+1VHJU5T^R1KKHG=*Y2=SP3<JZ//\XQAY[N)[ZW&OOYTM$8Y16
MG,D,P+0EI$1N(N,6K8S<\L";&\']\7?L X]CF+_#]=29X7N'\^EBN?$D7,G:
M%8/,DC28+D QTB91&;SFQ(>&T*1ZZWYRNCS2.$H8L9]&^K1K=7 120POV+I8
M/QOVO,JX&4P(OLX,EIE"<:<YLV"XDI[64FB2+=Z6P"[/,8YAY0;36@?&[LWE
MPKJ<*SSQ 8RJ/2NXR(9I[B,#K01+)4I5%"9Q.\DV;,75-5KZ["#3.,V[MS)Z
M-W+/%_//N%S7_HDWAU=/$F2>%$D-H4Y,D8+63Q&)Y<ACG>:&VK8Y@MB-SCX;
MV!S7Y@VCQ!Y,WP/LG9PLSB863JPB:T[VFCG+R98G$"R8C&30N3>0C?.IR<WD
M;U+69Y>;8^-P/T6-W)'MW,:O%W-<KS;3*W&]GB&>?)HMOB+B9CPFU,&8]=#;
M"\-]81' ,JUQ,U* ,T<+#7@(!?2MBOS'3KNV>66?+6P:GH -KH<^]^#-,JFW
MK5838R"A%(5)(<A*"UHP$34PI641I13);9-NOO>3TV>SFJ.<4^RGD@XVSNV%
M-E$@1$!#AEDY12%Z%BQZ@4P&[[.VP%$VV4&W)['/[C.M -A(=1V4X_U2"M:9
M%;^<M]]\2\;T];PR6_^O%TP_PPPWG?%(CM-$IG9SO6^>;WYP[2<G*G&(6D?&
M8R$18#VDUB3NF*6QD1<E>9,Q30UX&?<X>.""OK%UW8$-/HC9-YL9YG?;_)Q/
M+[@NUC-13P1QR6WPC-P5LCE(L/5*20KMT(<L,P^^27Q^7#;'/;8>>)%TC) .
MMHO#C$4*VOOJL,7H-=/@,S'++4NN*&^BPT8#(MMO <U.Q7M"]T[ZVQNLGS9K
MB/A>KCN +$\N!:SS0@HQJJ4"5JM1F/)"2>N+E\D\3<@V.TCO"K*[Z.] R/XR
M'Z8!Q;O33Y]F&P'"['*TW+PLEB=G*KP(:*2'9#FOM\_J](U,\HPA.V:+E$YR
M,,4UJ='=DKYQC]H'!F$+G731MNR!47*%8Q ):=D$3FZ)CH7Y*"WS)6M.3KYR
MODFO^@.&^[4;"=Y"]]M-]-M%#5W Z25,E_\!LU/\G1S?T^5&:G^?KC_^.5_$
M%2XWG?5?S3^=;CKM+^9I.CN;RDI?G2Z7Y"*3#*:KRVLY;TZ7Y#'7N]\JJZ"U
MH=7*:R/?8!P#GCE+FBNCM,28FN046C$T<G_'(T"Z"RB,/4>(^"+Q3C>#81>%
MA#I?G1&Q/+L^M#R[/@166*/ LZAX8=IP0^N<ECT([8U#(XW<:J;0=J\;^99J
M0^RUDOE@,/J7G^[(G!R4?VR^M?E._:VW6'ZH?__Y]M6-YY.57B_FJS2E7YV6
M:?I;6IR<O:9>:ES,IKF>A%UZ/JM%N9#OZKK0ZV3VV:(NR9OLK4ADLV_!;-\W
M_73%XFWFSU]X!V2-V<4O:YQGS#\>,(=[00^8;S;M*X(NB+A!PZL+&B[A#74*
MI?6*&:,-P:_VJ!<I,>ZS=MQ8CU9OL>0/(.%@U_%"\N\W\W),YDGHB+4/ :U7
MFVH/-9%9B4:'B+38<I/I"3?)&,=5/"88[KB.^ZMAY-WQDO)G7Z9DCR&@1+3,
M>*?K>%9DH9 TC$>')<?Z_Q8+XL9#1PX<#M#,8@@Q]:+?%XL3F,XG.:82"Y$.
MF5-(8P2R"#(R#AD+1/+F;D^?>ES#9X\=;\4?H)C[U+N'E#HX4;LOT2(D+Y5_
MI9.OD]. Q10#XS(J&ST([YOD3.^2TDD7_?W7_T!2[@ GYYG:6_G99^OGL%Q^
MI6AO$RI.M.="AQ+JW90Z45B9VH/5,VMUDC*4XGB3O--6U'6RF^P)@7O2ZL/J
MHP.0W3D8^!9[6GM9E&+6;2K(P+'H-+EA7)D J&0R38KZ=J2S$S,V#/!:ZJB+
M'.B#AU$U,[&9=KR>%!N<*4$PYTIFFM81BQ$X\UH7!R@#_=T>>/?2UE\/L\'
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MNFYQ>#@^%JV5U0$"7Z\_XO(!5KP.Y)@J8%+45H="!A8R!2G<&%.$C=Y@DQJ
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MV"2\?X2F<4_KQD#>86IYZN')_C7BVS[YJ+MQR]KQW<!95,RB#BA0DA.2;*8
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MV6:PE$J@+&$P'X)/K$IJ^0A:A^[Q41$]AR'U9$4V@=;=PMYN D92)WSRD$S
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M]TCI!0<]RK&!&.--FH]_H 9^I/?3Q7*^*@+Z/%[\L:DN2YIC!$8@9E::.OH
M-CD)W$LI#<G,U1EZ^111P[1).6.$T9M&FD)7N25>ZIEO-2%5(?'L%;)AA,2@
M'^-]IX($G:+BTEHC>95#M*>(&M83[4_UCV+J1#TT@*EWLWD:?YN^_3.L9\;N
M&-J:WY"88!H%%&GI0YM5QI6G R2C"?,ZDFBK@.I)JEI!U:G*OU\TUYLF!G:-
MMHR4"3QI&G[&-)V5UHS+%,?3F/R.(W0,HA:2@M:J# &FR%&T$MERN,VGZ'"W
M[^ B=7O;L&%2[YBI).8&[-&N;4F9I71O"9B [G_T&/8[4=ILEXA0*@(!,:%(
M4@)_7N>@ZC&2A@W$JEFBGG30 )KVN0"+7:.S5S__EN*W\?3;YS19*VUQ.?Z^
M=@X,IX9(IH#$Y$!@6%KB4/PL6L-D),[7:?M['+G#=*D;V(?O68L-8'4/&[O8
MVBCE2/8@J2I'>92#)3KC6@[*4%S*R:@:<'R4HE8\L'IPF-7030,@>^T6E^\F
MLW]M&=I5%*2LM2CERP9MN;"*@LDR A>&<&9$4*)*C=M>:H8%5T^:GO4M]@:P
M\WM:WG2_N\N)%.@** Q'E)(!"N%@K2VS+H.)W B;A*L!H,=)&M;AKX.BGA30
M )2VQ+])"XQ@-EHI)EI[(@A2#)E:% ZC"7R.')C6G*"--I)4.3'?3\XP_53/
MZ%?UH(4FL;1=:E8H:3$, IV#P T_.S"A='OETDN,?7.EDI['"&IB8SM)V<_B
MYPC)-X"@'0,I7BRV/-UXEKLK.(QJ1S0!_//2%-LR\(9BX*NRB%(RHU,5'[P#
M;:WAZA@0/(CX^M5( R![/RW=>J\+HCZ4/]@MPL!Y<#Y&,"7#*\H'] 4D!!J4
M#T[J2I;J"9J&Z;=\ULM._>BC76AMUZ$V5&H:*#CI/!1C#Z4^%R++U$=J\9\J
M3M635 U]C:0GW7?#U!&*: !5KV>+Y<=<1M3LBC$HQBPD$@_,8\0B',:KUK$,
M*D2OLH[)\SII@ON4-(F>8[1\/TUPDL@;P,SNY.#MG]_3=)%V13S2JN"X <XU
M>@+"A#)?-X&-(442&+>TRLV.O=0,?:.H%G9.%WUC_<=N[?8?KB<M<,$,[O@6
MM*1EXE%D8!7N^#HK2JS54=T_F>G4C6S?NSH!Q;Y #ZB*L!LP/D]T:_CKO PV
M<CDGA?\!C\2""!H7&E$1 PAEHPPZQ7CN'E%KPMKI@G<Z#+IW@CI<)VUC["*$
MU=5JL@Y:KV;SY?A_URH<*0Q%2U=!D"F61EJEA387' *QA+*@C+-5[M<>3NIP
M'?.&Q&$?>CL<F7:#S&GZ5E[\M3> [L2V65TJ!A]SSF#+'B%L(!C,> K:R.QP
M]Y=25"EDN$/%<'U3JL/J>&DW8,MVQ+^_^N[&^/I;"V'SK8V'6B8"1F/X^GB2
M.V1,!PV>Y?6P%L:$]IG0*O,\.U,XW$79LT&L7RVU8[">N=O^]L_M4+.='$8A
MI<28*?< !;*)41)X1P-@A.2RT?%A?_.S-.1Y0.AP5RNJ8[*JSAJPC#<+Z^&L
ME(?,,16]HH(!BQ1C,%QIX(7&+[F.7A+*>9V;%P=1.5R18'TT5M-6$TT%=I1_
MGDTF[V;S?[EY')7^Y)D0A:X%!DRXGBP8S='QR,*;8(S(INH\NENT#%<E<;:M
M]UC)-V#)KF$O0^;46@,J)(EF."8PC#I 5F(.R7&;J@XJ:V-(R-&:? 09!XGU
M:#A\3_/Q+'Y9NOFR5U!\G;OI8E.A=C&-GU;S<.D6"1W,,C^Y#%*._V^U&S6/
MKJ4A*B4@#F-@00(R6K;QK)R4BIC 397+JT?0VL94K;ZA5DM9#1FIB_#/50EQ
MWJSF98KQ&O6C&(QB*67(LMP YUYB4(U!3I"ELC$IP5W5V',?4</>^ZF%L)/%
MWQ"41CG20 )-$!@79;XL15E0!CHI;[6B7.NJW3*'[<U0;;\[1*PG[G=OI[%"
MFNLZ6\*5]T$81#+EN','%@$9X*C/Z)T@7')7)2V_GYSARJW.G, Z2OX-&)9U
M>_;7LRM\_V6:+M:7C\I1?N'E]NV.='T1*>79/'U.H?1E+',5=UOW5_?G2%'&
M&3,92"IMW"U3X'-"663<FTNS=Z:K;&J]<C'< 7EUS ZG[5\'ZH5SF9SQY7ZP
MY0SW'"LU6%SO$$NE+LDB6Q8;QGE7D-_4T/P[HOQ01?\Z$+_(2%)A/T;M$S$$
M:!86?2OEP!HM@0C!0PB22=\RSG=\= /[RZQ$&5+EC2/^P;W";MN:X<1+GP/$
M,@<<73D&AF@/SC.IK4F1UNEGUC\KW7#_,BM?!E9\X]"_Z26P.2E*L?SB;(KR
MP%^:)[=(;]+FWXU(;J79BB@<\5E@2 PB2@\82"?P5'(@D3A#0N L5HDB*_+4
M;3&\S'J=5J#P"Z^*ZPTRAXB1?.! 0SGSS[$T]J:B3"'P4AMGI*Q2;5N;L6[K
MXV46&S4%B@86R>9"3I'Q O>^+VG^8QS2XLML$D<Y!\&THRA79DJUE0&;+0?%
M&<]!)^I9E:&;CY/4#9@OL^*H)T4T *F#XY#[3MAF<97%Q(S 59C0\0JYA" D
M@;,FX[9#,NXVA(I<I?"H/Q:Z0?9EEB4-I.A? >+KG<(R:W,9)Y2H+LV1,+ZF
M7$/VR5J,/UR.5>QK'\1W@_7++(HZNW)_!4!?^S]>$AFM4I!#.?4BVH!/)(*,
MC"2EA?1<-XGJP[S?EWE2.8R:&\#WO;O#(R6]IL$0,*GT0,@"/S,V &,\6G3@
M@S.51D+>H:,;UE[F">,I(F\ ,3T%BK="Q!MO)VD5@Y*X>$SI,<QP!7GA$NCH
MHN%"\&S/?CA^(D_=2A)_O5/$<T+AEUP5ZY,F$S"(+>VSK$3EZ%*XE54$@TJC
MPI0^CV?WA(_FIMM*^/6.&,^C_E]R#=PD#Q6EC@H!B9<]4C(-/O, ,;I0.ISR
MZ,[N/)_&4K?5\.L=/)X1"*TLB8_?T]PMUXT,BQ2V?M_O:3GR1%HJO0+O%$?7
M3Y=YWE2"Y$XJSSUEHLK5G*?)Z@;-%WP,V(]"!FZ:M)NKB\O'CS?M-\O$#N0*
M98R?+<9QS671VKR,%5HOI,_ELX_YXVI9.%_\CYNLTM_&WRY1$IO;DI_FX]E\
M%Z*,LK#E"). W=P!2.B%4<N *1*%$2IG?\\AW]MTZ1RT=D/MRSJ<:U+/O>'^
MO__R0%4HKC_6/UK_I/S5YY3_H_S[]\_O[SS?SQ9+9#Z,\4]+%N:_D,_-:[9=
M8R\";C+CY3@5=;QSX_E:!K_AQK*:;V1TEZ'%^.K[)#T#YN[/_LL-&_<9W+[B
M ?QZ9RG]N4Q3W&'_L\(HG8MI?$#5F_$B3&:%F N_6,\.&B4FH@J,HAA#WG2F
ML"R6TB$5K(BEMTX5Q^T$FD]N%+53S,VC%]?RL)Q&M9YHG W*@V0+-J$3@ZX^
MT8Y8$F*5<0E/$=7@3)<*Z'K0%ZHO-37@9N[CY2NN_E?X2W^,@B%,I"0@JIQ*
MHW<*)C@//''M*.$JF#K-[YZB:EC0]:?\#J@Z3A.M;[-[]Y_.&]6GV62,#SUF
M#^[IQ;UNT#6$T=/N_234,Y,$46X@F)#*K$ &+ICR&6,\1^?1C@Z['9W \"T1
MKR7\<_/Q9CE:FC7+0H L@9XP94"F(+SDF$GTU*=09_A59PH;-I*'(.=1(]FK
MAAK8AV]\F<5]3IS461JN@>F@2D_)TNA49T1',"8GZZRJTK?G<9*&;991#5P]
MZ:#U[;?SYK+N%ETUUMV^89B(=Q][#<2]GCEO,_IWGI=$HA:FG-HD,!H#%"=I
MC'7FN@P8]]Z\>M.@W%E/&%,.2' 61$P<K(D)++$TEI9KE%8YO+Q'Q\N-;@_!
MT.-6\'!E-+61WHCM\WCQQWI.BXW<*.<"E+8F)9/*P<4RY9HF:X@,DM7I"_04
M4:V@[ AM=QBY?)3HFX+1GCGI+J3L%+% #$=>I+;@2C\WIXWD3$E/=>74Y$.B
M6H'1J:I_%%,GZJ$I3-V<[1":C41*H;3] Q&L Z<8@QB\4%P$P6R5^]![:!G6
MJZ]CB(X3= -8V8US^9A_GQ45N,G%56G:MUB?S"V6Z-2N!RCN&/TT6XS74X/7
MTKL)7'S@1G#.(5GE0; R)\BQTG' ZV 9]U)6253T1'\K5NU(',V&5VI36-[K
MT^X*X]]/KT=<?<SOQE,W#6,W^93F>3:_PB]N"2"ZE)C*'+P5&(XSJ\!:='>I
M-)1C/$XSJ6(U>^>D%9O;-[Z'4/2@C;=+O<633"\OW?+*_?2W^F.D6%1R\?'U
M^^7LK9M/<>TO_C5>7HZG7_^5)C_2;^CQ7-Y?^ZB!&+U*D'AD(#*C8#)J"LT!
MMZ6':[3W9@KOK:LY!ZW#=CSM"]Q-:K8IJ[ZNC+N5/,7-[<E9S(OKY;_8O_XO
MIO'FV]L]\,-L=Q/PCM"4U38IM-1>*@J"$/00LR<88"#B+?,LYBHCMIO@?MA^
ML?5VCY<"J*96X5X;]<A6NQ7!=5K\AGWIO=19)]#.EI":.? B)\B6$4%ELHQ5
M26WTS,<P<W0&\JNJ*KF)<29/'OGIR(T)44%D*H*P48-UAN*7/ 6,AURD5;:
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M@)V;K.0=+M"*Y^@" T5"&<EJ+8I$2N",&TJ8%TS5/?8]'#W53C?JH*<'P3<
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MP%!91$:)47Z5RHS:C'5;)2_Y7+,I:#2P5.YUR1DE3HTCT:(;Z(H;B(O<JZC
M1R\"_D"G7.5JS#TZNMU9>,GGDZ<(OIT\X<>][6_0 QM9$K01,@'7*I0K: HL
M]0*XPM60J&&TH@_Q*%G=</7BSP+[44L#YJDG<WW+4-^D*UT@FE#F@3')T>%/
M&/NFS"%X7?HVZ>1XO;99=7CJ!N]?]=SOG(#X)==&$8(U7G)B/83@(BHGA%(Y
MB.*@,6>IB.$AOXQ5T7D]O.23Q^%!\$NNA!MW7G"5=" 0?:D&X,:LFVE!*EV_
MI=(8%E>Y:%F/I6YKXE<]TCPC'!I8&/=3G>]0'>5:UW;*P2<4QBRB6_@Q(W,7
MR^5\[%?+TD'BZ^S36ILCD2(/+@4(6N'ZCXZ!88("4]:R)(3+=?!_,N7=8/Z2
M#S?/J]P&T'SO=LW>\ZVOLU>W$OPIOEG-,0SZ/?VYI.RWV71YN1@%P2DI,0^1
MI9>=$ 0,)0E\<(K*%$A,5<YY^B&_&ZY?\IGF &H>O''E3JA_7Y3!N(^?8"UG
M_AF^2Y"O+7$Y&PU!"HE.FZ1@5;D'E"G&,1EC'',O/?U(P\M>R>J&W)=X*CFT
M#ANPS7>F\1ZW8@O7RF<3?+E8@:L6A/(>G),9XW ,.JC@T<GZTY./)K\;PE_R
M(>, :FX W/=VI'5;/Q>*7N]6%JR[(##.7#8$6':X;GF99.XYBC@;W(,R>EJJ
M2M[[ !J[P?0EG_+54MC ?@(NG;!E*6V'5']#?B;(STA'$YAV&4S,MNP7N;3^
M+E\*XBV35MWO:;=WSW_B%=UZ/+W$,[D^9=N N=HKJ??3M9U>;"9E7BS?N?'\
M?]QDE4:&9LN<5&"T0.Y,C&"##. \1R<C,1M8E6DTAY'9#7TO^>2NHMI:!>6S
MO3#6;-_A6E 5)*,@$]$@I. HVX">@TA4\B"8#U6"]W[([P;BEWP^-X":FP+W
M-0L?\\TWU^R-K"9.JY" >(T\>1'++J( -Q=N2)D5%"KWE7J<N&[ ?,D'9;VK
MJ"G8[=DQ;@V9O;VRT-N3T3L*-$1D,5)T=[-)H%Q4V@1+%:G<.;0SK=U ^9)/
MJFHKL%6,/KLA['C_>9OSA!%9*"WS$RUN>$ /W#NG@5N=.9-E$'.55A3]L= -
MT2_Y4&H@=3<%]+T;S#6+(Y*M$MQST$0F0$%K\%HQ2+BL57!4V=H6^&D"NX'T
M)9\P55%5 Q"\YF8;+4[CG4GS;K%"FCY./Z>2Z< 5B+_P^VPZWWWYRBW&B\T
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MW<">N2> 9SH0#*=MN<-!-\VL'$L1%2T(IU0@<V<XE&XS*7:0=I]/BATBZN;
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M=[^_T]XX?._#VP/$\;J;]2G(!JS,GH6"AC<+% AX2U >D0=PI&06HD?'#&,
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MVS*$=X%J^OB]**N8^!$A23,?'"Z>@)XN925(YA*B);YTU S1=>DZ]>R+AFU
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M_MWTV]KR+T:2>$J"EI V57AEA);+ 25CI4Z>YTQIAPUN[\.'"P%Z1D$_XFO
M?-PJ"_YMO AI@MM^FJVNX<P9AB391:2?86 <'0,;2ZVPUD(180,Q58Y"GZ%K
M.#>\DCGI4P]MP6K'0<HQ>.DR&&UXJ>G-8),D*"SBDD;AQ(J5B(?O157*_NN#
MYQAI'X^761F]T@=>[EQ511]M?5OUYH;J[VDW'.U:7C)3)JD4P*U'-PVM+5@9
M+0:SRI;&TX*%*L?I!U/Z,J[4G5)%5E=Y362Z=BS></77^6QQO=JBHC%*%8&S
M7!:O1>N<.6+'**N(Q&W?5HGMGB9KV#/ZRJAX!(,]**B![?.B3#0NZ_7=;/YF
MMO++O)H\Y'#'7$C2T8AF/HN26)-9@LE.0B!4.ZTPEB55SDX/HG+8<J,S@[&:
M^@['IMU@<YJ^E7ZLY]VL1\ZHF#519="? X&;"-A@,"P.*CHJJ1*V2A*B,X7#
M5I8,8R+[55L#SN-OLQ]I,Y>M9/ VVMNMP,7F2"+-?Z3%Y]ED@BOR7VX>1P[C
M\"0T@>P)*8TS<=$IG2!0SGG4P2==Y3C_"%I?QM7X4QS(V@ILPH5\FK6M>$>$
M832?&0.E(BW-3RP8:P(XQ36ECBHCJHP3[43=L YE=93,:BOL:!Q^7\^[^;)T
M\V6E<.;U94EAOI_^EI:7L[AI"/L!'>BW?WY/TT7Z7&;Q+-QD9%(N>6P*%E<W
M"*8XF)0LD.1<IIHQ3\-Y(IV.% _K=YX;L^=1; ,1TM/BW Q<B5]G9?ATZ;6R
M879D4UQW[0'OBSOC','/E <39$Y1:VIBE:OX1U$[K&_:EK7M0Z'-H_9-BJM0
M?KH8,4ZE],D#BY)C3&C1%Z?. 3I1N-=(SRI-VNU*X+#3[=O"YI%J:R*4[^;C
MQ.+!ER,GJM:56\2!MQ@9LAA-%B)[8ZML^OTYI=7F[;0%Q6,4=J)3^G;:#Q*O
MFT+^GF[2'30$:XBCP(3S('B2X)/*P'@4M Q:5[I*7GT?,2^C6=@I8?C)*F@B
MSK[FXMUX.EY<IOC7V2PND*6/>;=,1BQ3J03E8+DJ?48#>@S,4G0; F6ZS"QF
M51J#=:!MV!C[= @\AJF>M-& $W?-TC]F\S_>3S_-9VB$[[%$"3$Z& 9$4Q29
M1&G9,KM1)6.9(]QF6Z719@?:A@V(ZP&L)VVT!+#/[E^_H:LW'[O)/8ZBDP'M
MN8>0#2X9+0D88S,(ZU!Z+#COJJ2OGR=MV*BU'KSZT45+Z$(N1DXEKB7'J+E,
MMQ-:1_ ":?<L)6^<ER%7B3-O$S%L+%D/,8?*MX&3M$=[%-\6#HE).L,-,*\L
M""4,N) "F,A-CA'YTE4.=;L0]S+ZJ9[BI/>NHB:<]@]N&D<I(MVA4,W7<;$,
M8"V1P&5IQ"ZM2Z%*>_SR\F'=[OZ5>G_4WZ'R;6"C>K5"F8VGWTJ"X_W5]_DV
MT[)8%W:-1.F,3G$-R5 F7\:DP'BB(%H1I&<A.5NEK?B35 WK6U='47\:&?CF
MR[5DWJWFT_%R-4_KR3A_EL^VW*1,'=%EJB$OU\ 8T6"5#1 =IT)8G46\=_%A
M[S68Y]\TK,-<#3,5Q-R 32J3+Y?S3;I_'6Q^0TZVK.2H0Q#&@(X\HI28 Y-]
M $64,9YK$W25+/D3- WK6E>W1WUIHP%@/2JK#3?,*2D2.HL^Y(!;=TK@#(O
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MP*[XH/SC%BLIHQBLL6!C+JRD",Z$ "0JQYT@5-LJ?1B>H*FMW$7/N.I+%PW
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M3Y'>+]/58B2]8=J5#D96<.1,4[ >W3Z>C,,0T@=#NDR6.>RMPYS,GL'45%9
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M]NO)QT^?\G)&8?GJ1)LH+C(?,^@2367ZY^ MJGJW**9L4\)!#0<['][1?'2
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M0<!8%IP8"+_7IKLW%YL/44J\>%0GF1 +9E%;H.HRD5>5VC-!813-9&5$T6H
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MPJZ_!32"A=?X78^>&[;Z=17>1RUG]O8J:[P1[,:G?T.A>U?BT?\!4$L#!!0
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MIWI4G]]S8:6NFT+B&(L)3JBLC$YCND3]4&F*3DNM/%9H@B6P K-G3*+/"5^
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M!4\@_)E:O^6Z\^PU&E[XS%\8-:^N]OX#4$L#!!0    ( '6$!E/D"6[M%P8
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MKB@ $               @ $     8G-X+3(P,C$P-C,P+FAT;5!+ 0(4 Q0
M   ( '6$!E/B'\U[714  .3C   0              "  <H_ P!B<W@M,C R
M,3 V,S N>'-D4$L! A0#%     @ =80&4\KO7F8])0  BW$! !0
M     ( !554# &)S>"TR,#(Q,#8S,%]C86PN>&UL4$L! A0#%     @ =80&
M4R4:D:F*HP  W?\& !0              ( !Q'H# &)S>"TR,#(Q,#8S,%]D
M968N>&UL4$L! A0#%     @ =80&4]Y8RLT>-0$ EB4- !0
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M;S,P,G$R,C R,2YH=&U02P$"% ,4    " !UA 93)GE>A0P&   5*P  &P
M            @ $%*P8 97AH:6)I=#,R,2UC96\Y,#9Q,C(P,C$N:'1M4$L!
M A0#%     @ =80&4^0);NT7!@  HRH  !L              ( !2C$& &5X
M:&EB:70S,C(M8V9O.3 V<3(R,#(Q+FAT;5!+!08     "@ * *@"  ":-P8
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
